Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.794137007358938,-2.087325199900174,0.0,0.07305063408516184,0.07,3/12,2.29%,FOXP1;SMARCA4;NCOR1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.8950268899442402,1.990764049968234,0.0,0.0,0.0,9/22,2.45%,CD22;LGALS3;FCGR2B;DGKZ;CD300A;LAPTM5;THY1;PTPRJ;DUSP3
prerank,B cell receptor signaling pathway (GO:0050853),0.8537569854472691,1.9895831913634479,0.0,0.0,0.0,13/32,6.25%,NCKAP1L;PTPRC;BTK;BLNK;RFTN1;SYK;PIK3CD;PLCG2;TEC;LAT2;VAV3;NFAM1;PRKCB
prerank,regulation of T cell proliferation (GO:0042129),0.8162899977707166,1.9876074646469895,0.0,0.0,0.0,18/61,9.89%,NCKAP1L;PTPRC;CD86;LILRB1;GPNMB;LGALS3;CD3E;PDCD1LG2;NCK2;TNFSF8;CCDC88B;ANXA1;AIF1;CD80;CEBPB;PNP;TNFRSF21;CD274
prerank,positive regulation of interleukin-12 production (GO:0032735),0.8515124334849191,1.9783487061000566,0.0,0.0005122044183671607,0.002,9/31,5.89%,IRF5;SCIMP;SYK;LAPTM5;PLCG2;TLR2;MDK;MAPK14;HMGB1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.8840561431170592,1.9778387002043027,0.0,0.0004097635346937286,0.002,7/23,2.23%,ARRB2;CD226;LILRB1;SLAMF6;KLRK1;NCR1;CRTAM
prerank,neutrophil chemotaxis (GO:0030593),0.8142347663344675,1.977799887333898,0.0,0.0003414696122447738,0.002,12/53,4.10%,NCKAP1L;PF4;LGALS3;CXCL5;PIK3CG;SYK;ITGB2;PIK3CD;CXCL2;CCL8;FCER1G;PIP5K1C
prerank,regulation of immune response (GO:0050776),0.77568872669356,1.9751897683010833,0.0,0.000292688239066949,0.002,33/135,6.65%,SLAMF7;CD300LB;CD22;CD226;TREM2;LILRB1;ITGAL;TREML2;FGR;LYN;SLAMF6;KLRK1;IRF4;NCR1;TREML4;CD3E;SYK;FCGR2B;ITGB2;ADCY7;PDCD1;TREML1;CD300A;ITGA4;CD200R1;CRTAM;FCGR1A;LAIR1;CD300LF;TRAF3;SAMHD1;TYROBP;RAET1E
prerank,positive regulation of T cell proliferation (GO:0042102),0.8101102905613834,1.9638896646896655,0.0,0.00025610220918358036,0.002,16/55,8.32%,NCKAP1L;PTPRC;CD86;CD3E;SYK;CCR2;PDCD1LG2;NCK2;PYCARD;CCDC88B;IL18;HMGB1;ANXA1;AIF1;CD80;PNP
prerank,negative regulation of T cell activation (GO:0050868),0.8464570456331243,1.9608404393172387,0.0,0.00022764640816318256,0.002,15/35,9.89%,NCKAP1L;CD86;LILRB1;GPNMB;LGALS3;FCGR2B;PDCD1LG2;LAPTM5;HAVCR2;DUSP3;RIPOR2;CD80;CEBPB;TNFRSF21;CD274
prerank,neutrophil migration (GO:1990266),0.7971932537353879,1.9582654173007776,0.0,0.0002048817673468643,0.002,12/58,4.10%,NCKAP1L;PF4;LGALS3;CXCL5;PIK3CG;SYK;ITGB2;PIK3CD;CXCL2;CCL8;FCER1G;PIP5K1C
prerank,regulation of interferon-gamma production (GO:0032649),0.777602457176962,1.9535348801280423,0.0,0.000186256152133513,0.002,21/71,5.89%,CD226;LILRB1;SLAMF6;SLC11A1;CCR2;PDCD1LG2;SIRPA;VSIR;LAPTM5;CYRIB;HAVCR2;CRTAM;NR1H4;TLR7;TLR8;IL12RB2;DDIT3;PYCARD;CD14;IL18;HMGB1
prerank,positive regulation of interferon-gamma production (GO:0032729),0.8060200626742262,1.9525736935140412,0.0,0.0001707348061223869,0.002,13/48,5.21%,CD226;LILRB1;SLAMF6;SLC11A1;CCR2;CYRIB;CRTAM;TLR7;TLR8;IL12RB2;PYCARD;CD14;IL18
prerank,regulation of interleukin-2 production (GO:0032663),0.8149260394749678,1.9441518856914926,0.0,0.00039400339874396984,0.004,18/43,8.54%,RUNX1;PTPRC;CD86;CARD11;IRF4;CCR2;IL1A;LAPTM5;HAVCR2;PLCG2;PRKD2;TRAF2;TNFAIP3;ANXA1;CD80;MALT1;PNP;TRIM27
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.8322939512674286,1.9397105873074254,0.0,0.00036586029883368623,0.004,11/33,4.08%,CD226;LGALS3;CARD11;DGKZ;CD300A;LAPTM5;THY1;PTPRJ;KCNN4;DUSP3;PRKD2
prerank,positive regulation of T cell activation (GO:0050870),0.7976545941365082,1.9382476720762234,0.0,0.0003414696122447739,0.004,19/62,8.32%,NCKAP1L;PTPRC;CD86;DOCK8;CD3E;CCR2;PDCD1LG2;SIRPA;CYRIB;THY1;MDK;NCK2;PYCARD;CCDC88B;ANXA1;AIF1;CD80;PRKCQ;PNP
prerank,regulation of phagocytosis (GO:0050764),0.7980050625830373,1.9347821001323133,0.0,0.0003201277614794755,0.004,14/53,4.91%,PTPRC;DOCK2;TREM2;FGR;HCK;SLC11A1;SYK;FCGR2B;SIRPA;TLR2;CAMK1D;TNF;FCER1G;PYCARD
prerank,regulation of interleukin-17 production (GO:0032660),0.8395714878186534,1.9345244294458932,0.0,0.0003012967166865652,0.004,10/31,5.21%,NCKAP1L;SLAMF6;LY9;TGFB1;RFTN1;VSIR;NR1H4;OSM;DDIT3;IL18
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.6009855528524481,-1.9295507174464372,0.005847953216374269,0.3256474049579503,0.467,10/25,13.64%,CDH5;BMPR1A;FOXD1;BMP4;SULF1;ZNF423;ACVRL1;SMAD4;CCN1;UBE2O
prerank,regulation of immunoglobulin production (GO:0002637),0.8659039815631665,1.9291162309833507,0.0,0.0003414696122447739,0.005,5/23,1.93%,PTPRC;CD86;CD22;FCGR2B;VAMP3
prerank,positive regulation of phagocytosis (GO:0050766),0.7994516866309597,1.9251695228362604,0.0,0.0004313300365197143,0.006,14/47,5.14%,NCKAP1L;PTPRC;DOCK2;TREM2;SLC11A1;FCGR2B;STAP1;SIRPA;PTPRJ;CAMK1D;TNF;FCER1G;PYCARD;CD300LF
prerank,granulocyte chemotaxis (GO:0071621),0.7905239409470779,1.9228274099553353,0.0,0.0004097635346937286,0.006,13/55,6.22%,NCKAP1L;PF4;LGALS3;CXCL5;PIK3CG;SYK;ITGB2;PIK3CD;CXCL2;CCL8;FCER1G;PIP5K1C;ANXA1
prerank,regulation of interleukin-6 production (GO:0032675),0.7522218561441901,1.9205495946706947,0.0,0.0003902509854225987,0.006,26/96,6.64%,NCKAP1L;TREM2;SLAMF1;SCIMP;SYK;CD74;SIRPA;IL1A;LPL;POU2F2;CD200R1;TLR1;PLCG2;TLR2;DHX9;TLR7;TLR8;NLRC3;TNF;IL6R;TNFAIP3;PYCARD;RAB7B;HMGB1;AIF1;TYROBP
prerank,T cell activation (GO:0042110),0.7791133508612839,1.9203015691751648,0.0,0.000372512304267026,0.006,18/69,5.96%,PTPRC;TREML2;PIK3CG;IRF4;CD3E;LCP1;CD7;CD74;LAT;PIK3CD;CRTAM;LFNG;MDK;NCK2;NLRC3;CTPS1;CD44;CHD7
prerank,dendritic cell differentiation (GO:0097028),0.8743967244479515,1.9191271494728523,0.0,0.0003563161171249814,0.006,6/22,1.17%,BATF3;TREM2;LILRB1;LYN;IRF8;FLT3
prerank,regulation of B cell proliferation (GO:0030888),0.8014947799712067,1.9168696396541427,0.0,0.0003414696122447738,0.006,13/44,9.54%,NCKAP1L;PTPRC;CD22;LYN;FCGR2B;CD74;CD300A;VAV3;TYROBP;MEF2C;RC3H1;GPR183;TNFRSF21
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.8991194237889159,1.9162705482948283,0.0,0.0003278108277549829,0.006,3/16,1.90%,PTPRC;LILRB1;CYRIB
prerank,B cell activation (GO:0042113),0.7706505874997448,1.9113255349220868,0.0,0.0004334037386183668,0.009,22/68,10.06%,PTPRC;CD86;CD22;BTK;BLNK;FLT3;ITGA4;PIK3CD;TPD52;PLCG2;PTPRJ;LAT2;CTPS1;HDAC5;ADGRG3;NFAM1;PRKCB;KLF6;MALT1;MEF2C;GPR183;HDAC4
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.8343135127563215,1.9100738346951585,0.0,0.0005311749523807593,0.012,13/31,9.89%,CD86;LILRB1;GPNMB;LYN;FCGR2B;PDCD1LG2;CD300A;TYROBP;CD80;CEBPB;RC3H1;TNFRSF21;CD274
prerank,regulation of B cell activation (GO:0050864),0.8552701016809096,1.9091642780405609,0.0,0.0005122044183671607,0.012,8/25,7.29%,THEMIS2;CD22;FCGR2B;LAPTM5;SLAMF8;TNFAIP3;SAMSN1;SH3KBP1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.9710837577496033,1.9087786755265725,0.0,0.0005298666396901664,0.013,5/10,0.98%,ARRB2;PTPRC;LILRB1;CX3CR1;FCGR2B
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.8916238402883846,1.898034332048883,0.0,0.0011951436428567085,0.03,6/17,2.45%,LGALS3;DGKZ;LAPTM5;THY1;PTPRJ;DUSP3
prerank,regulation of interleukin-12 production (GO:0032655),0.7759378024733303,1.8940990394938293,0.0,0.0012557269611582008,0.033,11/47,3.07%,SLAMF1;LILRB1;IRF5;SCIMP;SYK;LAPTM5;PLCG2;TLR2;TLR8;MDK;MAPK14
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.8291304223120349,1.8899750768581787,0.0,0.001408562150509692,0.037,9/30,3.07%,PTPRC;PLD4;SHH;MEOX1;TGFB1;PLEK;FLT3;CSF1R;SP7
prerank,regulation of mast cell degranulation (GO:0043304),0.9141757249586929,1.8844214682805982,0.0,0.001645262677179365,0.043,6/14,1.56%,CD84;FGR;LYN;SYK;UNC13D;CD300A
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.7688361437013351,1.8828509948067471,0.0,0.0017173912851134213,0.046,17/63,9.89%,NCKAP1L;PTPRC;CD86;CD3E;CD74;PDCD1LG2;NCK2;VAV3;CCDC88B;IL18;ANXA1;AIF1;CD80;MEF2C;PNP;GPR183;CD274
prerank,toll-like receptor signaling pathway (GO:0002224),0.7464642584175425,1.8806185068209387,0.0,0.0017561294344016942,0.048,30/84,9.38%,CTSS;BTK;SCIMP;RFTN1;CTSB;ITGB2;LGMN;MAPKAPK3;IRAK2;TLR1;PIK3AP1;PLCG2;TLR2;UNC93B1;NR1H4;CTSK;CTSL;TLR7;TLR8;SFTPA1;SFTPA2;UBE2D3;CD14;TRAF3;HMGB1;TICAM1;CNPY3;LY96;MAP3K1;ITGAM
prerank,T cell activation involved in immune response (GO:0002286),0.9360068242846321,1.8794795282537635,0.0,0.001735803862244267,0.049,7/12,3.96%,LILRB1;ITGAL;SLC11A1;LCP1;CD74;MDK;FCER1G
prerank,regulation of T cell activation (GO:0050863),0.7899462900750662,1.8792299505408203,0.0,0.0016888902443457734,0.049,17/42,12.11%,GPNMB;LGALS3;CCR2;SIRPA;LAT;LAPTM5;CYRIB;CRTAM;THY1;DUSP3;TNFSF8;PYCARD;CCDC88B;PRKCQ;CCL2;TNFRSF1B;METTL3
prerank,positive regulation of leukocyte migration (GO:0002687),0.8396806784264407,1.876577586485873,0.0,0.0016983620187963752,0.05,8/27,6.36%,NCKAP1L;LGALS3;ADAM8;THY1;MDK;TNF;IL6R;AIF1
prerank,positive regulation of interleukin-2 production (GO:0032743),0.8517695552269966,1.8747731228369042,0.0,0.0017598818477230652,0.053,14/25,8.32%,RUNX1;PTPRC;CD86;CARD11;IRF4;CCR2;IL1A;PLCG2;PRKD2;TRAF2;ANXA1;CD80;MALT1;PNP
prerank,positive regulation of interleukin-6 production (GO:0032755),0.7457555922348648,1.8712319029949256,0.0,0.0019207665688768527,0.061,19/68,6.64%,SCIMP;SYK;CD74;IL1A;LPL;POU2F2;TLR1;PLCG2;TLR2;DHX9;TLR7;TLR8;TNF;IL6R;PYCARD;RAB7B;HMGB1;AIF1;TYROBP
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.7524327137010896,1.8697820175196882,0.0,0.0019988465107011154,0.066,32/73,11.47%,NCKAP1L;VAV1;FGR;LYN;MYO1G;HCK;SYK;FCGR2B;PLCG2;PRKCD;GRB2;NCKIPSD;PIK3CB;VAV2;ELMO1;FCGR1A;WIPF1;FCER1G;VAV3;ARPC2;PLD2;WIPF2;ACTB;ARPC3;WASF2;ABI1;ACTG1;ACTR2;ACTR3;YES1;CYFIP1;ARPC4
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.7550688074897669,1.8692767400490702,0.0,0.001975645613701906,0.067,32/71,11.47%,NCKAP1L;VAV1;FGR;LYN;MYO1G;HCK;SYK;FCGR2B;PLCG2;PRKCD;GRB2;NCKIPSD;PIK3CB;VAV2;ELMO1;FCGR1A;WIPF1;FCER1G;VAV3;ARPC2;PLD2;WIPF2;ACTB;ARPC3;WASF2;ABI1;ACTG1;ACTR2;ACTR3;YES1;CYFIP1;ARPC4
prerank,ethanol metabolic process (GO:0006067),-0.7269020124932759,-1.8681242148072787,0.0034602076124567475,0.4359567961869497,0.733,7/12,21.78%,ALDH2;ALDH1A1;ACSS2;SULT1A1;ADH5;ACSS1;ADH1A
prerank,mononuclear cell differentiation (GO:1903131),0.8316887496475323,1.8619967498486645,0.0,0.0022632288253432685,0.08,8/24,2.06%,BATF3;TREM2;LILRB1;LYN;IRF8;IKZF1;FLT3;CSF1R
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.7525802388166808,1.8568671532961285,0.0,0.002561022091835804,0.091,31/70,11.47%,NCKAP1L;VAV1;FGR;LYN;MYO1G;HCK;SYK;FCGR2B;PLCG2;PRKCD;GRB2;NCKIPSD;PIK3CB;VAV2;ELMO1;FCGR1A;WIPF1;VAV3;ARPC2;PLD2;WIPF2;ACTB;ARPC3;WASF2;ABI1;ACTG1;ACTR2;ACTR3;YES1;CYFIP1;ARPC4
prerank,negative regulation of T cell proliferation (GO:0042130),0.8175980437033862,1.8548058434791845,0.0,0.0026634629755092364,0.095,10/28,9.89%,CD86;LILRB1;GPNMB;PDCD1LG2;CRTAM;CD80;CEBPB;RC3H1;TNFRSF21;CD274
prerank,positive regulation of lymphocyte activation (GO:0051251),0.8078736217268695,1.852928865482994,0.0,0.002739180150398295,0.099,13/28,12.42%,NCKAP1L;CCR2;SIRPA;CYRIB;THY1;PYCARD;CCDC88B;TYROBP;SH3KBP1;TICAM1;PRKCQ;CCL2;NOD2
prerank,vasculature development (GO:0001944),-0.634611283088233,-1.852166436718788,0.007692307692307693,0.38483602112936155,0.779,11/16,25.05%,ERRFI1;CDH5;ACVRL1;PDGFRA;FBXW7;STRA6;NOTCH4;FLT4;BMPR2;SOX18;ACVR2B
prerank,regulation of myeloid cell differentiation (GO:0045637),0.7461312930727791,1.8465835632254042,0.0,0.003334777702560664,0.117,22/62,12.33%,RUNX1;NFE2;PTK2B;LYN;PF4;LGALS3;ITGA2B;GP1BA;GATA1;SPI1;PRKCB;TNRC6A;LEO1;DPY30;PRKCQ;MEF2C;MOV10;AGO4;RBBP5;THBS1;AGO3;CDK6
prerank,neurotransmitter biosynthetic process (GO:0042136),0.8933902849638972,1.8432570304925742,0.0,0.003734823883927214,0.134,4/14,3.81%,SLC6A3;SLC6A4;DAGLB;ALDH9A1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.7373845685088236,1.8422737068248305,0.0,0.003679509291127359,0.135,18/73,6.64%,PTPRC;CD86;PF4;SYK;CCR2;IL1A;LPL;TLR1;HAVCR2;PLCG2;TLR2;ADAM8;PTPRJ;DHX9;PYCARD;CD14;HMGB1;TYROBP
prerank,defense response to fungus (GO:0050832),0.8675114781750479,1.8421080495115891,0.0,0.003626407282039498,0.136,3/17,2.04%,CLEC4D;CX3CR1;PLCG2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.804238926273469,1.8411992522899638,0.0,0.0036959063913551992,0.141,10/29,9.38%,CD226;SLAMF6;KLRK1;STAP1;CYRIB;CRTAM;SPI1;TYROBP;RAET1E;ITGAM
prerank,neuron fate commitment (GO:0048663),0.8810257777777525,1.8377650833020645,0.0,0.004117335516874485,0.161,4/14,5.24%,ASCL1;SHH;TGFBR1;MYT1L
prerank,regulation of cytokine production (GO:0001817),0.7147812166380562,1.8328479940910083,0.0,0.004774131748554291,0.186,27/126,6.34%,CLEC9A;PTPRC;TREM2;PLD4;GPNMB;FGR;LYN;PIK3CG;IRF8;SLC11A1;FCGR2B;CCR2;SIRPA;IL1A;SRGN;PIK3CD;CRTAM;MAPK14;TNF;RGCC;CCDC88B;TRAF3;NFAM1;PPP1R11;BTN3A3;ANXA1;PLD3
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.782739216412198,1.8319630725623075,0.0,0.004780574571426834,0.189,7/33,3.96%,RUNX1;PF4;HCLS1;CD74;ACIN1;TNF;OCSTAMP
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.9362352932225741,1.8262495312937097,0.0,0.00543867964229858,0.21,3/10,0.53%,LILRB1;FGR;LYN
prerank,positive regulation of chemokine production (GO:0032722),0.746420429983156,1.8261312514227968,0.0,0.005359853377913504,0.21,13/44,6.36%,SYK;CD74;LPL;CSF1R;TLR2;TLR7;FFAR2;TNF;IL6R;PYCARD;IL18;HMGB1;AIF1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.7479805571428721,1.824940277326556,0.0,0.005427569626206405,0.215,16/49,11.76%,RUNX1;NFE2;PF4;ITGA2B;GP1BA;GATA1;RAB7B;TNRC6A;DPY30;PRKCQ;MEF2C;MOV10;AGO4;RBBP5;THBS1;AGO3
prerank,negative regulation of B cell activation (GO:0050869),0.8240856779502527,1.8224150517348043,0.0,0.005740221929976802,0.231,10/21,10.48%,LYN;FCGR2B;CD300A;LAPTM5;TNFAIP3;SAMSN1;TYROBP;RC3H1;TNFRSF21;INHBA
prerank,T cell proliferation (GO:0042098),0.9028974491097645,1.8218340760150307,0.0,0.0058339215108937645,0.242,6/13,4.12%,LILRB1;DOCK8;PIK3CG;SLC11A1;CRTAM;CTPS1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.8692479312023326,1.8212876299645675,0.0,0.0057537629663244405,0.243,6/16,1.77%,SLAMF7;TUBB;KLRK1;PLEKHM2;LYST;CORO1A
prerank,regulation of interleukin-10 production (GO:0032653),0.7559478318892077,1.8211109240554901,0.0,0.005726613333219732,0.246,12/44,9.89%,LILRB1;IRF4;SYK;FCGR2B;PDCD1LG2;VSIR;PLCG2;PYCARD;HMGB1;TYROBP;TNFRSF21;CD274
prerank,platelet aggregation (GO:0070527),0.7931355439103959,1.8201388882699094,0.0,0.0057499076642507085,0.251,18/33,10.23%,FERMT3;PIK3CG;UBASH3B;GP1BA;PLEK;GATA1;ITGB3;PIK3CB;MYH9;MYL12A;ACTB;CLIC1;STXBP3;P2RY12;RAP2B;ACTG1;VCL;ACTN1
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.8230874988656163,1.8169592124083782,0.0,0.006276536682213463,0.269,7/22,3.79%,BTK;LILRB1;SCIMP;CCR2;LAPTM5;FFAR2;TNF
prerank,homotypic cell-cell adhesion (GO:0034109),0.776829116992958,1.8166214669720628,0.0,0.0061944721846278515,0.27,18/39,10.23%,FERMT3;PIK3CG;UBASH3B;GP1BA;PLEK;GATA1;ITGB3;PIK3CB;MYH9;MYL12A;ACTB;CLIC1;STXBP3;P2RY12;RAP2B;ACTG1;VCL;ACTN1
prerank,myeloid dendritic cell activation (GO:0001773),0.9086417365052522,1.816386058463979,0.0,0.006114932748506412,0.27,6/12,6.74%,DOCK2;BATF3;SLAMF1;PYCARD;HMGB1;TGFBR2
prerank,natural killer cell activation (GO:0030101),0.8198374701358981,1.8158380130824014,0.0,0.006130931674394804,0.275,7/23,2.75%,SLAMF7;PTPRC;KLRK1;NCR1;PIK3CD;IL21R;ELF4
prerank,phagosome maturation (GO:0090382),0.7649754287849104,1.8156224754636934,0.0011363636363636363,0.006070004599754115,0.275,16/35,10.59%,ATP6V0D2;CORO1A;SLAMF8;ATP6V0E1;RAB39A;RAB34;TCIRG1;RAB32;ATP6V1C1;ATP6V1E1;ATP6V0A2;RAB14;RAB7A;ATP6V0D1;RAB31;ATP6V0A1
prerank,lymphocyte proliferation (GO:0046651),0.8324041936368454,1.8142748161748827,0.0,0.0061615178562402576,0.281,6/22,8.17%,PTPRC;PIK3CG;FLT3;ELF4;CTPS1;MEF2C
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.7846617587780172,1.813850612498495,0.0,0.0061316065155257215,0.284,5/33,0.97%,NCKAP1L;FERMT3;LYN;PIK3CG;SYK
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.7455836489984001,1.8135676108602539,0.0,0.0060879153725925395,0.287,25/56,12.70%,CTSS;CTSB;LGMN;MAPKAPK3;IRAK2;TLR1;PLCG2;TLR2;UNC93B1;CTSK;CTSL;TLR7;TLR8;SFTPA1;SFTPA2;FFAR2;CD14;TRAF3;HMGB1;CNPY3;LY96;ALPK1;NOD2;TAB2;LACC1
prerank,regulation of B cell differentiation (GO:0045577),0.8533158773972318,1.8132417174427005,0.0,0.006088739846505405,0.291,4/17,1.97%,NCKAP1L;BTK;SYK;SLAMF8
prerank,natural killer cell mediated immunity (GO:0002228),0.8807433349401699,1.8123158328730435,0.0,0.006317187826528316,0.302,5/15,1.19%,SLAMF7;TUBB;KLRK1;PLEKHM2;LYST
prerank,regulation of interleukin-4 production (GO:0032673),0.8361593042245381,1.8116789686529549,0.0,0.006300815995804252,0.304,8/21,8.15%,CD86;IRF4;SYK;HAVCR2;FCER1G;DDIT3;CEBPB;PRKCQ
prerank,embryonic organ morphogenesis (GO:0048562),-0.48647414000543254,-1.8100436499854737,0.0,0.47808559560313135,0.912,23/42,26.23%,RYR2;NIPBL;EFEMP1;HOXC4;HOXB9;ACVR1;DSCAML1;HOXA3;MFAP5;PDGFRA;FBN1;SIX1;HES1;TBX1;HOXC9;SOX17;RBP4;FUZ;HOXD4;FOXE1;FGFR2;HOXD3;MFAP2
prerank,positive regulation of cytokine production (GO:0001819),0.6949632815856828,1.8056119944999947,0.0,0.007613849462214552,0.356,71/292,8.92%,CLEC9A;RUNX1;PTPRC;CD86;CD226;LILRB1;IRF5;SCIMP;FGR;SLAMF6;PIK3CG;LY9;CARD11;HPSE;IRF4;SLC11A1;TGFB1;RFTN1;SYK;CCR2;CD74;IL1A;LPL;POU2F2;PIK3CD;LAPTM5;TLR1;CYRIB;HAVCR2;PLCG2;CSF1R;TLR2;CRTAM;NR1H4;DHX9;TLR7;TLR8;MDK;MAPK14;OSM;IL12RB2;FFAR2;TNF;FCER1G;PRKD2;RGCC;TRAF2;IL6R;DDIT3;LRRFIP1;PYCARD;CD14;CCDC88B;IL18;RAB7B;NFAM1;HMGB1;XRCC5;ANXA1;CTNNB1;AIF1;TYROBP;CD80;TICAM1;CEBPB;MALT1;PRKCQ;PNP;TRIM27;LURAP1;SULF2
prerank,superoxide anion generation (GO:0042554),0.8735606704000466,1.7944274428855256,0.0,0.010367017427751334,0.459,4/13,2.57%,CYBB;NCF4;ALOX12;NCF2
prerank,negative regulation of interleukin-10 production (GO:0032693),0.8502563843625762,1.793853439334533,0.0,0.010540627767450518,0.464,7/16,9.89%,LILRB1;FCGR2B;PDCD1LG2;VSIR;TYROBP;TNFRSF21;CD274
prerank,inflammatory response (GO:0006954),0.6964397347392172,1.793506811019972,0.0,0.010550080617276844,0.468,54/195,14.26%,ITGAL;BLNK;PF4;CXCL5;CIITA;PIK3CG;CYBB;SLC11A1;TGFB1;FCGR2B;ITGB2;CCR2;NRROS;TMIGD3;IL1A;LAT;PIK3CD;IL10RB;TLR1;CSF1R;TLR2;ADAM8;CXCL2;ADGRE5;CCL8;TNF;CXCR4;CD14;IL18;HDAC5;CD44;NFAM1;HMGB1;ANXA1;AIF1;CEBPB;CCL14;NFX1;CMKLR1;HDAC4;F11R;CCL13;CCL2;THBS1;TACR1;TPST1;LTB4R2;HDAC9;ITCH;IKBKG;NFKB1;ADCY8;C3AR1;SIGLEC1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.705018313514281,1.7931631625734092,0.0,0.01057242453296319,0.472,34/101,13.37%,CD86;LILRB1;LYN;PF4;CXCL5;HCK;TGFB1;CX3CR1;STAP1;PDCD1LG2;SIRPA;IL1A;CXCL2;MAPK14;TNF;CD68;TNFAIP3;PYCARD;CASP1;CD14;IL18;HMGB1;CD80;TICAM1;CD180;MEF2C;LY96;CD274;CCL2;TNFRSF1B;NOD2;DEFA6;NFKB1;SHPK
prerank,positive regulation of immune system process (GO:0002684),0.8548873925242476,1.792252726762905,0.0,0.010646071581757949,0.479,4/16,6.22%,NCKAP1L;PIK3CD;PIK3CB;ANXA1
prerank,organophosphate catabolic process (GO:0046434),0.908003978771643,1.7916641709798653,0.0,0.010666657012496122,0.485,3/11,3.14%,PLBD1;ABHD12;ANGPTL3
prerank,negative regulation of lymphocyte activation (GO:0051250),0.8259458680566218,1.791258076732343,0.0,0.010648793092966654,0.489,7/21,5.51%,GPNMB;LGALS3;FCGR2B;LAPTM5;DUSP3;TNFAIP3;SAMSN1
prerank,B cell differentiation (GO:0030183),0.7492688047948759,1.7900970051729719,0.0,0.010881220692629198,0.504,12/46,6.69%,PTPRC;BLNK;FLT3;ITGA4;TPD52;PLCG2;PTPRJ;FNIP1;HDAC5;ADGRG3;NFAM1;KLF6
prerank,positive regulation of immune response (GO:0050778),0.7243704641429758,1.7883985147616834,0.0,0.011219128103512029,0.52,10/64,4.91%,PTPRC;CD226;LILRB1;FCGR2B;ITGB2;CD74;ADAM8;DHX9;TLR8;PYCARD
prerank,innate immune response (GO:0045087),0.6970923992467108,1.7877919318324078,0.0,0.011329473920549818,0.525,56/217,13.10%,CD300LB;SLA;CLEC4D;TREM2;PTK2B;BTK;IRF5;FGR;LYN;CIITA;PIK3CG;HCK;CYBB;SLC11A1;CX3CR1;SYK;CLEC5A;NRROS;TREML1;CD74;PIK3CD;CORO1A;NLRC5;PLCG2;TLR2;TRIM25;NCF2;S100B;MASP1;TLR8;TRIM5;SNCA;FCER1G;GCH1;OTULIN;DMBT1;HMGB1;TYROBP;CAPZA1;KYNU;MALT1;TRIM27;ADAR;TRIM8;SETD2;TRIM56;YES1;MID2;TRIM35;ALPK1;FYN;NOD2;DEFA6;RNF135;IKBKG;B2M
prerank,negative regulation of interleukin-17 production (GO:0032700),0.9108211924964609,1.7857349902453492,0.0014903129657228018,0.011798779425445893,0.544,3/10,4.80%,NCKAP1L;VSIR;DDIT3
prerank,chemokine-mediated signaling pathway (GO:0070098),0.7424825925771043,1.7836737874753446,0.0,0.012316729502131264,0.564,11/42,11.36%,PTK2B;PF4;CXCL5;CCR2;CXCL2;CCL8;WNK1;CCL14;SH2B3;CCL13;CCL2
prerank,positive regulation of immune effector process (GO:0002699),0.7741001309275928,1.782251300432813,0.0,0.012657925281487308,0.575,4/27,2.32%,PTPRC;LILRB1;CCR2;PTPRJ
prerank,negative regulation of interleukin-6 production (GO:0032715),0.791560138237379,1.7818893418103718,0.0,0.012653777335570542,0.577,7/27,4.82%,NCKAP1L;SLAMF1;SIRPA;CD200R1;NLRC3;TNF;TNFAIP3
prerank,positive regulation of interleukin-17 production (GO:0032740),0.8098603948152476,1.7809420232913504,0.0012610340479192938,0.01285690641159817,0.585,8/22,8.15%,SLAMF6;LY9;TGFB1;RFTN1;NR1H4;OSM;IL18;PRKCQ
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.8791363611904933,1.7804250001847286,0.0027816411682892906,0.01280511045917902,0.588,4/12,1.56%,RUNX1;PTPRC;LYN;CD300A
prerank,regulation of lymphocyte activation (GO:0051249),0.8900083411132332,1.7801863479262672,0.0013908205841446453,0.012743195639376398,0.589,3/12,2.23%,THEMIS2;LAT;CRTAM
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.8229511232246126,1.780126876813883,0.0,0.01262695240061653,0.589,6/20,6.73%,MRAP;PLEK;GRK3;SNCA;MGRN1;YWHAB
prerank,regulation of microglial cell activation (GO:1903978),0.8609783367627347,1.780126638268964,0.001349527665317139,0.012491178718889471,0.589,4/15,3.54%,PTPRC;TREM2;STAP1;CST7
prerank,cholesterol biosynthetic process (GO:0006695),-0.5059460486943451,-1.7790541270426306,0.006756756756756757,0.5358513379781047,0.954,20/31,31.26%,HMGCR;ACAA2;ACLY;NSDHL;CYP51A1;INSIG1;INSIG2;ACAT2;SQLE;LSS;PMVK;LBR;IDI1;MVK;HSD17B7;FDPS;DHCR7;EBP;TM7SF2;SC5D
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.760483511812003,1.775167086032489,0.0,0.013982090824788665,0.632,6/34,3.61%,PTPRC;CD86;SCIMP;LAPTM5;VAMP3;FFAR2
prerank,negative regulation of organelle assembly (GO:1902116),-0.48282444942335295,-1.7737910547418936,0.0,0.48457339718453296,0.958,23/35,26.83%,MTM1;FEZ1;TRIM37;SMAD4;CCP110;TMEM39A;EVI5L;CEP97;CDK5RAP2;PINK1;RBM14;CHMP4A;CHMP4B;NUPR1;CDK10;TBC1D7;PHF23;KAT2B;SMCR8;FEZ2;KAT2A;TESK1;STYXL1
prerank,negative regulation of cytokine production (GO:0001818),0.6888086932825294,1.7728364701917587,0.0,0.014600521736192331,0.647,51/163,13.65%,NCKAP1L;CD84;PTPRC;TREM2;SLAMF1;LILRB1;GPNMB;SLC11A1;FCGR2B;ADCY7;PDCD1LG2;SIRPA;VSIR;SRGN;CD200R1;NLRC5;LAPTM5;HAVCR2;TRIM25;NR1H4;TLR8;NLRC3;TNF;RGCC;DDIT3;TNFAIP3;PYCARD;HMGB1;PPP1R11;ANXA1;TYROBP;TAX1BP1;ABCD1;TMSB4X;ATP2B1;TRIM27;TNFRSF21;ANXA4;CD274;CMKLR1;INHBA;RPS6KA4;THBS1;HDAC9;RNF216;NLRX1;ITCH;RNF135;NPTN;GPATCH3;GAS6
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.6974332715763377,1.7721728111010406,0.0,0.014640509624994679,0.651,32/95,13.37%,CD86;LILRB1;PF4;CXCL5;CX3CR1;FCGR2B;STAP1;PDCD1LG2;SIRPA;IL1A;CYRIB;TLR2;CXCL2;MAPK14;CD68;TNFAIP3;PYCARD;CASP1;CD14;HMGB1;CD80;TICAM1;CD180;MEF2C;LY96;CD274;CCL2;TNFRSF1B;NOD2;DEFA6;NFKB1;SHPK
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.7097414932361146,1.7719367039473213,0.0,0.014605746610346049,0.654,18/69,9.41%,PTPRC;PF4;SYK;CCR2;IL1A;LPL;TLR1;HAVCR2;PLCG2;TLR2;PTPRJ;DHX9;PYCARD;CD14;HMGB1;TYROBP;LY96;ARFGEF2
prerank,outflow tract septum morphogenesis (GO:0003148),-0.550422765232293,-1.7711731138203064,0.005847953216374269,0.43500332405531605,0.96,11/24,13.19%,ZFPM2;PARVA;BMPR1A;ROBO2;BMP4;ACVR1;ROBO1;SEMA3C;SMAD4;TBX1;SMAD6
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.8966104386979397,1.7708760192297681,0.0,0.014780756072880924,0.662,4/11,4.82%,TREM2;LYN;TLR1;TNFAIP3
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.6941887604585926,1.7693992547396986,0.0,0.015035010502777467,0.669,29/121,7.69%,PTPRC;TREM2;PTK2B;LYN;TGFB1;CASS4;HCLS1;FLT3;GATA1;CD74;ITGB3;PLCG2;CSF1R;GPRC5B;PTPRJ;ANGPT4;PTPN1;TEC;OSM;FCGR1A;SEMA4D;TNF;IL6R;IL18;CD44;CD80;TP53;NEDD9;EPO
prerank,neutrophil activation (GO:0042119),0.8763664809131962,1.7690786955195696,0.0014184397163120568,0.014997345369790468,0.671,5/12,6.64%,PREX1;SYK;PRKCD;FCER1G;TYROBP
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.9130815948793349,1.7684199394249664,0.0,0.015051710036769635,0.675,4/10,1.56%,NCKAP1L;TREM2;STAP1;CD300A
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.7707708325897867,1.7670579410777052,0.0,0.01539626222268348,0.687,11/27,8.15%,ITGB2;CCR2;SIRPA;CYRIB;THY1;MDK;TNF;PYCARD;CCDC88B;CD44;PRKCQ
prerank,regulation of lymphocyte differentiation (GO:0045619),0.8312722453886738,1.7661244566595284,0.0,0.015634666906275275,0.697,4/18,2.23%,NCKAP1L;CCR2;SLAMF8;CRTAM
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.5041677657792205,-1.764813996203072,0.006896551724137931,0.4114110007982274,0.967,18/30,28.35%,HMGCR;ACAA2;ACLY;NSDHL;CYP51A1;INSIG1;INSIG2;ACAT2;SQLE;LSS;PMVK;LBR;IDI1;MVK;HSD17B7;FDPS;DHCR7;EBP
prerank,positive regulation of interleukin-4 production (GO:0032753),0.8465832770176622,1.7610772565121502,0.0,0.017582401668949654,0.748,7/17,8.15%,CD86;IRF4;SYK;HAVCR2;FCER1G;CEBPB;PRKCQ
prerank,leukocyte cell-cell adhesion (GO:0007159),0.7849877742813989,1.7592867014743712,0.0,0.018127158272879706,0.764,6/24,3.64%,ITGAL;FERMT3;SYK;ITGB2;ITGA4;SEMA4D
prerank,negative regulation of immune response (GO:0050777),0.6892702526788944,1.7591261216794865,0.0,0.018014132751629955,0.764,41/154,13.63%,TSHB;TREM2;LILRB1;FGR;LYN;LGALS3;CALCR;HCK;SYK;FCGR2B;ADCY7;CCR2;PDCD1;CD300A;PRKAR2B;HAVCR2;PLCG2;CYSLTR2;MAPK14;FCGR1A;NLRC3;ADCY6;RHBDF2;TNFAIP3;SPI1;TRAFD1;MYH9;SAMSN1;PLK2;RAMP1;TRIM27;RC3H1;CYSLTR1;YES1;IAPP;PRKACB;FYN;CREB1;ITCH;ADCY8;ADCY3
prerank,negative regulation of interferon-gamma production (GO:0032689),0.7799965114530832,1.7587734330400309,0.002466091245376079,0.018018106829289657,0.767,10/23,10.48%,LILRB1;PDCD1LG2;VSIR;LAPTM5;HAVCR2;NR1H4;DDIT3;HMGB1;CD274;INHBA
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.8624394750604604,1.7577046183267104,0.0,0.018353991658156595,0.771,6/12,9.47%,PTK2B;FCGR2B;LFNG;DOCK11;DOCK10;GPR183
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.8472969968016495,1.7576799554063738,0.0013404825737265416,0.01818560641358635,0.771,6/14,7.56%,LILRB1;CD74;LAPTM5;PLCG2;GPRC5B;TICAM1
prerank,positive regulation of interleukin-8 production (GO:0032757),0.7187805103029952,1.7556077113124937,0.0,0.019007440325225,0.783,13/49,5.89%,SYK;CD74;TLR1;TLR2;TLR7;TLR8;FFAR2;TNF;PRKD2;DDIT3;PYCARD;CD14;HMGB1
prerank,regulation of calcium-mediated signaling (GO:0050848),0.7926005357912084,1.7555236980418762,0.0,0.018891575574731135,0.783,5/25,5.60%,CD22;TREM2;PLEK;PLCG2;P2RX4
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.7435631579187985,1.7551323418036406,0.0,0.018850951897405682,0.784,12/45,5.76%,IRF5;PTAFR;CIITA;HCK;IRF4;IRF8;PRKCD;TRIM25;FCGR1A;TRIM5;CD44;IFNGR2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.876095183446791,1.7536450709890326,0.0,0.019427505638244698,0.793,3/12,5.21%,SLC11A1;CCR2;IL18
prerank,regulation of tumor necrosis factor production (GO:0032680),0.6864516298830107,1.7534228675802632,0.0,0.019302019134257217,0.796,27/112,9.41%,PTPRC;SLAMF1;LILRB1;PF4;CX3CR1;SYK;CCR2;SIRPA;IL1A;LPL;VSIR;TLR1;HAVCR2;PLCG2;TLR2;PTPRJ;NR1H4;DHX9;NLRC3;TNFAIP3;PYCARD;CD14;HMGB1;TYROBP;TRIM27;LY96;ARFGEF2
prerank,peptidyl-tyrosine modification (GO:0018212),0.7121306389433977,1.7515902474013731,0.0,0.020122952714633328,0.81,9/56,2.63%,PTK2B;BTK;FGR;LYN;HCK;SYK;FLT3;CSF1R;TEC
prerank,cellular response to chemokine (GO:1990869),0.724240951435217,1.7500402730457996,0.0,0.020814927829162038,0.823,13/46,11.36%,PTK2B;DOCK8;PF4;CXCL5;CCR2;CXCL2;CCL8;RIPOR2;WNK1;CCL14;SH2B3;CCL13;CCL2
prerank,arachidonic acid metabolic process (GO:0019369),0.7422738275250901,1.749183364238154,0.0,0.021057292755094388,0.83,6/35,3.22%,CYP1A1;TBXAS1;ALOX12;DAGLB;PTGES3;HPGDS
prerank,plasma membrane invagination (GO:0099024),0.7595534273291984,1.7490910872281324,0.0011737089201877935,0.020922248275675553,0.831,11/29,6.36%,ARHGAP25;BIN2;FCGR2B;ITGB2;ELMO1;MSR1;FCGR1A;SNX9;SNX33;MYH9;AIF1
prerank,regulation of macrophage cytokine production (GO:0010935),0.8628652822070007,1.748157189350151,0.0,0.02109937864567918,0.835,6/13,2.16%,LILRB1;TGFB1;CD74;LAPTM5;PLCG2;GPRC5B
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.6827287313808731,1.748075835289237,0.0,0.02096623419182912,0.835,55/163,15.82%,NCKAP1L;THEMIS2;PTPRC;LCP2;GRAP2;BTK;BLNK;INPP5D;FYB1;CARD11;RFTN1;CD3E;SYK;LAT;PIK3CD;PLCG2;THY1;PTPRJ;TEC;PIK3CB;THEMIS;LAT2;PRKD2;VAV3;NFAM1;BTN3A3;PRKCB;PSMB10;RC3H2;WNK1;NFKBID;MALT1;PRKCQ;MEF2C;DENND1B;RC3H1;SPPL3;TNFRSF21;BCAR1;EIF2B2;PSMA2;TXK;FYN;PSME3;TAB2;IKBKG;NFKB1;PSMB5;BMX;PSMD8;PAG1;PLEKHA1;PSMD7;ICOSLG;PSMB9
prerank,B cell proliferation (GO:0042100),0.8262310456097363,1.744784741302813,0.0038461538461538464,0.022139083537688026,0.852,4/17,8.17%,PTPRC;CTPS1;CD180;MEF2C
prerank,integrin-mediated signaling pathway (GO:0007229),0.7099552595418134,1.7445640032643905,0.0,0.02205837716476281,0.853,17/73,3.16%,PTK2B;FERMT3;FGR;FYB1;ITGA2B;HCK;PLEK;SYK;ITGB2;LAT;ITGB3;ITGB5;THY1;ITGA2;TEC;ANGPTL3;CCM2
prerank,T cell differentiation (GO:0030217),0.7373293094147233,1.7425902063003196,0.0011001100110011,0.02300339192731867,0.87,8/40,6.22%,PTPRC;SHH;PIK3CD;LFNG;FCER1G;SPI1;CHD7;ANXA1
prerank,defense response to protozoan (GO:0042832),0.8660318430749671,1.7389667617702649,0.001388888888888889,0.024734516590181926,0.884,4/12,1.19%,PF4;IRF4;SLC11A1;LYST
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.6959678604128472,1.7371555195111985,0.0,0.025495487128643794,0.893,15/72,5.21%,TREM2;FGR;LYN;PIK3CG;PIK3R5;HCLS1;FLT3;PIK3CD;CBL;PIK3AP1;PIK3CB;OSM;SEMA4D;TNF;IL18
prerank,myeloid cell activation involved in immune response (GO:0002275),0.8107869743856345,1.7361727604394828,0.0012970168612191958,0.025780955724480432,0.897,7/18,6.64%,DOCK2;SLAMF1;SYK;PLCG2;FCER1G;PYCARD;TYROBP
prerank,positive regulation of B cell proliferation (GO:0030890),0.7593467923958771,1.735105276969376,0.0011806375442739079,0.026207120555510326,0.904,7/29,11.49%,NCKAP1L;PTPRC;CD74;VAV3;MEF2C;GPR183;SASH3
prerank,muscle organ development (GO:0007517),-0.4240945862280618,-1.734401154554168,0.0,0.4933118121052193,0.988,21/54,18.05%,SGCD;UTRN;TCF12;FHL1;MRAS;CHD2;DMD;VAMP5;COL6A3;MKX;SRI;TEAD4;EVC;SGCE;ITGA11;TBX1;MAPK12;EMD;MEF2B;TAGLN;HBEGF
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.818753936794162,1.7317321145375593,0.0,0.028027185517528082,0.923,5/17,6.65%,CD226;SLAMF6;KLRK1;CRTAM;RAET1E
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.8503999387783217,1.7302331192164364,0.002652519893899204,0.028651682813468467,0.927,5/13,8.32%,NCKAP1L;RUNX1;SHH;TGFBR2;PNP
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.7899881674245848,1.7302218790599275,0.002554278416347382,0.028431285253364864,0.927,7/19,9.38%,SCIMP;ITGB2;PIK3AP1;NR1H4;CD14;LY96;ITGAM
prerank,cellular lipid catabolic process (GO:0044242),0.7722468566741455,1.729900987295382,0.0,0.02837847075197598,0.927,7/27,7.06%,PLBD1;LPIN2;ABHD12;ANGPTL3;CEL;NUDT19;ACADL
prerank,positive regulation of neutrophil migration (GO:1902624),0.8182661022307236,1.7290746447606045,0.002570694087403599,0.02865240473653875,0.93,6/18,5.98%,NCKAP1L;CD74;ADAM8;CAMK1D;MDK;RIPOR2
prerank,regulation of interferon-alpha production (GO:0032647),0.7792704554313351,1.7283401827380633,0.002421307506053269,0.02892221941306299,0.932,6/23,3.60%,IRF5;HAVCR2;DHX9;TLR7;TLR8;NLRC3
prerank,defense response to bacterium (GO:0042742),0.6771660180304101,1.7282116767344893,0.0,0.028843989111929817,0.932,19/105,7.75%,TREM2;FGR;SLC11A1;SYK;LYST;MPEG1;AQP1;SLAMF8;TLR2;PRKCD;FCER1G;IL6R;PYCARD;DMBT1;STAB2;PPP1R11;STAB1;EPX;CEBPB
prerank,immunoglobulin mediated immune response (GO:0016064),0.8927500095289168,1.7280954431426767,0.0014858841010401188,0.028713800282982763,0.932,4/10,3.96%,FCGR2B;CD74;TLR8;FCER1G
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.6056622687917395,-1.727715526812316,0.02109704641350211,0.4758292671461746,0.991,5/16,20.19%,CLDN5;CLDN11;CLDN14;CLDN12;CLDN1
prerank,myeloid cell differentiation (GO:0030099),0.7194249815198915,1.725764840458996,0.0,0.029979023310313234,0.94,15/47,12.61%,RUNX1;LYN;IKZF1;HCLS1;GATA1;ACIN1;CEBPA;SPI1;TAL1;EPO;ATP5IF1;SLC25A38;INHBA;PRDX3;RPS14
prerank,positive regulation of B cell activation (GO:0050871),0.7129580585611452,1.724762849798,0.0,0.030418212757921313,0.943,12/50,12.42%,NCKAP1L;PTPRC;BTK;SYK;CD74;MAD2L2;VAV3;SH3KBP1;MEF2C;GPR183;SASH3;NOD2
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.7384669128038865,1.72400748370652,0.0,0.030568953548347363,0.945,11/37,7.56%,TREM2;PLD4;ADCY7;SIRPA;MAPK14;NLRC3;TNF;PYCARD;PLD3;ABCD1;TICAM1
prerank,B cell homeostasis (GO:0001782),0.8931661073283772,1.7237221125588507,0.002894356005788712,0.030496429974148368,0.946,6/10,8.17%,NCKAP1L;LYN;TNFAIP3;DOCK11;DOCK10;MEF2C
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.8551247792021042,1.7237181486698814,0.0,0.03027859833147588,0.946,3/14,6.70%,CD84;IL18;CD80
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.8201928924869339,1.7227507745086512,0.00546448087431694,0.03073226510202965,0.949,5/14,6.74%,SYK;RASAL3;CCR2;IL18;TGFBR2
prerank,B cell mediated immunity (GO:0019724),0.8790717679765134,1.7218297024874363,0.001466275659824047,0.03112182902585819,0.952,4/10,3.96%,FCGR2B;CD74;TLR8;FCER1G
prerank,sterol biosynthetic process (GO:0016126),-0.48689931025853794,-1.720099433240839,0.007575757575757576,0.46749472054098545,0.996,20/33,31.26%,HMGCR;ACAA2;ACLY;NSDHL;CYP51A1;INSIG1;INSIG2;ACAT2;SQLE;LSS;PMVK;LBR;IDI1;MVK;HSD17B7;FDPS;DHCR7;EBP;TM7SF2;SC5D
prerank,lymphocyte differentiation (GO:0030098),0.6961825226108508,1.7195972194417026,0.0,0.0325876629252058,0.957,15/68,6.69%,PTPRC;BLNK;IKZF1;FLT3;ITGA4;PIK3CD;TPD52;PLCG2;PTPRJ;LFNG;HDAC5;ADGRG3;NFAM1;CHD7;KLF6
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.8005640153047675,1.719489530987948,0.0024906600249066002,0.03241115736223312,0.957,5/19,5.98%,NCKAP1L;CD74;CAMK1D;MDK;RIPOR2
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.8521413756346065,1.7175318463619476,0.00558659217877095,0.03351583118253532,0.961,7/13,3.97%,SYK;ITGB2;LPL;ABCA1;CD9;FCER1G;SREBF2
prerank,regulation of mast cell activation (GO:0033003),0.8908023544539331,1.717452884159705,0.001455604075691412,0.03336345218268287,0.961,4/10,5.14%,CD84;CD226;LYN;CD300LF
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.8210885394022707,1.716019150327132,0.0,0.03429330534401086,0.968,5/16,6.65%,CD226;SLAMF6;KLRK1;CRTAM;RAET1E
prerank,superoxide metabolic process (GO:0006801),0.749378556810441,1.7156882617681992,0.0,0.03426232257996548,0.968,8/29,4.06%,CYBB;PREX1;NRROS;NCF4;SH3PXD2B;ALOX12;NCF2;ATP7A
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.681510051014366,1.7134808307695704,0.0,0.035469296568539366,0.972,23/67,11.25%,NCKAP1L;VAV1;PTK2B;CYBB;MAPKAPK3;NCF4;ITGB3;NCF2;PIK3CB;VAV2;ELMO1;MAPK14;NCK2;PRKD2;VAV3;SHC2;VEGFB;WASF2;PDCD6;ABI1;BCAR1;NRP1;CYFIP1
prerank,regulation of mononuclear cell migration (GO:0071675),0.7727252477253411,1.7131454116365348,0.0012254901960784314,0.035492351496721794,0.972,10/23,11.47%,LYN;LGALS3;CSF1R;MDK;TNF;AIF1;STK10;AKIRIN1;CMKLR1;THBS1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.8089744852814443,1.713129100185464,0.00258732212160414,0.03527087114027641,0.972,6/18,8.62%,RUNX1;TGFB1;RGCC;COLGALT1;RB1;SMAD3
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.7857991727361361,1.7129761018555647,0.0,0.035106221253612374,0.972,7/20,7.56%,LYN;HCK;TGFB1;TNF;CD14;IL18;TICAM1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.8497581302105568,1.7124652480800828,0.001394700139470014,0.03526510681751419,0.973,4/12,5.21%,TREM2;STAP1;TNF;IL18
prerank,dendritic cell chemotaxis (GO:0002407),0.8247023545589375,1.7107395238783423,0.005249343832020997,0.036173605546501564,0.979,5/14,9.47%,PIK3CG;CCR2;CXCR4;HMGB1;GPR183
prerank,positive regulation of immunoglobulin production (GO:0002639),0.7431462783586087,1.710538683320629,0.0011614401858304297,0.036072409231586625,0.979,4/31,2.41%,PTPRC;CD86;VAMP3;MAD2L2
prerank,regulation of tissue remodeling (GO:0034103),0.808198140084905,1.7096051491109512,0.0038860103626943004,0.03651754834025361,0.981,5/18,5.21%,RUNX1;GPNMB;TGFB1;MDK;IL18
prerank,neutrophil activation involved in immune response (GO:0002283),0.6596685818298773,1.7082641613183207,0.0,0.0371397140044061,0.981,130/428,13.20%,ARHGAP45;NCKAP1L;PTPRC;CTSS;HK3;DOCK2;TUBB;CLEC4D;LILRB3;ITGAL;FGR;LGALS3;GMFG;PTAFR;P2RX1;CYBB;MGAM;ITGAX;HPSE;SLC11A1;ARHGAP9;BIN2;SYK;CTSB;ITGB2;CLEC5A;HEXB;GUSB;TMC6;SIRPA;ATP8B4;UNC13D;CTSD;CD300A;IQGAP2;TBC1D10C;CTSC;TLR2;CTSA;ADAM8;PTPRJ;PRKCD;TCIRG1;LPCAT1;OSTF1;ARSB;ADGRE5;MAPK14;GNS;PFKL;ATP8A1;GM2A;PSAP;NPC2;ATG7;FCER1G;SLC2A3;TTR;PPIE;DNAJC3;CD68;LAIR1;PYCARD;CD14;RAB14;GYG1;NBEAL2;CPPED1;RAP1B;RAB7A;CD44;ADGRG3;NFAM1;HMGB1;XRCC5;APAF1;ARL8A;B4GALT1;CDA;TYROBP;STK10;FUCA1;VPS35L;IRAG2;STXBP3;SVIP;EPX;DNAJC13;FABP5;RAP2B;CAP1;PNP;TSPAN14;ACTR10;RAB31;CCT8;TMEM179B;SLC44A2;PAFAH1B2;CTSZ;MAN2B1;FTL;SNAP29;ATP6AP2;ITGAM;ACTR2;VCL;FGL2;TMEM63A;SYNGR1;ATP6V0A1;CD53;DIAPH1;PSMA2;CYFIP1;CD63;GPI;TNFRSF1B;GRN;DYNC1H1;GGH;CD93;SDCBP;PRDX6;ARSA;COTL1;SNAP23;MGST1;B2M;NFKB1
prerank,regulation of chemokine production (GO:0032642),0.726865147421323,1.7077171148170516,0.003436426116838488,0.03725476693592033,0.981,12/36,6.36%,TREM2;CD74;LPL;CSF1R;TLR2;TLR7;FFAR2;TNF;IL6R;PYCARD;IL18;AIF1
prerank,prostaglandin metabolic process (GO:0006693),0.7459701258472649,1.7074340960065193,0.0035714285714285713,0.03719441644319018,0.981,6/26,4.59%,TBXAS1;CD74;DAGLB;PTGES3;HPGDS;HPGD
prerank,intracellular pH reduction (GO:0051452),0.728748640345981,1.707197843641255,0.0023121387283236996,0.03717323566299669,0.981,11/33,7.51%,ATP6V0D2;SLC11A1;SLAMF8;ATP6V0E1;RAB39A;TCIRG1;ATP6V1C1;ATP6V1E1;ATP6V0A2;RAB7A;ATP6V0D1
prerank,T cell differentiation in thymus (GO:0033077),0.8398595999705487,1.7067639842002154,0.0026560424966799467,0.03727321096639538,0.981,2/14,0.65%,PTPRC;SHH
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.7938191520718831,1.70667253495347,0.006180469715698393,0.03709371750792303,0.981,4/19,2.95%,NCKAP1L;BTK;SYK;MDK
prerank,vitamin D metabolic process (GO:0042359),0.8288919853642522,1.7058534447680505,0.002828854314002829,0.03749462036783413,0.981,2/13,1.27%,CYP1A1;LGMN
prerank,response to thyroid hormone (GO:0097066),0.8478268910638331,1.7053775308418195,0.0041841004184100415,0.037665763936024145,0.982,6/13,2.62%,CTSS;CTSB;GATA1;BRD8;GAS2L1;CTSL
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.8591447760713858,1.7050487367748326,0.00846262341325811,0.03770445373022749,0.983,2/11,0.36%,PTPRC;LILRB1
prerank,positive regulation of macrophage migration (GO:1905523),0.7834909585674525,1.704553159904248,0.002574002574002574,0.03785375785860439,0.983,8/19,11.47%,TREM2;CSF1R;MDK;P2RX4;P2RY12;AKIRIN1;CMKLR1;THBS1
prerank,regulation of osteoclast differentiation (GO:0045670),0.7344208167815186,1.7035801965646002,0.0,0.03829571477684054,0.983,8/33,7.75%,LILRB3;UBASH3B;MTOR;TNF;OCSTAMP;GPR137B;TMEM178A;CEBPB
prerank,regulation of chemotaxis (GO:0050920),0.7298713291481026,1.7034546761999174,0.0,0.03815922916835348,0.983,12/30,13.15%,TREM2;TGFB1;CYRIB;DUSP3;CXCR4;P2RX4;AIF1;P2RY12;GPR183;THBS1;STX3;ZSWIM6
prerank,negative regulation of B cell proliferation (GO:0030889),0.8622644429136471,1.7033595558775272,0.0014388489208633094,0.037963742866668974,0.984,6/11,9.54%,LYN;FCGR2B;CD300A;TYROBP;RC3H1;TNFRSF21
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.671687636656338,1.702473386119039,0.0,0.03835507203419975,0.985,28/116,14.33%,TSHB;TREM2;FGR;LYN;CALCR;HCK;SYK;FCGR2B;ADCY7;PRKAR2B;PLCG2;CYSLTR2;MAPK14;FCGR1A;ADCY6;RHBDF2;MYH9;PLK2;RAMP1;CYSLTR1;YES1;IAPP;PRKACB;FYN;CREB1;ADCY8;ADCY3;GNG2
prerank,neutrophil degranulation (GO:0043312),0.6575090128241241,1.70239983651635,0.0,0.03818468962189805,0.985,129/425,13.20%,ARHGAP45;NCKAP1L;PTPRC;CTSS;HK3;DOCK2;TUBB;CLEC4D;LILRB3;ITGAL;FGR;LGALS3;GMFG;PTAFR;P2RX1;CYBB;MGAM;ITGAX;HPSE;SLC11A1;ARHGAP9;BIN2;CTSB;ITGB2;CLEC5A;HEXB;GUSB;TMC6;SIRPA;ATP8B4;UNC13D;CTSD;CD300A;IQGAP2;TBC1D10C;CTSC;TLR2;CTSA;ADAM8;PTPRJ;PRKCD;TCIRG1;LPCAT1;OSTF1;ARSB;ADGRE5;MAPK14;GNS;PFKL;ATP8A1;GM2A;PSAP;NPC2;ATG7;FCER1G;SLC2A3;TTR;PPIE;DNAJC3;CD68;LAIR1;PYCARD;CD14;RAB14;GYG1;NBEAL2;CPPED1;RAP1B;RAB7A;CD44;ADGRG3;NFAM1;HMGB1;XRCC5;APAF1;ARL8A;B4GALT1;CDA;TYROBP;STK10;FUCA1;VPS35L;IRAG2;STXBP3;SVIP;EPX;DNAJC13;FABP5;RAP2B;CAP1;PNP;TSPAN14;ACTR10;RAB31;CCT8;TMEM179B;SLC44A2;PAFAH1B2;CTSZ;MAN2B1;FTL;SNAP29;ATP6AP2;ITGAM;ACTR2;VCL;FGL2;TMEM63A;SYNGR1;ATP6V0A1;CD53;DIAPH1;PSMA2;CYFIP1;CD63;GPI;TNFRSF1B;GRN;DYNC1H1;GGH;CD93;SDCBP;PRDX6;ARSA;COTL1;SNAP23;MGST1;B2M;NFKB1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.6807004542293996,1.700301316276354,0.0,0.039540989924878846,0.989,24/86,8.75%,PTPRC;TREM2;PTK2B;TGFB1;ITGB2;HCLS1;GATA1;CD74;ITGB3;PLCG2;PTPRJ;PRKCD;ANGPT4;TEC;OSM;SEMA4D;PDCL3;IL6R;SAMSN1;CD44;CD80;TP53;RAP2B;NTF3
prerank,phagosome acidification (GO:0090383),0.7452953314499468,1.7001128057293917,0.0012062726176115801,0.03947822956362845,0.989,11/26,10.59%,ATP6V0D2;SLAMF8;ATP6V0E1;RAB39A;TCIRG1;ATP6V1C1;ATP6V1E1;ATP6V0A2;RAB7A;ATP6V0D1;ATP6V0A1
prerank,receptor metabolic process (GO:0043112),0.697162001786388,1.7000691412739821,0.0,0.039274892815256666,0.989,29/53,18.44%,ARRB2;LILRB1;TGFB1;SYK;ITGB2;LGMN;GRB2;CD9;GRK3;SNCA;FCER1G;LDLRAP1;DNM2;RAMP1;RAB31;UVRAG;ARFGEF2;CLTC;BECN1;SNX25;GRK4;LRP1;CD36;AP2M1;SMURF1;ADM;PIK3R4;PICALM;ITGB1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.7668605170514402,1.6997688697467506,0.0049813200498132005,0.0392846154475659,0.99,8/21,6.25%,RUNX1;CD22;LYN;FCGR2B;STAP1;CD300A;NFAM1;PRKCB
prerank,positive regulation of calcium ion import (GO:0090280),0.8408945881611352,1.6969883362461242,0.005509641873278237,0.04090068690756862,0.992,2/12,0.55%,LGALS3;CALCR
prerank,dendritic cell migration (GO:0036336),0.8016196445547091,1.6965788702080513,0.003870967741935484,0.040906902022814606,0.992,5/16,9.47%,PIK3CG;CCR2;CXCR4;HMGB1;GPR183
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.8676295364603793,1.6961889813205286,0.002936857562408223,0.04092455751695371,0.992,6/11,9.38%,ITGB2;STAP1;SPI1;TYROBP;TICAM1;ITGAM
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.8658807922617734,1.6951321312410639,0.004347826086956522,0.04146280459296179,0.993,4/10,5.89%,NCKAP1L;RUNX1;IRF4;HMGB1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.8545375874419695,1.6948228198747346,0.0013986013986013986,0.041414572805086994,0.993,5/11,8.17%,LYN;PIK3CD;PIK3CB;ANXA1;MEF2C
prerank,phagolysosome assembly (GO:0001845),0.8380468421441446,1.6943071508966936,0.0027548209366391185,0.04158194322368542,0.993,7/12,5.34%,CORO1A;RAB39A;RAB34;CLN3;RAB14;RAB7A;RAB7B
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.8519714657701558,1.6942349547330855,0.004219409282700422,0.04139849996802712,0.993,6/12,2.62%,CTSS;CTSB;GATA1;BRD8;GAS2L1;CTSL
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.7637968628983882,1.694169113615414,0.006060606060606061,0.0412338551441804,0.993,8/21,6.25%,PTPRC;CD226;CARD11;STAP1;KCNN4;PRKD2;NFAM1;PRKCB
prerank,regulation of T cell differentiation (GO:0045580),0.7256853427253538,1.6940110427605517,0.002288329519450801,0.04112667433128497,0.993,4/33,2.95%,RUNX1;CCR2;CRTAM;MDK
prerank,neutrophil mediated immunity (GO:0002446),0.65415579955821,1.6933286366475355,0.0,0.041408266384320304,0.993,129/432,13.20%,ARHGAP45;NCKAP1L;PTPRC;CTSS;HK3;DOCK2;TUBB;CLEC4D;LILRB3;ITGAL;FGR;LGALS3;GMFG;PTAFR;P2RX1;CYBB;MGAM;ITGAX;HPSE;SLC11A1;ARHGAP9;BIN2;CTSB;ITGB2;CLEC5A;HEXB;GUSB;TMC6;SIRPA;ATP8B4;UNC13D;CTSD;CD300A;IQGAP2;TBC1D10C;CTSC;TLR2;CTSA;ADAM8;PTPRJ;PRKCD;TCIRG1;LPCAT1;OSTF1;ARSB;ADGRE5;MAPK14;GNS;PFKL;ATP8A1;GM2A;PSAP;NPC2;ATG7;FCER1G;SLC2A3;TTR;PPIE;DNAJC3;CD68;LAIR1;PYCARD;CD14;RAB14;GYG1;NBEAL2;CPPED1;RAP1B;RAB7A;CD44;ADGRG3;NFAM1;HMGB1;XRCC5;APAF1;ARL8A;B4GALT1;CDA;TYROBP;STK10;FUCA1;VPS35L;IRAG2;STXBP3;SVIP;EPX;DNAJC13;FABP5;RAP2B;CAP1;PNP;TSPAN14;ACTR10;RAB31;CCT8;TMEM179B;SLC44A2;PAFAH1B2;CTSZ;MAN2B1;FTL;SNAP29;ATP6AP2;ITGAM;ACTR2;VCL;FGL2;TMEM63A;SYNGR1;ATP6V0A1;CD53;DIAPH1;PSMA2;CYFIP1;CD63;GPI;TNFRSF1B;GRN;DYNC1H1;GGH;CD93;SDCBP;PRDX6;ARSA;COTL1;SNAP23;MGST1;B2M;NFKB1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.8632526257387505,1.691625520050002,0.0014492753623188406,0.042435860682999725,0.993,3/11,5.60%,TREM2;PLCG2;P2RX4
prerank,regulation of platelet activation (GO:0010543),0.7800694279452324,1.690985478800864,0.006172839506172839,0.04268552757130392,0.993,8/21,11.14%,LYN;PLEK;SYK;TEC;FCER1G;APOE;PRKCQ;TXK
prerank,positive regulation of superoxide anion generation (GO:0032930),0.8298252250281047,1.689159451009063,0.004120879120879121,0.0438970084507005,0.995,6/13,9.38%,TGFB1;SYK;ITGB2;PRKCD;TYROBP;ITGAM
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.8083628890156758,1.6890161399266637,0.006435006435006435,0.04374063128278294,0.995,4/14,4.08%,CD226;CARD11;KCNN4;PRKD2
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.7434434437911623,1.6883561531288633,0.0035502958579881655,0.04405497160503233,0.996,8/29,8.18%,LGALS3;CCR2;LGMN;CREB3;TNF;HMGB1;AIF1;PLA2G7
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.7091528462066281,1.6880533935993873,0.0022172949002217295,0.04408712375893258,0.997,8/41,4.82%,SLAMF1;LILRB1;SIRPA;VSIR;HAVCR2;NR1H4;NLRC3;TNFAIP3
prerank,activation of phospholipase C activity (GO:0007202),0.7473986187829753,1.6861232280607628,0.002328288707799767,0.04553283860776406,0.998,7/29,7.53%,GNA15;CD86;PLCB2;P2RY6;GNAQ;S1PR4;P2RY12
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.8043922411538487,1.684972795646483,0.0026246719160104987,0.0463054025475141,0.998,5/17,5.98%,NCKAP1L;CD74;CAMK1D;MDK;RIPOR2
prerank,cellular response to interferon-gamma (GO:0071346),0.6797166859265061,1.6843594939941111,0.0,0.04655251703427721,0.998,24/88,11.36%,IRF5;PTAFR;CIITA;HCK;IRF4;IRF8;SIRPA;TLR2;PRKCD;TRIM25;FCGR1A;CCL8;TRIM5;CASP1;CD44;IFNGR2;AIF1;IRF2;CCL14;EPRS1;TRIM8;CCL13;GBP3;CCL2
prerank,regulation of macrophage chemotaxis (GO:0010758),0.7614467644624514,1.6839259843029037,0.0012453300124533001,0.04668677606183547,0.998,8/21,11.47%,PTK2B;STAP1;SLAMF8;CSF1R;MDK;AKIRIN1;CMKLR1;THBS1
prerank,monocyte chemotaxis (GO:0002548),0.7336465821330446,1.6816024606274573,0.0011507479861910242,0.0484033175356967,0.998,9/32,11.52%,LGALS3;TNFRSF11A;CCL8;IL6R;ANXA1;CCL14;CCL13;CCL2;PTPRO
prerank,defense response to Gram-negative bacterium (GO:0050829),0.6996751591820962,1.6813123054323116,0.00331858407079646,0.04838121734505649,0.999,7/42,5.18%,TREM2;SLC11A1;MPEG1;AQP1;IL6R;PYCARD;DMBT1
prerank,macrophage migration (GO:1905517),0.8302084373417093,1.6774742654091983,0.006648936170212766,0.05156191144896085,0.999,6/13,11.36%,LGALS3;CCR2;EDNRB;P2RX4;P2RY12;CCL2
prerank,presynapse organization (GO:0099172),-0.6679651671290222,-1.6770091598993069,0.011494252873563218,0.6301040328365163,1.0,4/10,17.98%,NLGN1;WNT5A;LRRTM3;FZD1
prerank,vesicle transport along actin filament (GO:0030050),0.7780380541801329,1.6768390332088223,0.0037926675094816687,0.05181243689312034,0.999,7/19,8.24%,MYO1F;MYO1G;MYO1E;MYO5A;ACTN4;MYO7A;MYO19
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.824684758937742,1.6762061304424578,0.0027210884353741495,0.0521014334363076,0.999,5/13,9.38%,FGR;SYK;ITGB2;GAB2;ITGAM
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.8429454666785776,1.675798158227835,0.005578800557880056,0.05222446442794325,0.999,3/11,5.18%,ARRB2;GRK3;SAG
prerank,hyaluronan catabolic process (GO:0030214),0.7873052411347939,1.6756714154113719,0.007832898172323759,0.05204706876932842,0.999,7/18,7.13%,TGFB1;HEXB;GUSB;HEXA;CD44;STAB2;SLC9A1
prerank,microglial cell activation (GO:0001774),0.772281762256974,1.6748105302247922,0.006112469437652812,0.052502214469871335,0.999,10/21,11.82%,TREM2;CX3CR1;ITGB2;TNF;SNCA;AIF1;TYROBP;C1QA;ITGAM;GRN
prerank,positive regulation of lipid kinase activity (GO:0090218),0.730075106704184,1.6742342121773557,0.0035087719298245615,0.05276709831570711,0.999,5/29,1.26%,PTK2B;FGR;TGFB1;FLT3;DGKZ
prerank,T cell homeostasis (GO:0043029),0.8485927902336161,1.6730060541946088,0.0014044943820224719,0.053639046114664427,0.999,1/10,0.04%,NCKAP1L
prerank,regulation of superoxide anion generation (GO:0032928),0.8147465241374459,1.6726930529971484,0.005383580080753701,0.053667088184644655,0.999,6/14,9.38%,TGFB1;SYK;ITGB2;PRKCD;TYROBP;ITGAM
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.823358282736371,1.6710261122383032,0.005722460658082976,0.05498155640636866,0.999,3/12,8.15%,SLC11A1;CCR2;PRKCQ
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.6597905589857382,1.6709504247826177,0.0,0.0548206478927391,0.999,27/117,14.33%,TSHB;TREM2;FGR;LYN;CALCR;HCK;SYK;ADCY7;PRKAR2B;PLCG2;CYSLTR2;MAPK14;FCGR1A;ADCY6;RHBDF2;MYH9;PLK2;RAMP1;CYSLTR1;YES1;IAPP;PRKACB;FYN;CREB1;ADCY8;ADCY3;GNG2
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.6667266946132996,1.670387692122155,0.0010449320794148381,0.05505829886620399,0.999,9/67,2.63%,PTK2B;BTK;FGR;LYN;HCK;SYK;FLT3;CSF1R;TEC
prerank,myeloid leukocyte differentiation (GO:0002573),0.6726976884147512,1.6692207803627577,0.0031479538300104933,0.055752231404936,0.999,15/65,6.74%,RUNX1;BATF3;TREM2;PIK3CD;CBFA2T3;CSF1R;TNFRSF11A;MAPK14;CEBPA;SPI1;MYH9;GAB2;EFNA2;TYROBP;TGFBR2
prerank,cortical actin cytoskeleton organization (GO:0030866),0.7819265163919868,1.668633925763499,0.005161290322580645,0.05606574998392391,0.999,6/20,5.74%,NCKAP1L;PLEK;LCP1;TNF;FHOD1;FMNL3
prerank,regulation of interleukin-8 production (GO:0032677),0.6648702043193949,1.6670394259225452,0.0010449320794148381,0.05733790215419556,1.0,16/69,7.57%,PTPRC;SYK;CD74;TLR1;TLR2;TLR7;TLR8;FFAR2;TNF;PRKD2;DDIT3;PYCARD;CD14;HMGB1;ANXA1;TMSB4X
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.5971690112272128,-1.6666933299900921,0.011406844106463879,0.6386586847428218,1.0,10/15,32.74%,RAI2;STOX2;RICTOR;UBR3;USP22;CELF4;TGFB2;SCEL;NR5A2;BRCA1
prerank,mesoderm development (GO:0007498),0.7799403146883079,1.6656329100556284,0.010101010101010102,0.05846344516123198,1.0,4/18,2.23%,BTK;HCK;IKZF1;HES7
prerank,cellular response to interleukin-2 (GO:0071352),0.8343853953483986,1.664592979769423,0.007042253521126761,0.059101242841174524,1.0,3/11,1.33%,PTK2B;SYK;STAT5A
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.8343853953483986,1.664592979769423,0.007042253521126761,0.059101242841174524,1.0,3/11,1.33%,PTK2B;SYK;STAT5A
prerank,pinocytosis (GO:0006907),0.8600665682251686,1.6645588029613694,0.004341534008683068,0.058870309677699684,1.0,6/10,4.91%,DOCK2;MAPKAPK3;SNX5;RAB34;SNX33;PYCARD
prerank,prostaglandin biosynthetic process (GO:0001516),0.7731553891741982,1.664349184831297,0.002621231979030144,0.05882089449635781,1.0,5/18,3.22%,TBXAS1;CD74;DAGLB;PTGES3;HPGDS
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.8408192891621027,1.6642948042490837,0.0070921985815602835,0.058588666864236326,1.0,4/11,9.89%,RUNX1;VSIR;HMGB1;CD274
prerank,catecholamine biosynthetic process (GO:0042423),0.8495481953457227,1.664141003509254,0.00697350069735007,0.0584427580189891,1.0,3/11,4.58%,SNCA;GCH1;DDC
prerank,negative regulation of leukocyte activation (GO:0002695),0.8032672551955592,1.6639182922103755,0.006657789613848202,0.058377334482446315,1.0,5/15,5.14%,CD84;FCGR2B;CD300A;HAVCR2;CD300LF
prerank,positive regulation of bone resorption (GO:0045780),0.8475631536131291,1.6629498688481494,0.004201680672268907,0.059091239143389734,1.0,6/11,11.17%,SYK;ADAM8;TNFRSF11A;SPP1;PLEKHM1;ATP6AP1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.785532754857898,1.6621437267617083,0.006587615283267457,0.05951261606920065,1.0,5/17,9.88%,NCKAP1L;CD3E;SYK;P2RY12;PODXL
prerank,hyaluronan metabolic process (GO:0030212),0.7453566597823388,1.659163126636013,0.007434944237918215,0.06226384472240804,1.0,7/23,7.13%,TGFB1;HEXB;GUSB;HEXA;CD44;STAB2;SLC9A1
prerank,negative regulation of phagocytosis (GO:0050765),0.7948301352887227,1.6588777822859022,0.0013297872340425532,0.062209970562932926,1.0,6/17,5.89%,FCGR2B;SIRPA;CD300A;TLR2;CD300LF;HMGB1
prerank,erythrocyte differentiation (GO:0030218),0.7021250896338121,1.6574970114734326,0.0,0.06335854831997696,1.0,13/44,12.61%,NCKAP1L;LYN;IKZF1;HCLS1;GATA1;ACIN1;TAL1;EPO;ATP5IF1;SLC25A38;INHBA;SH2B3;RPS14
prerank,positive regulation of T cell differentiation (GO:0045582),0.7113149720014168,1.6544228033177988,0.003367003367003367,0.0663100746574619,1.0,7/36,9.05%,NCKAP1L;SHH;VSIR;ADAM8;MDK;PNP;DUSP10
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.7327649562110303,1.6523188253037255,0.013333333333333334,0.06833754632012261,1.0,10/25,13.10%,CD226;SCIMP;LAPTM5;PLCG2;FFAR2;TRAF2;MALT1;NOD2;LACC1;B2M
prerank,cholesterol efflux (GO:0033344),0.7829854388127073,1.6522318971099723,0.0025,0.06814115972768738,1.0,6/20,5.61%,ABCA1;NPC2;APOE;ABCG1;NPC1;SOAT2
prerank,T cell receptor signaling pathway (GO:0050852),0.6489551517131724,1.6502822913234527,0.0,0.07007135379304111,1.0,44/138,15.82%,THEMIS2;PTPRC;LCP2;GRAP2;INPP5D;FYB1;CARD11;RFTN1;CD3E;LAT;PIK3CD;PLCG2;THY1;PTPRJ;TEC;PIK3CB;THEMIS;PRKD2;BTN3A3;PSMB10;RC3H2;WNK1;NFKBID;MALT1;PRKCQ;DENND1B;RC3H1;SPPL3;TNFRSF21;BCAR1;EIF2B2;PSMA2;TXK;FYN;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;PAG1;PSMD7;ICOSLG;PSMB9
prerank,protein autoprocessing (GO:0016540),0.7712205014167621,1.6484562536539793,0.013089005235602094,0.07187786872703689,1.0,4/17,4.94%,PCSK9;FAM111A;CTSL;CASP1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.6903154263332758,1.6475074013112434,0.003289473684210526,0.07271085405669238,1.0,8/43,4.82%,SLAMF1;LILRB1;SIRPA;VSIR;HAVCR2;NR1H4;NLRC3;TNFAIP3
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.7725218504182993,1.6468126808377777,0.011873350923482849,0.07311718072191221,1.0,6/17,8.18%,CCR2;LGMN;CREB3;HMGB1;AIF1;PLA2G7
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.7776007667009247,1.6466334675510237,0.0025252525252525255,0.07301880669735457,1.0,5/18,4.49%,PTK2B;LYN;CAMK1D;MDK;IL6R
prerank,receptor internalization (GO:0031623),0.6893751266303312,1.6448110991412228,0.004381161007667032,0.07481248979039669,1.0,20/44,15.68%,ARRB2;LILRB1;SYK;ITGB2;GRB2;CD9;GRK3;SNCA;FCER1G;LDLRAP1;SAG;DNM2;RAMP1;RAB31;SCYL2;CLTC;GRK4;LRP1;CD36;AP2M1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.8141653029069287,1.6437043970424488,0.00697350069735007,0.07590215602220429,1.0,4/14,3.54%,PTPRC;TREM2;CD200R1;CST7
prerank,negative regulation of complement activation (GO:0045916),-0.6806620212312192,-1.6431219628584117,0.03134796238244514,0.717128393404697,1.0,4/10,7.82%,CD55;SERPING1;CR1L;CD46
prerank,negative regulation of interleukin-2 production (GO:0032703),0.7589577790016256,1.6427378455844408,0.013140604467805518,0.07676989273933565,1.0,5/18,8.54%,PTPRC;LAPTM5;HAVCR2;TNFAIP3;TRIM27
prerank,regulation of platelet aggregation (GO:0090330),0.7647108062941654,1.6421786684769655,0.010484927916120577,0.07714187556623392,1.0,8/17,11.03%,LYN;SYK;ALOX12;PRKCD;CD9;PRKCQ;F11R;SH2B3
prerank,regulation of lymphocyte proliferation (GO:0050670),0.7864293147711504,1.641740687359629,0.0076824583866837385,0.07729552054653341,1.0,3/16,4.43%,CD22;LGALS3;TNFSF8
prerank,vacuolar acidification (GO:0007035),0.7388353452876814,1.6416332202837838,0.014943960149439602,0.0770835502921759,1.0,10/21,11.82%,ATP6V0D2;SLC11A1;ATP6V0E1;TCIRG1;CLN3;ATP6V0A2;ATP6V0D1;ATP6AP2;ATP6V0A1;GRN
prerank,negative regulation of transport (GO:0051051),0.6747275220500581,1.6411376456330442,0.002145922746781116,0.07734286717344128,1.0,10/51,5.34%,LILRB1;LGALS3;FCGR2B;SIRPA;ITGB3;TLR2;SNCA;MCTP1;SNX33;RAB7A
prerank,triglyceride catabolic process (GO:0019433),0.7675751668316826,1.6410800321367187,0.007471980074719801,0.07706869966319496,1.0,4/19,8.01%,LPL;FABP4;LIPC;FABP5
prerank,response to interferon-gamma (GO:0034341),0.660097241836102,1.6379567719510448,0.0,0.08072934266677788,1.0,17/67,11.36%,CIITA;IRF8;SLC11A1;CD74;SIRPA;TLR2;CCL8;SNCA;GCH1;CASP1;AIF1;KYNU;CCL14;EPRS1;CCL13;GBP3;CCL2
prerank,macrophage activation involved in immune response (GO:0002281),0.8012541368380972,1.637331573734573,0.004225352112676056,0.08116859153285033,1.0,7/13,11.82%,TREM2;CX3CR1;SYK;PLCG2;TYROBP;DYSF;GRN
prerank,regulation of monocyte chemotaxis (GO:0090025),0.7295945901468829,1.636683773524938,0.00849514563106796,0.08154126404530326,1.0,8/24,8.18%,LYN;CCR2;LGMN;SLAMF8;CREB3;HMGB1;AIF1;PLA2G7
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.8309455365678939,1.6365719954587306,0.004166666666666667,0.08132969911558895,1.0,2/11,0.66%,PF4;CIITA
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.8201044663077903,1.6362381238584442,0.011347517730496455,0.08141135267543086,1.0,3/12,3.96%,LYN;CSF1R;OCSTAMP
prerank,negative regulation of type I interferon production (GO:0032480),0.6900235027423383,1.636133269422509,0.0055309734513274336,0.08122276380002005,1.0,15/40,13.60%,LILRB1;SIRPA;NLRC5;HAVCR2;TRIM25;NLRC3;TNFAIP3;PYCARD;YY1;TAX1BP1;RNF216;NLRX1;ITCH;RNF135;GPATCH3
prerank,regulation of interferon-beta production (GO:0032648),0.6800055596345558,1.635201885687823,0.004429678848283499,0.0820601046393711,1.0,15/46,13.35%,LILRB1;IRF5;SIRPA;TLR2;DHX9;TLR7;TLR8;NLRC3;PYCARD;TRAF3;YY1;TRIM56;RNF216;RNF135;IRF1
prerank,pyroptosis (GO:0070269),0.7809791979604714,1.6348325763856824,0.011019283746556474,0.08226537790899395,1.0,4/15,4.94%,TREM2;AIM2;DHX9;CASP1
prerank,regulation of protein processing (GO:0070613),0.744149199258803,1.6336168180087691,0.009888751545117428,0.08346473438176559,1.0,4/21,4.47%,RUNX1;BAG2;ADAM8;CLN3
prerank,actin filament-based transport (GO:0099515),0.7433770485363946,1.6302583204238656,0.012254901960784314,0.08734819889955359,1.0,7/21,8.24%,MYO1F;MYO1G;MYO1E;MYO5A;ACTN4;MYO7A;MYO19
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.7630766367769968,1.6302420907363069,0.010101010101010102,0.08701783952037655,1.0,1/17,0.08%,PLBD1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.7484421381554891,1.628111822277665,0.02236024844720497,0.08961755250371833,1.0,4/19,2.89%,IRF5;DHX9;TLR7;TLR8
prerank,response to lipopolysaccharide (GO:0032496),0.6345814575330424,1.6276987664374636,0.0,0.08986162713101346,1.0,38/138,13.37%,CD86;LILRB1;PF4;CXCL5;SLC11A1;CX3CR1;STAP1;PDCD1LG2;MAPKAPK3;SIRPA;IL1A;CXCL2;TNFRSF11A;MAPK14;SNCA;GCH1;CD68;IFNAR1;TNFAIP3;PYCARD;CASP1;CD14;HMGB1;CD80;TICAM1;ERBIN;CD180;MEF2C;LY96;CD274;CCL2;TNFRSF1B;PRDX3;NOD2;DEFA6;TAB2;NFKB1;SHPK
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.6307193456691094,1.626389550284571,0.0,0.091208542075357,1.0,28/138,11.53%,LCP2;SLA;PTK2B;GP6;BLNK;FGR;LYN;HCK;CD3E;SYK;CASS4;STAP1;FLT3;CD7;CSF1R;PIK3CB;GUCY2F;CLNK;SHC2;MTSS1;NEDD9;NTF3;ABI1;BCAR1;NPR2;YES1;RAPGEF1;PTPRU
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.732717496732411,1.625210362199639,0.015037593984962405,0.09262896778408623,1.0,10/20,19.25%,MRAP;TGFB1;BCL2L1;CLTC;NUMB;PPFIA1;PID1;AP2M1;PICALM;TMEM59
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.6376714495889655,1.623235534476806,0.0,0.09496309776793183,1.0,27/150,8.16%,CD86;VAV1;CALCR;PIK3CG;PIK3R5;HPSE;TGFB1;CX3CR1;CASS4;HCLS1;FLT3;F10;PIK3CD;PIK3AP1;TGFBR1;ADAM8;PTPRJ;GRB2;PIK3CB;OSM;TNF;IL18;P2RX4;GAB2;CD80;P2RY12;FLT3LG
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.7769835770139557,1.620173990799338,0.018158236057068743,0.09885148216797547,1.0,6/16,7.38%,TREM2;ADCY7;SIRPA;NLRC3;PYCARD;ABCD1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.7104619094439881,1.6200093499064037,0.01179245283018868,0.09875063871330429,1.0,4/27,1.17%,PTK2B;FGR;TGFB1;FLT3
prerank,positive regulation of phospholipase C activity (GO:0010863),0.686480974895205,1.619345402769191,0.005488474204171241,0.09929279651746785,1.0,8/40,8.75%,GNA15;CD86;PLCB2;P2RY6;GNAQ;S1PR4;P2RY12;NTF3
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.7317821221744306,1.6191266153224146,0.009962640099626401,0.09925383395914762,1.0,3/22,2.95%,RUNX1;VSIR;MDK
prerank,negative regulation of interleukin-12 production (GO:0032695),0.7933442597746733,1.6188175572635688,0.016506189821182942,0.09929727793017112,1.0,5/14,11.47%,SLAMF1;LILRB1;TLR8;CMKLR1;THBS1
prerank,regulation of macrophage differentiation (GO:0045649),0.7647124531021896,1.618668664758863,0.025991792065663474,0.09911837136265507,1.0,5/15,12.71%,PF4;C1QC;HSF1;INHBA;CASP8
prerank,regulation of cholesterol storage (GO:0010885),0.788144949469411,1.6170321846454172,0.01510989010989011,0.10121857767505599,1.0,6/15,4.10%,TREM2;LPL;ABCA1;MSR1;SREBF2;ABCG1
prerank,regulation of adaptive immune response (GO:0002819),0.7538265442513469,1.6162048942983778,0.016927083333333332,0.10214322525672068,1.0,7/18,13.35%,FCGR2B;ADCY7;PYCARD;SAMSN1;TRIM27;SASH3;IRF1
prerank,positive regulation of macrophage differentiation (GO:0045651),0.8039721415322405,1.6158272040240507,0.023494860499265784,0.10232149768118118,1.0,4/11,12.71%,PF4;TGFB1;HSF1;CASP8
prerank,negative regulation of immune effector process (GO:0002698),0.804145212209387,1.6158144455446661,0.009446693657219974,0.1019497813097543,1.0,5/13,1.97%,LILRB1;LGALS3;CD300A;HAVCR2;SLAMF8
prerank,negative regulation of immune system process (GO:0002683),0.7643548748176223,1.6154531028965984,0.017356475300400534,0.10214655725392267,1.0,3/16,1.27%,LYN;FCGR2B;PDCD1
prerank,response to peptide (GO:1901652),0.6961903346741584,1.6148127133937225,0.009060022650056626,0.10261225318143605,1.0,14/33,14.00%,IRF5;MMP12;CALCR;STAT5A;ANXA1;CACNA1A;STAT4;ERBIN;STAT5B;EIF2B2;FYN;NOD2;KAT7;CACNA1B
prerank,regulation of acute inflammatory response (GO:0002673),0.7670739984218204,1.6147793818581713,0.013681592039800995,0.10227014886730977,1.0,3/18,3.61%,ADAM8;OSM;FFAR2
prerank,prostanoid biosynthetic process (GO:0046457),0.778416457309499,1.614612038783026,0.012228260869565218,0.1021800563312378,1.0,4/15,2.92%,TBXAS1;CD74;DAGLB;PTGES3
prerank,receptor-mediated endocytosis (GO:0006898),0.627630038702464,1.6140631174761229,0.0,0.10262542791240269,1.0,48/132,18.55%,CLEC9A;ARRB2;LILRB1;SYK;FCGR2B;ITGB2;GRB2;CTSL;MASP1;MSR1;FCGR1A;CD9;GRK3;SNX9;SNCA;FCER1G;APOE;PIP5K1C;LDLRAP1;CLN3;STAB2;DNM2;STAB1;MICALL1;AP2S1;GPR107;RAMP1;DNAJC13;RAB31;ITGAM;CLTC;ARHGAP27;GRK4;SORL1;FNBP1L;CUBN;LRP1;GAK;EPS15;CD36;AP2M1;CXCL16;HSP90AA1;ADM;VLDLR;PICALM;ITGB1;LRP1B
prerank,negative regulation of inflammatory response (GO:0050728),0.6306531926654804,1.6131657139208746,0.0,0.10352157870998706,1.0,42/182,13.63%,TSHB;TREM2;FGR;LYN;CALCR;HCK;SYK;ADCY7;SIRPA;CD200R1;METRNL;PRKAR2B;SLAMF8;PLCG2;CYSLTR2;PRKCD;NR1H4;MDK;MAPK14;FCGR1A;NLRC3;APOE;OTULIN;ADCY6;RHBDF2;TNFAIP3;MYH9;PLK2;RAMP1;RB1;CYSLTR1;YES1;IAPP;PRKACB;TNFRSF1B;GRN;FYN;CREB1;GPS2;FNDC4;ADCY8;ADCY3
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.7729362017178463,1.6128094911828668,0.022486772486772486,0.10369335433148325,1.0,3/15,1.17%,SHH;SYK;CCR2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.671630384440675,1.6122099028047143,0.003289473684210526,0.10415816539610315,1.0,9/49,7.69%,LYN;HCLS1;FLT3;CSF1R;OSM;TNF;IL6R;IL18;EPO
prerank,negative regulation of macrophage activation (GO:0043031),0.7636455549522905,1.6120859883215013,0.017150395778364115,0.10392182253523287,1.0,3/16,3.54%,PTPRC;FCGR2B;CST7
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.7507988169901828,1.610892478633837,0.01509433962264151,0.10518496799421506,1.0,4/18,7.14%,GNA15;RGS10;GNAQ;AGRN
prerank,positive regulation of chemotaxis (GO:0050921),0.6703039238907985,1.6093452080194806,0.007633587786259542,0.10722759978464758,1.0,16/43,13.47%,TREM2;TGFB1;CCR2;LGMN;SMOC2;MDK;PRKD2;IL6R;P2RX4;AIF1;P2RY12;TMSB4X;NRP1;THBS1;STX3;MEGF8
prerank,iron ion transport (GO:0006826),0.6670780316792662,1.6087290885857133,0.003289473684210526,0.10773182680509581,1.0,18/47,15.17%,ATP6V0D2;SLC11A1;ATP6V0E1;TCIRG1;ATP6V1C1;ATP6V1E1;ATP6V0A2;IREB2;DNM2;ATP6V0D1;HFE;ARHGAP1;ATP6V0A1;CLTC;ATP6AP1;FTH1;ATP6V0B;STEAP3
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.7851026287830274,1.6082147503824609,0.016194331983805668,0.10804586345156424,1.0,5/13,7.57%,GATA1;MAD2L2;DDIT3;TAF1;TMSB4X
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.7294244095407741,1.6036925937984077,0.01608910891089109,0.11410310384678837,1.0,5/23,7.79%,PTK2B;IL10RA;IL10RB;TNF;OCIAD1
prerank,positive regulation of locomotion (GO:0040017),0.698614104572336,1.602950034868485,0.021608643457382955,0.11476648361328871,1.0,7/27,12.93%,TREM2;TGFB1;CSF1R;AIF1;P2RY12;THBS1;STX3
prerank,transferrin transport (GO:0033572),0.687168506312425,1.6027496011532658,0.010368663594470046,0.11467225278765573,1.0,15/33,15.17%,ATP6V0D2;ATP6V0E1;TCIRG1;ATP6V1C1;ATP6V1E1;ATP6V0A2;DNM2;ATP6V0D1;HFE;ARHGAP1;ATP6V0A1;CLTC;ATP6AP1;ATP6V0B;STEAP3
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.626330055068362,1.6023564844313227,0.0,0.11487807264899534,1.0,21/151,5.89%,ARRB2;PTPRC;TREM2;PTK2B;SLAMF1;SCIMP;GPNMB;CALCR;TGFB1;CD74;P2RY6;CSF1R;DSTYK;TNFRSF11A;CCL8;TNF;APOE;PRKD2;PYCARD;CD44;HMGB1
prerank,lymphocyte migration (GO:0072676),0.7015024734728628,1.6020305711618057,0.008111239860950173,0.11505009840769181,1.0,7/32,11.36%,MYO1G;CRTAM;ADAM8;CCL8;CCL14;CCL13;CCL2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.5621552561361912,-1.6017319663880514,0.05128205128205128,0.9241345275833724,1.0,12/15,30.35%,SIK1;GPLD1;FBXW7;SCARB1;CTDNEP1;SLC27A1;NR1H2;NR1H3;MFSD2A;LDLR;CNEP1R1;FITM2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.7345174233250232,1.6016828563651668,0.01403061224489796,0.11525315783077016,1.0,11/20,19.25%,MRAP;TGFB1;BCL2L1;CLTC;NUMB;PPFIA1;PID1;AP2M1;PICALM;CSK;TMEM59
prerank,regulation of neutrophil migration (GO:1902622),0.8152590784734398,1.601392501714282,0.017142857142857144,0.11531916619237792,1.0,3/10,8.47%,NCKAP1L;SLAMF8;MPP1
prerank,negative regulation of ossification (GO:0030279),0.7092250130434367,1.6009367337447256,0.015,0.1156906160235549,1.0,6/23,12.06%,PTK2B;SRGN;MDK;MEF2C;SOX9;CHSY1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.7778776475659257,1.600483123900247,0.016042780748663103,0.11592834257922487,1.0,6/14,8.05%,CD86;IL18;ANXA1;CD80;NFKBID;MALT1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.7921944403657584,1.5986900226893903,0.006765899864682003,0.11849231041177959,1.0,3/14,7.31%,PTK2B;CCR2;WNK1
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.71990519699385,1.5975342847586755,0.013819095477386936,0.11975022473948942,1.0,2/22,1.27%,CYP1A1;LGMN
prerank,stem cell differentiation (GO:0048863),0.673428282309509,1.597187824078131,0.007717750826901874,0.1198698668956791,1.0,9/39,10.12%,PTPRC;SHH;MEOX1;SP7;EEF1AKMT4-ECE2;TP53;SETD6;MEF2C;SETD2
prerank,negative regulation of bone mineralization (GO:0030502),0.7867222892143565,1.5962859950385437,0.018387553041018388,0.12096415335608894,1.0,2/13,1.59%,PTK2B;SRGN
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.6647628381610189,1.596113855525513,0.011135857461024499,0.1207826799882943,1.0,13/47,11.47%,TGFB1;SYK;ITGB2;PLCG2;PRKCD;GRB2;MAPK14;XDH;TYROBP;TGFBR2;TP53;ITGAM;THBS1
prerank,response to amyloid-beta (GO:1904645),0.6695112538277768,1.5948999154607788,0.006615214994487321,0.122314415106078,1.0,6/44,1.57%,TREM2;MMP12;CALCR;FCGR2B;LGMN;ITGA4
prerank,regulation of collagen biosynthetic process (GO:0032965),0.732928650740292,1.594849195564413,0.023779724655819776,0.12198425090667105,1.0,5/19,6.39%,RUNX1;CIITA;TGFB1;RGCC;CREB3L1
prerank,macrophage activation (GO:0042116),0.6804294542787406,1.5944153144870299,0.013559322033898305,0.12223922280762409,1.0,13/34,11.97%,TREM2;SLC11A1;SYK;ITGB2;TLR1;PLCG2;TNF;SNCA;AIF1;C1QA;ITGAM;DYSF;CD93
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.6891672445687155,1.5940504670497018,0.012528473804100227,0.12234810371882966,1.0,4/29,6.49%,PLBD1;DBI;LPCAT1;LPCAT2
prerank,glycosaminoglycan catabolic process (GO:0006027),0.6552111175749157,1.5938611452075118,0.003246753246753247,0.12223355875642272,1.0,16/55,9.18%,HPSE;TGFB1;HEXB;GUSB;PRELP;ARSB;GNS;IDS;HEXA;CD44;STAB2;FUCA1;FMOD;SLC9A1;AGRN;BCAN
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.6896926001974175,1.5932550494425444,0.005688282138794084,0.1227583256019962,1.0,10/34,8.95%,TREM2;LYN;CD300A;TNFAIP3;CD14;CD300LF;RAB7B;TICAM1;LY96;GRAMD4
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.6310300708330419,1.5928526594798402,0.0010193679918450561,0.12299032073722563,1.0,18/100,5.21%,TREM2;FGR;LYN;PIK3CG;PIK3R5;HCLS1;FLT3;PIK3CD;CBL;PIK3AP1;PIK3CB;OSM;NLRC3;SEMA4D;TNF;PIP5K1C;PIP4K2A;IL18
prerank,regulation of sequestering of triglyceride (GO:0010889),0.7681805493688699,1.5923778528512238,0.021768707482993196,0.12338359942839143,1.0,5/15,8.10%,TREM2;LPL;PLIN2;OSBPL11;PLIN3
prerank,keratan sulfate catabolic process (GO:0042340),0.8071552045657373,1.59231160513315,0.022566995768688293,0.1230913429961161,1.0,5/11,7.02%,HEXB;PRELP;GNS;HEXA;FMOD
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.6280863574442647,1.5908577505655825,0.002061855670103093,0.1250048362088697,1.0,21/76,11.22%,ARRB2;TMIGD3;AIM2;IRAK2;NLRC5;HAVCR2;NLRC3;OTULIN;DDIT3;TNFAIP3;SPI1;PYCARD;TRAF3;SETD6;TAX1BP1;TMSB4X;ERBIN;ANXA4;CMKLR1;USP7;DAP
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.5613609418419432,-1.5904457448738696,0.055970149253731345,0.9448434245600307,1.0,6/15,11.97%,FOXC1;EDA;GLI2;WNT6;HDAC2;TBX1
prerank,lipid modification (GO:0030258),0.6758008169204758,1.58836414933365,0.010273972602739725,0.12867918476382076,1.0,9/37,8.70%,CYP1A1;DGKZ;ALOX12;DGKK;DGKE;PLA2G7;DGKD;DGKG;PLPPR1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.7551017737681335,1.5882843224403815,0.016883116883116882,0.1283590967910698,1.0,3/17,2.55%,PTPRC;CD300A;MTOR
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.7305800867334219,1.5881438866888353,0.010869565217391304,0.1281578833630459,1.0,7/22,11.87%,NCKAP1L;LGALS3;MGAT5;TNF;PPP1R11;BOD1L1;PPP4R4
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.6183472234712969,1.58810073423835,0.0010080645161290322,0.12779167637988995,1.0,27/140,9.00%,ARHGAP45;ARHGAP30;FGD2;VAV1;ARHGAP25;PREX1;ARHGAP9;ABR;ARHGAP15;ARHGAP39;ARHGAP22;CYRIB;ARHGAP24;VAV2;NUP62;ARHGEF18;ARAP1;VAV3;FAM13B;TAGAP;MYO9B;GNA13;FLCN;ITSN1;ARHGAP21;ARHGAP10;ARHGAP1
prerank,platelet degranulation (GO:0002576),0.6275708607013052,1.5874997693326047,0.0,0.12839920468194263,1.0,32/118,12.87%,FERMT3;LYN;PF4;MMRN1;ITGA2B;TGFB1;LY6G6F;PLEK;SRGN;ITGB3;CYRIB;F13A1;CD9;PSAP;TUBA4A;TTN;CYB5R1;TIMP1;LHFPL2;ACTN4;VEGFB;TMSB4X;SYTL4;VCL;BRPF3;ACTN1;CD63;THBS1;TLN1;F5;TEX264;NHLRC2
prerank,"phagocytosis, engulfment (GO:0006911)",0.6803385191378662,1.5865979249870095,0.012373453318335208,0.12937292244564094,1.0,9/36,6.36%,ARHGAP25;BIN2;FCGR2B;ITGB2;ELMO1;MSR1;FCGR1A;MYH9;AIF1
prerank,leukocyte tethering or rolling (GO:0050901),0.7459171752806348,1.5859162936185487,0.02518891687657431,0.13007357091254543,1.0,4/17,3.84%,CX3CR1;ITGA4;TNF;GCNT1
prerank,cellular response to cytokine stimulus (GO:0071345),0.6147989004478935,1.5857332611136707,0.0,0.13000470477722906,1.0,121/416,16.95%,CD86;SLA;GRAP2;VAV1;PTPN7;DOCK8;IRF5;INPP5D;IL10RA;PF4;PTAFR;HCK;ITGAX;IRF4;IRF8;TGFB1;SYK;ITGB2;HCLS1;FLT3;CCR2;CSF3R;AIM2;STAT5A;SIRPA;NFE2L2;IL1A;IRAK2;CSF2RB;PIK3CD;IL10RB;CBL;CSF1R;TLR2;F13A1;TYK2;CXCL2;PTPRJ;GRB2;TEC;PIK3CB;DHX9;OSM;PTPN18;IL12RB2;CCL8;TNF;OCSTAMP;LDLRAP1;TANK;CXCR4;MYLK3;IL6R;IFNAR1;FOXO3;CEBPA;PYCARD;CASP1;TIMP1;IL18;IFNGR2;RIPOR2;ANXA1;AIF1;GAB2;BCL2L1;CD80;TP53;PIM1;WNK1;STAT4;ERBIN;FLT3LG;SMAD3;RC3H1;CCL14;ITGAM;TNFRSF21;EPRS1;STAT5B;TPR;NPR2;IL18BP;SH2B3;RAPGEF1;CCL13;GBP3;SOX9;CCL2;TNFRSF1B;CDC34;FYN;STX3;LRP8;PRLR;NFKB1;IRF1;SHPK;UBE2G2;PID1;GAS6;TRADD;IL2RG;SOX2;PTPRT;RO60;IL3RA;MAOA;CD36;SBNO2;GSK3A;SELPLG;IL13RA1;IRGM;HIF1A;IL20RB;PTPN12;HSP90AA1;CD47;CCL25;ASAH1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.7211446450002512,1.5853318221719521,0.0175,0.13022101851752454,1.0,5/22,7.79%,IL10RA;IL10RB;MGAT5;TNF;OCIAD1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.7581695177098335,1.5835854104842042,0.019021739130434784,0.1325532835557818,1.0,4/15,7.97%,LILRB1;TGFB1;TNF;HFE
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.7400360062486148,1.5833640071784412,0.019083969465648856,0.13251297419178856,1.0,4/18,7.42%,LILRB1;LILRB3;GPR137B;TMEM178A
prerank,cellular defense response (GO:0006968),0.6707794680095476,1.5817609425887165,0.0078125,0.13492372083823564,1.0,8/40,8.58%,PTK2B;NCR1;CX3CR1;CLEC5A;TCIRG1;NCF2;TYROBP;LY96
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.7246184450194937,1.5813806739714928,0.007453416149068323,0.13508300878337973,1.0,6/23,8.47%,NCKAP1L;CD74;CAMK1D;MDK;RIPOR2;MPP1
prerank,positive regulation of endocytosis (GO:0045807),0.6554277381492692,1.5813358622864446,0.005482456140350877,0.13473875473348973,1.0,18/45,18.35%,NCKAP1L;TREM2;STAP1;CBL;SNCA;APOE;LDLRAP1;CLN3;HFE;RAB31;NEDD4L;B2M;TOR1A;LRP1;APPL2;VPS28;CDC42;FLOT1
prerank,negative regulation of lipid storage (GO:0010888),0.724984558467403,1.5791682573575374,0.02781289506953224,0.13810572549403208,1.0,5/19,4.10%,TREM2;ABCA1;ITGB3;TNF;ABCG1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.6715567618064922,1.5771377688047143,0.014606741573033709,0.1411699402572191,1.0,10/35,12.33%,NCKAP1L;LYN;GATA1;MAPK14;FOXO3;SPI1;TAL1;STAT5B;INHBA;CDK6
prerank,regulation of leukocyte migration (GO:0002685),0.744027766636782,1.577052954850369,0.028423772609819122,0.14090887157996024,1.0,2/16,6.22%,NCKAP1L;ANXA1
prerank,response to molecule of bacterial origin (GO:0002237),0.6318314402709745,1.5770269062846978,0.0031446540880503146,0.14052853147897035,1.0,14/69,8.58%,IRF5;SLC11A1;FCGR2B;MAPKAPK3;CYRIB;CXCL2;TNFRSF11A;SNCA;GCH1;IFNAR1;TNFAIP3;CD14;ERBIN;LY96
prerank,stem cell development (GO:0048864),0.7486936819539194,1.5762897489838723,0.018229166666666668,0.14137159101372257,1.0,2/16,0.65%,PTPRC;SHH
prerank,fibrinolysis (GO:0042730),0.786517530524307,1.576132960023419,0.022339027595269383,0.1412261404642344,1.0,1/13,0.83%,GP1BA
prerank,negative regulation of endocytosis (GO:0045806),0.6983408686676211,1.576100534243691,0.02155688622754491,0.14083572687423454,1.0,5/24,4.76%,LILRB1;LGALS3;CD300A;MCTP1;SNX33
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.7324228746214887,1.5753978035701541,0.028169014084507043,0.14172036360956414,1.0,4/18,7.31%,GPNMB;LAPTM5;DUSP3;WNK1
prerank,eosinophil migration (GO:0072677),0.7704203413160984,1.5753458935300433,0.023715415019762844,0.14093741819046646,1.0,4/14,11.36%,LGALS3;CCL8;CCL13;CCL2
prerank,eosinophil chemotaxis (GO:0048245),0.7704203413160984,1.5753458935300433,0.023715415019762844,0.14093741819046646,1.0,4/14,11.36%,LGALS3;CCL8;CCL13;CCL2
prerank,positive regulation of type 2 immune response (GO:0002830),0.7688392590687487,1.5749759106689554,0.03337783711615487,0.14111620939099145,1.0,5/14,12.42%,CD86;CD74;IL18;DENND1B;NOD2
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.6163627916351114,1.5744919659349448,0.0,0.1414056706997631,1.0,22/109,8.63%,LCP2;GRAP2;VAV1;BTK;LYN;CARD11;SYK;LAT;PLCG2;NFATC1;GRB2;TEC;PIK3CB;VAV2;LAT2;FCER1G;VAV3;GAB2;PSMB10;MALT1;PRKCQ;MAP3K1
prerank,Fc receptor signaling pathway (GO:0038093),0.6172479472785259,1.574160169446561,0.0,0.1415355435695891,1.0,22/110,8.63%,LCP2;GRAP2;VAV1;BTK;LYN;CARD11;SYK;LAT;PLCG2;NFATC1;GRB2;TEC;PIK3CB;VAV2;LAT2;FCER1G;VAV3;GAB2;PSMB10;MALT1;PRKCQ;MAP3K1
prerank,cellular response to zinc ion (GO:0071294),0.7606413651524147,1.5729125387427212,0.02699055330634278,0.14313027924576802,1.0,13/15,22.40%,P2RX4;GLRA2;HVCN1;ATP13A2;MT3;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,positive regulation of collagen metabolic process (GO:0010714),0.7340454941291035,1.57270411310886,0.028205128205128206,0.1431034542558774,1.0,5/17,6.39%,RUNX1;TGFB1;VSIR;RGCC;CREB3L1
prerank,negative regulation of biomineral tissue development (GO:0070168),0.7086968289979476,1.5722026230617545,0.021628498727735368,0.1435644575744315,1.0,3/21,1.59%,PTK2B;TGFB1;SRGN
prerank,positive regulation of response to external stimulus (GO:0032103),0.6092690928976645,1.571945768763591,0.0010152284263959391,0.143585423668239,1.0,31/128,13.86%,TREM2;SCIMP;TGFB1;CCR2;LPL;TLR2;GPRC5B;ADAM8;DHX9;TLR7;TLR8;MDK;LY86;OSM;TNF;SNCA;CEBPA;IL18;USF1;AIF1;P2RY12;CD180;PLA2G7;LY96;PUM2;ABCC1;THBS1;GRN;STX3;NINJ1;TRADD
prerank,positive regulation of lipid storage (GO:0010884),0.7202767243683785,1.571383090362698,0.012484394506866416,0.1441489577404724,1.0,8/21,13.20%,LPL;MSR1;SREBF2;PLIN2;OSBPL11;PLIN3;VSTM2A;NFKB1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.80542919270676,1.5705451364994045,0.021834061135371178,0.1451590361441367,1.0,4/10,9.88%,FERMT3;CD3E;WNK1;PODXL
prerank,positive regulation of dendrite development (GO:1900006),-0.6437788010371686,-1.569733004635788,0.039711191335740074,1.0,1.0,6/10,11.03%,COBL;PTN;ALK;DAB2IP;BMP5;PACSIN1
prerank,positive regulation of acute inflammatory response (GO:0002675),0.7700688404757999,1.5695843358791353,0.02557200538358008,0.14643894013163378,1.0,4/14,3.79%,ADAM8;OSM;FFAR2;TNF
prerank,transepithelial transport (GO:0070633),-0.5613778397251312,-1.5694875136637865,0.03111111111111111,0.9784708584533123,1.0,4/15,8.52%,SLC12A2;ABCG2;CXADR;GPLD1
prerank,regulation of innate immune response (GO:0045088),0.6333745909593265,1.5689573528664447,0.009574468085106383,0.14711900948793644,1.0,18/57,13.98%,TREM2;FGR;FCGR2B;ADAM8;PTPN1;DHX9;TLR8;NLRC3;TNFAIP3;TRAFD1;SAMHD1;RNASEL;USP18;CASP8;RNF135;LRP8;IRF1;ERAP1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.7871602708612688,1.5686610756060348,0.03762662807525326,0.14720754983872203,1.0,3/11,8.15%,LYN;SYK;PRKCQ
prerank,positive chemotaxis (GO:0050918),0.7403657822205085,1.5670822145180507,0.022988505747126436,0.14956068603172495,1.0,4/17,2.32%,GPNMB;LGALS3;CORO1A;PTPRJ
prerank,lipid oxidation (GO:0034440),0.7924813511357478,1.5660756978728023,0.021917808219178082,0.15092357791723837,1.0,5/12,17.07%,ALOX12;PLA2G7;PPARGC1A;ADIPOR1;ADIPOR2
prerank,melanocyte differentiation (GO:0030318),0.7869858893711706,1.5654219237904354,0.022727272727272728,0.1516752267450511,1.0,3/11,8.17%,LRMDA;MITF;MEF2C
prerank,regulation of defense response (GO:0031347),0.624898949347677,1.5650447311479974,0.003121748178980229,0.1517911837965751,1.0,27/76,14.25%,TREM2;FGR;HCK;FCGR2B;CCR2;PIK3AP1;DAGLB;APOE;CASP1;TRAF3;SAMHD1;ANXA1;AKNA;SETD6;TMSB4X;ZMPSTE24;GRN;USP18;NOD2;LACC1;CASP8;RNF135;LRP8;IRF1;SHPK;ERAP1;AREL1
prerank,negative regulation of bone remodeling (GO:0046851),0.7970540234257969,1.5649221277857963,0.029745042492917848,0.1515263981083744,1.0,4/11,4.82%,UBASH3B;P2RX7;GPR137B;TNFAIP3
prerank,negative regulation of signaling (GO:0023057),0.6865284231644755,1.5633547287514968,0.021634615384615384,0.154084708353076,1.0,4/25,3.17%,UBASH3B;PCSK9;PTPN1;OSM
prerank,heart process (GO:0003015),-0.5653252173892289,-1.5625410389329546,0.05791505791505792,0.9755780162855137,1.0,4/14,9.47%,SGCD;SGCZ;SOD1;ACE
prerank,cellular response to copper ion (GO:0071280),0.7463934946955142,1.5616015686486597,0.026845637583892617,0.15700320102364465,1.0,12/16,22.40%,AQP1;SNCA;HSF1;MT3;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,lipid translocation (GO:0034204),0.7205468719913778,1.561281500238549,0.02258469259723965,0.15714961422144186,1.0,8/21,12.98%,ATP8B4;ABCA1;RFT1;ATP8A1;ATP8A2;ABCB4;ABCC1;ABCA4
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.5913011551947454,-1.5610904264740655,0.057971014492753624,0.9380070232128553,1.0,10/13,23.45%,MTM1;FEZ1;TMEM39A;PINK1;CHMP4A;CHMP4B;NUPR1;PHF23;SMCR8;FEZ2
prerank,response to acidic pH (GO:0010447),0.7663608904037835,1.5608743164010672,0.01637107776261937,0.15746543396976911,1.0,5/13,12.59%,CTSS;LGMN;SLC9A1;IMPACT;RAB11FIP5
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.7947697423795194,1.5608515968984047,0.022727272727272728,0.1570623628481062,1.0,3/11,9.16%,TREM2;KCNIP2;NOS1AP
prerank,positive regulation of interleukin-10 production (GO:0032733),0.6871867579803579,1.5608509930840457,0.01410105757931845,0.15661489172888082,1.0,7/30,12.42%,IRF4;SYK;PLCG2;PYCARD;HMGB1;CD274;NOD2
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.5875233766223661,-1.5605463656377305,0.03383458646616541,0.8987708353544609,1.0,3/11,2.36%,ZFPM2;BMPR1A;BMP4
prerank,triglyceride homeostasis (GO:0070328),0.6881246004045887,1.5599277576282373,0.021454112038140644,0.1578258966617585,1.0,7/26,6.37%,LPL;NR1H4;MLXIPL;ANGPTL3;APOE;IL18;LIPC
prerank,response to ATP (GO:0033198),0.7315736479823893,1.5597205886265912,0.021108179419525065,0.15785472712227597,1.0,6/18,7.53%,KCNJ11;P2RX7;P2RY2;P2RX4;TAF1;P2RY12
prerank,macrophage chemotaxis (GO:0048246),0.797879050777597,1.559215417599187,0.03361344537815126,0.15840138673774942,1.0,2/10,2.44%,LGALS3;EDNRB
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.6615815900934162,1.5590410491309898,0.021493212669683258,0.15828703639827532,1.0,10/35,11.65%,PTPRC;IL10RA;IL10RB;TNF;OCIAD1;DOT1L;NF2;SH2B3;NLK;ADIPOR1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.6881012230301984,1.558736056949892,0.030915576694411414,0.15831432856913533,1.0,7/27,5.21%,PF4;LPL;ABCA1;ITGB3;MSR1;ABCG1;IL18
prerank,negative regulation of interferon-beta production (GO:0032688),0.8177487556659875,1.5578115826390813,0.013254786450662739,0.15962413100800235,1.0,5/10,7.13%,LILRB1;SIRPA;NLRC3;PYCARD;YY1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.6954537280960305,1.5569655565279816,0.02158273381294964,0.16084935623047397,1.0,2/25,0.39%,ARRB2;NPAS4
prerank,phagosome-lysosome fusion (GO:0090385),0.7951913066022027,1.5559622353118612,0.03008595988538682,0.16218474945255887,1.0,5/10,5.34%,RAB39A;RAB34;CLN3;RAB7A;RAB7B
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.7173622637617005,1.555486468952172,0.03329223181257707,0.16265335863259395,1.0,8/21,12.64%,CX3CR1;MDK;FZD9;FZD3;CTNNB1;DISC1;NAP1L1;SMARCD3
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.6222599207033159,1.5550869294965521,0.0031282586027111575,0.16296329827140893,1.0,22/72,15.11%,RUNX1;PTPRC;SYK;CD74;IRAK2;PTPN1;TNF;OTULIN;TRAF2;TNFAIP3;PYCARD;IFNGR2;CFLAR;TAX1BP1;RNASEL;USP18;CASP8;IKBKG;GAS6;TRADD;SPPL2A;PIAS1
prerank,acylglycerol homeostasis (GO:0055090),0.7177086503389517,1.5547767407807858,0.03015075376884422,0.16313569232060823,1.0,6/20,6.37%,LPL;MLXIPL;ANGPTL3;APOE;IL18;LIPC
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.6687323182784728,1.5537084171332052,0.015819209039548022,0.1648564490785368,1.0,11/35,10.88%,PTK2B;HCK;HCLS1;STAP1;IQGAP2;CSF1R;MDK;NTF3;ARHGDIB;F11R;NRP1
prerank,inositol lipid-mediated signaling (GO:0048017),0.6433094789960141,1.5536906653686255,0.005330490405117271,0.16444857570575994,1.0,9/50,6.43%,PTAFR;PIK3CG;PLCB2;PLCL2;PIK3CD;CSF1R;PIK3CB;ADAP2;GAB2
prerank,secretory granule organization (GO:0033363),0.8050439054240517,1.553469007500163,0.03170028818443804,0.16436288960458104,1.0,3/10,1.59%,LYST;ABCA1;SRGN
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.689675157234875,1.5528837198152683,0.02026221692491061,0.1651089543140919,1.0,7/25,10.48%,NCKAP1L;GATA1;MAPK14;FOXO3;TAL1;STAT5B;INHBA
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.7962696773239124,1.5526924952415138,0.027220630372492838,0.1649856488088707,1.0,2/10,0.53%,LILRB1;LYN
prerank,phospholipid homeostasis (GO:0055091),0.7950355664029399,1.552404218727525,0.02881844380403458,0.16506344125814762,1.0,3/11,4.10%,ABCA1;ANGPTL3;ABCG1
prerank,mammary gland development (GO:0030879),-0.46929394638237765,-1.5521895120204667,0.041025641025641026,0.908981017317409,1.0,8/21,16.10%,CAV1;ARHGAP35;WNT4;GLI2;TBX3;GPAT4;TGFB3;NOTCH4
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.6440976340703436,1.5489239929221723,0.022197558268590455,0.171115142194562,1.0,10/38,8.07%,PTPRC;CASS4;CSF1R;GPRC5B;THY1;PTPN1;FCGR1A;NCK2;NEDD9;RAP2B
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.7567144357009763,1.547746227907055,0.032520325203252036,0.1731167873905052,1.0,4/13,2.88%,IRAK2;PIK3AP1;UNC93B1;TLR7
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.7211736901273843,1.5473808222273446,0.023346303501945526,0.17339845317854968,1.0,7/19,11.47%,CSF1R;CAMK1D;MDK;MPP1;AKIRIN1;CMKLR1;THBS1
prerank,somite development (GO:0061053),0.7931645064407621,1.5470014625520583,0.03170028818443804,0.17363179025207648,1.0,2/11,0.68%,SHH;MEOX1
prerank,T cell migration (GO:0072678),0.7696542367090531,1.5465743185171366,0.023578363384188627,0.17410006696585018,1.0,3/13,1.61%,MYO1G;PIK3CG;PIK3CD
prerank,phospholipid catabolic process (GO:0009395),0.6936102313096935,1.5465561892889794,0.022170361726954493,0.1736619493760146,1.0,3/24,3.14%,PLBD1;ABHD12;ANGPTL3
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.7399109919494851,1.5459552365441447,0.03229974160206718,0.17436531103977337,1.0,1/16,0.06%,MRAP
prerank,response to copper ion (GO:0046688),0.7081063283994099,1.5452868595086158,0.03299492385786802,0.17515211514887252,1.0,13/20,22.40%,IL1A;AQP1;SNCA;HSF1;MT3;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,positive regulation of lipid transport (GO:0032370),0.7840739119948608,1.5451141173476926,0.03193033381712627,0.17501359245725248,1.0,6/12,15.52%,DBI;SPP1;APOE;ABCB4;LRP1;ABCA3
prerank,regulation of protein kinase activity (GO:0045859),0.6102312020912591,1.544551621422866,0.0010121457489878543,0.17569153565251147,1.0,26/106,13.81%,PTPRC;LCP2;PTK2B;FGR;UBASH3B;LAT;MMD;THY1;GNAQ;SNX9;TNF;SNCA;TTN;XRCC5;MAP2K3;RAP2B;TRIM27;RB1;UVRAG;QARS1;DUSP19;DTNBP1;TAB2;CAMKK2;GAS6;RTRAF
prerank,retinol metabolic process (GO:0042572),0.7414701822780022,1.5442204974982865,0.02880658436213992,0.17594694782907827,1.0,2/14,3.02%,CYP1A1;DHRS3
prerank,regulation of protein kinase B signaling (GO:0051896),0.6042484826927107,1.5432725984184228,0.0,0.17739795658237378,1.0,34/193,9.45%,ARRB2;CD86;VAV1;CALCR;PIK3CG;PIK3R5;HPSE;TGFB1;CX3CR1;CASS4;HCLS1;FLT3;F10;PIK3CD;PIK3AP1;TGFBR1;ADAM8;PTPRJ;GRB2;PIK3CB;OSM;TNF;DDIT3;IL18;XDH;P2RX4;OTUD3;GAB2;CD80;P2RY12;FLT3LG;FLCN;PDCD6;STRN
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.7391860313880543,1.5431667364121606,0.0374331550802139,0.1771823976984733,1.0,7/15,15.32%,PF4;LPL;MSR1;IL18;PRKCH;NFKB1;CD36
prerank,zymogen activation (GO:0031638),0.6502169473660432,1.5426789801072893,0.017486338797814208,0.17770007109257352,1.0,9/39,13.97%,KLK3;LGMN;VSIR;CTSL;ASPH;TBC1D10A;BAK1;CASP8;KLK2
prerank,regulation of MAP kinase activity (GO:0043405),0.6119187282947463,1.5424132940417261,0.002028397565922921,0.17769347537452912,1.0,13/92,4.04%,LYN;PIK3CG;PIK3R5;TGFB1;FLT3;CD300A;ADAM8;PTPRJ;PRKCD;PTPN1;PIK3CB;TNF;APOE
prerank,erythrocyte development (GO:0048821),0.8073507229207666,1.5411578147332328,0.024817518248175182,0.17960501284671404,1.0,2/10,1.20%,NCKAP1L;GATA1
prerank,regulation of nervous system process (GO:0031644),-0.5040514339968285,-1.5411262568416615,0.03361344537815126,0.9342560009807142,1.0,7/18,12.19%,APP;DLGAP1;HTR2C;DLGAP2;SLC8A3;CHRNA7;NOS3
prerank,inorganic ion transmembrane transport (GO:0098660),0.7690774771521837,1.5407765043865578,0.031724137931034485,0.17990481734576022,1.0,2/12,4.08%,KCNJ11;PKD2
prerank,negative regulation of cell development (GO:0010721),0.6927656259407212,1.540538023918534,0.027413587604290822,0.17990317674752898,1.0,9/25,16.59%,HOOK3;LILRB1;TNF;PCM1;SORL1;B2M;RFLNA;GSK3A;APPL2
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.6807130717292178,1.5400279720743677,0.019002375296912115,0.18038595500800278,1.0,6/25,8.59%,TGFB1;GATA1;MAD2L2;NSD1;DOT1L;RB1
prerank,hemopoiesis (GO:0030097),0.6093583565168971,1.539882052920745,0.002061855670103093,0.18018242541993243,1.0,17/87,12.00%,RUNX1;PTPRC;PLD4;TGFB1;PLEK;FLT3;CSF1R;CEBPA;TGFBR2;TP53;TAL1;FLT3LG;FLCN;INHBA;SH2B3;ETV6;PRDX3
prerank,anterior/posterior axis specification (GO:0009948),0.7450488649230562,1.5392465132282953,0.026595744680851064,0.1809595825836392,1.0,3/15,4.80%,SHH;SKI;DDIT3
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.6691028259195857,1.5357096998451023,0.024447031431897557,0.1876270451712034,1.0,4/29,4.35%,TGFB1;MYL3;PKP2;TTN
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.6799623590299729,1.5352258411003472,0.032766990291262135,0.18814014978488908,1.0,3/27,6.04%,GNA15;LPAR6;GPR17
prerank,regulation of response to external stimulus (GO:0032101),0.6008298340285497,1.5348851388954539,0.001017293997965412,0.1883866944451627,1.0,40/121,15.55%,TREM2;FGR;HCK;GP1BA;FCGR2B;CCR2;CYRIB;PIK3AP1;DAGLB;TRIM5;GUCY2F;CXCR4;CASP1;TRAF3;SAG;P2RX4;SAMHD1;ANXA1;CNGB1;AKNA;SETD6;P2RY12;TMSB4X;ZMPSTE24;GRN;USP18;GRK4;NOD2;LACC1;CASP8;RNF135;LRP8;IRF1;SHPK;STK24;ERAP1;AREL1;CD36;METAP2;SBNO2
prerank,cellular response to lipid (GO:0071396),0.5932439162846754,1.5348554216487604,0.0,0.18796207839204884,1.0,48/191,13.64%,CD86;PTK2B;LILRB1;LYN;PF4;CXCL5;CX3CR1;STAP1;PDCD1LG2;SIRPA;IL1A;LPL;MAP4K1;AQP1;FZD10;CXCL2;NR1H4;MAPK14;FFAR2;SPP1;CD68;ADCY6;TNFAIP3;PYCARD;CASP1;CD14;HMGB1;ABCB4;CD80;TICAM1;CD180;MEF2C;LY96;CD274;SOX9;CCL2;NRIP1;TNFRSF1B;TWF2;NOD2;DEFA6;CREB1;MGST1;NFKB1;SHPK;ADCY8;ADCY3;PID1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.7208683768631637,1.5346889219517261,0.037641154328732745,0.18780742006048287,1.0,4/18,3.84%,CX3CR1;ITGA4;TNF;GCNT1
prerank,excitatory postsynaptic potential (GO:0060079),0.7186379331589727,1.5340073163948773,0.02392947103274559,0.18861311764348607,1.0,2/19,0.39%,ARRB2;NPAS4
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.6612608107365544,1.533975738245954,0.028768699654775604,0.18822218929492232,1.0,6/32,12.50%,PF4;CXCL5;CXCL2;CXCL14;CCL13;DEFA6
prerank,cellular protein catabolic process (GO:0044257),0.6208016611596174,1.5330384594527184,0.009584664536741214,0.18969368066419875,1.0,22/59,16.57%,CTSS;CTSB;PCSK9;LGMN;CTSC;MYLIP;TCIRG1;CTSK;CTSL;RAB7A;LONP1;AP2S1;MALT1;CHEK2;CTSZ;CLTC;CASP8;UBE2G2;CAPN2;AP2M1;IDE;YME1L1
prerank,tryptophan metabolic process (GO:0006568),0.7750187498289843,1.532308486372025,0.032670454545454544,0.1907639721973976,1.0,4/11,7.90%,ATP7A;HAAO;KYNU;KMO
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.5088038982720974,-1.5317915022720603,0.03626943005181347,0.9506439866031926,1.0,7/19,11.79%,DLG2;CLIC4;PRKCI;SYNJ2BP;PARD3;DLG1;MTCL1
prerank,lymphocyte chemotaxis (GO:0048247),0.6576500756909722,1.5315450915594653,0.023542600896860985,0.19178525236896513,1.0,12/34,18.79%,PIK3CG;PIK3CD;ADAM8;CCL8;CCL14;GPR183;CCL13;CCL2;GAS6;CXCL16;CCL25;CKLF
prerank,regulated exocytosis (GO:0045055),0.5979482368828192,1.5306949994192276,0.0,0.19299862484074617,1.0,43/173,12.87%,FERMT3;LYN;PF4;MMRN1;ITGA2B;TGFB1;LY6G6F;SYT17;PLEK;SRGN;ITGB3;CYRIB;F13A1;SDF4;CD9;PSAP;SNCA;PIP5K1C;TUBA4A;TTN;CYB5R1;TIMP1;MYH9;LHFPL2;ACTN4;SYT2;VEGFB;TMSB4X;RAB31;SYT10;SYTL4;VCL;BRPF3;SYNGR1;ACTN1;SYNGR2;CD63;THBS1;TLN1;F5;RAB11FIP5;TEX264;NHLRC2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.718631253304467,1.528474460947362,0.043092522179974654,0.19718975984709616,1.0,3/17,1.81%,SCIMP;LYN;TAOK3
prerank,positive regulation of actin filament polymerization (GO:0030838),0.6460053858242164,1.5281054957598692,0.008714596949891068,0.19751723615740613,1.0,6/44,4.91%,NCKAP1L;PTK2B;HCK;NCK2;SNX9;PYCARD
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.6943099989978322,1.527930817069817,0.03067484662576687,0.19740078668555142,1.0,5/22,9.17%,TREM2;LYN;TNFAIP3;RAB7B;WDFY1
prerank,heterotypic cell-cell adhesion (GO:0034113),0.6879744904086782,1.5272273625429285,0.031862745098039214,0.19848681911358718,1.0,6/25,3.74%,ITGAX;ITGB2;ITGA4;CD200R1;ITGB3;PKP2
prerank,negative regulation of ion transport (GO:0043271),0.6892646689722753,1.5256899447295442,0.030193236714975844,0.20115089565752328,1.0,4/24,7.31%,PTK2B;LILRB1;SNCA;WNK1
prerank,negative regulation of protein localization to membrane (GO:1905476),0.6835460274331949,1.5249384689321255,0.029593094944512947,0.20225514271868592,1.0,11/24,20.24%,MRAP;TGFB1;BCL2L1;CLTC;NUMB;PPFIA1;PID1;AP2M1;PICALM;TMEM59;INPP5K
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.6753270893512413,1.524899626355846,0.025,0.20185888033723798,1.0,10/27,15.32%,BTK;IRAK2;TLR1;TLR2;CD14;LY96;MAP3K1;TAB2;TAB3;CD36
prerank,regulation of activated T cell proliferation (GO:0046006),0.6617419433024645,1.5247100574744843,0.026869158878504672,0.20180854083666133,1.0,7/30,9.89%,PDCD1LG2;CRTAM;PYCARD;IL18;HMGB1;RC3H1;CD274
prerank,regulation of neuroinflammatory response (GO:0150077),0.7167247151543762,1.5246847269939232,0.03209242618741977,0.2013777380984748,1.0,4/19,5.21%,TREM2;CD200R1;TNF;IL18
prerank,renal water homeostasis (GO:0003091),0.6897070430542965,1.5240928185769644,0.033734939759036145,0.20211336492954327,1.0,10/23,14.48%,ADCY7;PRKAR2B;AQP1;ADCY6;TFAP2B;RAB11A;PRKACB;ADCY8;ADCY3;WFS1
prerank,regulation of hemopoiesis (GO:1903706),0.7985505881334062,1.52367442850052,0.029829545454545456,0.202441630482721,1.0,3/10,6.25%,RUNX1;LGALS3;PRKCB
prerank,positive regulation of protein kinase activity (GO:0045860),0.5950288037200375,1.5236214524893523,0.0,0.20207707519192178,1.0,49/148,18.86%,PTPRC;LCP2;PTK2B;SLC11A1;CASS4;LAT;ITGB3;TAOK3;CSF1R;GPRC5B;MMD;PRKCD;PTPN1;FCGR1A;SNX9;TNF;SNCA;IL6R;XRCC5;MAP2K3;TGFBR2;NEDD9;TNIK;KIF14;STRADB;MAP2K2;DUSP19;PARP16;PPP2CA;TAB2;LRP8;GAS6;STK3;RAP1A;PIH1D1;SRC;STRADA;INCENP;SYAP1;ALS2;IRGM;STK4;EPHA4;HSP90AA1;IQGAP1;RHOA;TAOK1;MINK1;RPTOR
prerank,regulation of BMP signaling pathway (GO:0030510),-0.37969815324411177,-1.5218394742982624,0.02857142857142857,0.9708490201864881,1.0,21/73,13.64%,FSTL1;CDH5;CRIM1;BMPR1A;BMPER;FOXD1;BMP4;NBL1;SULF1;ZNF423;ACVRL1;SMAD9;XIAP;PCSK6;SMAD4;SMAD5;SMAD1;TWSG1;CCN1;SMAD6;UBE2O
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.6296817195308437,1.5215664339495134,0.006521739130434782,0.20583920514584605,1.0,13/48,13.65%,PTPRC;TREM2;STAP1;NLRC5;RFFL;SAMHD1;YTHDF3;SH2B3;TTLL12;USP18;METTL3;GPS2;GAS6
prerank,lysosome localization (GO:0032418),0.644179247658592,1.521332861263657,0.01991150442477876,0.20583689249415768,1.0,13/37,12.77%,PIK3CG;PLEKHM2;PIK3CD;RAB34;KLC2;PLEKHM1;MYH9;TFEB;FLCN;SYTL4;HDAC6;BORCS5;PIP4P1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.6970852999692687,1.5202697016883941,0.02926829268292683,0.20723101261187524,1.0,5/21,6.47%,PF4;GATA1;IL1A;TNF;BCL2L1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.6970852999692687,1.5202697016883941,0.02926829268292683,0.20723101261187524,1.0,5/21,6.47%,PF4;GATA1;IL1A;TNF;BCL2L1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6758815771683293,1.5194565930824824,0.024096385542168676,0.20848316627888475,1.0,4/26,1.38%,HPSE;TGFB1;CCR2;IL1A
prerank,intracellular cholesterol transport (GO:0032367),0.7415597626183325,1.5183840902517147,0.03580901856763926,0.21039592974555385,1.0,7/15,14.72%,ABCA1;NPC2;ABCG1;LDLRAP1;NPC1;OSBP;STARD4
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.6545147694559276,1.5182215112913906,0.026285714285714287,0.2102091822758478,1.0,4/33,2.70%,PIK3CG;PIK3R5;PIK3CD;PIK3CB
prerank,cellular component disassembly (GO:0022411),0.626036226223014,1.5174164417393408,0.015940488841657812,0.21151847316770736,1.0,9/53,5.66%,CTSS;MMP12;LCP1;SH3PXD2B;ADAM8;CTSK;CTSL;TIMP1;CD44
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.6202588762689798,1.5165862900907672,0.015005359056806002,0.2128337105260752,1.0,12/57,12.38%,LYN;HCLS1;FLT3;CSF1R;OSM;TNF;IL6R;IL18;EPO;NF2;SH2B3;PPP2CA
prerank,regulation of Golgi organization (GO:1903358),0.7041328255334138,1.5158562739969401,0.050518134715025906,0.21390724615013018,1.0,9/17,17.68%,MYO5A;ARMH3;RBSN;USP6NL;MAP2K2;STX5;RAB33B;CAMSAP2;AKAP9
prerank,positive regulation of MAP kinase activity (GO:0043406),0.6166140065732171,1.515799861270743,0.006263048016701462,0.21350326961346996,1.0,10/66,4.39%,PIK3CG;PIK3R5;TGFB1;FLT3;TAOK3;FZD10;ADAM8;TNFRSF11A;TNF;TRAF2
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.6158559860176649,1.5151254127604816,0.007246376811594203,0.21445177537116772,1.0,18/76,11.87%,NCKAP1L;PTK2B;HCK;PLEK;HCLS1;STAP1;P2RX7;NUP62;NCK2;SNX9;MYLK3;PYCARD;PLK4;NTF3;PFN2;NRP1;PFN1;DYNC1H1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.455443929566431,-1.5147814101775223,0.03571428571428571,0.9778223429953589,1.0,5/26,2.29%,FOXP1;SMARCA4;KANK2;CLOCK;NCOR1
prerank,phosphatidylinositol metabolic process (GO:0046488),0.5978950004925092,1.5147772789366125,0.00101010101010101,0.2146919884421789,1.0,15/109,4.98%,PLBD1;INPP5D;PIK3CG;PIK3R5;PLCB2;PLEK;PIK3CD;PLCG2;CSF1R;PIK3CB;PIP5K1C;INPP4B;PIP4K2A;PI4K2A;RAB14
prerank,positive regulation of transport (GO:0051050),0.5934425622273174,1.5146358520686922,0.006166495375128468,0.2144765825078266,1.0,30/85,20.32%,DOCK2;TREM2;SLC11A1;FCGR2B;SIRPA;CAMK1D;TNF;SNCA;FCER1G;APOE;PYCARD;ANXA1;ACTB;BAK1;NEDD4L;DYNC1H1;MERTK;GAS6;IL2RG;LRP1;GSK3A;CD47;LMAN2;FLOT1;RXRA;PLA2G5;PLAA;SMPD1;INPP5K;GSK3B
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.7675952680234118,1.5141915018051886,0.0513950073421439,0.21490513999294394,1.0,3/10,8.15%,NCKAP1L;TGFBR2;PRKCQ
prerank,cyclooxygenase pathway (GO:0019371),0.772699421149852,1.514122273382825,0.0436046511627907,0.21452269910940133,1.0,3/10,3.22%,TBXAS1;PTGES3;HPGDS
prerank,angiogenesis involved in wound healing (GO:0060055),0.7579131630259635,1.5140063290730492,0.04126547455295736,0.21430441832531102,1.0,2/11,1.71%,HPSE;ITGB3
prerank,intracellular sterol transport (GO:0032366),0.7626092762688506,1.5138207432281843,0.02880658436213992,0.21419435837661888,1.0,7/13,14.97%,ABCA1;NPC2;ABCG1;NPC1;OSBP;STARD4;ARV1
prerank,extracellular matrix disassembly (GO:0022617),0.6257801697312102,1.5130668036940593,0.013888888888888888,0.21537304485346595,1.0,9/53,5.66%,CTSS;MMP12;LCP1;SH3PXD2B;ADAM8;CTSK;CTSL;TIMP1;CD44
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.6121144643141383,1.5129109683331547,0.013513513513513514,0.2152349362847857,1.0,8/69,2.70%,PTAFR;PIK3CG;PIK3R5;PLCB2;PLCL2;PIK3CD;CSF1R;PIK3CB
prerank,cholesterol transport (GO:0030301),0.6327209931120295,1.5127846565355738,0.02054054054054054,0.21499336865911028,1.0,10/45,6.37%,ABCA1;MSR1;NPC2;APOE;ABCG1;LDLRAP1;CEL;NPC1;SOAT2;LIPC
prerank,lysosome organization (GO:0007040),0.6401557425568786,1.5118332744153031,0.02771618625277162,0.21668135208150685,1.0,15/36,17.60%,HOOK3;ABCA1;CORO1A;MTOR;ARSB;CLN3;VPS18;TFEB;MYO7A;GRN;HOOK2;LRRK2;GNPTAB;TMEM165;LAMTOR1
prerank,mesenchyme development (GO:0060485),0.7271896332470431,1.5107896799438167,0.044,0.21844870828577564,1.0,3/15,4.08%,MEOX1;TGFBR1;PKD2
prerank,regulation of amyloid-beta clearance (GO:1900221),0.7152309271456204,1.5107705248131555,0.05228758169934641,0.21798997124626976,1.0,4/16,7.06%,TREM2;TNF;APOE;MYOCD
prerank,positive regulation of glucose import (GO:0046326),-0.48062519912913065,-1.5101901585264548,0.034482758620689655,0.970781318023295,1.0,6/21,15.19%,SORBS1;PRKCI;IRS1;ARPP19;OCLN;AKT1
prerank,calcium-mediated signaling (GO:0019722),0.6029677416834998,1.5097075978446555,0.002034587995930824,0.21976499779177555,1.0,17/93,7.53%,PTPRC;BTK;CX3CR1;CCR2;LAT;PLCG2;PTPRJ;EDNRB;P2RX7;SLC8A1;LAT2;CXCR4;MCTP1;P2RX4;NUDT4;SLC9A1;P2RY12
prerank,osteoclast differentiation (GO:0030316),0.6805313367313054,1.5093793829384101,0.04197530864197531,0.21999530593813643,1.0,9/22,9.47%,TREM2;CSF1R;TNFRSF11A;MAPK14;OCSTAMP;GAB2;EFNA2;TYROBP;GPR183
prerank,acetyl-CoA metabolic process (GO:0006084),-0.531846546993246,-1.5085476556542512,0.0546875,0.9461984291122103,1.0,9/15,24.67%,DIP2A;ACACB;HMGCS2;ACLY;MLYCD;ACSS1;PMVK;MVK;PPCS
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.7774166329380482,1.5078121664085138,0.04113475177304964,0.2229617665883621,1.0,3/10,7.56%,TREM2;CD68;TICAM1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.6324424834047974,1.505802136202097,0.03128491620111732,0.22692751115376722,1.0,9/38,11.82%,SCIMP;ADAM8;DHX9;TLR8;LY86;CD180;LY96;PUM2;GRN
prerank,negative regulation of nervous system development (GO:0051961),0.7101956387907432,1.505655930532041,0.045859872611464965,0.22670097869254568,1.0,6/17,13.10%,HOOK3;TLR2;TNF;PCM1;SORL1;B2M
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.6825015731242298,1.505066980983653,0.046228710462287104,0.227592586783877,1.0,9/21,19.61%,HK3;RPE;GPI;SHPK;HK2;GCK;PGLS;PGD;RBKS
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.6917697601828381,1.5042882781659426,0.05391527599486521,0.2288732835570643,1.0,5/18,9.03%,FCGR2B;ERN1;DDIT3;ATXN3;BAK1
prerank,Golgi localization (GO:0051645),0.7584543881581804,1.5032884760611163,0.05916305916305916,0.23040892808927094,1.0,4/11,9.39%,HOOK3;RIPOR1;ARHGAP21;UVRAG
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.767523565374686,1.5030295885977107,0.04838709677419355,0.23045055150328705,1.0,4/10,9.89%,PDCD1LG2;CRTAM;RC3H1;CD274
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.7637321793960689,1.5028735377688218,0.05135520684736091,0.23029215963563515,1.0,4/11,7.56%,SCIMP;RFTN1;UNC93B1;TICAM1
prerank,positive regulation of MAPK cascade (GO:0043410),0.5816047440524504,1.50247185622725,0.0,0.23062949280706588,1.0,30/245,5.89%,ARRB2;PTPRC;TREM2;PTK2B;SLAMF1;SCIMP;GPNMB;CALCR;PIK3CG;PIK3R5;TGFB1;FLT3;CD74;P2RY6;TAOK3;LAPTM5;PLCG2;CSF1R;ADAM8;PTPRJ;DSTYK;OSM;CCL8;TRIM5;TNF;APOE;PRKD2;PYCARD;CD44;HMGB1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.7021121785680109,1.5023366244699459,0.046875,0.23042796271292643,1.0,5/17,8.58%,SCIMP;LY86;TRIM5;CD180;LY96
prerank,regulation of calcium ion import (GO:0090279),0.6884404457495779,1.5023311975379314,0.052763819095477386,0.22992160472583797,1.0,6/21,12.40%,LGALS3;PKD2;CTNNB1;TRIM27;CCL2;FYN
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.5674368011595274,-1.5019537776270397,0.05627705627705628,0.9500396319597572,1.0,8/13,25.42%,CPSF6;CPSF7;FIP1L1;CSTF2;TUT1;CSTF2T;NCBP2;CPSF1
prerank,positive regulation of T cell migration (GO:2000406),0.6979828696883812,1.501679840971325,0.04025157232704402,0.23090630472807933,1.0,5/20,7.31%,DOCK8;CCR2;PYCARD;AIF1;WNK1
prerank,regulation of epidermal cell differentiation (GO:0045604),0.6803340390050443,1.5007077503308808,0.045177045177045176,0.2326066770168846,1.0,4/21,5.41%,RUNX1;CTSK;CTSL;MAFG
prerank,negative regulation of cilium assembly (GO:1902018),-0.5766387118863057,-1.5006767996349897,0.06498194945848375,0.9275130839207741,1.0,6/12,19.20%,MAP4;CCP110;EVI5L;CEP97;CDK10;TBC1D7
prerank,cytokine-mediated signaling pathway (GO:0019221),0.5787381491569683,1.5002520537264534,0.0,0.2331663299186438,1.0,115/532,13.35%,CD86;SLA;GRAP2;VAV1;PTK2B;IRF5;INPP5D;IL10RA;PF4;PTAFR;CXCL5;CIITA;HCK;ITGAX;IRF4;IRF8;TGFB1;SYK;ITGB2;LCP1;FLT3;CCR2;CSF3R;AIM2;STAT5A;IL1A;IRAK2;CSF2RB;PIK3CD;IL10RB;CBL;CSF1R;F13A1;TYK2;CXCL2;PTPRJ;PRKCD;TRIM25;IL21R;GRB2;TEC;PIK3CB;TNFRSF11A;OSM;FCGR1A;IL12RB2;CCL8;TRIM5;TNF;FCER1G;AIP;UBE2V1;TRAF2;TNFSF8;IL6R;IFNAR1;FOXO3;CEBPA;SPI1;PYCARD;CASP1;TIMP1;MAP3K14;CD300LF;TRAF3;IL18;RAP1B;CD44;IFNGR2;SAMHD1;ANXA1;GAB2;BCL2L1;PSMB10;CD80;ACTN4;TP53;PIM1;STAT4;TMSB4X;P4HB;CAPZA1;EPO;ST18;FLT3LG;IL18RAP;ADAR;IRF2;CCL14;ITGAM;STAT5B;TRAF5;TRIM8;RNASEL;LIMS1;IL18BP;SH2B3;RAPGEF1;PSMA2;CCL13;RPS6KA4;CCL2;ADIPOR1;TNFRSF1B;FYN;NOD2;PSME3;TAB2;STX3;LRP8;IKBKG;B2M;PRLR;NFKB1;IRF1
prerank,cellular component maintenance (GO:0043954),0.7522425293341031,1.499961777086309,0.04143646408839779,0.23334133734752974,1.0,1/12,0.31%,TREM2
prerank,regulation of response to cytokine stimulus (GO:0060759),0.6997244804725743,1.4999511346319365,0.02608695652173913,0.23284316449402667,1.0,3/19,2.86%,RUNX1;IRAK2;DHX9
prerank,regulation of cellular biosynthetic process (GO:0031326),0.662809994809604,1.4993144404414804,0.03841536614645858,0.23389842907836308,1.0,10/28,17.07%,CX3CR1;SIRPA;NR1H4;MITF;NOS1AP;ADIPOR1;TNFRSF1B;CTNS;CD47;ADIPOR2
prerank,acylglycerol catabolic process (GO:0046464),0.6571756981317723,1.499199945135143,0.02508551881413911,0.23363485660423838,1.0,8/30,17.15%,LPL;FABP4;ABHD12;LIPC;FABP5;LIPE;ABHD16A;PNPLA3
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.7583363810804243,1.498972907705315,0.04297994269340974,0.23363694580994504,1.0,6/11,12.29%,ATF3;DDIT3;CREB3L1;TP53;CEBPB;ATF6B
prerank,negative regulation of cholesterol transport (GO:0032375),0.7942000744416006,1.4975891520639348,0.0357653791130186,0.2361911011822509,1.0,2/10,3.97%,SHH;SREBF2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.6173690072917474,1.4967174439603677,0.025889967637540454,0.23763606819199048,1.0,13/51,11.47%,CCR2;LGMN;CSF1R;MDK;CREB3;IL6R;HMGB1;AIF1;VEGFB;PLA2G7;AKIRIN1;CMKLR1;THBS1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.6407090888594442,1.4966295024829592,0.03409090909090909,0.23732212283536186,1.0,8/33,10.48%,NCKAP1L;GATA1;MAPK14;FOXO3;RAB7B;TAL1;STAT5B;INHBA
prerank,base conversion or substitution editing (GO:0016553),0.764961410084535,1.4953556027197519,0.05649717514124294,0.23986055150962993,1.0,4/11,12.94%,APOBEC1;ADAR;METTL3;ADARB1
prerank,vesicle organization (GO:0016050),0.6219825586054115,1.4948418583003382,0.02608695652173913,0.24050990844783204,1.0,23/46,20.04%,HOOK3;SRGN;CORO1A;SNX33;PI4K2A;VPS18;DNAJC13;VPS11;ARFGEF2;WASHC4;EXOC8;PI4K2B;SAR1A;FNBP1L;HOOK2;EPS15;USP8;ALS2;LAMTOR1;SNX10;VPS33B;LAPTM4B;SORT1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.73097611168388,1.4947528621387276,0.050734312416555405,0.24020949066465463,1.0,2/14,2.41%,CD226;MAD2L2
prerank,regulation of viral entry into host cell (GO:0046596),0.6514224892361329,1.4937150883009622,0.03391812865497076,0.24215788544906755,1.0,8/30,11.31%,CIITA;CD74;TRIM25;TRIM5;P4HB;TRIM27;LGALS1;MID2
prerank,cellular response to hydrogen peroxide (GO:0070301),0.6472695231221263,1.4935832369929463,0.036036036036036036,0.24193672784981335,1.0,9/33,11.44%,SIRPA;NFE2L2;AQP1;PRKCD;TNFAIP3;ANXA1;MAP3K5;IMPACT;HDAC6
prerank,second-messenger-mediated signaling (GO:0019932),0.6001083370620128,1.4935329070183931,0.009211873080859774,0.24154944845572376,1.0,19/82,14.11%,BTK;CX3CR1;CCR2;LAT;PLCG2;EDNRB;LAT2;APOE;CXCR4;MCTP1;P2RX4;NUDT4;P2RY12;DGKD;RCAN1;PPP2CA;CAMKK2;DDAH1;LRRK2
prerank,regulation of sequestering of calcium ion (GO:0051282),0.7438094108209127,1.4934324223964905,0.058011049723756904,0.24130641131682878,1.0,2/12,0.77%,PTK2B;UBASH3B
prerank,positive regulation of leukocyte activation (GO:0002696),0.7156178678365923,1.4933901319143938,0.041343669250646,0.2409090003464588,1.0,3/18,4.65%,CLEC4D;CD226;CEBPA
prerank,reverse cholesterol transport (GO:0043691),0.7561840202357601,1.4923111613799485,0.048678720445062586,0.2427499464565934,1.0,4/13,6.37%,ABCA1;APOE;ABCG1;LIPC
prerank,lipid phosphorylation (GO:0046834),0.7639695660281917,1.491173162228324,0.04903417533432392,0.24490563855740125,1.0,6/10,12.92%,DGKZ;DGKK;DGKE;DGKD;DGKG;DGKI
prerank,phospholipid metabolic process (GO:0006644),0.6018828137880972,1.4911233325162299,0.012448132780082987,0.24449659229862425,1.0,9/71,4.73%,PLBD1;PLCB2;LPL;ABHD12;LPCAT1;ANGPTL3;CLN8;PIP4K2A;SMPD3
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.6302889585960522,1.4896024887323422,0.03926096997690531,0.24736434906346946,1.0,2/33,0.15%,RUNX1;KLK3
prerank,myeloid cell development (GO:0061515),0.6995459161359068,1.4882096682603196,0.04534005037783375,0.2500120661626567,1.0,4/18,2.06%,NCKAP1L;GATA1;NRROS;TLR2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.6845907460226535,1.4881719292675641,0.05486284289276808,0.24958835214999972,1.0,8/20,12.99%,SMOC2;DSTYK;PRKD2;FGFBP3;CREB3L1;SULF2;THBS1;NPTN
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.5615600329536318,-1.4880997793105468,0.0673758865248227,0.9678383896170029,1.0,7/13,16.01%,NFIB;BMP4;REST;PPARA;NFATC4;RELA;PPARG
prerank,regulation of T cell migration (GO:2000404),0.7110423624629083,1.4877415093302093,0.046875,0.24998810591591344,1.0,5/18,6.36%,DOCK8;CD200R1;PYCARD;RIPOR2;AIF1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.7024177436923957,1.4872304974512347,0.06266318537859007,0.25070684583548597,1.0,4/16,6.39%,RUNX1;TGFB1;RGCC;CREB3L1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.6296765216218203,1.486273502963569,0.03389830508474576,0.2524727522987145,1.0,10/40,8.20%,PTK2B;RPL23;LAPTM5;PDCL3;XPO1;TAF1;GNA12;HFE;CSNK2A1;CSNK2A2
prerank,positive regulation of cellular component movement (GO:0051272),0.669031538967717,1.4860503545294357,0.04151404151404151,0.25252963694333747,1.0,4/24,6.77%,LYN;CSF1R;TGFBR1;ACTN4
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.6573448855836077,1.485846242407536,0.0407673860911271,0.25247293612316674,1.0,11/24,17.05%,NFE2L2;ATF3;DDIT3;CREB3L1;TP53;CEBPB;HSF1;ATF6B;RBPJ;HIF1A;GCN1
prerank,positive regulation of neuron death (GO:1901216),0.6136641335047962,1.4858038098615876,0.024864864864864864,0.25204939172325025,1.0,16/46,12.62%,FCGR2B;ITGB2;PCSK9;TNF;SNCA;FOXO3;DDIT3;CTNNB1;TYROBP;MAP3K5;C1QA;TFAP2B;ITGAM;GRN;FYN;DDIT4
prerank,cellular response to ATP (GO:0071318),0.7230817710318295,1.4848670456737705,0.06473829201101929,0.25379995148605483,1.0,5/14,7.53%,P2RX7;P2RY2;P2RX4;TAF1;P2RY12
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.7340581901496007,1.484552167995033,0.06084656084656084,0.2539853809649344,1.0,3/13,8.22%,PTPRC;MGAT5;DOT1L
prerank,acylglycerol metabolic process (GO:0006639),0.6248391427531073,1.4828951209409202,0.03611738148984198,0.2574087016130387,1.0,10/37,8.30%,DGKZ;LPL;ABHD12;APOE;SEL1L;PGS1;DGKK;DGKE;DGKD;DGKG
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.5954608610721394,1.4824127546171204,0.03514376996805112,0.25799651891266556,1.0,13/61,13.42%,VAV1;LPAR6;LYN;PIK3CG;GRB2;PIK3CB;GPR17;EPO;ERBIN;F11R;RAPGEF1;ADGRG1;ARHGEF3
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.6350325711097187,1.4815811690077463,0.03185437997724687,0.2594753657037138,1.0,5/34,3.00%,PTK2B;FGR;TGFB1;FLT3;WDR91
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.6251683521983435,1.4805840520527545,0.03225806451612903,0.26134018440844625,1.0,10/40,13.10%,ARRB2;PCSK9;CBL;LDLRAP1;HFE;DGKD;NTF3;SCYL2;CD63;B2M
prerank,sulfur compound catabolic process (GO:0044273),0.6241501989445846,1.4800742360151746,0.029345372460496615,0.2620151727155315,1.0,9/38,9.71%,HEXB;PRELP;ARSB;GNS;IDS;HEXA;FMOD;BCAN;TXN2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.5682508859482236,-1.4798975889829298,0.08013937282229965,0.9855034611467012,1.0,4/12,4.87%,NFIB;PAFAH1B1;GLI2;EPHB2
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4445996719911802,-1.4789948257953083,0.032679738562091505,0.9614364282625781,1.0,12/26,20.44%,STMN2;SLAIN2;CLIP1;PAK1;DRG1;MET;CDK5RAP2;MAPT;NAV3;OCLN;TRPV4;RAC1
prerank,regulation of cellular component size (GO:0032535),0.6421887198942275,1.4786028207261008,0.04878048780487805,0.265028000933159,1.0,6/30,4.83%,VAV1;PEX11A;RIN3;MTOR;VAV2;VAV3
prerank,macromolecule catabolic process (GO:0009057),0.6432365045339069,1.4785032141544348,0.06658878504672897,0.2647017966575976,1.0,13/26,17.75%,TGFB1;LGMN;MTOR;CLN8;UVRAG;TRIM24;BECN1;SNX25;CAPN3;SMURF1;IDE;PIK3R4;USE1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.5974921165338191,1.4773919689227735,0.01164021164021164,0.26678951117008215,1.0,15/57,9.03%,SYK;LGMN;AIM2;CTSD;TNF;PYCARD;CASP1;HMGB1;ASPH;MAP3K5;TBC1D10A;MALT1;GRAMD4;BAK1;PDCD6
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.5749377039805558,1.4773129816460673,0.0,0.2664297524459733,1.0,26/214,5.89%,ARRB2;PTPRC;TREM2;PTK2B;SLAMF1;SCIMP;GPNMB;LYN;CALCR;TGFB1;SYK;CD74;SIRPA;P2RY6;CSF1R;DUSP3;PTPN1;DUSP29;DSTYK;CCL8;TNF;APOE;PRKD2;PYCARD;CD44;HMGB1
prerank,positive regulation of endothelial cell migration (GO:0010595),0.5917718205284147,1.4770238109638916,0.006122448979591836,0.26653160727951986,1.0,23/84,11.82%,PTK2B;PIK3CG;TGFB1;RIN2;LGMN;STAT5A;SMOC2;PIK3CD;ITGB3;ANGPT4;PIK3CB;MAPK14;PRKD2;P2RX4;HMGB1;MAP2K3;TMSB4X;PDCD6;BCAR1;NRP1;GPI;THBS1;GRN
prerank,defense response to symbiont (GO:0140546),0.5876665278370742,1.4767601628488836,0.006134969325153374,0.266618503550137,1.0,21/92,13.57%,PTPRC;LILRB1;LYST;NLRC5;TLR2;TLR7;TLR8;TRIM5;ATG7;PYCARD;MAP3K14;SAMHD1;BCL2L1;MOV10;IRF2;SETD2;TRIM56;RNASEL;DDIT4;IRF1;AGBL5
prerank,regulation of microtubule polymerization (GO:0031113),-0.3991740502837823,-1.4759678257314273,0.021739130434782608,0.9495828035538316,1.0,15/40,15.02%,CDH5;STMN2;SLAIN2;EML2;CLIP1;PAK1;DYRK1A;ABL1;DRG1;MET;CDK5RAP2;MAPT;NAV3;OCLN;TUBB4A
prerank,androgen metabolic process (GO:0008209),0.6933366892202837,1.4758900139318083,0.05994897959183673,0.26809650212218633,1.0,3/18,11.63%,SHH;SPP1;HSD17B11
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.7139312530850361,1.4758127192064145,0.057971014492753624,0.2677597747943368,1.0,2/15,3.60%,TREM2;NLRC3
prerank,regulation of T cell mediated immunity (GO:0002709),0.7462407891903812,1.4751918284101215,0.0688622754491018,0.26884742477125684,1.0,3/10,11.73%,CCR2;HMGB1;TNFRSF1B
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.6340826995909814,1.474418958516409,0.05281285878300804,0.27019452953921935,1.0,10/30,12.38%,PTPRC;CD300A;THY1;PRKCD;SEMA4D;SAMSN1;NTF3;NF2;SH2B3;PPP2CA
prerank,chondroitin sulfate catabolic process (GO:0030207),0.7235002652683848,1.473536032073707,0.07133058984910837,0.2718468381722641,1.0,5/13,9.18%,HEXB;ARSB;IDS;HEXA;BCAN
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.580797128894908,1.473510554888072,0.016359918200409,0.27084754997953425,1.0,22/78,12.02%,CTSS;FCGR2B;LGMN;CD74;CTSD;CTSL;KLC2;AP1S3;FCER1G;RAB7A;CAPZB;DNM2;AP2S1;CAPZA1;AP1B1;ACTR10;KIF23;CTSE;CLTC;SEC24D;DYNC1H1;DCTN5
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.580797128894908,1.473510554888072,0.016359918200409,0.27084754997953425,1.0,22/78,12.02%,CTSS;FCGR2B;LGMN;CD74;CTSD;CTSL;KLC2;AP1S3;FCER1G;RAB7A;CAPZB;DNM2;AP2S1;CAPZA1;AP1B1;ACTR10;KIF23;CTSE;CLTC;SEC24D;DYNC1H1;DCTN5
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.7179732306499225,1.4721975305602315,0.06747638326585695,0.2734026546279099,1.0,4/14,11.17%,TNF;OCSTAMP;TYROBP;ATP6AP1
prerank,response to organic cyclic compound (GO:0014070),0.6030253804378902,1.4716705909880712,0.024945770065075923,0.27416812837005244,1.0,13/52,14.11%,CYP1A1;TGFB1;TNF;SPP1;IL18;ABCB4;ANXA1;CTNNB1;KYNU;STAT5B;CCL2;TIPARP;LRRK2
prerank,receptor catabolic process (GO:0032801),0.6635316051916419,1.4712043683291567,0.05315203955500618,0.27474319145520915,1.0,14/24,17.76%,TGFB1;PCSK9;LGMN;MYLIP;AP2S1;UVRAG;CLTC;BECN1;SNX25;AP2M1;SMURF1;PIK3R4;ZNRF3;VLDLR
prerank,regulation of neurogenesis (GO:0050767),0.6071825542291603,1.4708918859487645,0.02676659528907923,0.27495824247402545,1.0,12/55,13.10%,HOOK3;ASCL1;CX3CR1;HES7;TNF;BHLHE41;CTNNB1;NAP1L1;PCM1;NUMB;SORL1;B2M
prerank,regulation of glucose import (GO:0046324),-0.4219076497061422,-1.4708536715089038,0.037037037037037035,0.9499271711442313,1.0,8/30,15.19%,SORBS1;GRB10;PRKCI;IRS1;SELENOS;ARPP19;OCLN;AKT1
prerank,positive regulation of protein maturation (GO:1903319),0.7514626372992506,1.4704991830863914,0.0800561797752809,0.2753813806376853,1.0,4/11,14.67%,BAG2;ADAM8;CCBE1;SOX4
prerank,endothelial cell differentiation (GO:0045446),-0.5752798605193682,-1.4703856060674896,0.05054151624548736,0.9267749119478964,1.0,8/12,25.19%,FSTL1;ACVRL1;JAG1;BMPR2;SOX18;EDF1;ACVR2B;SCUBE1
prerank,endosome organization (GO:0007032),0.6236819245551809,1.4694770340695862,0.042175360710321866,0.27727265030162546,1.0,19/41,19.38%,HOOK3;SNX33;PI4K2A;VPS18;DNAJC13;VPS11;ARFGEF2;WASHC4;TMCC1;EXOC8;PI4K2B;HOOK2;USP8;ALS2;CORO1C;LAMTOR1;SNX10;VPS33B;LAPTM4B
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.6207121326829079,1.469382878342769,0.04114285714285714,0.27695206083301127,1.0,8/39,8.24%,MYO1F;MYO1G;MYO1E;MYO5A;CLN3;ACTN4;MYO7A;MYO19
prerank,metanephric mesenchyme development (GO:0072075),0.7569556498283371,1.4692210733349835,0.07541899441340782,0.2768101901765425,1.0,3/10,4.08%,SHH;BASP1;PKD2
prerank,negative regulation of protein metabolic process (GO:0051248),0.6079378145903486,1.468927864499297,0.03925845147219193,0.27700699226247905,1.0,6/48,4.04%,CD84;TREM2;ITGB3;MAD2L2;EDNRB;APOE
prerank,regulation of macrophage migration (GO:1905521),0.7751444608653416,1.4685284787860258,0.044642857142857144,0.2774058956980985,1.0,4/10,7.53%,PTK2B;CX3CR1;CD200R1;P2RY12
prerank,response to hydrogen peroxide (GO:0042542),0.6117983134658531,1.4684472264328603,0.03787878787878788,0.277055479558428,1.0,14/45,15.05%,SIRPA;NFE2L2;AQP1;PRKCD;TNFAIP3;ANXA1;MAP3K5;IMPACT;APTX;HDAC6;PRDX3;FYN;STK24;PLEKHA1
prerank,negative regulation of cell communication (GO:0010648),0.661292785536181,1.4682714293073198,0.07116104868913857,0.27694252645589423,1.0,3/21,3.17%,UBASH3B;PTPN1;OSM
prerank,glycoprotein catabolic process (GO:0006516),0.7061511402310024,1.4679098064731018,0.05827814569536424,0.2773192538040524,1.0,4/17,7.10%,MMP12;EDEM1;CTSL;OGA
prerank,embryonic appendage morphogenesis (GO:0035113),0.7386875890900146,1.4677232821618786,0.07005494505494506,0.2772321362012016,1.0,2/12,4.38%,SHH;SKI
prerank,response to glucagon (GO:0033762),0.6791268838805694,1.4673257223753142,0.05137844611528822,0.27762672961523494,1.0,8/19,13.63%,ADCY7;PRKAR2B;CYSLTR2;ADCY6;PRKACB;CREB1;ADCY8;ADCY3
prerank,regulation of response to biotic stimulus (GO:0002831),0.6331789148509938,1.4665002876192763,0.06405693950177936,0.2792189078171743,1.0,14/28,16.59%,TREM2;FGR;FCGR2B;TRIM5;TRAF3;SAMHD1;ZMPSTE24;CASP8;RNF135;LRP8;IRF1;ERAP1;CD36;APPL2
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.500047992734904,-1.466338409160919,0.06550218340611354,0.9233007219945756,1.0,7/17,10.53%,FSTL1;SULF1;XIAP;SLIT2;PCSK6;TMEM204;TWSG1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.6416469265225087,1.4662958409451223,0.04994054696789536,0.27916230597645086,1.0,4/28,1.99%,TREM2;BAG2;LAPTM5;CTSC
prerank,regulation of endocytosis (GO:0030100),0.5918445614916129,1.4658026619593583,0.010570824524312896,0.27988510623100693,1.0,10/61,7.45%,CD22;LILRB1;LGALS3;PTPN1;SNCA;APOE;MCTP1;SNX33;AP2S1;STON2
prerank,steroid metabolic process (GO:0008202),0.5905325439461865,1.46487867538039,0.016913319238900635,0.28167295384618757,1.0,7/72,6.12%,CYP1A1;SHH;LGMN;TSPO;LIPA;NPC1;DHRS11
prerank,amyloid-beta metabolic process (GO:0050435),-0.5125394030136148,-1.4638448798707273,0.07264957264957266,0.9119255708209156,1.0,9/16,24.29%,MGAT3;BACE1;DYRK1A;MME;ACE;BACE2;PSEN2;APEH;PSENEN
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.6663932727169177,1.4635510888529832,0.06056860321384425,0.28447242391013994,1.0,7/21,16.47%,BAG2;RPL23;MAD2L2;UBE2S;FZR1;RPL11;PTEN
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.5744745768955879,-1.462685795560539,0.09764309764309764,0.8950242899644963,1.0,6/12,26.85%,CAV1;SRI;CALM3;GJD3;PDE4D;CALM2
prerank,positive regulation of kinase activity (GO:0033674),0.576569290465021,1.4626118441399178,0.003045685279187817,0.2862229749608032,1.0,14/107,6.35%,PTPRC;LCP2;TREM2;PTK2B;FLT3;CD74;LAT;CSF1R;MMD;DSTYK;SNX9;TNF;XRCC5;MAP2K3
prerank,positive regulation of phospholipid transport (GO:2001140),0.7570691347017886,1.461682405113858,0.07186544342507645,0.28807082977822046,1.0,3/10,6.05%,DBI;APOE;ABCB4
prerank,lytic vacuole organization (GO:0080171),0.6275914189406157,1.4616033391026175,0.0472972972972973,0.28772569038640183,1.0,11/32,14.11%,HOOK3;ABCA1;MTOR;ARSB;CLN3;VPS18;TFEB;MYO7A;GRN;HOOK2;LRRK2
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.740691945018003,1.461540739093754,0.0673076923076923,0.28734472372528114,1.0,3/12,3.90%,CBL;PTPRJ;SNCA
prerank,sterol homeostasis (GO:0055092),0.5952909264905993,1.4607148205673615,0.013669821240799159,0.288750606624035,1.0,16/65,12.48%,PCSK9;LPL;ABCA1;ANGPTL3;NPC2;APOE;ABCG1;LDLRAP1;IL18;NPC1;SOAT2;LIPC;ABCD1;LRP5;TTC39B;HDAC9
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.7536472223505366,1.4606242669157152,0.08522727272727272,0.28842367126427015,1.0,5/10,12.64%,CX3CR1;FZD3;CTNNB1;DISC1;SMARCD3
prerank,megakaryocyte differentiation (GO:0030219),0.7351548331081006,1.4606119302402423,0.07584269662921349,0.287901647817616,1.0,3/11,11.03%,GATA1;TAL1;SH2B3
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.6837205325845874,1.4603048671958456,0.06718346253229975,0.2880800623030029,1.0,5/18,14.13%,LYN;FCER1G;BCAR1;CMKLR1;C3AR1
prerank,response to axon injury (GO:0048678),0.6829279160115773,1.4585392101993468,0.059202059202059204,0.29195651846928167,1.0,5/18,7.53%,TREM2;RTN4RL1;P2RX4;TYROBP;P2RY12
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.6941631109221131,1.458518868118566,0.0683311432325887,0.29145204543836156,1.0,5/15,10.85%,TREM2;MAPK14;RIPOR2;TYROBP;CD53
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.7130979613607086,1.457434576385225,0.06591865357643759,0.29367930018529625,1.0,5/14,11.47%,CSF1R;MDK;AKIRIN1;CMKLR1;THBS1
prerank,regulation of GTPase activity (GO:0043087),0.5644646519938342,1.4570357218165604,0.001002004008016032,0.2941150942324004,1.0,52/177,16.99%,FGD2;VAV1;DOCK8;RGS10;KLRK1;ARHGAP9;ARHGAP15;FZD10;THY1;VAV2;PLXNC1;SNX9;ARAP1;CCL8;RASA4;SEMA4D;ITGA6;GPR137B;PLXNB2;VAV3;RASGRP2;RAB3GAP2;ARFGEF1;FGD6;USP6NL;DOCK11;DOCK10;AGRN;WNK1;FLCN;CCL14;F11R;TBC1D2;LIMS1;RAPGEF1;CCL13;CCL2;ADAP1;ARHGAP27;MMUT;LRRK2;RAP1A;BCAR3;NF1;GNB5;ALS2;RGS1;CPEB2;EPHA4;SNX13;CCL25;SNX18
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.5742498289296469,1.4570200595717349,0.022517911975435005,0.2936113327440063,1.0,22/79,12.02%,CTSS;FCGR2B;LGMN;CD74;CTSD;CTSL;KLC2;AP1S3;FCER1G;RAB7A;CAPZB;DNM2;AP2S1;CAPZA1;AP1B1;ACTR10;KIF23;CTSE;CLTC;SEC24D;DYNC1H1;DCTN5
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.7472048463049958,1.4562736954332751,0.06926406926406926,0.29478994890347004,1.0,2/10,3.18%,HK3;PFKL
prerank,positive regulation of interferon-beta production (GO:0032728),0.6211164008590014,1.4550612399432885,0.041379310344827586,0.2973791835639201,1.0,5/33,2.89%,IRF5;TLR2;DHX9;TLR7;TLR8
prerank,ganglion development (GO:0061548),0.7468967671312374,1.4547087736371607,0.07735583684950774,0.2977742432808848,1.0,5/11,10.88%,ASCL1;TUBB3;FZD3;CTNNB1;NRP1
prerank,water transport (GO:0006833),0.7243018463825512,1.454671566940393,0.0782122905027933,0.2973341879492706,1.0,2/12,8.26%,AQP1;AQP11
prerank,small GTPase mediated signal transduction (GO:0007264),0.5704008146933593,1.4541366042714656,0.008130081300813009,0.2982057931944899,1.0,19/103,9.00%,ARHGAP30;GRAP2;ABR;RIN2;LAT;RREB1;GRB2;ARHGEF18;MAPK14;RASGRP2;RGS19;PLD2;RGL2;SHC2;TP53;PLK2;RASGRP3;RB1;ARHGAP1
prerank,response to fatty acid (GO:0070542),0.6830945543917186,1.4532331420269125,0.07692307692307693,0.2999332232703465,1.0,7/17,15.32%,LPL;NR1H4;FFAR2;FOXO3;SOX9;PID1;CD36
prerank,negative regulation of receptor binding (GO:1900121),0.756466612439414,1.45314567903982,0.06340057636887608,0.2996414817981904,1.0,4/10,13.62%,PCSK9;HFE;B2M;ATP2A3
prerank,regulation of cholesterol metabolic process (GO:0090181),0.6652826464345556,1.4530209703451527,0.06364749082007344,0.2993924768830629,1.0,10/20,14.97%,NR1H4;SREBF2;APOE;LDLRAP1;FMO5;ACADL;SEC14L2;TTC39B;SREBF1;ARV1
prerank,cellular response to glucagon stimulus (GO:0071377),0.6858650105867584,1.4525305786781912,0.0583756345177665,0.30005917655614517,1.0,7/17,13.63%,ADCY7;PRKAR2B;CYSLTR2;ADCY6;PRKACB;ADCY8;ADCY3
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.7335902420960896,1.451677186984333,0.06482758620689655,0.301681799414706,1.0,4/12,7.06%,WDTC1;ERLIN2;ERLIN1;ACADL
prerank,positive regulation of interleukin-13 production (GO:0032736),0.7520547654975978,1.450957345606005,0.07544378698224852,0.302951965523862,1.0,2/10,5.21%,IRF4;IL18
prerank,positive regulation of receptor internalization (GO:0002092),0.6556254871615493,1.4508786545467487,0.06150061500615006,0.30260473142359345,1.0,9/22,19.47%,ARRB2;PCSK9;NTF3;SCYL2;CD63;AHI1;ANGPT1;GREM1;TBC1D5
prerank,phosphatidylcholine metabolic process (GO:0046470),0.5864499056419002,1.4506848690589864,0.016666666666666666,0.30254207644886966,1.0,14/70,10.05%,PLBD1;DBI;LPIN2;LPCAT1;PCYT1A;CHKB;LIPC;LPCAT2;PLA2G7;CSNK2A1;CSNK2A2;SLC44A2;ABHD4;STARD10
prerank,"wound healing, spreading of cells (GO:0044319)",0.6435016310183557,1.450215913026542,0.06796116504854369,0.30312575851001927,1.0,5/24,5.92%,MMP12;LCP1;ARHGAP24;CD44;MRTFA
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.45676139678165717,-1.450198948799123,0.05670103092783505,0.9127347728666978,1.0,8/20,16.97%,ACADSB;AUH;MCCC1;HIBCH;DLD;IVD;BCKDK;SLC25A44
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.45676139678165717,-1.450198948799123,0.05670103092783505,0.9127347728666978,1.0,8/20,16.97%,ACADSB;AUH;MCCC1;HIBCH;DLD;IVD;BCKDK;SLC25A44
prerank,positive regulation of nuclear division (GO:0051785),0.650222783132914,1.4501002337416866,0.07448107448107448,0.3028698374270462,1.0,5/25,11.86%,IL1A;NUP62;RGCC;LRP5;PHIP
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.6580907250498886,1.4484276389051434,0.06690997566909976,0.30681697744150777,1.0,6/23,12.40%,PTK2B;UBASH3B;NOS1AP;DIAPH1;CACNB1;FYN
prerank,regulation of B cell apoptotic process (GO:0002902),0.7414086809605295,1.4476481745588927,0.07768361581920905,0.308170116512504,1.0,3/12,3.86%,BTK;LYN;FNIP1
prerank,cell proliferation in forebrain (GO:0021846),0.7364075891140576,1.4473298271299426,0.09251101321585903,0.30838238429967685,1.0,5/10,12.58%,HOOK3;AKNA;KIF14;PCM1;NUMB
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.5964290409299378,1.4471520126207171,0.04299889746416759,0.30829324127684005,1.0,13/45,15.32%,AIM2;LPL;P2RX7;TLR8;TNF;PYCARD;CASP1;TYROBP;MALT1;NOD2;CASP8;TMEM106A;CD36
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.6232069877650962,1.4459064452518575,0.05420991926182238,0.31097199172258694,1.0,8/34,11.86%,IL1A;NUP62;ESPL1;RGCC;CDC23;RB1;LRP5;PHIP
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.6031966656002992,1.445812387082393,0.043859649122807015,0.3106566025232423,1.0,12/41,16.70%,CASS4;STAP1;CSF1R;GPRC5B;PTPN1;FCGR1A;NEDD9;FYN;LRP8;GAS6;SRC;EPHA4
prerank,defense response to virus (GO:0051607),0.5750953999507712,1.4450205006468606,0.012269938650306749,0.3120829219931574,1.0,24/100,14.35%,PTPRC;LILRB1;LYST;NLRC5;TLR2;TLR7;TLR8;TRIM5;ATG7;PYCARD;MAP3K14;SAMHD1;BCL2L1;MOV10;IRF2;SETD2;TRIM56;RNASEL;DDIT4;RNF135;IRF1;AGBL5;ATAD3A;ZDHHC1
prerank,regulation of establishment of protein localization (GO:0070201),0.6976918675692925,1.4448460063941528,0.08953168044077135,0.3119564427907764,1.0,3/13,7.08%,TREM2;CTSD;GAPVD1
prerank,actin crosslink formation (GO:0051764),0.7319411797992572,1.44403951548383,0.0702247191011236,0.3134801389653351,1.0,4/12,6.36%,LCP1;GAS2L1;GAS2L3;AIF1
prerank,cell chemotaxis (GO:0060326),0.5917186843588821,1.4432686193377076,0.023255813953488372,0.3148570127872457,1.0,11/60,10.88%,ARRB2;CX3CR1;BIN2;CCR2;PRKCD;CXCR4;DOCK4;PRKCQ;BCAR1;ABCC1;NRP1
prerank,cell projection organization (GO:0030030),0.6321999460780607,1.442855537262771,0.04074505238649592,0.3154079672773123,1.0,7/30,13.68%,NCKAP1L;PLEK;NEFH;P2RY12;PARVB;CYFIP1;ATP1B2
prerank,regulation of protein kinase A signaling (GO:0010738),0.660578991383497,1.4412374100420815,0.07380073800738007,0.3189624964276902,1.0,5/20,14.11%,CALCR;PRKAR2B;AKAP5;IAPP;LRRK2
prerank,regulation of vesicle-mediated transport (GO:0060627),0.5703538473993459,1.4411148439745785,0.012282497441146366,0.31867514609690484,1.0,15/91,11.89%,PTPRC;CD22;FGR;HCK;SYK;RAB8B;PTPN1;AP2S1;STON2;DNAJC13;RAB11A;MAP2K2;NRP1;USP7;STON1
prerank,cholesterol homeostasis (GO:0042632),0.5868153214092602,1.439342110496284,0.022128556375131718,0.3227379989424711,1.0,15/64,12.48%,PCSK9;LPL;ABCA1;ANGPTL3;NPC2;APOE;ABCG1;LDLRAP1;IL18;NPC1;SOAT2;LIPC;LRP5;TTC39B;HDAC9
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.6121480850835083,1.4378882715045318,0.04540420819490587,0.32585298777571803,1.0,12/38,16.47%,ARRB2;PTPRJ;PIK3CB;DDIT3;XDH;OTUD3;FLCN;PDCD6;SH2B3;PLEKHA1;PHLPP1;PTEN
prerank,regulation of interleukin-1 beta production (GO:0032651),0.574829823965003,1.4362927479827892,0.031545741324921134,0.3293619716318821,1.0,17/66,15.83%,CX3CR1;AIM2;SIRPA;LPL;P2RX7;TLR8;TNF;TNFAIP3;PYCARD;CASP1;TYROBP;MALT1;NOD2;CASP8;TMEM106A;CD36;CD33
prerank,response to sterol (GO:0036314),0.7292134255403819,1.4358751271526151,0.09289617486338798,0.3298578323154662,1.0,3/11,6.74%,TGFB1;TGFBR1;TGFBR2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6428253313245951,1.4354502227104644,0.06038647342995169,0.33040261831011286,1.0,5/26,6.47%,PF4;GATA1;IL1A;TNF;BCL2L1
prerank,cellular response to drug (GO:0035690),0.6344232247731472,1.4353926333756806,0.0744297719087635,0.3299662417624327,1.0,5/25,8.17%,AIM2;SLAMF8;RAP2A;TP53;MEF2C
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.6471575778016367,1.435344744928496,0.06524466750313676,0.32951877699510157,1.0,3/23,4.59%,CYP1A1;ALOX12;HPGD
prerank,regulation of actin filament polymerization (GO:0030833),0.5840889415805992,1.4351879044631084,0.021920668058455117,0.32937174596491026,1.0,10/69,5.09%,NCKAP1L;PTK2B;HCK;HCLS1;CYRIB;PRKCD;NCK2;SNX9;PYCARD;ARFGEF1
prerank,regulation of cell size (GO:0008361),0.6529090189149007,1.4347500515777214,0.07178217821782178,0.329983652813951,1.0,5/23,4.83%,VAV1;PLEK;MTOR;VAV2;VAV3
prerank,regulation of cellular respiration (GO:0043457),0.6773244158392889,1.4344263537859547,0.09114927344782034,0.3302399863625806,1.0,4/17,7.85%,IL10RB;CBFA2T3;IFNAR1;TRAP1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.5894461727266019,1.4337159039944976,0.04202586206896552,0.3314840139860005,1.0,17/54,15.03%,SYK;LAPTM5;RFFL;TNF;OTULIN;TRAF2;TNFAIP3;PYCARD;CASP1;CFLAR;TAX1BP1;CASP8;IKBKG;GPS2;GAS6;TRADD;SPPL2A
prerank,cellular response to type I interferon (GO:0071357),0.6035572714920084,1.4333969303412912,0.05292171995589857,0.3310785848631023,1.0,9/41,10.77%,IRF5;IRF4;IRF8;TYK2;IFNAR1;SAMHD1;ADAR;IRF2;RNASEL
prerank,type I interferon signaling pathway (GO:0060337),0.6035572714920084,1.4333969303412912,0.05292171995589857,0.3310785848631023,1.0,9/41,10.77%,IRF5;IRF4;IRF8;TYK2;IFNAR1;SAMHD1;ADAR;IRF2;RNASEL
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.6290060609241361,1.4330216370559956,0.07656065959952886,0.33158777859650773,1.0,6/29,11.05%,VAV1;LYN;GRB2;EPO;ERBIN;RAPGEF1
prerank,positive regulation of macrophage activation (GO:0043032),0.6856683540963482,1.4324716851254857,0.07383419689119171,0.33251492736116744,1.0,3/17,4.65%,TREM2;STAP1;CEBPA
prerank,carboxylic acid catabolic process (GO:0046395),0.7198261602851413,1.4316113126712011,0.06843575418994413,0.3342360194016753,1.0,4/12,7.14%,NPL;RENBP;NAGK;PON3
prerank,positive regulation of cellular metabolic process (GO:0031325),0.5634888023483863,1.4315320399173677,0.014198782961460446,0.33386689176038287,1.0,31/98,19.48%,ARRB2;TGFB1;PCSK9;IL10RB;VAMP3;GRB2;MAPK14;SNCA;APOE;IFNAR1;XDH;TGFBR2;TP53;NTF3;SCYL2;RAB1B;INHBA;CD63;THBS1;PID1;FASN;STARD4;AHI1;ACACA;PPARD;ANGPT1;GREM1;GHITM;SCRIB;TBC1D5;RAB29
prerank,regulation of neuron death (GO:1901214),0.571766482137358,1.430745647452868,0.015432098765432098,0.33543639267091546,1.0,22/82,14.11%,GPNMB;FCGR2B;ITGB2;PCSK9;CD200R1;SNCA;TRAF2;TYROBP;MAP3K5;C1QA;MEF2C;KIF14;CTSZ;PPARGC1A;ITGAM;TNFRSF1B;FYN;DDIT4;SORL1;IKBKG;RRAS2;LRRK2
prerank,regulation of store-operated calcium entry (GO:2001256),0.7387354326578588,1.4291134004267005,0.06637168141592921,0.33932659605758253,1.0,1/10,0.10%,CD84
prerank,fluid transport (GO:0042044),0.7061445285000729,1.4290974879812026,0.09575923392612859,0.3387866367199935,1.0,2/12,8.26%,AQP1;AQP11
prerank,pre-miRNA processing (GO:0031054),0.6976409357472388,1.4289077789022788,0.0782967032967033,0.33871321320984954,1.0,11/14,25.10%,ADAR;AGO4;AGO3;PRKRA;TUT7;TARBP2;AGO2;DICER1;LIN28B;AGO1;DROSHA
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.6637702242199843,1.4286677915440709,0.08706467661691543,0.3387226268563897,1.0,8/18,15.81%,CD300A;NLRC3;SKI;MORC3;TP53;B4GALT7;FTH1;NF1
prerank,regulation of leukocyte activation (GO:0002694),0.7036909768235662,1.4283854235589264,0.0821917808219178,0.338900404237576,1.0,3/14,4.56%,LYN;CD74;GPR137B
prerank,positive regulation of cellular component organization (GO:0051130),0.5623620205652322,1.4283682651868783,0.01015228426395939,0.3383613632102381,1.0,17/107,9.03%,RUNX1;TREM2;LGALS3;PLEKHM2;TGFB1;SYK;FNIP2;TGFBR1;TNF;FNIP1;SNCA;ASAP1;APOE;ABCB4;TAL1;RB1;BAK1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.67837385122503,1.428324353607638,0.08627450980392157,0.33789933184507465,1.0,3/16,3.79%,ITGB2;MDK;TNF
prerank,regulation of cell projection organization (GO:0031344),0.6970559066298915,1.4282446171957077,0.08974358974358974,0.33752962300502287,1.0,4/13,8.37%,TREM2;SEMA4D;MACF1;MOV10
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.73124261426137,1.4275953163872048,0.10909090909090909,0.3387082380845291,1.0,5/10,13.16%,LYN;STAT5A;PTPN1;STAT5B;PRLR
prerank,positive regulation of phosphatase activity (GO:0010922),0.6474572112034451,1.4271932984469557,0.08484848484848485,0.3391471550857712,1.0,4/21,8.17%,PLEK;CD300A;MTOR;MEF2C
prerank,cell projection assembly (GO:0030031),0.6454319655353891,1.427188700426336,0.07177615571776155,0.3386018462639724,1.0,2/22,1.29%,NCKAP1L;NEFH
prerank,regulation of interleukin-13 production (GO:0032656),0.699925305298313,1.42652498401476,0.09568733153638814,0.33979693114926013,1.0,3/13,9.54%,IRF4;IL18;TNFRSF21
prerank,protein homotrimerization (GO:0070207),-0.5319957902649255,-1.425202274303085,0.07307692307692308,1.0,1.0,7/14,28.57%,DISP1;SLC1A5;SCARA5;SIGMAR1;MLKL;MIF;PNPT1
prerank,protein trimerization (GO:0070206),-0.5319957902649255,-1.425202274303085,0.07307692307692308,1.0,1.0,7/14,28.57%,DISP1;SLC1A5;SCARA5;SIGMAR1;MLKL;MIF;PNPT1
prerank,T cell mediated immunity (GO:0002456),0.695020922593886,1.4250601420111244,0.0877914951989026,0.3432236816549704,1.0,3/13,6.18%,MYO1G;CRTAM;BTN3A3
prerank,lipid homeostasis (GO:0055088),0.581799714118275,1.4244716668402357,0.045064377682403435,0.34423246418330744,1.0,12/57,9.06%,TREM2;ABCA1;MLXIPL;ANGPTL3;CLN8;APOE;ABCG1;CEBPA;ABCB4;USF1;ABCD1;ABHD4
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.6413050733747527,1.4243668968207515,0.08859223300970874,0.34393405707254043,1.0,3/23,5.00%,HOOK3;TUBB;CCDC88B
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.6923038523339431,1.4242768496667604,0.07611548556430446,0.3436280445332657,1.0,3/15,2.41%,BAG2;RPL23;MAD2L2
prerank,growth hormone receptor signaling pathway (GO:0060396),0.6901709956692489,1.424262018170886,0.10561497326203209,0.34309445758089163,1.0,3/14,2.50%,LYN;STAT5A;PTPN1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.5533735934151738,1.4234856479588058,0.012108980827447022,0.34464922627235967,1.0,48/132,16.98%,LAPTM5;DAGLB;ADAM8;PRKCD;P2RX7;PTPN1;PIK3CB;MLXIPL;SNX9;TRIM5;TNF;SNCA;APOE;FOXO3;CNOT8;SNX33;PFKFB4;HMGB1;TFEB;GTPBP1;ABCD1;PIM2;SVIP;PLK2;TICAM1;GRSF1;FLCN;VPS11;MOV10;TRIM27;RC3H1;AMER1;TRIM8;ZC3H18;MID2;TNFRSF1B;ITCH;LRRK2;RNF152;MTDH;GSK3A;IRGM;HIF1A;PFKFB3;FAF1;HSP90AA1;GAPDHS;FURIN
prerank,dopaminergic neuron differentiation (GO:0071542),0.6621195816771466,1.4232975105921473,0.08497536945812807,0.3446107900657747,1.0,2/19,6.34%,SHH;CTNNB1
prerank,dendrite morphogenesis (GO:0048813),-0.3858855052819238,-1.4226825042821842,0.037037037037037035,0.9908873559990772,1.0,11/35,10.98%,PTN;DCDC2;BTBD3;TAOK2;FARP1;EPHB2;DIP2A;CHRNA7;SHANK3;MAP6;SHANK1
prerank,positive regulation of cation channel activity (GO:2001259),0.59847712392368,1.4218194245729414,0.05704697986577181,0.34801340135822584,1.0,7/40,7.57%,CTSS;CCR2;P2RY6;PKD2;KCNIP2;STAC;TMSB4X
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.4699994396754064,-1.421169394661416,0.07894736842105263,0.9779562755355884,1.0,7/21,10.38%,CACNA1C;ANK2;RYR2;DMD;SRI;ATP1A2;CALM3
prerank,negative regulation of MAP kinase activity (GO:0043407),0.5895125355040423,1.4200291543551145,0.04143947655398037,0.35217639193670874,1.0,11/44,12.90%,LYN;CD300A;PTPRJ;PRKCD;PTPN1;PIK3CB;APOE;DUSP10;DUSP19;SH2B3;SORL1
prerank,regulation of hydrolase activity (GO:0051336),0.5684689310108719,1.4199331357346159,0.029866117404737384,0.3518375614698033,1.0,11/71,5.93%,FGD2;VAV1;ARHGAP9;ARHGAP15;VAV2;PLXNC1;GPR137B;PLXNB2;VAV3;RAB3GAP2;FGD6
prerank,regulation of cell development (GO:0060284),0.6063906929801878,1.4194401212271548,0.05909090909090909,0.35257191244488506,1.0,6/36,6.34%,ASCL1;CX3CR1;SLAMF8;HES7;BHLHE41;CTNNB1
prerank,regulation of phospholipase C activity (GO:1900274),-0.4863422871583635,-1.4192264958316656,0.09876543209876543,0.966155963852817,1.0,4/15,7.77%,NTRK3;PLCG1;ABL1;PDGFRA
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.6379253463652217,1.4187183178485148,0.08543922984356198,0.35395109105652683,1.0,12/25,20.61%,HK3;PFKL;ALDOB;ENO3;GPI;FOXK1;HK2;GCK;PGAM1;GAPDHS;ENO1;PKM
prerank,regulation of stem cell proliferation (GO:0072091),0.6726676189580497,1.4176535443676808,0.08661417322834646,0.3561550669594597,1.0,1/17,0.12%,PTPRC
prerank,canonical glycolysis (GO:0061621),0.6387211719144311,1.4174714396545132,0.08795180722891566,0.35547831856493445,1.0,12/24,20.61%,HK3;PFKL;ALDOB;ENO3;GPI;FOXK1;HK2;GCK;PGAM1;GAPDHS;ENO1;PKM
prerank,glucose catabolic process to pyruvate (GO:0061718),0.6387211719144311,1.4174714396545132,0.08795180722891566,0.35547831856493445,1.0,12/24,20.61%,HK3;PFKL;ALDOB;ENO3;GPI;FOXK1;HK2;GCK;PGAM1;GAPDHS;ENO1;PKM
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.6067156211920588,1.4173110519949381,0.06306306306306306,0.35536691916552327,1.0,4/34,8.17%,ARRB2;NPAS4;GABRA5;MEF2C
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.6845312913502597,1.417248308644464,0.12021857923497267,0.35496608634321825,1.0,5/15,4.76%,ADAM8;SNX9;TNF;APOE;SNX33
prerank,positive regulation of lymphocyte migration (GO:2000403),0.7080107013265016,1.4168203657428322,0.09985935302390998,0.35556574697684884,1.0,3/12,6.36%,DOCK8;PYCARD;AIF1
prerank,phospholipid translocation (GO:0045332),0.6266889546624606,1.4160041900978568,0.07100591715976332,0.35711395856183076,1.0,8/28,12.98%,ATP8B4;ABCA1;P2RX7;ATP8A1;ATP8A2;ABCB4;ABCC1;ABCA4
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.590138109695158,1.4140814788324447,0.04202586206896552,0.3617286522511128,1.0,20/54,18.32%,TGFB1;STAT5A;ANGPT4;MAPK14;TNF;APOE;PRKD2;RGCC;P2RX4;HMGB1;MAP2K3;TMSB4X;MEF2C;THBS1;ATP5F1A;PRCP;NF1;HIF1A;PDPK1;ANGPT1
prerank,cellular response to amyloid-beta (GO:1904646),0.6046764613425937,1.41389124810356,0.07361268403171008,0.36170336064092495,1.0,11/35,16.70%,TREM2;FCGR2B;LGMN;ITGA4;CACNA1A;ABCC1;CACNB1;FYN;LRP1;CD36;EPHA4
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.5517206090063737,1.4132780213688954,0.0030120481927710845,0.36275102344575155,1.0,43/190,12.71%,ARRB2;CD22;TREM2;LYN;ARHGAP25;PLEK;CYRIB;PTPRJ;DUSP3;NR1H4;P2RX7;PIK3CB;RFFL;MAPK14;TSPAN6;NLRC3;FNIP1;HERPUD1;TANK;DDIT3;TNFAIP3;SPI1;PYCARD;MGRN1;XDH;WWC2;ADGRG3;MAP2K3;OTUD3;BCL2L1;TMSB4X;FLCN;DGKD;DGKG;PDCD6;PDE11A;SH2B3;THBS1;ADIPOR1;CDC34;DDIT4;NLRX1;CASP8
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.5518343487169748,1.413274678685574,0.004016064257028112,0.3621702342431044,1.0,21/152,7.63%,GNA15;CNR2;PF4;CALCR;ADCY7;ABCA1;ADGRE1;ADGRG5;GNAQ;ADGRE5;PSAP;GNAZ;ADCY6;AKAP5;S1PR4;ADGRG3;GNA13;GNA12;P2RY12;RAMP1;WASF2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.6906800835356157,1.4132373132728904,0.0907840440165062,0.36168794470051563,1.0,4/13,9.69%,ITGB2;MDK;TNF;FUT9
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5911589581820306,1.4131660455513768,0.05382131324004306,0.3612820560941902,1.0,6/46,2.65%,PTPRC;LYN;SIRPA;DUSP3;PTPN1;DUSP29
prerank,estrogen metabolic process (GO:0008210),0.6856155784753957,1.4131072675579444,0.09249329758713137,0.36085921980554475,1.0,1/15,0.45%,CYP1A1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.706850139641751,1.4128737309406507,0.09809264305177112,0.3609234344258645,1.0,5/11,13.65%,LILRB1;HCLS1;NOD2;MERTK;GAS6
prerank,pancreas development (GO:0031016),-0.5233388295112298,-1.4119478983580704,0.08303249097472924,0.9815995595168305,1.0,5/12,20.19%,TCF7L2;NPHP3;MET;CCDC39;ZIC3
prerank,high-density lipoprotein particle assembly (GO:0034380),0.734579401971095,1.4116641973212956,0.10274963820549927,0.3635592207796971,1.0,3/10,11.51%,ABCA1;APOE;PRKACB
prerank,cortical cytoskeleton organization (GO:0030865),0.6061674323711486,1.4115848408454128,0.04888888888888889,0.36319919624720176,1.0,6/41,5.74%,NCKAP1L;PLEK;LCP1;TNF;FHOD1;FMNL3
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.6504012769738994,1.411175389601145,0.09182389937106918,0.3637525664583121,1.0,2/18,1.17%,PTK2B;CCR2
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.41886010739049817,-1.4109541916996033,0.05844155844155844,0.9663627156173572,1.0,7/26,15.19%,SORBS1;PRKCI;IRS1;C2CD5;ARPP19;OCLN;AKT1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.7092677959285095,1.4107105336989676,0.11379800853485064,0.3643799174830358,1.0,2/11,5.66%,CD74;CD44
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.717035197483225,1.4098968715299551,0.10571428571428572,0.36603130769246695,1.0,3/11,6.74%,TGFB1;TGFBR1;TGFBR2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.6315234300630969,1.409679936813776,0.08058608058608059,0.36601438230569505,1.0,4/22,4.10%,GSAP;LYN;TNF;ABCG1
prerank,negative regulation of neurogenesis (GO:0050768),0.6038181314455443,1.40912592416331,0.08,0.36690226896476463,1.0,14/34,17.66%,HOOK3;THY1;TNF;PCM1;SORL1;B2M;ARHGDIA;EFNB3;YWHAH;NF1;RTN4;PTEN;APPL2;RHOA
prerank,negative regulation of GTPase activity (GO:0034260),0.6427370684463741,1.4078727204625068,0.08663366336633663,0.36984759164960146,1.0,8/22,16.54%,KLRK1;FZD10;RASA4;ARFGEF1;WNK1;F11R;LRRK2;CPEB2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.6298331590988007,1.4077882218010398,0.09177592371871275,0.3694537821898862,1.0,1/23,0.08%,PLBD1
prerank,positive regulation of lipid localization (GO:1905954),0.7184927117090368,1.4072468417725759,0.07703281027104136,0.3702585455089646,1.0,4/11,14.23%,LPL;VSTM2A;NFKB1;LRP1
prerank,activation of GTPase activity (GO:0090630),0.5619751477358955,1.4068336167981828,0.027466937945066123,0.3708262271124184,1.0,18/89,11.55%,ARHGAP45;ARHGAP25;TBC1D9;ABR;SIPA1L2;ARHGAP22;TBC1D10C;ARHGAP24;TBC1D16;TBC1D22A;USP6NL;TBC1D10A;NTF3;SIPA1;RAP1GAP2;TBC1D2;TBC1D17;TBC1D2B
prerank,sympathetic nervous system development (GO:0048485),0.6867994595765313,1.4066319485148424,0.10312075983717775,0.37080835611969026,1.0,7/15,15.81%,ASCL1;FZD3;CTNNB1;TFAP2B;NRP1;SOX4;NF1
prerank,positive regulation of defense response (GO:0031349),0.5505781392528692,1.406562286156965,0.024742268041237112,0.37045610718974864,1.0,16/89,8.18%,CCR2;LPL;TLR2;GPRC5B;ADAM8;DHX9;TLR7;TLR8;MDK;OSM;TNF;SNCA;CEBPA;IL18;MEF2C;PLA2G7
prerank,regulation of cholesterol efflux (GO:0010874),0.6115791454913381,1.4064586584626049,0.07995226730310262,0.37015359997335423,1.0,12/30,18.49%,TREM2;SHH;SREBF2;APOE;EEPD1;TTC39B;GPS2;LRP1;ABCA3;LAMTOR1;RXRA;NAXE
prerank,ureteric bud development (GO:0001657),-0.464637518738943,-1.4060250849005176,0.09954751131221719,0.9703764590874014,1.0,7/17,14.08%,ROBO2;FOXC1;BMP4;SALL1;SLIT2;SIX1;GPC3
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.7072696849987608,1.405968773644042,0.12262773722627737,0.3709784127645426,1.0,3/11,8.15%,NFKBID;MALT1;PRKCQ
prerank,indolalkylamine catabolic process (GO:0046218),0.7217773877038207,1.4056839196936535,0.11510791366906475,0.3712060140770234,1.0,3/10,7.90%,HAAO;KYNU;KMO
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.7122982281831652,1.4053692834143554,0.09695290858725762,0.3708698237179052,1.0,8/12,24.43%,TNF;SLC9A1;SPPL3;CHERP;LMCD1;PTBP1;IGF1;CAMTA1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.7122982281831652,1.4053692834143554,0.09695290858725762,0.3708698237179052,1.0,8/12,24.43%,TNF;SLC9A1;SPPL3;CHERP;LMCD1;PTBP1;IGF1;CAMTA1
prerank,protein processing (GO:0016485),0.5578992479068522,1.404771420961774,0.024439918533604887,0.3719263429972057,1.0,19/102,9.62%,CTSS;KLK3;PCSK9;LGMN;FAM111A;VSIR;SRGN;CTSL;ECE2;EEF1AKMT4-ECE2;CLN3;CASP1;DDI2;SPCS2;ATP23;SEC11C;ZMPSTE24;SPPL3;SPCS1
prerank,cellular response to interleukin-12 (GO:0071349),0.5680874552869176,1.4044834428291642,0.06766917293233082,0.37211249580253253,1.0,9/48,7.68%,LCP1;SIRPA;TYK2;IL12RB2;AIP;RAP1B;STAT4;P4HB;CAPZA1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.7233779961651771,1.4040484508354751,0.09388335704125178,0.3727325179179445,1.0,4/10,11.24%,SHH;TGFBR2;LRP5;SOX9
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.6538063898965805,1.4038251998083102,0.09600997506234414,0.372799982714501,1.0,2/19,2.32%,PTPRC;PTPRJ
prerank,regulation of inflammatory response (GO:0050727),0.5423720999573246,1.4032104519161028,0.006006006006006006,0.3738852532823628,1.0,45/190,14.25%,HCK;CCR2;SIRPA;LPL;CD200R1;METRNL;PIK3AP1;VAMP3;TLR2;GPRC5B;DAGLB;PRKCD;NR1H4;DHX9;TLR7;MDK;OSM;NLRC3;FFAR2;TNF;SNCA;APOE;OTULIN;CEBPA;TNFAIP3;CASP1;IL18;ANXA1;AKNA;SETD6;TMSB4X;PLA2G7;RB1;ABCC1;TNFRSF1B;GRN;USP18;NOD2;LACC1;NINJ1;SHPK;GPS2;FNDC4;TRADD;AREL1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.6974262086509109,1.403096437146558,0.12285714285714286,0.37362519928195465,1.0,3/12,5.66%,THY1;TNF;CD44
prerank,protein-containing complex subunit organization (GO:0043933),0.5539765283687861,1.4025383354926142,0.023350253807106598,0.37451622349013586,1.0,27/109,13.56%,NCKAP1L;PTK2B;CD3E;CD74;VAMP3;SKAP2;SNX9;WIPF1;MITF;TRAF2;TEAD1;TP53;SEH1L;CAPZA1;HFE;PPARGC1A;EPRS1;TUBGCP4;TPR;SOX9;NUP205;DET1;MDN1;RANBP9;IKBKG;TSPAN4;DARS1
prerank,protein-DNA complex disassembly (GO:0032986),0.6754065143636099,1.402374269040215,0.09066666666666667,0.3743848437965112,1.0,5/16,12.90%,NFE2;RPL23;ARID1A;SMARCD3;SMARCB1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.5532228282190498,-1.4016676031653674,0.09395973154362416,0.9733009004887886,1.0,4/11,15.19%,GHR;IRS1;EIF2AK3;AKT1
prerank,regulation of nervous system development (GO:0051960),0.5971543841539121,1.4016623647867614,0.0713489409141583,0.37570551439151034,1.0,6/37,8.21%,ASCL1;CX3CR1;HES7;BHLHE41;CTNNB1;KIF14
prerank,defense response to Gram-positive bacterium (GO:0050830),0.6010637450145531,1.4013570453327668,0.06363636363636363,0.37597390080342696,1.0,6/40,5.93%,FGR;MPEG1;TLR2;DMBT1;STAB2;PPP1R11
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.6677109306005016,1.4007687694472037,0.09620253164556962,0.3769587020997589,1.0,6/16,17.11%,KLK3;DDAH1;KLK2;GSK3A;PRCP;ADM
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.6555168932090621,1.4006656560745818,0.10691003911342895,0.3766820851296817,1.0,6/18,8.47%,PTK2B;CYRIB;ARFGEF1;RAP1B;RIPOR2;KIF20B
prerank,cellular response to oxygen-containing compound (GO:1901701),0.5396234666998356,1.4006035699933843,0.001,0.3762800452428116,1.0,66/291,14.64%,CD86;PTK2B;LILRB1;LYN;PF4;CXCL5;CX3CR1;STAP1;PDCD1LG2;SIRPA;IL1A;LPL;P2RY6;AQP1;FZD10;TLR2;HCN4;CXCL2;PRKCD;NR1H4;P2RX7;MTOR;MAPK14;P2RY2;FFAR2;PKD2;CD68;ADCY6;TNFAIP3;PYCARD;CASP1;CD14;RAP1B;P2RX4;HMGB1;TAF1;ABCB4;ACTB;CD80;P2RY12;TICAM1;CD180;MEF2C;LY96;CD274;IMPACT;CPEB3;RAPGEF1;SOX9;CCL2;NRIP1;GLRA2;TNFRSF1B;PRDX3;TWF2;NOD2;DEFA6;CREB1;NFKB1;CAMKK2;SHPK;PID1;LAMTOR3;CAPN2;GNG2;RAP1A
prerank,positive regulation of proteolysis (GO:0045862),0.5761052724828389,1.4003201934505427,0.060279870828848225,0.37650649581254764,1.0,18/55,15.00%,BAG2;CTSC;ADAM8;SNX9;TNF;AURKAIP1;APOE;TANK;SNX33;ASPH;TBC1D10A;ATP5IF1;BAK1;CCBE1;TNFRSF1B;CASP8;STUB1;CAPN3
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6959975348975855,1.400156885755333,0.11420612813370473,0.3752081695379141,1.0,7/12,21.35%,ESPL1;CDC23;RB1;ANAPC11;CUL3;NSMCE2;CDC16
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.6959975348975855,1.400156885755333,0.11420612813370473,0.3752081695379141,1.0,7/12,21.35%,ESPL1;CDC23;RB1;ANAPC11;CUL3;NSMCE2;CDC16
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6959975348975855,1.400156885755333,0.11420612813370473,0.3752081695379141,1.0,7/12,21.35%,ESPL1;CDC23;RB1;ANAPC11;CUL3;NSMCE2;CDC16
prerank,regulation of chromatin binding (GO:0035561),-0.5668708336036894,-1.400141239080531,0.10452961672473868,0.9623016220833818,1.0,5/10,17.22%,WAPL;BTAF1;DTX3L;HMBOX1;KDM4D
prerank,positive regulation of GTPase activity (GO:0043547),0.5441695902053544,1.3999576871859893,0.006006006006006006,0.3751764222718165,1.0,55/188,17.14%,ARHGAP45;DOCK8;ARHGAP25;RGS10;TBC1D9;ABR;SIPA1L2;ARHGAP22;FZD10;TBC1D10C;THY1;ARHGAP24;SNX9;ARAP1;CCL8;SEMA4D;ITGA6;RASGRP2;TBC1D16;TBC1D22A;USP6NL;DOCK11;DOCK10;AGRN;TBC1D10A;FLCN;NTF3;SIPA1;CCL14;RAP1GAP2;F11R;TBC1D2;LIMS1;RAPGEF1;TBC1D17;CCL13;CCL2;TBC1D2B;ARHGAP27;TBC1D8;MMUT;RAP1A;SIPA1L3;TBC1D14;BCAR3;TBC1D22B;NF1;GNB5;ALS2;ARHGEF26;RGS1;SNX13;CCL25;SNX18;CORO1C
prerank,regulation of lipase activity (GO:0060191),0.6940176706035005,1.3997529153035002,0.10973936899862825,0.3751478999098496,1.0,4/13,6.37%,LPL;ANGPTL3;SNCA;LIPC
prerank,positive regulation of interleukin-1 production (GO:0032732),0.5730894929750087,1.3996877949263125,0.06373626373626373,0.37473374959369166,1.0,14/51,15.32%,AIM2;LPL;P2RX7;TLR8;TNF;PYCARD;CASP1;HMGB1;TYROBP;MALT1;NOD2;CASP8;TMEM106A;CD36
prerank,cellular response to fluid shear stress (GO:0071498),0.7115887580923751,1.3991258403729196,0.10013908205841446,0.37568673845806866,1.0,5/12,8.17%,NFE2L2;SREBF2;PKD2;MTSS1;MEF2C
prerank,regulation of hormone secretion (GO:0046883),0.6811600363104824,1.3982932547157747,0.09379128137384413,0.3773296299890385,1.0,4/15,6.22%,VAMP3;OSM;FFAR2;ANXA1
prerank,diacylglycerol metabolic process (GO:0046339),0.6276976038765704,1.3977614000038712,0.10097323600973236,0.3781902905618458,1.0,8/23,13.03%,DGKZ;PGS1;DGKK;DGKE;DGKD;DGKG;DGKI;LIPE
prerank,endocardial cushion development (GO:0003197),-0.42783823334806304,-1.39740700381379,0.0851063829787234,0.9576126085826192,1.0,5/21,12.19%,BMPR1A;BMP4;ACVR1;ACVRL1;NOS3
prerank,cellular response to nutrient levels (GO:0031669),0.5678574275999443,1.397298615003033,0.05128205128205128,0.37896142353464896,1.0,12/62,8.23%,PCSK9;LPL;GAS2L1;MTOR;ATG7;FNIP1;SREBF2;MAP1LC3B;CD68;TFEB;RIPOR1;FLCN
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.6403820242297082,1.3966961976139245,0.10565110565110565,0.3800897737301098,1.0,3/23,3.74%,TGFB1;MYL3;PKP2
prerank,regulation of neuroblast proliferation (GO:1902692),0.6719292646939513,1.396176631639853,0.11681643132220795,0.3809640288622144,1.0,8/15,15.81%,CX3CR1;FZD3;CTNNB1;DISC1;SMARCD3;TAFA1;LRRK2;NF1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.6211894918202647,1.3959131398283209,0.08685162846803378,0.38114189171987256,1.0,7/26,11.26%,PTPRC;PLCG2;PKD2;ITPR2;IBTK;SLC8B1;CHERP
prerank,regulation of extracellular matrix organization (GO:1903053),0.6706545833467633,1.3958434035980616,0.10889774236387782,0.38077153038663325,1.0,1/15,0.09%,RUNX1
prerank,glycogen catabolic process (GO:0005980),-0.5012804972965086,-1.3954748839083937,0.10460251046025104,0.9490551923571815,1.0,7/15,21.83%,PHKA2;PYGB;PHKG2;PHKB;PYGM;AGL;PHKA1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.654125804086121,1.3952833033200276,0.0916030534351145,0.38173632510644406,1.0,2/19,4.82%,CX3CR1;TNFAIP3
prerank,regulation of proteolysis (GO:0030162),0.5775160514004022,1.39512733764048,0.06073752711496746,0.3815907535321283,1.0,16/48,15.00%,GSAP;SHH;CLN8;AURKAIP1;CLN3;TRAF3;ASPH;TBC1D10A;BAK1;HDAC6;SPOP;PARL;CASP8;ITCH;STUB1;CAPN3
prerank,regulation of receptor internalization (GO:0002090),0.5968485854089083,1.3944200462240763,0.07903780068728522,0.38297224871472785,1.0,13/35,19.47%,ARRB2;PCSK9;RIN3;NTF3;SCYL2;CD63;SDCBP;ANKRD13A;AHI1;ANGPT1;FLOT1;GREM1;TBC1D5
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.6276214914465461,1.3943767344194218,0.09367396593673966,0.38250935228887484,1.0,3/24,1.38%,HPSE;TGFB1;IL1A
prerank,sensory perception of pain (GO:0019233),0.648667218996573,1.3931529251181987,0.09270704573547589,0.3852450977822339,1.0,7/21,13.58%,CCR2;P2RX7;PRDM12;P2RX4;CCL2;SCN9A;RETREG1
prerank,response to cytokine (GO:0034097),0.5431568630538552,1.39312673554083,0.009054325955734407,0.38473279280391137,1.0,28/141,10.93%,PTPN7;CIITA;SLC11A1;HCLS1;FLT3;CD74;MAPKAPK3;IRAK2;CSF1R;TNFRSF11A;PTPN18;SNCA;GCH1;LDLRAP1;CXCR4;IL6R;CASP1;TIMP1;ANXA1;BCL2L1;KYNU;SMAD3;ADAR;CD274;HDAC4;SETD2;TRIM56;IL18BP
prerank,TOR signaling (GO:0031929),0.6134863021938449,1.3923995977140065,0.10446009389671361,0.38612274358071674,1.0,7/26,9.27%,CARD11;MTOR;FNIP1;EIF4EBP2;FLCN;LARP1;SMG1
prerank,regulation of transmembrane transport (GO:0034762),0.6030967131169406,1.3919021235579978,0.08840413318025259,0.3869658648226546,1.0,7/31,13.69%,KCNJ11;SNCA;PRKCB;ACTB;PIM1;NEDD4L;CTTNBP2NL
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.6671934023487083,1.3918522585376731,0.10290237467018469,0.3865370050656023,1.0,3/17,7.59%,TREM2;NFE2L2;P4HB
prerank,negative regulation of innate immune response (GO:0045824),0.6036573467278573,1.391487188102636,0.07931034482758621,0.3869605587626826,1.0,11/34,12.11%,NLRC5;SLAMF8;NLRC3;TNFAIP3;TRAFD1;SAMHD1;YTHDF3;TTLL12;GRN;USP18;METTL3
prerank,positive regulation of wound healing (GO:0090303),0.5852643025808674,1.3911124127507448,0.09020044543429843,0.3873949986276143,1.0,8/36,11.47%,HPSE;SMOC2;RREB1;MTOR;ARFGEF1;ANXA1;ACTG1;THBS1
prerank,thymus development (GO:0048538),0.675900652326759,1.39093111798264,0.11288180610889774,0.38732352573757206,1.0,2/13,2.11%,SHH;TGFBR1
prerank,response to purine-containing compound (GO:0014074),0.6579947565260215,1.3908621918452568,0.09844559585492228,0.3869496321362052,1.0,5/17,10.54%,KCNJ11;P2RY6;P2RX7;P2RX4;VGF
prerank,negative regulation of cyclase activity (GO:0031280),0.6724635575127271,1.3907526982430904,0.11994609164420485,0.3866841173174502,1.0,5/14,14.34%,CCR2;EDNRB;AKAP5;LTB4R2;GNAI3
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.6971643450443497,1.3905467738437685,0.1063257065948856,0.38669547708891605,1.0,2/13,1.23%,ANAPC15;PCID2
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.6203470053839609,1.3901797464862975,0.11260709914320685,0.387116566983983,1.0,9/24,11.82%,PCSK9;TNF;FOXO3;DDIT3;CTNNB1;TYROBP;TFAP2B;ITGAM;GRN
prerank,hematopoietic stem cell differentiation (GO:0060218),0.7219573743715263,1.3897648779118483,0.12965722801788376,0.3877605566395247,1.0,3/10,6.80%,MEOX1;SP7;TP53
prerank,wound healing (GO:0042060),0.5698138111614067,1.389456713907433,0.0472193074501574,0.38805267644423025,1.0,18/62,17.24%,MMP12;HPSE;SLC11A1;ITGB3;TGFBR1;MYH9;CFLAR;MACF1;SMAD3;SYTL4;DYSF;NRG1;PRCP;NF1;DST;AHNAK2;ARL8B;DCBLD2
prerank,regulation of type I interferon production (GO:0032479),0.5504640211988128,1.38944661031166,0.03189300411522634,0.3875070153257921,1.0,22/84,14.04%,IRF5;IRF8;NLRC5;TRIM25;DHX9;TNFAIP3;LRRFIP1;CD14;TRAF3;XRCC5;CTNNB1;TAX1BP1;TRIM56;POLR2L;RNF216;NLRX1;ITCH;RNF135;NFKB1;IRF1;GPATCH3;DTX4
prerank,positive regulation of stem cell proliferation (GO:2000648),0.652689206865112,1.389427869923524,0.11757105943152454,0.38698841016124497,1.0,1/17,0.12%,PTPRC
prerank,early endosome to late endosome transport (GO:0045022),0.6360448621820625,1.3889183354275556,0.10643564356435643,0.3877753841440867,1.0,7/20,13.95%,HOOK3;WDR91;RAB7A;BECN1;WDR81;STX8;HOOK2
prerank,lipoxygenase pathway (GO:0019372),0.6770690595242237,1.3887665773642226,0.10150891632373114,0.38763869311201476,1.0,3/14,7.14%,ALOX12;HPGD;PON3
prerank,positive regulation of endopeptidase activity (GO:0010950),0.6138469666362908,1.3884501310317505,0.09212121212121212,0.38788413023753837,1.0,4/26,4.91%,LYN;AIM2;VSIR;PYCARD
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.6895210264529289,1.3883771151294986,0.11797752808988764,0.387488598360087,1.0,3/12,10.53%,CD74;CD44;RPL26
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.5667430317989053,1.3881828951434916,0.052127659574468084,0.38745699510370685,1.0,18/59,14.80%,CARD11;IRAK2;TLR2;TLR7;TLR8;NLRC3;TNF;TANK;TRAF2;CD14;MAP3K14;TICAM1;LY96;IRAK1BP1;TAB2;IKBKG;TRADD;TAB3
prerank,lipid catabolic process (GO:0016042),0.6447781805384957,1.3878150392634696,0.10695876288659793,0.3879035409081111,1.0,6/18,16.90%,LPL;CEL;LIPC;ACADL;LIPE;PLAAT3
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.6280255262391887,1.3876789022370286,0.07859733978234583,0.3876979759007422,1.0,4/23,4.62%,PTPRC;CBL;THY1;ZFYVE28
prerank,granulocyte differentiation (GO:0030851),0.6565405863342189,1.3866430438379362,0.10286458333333333,0.3899652055282882,1.0,5/18,7.01%,GATA1;CBFA2T3;CEBPA;SPI1;TAL1
prerank,regulation of fibroblast proliferation (GO:0048145),0.5824740598144508,1.3862818777638233,0.06385281385281386,0.39035889573296173,1.0,14/45,15.81%,CD74;CD300A;AQP1;DHX9;NLRC3;SKI;MORC3;CTNNB1;TP53;CDK6;B4GALT7;GAS6;FTH1;NF1
prerank,serine family amino acid metabolic process (GO:0009069),0.6546362781206697,1.3859971406506566,0.11810012836970475,0.3906053181346872,1.0,1/16,0.19%,SEPSECS
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.6092650146073585,1.385177136153676,0.0800942285041225,0.3921952916361223,1.0,14/28,17.21%,IRAK2;MAP2K6;UBE2V1;OTULIN;TNFAIP3;NOD2;TAB2;LACC1;CASP8;ITCH;IKBKG;TAB3;IRGM;UBE2N
prerank,neurotransmitter uptake (GO:0001504),-0.5336122586494341,-1.3848129992743,0.1326530612244898,0.9825590325220199,1.0,10/12,42.70%,SNAP25;ATP1A2;GLUL;SLC29A1;SLC22A2;SLC1A6;SLC38A1;SLC22A3;SLC29A2;SLC29A4
prerank,cell differentiation in spinal cord (GO:0021515),0.7077049041197508,1.384495610644994,0.1150070126227209,0.3934819103374714,1.0,3/10,14.67%,DRAXIN;SOX6;SOX4
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6774165556291384,1.3844364280604755,0.12569832402234637,0.39305405970831614,1.0,4/13,6.60%,PLEK;APOE;ERLIN2;ERLIN1
prerank,apoptotic cell clearance (GO:0043277),0.6041693845875418,1.3833733360576754,0.09070034443168772,0.39547464581916514,1.0,9/30,16.01%,TREM2;ITGB3;HMGB1;ANXA1;TYROBP;THBS1;GAS6;LRP1;TXNDC5
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.6992979797422897,1.383337103643892,0.1199442119944212,0.39502758211380934,1.0,3/11,8.18%,ABCG1;LIPC;PLA2G7
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.6308602077402021,1.3830500489318636,0.0911300121506683,0.3952169292121013,1.0,5/22,10.48%,PLEK;STAP1;CDA;TP53;INHBA
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6761690683862708,1.382968691270905,0.09198423127463863,0.39486065121724273,1.0,5/15,7.57%,LGMN;SMOC2;PRKD2;P2RX4;TMSB4X
prerank,glycine transport (GO:0015816),0.7130515464056068,1.382020804590788,0.11159420289855072,0.39680957850613524,1.0,3/10,9.28%,SLC7A8;SLC36A1;SLC25A38
prerank,positive regulation of integrin activation (GO:0033625),0.6986221182034138,1.3818710778389465,0.1271186440677966,0.3966924859518981,1.0,3/11,7.53%,PLEK;RAP1B;P2RY12
prerank,positive regulation of defense response to virus by host (GO:0002230),0.6146037189674094,1.381719029898277,0.10295857988165681,0.3965771811731513,1.0,2/24,1.32%,LILRB1;AIM2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.6185832571460687,1.3815946040744238,0.1053921568627451,0.39633869321487986,1.0,6/24,11.26%,PTPRC;PLCG2;PKD2;ITPR2;IBTK;CHERP
prerank,response to retinoic acid (GO:0032526),0.5556677614001597,1.3815291487059402,0.06998939554612937,0.395961584474158,1.0,6/59,3.65%,PTK2B;LYN;ASCL1;AQP1;FZD10;RXRB
prerank,polyol metabolic process (GO:0019751),0.5811165857046097,1.3813583559266938,0.06427015250544663,0.39589272027497663,1.0,6/46,6.72%,PLD4;INPP5D;PLCB2;PLCG2;INPP4B;NUDT4
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.6949308539895951,1.3811512863233661,0.11584553928095873,0.3959383561132252,1.0,2/13,2.25%,SHH;ADAM8
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.5503380434571199,1.3804296053122065,0.042224510813594233,0.3972972449287868,1.0,25/88,16.45%,LGALS3;TGFB1;PLEK;SYK;FNIP2;TNF;FNIP1;RGCC;SMPD3;RAB7A;TAL1;SMAD3;BAK1;TPR;PFN2;PFN1;SDCBP;NRG1;SYNPO;SLX4;BMF;SLF2;PIH1D1;PDCD6IP;FAF1
prerank,regulation of T cell cytokine production (GO:0002724),0.6659378923677189,1.3799082273421903,0.11416781292984869,0.39822667123101363,1.0,6/15,13.10%,CCR2;TRAF2;HFE;MALT1;TNFRSF1B;B2M
prerank,inositol phosphate metabolic process (GO:0043647),0.580478140285557,1.3795835364877056,0.06818181818181818,0.3986146238939393,1.0,6/46,6.72%,PLD4;INPP5D;PLCB2;PLCG2;INPP4B;NUDT4
prerank,regulation of cell killing (GO:0031341),-0.4837132194925934,-1.379402410698348,0.12955465587044535,0.9899869709604869,1.0,5/16,10.92%,MAPK8;CD55;WNT5A;CR1L;CFH
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.6330004118582071,1.378799594099952,0.12039312039312039,0.40019567126074657,1.0,2/20,0.53%,PTK2B;PF4
prerank,response to organonitrogen compound (GO:0010243),0.5836331923812673,1.3786832125359234,0.08876404494382023,0.39997346202401235,1.0,8/38,12.85%,IRF5;NR1H4;MTOR;SEL1L;KYNU;DERL1;GLRA2;KAT7
prerank,ceramide catabolic process (GO:0046514),0.6582953265280186,1.3778271617004652,0.13123359580052493,0.401704564895498,1.0,4/14,9.86%,HEXB;GM2A;HEXA;ACER3
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.7092864399670228,1.377428773997597,0.12410841654778887,0.40229466299317473,1.0,2/10,6.82%,SAG;CNGB1
prerank,hematopoietic stem cell proliferation (GO:0071425),0.6920789161158213,1.37689636333634,0.1456859971711457,0.4031778449234939,1.0,1/11,0.09%,RUNX1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.5374633408652111,1.3764770565216269,0.006,0.40375566975862703,1.0,46/198,16.94%,PLBD1;PTPRC;HK3;PLD4;INPP5D;PIK3CG;PLCB2;TGFB1;LPL;PIK3CD;PLCG2;DUSP3;MTOR;PIK3CB;ANGPTL3;PFKL;CLN8;ALDOB;INPP4B;PIP4K2A;PFKFB4;NADK;NUDT4;CERK;PLPPR1;PPA2;DUSP10;AGK;FRA10AC1;GPI;SYNJ1;PIP4P1;SHPK;THNSL2;PXYLP1;HK2;PLCH1;LRRK2;GDE1;XYLB;PFKFB3;PTEN;GCK;GK;PLAAT3;PPP3CB
prerank,positive regulation of JUN kinase activity (GO:0043507),0.6248176510191656,1.3750250692939143,0.09200968523002422,0.407253875719055,1.0,7/23,10.72%,TAOK3;FZD10;TNFRSF11A;TNF;TRAF2;MAP3K5;DUSP19
prerank,substrate-dependent cell migration (GO:0006929),0.6810444988800719,1.3749905618073144,0.12601626016260162,0.4067871924685019,1.0,5/14,12.21%,PTPRC;ITGA2;P2RY12;NRP1;SDCBP
prerank,activation of protein kinase activity (GO:0032147),0.5459369831957482,1.3740435691398056,0.01641025641025641,0.408787500718729,1.0,25/106,13.66%,CD86;PTK2B;SLC11A1;ADCY7;PRKAR2B;ITGB3;TAOK3;PRKCD;MTOR;TRAF2;ADCY6;IL18;TGFBR2;TNIK;MALT1;KIF14;NTF3;STRADB;PRKACB;NRG1;PRLR;ADCY8;ADCY3;GAS6;STK3
prerank,activation of protein kinase A activity (GO:0034199),0.6509818372153638,1.373983837099914,0.11660329531051965,0.4083782384165914,1.0,6/16,13.63%,ADCY7;PRKAR2B;ADCY6;PRKACB;ADCY8;ADCY3
prerank,negative regulation of secretion by cell (GO:1903531),0.5837838201844736,1.3739817689777825,0.08498896247240618,0.40781687413417256,1.0,7/38,6.22%,LILRB1;VAMP3;OSM;SNCA;APOE;RHBDF2;ANXA1
prerank,mesonephric tubule development (GO:0072164),-0.4783930976313475,-1.3736099820953702,0.10572687224669604,1.0,1.0,6/15,10.25%,ROBO2;FOXC1;BMP4;SALL1;SLIT2;SIX1
prerank,cellular response to osmotic stress (GO:0071470),0.6377749927698179,1.3734186897371894,0.11596009975062344,0.40880571951581385,1.0,8/21,20.22%,AQP1;LRRC8D;PKD2;EPO;CAPN3;RCSD1;ARHGEF2;ZFP36L1
prerank,neuronal action potential (GO:0019228),-0.439772367128224,-1.373337248504899,0.11170212765957446,0.9850454634408381,1.0,12/22,28.10%,SCN1A;CACNA1G;KCNA1;KCNA2;SCN8A;ANK3;SCN3A;KCNMB2;GPER1;CACNA1H;MYH14;CACNA1I
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.4840397946148587,-1.373330720410645,0.11353711790393013,0.9683646950455953,1.0,6/16,10.38%,CACNA1C;ANK2;RYR2;DMD;ATP1A2;CALM3
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.675846430136061,1.3729979255446267,0.13793103448275862,0.4094678144632349,1.0,5/13,14.34%,CCR2;EDNRB;AKAP5;LTB4R2;GNAI3
prerank,activation of adenylate cyclase activity (GO:0007190),0.5919883245909,1.3724094940691112,0.08987485779294653,0.41046578461353134,1.0,8/35,15.58%,CALCR;ADCY7;TMIGD3;ADCY6;CAP1;ADCY8;ADCY3;LGR4
prerank,response to laminar fluid shear stress (GO:0034616),0.7124753975897866,1.3722892876362487,0.12769010043041606,0.4102207088853291,1.0,3/10,3.97%,NFE2L2;ABCA1;SREBF2
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.6405296999981906,1.372069706524707,0.12055837563451777,0.410208807310521,1.0,5/19,10.07%,RUNX1;TNF;SNAI1;PRKCH;F11R
prerank,negative regulation of cell activation (GO:0050866),0.6719295820359047,1.3714143614062901,0.13568521031207598,0.41149011387322454,1.0,2/14,4.04%,TREM2;APOE
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.6814027117502832,1.37129402749635,0.11875843454790823,0.4112811774148165,1.0,2/12,0.89%,PF4;TGFB1
prerank,negative regulation of autophagy (GO:0010507),0.5609367552900535,1.3710357698096611,0.06878306878306878,0.411380136036082,1.0,15/54,15.20%,TREM2;IL10RA;CTSA;MTOR;ATG7;SNCA;SMG1;EIF4G3;DAP;TAB2;FOXK1;LRRK2;BMF;TAB3;TBC1D14
prerank,digestive tract morphogenesis (GO:0048546),-0.5018027443005016,-1.3709754863402173,0.12546125461254612,0.9632562225844019,1.0,5/14,14.33%,NIPBL;PDGFRA;GLI1;SOX17;STRA6
prerank,regulation of defense response to virus by host (GO:0050691),0.595105329573135,1.370917923539485,0.10672853828306264,0.4111985478932032,1.0,4/30,4.82%,LILRB1;AIM2;DHX9;TNFAIP3
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.5465503112212946,1.3707258081796965,0.04132231404958678,0.41119658749265753,1.0,23/78,14.23%,MRAP;TREM2;LGALS3;TGFB1;PLS1;TNF;LDLRAP1;CLN3;AKAP5;STAC;BCL2L1;ACTB;ZDHHC7;PRKCH;CLTC;NUMB;STX3;STAC3;PPFIA1;PID1;STX8;ARF6;LRP1
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.5455155527233052,-1.3703855521129185,0.12027491408934708,0.9504373729195862,1.0,5/11,18.83%,PPIP5K2;IP6K1;IP6K2;ITPKC;IPMK
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.5987523123382799,1.369933363583647,0.11269276393831554,0.4128479416550829,1.0,9/29,13.00%,UBE2D3;TANK;CD14;CD300LF;TRAF3;TICAM1;LY96;CASP8;IKBKG
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.662186740778107,1.3699179324960875,0.11621966794380588,0.41233013939502894,1.0,6/15,11.47%,LGMN;SMOC2;PRKD2;P2RX4;TMSB4X;THBS1
prerank,regulation of mitochondrion organization (GO:0010821),0.5678829970552512,1.3696905245414306,0.09090909090909091,0.41239354758477315,1.0,22/47,21.05%,TREM2;CYRIB;SREBF2;CSNK2A2;FLCN;MYO19;PPARGC1A;IAPP;HDAC6;PARL;PID1;LRRK2;SREBF1;VDAC1;GSK3A;GOLPH3;FIS1;INF2;DNM1L;ATP13A2;GSK3B;PRKN
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5776673121689493,1.3696157313741437,0.09009009009009009,0.41202669878140524,1.0,13/38,20.32%,LGALS3;RFFL;TRAF2;TNFAIP3;CFLAR;BCL2L1;THBS1;CASP8;TRADD;ARHGEF2;FEM1B;TNFSF10;GSK3B
prerank,positive regulation of biosynthetic process (GO:0009891),0.5771232339591196,1.369305330653313,0.09173272933182333,0.41236000105332127,1.0,8/40,6.39%,RUNX1;TGFB1;PLCG2;MTOR;MLXIPL;APOE;RGCC;CREB3L1
prerank,endoderm development (GO:0007492),-0.5121984743104072,-1.3692860747609248,0.13523131672597866,0.9405304627501743,1.0,5/13,23.40%,KIF16B;DUSP1;SOX17;LAMC1;SOX7
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.6704689304621884,1.3689914637576508,0.13869625520110956,0.41268545962777436,1.0,5/13,12.71%,LGMN;ASPH;TBC1D10A;BAK1;CASP8
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.5947918297493152,1.3688968686974667,0.10433763188745604,0.4123848568997701,1.0,9/30,13.00%,UBE2D3;TANK;CD14;CD300LF;TRAF3;TICAM1;LY96;CASP8;IKBKG
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5400028046322644,1.3688296451267399,0.030518819938962362,0.41197708838283426,1.0,14/110,7.60%,CNR2;PF4;CALCR;ADCY7;ABCA1;ADGRE1;ADGRG5;GNAQ;ADGRE5;ADCY6;S1PR4;ADGRG3;GNA13;RAMP1
prerank,vasoconstriction (GO:0042310),0.692615040608354,1.3687621178439047,0.13869625520110956,0.41162295424218703,1.0,2/11,3.21%,EDNRB;SLC8A1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.5275824011289212,1.3685863014706607,0.001,0.4115983586075021,1.0,76/390,12.81%,NCKAP1L;LCP2;SLA;VAV1;PTK2B;BLNK;FGR;LYN;ATP6V0D2;HCK;CYBB;UBASH3B;CD3E;SYK;CASS4;STAP1;FLT3;CD7;MAPKAPK3;NCF4;ITGB3;CBL;ATP6V0E1;CSF1R;PTPRJ;TCIRG1;GRB2;NCF2;PIK3CB;VAV2;ELMO1;MAPK14;ATP6V1C1;NCK2;PRKD2;ATP6V1E1;CLNK;VAV3;ATP6V0A2;RAB14;ARPC2;SHC2;EFNA2;MTSS1;ACTB;AP2S1;NEDD9;ARPC3;VEGFB;ATP6V0D1;WASF2;ITSN1;AP3S1;NTF3;SULF2;ABI1;BCAR1;ACTG1;ACTR2;FLRT1;ATP6V0A1;ACTR3;NRP1;POLR2L;YES1;RAPGEF1;ATP6AP1;CYFIP1;ARPC4;ZNF106;PHIP;SDCBP;FYN;DDIT4;NRG1;MERTK
prerank,regulation of calcium ion transport (GO:0051924),0.5618768601827429,1.3683634189188774,0.06296691568836713,0.4116248428089256,1.0,9/54,10.78%,CD84;LILRB1;PKD2;P2RX4;CTNNB1;ATP2B1;EPB41;CACNB2;SLC8B1
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6941668252260393,1.3681164544075302,0.15,0.4111853316563908,1.0,3/10,4.73%,PRKCD;TNF;SMPD3
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.6941668252260393,1.3681164544075302,0.15,0.4111853316563908,1.0,3/10,4.73%,PRKCD;TNF;SMPD3
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5934608256855115,1.3679366722552286,0.09897610921501707,0.4111339904833545,1.0,9/33,11.47%,TGFB1;ANGPT4;TNF;APOE;RGCC;HDAC5;HMGB1;MEF2C;THBS1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.6967995400381287,1.3678021721339364,0.12411847672778561,0.41090862355406754,1.0,3/11,2.11%,STAP1;SLAMF8;RIN3
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.6437990745045855,1.3676730655475184,0.12148337595907928,0.41071124982076096,1.0,5/18,8.04%,CBL;IL6R;CEBPA;SPI1;ST18
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.689039469369723,1.3675695939047607,0.13179347826086957,0.4104364441031723,1.0,4/13,10.88%,SHH;CTNNB1;TGFBR2;NRP1
prerank,response to zinc ion (GO:0010043),0.6181014211797982,1.3672624213351356,0.09963985594237695,0.4107128202157691,1.0,15/25,22.40%,HAAO;P2RX4;GLRA2;HVCN1;ATP13A2;SLC30A4;MT3;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,positive regulation of TOR signaling (GO:0032008),0.5706585242243675,1.367219357857759,0.10363836824696802,0.4102859695598661,1.0,18/40,22.01%,NCKAP1L;TREM2;FNIP1;GPR137B;SEH1L;FLCN;PIP4P1;GAS6;LAMTOR3;PIH1D1;LAMTOR1;GOLPH3;RPTOR;SEC13;TELO2;RRAGA;PIK3CA;RRAGB
prerank,PERK-mediated unfolded protein response (GO:0036499),0.7061437746181071,1.3666808053109356,0.12973760932944606,0.41120479074328303,1.0,4/10,11.36%,NFE2L2;HERPUD1;DDIT3;CCL2
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.6963146540466675,1.3666284050223214,0.13069016152716592,0.41080698964429335,1.0,1/10,0.12%,PTPRC
prerank,lipoprotein localization (GO:0044872),0.7073307155910628,1.3665019901167068,0.13578500707213578,0.41061947311168967,1.0,5/11,15.32%,PRKCB;VMP1;ZDHHC3;LRP1;CD36
prerank,regulation of Rac protein signal transduction (GO:0035020),0.6420049935525338,1.3662405789106151,0.12611464968152866,0.4107662342041216,1.0,3/16,2.70%,PIK3CG;ARHGAP24;PIK3CB
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.6033141157802832,1.3654452529717904,0.12740384615384615,0.4124519303710843,1.0,6/26,12.33%,LILRB3;C1QC;GPR137B;TMEM178A;INHBA;CDK6
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6525373149379612,1.3650041842780383,0.13307984790874525,0.413133122545074,1.0,5/17,10.88%,HCK;HCLS1;STAP1;NTF3;NRP1
prerank,positive regulation of protein transport (GO:0051222),0.5550504280010248,1.3646464690966418,0.058577405857740586,0.4135624967518555,1.0,17/67,14.14%,TREM2;TGFB1;IL1A;ADAM8;TNF;ABCG1;TTN;CLN3;RIPOR1;ATP2C1;KIF20B;SYTL4;TPR;EXOC1;PCM1;ARF6;MYH10
prerank,sterol transport (GO:0015918),0.6390378321682488,1.3643007210586426,0.11990111248454882,0.4139151573311394,1.0,7/19,15.32%,MSR1;NPC2;LDLRAP1;NPC1;OSBP;ARV1;CD36
prerank,negative regulation of leukocyte migration (GO:0002686),0.7154110911425475,1.3641986260978152,0.1344165435745938,0.4136198948014877,1.0,3/10,1.97%,CD300A;CD200R1;SLAMF8
prerank,negative regulation of developmental growth (GO:0048640),0.598778806662551,1.3640945873604375,0.11475409836065574,0.4132931010142508,1.0,5/30,9.05%,SLC6A4;FGF13;DIP2B;WWC2;DUSP10
prerank,endocytic recycling (GO:0032456),0.5650951302858324,1.363944167583259,0.0781758957654723,0.41318226392183277,1.0,15/50,14.93%,DENND1C;MICALL2;CCDC93;RAB14;RAB7A;MICALL1;VPS35L;DENND1A;SNX27;DENND1B;ACAP2;ARF6;VPS29;EPS15;VPS39
prerank,aminoglycan catabolic process (GO:0006026),0.6007744449185584,1.3634929911189693,0.10588235294117647,0.4138866795660892,1.0,6/28,7.14%,HPSE;GUSB;GNS;IDS;FUCA1;AGRN
prerank,regulation of plasminogen activation (GO:0010755),0.6938699426090809,1.3627333306898954,0.14367816091954022,0.41544069047217513,1.0,4/12,15.46%,RUNX1;CTSZ;THBS1;PLGRKT
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.5253954184172682,1.362552082626424,0.001,0.41542523477439885,1.0,96/509,12.71%,PTPRC;CD86;VAV1;TREM2;FGR;LYN;CALCR;PIK3CG;PIK3R5;CARD11;HPSE;TGFB1;CX3CR1;CASS4;HCLS1;FLT3;F10;CD74;PIK3CD;CBL;RPL23;LAPTM5;PIK3AP1;PLCG2;TLR2;TGFBR1;GPRC5B;ADAM8;PTPRJ;TRIM25;GRB2;PIK3CB;S100B;TLR7;NUP62;OSM;NEK6;TSPAN6;SEMA4D;TRIM5;TNF;FNIP1;PRKD2;UBE2V1;TRAF2;DDIT3;CASP1;CD14;MAP3K14;IL18;P2RX4;HMGB1;CFLAR;PRKCB;GAB2;BCL2L1;CD80;ACTN4;TP53;SEH1L;PIM2;P2RY12;PLK2;TICAM1;EPO;ATP2C1;MALT1;FLT3LG;FLCN;TRIM27;SLC44A2;ZDHHC13;NTF3;LURAP1;NOS1AP;PUM2;STRN;LITAF;TRAF5;TRIM8;DUSP19;LGALS1;RPS20;LIMS1;GPR37;IAPP;SOX9;BECN1;MID2;THBS1;ALPK1;FYN;NOD2;TAB2;NRG1;CASP8
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.638355904535308,1.3618406410212134,0.13402061855670103,0.4168982881453965,1.0,5/16,10.08%,PLEKHN1;ZC3H12D;MOV10;RC3H1;CPEB3
prerank,keratan sulfate metabolic process (GO:0042339),0.5931631880901911,1.3613116834635262,0.11098130841121495,0.4177811699569831,1.0,7/31,8.38%,HEXB;PRELP;GNS;HEXA;B4GALT1;FMOD;ST3GAL1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.6543818980377024,1.361288899214848,0.1469440832249675,0.4172932064168604,1.0,4/15,8.93%,HAAO;KYNU;KMO;QDPR
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.4618784308549448,-1.360786461552161,0.11210762331838565,0.9622175316981461,1.0,5/17,14.41%,BMP4;AR;TFPI;ATP1A2;UBE2L3
prerank,plasma membrane tubulation (GO:0097320),0.6739016203981879,1.36021171106498,0.11627906976744186,0.4197625109336868,1.0,6/13,13.57%,BIN2;SNX9;SNX33;MICALL1;BIN3;FNBP1L
prerank,sodium ion import across plasma membrane (GO:0098719),0.6475740951721007,1.3601736742343389,0.14377406931964057,0.4193198056992645,1.0,5/17,7.13%,HCN4;SLC9A4;SLC8A1;SLC9A9;SLC9A1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.6038704514377008,1.3600335560864403,0.10643564356435643,0.41911475310220614,1.0,7/25,12.21%,NCKAP1L;PTGES3;SNCA;ITGA6;NRP1;THBS1;SDCBP
prerank,negative regulation of MAPK cascade (GO:0043409),0.5447927588796538,1.3599278047200856,0.029743589743589743,0.4188080562367094,1.0,12/87,4.04%,PTPRC;LYN;SIRPA;CD300A;PTPRJ;PRKCD;DUSP3;P2RX7;PTPN1;DUSP29;PIK3CB;APOE
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.6373481498594837,1.3591484524359192,0.12853470437017994,0.42037603917570593,1.0,10/18,20.15%,PCSK9;CTSC;APOE;VPS11;ATP5IF1;AMER1;FAF1;HSP90AA1;DACT1;ABCA2
prerank,chondroitin sulfate metabolic process (GO:0030204),0.5861518646168695,1.3589411275618544,0.10665137614678899,0.4203715926090072,1.0,8/30,12.78%,HEXB;ARSB;IDS;HEXA;CHSY3;BCAN;CHSY1;CHST15
prerank,regulation of lipid storage (GO:0010883),0.6152178896007795,1.3589324155977038,0.11694510739856802,0.4198542921900252,1.0,5/22,13.20%,LPL;ITGB3;TNF;VSTM2A;NFKB1
prerank,cellular response to interferon-beta (GO:0035458),0.6513924430690686,1.3587461510311964,0.14979195561719832,0.4198729713840784,1.0,7/14,20.69%,AIM2;CDC34;IRF1;UBE2G2;IRGM;UBE2K;IFITM2
prerank,regulation of phospholipase activity (GO:0010517),0.6988631170024956,1.3585457344598062,0.13583815028901733,0.4198981945752946,1.0,5/10,18.72%,ANGPTL3;SNCA;LRP1;PDPK1;PLA2G5
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5642101561822936,1.3583807244648414,0.07874865156418555,0.41979563100102785,1.0,13/48,12.96%,TGFB1;STAT5A;ANGPT4;MAPK14;PRKD2;P2RX4;HMGB1;ANXA1;MAP2K3;TMSB4X;THBS1;HDAC9;ATP5F1A
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.6223823356614636,1.3581362046737215,0.12656641604010024,0.4199116258273342,1.0,3/21,1.90%,ARHGAP25;RASAL3;CYRIB
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.6347305567822379,1.3574977171298015,0.1272965879265092,0.4211279060581672,1.0,4/17,7.22%,CD74;RFFL;CD44;SNAI1
prerank,regulation of neuron apoptotic process (GO:0043523),0.5358764719092636,1.356795951579145,0.04044489383215369,0.42252339277791745,1.0,25/96,15.90%,TREM2;PTK2B;PCSK9;LGMN;ADAM8;MDK;TNF;APOE;CLN3;FOXO3;DDIT3;FZD9;CTNNB1;MEF2C;KIF14;TFAP2B;NTF3;PPARGC1A;CCL2;GRN;RETREG1;WFS1;CPEB4;NF1;RASA1
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.4636284053472397,-1.3566763616059878,0.1261682242990654,0.96576183733032,1.0,6/17,16.01%,CAV1;PANK2;NCOR1;PPARA;PRKAB2;PPARG
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5728651573617684,1.3559507230711298,0.09786276715410573,0.4242965163238189,1.0,5/42,2.32%,PTK2B;CD3E;RIN2;THY1;PTPRJ
prerank,regulation of protein-containing complex assembly (GO:0043254),0.5322810324642624,1.355444340976412,0.03538928210313448,0.4252317156346097,1.0,33/110,16.75%,LGALS3;HCK;TGFB1;SYK;FNIP2;ABCA1;TNF;FNIP1;APOE;TRAF2;TAL1;TFIP11;SVIP;RB1;BAK1;HSF1;ATF7IP;IMPACT;GFAP;IAPP;HDAC6;NRG1;SORL1;SAR1A;HCFC1;BMF;SLF2;PIH1D1;SRC;CD36;IRGM;FAF1;HSP90AA1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.6005952933836876,1.3546427863570458,0.11097992916174734,0.42703998066222504,1.0,5/25,7.97%,CALCR;CBL;TNF;ZFYVE28;HFE
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.5309196868474544,1.354520285794945,0.05246913580246913,0.426833970354011,1.0,18/93,12.42%,PTK2B;SLAMF1;SCIMP;FCGR2B;TAOK3;TRAF2;SPI1;PYCARD;TRAF3;XDH;HMGB1;MAP3K5;GADD45B;TRAF5;RELL1;DUSP19;SDCBP;NOD2
prerank,urogenital system development (GO:0001655),0.6865774823802441,1.3543665684102542,0.1514726507713885,0.4267118966694196,1.0,3/11,11.24%,SHH;ANXA1;SOX9
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.7001767579665067,1.3534278506069592,0.15568022440392706,0.42866888913429957,1.0,4/10,16.73%,PTPRJ;SNCA;LRP1;PTPN12
prerank,regulation of fibroblast migration (GO:0010762),0.6234520855557245,1.3533125547093936,0.1291139240506329,0.4284407958071322,1.0,8/20,18.44%,TGFB1;RFFL;CLN3;GNA12;THBS1;APPL2;CORO1C;ITGB1
prerank,ventricular septum morphogenesis (GO:0060412),-0.4246962546576002,-1.3532090023443435,0.10218978102189781,0.96690875428866,1.0,9/27,7.20%,ZFPM2;BMPR1A;ROBO2;BMP4;ACVR1;TGFBR3;ROBO1;SLIT2;SMAD4
prerank,positive regulation of inflammatory response (GO:0050729),0.5326300722501919,1.352040694259476,0.050515463917525774,0.4314552944343121,1.0,13/86,5.21%,CCR2;LPL;TLR2;GPRC5B;ADAM8;DHX9;TLR7;MDK;OSM;TNF;SNCA;CEBPA;IL18
prerank,response to organophosphorus (GO:0046683),0.6495168967875083,1.3511967742383704,0.12137203166226913,0.43325102489596756,1.0,4/16,10.54%,KCNJ11;P2RX7;P2RX4;VGF
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.3877456944004099,-1.3511432598150002,0.05405405405405406,0.9611932556086855,1.0,9/28,14.30%,SLAIN2;CLIP1;PAK1;DRG1;MET;CDK5RAP2;MAPT;NAV3;OCLN
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.6934768924814361,1.3510279458488075,0.14104372355430184,0.4331578725278232,1.0,4/10,8.38%,NPL;RENBP;NAGK;ST3GAL1
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.5010904219407916,-1.3509519440338174,0.12056737588652482,0.9477272157360339,1.0,3/13,0.48%,CACNA1C;ANK2;KCNN2
prerank,negative regulation of lyase activity (GO:0051350),0.6366770909882241,1.3506355587352121,0.14342105263157895,0.43364312553184614,1.0,5/16,14.34%,CCR2;EDNRB;AKAP5;LTB4R2;GNAI3
prerank,retina homeostasis (GO:0001895),0.612280260696924,1.350282409593071,0.13205282112845138,0.4341051938495733,1.0,11/23,22.12%,WHRN;POTEF;ACTB;CNGB1;ACTG1;PRDX1;B2M;ATP1B2;CCDC66;HSPB1;CDH3
prerank,non-motile cilium assembly (GO:1905515),-0.3850513821020974,-1.34984472032204,0.078125,0.9391355348308392,1.0,15/30,24.92%,TTC8;IFT57;CEP250;BBS4;PIBF1;TBC1D32;CEP89;FUZ;TMEM216;BBS1;VANGL2;RPGRIP1L;GORAB;IFT122;ARL13B
prerank,filopodium assembly (GO:0046847),0.6453542730099606,1.3497129665793437,0.13367609254498714,0.4351441022456651,1.0,2/16,5.93%,FGD2;FGD6
prerank,regulation of cell junction assembly (GO:1901888),0.5883238408406085,1.3494392940288977,0.11981020166073547,0.4353570042726181,1.0,11/27,19.50%,RUNX1;RAP1B;SNAI1;MEF2C;PRKCH;F11R;RAPGEF1;RAP1A;MYO1C;FLOT1;ROCK2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.44759318608218673,-1.34915787803314,0.11057692307692307,0.9284458798307593,1.0,15/18,47.21%,NPHP3;CCDC39;SPEF2;OFD1;NEK10;CABYR;CFAP53;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;ODAD4;CCDC40;DNAAF4
prerank,regulation of establishment of cell polarity (GO:2000114),0.6490710913947624,1.348602751187842,0.13368983957219252,0.43717033191369614,1.0,6/16,8.47%,PTK2B;CYRIB;ARFGEF1;RAP1B;RIPOR2;KIF20B
prerank,embryonic digestive tract development (GO:0048566),-0.46250340192914674,-1.3472842341996454,0.12719298245614036,0.9236441704871038,1.0,9/18,14.56%,PCSK5;NIPBL;SALL1;GLI2;GLI3;PDGFRA;PKDCC;STRA6;RARB
prerank,cellular response to fatty acid (GO:0071398),0.6696716577616051,1.346633731370872,0.15857142857142856,0.44208832495098266,1.0,3/12,3.61%,LPL;NR1H4;FFAR2
prerank,negative regulation of secretion (GO:0051048),0.6872156514063893,1.3457145841638396,0.15648286140089418,0.4441274446568127,1.0,2/10,1.93%,CD74;VAMP3
prerank,glycolytic process (GO:0006096),0.5957246897519825,1.345669348449445,0.1205098493626883,0.44373313685802884,1.0,11/28,16.93%,HK3;PFKL;ALDOB;ENO3;GPI;HK2;GCK;PGAM4;PGAM1;GAPDHS;LDHA
prerank,integrated stress response signaling (GO:0140467),0.6617085540360682,1.3451645605470481,0.13432835820895522,0.44457294696596084,1.0,5/14,11.36%,NFE2L2;HERPUD1;DDIT3;IMPACT;CCL2
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5106402379810004,-1.3451535583375442,0.13602941176470587,0.9199942065610675,1.0,8/13,29.33%,BMP4;NR3C2;AR;CALCOCO1;GPER1;PLPP1;PGR;BMP7
prerank,positive regulation of myelination (GO:0031643),0.6872959956821789,1.3443471618538363,0.13049645390070921,0.4463250825396222,1.0,4/11,11.73%,ITGAX;CST7;RNF10;TNFRSF1B
prerank,focal adhesion assembly (GO:0048041),-0.4333115751955042,-1.3437398228188147,0.14814814814814814,0.9132062700746486,1.0,7/21,5.31%,SORBS1;PEAK1;TAOK2;ACTN2;PTPRK;BCR;WHAMM
prerank,amyloid precursor protein metabolic process (GO:0042982),0.6292382865221618,1.343723697051688,0.1272264631043257,0.44756192159727237,1.0,4/18,4.47%,APOE;ABCG1;LDLRAP1;CLN3
prerank,histone H2A ubiquitination (GO:0033522),-0.4634012432200002,-1.3432617585570443,0.12017167381974249,0.9028306044230356,1.0,7/17,12.39%,DDB2;RYBP;DDB1;UBR2;UBE2B;TRIM37;DTX3L
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.6717392728420434,1.343163585689696,0.1447721179624665,0.4485992181406355,1.0,4/12,11.52%,BASP1;MYO1E;PODXL;PTPRO
prerank,positive regulation of lipid catabolic process (GO:0050996),0.6244126457301751,1.3430130322605893,0.1259351620947631,0.4485037718590359,1.0,4/19,7.38%,DAGLB;PRKCD;ANGPTL3;ABCD1
prerank,actin nucleation (GO:0045010),0.6195774382131706,1.3429125347746984,0.15560916767189384,0.44824313022810425,1.0,7/21,11.47%,IQGAP2;ARPC2;ARPC3;TRIM27;ACTR2;ACTR3;ARPC4
prerank,negative regulation of protein kinase activity (GO:0006469),0.5335126917096682,1.342081448810918,0.060824742268041236,0.45002814008795117,1.0,26/88,17.75%,PTPRC;UBASH3B;THY1;DUSP3;PTPN1;GNAQ;SLC8A1;SNCA;PYCARD;TRIM27;RB1;ADAR;DUSP10;QARS1;LRP5;DUSP19;DTNBP1;PTPRO;SORL1;ADARB1;RTRAF;PTPRT;NF1;TARBP2;CORO1C;PDPK1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.5307435056088552,1.3420709048627841,0.044489383215369056,0.44950729710923654,1.0,28/105,17.93%,CLEC4D;LYN;CARD11;SYK;PLCG2;PRKCD;FFAR2;FCER1G;MUC13;TYROBP;PSMB10;MALT1;PSMA2;PRKACB;FYN;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;TAB3;SRC;PSMD7;PSMB9;RPS6KA5;PDPK1;PSMD2
prerank,tryptophan catabolic process (GO:0006569),0.681515760993088,1.3420451102858983,0.1558073654390935,0.44901056433475295,1.0,3/11,7.90%,HAAO;KYNU;KMO
prerank,positive regulation of cell adhesion (GO:0045785),0.5450875062193237,1.3415500973473464,0.06172839506172839,0.44986109986558154,1.0,14/74,13.76%,NCKAP1L;SYK;ADAM8;PTPRJ;MDK;TNF;PRKD2;P2RY12;P4HB;FLCN;LIMS1;ADGRG1;STX3;ZFHX3
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.588867031531175,1.3413006992318257,0.11659192825112108,0.449997507932036,1.0,5/32,5.60%,CALCR;THY1;P2RX7;SNCA;P2RX4
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.6091887012258614,1.3411414102415888,0.15920398009950248,0.4498758984660284,1.0,8/20,14.13%,P2RX7;PSTPIP1;PYCARD;CASP1;IL18;P2RX4;ENTPD1;C3AR1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.6524556717726022,1.3403206201401556,0.16251638269986893,0.45167850906769547,1.0,7/15,11.47%,IQGAP2;ARPC2;ARPC3;TRIM27;ACTR2;ACTR3;ARPC4
prerank,positive regulation of JNK cascade (GO:0046330),0.5324885027954054,1.3399517978586968,0.07684210526315789,0.45222546998168667,1.0,14/70,12.42%,PTK2B;SLAMF1;FCGR2B;TAOK3;TRAF2;PYCARD;TRAF3;HMGB1;MAP3K5;GADD45B;TRAF5;DUSP19;SDCBP;NOD2
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.6698632375682925,1.3399143831036582,0.14477611940298507,0.45177436489995115,1.0,5/11,18.48%,TGFB1;MYOCD;MEF2C;SOX6;GREM1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5946270636462286,1.339615032851285,0.14516129032258066,0.4520521370288078,1.0,3/24,2.62%,RUNX1;CTSK;CTSL
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5917098465037781,1.3395189594042205,0.13012048192771083,0.4517479767610153,1.0,13/26,24.70%,PLCG2;TNF;SLC9A1;SPPL3;CHERP;RCAN1;LMCD1;GSK3B;PTBP1;CHP1;IGF1;CAMTA1;ATP2B4
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.5291772893020554,1.339434317741356,0.02012072434607646,0.4514295146749789,1.0,44/149,17.58%,BTK;CARD11;CX3CR1;AIM2;IRAK2;TLR2;ADAM8;TRIM25;TNFRSF11A;DHX9;TRIM5;TNF;PRKD2;UBE2V1;TRAF2;PYCARD;IL18;RAB7B;CFLAR;PRKCB;TICAM1;MALT1;PRKCQ;IL18RAP;TRIM27;PRKCH;TRAF5;TRIM8;RPS6KA4;MID2;PRDX3;NOD2;TAB2;IKBKG;NFKB1;TRADD;TAB3;CAPN3;CD36;MTDH;TRIM62;UBE2N;ARHGEF2;RPS6KA5
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.5756838095425485,1.3389198031655736,0.1136890951276102,0.4523428750958887,1.0,9/36,13.46%,TREM2;SIRPA;TAOK3;DUSP3;DUSP10;QARS1;DUSP19;ITCH;GPS2
prerank,import into cell (GO:0098657),0.5681064489871681,1.3385148341715918,0.10321864594894561,0.4529613168493532,1.0,6/41,7.46%,TREM2;IL10RA;LRRC8D;SLC7A8;SLC36A1;SLC16A2
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5583118327621523,1.3382465904752892,0.1187010078387458,0.4531459996503579,1.0,11/40,13.07%,TGFB1;TGFBR1;MTOR;MDK;RGCC;CTNNB1;TGFBR2;SNAI1;SMAD3;SDCBP;BAMBI
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.6005780505602936,1.3376340574792482,0.13801452784503632,0.4543746055095169,1.0,8/24,16.70%,PTK2B;CTSC;APOE;ATP5IF1;PSME3;RHBDF1;TMF1;EPHA4
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6600429520865088,1.3375322036410178,0.15208034433285508,0.4541209358201091,1.0,4/12,5.89%,CD74;LPL;TNF;HMGB1
prerank,positive regulation of epithelial cell migration (GO:0010634),0.5352788445682491,1.3368878430307436,0.0508646998982706,0.4554088523752406,1.0,22/92,11.82%,PTK2B;PIK3CG;RIN2;SMOC2;PIK3CD;ITGB3;PLCG2;RREB1;ANGPT4;MTOR;PIK3CB;PRKD2;PDCD6;BCAR1;RAB11A;NRP1;SOX9;PFN1;HDAC6;GPI;THBS1;GRN
prerank,B cell activation involved in immune response (GO:0002312),0.6475058699740148,1.3366751009987865,0.1644021739130435,0.45546410367231316,1.0,3/13,9.47%,FCGR2B;CD180;GPR183
prerank,protein kinase A signaling (GO:0010737),0.6653417872449177,1.336283512374883,0.15629322268326418,0.45602956288369334,1.0,3/12,11.51%,LCP1;TTN;PRKACB
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6797845900694506,1.3361887265382206,0.17784256559766765,0.4557453531329075,1.0,2/12,6.70%,IL18;CD80
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.617214418275398,1.336157709362182,0.14782608695652175,0.45526735406184876,1.0,4/20,7.14%,RGS10;GNAQ;LY6G6D;AGRN
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.6466791111098988,1.3360954265055662,0.1524547803617571,0.45489196069459953,1.0,6/15,12.11%,NLRC5;SAMHD1;YTHDF3;TTLL12;USP18;METTL3
prerank,regulation of bone mineralization (GO:0030500),0.5432910489476053,1.335982674530751,0.09081196581196581,0.45465710892600597,1.0,9/55,8.35%,PTK2B;TGFB1;SRGN;P2RX7;BMP2K;SLC8A1;FZD9;MEF2C;ATP2B1
prerank,retrograde axonal transport (GO:0008090),-0.45912262285752886,-1.3358844016604625,0.1306122448979592,0.9221126116285568,1.0,6/16,10.56%,DLG2;KIF5B;PAFAH1B1;SOD1;NEFL;KIF5A
prerank,cellular response to organic substance (GO:0071310),0.5215738284304063,1.3358713250748302,0.03850050658561297,0.4544277599753451,1.0,26/116,14.11%,PTPN7;CYP1A1;TGFB1;HCLS1;FLT3;CSF1R;TGFBR1;NR1H4;PTPN18;TNF;LDLRAP1;CXCR4;CASP1;IL18;CTNNB1;TGFBR2;RAMP1;SMAD3;STAT5B;IL18BP;CCL2;HDAC6;TWF2;TIPARP;PID1;LRRK2
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6305435278569576,1.3358587923097704,0.14556962025316456,0.4539191305095971,1.0,4/17,5.63%,CCND3;PKD2;RGCC;CCND2
prerank,carbohydrate derivative transport (GO:1901264),0.629472797139608,1.3354983117454,0.1415929203539823,0.4544250512019787,1.0,4/18,4.47%,SLC15A3;NPC2;ABCG1;CLN3
prerank,negative regulation of response to stimulus (GO:0048585),0.5345765295131053,1.3354573933213085,0.0974304068522484,0.45398159487814554,1.0,14/60,15.21%,LYN;UBASH3B;FCGR2B;PDCD1;THY1;PTPN1;MCTP1;AQP11;CASK;SH2B3;CDK6;DDAH1;WFS1;TLE5
prerank,cilium-dependent cell motility (GO:0060285),-0.42360960184807633,-1.3352412696789475,0.1206896551724138,0.9121178449643836,1.0,15/22,48.02%,CCDC39;CFAP54;DNAH2;CFAP44;GAS8;DNAH3;DRC1;CCDC65;DNAAF2;DNAH8;TEKT2;DNAH17;EFHC2;TEKT5;DNAH1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.6845370088874497,1.3350558921383986,0.14449213161659513,0.4545550126797644,1.0,2/10,6.64%,LILRB1;TYROBP
prerank,positive regulation of protein polymerization (GO:0032273),0.5462979189085025,1.3347923579100476,0.07958115183246073,0.45472833502324916,1.0,7/65,6.61%,NCKAP1L;PTK2B;HCK;NCK2;SNX9;PYCARD;MAPRE1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.5201958601825137,1.3346462888242194,0.020181634712411706,0.45454588558761916,1.0,28/136,11.22%,ARRB2;TMIGD3;AIM2;IRAK2;NLRC5;HAVCR2;MAD2L2;NLRC3;PKD2;OTULIN;DDIT3;TNFAIP3;SPI1;PYCARD;TRAF3;ADGRG3;TAF1;SETD6;PIM1;TAX1BP1;TMSB4X;ERBIN;RB1;ANXA4;CMKLR1;HDAC4;USP7;DAP
prerank,cAMP-mediated signaling (GO:0019933),-0.4126450325776726,-1.3346086685395555,0.07471264367816093,0.9028030012699819,1.0,9/24,16.22%,RAPGEF3;PDE7A;ADGRG6;ADCY2;RIMS2;RAPGEF2;CAP2;DGKQ;PDE2A
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.6104122442983115,1.3345921653282662,0.1475609756097561,0.45416070381265045,1.0,7/22,16.59%,MDK;FZD9;SLC16A2;NAP1L1;TAFA1;LRRK2;APPL2
prerank,response to iron ion (GO:0010039),0.6740892579301593,1.3344726109530711,0.1573187414500684,0.4539695876221136,1.0,5/12,16.28%,SNCA;HFE;ACO1;B2M;HIF1A
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.5210407487112495,1.3343443696888437,0.01701701701701702,0.4538350924552606,1.0,32/172,10.05%,INPP5D;PIK3CG;PIK3R5;DGKZ;PIK3CD;LPIN2;PLCG2;DDHD1;LPCAT1;PIK3CB;PIP5K1C;INPP4B;CLN3;PIP4K2A;PI4K2A;RAB14;PCYT1A;CHKB;PLD2;PGS1;CDS2;DGKE;LPCAT2;MTMR3;CSNK2A1;CSNK2A2;DGKD;DGKG;SLC44A2;ABHD4;AGK;STARD10
prerank,catecholamine metabolic process (GO:0006584),0.654013229469766,1.33434280094318,0.14905149051490515,0.4533021297892667,1.0,4/14,12.77%,RNF180;ATP7A;DDC;COMT
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.5150487910360815,-1.3336028807216278,0.11888111888111888,0.8954332066339371,1.0,6/12,10.43%,CACNA1C;CAV1;RYR2;JUP;CTNNA3;DLG1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5365468696224601,1.333305064864135,0.07061266874350987,0.4556329325116887,1.0,12/74,6.47%,PF4;LGALS3;GATA1;IL1A;TGFBR1;RFFL;TNF;ITGA6;TRAF2;TNFAIP3;CFLAR;BCL2L1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.673829938423831,1.3330823452837315,0.15112994350282485,0.4556903864489352,1.0,3/12,4.10%,ABCA1;ITGB3;ABCG1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.5372435986048909,1.3328682345369653,0.0711340206185567,0.455797527046243,1.0,7/76,7.53%,GNA15;LPAR6;CX3CR1;P2RY6;GPR17;CCKBR;P2RY12
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.6770605532864475,1.3327007314453527,0.149519890260631,0.45573327436490835,1.0,6/12,19.98%,HOOK3;BICD2;PCM1;NINL;CCDC120;KIF3A
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.523998182027727,-1.3326163423102826,0.15202702702702703,0.8882072463156623,1.0,9/11,30.28%,GPLD1;SCARB1;CTDNEP1;SLC27A1;NR1H2;NR1H3;MFSD2A;LDLR;CNEP1R1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.569243444833902,1.3326137564704654,0.1423650975889782,0.4554206485401799,1.0,10/33,14.00%,CX3CR1;ABR;CEL;BTBD9;CACNA1A;FABP5;EIF4EBP2;NTF3;LRP8;CACNA1B
prerank,bone development (GO:0060348),0.5700512911858188,1.3319581287999582,0.12111111111111111,0.45674466762098037,1.0,6/39,9.80%,PTPRC;SH3PXD2B;SKI;TP53;SULF2;LRP5
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.6620226406022884,1.3307395959967858,0.167574931880109,0.45960035940031,1.0,2/12,3.79%,TGFB1;TNF
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.6643265515806005,1.3304789315225536,0.143646408839779,0.45973245818745323,1.0,4/12,14.73%,TREM2;APOE;IAPP;PFDN1
prerank,cellular response to hormone stimulus (GO:0032870),0.5347901200545057,1.330378882085779,0.07987551867219916,0.4594359005145082,1.0,13/69,11.27%,CTSS;CTSB;GATA1;BRD8;GAS2L1;CTSL;OCSTAMP;RAMP1;LMO2;MEF2C;STAT5B;TRIM24;SRA1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.5341835864844865,1.330014609618761,0.0649746192893401,0.4600005440471798,1.0,11/86,6.61%,NCKAP1L;PTK2B;HCK;PLEK;NCK2;SNX9;APOE;COLGALT1;MYLK3;PYCARD;MAPRE1
prerank,regulation of myelination (GO:0031641),0.5939155893084757,1.3299859022553817,0.13532934131736526,0.45953102533662765,1.0,7/25,11.73%,ITGAX;CST7;KIF14;TMEM98;TNFRSF21;RNF10;TNFRSF1B
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.4360477981974992,-1.3297914001747864,0.14210526315789473,0.889152219969005,1.0,7/20,10.38%,CACNA1C;ANK2;RYR2;ATP1B1;DMD;ATP1A2;CALM3
prerank,regulation of cell adhesion (GO:0030155),0.5239119288751473,1.3293845997487617,0.03413654618473896,0.46073508846799865,1.0,34/129,16.77%,PTK2B;LYN;PIK3CG;ADAM8;PTPRJ;PLXNC1;MDK;SEMA4D;TNF;PRKD2;TGFBI;CXCR4;PLXNB2;CYTIP;IL18;RIPOR2;ATXN3;P4HB;KIF14;FLCN;SIPA1;PODXL;ARHGDIB;CYTH1;PPP2CA;ADGRG1;STX3;ARHGDIA;ZFHX3;SRC;RASA1;LPXN;EPHA4;EPHA8
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.6179158337094129,1.328660525034554,0.15335868187579213,0.46221614941026823,1.0,4/19,8.17%,RUNX1;TGFBR1;PIM1;MEF2C
prerank,receptor clustering (GO:0043113),0.5947421480104378,1.3282196256630103,0.1338962605548854,0.4629476267245128,1.0,4/27,2.31%,ITGAL;ITGB2;ITGA4;THY1
prerank,long-term memory (GO:0007616),0.6193865292610548,1.3278194894342308,0.15796178343949044,0.46349407771519135,1.0,3/19,10.08%,NPAS4;APOE;CPEB3
prerank,carbohydrate catabolic process (GO:0016052),0.5649961650403249,1.3277561973858116,0.12403100775193798,0.46311417247599035,1.0,13/38,16.93%,HK3;PFKL;ALDOB;ENO3;MAN2B1;MAN2B2;GPI;HK2;GCK;PGAM4;PGAM1;GAPDHS;LDHA
prerank,regulation of receptor recycling (GO:0001919),0.6278344799762747,1.3276499048721677,0.1445466491458607,0.4628738136026466,1.0,4/16,5.33%,PCSK9;VAMP3;SNCA;TBC1D16
prerank,steroid catabolic process (GO:0006706),0.6724615251066247,1.3276268710637813,0.17246376811594202,0.4624131343131615,1.0,3/10,15.76%,SPP1;HSD17B11;YWHAH
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.602383733015582,1.3275449387501939,0.14766839378238342,0.4620882868713248,1.0,13/20,28.52%,CNOT8;TNRC6A;MOV10;AGO4;AGO3;NRDE2;AGO2;CNOT7;CNOT1;AGO1;LIMD1;EIF6;TNRC6C
prerank,positive regulation of cell migration (GO:0030335),0.5158470564149661,1.3275270014527607,0.008,0.4615950483132874,1.0,48/253,12.58%,NCKAP1L;PTPRC;PTK2B;FERMT3;GPNMB;FGR;ITGAX;TGFB1;CASS4;CCR2;F10;VSIR;PIK3CD;PLCG2;CSF1R;TGFBR1;MGAT5;RREB1;MTOR;MDK;ANGPTL3;SEMA4D;ITGA6;LGR6;AIF1;CCAR1;MAPRE1;ACTN4;RIPOR1;SNAI1;NEDD9;KIF20B;FAM89B;NTF3;PTP4A1;BCAR1;ACTG1;RAB11A;PODXL;NRP1;SEMA4A;SOX9;PFN1;HDAC6;THBS1;GRN;SDCBP;NUMB
prerank,ruffle organization (GO:0031529),0.6475829947192001,1.3270026689865455,0.14228187919463087,0.4625045276260853,1.0,9/16,20.24%,PLEK;CSF1R;AIF1;CYFIP1;ARF6;PLEKHA1;ARFIP2;AIF1L;INPP5K
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.45232897454025606,-1.325917010492041,0.15942028985507245,0.8938911250080548,1.0,4/18,4.84%,UNC13B;GRIK4;GRIA2;SLC17A6
prerank,secondary alcohol metabolic process (GO:1902652),0.5505159428587725,1.325787974503485,0.12445414847161572,0.4654440767210061,1.0,7/42,5.61%,ABCA1;ANGPTL3;CLN8;APOE;ABCG1;LDLRAP1;SOAT2
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.34124671060054523,-1.3256448134747685,0.08333333333333333,0.8729368307590673,1.0,20/51,21.42%,SPAST;NUP93;IST1;NUP188;NUP98;PPP2R2A;AHCTF1;NDC1;NUP37;VPS4A;RCC1;EMD;CHMP4A;CHMP4B;NUP133;LMNA;CHMP2A;RAN;NUP43;LBR
prerank,mitotic nuclear membrane organization (GO:0101024),-0.34124671060054523,-1.3256448134747685,0.08333333333333333,0.8729368307590673,1.0,20/51,21.42%,SPAST;NUP93;IST1;NUP188;NUP98;PPP2R2A;AHCTF1;NDC1;NUP37;VPS4A;RCC1;EMD;CHMP4A;CHMP4B;NUP133;LMNA;CHMP2A;RAN;NUP43;LBR
prerank,cytosolic transport (GO:0016482),0.52022743574861,1.3251902213457338,0.048582995951417005,0.4665428485842417,1.0,33/108,17.43%,HOOK3;LAPTM5;VAMP3;TBC1D10C;SNX5;WDR91;TMEM87B;HEATR5A;RBSN;CLN3;RAB14;RAB7A;TMEM87A;TBC1D10A;TRIM27;VPS54;TBC1D17;CLTC;BECN1;YKT6;WDR81;STX5;STX8;HOOK2;VPS29;VTI1A;SNX2;GAK;EPS15;HEATR5B;MON2;CCDC91;TBC1D23
prerank,response to interleukin-1 (GO:0070555),0.5352152251579976,1.325168116778758,0.06853582554517133,0.46606926530446496,1.0,22/73,16.92%,SIRPA;IRAK2;TNFRSF11A;CCL8;SNCA;TANK;MYLK3;PYCARD;ANXA1;RC3H1;CCL14;HDAC4;CCL13;GBP3;SOX9;CCL2;NFKB1;TLE5;SRC;HIF1A;CD47;CCL25
prerank,neurogenesis (GO:0022008),0.5559366102350091,1.324573980209297,0.12786885245901639,0.46721332968792745,1.0,7/43,6.22%,ASCL1;PCSK9;DAGLB;PRDM12;CXCR4;THOC2;ANXA1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.6725735704807573,1.324243158627231,0.16204379562043797,0.46757520752153436,1.0,4/10,9.06%,RC3H2;NFKBID;MALT1;RC3H1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.6004374910398981,1.3240335872305005,0.18727050183598531,0.46763613541258336,1.0,6/22,4.99%,ADAM8;SNX9;TNF;APOE;SNX33;TIMP1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.5220295435703102,1.3240233399866808,0.027135678391959798,0.4671221681892641,1.0,23/140,14.13%,GNA15;LPAR6;CALCR;CX3CR1;CCR2;CD52;P2RX7;SLC8A1;CXCR4;P2RX4;S1PR4;HMGB1;GPR17;CCKBR;CACNA1A;SPPL3;CMKLR1;CYSLTR1;IAPP;TACR1;NPTN;ADCY8;C3AR1
prerank,cellular response to retinoic acid (GO:0071300),0.5535192539494647,1.3237823631340329,0.12121212121212122,0.46726599573753014,1.0,4/42,1.91%,PTK2B;LYN;AQP1;FZD10
prerank,regulation of transposition (GO:0010528),0.6472323816012957,1.3235956177002313,0.1833810888252149,0.4672658399143271,1.0,1/13,0.91%,SMYD5
prerank,lipoprotein catabolic process (GO:0042159),0.6542391720650443,1.3226449097355126,0.18492176386913228,0.46948268864782955,1.0,4/11,11.35%,CTSD;APOE;ABHD17B;ABHD17C
prerank,receptor signaling pathway via STAT (GO:0097696),0.5892912126336882,1.3223274597329429,0.12945368171021376,0.46983477489736714,1.0,7/25,11.36%,CCR2;STAT5A;PKD2;IFNAR1;STAT4;STAT5B;CCL2
prerank,regulation of autophagy (GO:0010506),0.5112137315352251,1.3220411032482302,0.013013013013013013,0.47011212812375097,1.0,57/216,15.66%,TREM2;IL10RA;ATP6V0D2;SNX5;ATP6V0E1;CTSA;DRAM2;MTOR;PIK3CB;ATP6V1C1;PSAP;TRIM5;ERN1;SREBF2;ATP6V1E1;PIP4K2A;GPR137B;FOXO3;DDIT3;ATP6V0A2;DCAF12;HMGB1;TFEB;PIM2;ATP6V0D1;SVIP;PLK2;TICAM1;MTMR3;CSNK2A2;FLCN;TRIM27;RAB39B;TRIM8;ATP6V0A1;EIF4G3;GFAP;DAP;MID2;HDAC6;EXOC8;EXOC7;EXOC1;TAB2;FOXK1;LAMTOR3;LRRK2;VPS29;SREBF1;BMF;ATP6V0B;TAB3;VDAC1;TBC1D14;RNF152;MTDH;GSK3A
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.48037696412695685,-1.322001955847869,0.14767932489451477,0.876968143433162,1.0,7/14,19.65%,IRS1;DDB1;GPLD1;ARPP19;AKT1;NNMT;IRS2
prerank,gene silencing by miRNA (GO:0035195),0.567029681214973,1.321785255306354,0.12971698113207547,0.47024702348320374,1.0,19/32,26.43%,CNOT8;TNRC6A;MOV10;ADAR;PUM2;AGO4;SNIP1;AGO3;PRKRA;TARBP2;AGO2;ZC3H7A;DICER1;CNOT7;CNOT1;ZC3H7B;AGO1;PUM1;LIMD1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.5674545985289144,1.3213697394293025,0.13712374581939799,0.4708276673867443,1.0,15/37,22.19%,PCSK9;ITGB3;RIN3;EDNRB;APOE;TRAP1;SDCBP;NFKB1;ANKRD13A;OPTN;ABCA2;PRKN;SIRT5;MT3;AATF
prerank,triglyceride metabolic process (GO:0006641),0.5506046325824484,1.320559647145339,0.10978260869565218,0.4726325340906166,1.0,14/48,20.95%,LPL;LPIN2;FABP4;APOE;SEL1L;LIPC;FABP5;AGMO;GK;PLAAT3;PNPLA3;DGAT2;MOGAT1;LPIN1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5542565682210528,1.320538489840858,0.11860718171926006,0.4721450100937246,1.0,14/45,17.75%,PTK2B;TGFB1;CBL;GRB2;NCK2;ERBIN;DGKD;BCAR1;SOX9;BRAF;SRC;IQGAP1;RPS6KA5;PDPK1
prerank,protein K63-linked ubiquitination (GO:0070534),0.551207602415625,1.3201958921208619,0.11672278338945005,0.4725966657696437,1.0,16/41,15.21%,UBE2V2;TRIM5;UBE2V1;TRAF2;TRAF3;HECTD1;UBE2S;TRIM27;UBE2E3;RNF4;TRAF5;TRIM56;ITCH;RNF135;STUB1;RNF152
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.5158716596489624,1.3200658220211623,0.008,0.4724109715750181,1.0,65/234,17.22%,BTK;SHH;CARD11;CX3CR1;HCLS1;AIM2;IRAK2;PLCG2;TLR2;ADAM8;TRIM25;CAMK1D;TNFRSF11A;DHX9;TRIM5;TNF;PRKD2;RGCC;UBE2V1;TRAF2;DDIT3;PYCARD;IL18;RAB7B;HDAC5;NFAM1;TAF1;CFLAR;PRKCB;CTNNB1;MYOCD;TICAM1;MALT1;PRKCQ;IL18RAP;TRIM27;SMAD3;HSF1;PPARGC1A;PRKCH;TRAF5;HDAC4;TRIM8;RPS6KA4;MID2;PRDX3;NOD2;TAB2;SMARCB1;LRP8;IKBKG;NFKB1;ADCY8;STK3;TRADD;TAB3;CAPN3;BUD31;CD36;MTDH;FANK1;PTEN;TRIM62;UBE2N;ARHGEF2
prerank,lymphocyte mediated immunity (GO:0002449),0.6468376692280937,1.319841549051289,0.164804469273743,0.4724887862275416,1.0,2/12,6.18%,MYO1G;BTN3A3
prerank,cellular response to mechanical stimulus (GO:0071260),0.5408049458278396,1.3196121774509595,0.12084257206208426,0.4726513071408786,1.0,14/46,13.35%,AQP1;TLR7;TLR8;CASP1;MAP3K14;CRADD;SLC9A1;MAP3K1;BAK1;F11R;SOX9;CASP8;NFKB1;IRF1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.5325513051598773,1.319479679181006,0.08601036269430051,0.47248825037154846,1.0,16/75,11.03%,LYN;CD300A;PRKAR2B;PTPRJ;PRKCD;PTPN1;PIK3CB;SLC8A1;PKIB;APOE;CEBPA;PYCARD;MYOCD;RB1;LRP5;SH2B3
prerank,lipoprotein transport (GO:0042953),0.6801374878071975,1.3190703353504671,0.19322990126939352,0.4730982201014297,1.0,4/10,15.32%,PRKCB;VMP1;LRP1;CD36
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.6532169979311764,1.3189474434662756,0.15710382513661203,0.4728921498407183,1.0,4/13,13.64%,TREM2;TMSB4X;PPARGC1A;PID1
prerank,sodium ion transmembrane transport (GO:0035725),0.5224345935565862,1.3188924603715717,0.07407407407407407,0.47249902636980406,1.0,10/84,9.12%,SLC6A3;SLC6A4;SCN4B;HCN4;SLC9A4;SLC8A1;PKD2;SLC9A9;SLC9A1;SLC6A15
prerank,negative regulation of platelet activation (GO:0010544),0.6274184596024619,1.3187918568708485,0.17345597897503284,0.47226519212865775,1.0,4/16,4.04%,ALOX12;PRKCD;CD9;APOE
prerank,positive regulation of cell death (GO:0010942),0.5344026195616439,1.3181018512848675,0.09957173447537473,0.4736406805234226,1.0,15/59,16.45%,CALCR;FCGR2B;ITGB2;TNF;SNCA;TYROBP;MAP3K5;C1QA;ITGAM;FYN;DDIT4;LRRK2;LRP1;CD36;FAF1
prerank,cellular response to lectin (GO:1990858),0.5219594988976524,1.3180156968919927,0.06592292089249494,0.4728297840013433,1.0,27/104,17.93%,CLEC4D;LYN;CARD11;SYK;PLCG2;PRKCD;FCER1G;MUC13;TYROBP;PSMB10;MALT1;PSMA2;PRKACB;FYN;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;TAB3;SRC;PSMD7;PSMB9;RPS6KA5;PDPK1;PSMD2
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.5219594988976524,1.3180156968919927,0.06592292089249494,0.4728297840013433,1.0,27/104,17.93%,CLEC4D;LYN;CARD11;SYK;PLCG2;PRKCD;FCER1G;MUC13;TYROBP;PSMB10;MALT1;PSMA2;PRKACB;FYN;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;TAB3;SRC;PSMD7;PSMB9;RPS6KA5;PDPK1;PSMD2
prerank,mesoderm formation (GO:0001707),0.6180421922425801,1.3174976962078924,0.16623711340206185,0.4737752747356453,1.0,3/17,7.22%,ITGB3;ITGA2;SNAI1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.5861136745102012,1.3174603815349641,0.15169902912621358,0.47334586633130604,1.0,9/25,16.70%,RPL23;PDCL3;TAF1;HFE;CSNK2A1;CSNK2A2;PSME3IP1;RPL11;EPHA4
prerank,regulation of ATP biosynthetic process (GO:2001169),0.6219104615896723,1.3169537903435111,0.17290322580645162,0.4741830020467984,1.0,5/16,13.64%,TREM2;TMSB4X;FLCN;PPARGC1A;PID1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.5433803310807584,1.316153365619041,0.10087719298245613,0.4759233676623496,1.0,7/50,6.77%,CD86;LAPTM5;TLR2;TLR7;TNF;CD14;ACTN4
prerank,positive regulation of secretion by cell (GO:1903532),0.536030040721569,1.3160748480750222,0.0886339937434828,0.4756339395926912,1.0,17/70,14.20%,TREM2;TGFB1;IL1A;UNC13D;ADAM8;SNCA;ABCG1;RGCC;TTN;P2RX4;SYTL4;DTNBP1;ATP6AP1;EXOC1;ARF6;MYH10;NMB
prerank,regulation of steroid metabolic process (GO:0019218),0.5993686676589063,1.3160431500436194,0.15667074663402691,0.47518606015748316,1.0,11/23,20.15%,NR1H4;APOE;ABCG1;FMO5;ACADL;TTC39B;STUB1;ARV1;ASAH1;LAMTOR1;ABCA2
prerank,positive regulation of isotype switching (GO:0045830),0.6471820552053149,1.3160137310422477,0.1611185086551265,0.474750613587496,1.0,2/15,2.41%,TGFB1;MAD2L2
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5617990939081269,1.3158022782011745,0.1310344827586207,0.474824345195309,1.0,6/38,4.91%,TREM2;NR1H4;NLRC3;TANK;TNFAIP3;PYCARD
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.5289418619178892,1.3154610467826073,0.08641975308641975,0.47525611345292035,1.0,20/71,16.57%,CTSS;CTSB;LGMN;CTSC;CTSK;CTSL;TNFAIP3;DDI2;ATXN3;LONP1;MALT1;CTSZ;HDAC6;CASP8;STUB1;USP9X;CAPN2;PDCD6IP;IDE;YME1L1
prerank,negative regulation of neuron death (GO:1901215),0.5229112022285001,1.31475523490511,0.057926829268292686,0.4766908190282711,1.0,25/93,15.90%,PTK2B;GPNMB;LGMN;CD200R1;ADAM8;MDK;SNCA;APOE;TRAF2;CLN3;FZD9;MEF2C;KIF14;NTF3;PPARGC1A;CCL2;TNFRSF1B;GRN;SORL1;IKBKG;RETREG1;LRRK2;WFS1;CPEB4;RASA1
prerank,cellular response to interleukin-6 (GO:0071354),0.587279973234466,1.3144944660595415,0.16326530612244897,0.4768987369251328,1.0,11/26,15.78%,CBL;IL6R;CEBPA;SPI1;ST18;NFKB1;PID1;PTPRT;SRC;SBNO2;SELPLG
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.6153418652135061,1.3141337651083589,0.17662337662337663,0.47738133973064717,1.0,7/17,14.60%,SREBF2;APOE;ABCG1;ERLIN2;ERLIN1;SEC14L2;SREBF1
prerank,protein insertion into membrane (GO:0051205),-0.3820372748128074,-1.3140504690398587,0.11538461538461539,0.8998262270845808,1.0,12/32,19.60%,APP;EGFR;OXA1L;TRAM1;ALDH3A2;SEC61G;COX18;EMD;SERP1;SEC61B;GET4;VAPA
prerank,negative regulation of kinase activity (GO:0033673),0.5344652006850104,1.3140194932216445,0.11534391534391535,0.4771610047681871,1.0,15/62,17.75%,PTPRC;UBASH3B;THY1;GNAQ;SNCA;TRIM27;RB1;QARS1;DUSP19;DTNBP1;PRDX3;RTRAF;NF1;TARBP2;PDPK1
prerank,regulation of mitotic nuclear division (GO:0007088),0.542146820072344,1.3138635953883528,0.11039657020364416,0.47701489709732475,1.0,9/55,11.86%,ANAPC15;IL1A;NUP62;AURKAIP1;NME6;RGCC;KIF20B;LRP5;PHIP
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5903085194024027,1.3136938920948413,0.13947990543735225,0.47694843636663176,1.0,12/26,17.21%,IRAK2;MAP2K6;UBE2V1;TNFAIP3;ALPK1;NOD2;TAB2;CASP8;ITCH;IKBKG;TAB3;UBE2N
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.5809241481834,1.3136570589769956,0.1619047619047619,0.47652216448829227,1.0,6/26,11.65%,WDTC1;MLXIPL;ERLIN2;ERLIN1;ACADL;ADIPOR1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5614383826157427,1.3135692598026885,0.13166855845629966,0.47623025550894976,1.0,7/33,8.62%,TGFB1;TNF;FOXO3;SPI1;TEAD1;TP53;SMAD3
prerank,inhibitory synapse assembly (GO:1904862),0.6516134414522705,1.3134121344250669,0.18218623481781376,0.4761298668287989,1.0,2/11,2.80%,NPAS4;FGF13
prerank,response to cholesterol (GO:0070723),0.6264185303524602,1.3132034968405333,0.17054263565891473,0.47618651956458014,1.0,3/17,6.74%,TGFB1;TGFBR1;TGFBR2
prerank,response to lipid (GO:0033993),0.5166726912252342,1.3131602676207546,0.05786802030456853,0.47578099306105165,1.0,20/105,12.61%,ASCL1;SLC11A1;TGFB1;MAPKAPK3;TNFRSF11A;RXRB;SNCA;SPP1;GCH1;ABCG1;IFNAR1;FOXO3;ANXA1;CTNNB1;ERBIN;LY96;STAT5B;SOX9;PRDX3;TAB2
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.6649262914426003,1.312904988928523,0.19327731092436976,0.47597074009466894,1.0,3/11,8.17%,TGFB1;MYOCD;MEF2C
prerank,Rap protein signal transduction (GO:0032486),0.6713856725720883,1.312894291572202,0.17024320457796852,0.4754808796294336,1.0,6/10,14.64%,RAP2A;RAP1B;PLK2;RAP2B;RAPGEF1;RAP1A
prerank,positive regulation of signal transduction (GO:0009967),0.5094003034035204,1.312769706390169,0.008,0.47530772815987016,1.0,55/238,14.30%,PTPRC;CD226;TREM2;PTK2B;SCIMP;SHH;CD74;SMOC2;ITGB3;P2RY6;SNX5;TLR2;TGFBR1;RAB34;MGAT5;BMP2K;DSTYK;LY86;MAML3;ERN1;PRKD2;PKD2;SKI;TNFAIP3;LGR6;FGFBP3;PRKCB;MACF1;CD80;CRADD;ASXL2;DISC1;CD180;CSNK2A1;TSPAN14;LY96;NTF3;SULF2;BAK1;ATP6AP2;POGLUT1;NRP1;LIMS1;CD63;CCBE1;PHIP;NOD2;SORL1;SMARCB1;NPTN;TXNDC15;GPS2;GAS6;LRRK2;MBD5
prerank,"phototransduction, visible light (GO:0007603)",0.639179794663836,1.3125073945283283,0.17733333333333334,0.4755287867720515,1.0,4/14,12.98%,GNAQ;SAG;CNGB1;ABCA4
prerank,sodium ion transport (GO:0006814),0.5238335692504665,1.3124195353082964,0.06570841889117043,0.4752831099429792,1.0,7/85,4.08%,SLC6A3;SLC6A4;SCN4B;HCN4;FGF13;SLC8A1;PKD2
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.620714176802134,1.312288945320059,0.17466666666666666,0.47512977505737164,1.0,2/15,2.63%,PTK2B;TEC
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5876134867442248,1.312072074826684,0.15144230769230768,0.4752630726302524,1.0,11/24,17.21%,IRAK2;MAP2K6;UBE2V1;TNFAIP3;NOD2;TAB2;CASP8;ITCH;IKBKG;TAB3;UBE2N
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.5804266731258392,1.311770602510752,0.1423487544483986,0.475564766210986,1.0,9/25,17.17%,CBL;NUP62;ARAP1;DOK1;DGKD;BCAR3;RBPJ;RTN4;PDE6H
prerank,Golgi to lysosome transport (GO:0090160),0.6656138261667591,1.311733095983193,0.17862165963431786,0.4751516176973063,1.0,6/11,20.04%,LAPTM5;RBSN;CLN3;GAK;CCDC91;SORT1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.5207583105396488,1.3105832064472014,0.08163265306122448,0.47775017164831296,1.0,27/87,17.66%,ARRB2;TGFB1;NRROS;CBL;ITGB5;TGFBR1;ARHGEF18;SKI;HPGD;ZMIZ2;TGFBR2;FMOD;TGFBRAP1;ZFYVE9;SMAD3;F11R;NLK;BAMBI;USP9X;ZYX;LTBP2;SRC;SMURF1;APPL2;LPXN;FURIN;RHOA
prerank,calcium ion transport into cytosol (GO:0060402),-0.40951756802224115,-1.3105114455865485,0.12376237623762376,0.9037673274068293,1.0,13/21,27.18%,CACNA1C;RYR2;JPH1;ITPR3;GRIN2B;GRIN1;CACNA2D1;TRPV4;JPH2;JPH4;TRPM2;CACNB3;GRIN2D
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.5209455865504115,1.3104970670176543,0.06795131845841786,0.4774903206562595,1.0,23/101,16.24%,PIK3CG;PIK3R5;TGFB1;FLT3;CSF1R;ADAM8;CCND3;TNF;SNCA;PKD2;RGCC;CCND2;MAP2K2;PARP16;PPP2CA;NOD2;LRRK2;PIH1D1;SRC;CEMIP;INCENP;SYAP1;IRGM
prerank,phospholipid transport (GO:0015914),0.5424145475069054,1.3094127600637762,0.125,0.47992163652418907,1.0,9/52,6.05%,ATP8B4;ABCA1;ATP8A1;NPC2;APOE;ABCG1;ATP8A2;PRELID3B;ABCB4
prerank,cellular response to peptide (GO:1901653),0.5384058553628845,1.308367121731822,0.1178343949044586,0.4823698998378875,1.0,16/56,17.22%,TREM2;FCGR2B;LGMN;ITGA4;RPL23;TP53;CACNA1A;ABCC1;CACNB1;FYN;NOD2;LRP1;SRC;CD36;EPHA4;ARHGEF2
prerank,autonomic nervous system development (GO:0048483),0.6247468210474846,1.3083113186208992,0.17105263157894737,0.4819860224865916,1.0,6/17,15.81%,ASCL1;EDNRB;TFAP2B;NRP1;SOX4;NF1
prerank,mesonephros development (GO:0001823),-0.5044864836109385,-1.3081722533770608,0.16,0.9026020907502006,1.0,7/11,34.66%,BMP4;PAX2;ZBTB16;FGF10;BMP7;FGF1;OSR1
prerank,cell-matrix adhesion (GO:0007160),0.5158460907850391,1.3076714389105843,0.07433808553971487,0.4832404780428273,1.0,10/95,3.14%,ITGAL;FERMT3;HPSE;ITGB2;ITGA4;ITGB3;ITGB5;THY1;ITGA2;ANGPTL3
prerank,ganglioside metabolic process (GO:0001573),0.6053625713451133,1.3076372401072935,0.15835411471321695,0.4828276953366586,1.0,5/20,7.52%,HEXB;GM2A;ST8SIA4;HEXA;ST6GALNAC4
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.5402625646179635,-1.307522743806892,0.17891373801916932,0.8947058757963989,1.0,3/10,7.49%,ERRFI1;CAV1;MVP
prerank,regulation of metal ion transport (GO:0010959),-0.4739188501629961,-1.307096521795192,0.11894273127753303,0.8860689863281527,1.0,6/16,14.97%,ANK2;SRI;CAMK2G;DLG1;CACNA2D1;IL16
prerank,actin filament organization (GO:0007015),0.5158272949801657,1.3070880466511643,0.04020100502512563,0.48380528311035004,1.0,26/151,11.47%,MYO1F;ARHGAP25;MYO1G;CASS4;LCP1;MYO1E;CORO1A;GAS2L1;MYO5A;MAD2L2;ELMO1;PLS1;GAS2L3;TTN;FHOD1;FLII;AIF1;NEDD9;MYO7A;MYO19;ABI1;TPM4;BCAR1;ACTN1;BIN3;ARPC4
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.6383183000328176,1.306862208870263,0.2019774011299435,0.4833918159451754,1.0,4/13,14.18%,STAT5A;GRB2;STAT5B;IL2RG
prerank,cellular response to interleukin-15 (GO:0071350),0.6383183000328176,1.306862208870263,0.2019774011299435,0.4833918159451754,1.0,4/13,14.18%,STAT5A;GRB2;STAT5B;IL2RG
prerank,microvillus organization (GO:0032528),0.6364423837228537,1.3062205576414236,0.16937669376693767,0.48468321734755354,1.0,9/13,22.46%,RAP2A;RAP1B;TNIK;RAP2B;RAP1A;FXYD5;MINK1;MAP4K4;RAPGEF6
prerank,regulation of protein transport (GO:0051223),0.5748429771594448,1.3059126943474526,0.1728247914183552,0.48501021905393826,1.0,5/27,7.08%,LCP1;PTPN1;TNF;RHBDF2;GAPVD1
prerank,membrane raft organization (GO:0031579),0.6275974273169808,1.3057883997995527,0.1727891156462585,0.48481386071643306,1.0,3/15,5.53%,RFTN1;CLN3;NPC1
prerank,chromatin disassembly (GO:0031498),0.638136777999416,1.304332879464299,0.17462482946793997,0.48783820089148233,1.0,4/14,12.90%,NFE2;ARID1A;SMARCD3;SMARCB1
prerank,nucleosome disassembly (GO:0006337),0.638136777999416,1.304332879464299,0.17462482946793997,0.48783820089148233,1.0,4/14,12.90%,NFE2;ARID1A;SMARCD3;SMARCB1
prerank,regulation of ion transport (GO:0043269),0.5241936681073744,1.3039375635953703,0.08847736625514403,0.4884083004637477,1.0,16/76,13.94%,KCNJ11;SYT17;ITGB3;VAMP3;P2RX7;SNCA;P2RX4;SYT2;WNK1;HFE;SYT10;NEDD4L;DTNBP1;B2M;TOR1A;KCNA5
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5655101537502182,1.30363500510119,0.14585764294049008,0.4887964025416754,1.0,7/29,11.36%,CCR2;STAT5A;PKD2;IFNAR1;STAT4;STAT5B;CCL2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.5688440836418721,1.303001679379418,0.15734265734265734,0.4900515772727812,1.0,11/26,20.18%,TREM2;TLR2;IRF1;GPS2;CD36;LGR4;APPL2;FLOT1;BIRC2;NFKBIL1;BIRC3
prerank,peptidyl-proline hydroxylation (GO:0019511),0.6602884189956402,1.302797404831768,0.1792717086834734,0.4900577270056591,1.0,3/11,9.87%,CRTAP;P4HB;P3H2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.5921911258622967,1.3023771783830433,0.15906288532675708,0.49076391273521175,1.0,5/24,8.29%,CD74;CD44;BCL2L1;SNAI1;TPT1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.5327072623245184,1.3016392737453089,0.12554585152838427,0.4922715388613324,1.0,8/46,7.68%,LCP1;TYK2;IL12RB2;AIP;RAP1B;STAT4;P4HB;CAPZA1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.6295449722420814,1.3016155443995945,0.1836734693877551,0.49182522129595674,1.0,5/16,11.24%,WDTC1;ERLIN2;ERLIN1;ACADL;SOX9
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.558341120143256,1.3016146094994778,0.1351039260969977,0.4913058249146754,1.0,5/34,3.39%,UBASH3B;PTPRJ;DUSP3;PTPN1;PTPN18
prerank,cellular response to organic cyclic compound (GO:0071407),0.5056980879576488,1.3012735141482148,0.03919597989949749,0.4917260289780483,1.0,34/141,14.64%,CYP1A1;TGFB1;P2RY6;AQP1;HCN4;NR1H4;P2RX7;P2RY2;TNF;SPP1;PKD2;ADCY6;IL18;RAP1B;P2RX4;TAF1;ABCB4;CTNNB1;ACTB;P2RY12;MEF2C;LARP1;IMPACT;DIAPH1;RAPGEF1;CCL2;NRIP1;CASP7;TIPARP;ADCY8;ADCY3;LRRK2;GNG2;RAP1A
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.5230518234270137,-1.3009381910535278,0.1791530944625407,0.9007270751832672,1.0,8/10,42.71%,BMP5;LIN7C;ARHGAP12;BMP7;SOX11;DLL4;LRP6;TBX20
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6782432295842025,1.3007774604522702,0.19912790697674418,0.49264505346217513,1.0,2/10,7.31%,CCR2;WNK1
prerank,negative regulation of interleukin-1 production (GO:0032692),0.5906616607120984,1.2999900372449578,0.17370325693606756,0.4943673335690655,1.0,4/23,15.83%,CX3CR1;TNFAIP3;GAS6;CD33
prerank,regulation of defense response to virus (GO:0050688),0.6479574399948715,1.299837932864426,0.18963165075034105,0.49427346961750745,1.0,6/14,12.82%,DHX9;TNFAIP3;TRAF3;ZMPSTE24;RNF216;ITCH
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.6738170911334977,1.299492621752876,0.18594436310395315,0.4946606048746314,1.0,2/10,10.69%,LYN;MAP2K2
prerank,regulation of glucose metabolic process (GO:0010906),-0.3694452592974682,-1.2992180687862196,0.07017543859649122,0.8975057623070812,1.0,13/34,21.48%,OGT;IRS1;PDK3;GPLD1;SELENOS;RORA;ZNF692;DGKQ;MLYCD;AKT1;BCKDK;IRS2;PDK2
prerank,positive regulation of protein phosphorylation (GO:0001934),0.5029032104970638,1.2991092185162534,0.008,0.4951637505687703,1.0,45/348,8.23%,PTPRC;LCP2;TREM2;PTK2B;GPNMB;LYN;CALCR;TGFB1;CX3CR1;HCLS1;GATA1;CD74;LAT;FNIP2;ITGB3;PLCG2;CSF1R;NIBAN1;TGFBR1;MMD;PTPRJ;MAD2L2;ANGPT4;TEC;OSM;RAP2A;SNX9;SEMA4D;CCND3;TNF;FNIP1;SNCA;PRKD2;IL6R;BRAT1;CCND2;CD44;XRCC5;MAP2K3;CD80;TP53;VEGFB;TNIK;HFE;FLCN
prerank,hydrogen peroxide catabolic process (GO:0042744),0.6722638486692674,1.2987765362479722,0.18620689655172415,0.4955891121713519,1.0,5/11,16.61%,PRDX1;PRDX3;PXDN;PRDX2;PRDX5
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.6148636634008132,1.2984862407115156,0.18085106382978725,0.49585813489543495,1.0,4/15,9.23%,BMP2K;PIK3CB;DGKD;SCYL2
prerank,heme catabolic process (GO:0042167),0.630040426312365,1.2984332545910025,0.17748344370860927,0.4949478152499328,1.0,4/14,14.69%,BLVRB;SLCO2B1;ABCC1;SLCO1B1
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.630040426312365,1.2984332545910025,0.17748344370860927,0.4949478152499328,1.0,4/14,14.69%,BLVRB;SLCO2B1;ABCC1;SLCO1B1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.526571614166437,1.2982774240163473,0.10669456066945607,0.4948949219935177,1.0,19/69,16.28%,PTK2B;CX3CR1;LGMN;ADAM8;MDK;APOE;CLN3;FZD9;MEF2C;KIF14;NTF3;PPARGC1A;CCL2;GRN;RETREG1;WFS1;CPEB4;RASA1;HIF1A
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.3993781098526399,-1.2981727365882891,0.13253012048192772,0.8915601153499784,1.0,16/24,30.98%,LEPR;NDUFS1;SLC25A13;NDUFS4;COQ10B;GFPT1;COX15;SDHAF4;MRAP2;GFPT2;ACADVL;LYRM7;COX10;MTLN;CYCS;NR4A3
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.6166476829920962,1.2980312927253341,0.18513513513513513,0.4950592757166756,1.0,3/15,10.70%,NPAS4;CLN3;ZDHHC3
prerank,regulation of myoblast fusion (GO:1901739),0.6475288981679183,1.2979724153350818,0.1912568306010929,0.4947035638377101,1.0,4/11,10.85%,MAPK14;RIPOR2;CFLAR;CD53
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.5374572707873625,1.2976006407448923,0.12091503267973856,0.4951981589979608,1.0,18/49,21.41%,TREM2;NLRC3;HMGB1;TFIP11;SVIP;KIF14;HSF1;IMPACT;IAPP;HDAC6;SORL1;SRC;LDLRAD4;CDC42;DACT1;RIOK3;GSK3B;CRYAB
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.5720124224574464,1.2974284181407119,0.1515499425947187,0.49515808387472404,1.0,9/32,12.60%,LPIN2;LPCAT1;PCYT1A;CHKB;CSNK2A1;CSNK2A2;SLC44A2;STARD10;ABHD3
prerank,positive regulation of coagulation (GO:0050820),0.6540813529568799,1.2966121682406657,0.2052401746724891,0.49631966547604556,1.0,2/10,11.47%,HPSE;THBS1
prerank,positive regulation of hemostasis (GO:1900048),0.6540813529568799,1.2966121682406657,0.2052401746724891,0.49631966547604556,1.0,2/10,11.47%,HPSE;THBS1
prerank,regulation of T cell chemotaxis (GO:0010819),0.6601867046010981,1.296201384096441,0.21045197740112995,0.49701667609324146,1.0,2/11,7.31%,CCR2;WNK1
prerank,carbohydrate transport (GO:0008643),0.6679087250709381,1.2953910062384528,0.2099290780141844,0.49873024088648976,1.0,2/11,8.26%,AQP1;AQP11
prerank,mesenchyme morphogenesis (GO:0072132),-0.4267110803503294,-1.2953891408318616,0.14222222222222222,0.892536014699233,1.0,4/17,12.19%,BMPR1A;ACVR1;ACVRL1;NOS3
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5712672284983406,1.2946724263276075,0.17253948967193194,0.5002345049148302,1.0,8/26,18.35%,TREML4;TLR1;TLR2;HMGB1;WDFY1;NINJ1;RTN4;FLOT1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.5047826109448098,-1.2940344700706683,0.1694915254237288,0.8882953319258382,1.0,6/12,18.85%,SEC61G;SGTB;CHMP4A;CHMP4B;SEC61B;SEC61A1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.4983162369294355,1.2937444247782248,0.03803803803803804,0.502334100791599,1.0,53/199,17.88%,SLC6A4;GPNMB;SHH;SLC11A1;TGFB1;PLCL2;FCGR2B;SRGN;SLAMF8;MAD2L2;NR1H4;MDK;TLE3;MAP2K6;TNF;RGCC;DDIT3;SPI1;TIMP1;WWC2;PPP1R11;NKX2-1;MYOCD;MEF2C;FLCN;ATP2B1;RB1;DUSP10;ARHGDIB;PFN2;RPS6KA4;SOX9;PTPRO;ADIPOR1;GRN;CHSY1;PPP2CA;HDAC9;RAB11FIP5;NPTN;VASN;GAS6;TRPV3;LGR4;GSK3A;LAMA4;RBPJ;PTEN;ADM;CORO1C;LDLRAD4;RPS6KA5;SFMBT1
prerank,eye development (GO:0001654),-0.3160650422504348,-1.2934021436693772,0.04477611940298507,0.8810925172155837,1.0,13/54,11.07%,COL5A2;CACNA1C;FOXC1;PBX1;NIPBL;EFEMP1;SHROOM2;MEIS2;FBN1;PBX4;SMG9;PBX2;PBX3
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.4575875851639437,-1.2933864049191206,0.16182572614107885,0.8718827106854253,1.0,4/15,9.57%,TJP1;BMPER;KLF4;SMAD1
prerank,RNA polyadenylation (GO:0043631),-0.3929839237743664,-1.293123436859724,0.09558823529411764,0.8548403166147499,1.0,10/26,15.27%,WDR33;APP;SCAF8;AHCYL1;FIP1L1;PAPOLA;PAF1;PAPOLG;TUT1;CSTF3
prerank,mRNA polyadenylation (GO:0006378),-0.3929839237743664,-1.293123436859724,0.09558823529411764,0.8548403166147499,1.0,10/26,15.27%,WDR33;APP;SCAF8;AHCYL1;FIP1L1;PAPOLA;PAF1;PAPOLG;TUT1;CSTF3
prerank,positive regulation of translational initiation (GO:0045948),0.5935624318627337,1.2930797905450453,0.17091836734693877,0.5037176751693763,1.0,3/18,8.64%,MTOR;YTHDF3;LARP1
prerank,gas transport (GO:0015669),0.6703239557592182,1.2923559852576276,0.19318181818181818,0.5052290868274055,1.0,2/10,13.31%,AQP1;IPCEF1
prerank,cellular glucose homeostasis (GO:0001678),0.5455787521047494,1.2918773884775703,0.16416309012875535,0.5060367340755272,1.0,12/41,16.55%,HK3;LRRC8D;ERN1;PPARGC1A;TRA2B;FOXK1;ADCY8;GAS6;HK2;SOX4;HIF1A;GCK
prerank,regulation of JUN kinase activity (GO:0043506),0.5622315820332997,1.2918058801883439,0.13821138211382114,0.505727100380853,1.0,8/33,10.72%,TAOK3;FZD10;TNFRSF11A;TNF;TRAF2;MAP3K5;DUSP10;DUSP19
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.6344831621580007,1.2914281133021959,0.1994572591587517,0.5063344603895549,1.0,4/13,12.93%,TNF;SNX33;TYROBP;STX3
prerank,bile acid and bile salt transport (GO:0015721),0.5772586066546721,1.290970500652881,0.17139479905437352,0.5070950734665892,1.0,3/24,3.14%,SLCO2B1;NR1H4;ABCC3
prerank,protein localization to synapse (GO:0035418),-0.4983757561810296,-1.2906234968351107,0.1925925925925926,0.8555653621985422,1.0,3/12,10.98%,NLGN1;BSN;SHANK1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6422279024281641,1.2902465218435126,0.2053072625698324,0.5086026011259288,1.0,3/13,5.89%,ITGA4;MDK;HMGB1
prerank,ERBB signaling pathway (GO:0038127),0.5277182717848469,1.2901832470248145,0.11087645195353749,0.5082504114756832,1.0,19/64,17.75%,PTK2B;TGFB1;CBL;GRB2;NCK2;PTPN18;ERBIN;DGKD;BCAR1;SOX9;NRG1;BRAF;STUB1;SRC;PTPN12;HSP90AA1;IQGAP1;RPS6KA5;PDPK1
prerank,microtubule anchoring at centrosome (GO:0034454),0.6754685468164526,1.289704299123038,0.18028169014084508,0.5090256914618255,1.0,1/10,0.16%,HOOK3
prerank,microvillus assembly (GO:0030033),0.6214037167177328,1.288753480210929,0.18120805369127516,0.5111283675211673,1.0,9/14,22.46%,RAP2A;RAP1B;TNIK;RAP2B;RAP1A;FXYD5;MINK1;MAP4K4;RAPGEF6
prerank,glutathione derivative biosynthetic process (GO:1901687),0.5916688089114082,1.2881663009774489,0.18147684605757197,0.5116638165785761,1.0,3/20,3.22%,ESD;AKR1A1;HPGDS
prerank,glutathione derivative metabolic process (GO:1901685),0.5916688089114082,1.2881663009774489,0.18147684605757197,0.5116638165785761,1.0,3/20,3.22%,ESD;AKR1A1;HPGDS
prerank,atrial septum development (GO:0003283),-0.4803575248486899,-1.2880731720121534,0.15985130111524162,0.8563646622272584,1.0,6/13,26.66%,ANK2;NPHP3;HEY2;BMPR2;DAND5;TGFB2
prerank,positive regulation of multicellular organismal process (GO:0051240),0.4980104894386821,1.2877712904345717,0.007,0.5122317359361404,1.0,52/308,13.72%,CLEC9A;TREM2;FGR;SHH;PIK3CG;ITGAX;IRF4;SLC11A1;TGFB1;SYK;CCR2;IL1A;ABCA1;PIK3CD;TGFBR1;FABP4;CRTAM;RREB1;MAD2L2;MTOR;MDK;TNF;APOE;RGCC;CXCR4;CCDC88B;IL18;NFAM1;CTNNB1;TGFBR2;ACADL;SNAI1;CEBPB;FABP5;SMAD3;LURAP1;HSF1;PPARGC1A;PRKCH;CMKLR1;INHBA;TXK;SOX9;NR2C2;ADIPOR1;DYNC1H1;SDCBP;SORL1;BAMBI;PRLR;GAS6;SOX6
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.6174082917412425,1.2872714137242445,0.21657754010695188,0.5131259664805345,1.0,2/14,3.27%,PRKAR2B;PKIB
prerank,regulation of cell division (GO:0051302),0.5149678859114103,1.2862723016852262,0.1154639175257732,0.5154129045907094,1.0,14/72,11.30%,SHH;SMYD5;ZFYVE26;KLHL21;BCL2L1;TAL1;PLK4;PLK2;FLCN;MYO19;UVRAG;RAB11A;SETD2;BECN1
prerank,positive regulation of secretion (GO:0051047),0.6518978788683759,1.2857466923798737,0.20057306590257878,0.51634395182603,1.0,1/11,1.89%,AQP1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.5455628863517167,1.2847109997892974,0.15138121546961325,0.5187882594302173,1.0,8/39,7.29%,LGMN;CBL;PTPRJ;DUSP3;GRB2;PTPN18;ZFYVE28;SH3KBP1
prerank,ear morphogenesis (GO:0042471),-0.426464542784986,-1.2841945127597112,0.1407766990291262,0.8630184308258588,1.0,7/20,15.17%,NIPBL;MYO6;ZIC1;EPHB2;SIX1;TBX1;PAX2
prerank,glycolipid metabolic process (GO:0006664),0.5332700791059773,1.2840475000757463,0.12364425162689804,0.520066233531527,1.0,18/47,20.15%,HEXB;CTSA;GM2A;PSAP;SMPD3;HEXA;FUCA1;CERK;ST6GALNAC4;B3GALNT1;PGAP1;ARSA;SUMF2;ASAH1;B4GALNT1;GBA2;SMPD1;ABCA2
prerank,dendritic spine organization (GO:0097061),0.5702142930537466,1.2834077268845367,0.17785630153121318,0.5214063456549313,1.0,3/26,6.48%,TREM2;LGMN;DOCK10
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5928523584754111,1.2830754109923361,0.1850443599493029,0.5217714788984138,1.0,9/20,13.68%,SLC8A1;KCNMA1;SLC9A1;TFAP2B;NEDD4L;ATP6AP1;LACC1;ATP1B3;ATP1B2
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.5577890942866186,1.28285392083669,0.17482517482517482,0.5218586640065369,1.0,3/29,8.25%,RUNX1;VPS18;VPS11
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.46861096704460226,-1.282765415806189,0.16153846153846155,0.859928745412375,1.0,4/13,12.27%,SESN3;CASTOR2;KPTN;ATM
prerank,rRNA 3'-end processing (GO:0031125),-0.5227338790505605,-1.2824969575732608,0.18461538461538463,0.8525335162865767,1.0,5/10,19.35%,RPS21;ERI1;EXOSC7;EXOSC8;EXOSC9
prerank,positive regulation of catabolic process (GO:0009896),0.5141228957404274,1.2822577112842888,0.12815126050420167,0.5230283804357856,1.0,25/65,21.05%,VSIR;ANGPTL3;TNF;ATG7;TNFAIP3;RAB7A;PLK2;CSNK2A1;NEDD4L;FZR1;ITCH;STX5;SORL1;TIPARP;HUWE1;AREL1;GSK3A;SMURF1;IDE;VPS28;DACT1;SEC22B;GSK3B;WWP1;PRKN
prerank,response to glucocorticoid (GO:0051384),0.5809164208214519,1.2816246764923325,0.17417783191230207,0.5242706024522285,1.0,3/26,6.22%,CALCR;TNF;ANXA1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.33289696310227385,-1.2814426499653564,0.10294117647058823,0.8481358915378199,1.0,14/52,15.44%,RBFOX2;FXR2;YTHDC1;MBNL2;RBFOX3;REST;SRRM4;KHDRBS3;FMR1;NOVA2;HNRNPA1;HNRNPU;KHDRBS2;PUF60
prerank,regulation of cell-matrix adhesion (GO:0001952),0.5173516202272456,1.2813672492160788,0.1474019088016967,0.5244536883317629,1.0,25/64,20.32%,PTK2B;CD3E;THY1;DUSP3;PIK3CB;MACF1;SLC9A1;CASK;ACTG1;VCL;NF2;THBS1;CDK6;CD36;PTPRA;NF1;RASA1;CCL25;CORO1C;RHOA;MINK1;PLEKHA2;ROCK2;MAP4K4;GSK3B
prerank,membrane fusion (GO:0061025),0.5536485213041092,1.2810099552191452,0.18098510882016036,0.5249415462743579,1.0,16/33,22.64%,VAMP3;RABEP1;STX11;DNM2;SNAP29;DYSF;SNAP23;HUWE1;UBXN2A;VPS33B;DNM1L;USO1;NSFL1C;RIMS1;CHP1;NAPA
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.5956266372119977,1.280751997008431,0.18814432989690721,0.5251567616753442,1.0,4/17,10.93%,MYO1G;IL18;BTN3A3;IL18BP
prerank,bicellular tight junction assembly (GO:0070830),-0.3290478793403415,-1.2807369585878263,0.08333333333333333,0.8427480646550822,1.0,10/46,10.43%,CDH5;AFDN;PRKCI;PARD3;CLDN5;CLDN11;MPP7;PARD6G;CLDN14;DLG1
prerank,eye morphogenesis (GO:0048592),-0.4305158676512064,-1.280472091078359,0.15416666666666667,0.8355936385596703,1.0,7/19,9.84%,COL5A2;NIPBL;EFEMP1;SHROOM2;MFAP5;FBN1;TENM3
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.5787430663812142,1.2803128673749986,0.16606929510155316,0.5258003641618774,1.0,3/23,2.95%,ITGAX;PIK3CD;MDK
prerank,negative regulation of calcium ion transport (GO:0051926),0.6141410701692361,1.279867955233991,0.20861372812920592,0.5265544201326473,1.0,3/15,8.54%,LILRB1;EPO;TRIM27
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.6280353352321386,1.2789232471571084,0.20457604306864063,0.5286528476407395,1.0,3/15,6.37%,APOE;ABCG1;LIPC
prerank,glycerophospholipid metabolic process (GO:0006650),0.5100020701973431,1.2786765350239244,0.11958762886597939,0.5287994284541775,1.0,18/75,15.61%,PLCB2;PLEK;PIGM;CSF1R;ABHD12;CLN3;PIGL;PIGX;PIGV;PLA2G7;AGK;PIGH;PRDX6;SYNJ1;ABHD3;GDE1;ABCA3;GDPD3
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5422113599329225,1.278319639496064,0.16027088036117382,0.5292923418028782,1.0,11/36,17.86%,CD74;NLRC5;LAPTM5;CXCR4;CASP1;CD300LF;TXK;GAS6;IRGM;HIF1A;UBE2K
prerank,regulation of kinase activity (GO:0043549),0.5058756177538551,1.277396875319748,0.10736196319018405,0.5313775592108281,1.0,9/89,4.35%,TREM2;FGR;FLT3;CD74;NLRC5;SLAMF8;CSF1R;DSTYK;TTN
prerank,heterochromatin organization (GO:0070828),-0.46546929661537556,-1.2760784552657993,0.17266187050359713,0.8435446827969915,1.0,5/14,10.44%,SMCHD1;EZH1;MECOM;SETDB2;SETD7
prerank,striated muscle tissue development (GO:0014706),-0.37468966652457225,-1.2757526243200066,0.14074074074074075,0.8367057256814262,1.0,6/29,10.25%,SGCD;CAV1;SGCZ;PGM5;BMP5;SIX1
prerank,embryonic skeletal system development (GO:0048706),-0.3565811609580433,-1.275574187952867,0.1452991452991453,0.8296837412104334,1.0,13/35,19.28%,PCSK5;HOXC4;WNT5A;HOXB9;SULF1;DSCAML1;HOXA3;PDGFRA;SIX1;HOXC9;COL1A1;RBP4;FUZ
prerank,icosanoid metabolic process (GO:0006690),0.5382680531384432,1.2751209100706986,0.16591422121896163,0.5371588117186848,1.0,6/40,10.29%,TBXAS1;ALOX12;DAGLB;HPGD;PON3;ABCC1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.5043510445127525,1.2749187360631433,0.08766564729867482,0.5372150104182336,1.0,15/113,7.01%,LGALS3;TGFB1;PLEK;SYK;LCP1;FNIP2;ABCA1;GTF2H1;TNF;FNIP1;SNCA;ASAP1;RAP1B;TP53;TAL1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.501948462922453,1.2742364487277915,0.12770339855818744,0.5386171099991492,1.0,29/80,20.15%,GSAP;NIBAN1;PRKCD;MTOR;TNF;ABCG1;PLXNB2;SMPD3;CIRBP;YTHDF3;LARP4B;CPEB3;RPL26;THBS1;ZCCHC4;METTL3;PCIF1;NSMAF;POLDIP3;UPF3B;HNRNPD;SOX4;GSK3A;EPHA4;RPS4X;PICALM;ROCK2;PYM1;ABCA2
prerank,protein depolymerization (GO:0051261),-0.36702074265787094,-1.2740784405216006,0.15584415584415584,0.8277403118534442,1.0,11/27,18.29%,NCKAP5;GSN;CFL2;STMN2;WDR1;MICAL3;MICAL2;KIF24;STMN4;STMN3;KIF18A
prerank,rRNA catabolic process (GO:0016075),0.6067762474791265,1.2739948104515815,0.2130718954248366,0.5387435871785494,1.0,1/16,0.38%,SLFN14
prerank,blood vessel endothelial cell migration (GO:0043534),-0.41808417182220864,-1.2734349468610904,0.1717171717171717,0.8224397237254966,1.0,8/22,8.52%,CDH5;PIK3R3;EPHB4;EFNB2;ID1;ROBO1;SLIT2;GPLD1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.4186106500970428,-1.2727223249924395,0.1688888888888889,0.8175755922235017,1.0,9/18,26.11%,ACSL1;HACD1;ELOVL5;ACSL6;ELOVL1;ACSBG1;HACD2;ACSL4;ACSL3
prerank,regulation of coagulation (GO:0050818),0.6429673113724811,1.272411116261326,0.22928994082840237,0.5427849191970816,1.0,1/11,0.83%,GP1BA
prerank,positive regulation of type I interferon production (GO:0032481),0.5050755931146322,1.2722450488132528,0.12989690721649486,0.5427389725637007,1.0,21/73,19.19%,IRF5;TLR2;DHX9;TLR7;TLR8;LRRFIP1;CD14;XRCC5;CTNNB1;SETD2;TRIM56;POLR2L;RNF135;NFKB1;IRF1;HSP90AA1;DDX41;FLOT1;CRCP;POLR2E;RIOK3
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.48805456572517225,1.2716804725229292,0.011,0.5437697192265348,1.0,58/348,11.85%,ARRB2;TREM2;LILRB1;PF4;CALCR;ITGAX;SLC11A1;TGFB1;CD3E;PCSK9;STAP1;CD74;NFE2L2;IL1A;VSIR;PIK3CD;RPL23;LAPTM5;VAMP3;PLCG2;TLR2;TGFBR1;P2RX7;PTPN1;MTOR;PIK3CB;MAPK14;TNF;SNCA;RGCC;MITF;PDCL3;TTN;TYROBP;TP53;NKX2-1;TNRC6A;TICAM1;RESF1;HFE;MEF2C;MOV10;SMAD3;NTF3;NOS1AP;SCYL2;PPARGC1A;AGO4;ATF7IP;ACTG1;INHBA;LIMS1;DTNBP1;SOX9;CD63;SEC16B;AGO3;VSTM2A
prerank,positive regulation of gene expression (GO:0010628),0.48600557745020023,1.2709846290743412,0.005,0.5452073541542073,1.0,74/442,12.11%,CLEC9A;TREM2;LILRB1;FGR;PF4;CALCR;PIK3CG;ITGAX;SLC11A1;TGFB1;CD3E;STAP1;CD74;NFE2L2;IL1A;VSIR;PIK3CD;RPL23;PLCG2;TLR2;NIBAN1;TGFBR1;CRTAM;TAF1A;P2RX7;MTOR;PIK3CB;MAPK14;POLR1E;ERN1;TNF;SF3B1;RGCC;MITF;PDCL3;TTN;PLXNB2;TENT4B;CCDC88B;NFAM1;CIRBP;TYROBP;ACTB;TP53;NKX2-1;TNRC6A;YTHDF3;TICAM1;HFE;MEF2C;MOV10;LARP4B;SMAD3;LURAP1;NOS1AP;PPARGC1A;AGO4;ACTG1;CPEB3;INHBA;RPL26;MAP2K2;POLR1B;LIMS1;POLR2L;DTNBP1;TXK;SOX9;THBS1;SEC16B;AGO3;VSTM2A;ZCCHC4;METTL3
prerank,regulation of protein localization (GO:0032880),0.5208296540412162,1.2702239868081762,0.12879581151832462,0.5469097147502437,1.0,11/58,10.17%,PLEKHM2;CTSD;ITGB3;MMD;TRIM25;TRIM5;RAB14;ZDHHC7;TRIM27;ATCAY;TPR
prerank,regulation of immune effector process (GO:0002697),0.5306048968627578,1.2701667152712857,0.17245240761478164,0.5465343583280802,1.0,5/41,8.63%,IRF4;FCGR2B;C1QC;C1QA;C1QB
prerank,mRNA 3'-end processing (GO:0031124),-0.2741781881398318,-1.2697510331923572,0.08333333333333333,0.8206251738645954,1.0,24/78,15.27%,WDR33;APP;SARNP;SRRM1;RPRD2;CPSF6;SCAF8;AHCYL1;CPSF7;FIP1L1;THOC7;CSTF2;THOC1;PAPOLA;THOC5;U2AF2;PAF1;SRSF11;PAPOLG;RPRD1B;EIF4A3;TUT1;SRSF1;CSTF3
prerank,glycosphingolipid metabolic process (GO:0006687),0.5307699499761773,1.2695930632788541,0.15995647442872687,0.5476846400478059,1.0,19/42,21.79%,HEXB;CTSA;GM2A;PSAP;SMPD3;HEXA;CERK;B3GALNT1;ST8SIA1;ARSA;SUMF2;LARGE1;ASAH1;B4GALNT1;GBA2;SMPD1;ABCA2;SUMF1;B4GALT6
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.5350366978004982,1.2691534767629322,0.17474633596392333,0.5484039310282626,1.0,9/36,9.57%,CX3CR1;TGFBR1;TNF;PYCARD;CRADD;CSNK2A1;CSNK2A2;RB1;QARS1
prerank,positive regulation of cell population proliferation (GO:0008284),0.4901772705112293,1.2690795262366117,0.007,0.5480729696823698,1.0,75/423,13.65%,PTPRC;CD86;PTK2B;SLAMF1;LYN;CXCL5;SHH;HCK;ITGAX;HPSE;TGFB1;HCLS1;FLT3;LGMN;CD74;RPL23;AQP1;CSF1R;TGFBR1;TCIRG1;MLXIPL;S100B;TNFRSF11A;DHX9;MDK;OSM;IL12RB2;TNF;IL6R;CNOT8;TIMP1;IL18;CCND2;FZD9;AIF1;GAB2;CCAR1;TGFBR2;RPS15A;PIM1;CCKBR;EPO;FLT3LG;MEF2C;CSNK2A1;KIF14;DOT1L;AQP11;KIF20B;TFAP2B;NTF3;GID8;CCL14;HSF1;PRKCH;LRP5;ACER3;HDAC4;NAP1L1;SOX9;THBS1;GRN;PHIP;PRDX3;SDCBP;CIAO1;CDK6;NOD2;NRG1;TBC1D8;STX3;BAMBI;PRLR;PID1;GAS6
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.6154944682988749,1.2683672133869186,0.2259810554803789,0.5495933083507478,1.0,3/13,7.22%,CD74;CD44;SNAI1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.5818788716054178,1.2676759434444076,0.1881918819188192,0.5510080910529742,1.0,6/23,12.65%,TGFB1;MAPK14;MYLK3;MYOCD;MEF2C;NRG1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.6542191354850702,1.2674929010437845,0.19616519174041297,0.5510315418117415,1.0,4/10,11.03%,ALOX12;PRKCD;CD9;SH2B3
prerank,prostanoid metabolic process (GO:0006692),0.6193292706909306,1.267009917316394,0.1937244201909959,0.551894941160158,1.0,2/13,4.59%,HPGDS;HPGD
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.5607004113522316,1.266721417742733,0.21428571428571427,0.5522292458419386,1.0,10/26,21.35%,ANAPC15;NEK6;ESPL1;CDC23;RB1;CDC6;ANAPC11;CUL3;NSMCE2;CDC16
prerank,vasculogenesis (GO:0001570),0.5535686941832767,1.266639187327859,0.19014891179839633,0.55189040098197,1.0,4/32,6.74%,SHH;TGFB1;CCM2;TGFBR2
prerank,blood circulation (GO:0008015),-0.33875655281057554,-1.266560421330214,0.06756756756756757,0.8250850645637539,1.0,15/49,12.31%,SGCD;ELN;SGCZ;SERPING1;COL4A3;ACVRL1;SOD1;HTR7;SCPEP1;ROCK1;ACE;CYB5R3;CXCL12;NOS3;GUCY1A1
prerank,regulation of cholesterol esterification (GO:0010872),0.6605291572982714,1.2658497225123697,0.22302158273381295,0.5536050831890271,1.0,5/10,20.15%,APOE;ABCG1;STARD4;LAMTOR1;ABCA2
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.5182117889061002,1.2657497331827674,0.11318795430944964,0.5533412457331256,1.0,9/75,8.27%,MRAP;CALCR;PLEK;GUCY2F;MGRN1;SAG;YWHAB;CNGB1;ZDHHC7
prerank,hexose metabolic process (GO:0019318),0.5395189689062758,1.2653005108559232,0.17324561403508773,0.5540438564470106,1.0,11/39,17.29%,KCNJ11;AKR1A1;ALDOB;BRAT1;SORD;FUCA1;TFAP2B;CHST15;PMM1;GALM;PPARD
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.4966468836900761,-1.2649349324904444,0.19112627986348124,0.8236995562439231,1.0,4/12,13.87%,REST;HES1;HNRNPU;JAG1
prerank,modulation by host of viral genome replication (GO:0044827),-0.4746736312764487,-1.2642867236165838,0.17647058823529413,0.8188023246589009,1.0,10/13,19.60%,NUCKS1;PPIB;IFI27;CCNK;FMR1;FBXL2;TBC1D20;EIF2AK4;ZC3H12A;VAPA
prerank,chemical homeostasis (GO:0048878),0.5108628764907739,1.26410278778498,0.16227608008429925,0.5569107481614375,1.0,13/61,11.34%,TREM2;ANGPTL3;CLN8;TENT4B;CEBPA;ABCB4;USF1;WNK1;AQP11;ABHD4;NEDD4L;VGF;SLC66A1
prerank,neural tube development (GO:0021915),0.5984588456386037,1.2640015004817464,0.21822849807445444,0.5566625543268094,1.0,2/15,4.08%,TGFB1;PKD2
prerank,regulation of integrin activation (GO:0033623),0.6050352531692442,1.2638792488500017,0.21586475942782835,0.5565073359589614,1.0,7/15,22.56%,PLEK;RAP1B;KIF14;SRC;FBLIM1;PIEZO1;SELP
prerank,cardiac atrium morphogenesis (GO:0003209),-0.44439978287183823,-1.2634126963944652,0.19004524886877827,0.8148468942885375,1.0,12/16,49.28%,HEY2;BMPR2;TGFB2;PROX1;DLL4;TBX20;NOG;MYH6;NOTCH2;ZFPM1;GATA4;ISL1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.532298323446636,1.2630988929842657,0.17089305402425578,0.5582485826112017,1.0,11/38,16.76%,CX3CR1;SIRPA;TNF;PKD2;P2RX4;SMAD3;NOS1AP;DDAH1;CD36;HSP90AA1;CD47
prerank,protein-containing complex assembly (GO:0065003),0.4920100533489513,1.2627075906475704,0.027,0.5588365922211286,1.0,64/259,16.64%,NCKAP1L;PTK2B;FERMT3;CD3E;BIN2;AIM2;CD74;SH3PXD2B;VAMP3;CTSC;P2RX7;SKAP2;DHX9;TLE3;SNX9;WIPF1;TNF;MITF;PPP6R1;TRAF2;TEAD1;CTNNB1;TRAPPC9;TP53;SLC9A1;LEO1;CAPZA1;HFE;MCFD2;CTSZ;PDCD6;HSF1;PPARGC1A;EPRS1;TUBGCP4;AMER1;RAB1B;RBBP5;SOX9;PYGO2;SEC24D;SEC16B;SEC16A;CSNK1A1;DET1;MDN1;F5;RANBP9;CASP8;STX5;IKBKG;TRAPPC6A;TSPAN4;DARS1;ADCY8;TRADD;LRRK2;PDZD11;CAPN3;GRIA1;AP2M1;BCL9;ZNHIT6;LPXN
prerank,zinc ion transmembrane transport (GO:0071577),-0.3924329706713264,-1.2626027246247478,0.17708333333333334,0.8108612860990385,1.0,9/22,26.09%,SLC39A13;SLC39A8;SLC30A1;SLC39A1;SLC39A14;SLC39A3;SLC39A10;SLC39A12;TRPM2
prerank,negative regulation of hydrolase activity (GO:0051346),0.5176700660446509,1.26233472752446,0.16344086021505377,0.5594044063446387,1.0,8/49,10.07%,KLRK1;FZD10;CST7;RASA4;ARFGEF1;WNK1;ATP5IF1;F11R
prerank,glucose homeostasis (GO:0042593),0.5071686255747767,1.2621596314229382,0.12615384615384614,0.5593712854520679,1.0,20/83,17.07%,HK3;LRRC8D;MLXIPL;FFAR2;CEBPA;USF1;TFAP2B;PPARGC1A;SLC8B1;ADIPOR1;FOXK1;ADCY8;HK2;MBD5;WFS1;SOX4;HIF1A;GCK;APPL2;ADIPOR2
prerank,positive regulation of programmed cell death (GO:0043068),0.4854923857317986,1.261773546423743,0.02902902902902903,0.5599204616149313,1.0,60/272,16.57%,FGD2;VAV1;LILRB1;IRF5;PREX1;SYK;ABR;PLEKHN1;CTSD;LAPTM5;TNFAIP8;VAV2;ARHGEF18;MTCH1;TNF;ATG7;SNCA;ITGA6;FOXO3;VAV3;PYCARD;FZD9;HMGB1;APAF1;CTNNB1;CCAR1;DNM2;GNA13;TP53;CRADD;KCNMA1;MAP3K5;FLCN;GADD45B;ITSN1;BAK1;STK17B;ARHGEF17;IAPP;HDAC6;TRIM35;UTP11;CTNNBL1;CASP8;ARHGEF3;STK3;TRADD;LRRK2;ARHGEF11;BMF;SOX4;PTPA;NF1;RPS6KA2;FANK1;TOP2A;MAP3K11;ARHGEF26;FAF1;STK4
prerank,blood vessel morphogenesis (GO:0048514),0.526462188037281,1.2616979044816592,0.15135135135135136,0.5595940708661182,1.0,15/54,17.11%,SHH;TGFB1;SYK;TGFBR1;ANGPTL3;CCM2;TGFBR2;LOX;LRP5;NRP1;CCBE1;NF1;RASA1;RBPJ;ADM
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.4888870582354537,-1.2605160575905925,0.17845117845117844,0.8109709355535506,1.0,8/11,30.83%,UQCRC2;UQCRH;UQCRC1;UQCRQ;CYC1;UQCRFS1;CYCS;UQCC3
prerank,response to nutrient levels (GO:0031667),0.5896775366201618,1.2600310267966344,0.21326397919375814,0.5637004321716533,1.0,2/17,4.50%,MTOR;CD68
prerank,regulation of translational initiation (GO:0006446),0.5052953020402391,1.259994541095008,0.1587802313354364,0.5632612739826263,1.0,15/63,10.60%,NCK2;DNAJC3;ATF3;EIF5B;YTHDF3;CEBPB;EIF4EBP2;LARP1;EIF1;EIF4H;IMPACT;CTIF;TPR;EIF2B2;EIF4G3
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.6433729624695554,1.259899974473135,0.2357142857142857,0.5624084156729675,1.0,6/10,17.76%,PCSK9;MYLIP;AP2S1;CLTC;AP2M1;VLDLR
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.6433729624695554,1.259899974473135,0.2357142857142857,0.5624084156729675,1.0,6/10,17.76%,PCSK9;MYLIP;AP2S1;CLTC;AP2M1;VLDLR
prerank,protein autophosphorylation (GO:0046777),0.49024146864539647,1.2596509071966786,0.07931726907630522,0.5625754959839049,1.0,40/157,18.77%,PTK2B;FGR;LYN;HCK;FLT3;MAPKAPK3;MAP4K1;TAOK3;CSF1R;MTOR;TEC;NEK6;ERN1;PRKD2;TAF1;MKNK1;STK10;PIM1;PIM2;TNIK;CHEK2;SMG1;STK17B;MAP2K2;TXK;MAP3K12;CAMKK2;STK24;LRRK2;BMX;SRC;MAP3K11;STK4;EPHA4;EPHA8;SIK2;PDPK1;TAOK1;VRK1;MINK1
prerank,negative regulation of apoptotic process (GO:0043066),0.4856722822447867,1.2588889382917847,0.009,0.5641800015384241,1.0,99/444,16.61%,NCKAP1L;TREM2;PTK2B;ASCL1;SHH;HCK;CX3CR1;CLEC5A;HCLS1;GATA1;PCID2;LGMN;CD74;CBL;AQP1;ALOX12;ADAM8;PRKCD;ANGPT4;NR1H4;TNFAIP8;DSTYK;MDK;NUP62;SEMA4D;TNF;FNIP1;SNCA;APOE;DNAJC3;CLN3;CCND2;CD44;FZD9;FZD3;CFLAR;ANXA1;CTNNB1;BCL2L1;TP53;PIM1;TAX1BP1;PIM2;PLK2;MALT1;MEF2C;CSNK2A1;CSNK2A2;KIF14;TPT1;TFAP2B;TRIM27;RB1;NTF3;ARHGAP10;PPARGC1A;PRKCH;MGMT;BABAM2;QARS1;ANXA4;SON;BNIP1;MAEA;SOX9;CCL2;THBS1;ANGPTL4;GRN;PHIP;PRDX3;MERTK;ITCH;PRDX2;PRLR;NFKB1;BRAF;ARHGDIA;RNF144B;RETREG1;GAS6;ATAD3A;AREL1;BAG1;WFS1;MIEN1;CAPN3;VDAC1;CPEB4;SRC;ERCC5;AHI1;MTDH;RASA1;TXNDC5;FANK1;NAA38;YME1L1;PRDX5
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6270453465309155,1.2583614652887487,0.22905027932960895,0.5651838257646261,1.0,3/11,10.69%,TGFB1;TP53;MAP2K2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.49008217119287173,1.2583113368000034,0.04312938816449348,0.5647874330418953,1.0,64/208,20.34%,TREM2;CARD11;CD74;PLCG2;GPRC5B;TRIM25;NR1H4;S100B;NUP62;NEK6;TSPAN6;NLRC3;TRIM5;TNF;UBE2V1;TANK;TRAF2;TNFAIP3;PYCARD;CASP1;MAP3K14;TRAF3;CFLAR;PRKCB;PIM2;PLK2;TICAM1;ATP2C1;MALT1;TRIM27;SLC44A2;ZDHHC13;LURAP1;LITAF;TRAF5;TRIM8;LGALS1;MID2;ALPK1;NOD2;TAB2;NLRX1;CASP8;IKBKG;TRADD;TMEM106A;DDX1;TAB3;CAPN3;MTDH;REL;TRIM62;UBE2N;RHOA;PDPK1;BIRC2;TNFSF10;EDA2R;PER1;RIOK3;OPTN;BIRC3;ZMYND11;HSPB1
prerank,positive regulation of cellular respiration (GO:1901857),0.6319271050928597,1.258287702534773,0.22772277227722773,0.564311558374938,1.0,2/11,4.55%,IL10RB;IFNAR1
prerank,plasma membrane repair (GO:0001778),0.6252706734020181,1.258151048560158,0.21466666666666667,0.5641543184769912,1.0,6/13,19.94%,MYH9;SYTL4;DYSF;AHNAK2;ARL8B;SMPD1
prerank,metal ion export (GO:0070839),0.5425705861781154,1.2579817076031328,0.1927570093457944,0.5640784646836852,1.0,7/31,13.94%,SLC11A1;ATP7A;KCNIP2;SLC9A1;ATP1B3;ATP1B2;KCNA5
prerank,cellular response to tumor necrosis factor (GO:0071356),0.491691822021395,1.2577643684958248,0.066,0.5641538994724496,1.0,43/175,18.82%,PTK2B;AIM2;NFE2L2;TNFRSF11A;DHX9;CCL8;TNF;OCSTAMP;TANK;TRAF2;TNFSF8;FOXO3;PYCARD;MAP3K14;TRAF3;PSMB10;ACTN4;TP53;TMSB4X;ERBIN;ST18;CCL14;TNFRSF21;TRAF5;LIMS1;PSMA2;CCL13;GBP3;CCL2;TNFRSF1B;PSME3;PID1;PSMB5;TRADD;PSMD8;PSMD7;PSMB9;CCL25;ASAH1;ARHGEF2;PSMD2;BIRC2;EDA2R
prerank,phosphate ion homeostasis (GO:0055062),0.6589006217662419,1.2574720451550525,0.2245762711864407,0.5645371037096567,1.0,2/10,9.69%,TFAP2B;XPR1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.4990263622989472,1.2570506538704997,0.1518324607329843,0.5651926802657293,1.0,20/67,16.67%,CYBB;NCF4;VAMP3;ITGB5;NCF2;FCGR1A;PSMB10;TAP1;PSMA2;PSME3;IKBKG;SNAP23;B2M;PSMB5;PSMD8;CD36;PSMD7;PSMB9;PDIA3;TAP2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5998504853763055,1.2570026769791036,0.22709163346613545,0.5647861419465373,1.0,5/16,9.67%,PIGM;PIGL;PIGX;PIGV;PIGH
prerank,cellular response to increased oxygen levels (GO:0036295),0.6282088472499378,1.2569726564943873,0.22252747252747251,0.5643331496912023,1.0,4/11,11.17%,ATG7;ATP6V0A2;ATP6V0D1;ATP6AP1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.49912936276789766,1.2566055303731085,0.14570230607966456,0.5648838071460205,1.0,21/70,16.67%,CYBB;NCF4;VAMP3;ITGB5;NCF2;FCGR1A;FCER1G;PSMB10;TAP1;PSMA2;PSME3;IKBKG;SNAP23;B2M;PSMB5;PSMD8;CD36;PSMD7;PSMB9;PDIA3;TAP2
prerank,phosphorylation (GO:0016310),0.4859516644762566,1.2564682949543124,0.012,0.5647449038055748,1.0,105/384,17.75%,PTK2B;BTK;FGR;LYN;GMFG;PIK3CG;HCK;TGFB1;SYK;DGKZ;RSKR;FNIP2;PIK3CD;MAP4K1;TAOK3;TGFBR1;TYK2;PRKCD;MTOR;TEC;BMP2K;PIK3CB;GRK3;NEK6;CDK14;ERN1;PRKD2;MYLK3;CDK8;DGKK;MORC3;TLK1;DGKE;TAF1;PRKCB;MKNK1;CDK11B;STK10;NADK;TGFBR2;PIM1;MAP3K5;WNK1;PLK4;CDK17;PIM2;CERK;PLK2;CSNK1G2;TNIK;CHEK2;CSNK2A1;DGKD;DGKG;MAP3K1;STRADB;CDK7;PRKCH;AGK;STK17B;FAM20C;RNASEL;PKN1;TXK;RPS6KA4;POMK;CCL2;NLK;PRKACB;CSNK1A1;CDK6;GRK4;FYN;MAP3K12;CREB1;MERTK;DGKI;LIPE;CAMKK2;BRAF;SHPK;GAS6;STK24;STK3;LRRK2;BMX;WNK4;NIM1K;TESK2;XYLB;SGK3;STRADA;GSK3A;CDK15;COQ8B;MAP3K11;GNPTAB;GK;STK4;PPP3CB;PIK3R4;CDK18;RPS6KA5;SIK2;PDPK1
prerank,defense response to tumor cell (GO:0002357),0.6348874915097582,1.2564401633794604,0.2272069464544139,0.5642795154690068,1.0,3/10,13.07%,LAPTM5;SPI1;PRDX2
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.5754294796049915,1.256423708173979,0.20024570024570024,0.5637914907349186,1.0,6/23,19.88%,GUCY2F;SAG;CNGB1;GRK4;METAP2;NMT1
prerank,actin cytoskeleton reorganization (GO:0031532),0.5076131899722469,1.2552978268811226,0.14345549738219895,0.5665137564477202,1.0,16/63,11.01%,PLEK;CASS4;GRB2;PTPN1;RAP2A;MICALL2;MYH9;ANXA1;NEDD9;TNIK;ATP2C1;THSD7B;BCAR1;NRP1;DTNBP1;PARVB
prerank,amino acid transport (GO:0006865),0.5149571257656945,1.2551865203463741,0.17270788912579957,0.5662935963159161,1.0,13/49,16.84%,SLC16A10;SLC7A7;SLC7A8;SLC38A6;SLC36A1;SLC38A4;SLC43A2;SLC6A15;SLC36A4;SLC38A10;SLC25A45;SLC1A4;SLC43A1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.5225355680804739,1.2549149350686342,0.16777041942604856,0.566573353393878,1.0,11/45,11.50%,TGFB1;NABP1;AURKAIP1;NME6;RGCC;FZD3;CTNNB1;PLK2;SMAD3;ANGEL2;TRIM35
prerank,nitrogen compound transport (GO:0071705),0.49557994567399544,1.254847803684917,0.06143001007049345,0.5662353927416475,1.0,20/141,11.09%,SLC6A3;SLC6A4;SLC11A1;SLC15A3;SLC16A10;AQP1;SLC52A1;LRRC8D;SLC7A7;SLC7A8;MYH9;RAB7A;SLC36A1;SLC38A4;RAMP1;SLC43A2;SLC44A2;SLC6A15;ABCC1;ARRDC4
prerank,negative regulation of protein binding (GO:0032091),0.5072637540129752,1.2545957532819765,0.14476386036960986,0.566466866635246,1.0,15/71,15.21%,ARRB2;BAG2;ITGA4;PRKCD;ACTB;TFIP11;DISC1;HFE;CTSZ;PSME3IP1;SORL1;B2M;ATP2A3;LRRK2;TLE5
prerank,inner ear morphogenesis (GO:0042472),-0.3987991085143868,-1.254551272505623,0.14427860696517414,0.8243842084675906,1.0,8/22,15.17%,MYO6;TTC39C;ZIC1;EPHB2;SIX1;TBX18;TBX1;PAX2
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4914548549418872,1.2545420296736622,0.13394683026584867,0.5660896877582362,1.0,31/93,18.86%,CALCR;TGFB1;HCLS1;FNIP2;MAD2L2;NSD1;MLXIPL;OSM;NCK2;TNF;FNIP1;SNCA;PRKD2;CD44;NTF3;PFN2;HDAC6;DDIT4;BRAF;GAS6;BCAR3;IRGM;PTEN;STK4;HSP90AA1;SPTBN4;AKAP9;CREBL2;PAQR3;CNKSR3;RPTOR
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.5215751560586492,1.2543937867355759,0.18082788671023964,0.5659878298410297,1.0,8/46,11.01%,FERMT3;ITGA4;ITGB3;VAMP3;MICALL2;KIF14;NRP1;PARVB
prerank,regulation of Ras protein signal transduction (GO:0046578),0.493002305002332,1.2543353154189163,0.1282051282051282,0.5656059851914916,1.0,20/85,14.12%,VAV1;LYN;RASAL3;GRB2;NUP62;ARHGEF18;MYO9B;EPO;ERBIN;DENND1A;KIF14;FLCN;DENND4B;ARHGDIB;DENND4C;RAPGEF1;DENND4A;SYNGAP1;ARHGDIA;ARF6
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.5167695835100046,1.2541426485879157,0.16916488222698073,0.5656223823859037,1.0,8/46,9.06%,DGKZ;DDHD1;LPCAT1;PLD2;DGKE;DGKD;DGKG;ABHD4
prerank,regulation of ERBB signaling pathway (GO:1901184),0.6250287908523848,1.2539424762515696,0.2106703146374829,0.565669820611962,1.0,7/15,16.73%,LGMN;PTPN18;RHBDF2;MVB12B;RBPJ;RHBDF1;PTPN12
prerank,chondrocyte differentiation (GO:0002062),0.5378454048587099,1.2535941507283705,0.20984759671746775,0.5661081128955503,1.0,8/32,13.72%,RUNX1;TGFB1;MEF2C;SULF2;CREB3L2;SOX9;SNX19;SOX6
prerank,regulation of blood coagulation (GO:0030193),0.5470747339601312,1.2535371278462835,0.21855921855921856,0.5657479519556764,1.0,3/27,4.04%,HPSE;GP1BA;APOE
prerank,endochondral bone morphogenesis (GO:0060350),-0.49592895819133176,-1.252666694357875,0.19112627986348124,0.8240492913658908,1.0,8/11,25.46%,FOXC1;BMP4;INPPL1;TRPV4;TMEM119;COL13A1;BMPR2;FGFR3
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.547684801366368,1.2523050757906202,0.19747416762342135,0.568788966967117,1.0,4/32,2.55%,TGFB1;CD300A;PRKCD;MTOR
prerank,cellular response to heat (GO:0034605),0.537095346678639,1.2517410708985903,0.19977298524404086,0.5698944034522991,1.0,12/35,18.38%,IL1A;ATXN3;HSBP1;PDCD6;HSF1;TPR;THBS1;RBBP7;STUB1;IER5;HSP90AA1;SLU7
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.493122305922838,1.2516847836455913,0.09337349397590361,0.5694891672326579,1.0,39/122,17.24%,CIITA;SMOC2;PPP1R3E;NLRC5;TLR2;NIBAN1;MTOR;DHX9;PRKD2;RGCC;PLXNB2;SLC25A37;CIRBP;YTHDF3;LARP4B;CPEB3;BRPF3;RPL26;CCL2;THBS1;STN1;ZCCHC4;METTL3;NOD2;DNA2;KAT7;NFKB1;PCIF1;POLDIP3;TMEM106A;UPF3B;HNRNPD;SOX4;BCAR3;FAF1;GCK;NOX1;IL33;RPS4X
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.50556573939948,1.2511324494485145,0.1720881427072403,0.5705281361811195,1.0,13/70,12.11%,FERMT3;ITGA4;ITGB3;VAMP3;MICALL2;SPI1;MEF2C;KIF14;RB1;ACTN1;NRP1;PARVB;METTL3
prerank,positive regulation of innate immune response (GO:0045089),0.5435441504175991,1.2511148570612305,0.2,0.5700381812817021,1.0,5/30,4.86%,NLRC5;ADAM8;DHX9;TLR8;SPI1
prerank,response to alcohol (GO:0097305),0.5637834307606395,1.2510780950498506,0.205158264947245,0.5696243165036999,1.0,4/27,6.74%,TGFB1;TGFBR1;SDF4;TGFBR2
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.43341303006507537,-1.251065795943514,0.1810344827586207,0.822679758667726,1.0,4/16,3.07%,ANK2;RYR2;UBAC2;BCAP31
prerank,regulation of protein export from nucleus (GO:0046825),-0.3930889676410678,-1.2503946735407332,0.16393442622950818,0.8183027280545038,1.0,7/23,7.73%,RAPGEF3;PTPN14;TCF7L2;SP100;ANP32B;BAG3;IFI27
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.5773484382469327,1.2503425794399017,0.20563035495716034,0.5711541404118685,1.0,4/20,5.63%,CCND3;PKD2;RGCC;CCND2
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.48892042206878666,1.2502607124029221,0.0592964824120603,0.5708477362537161,1.0,47/158,18.82%,CARD11;CD74;GPRC5B;TRIM25;S100B;NUP62;NEK6;TSPAN6;TRIM5;TNF;UBE2V1;TRAF2;CASP1;MAP3K14;CFLAR;PRKCB;PIM2;PLK2;TICAM1;ATP2C1;MALT1;TRIM27;SLC44A2;ZDHHC13;LURAP1;LITAF;TRAF5;TRIM8;LGALS1;MID2;ALPK1;NOD2;TAB2;CASP8;IKBKG;TRADD;TMEM106A;DDX1;TAB3;MTDH;REL;TRIM62;UBE2N;RHOA;BIRC2;TNFSF10;EDA2R
prerank,dephosphorylation (GO:0016311),0.48889506359825324,1.2502173427279994,0.08124373119358075,0.570434276765922,1.0,35/147,18.57%,PTPRC;PTPN7;PPM1H;DAPP1;PPP2CB;PTPRJ;DUSP3;PTPN1;DUSP29;PTPN18;PTPRE;MTMR3;PLPPR1;DUSP10;FRA10AC1;TIMM50;PTPRO;PTPRU;PPP2CA;ILKAP;SSH2;CTTNBP2NL;THNSL2;PXYLP1;PTPRT;PPP1CC;PTPRA;PTEN;PTPN12;PPP3CB;PPM1M;PTPN3;PPP2R5C;DUSP23;PPP4R2
prerank,protein dephosphorylation (GO:0006470),0.4913917997260437,1.2495095762193762,0.08559919436052367,0.5718841537938171,1.0,32/135,18.57%,PTPRC;PTPN7;PPM1H;UBASH3B;DAPP1;PPP2CB;PTPRJ;DUSP3;PTPN1;DUSP29;PTPN18;PTPRE;MTMR3;DUSP10;RPAP2;TIMM50;PTPRO;PTPRU;PPP2CA;ILKAP;SSH2;CTTNBP2NL;PTPRT;PPP1CC;PTPRA;PTEN;PTPN12;PPP3CB;PPM1M;PTPN3;PPP2R5C;PPP4R2
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.49577087829126143,1.2492453591091395,0.14375,0.5721246618416862,1.0,15/76,12.42%,CD86;LAPTM5;TLR2;TLR7;TSPAN6;NLRC3;TNF;SPI1;CD14;ADGRG3;ACTN4;TMSB4X;LIMS1;ADIPOR1;NOD2
prerank,positive regulation of ATP metabolic process (GO:1903580),0.5425801233633942,1.2485833098628594,0.1969872537659328,0.5734111693597312,1.0,10/32,16.89%,TREM2;P2RX7;MLXIPL;PFKFB4;TMSB4X;PPARGC1A;PID1;HIF1A;PFKFB3;GAPDHS
prerank,axonal fasciculation (GO:0007413),-0.4712726051007259,-1.247651542382614,0.16304347826086957,0.8207516731155091,1.0,4/12,4.87%,SEMA5A;ARHGAP35;EPHA3;EPHB2
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.6144016389078661,1.2475399139256307,0.2327823691460055,0.5758173349540535,1.0,5/13,14.55%,SPI1;ZMIZ2;ARID1A;ARID1B;ELOF1
prerank,histone lysine demethylation (GO:0070076),-0.37430959293267285,-1.2475237591864803,0.16666666666666666,0.8145443808407667,1.0,11/25,18.10%,PHF2;KDM5C;JMJD1C;KDM3A;KDM4B;KDM4A;KDM1B;KDM6A;KDM2A;KDM4D;KDM8
prerank,negative regulation of cell adhesion (GO:0007162),0.5031123560650802,1.2473784524944478,0.14822546972860126,0.5757206357372286,1.0,14/72,11.52%,PTPRC;TGFB1;PLXNC1;MDK;SEMA4D;TGFBI;PLXNB2;RIPOR2;SIPA1;SPINT2;PODXL;ARHGDIB;NF2;PTPRO
prerank,regulation of adenylate cyclase activity (GO:0045761),0.5708119813535689,1.247373117855814,0.20199501246882792,0.575201739405289,1.0,9/22,18.45%,CCR2;EDNRB;AKAP5;CAP1;LTB4R2;GNAI3;NF1;CACNA1D;GNAI2
prerank,positive regulation of cholesterol efflux (GO:0010875),0.5726818802750295,1.2471289737694475,0.22617534942820838,0.5753626123888964,1.0,6/21,15.52%,TREM2;APOE;EEPD1;GPS2;LRP1;ABCA3
prerank,mRNA stabilization (GO:0048255),0.5234707709520493,1.2465757779780748,0.19296254256526674,0.5764016592949108,1.0,7/40,9.60%,SLC11A1;DHX9;MAPK14;CIRBP;LARP1;TENT5C;ANGEL2
prerank,positive regulation of cell motility (GO:2000147),0.4850041397289425,1.2463841845176562,0.045090180360721446,0.5763972113615181,1.0,36/205,12.58%,PTK2B;FERMT3;GPNMB;FGR;ITGAX;TGFB1;CASS4;F10;VSIR;PIK3CD;CSF1R;TGFBR1;MGAT5;MDK;ANGPTL3;SEMA4D;ITGA6;LGR6;AIF1;CCAR1;MAPRE1;ACTN4;RIPOR1;SNAI1;NEDD9;FAM89B;NTF3;PTP4A1;BCAR1;ACTG1;PODXL;SEMA4A;THBS1;GRN;SDCBP;NUMB
prerank,ureteric bud morphogenesis (GO:0060675),0.5877980128160075,1.2463676242651616,0.23404255319148937,0.5759062727034929,1.0,2/16,4.08%,SHH;PKD2
prerank,intestinal lipid absorption (GO:0098856),0.6373131224500643,1.2461083419586578,0.23214285714285715,0.5761248665066407,1.0,3/11,15.32%,CEL;SOAT2;CD36
prerank,double-strand break repair via break-induced replication (GO:0000727),0.6264440908942113,1.2457255584046025,0.2276657060518732,0.5767136664867087,1.0,3/12,10.07%,MCM5;MCM2;MCM6
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.49729511207315924,1.2457090424761277,0.1545643153526971,0.5762342429890664,1.0,23/73,18.86%,CALCR;TGFB1;HCLS1;FNIP2;MAD2L2;OSM;TNF;FNIP1;SNCA;PRKD2;CD44;NTF3;PFN2;HDAC6;BRAF;GAS6;BCAR3;IRGM;STK4;HSP90AA1;AKAP9;CREBL2;RPTOR
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.5181693660827482,1.2456317269496127,0.20044543429844097,0.5759311847523417,1.0,8/39,10.66%,TGFB1;MAD2L2;RGCC;AKNA;WNK1;SPINT2;PODXL;NF2
prerank,regulation of cellular component movement (GO:0051270),0.5090792545997341,1.2453014431022589,0.1858974358974359,0.5763346859049236,1.0,13/49,14.37%,LYN;TGFBR1;CD9;ARAP1;ACTN4;ACTN1;DIAPH1;PKN1;HDAC6;CDK6;NRG1;ZSWIM6;ARHGAP18
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5141372116319126,1.244149401907204,0.19614147909967847,0.5791214166772763,1.0,13/44,18.56%,PCID2;AQP1;CST7;TNF;FNIP1;SNCA;CD44;CSNK2A1;THBS1;GAS6;SRC;DNAJB6;MAP2K5
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.5507775443619795,1.2433203591932238,0.20301624129930396,0.5809135905661862,1.0,9/26,16.75%,TNF;PKD2;P2RX4;SMAD3;NOS1AP;DDAH1;TMEM106A;CD36;HSP90AA1
prerank,neutral amino acid transport (GO:0015804),0.5414495255218695,1.2418268241182726,0.20794392523364486,0.5847569456942864,1.0,9/28,16.84%,SLC7A8;SLC38A6;SLC36A1;SLC43A2;SLC6A15;SLC36A4;CTNS;SLC1A4;SLC43A1
prerank,cellular iron ion homeostasis (GO:0006879),0.5089354902047198,1.2408007455885353,0.17164179104477612,0.587343154269306,1.0,9/55,11.40%,SLC11A1;FRRS1;ATP6V0A2;IREB2;ATP6V0D1;HFE;FTL;ATP6AP1;ACO1
prerank,presynaptic endocytosis (GO:0140238),0.5528841304833002,1.2400498872899792,0.20843672456575682,0.5890058392493631,1.0,7/24,12.60%,SNCA;PIP5K1C;CEL;SYT2;STON2;STON1;SYNJ1
prerank,regulation of ruffle assembly (GO:1900027),0.5593973459135791,1.2391685768429979,0.21972534332084895,0.5910848412141366,1.0,7/23,11.33%,STAP1;ARHGAP24;PLEKHM1;P2RX4;P2RY12;PFN2;PFN1
prerank,regulation of dendrite extension (GO:1903859),0.5762007612713005,1.2387891139942317,0.23366834170854273,0.5916158758111033,1.0,9/18,21.94%,SYT17;SYT2;NEDD4L;SMURF1;RASAL1;PLAA;UNC13A;RIMS1;ITSN2
prerank,response to muramyl dipeptide (GO:0032495),0.623155420516381,1.2385337828457674,0.2446236559139785,0.5918232792784154,1.0,3/12,12.42%,IRF5;ERBIN;NOD2
prerank,positive regulation of cellular process (GO:0048522),0.4787178725161151,1.238469339176881,0.002,0.5914739260133592,1.0,97/565,14.42%,CD86;DOCK2;TREM2;PTK2B;SLAMF1;LYN;CALCR;CXCL5;SHH;HCK;ITGAX;SLC11A1;TGFB1;FCGR2B;HCLS1;FLT3;LGMN;SIRPA;RPL23;CSF1R;TLR2;TGFBR1;ADAM8;PTPRJ;PRKCD;CAMK1D;TCIRG1;P2RX7;MLXIPL;S100B;TNFRSF11A;MDK;OSM;IL12RB2;CST7;TNF;FCER1G;PRKD2;IL6R;CNOT8;BRAT1;PYCARD;TIMP1;P2RX4;CCND2;AIF1;GAB2;CCAR1;TGFBR2;ACTN4;RPS15A;TAL1;CCKBR;P4HB;EPO;FLT3LG;CSNK2A1;KIF14;DOT1L;FLCN;AQP11;KIF20B;TFAP2B;NTF3;GID8;CCL14;HSF1;LRP5;ACER3;HDAC4;NAP1L1;RNF10;SOX9;THBS1;TNFRSF1B;GRN;PHIP;DYNC1H1;PRDX3;SDCBP;CIAO1;ADGRG1;NRG1;TBC1D8;MERTK;STX3;BAMBI;PRLR;INO80;GAS6;HCFC1;ZFHX3;CDC6;IL2RG;LRP1;FASN;MEIS1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.585199929498814,1.2381711109393871,0.24101198402130491,0.5918350693450963,1.0,5/15,13.79%,PTTG1;NEK6;CDC23;TPR;CDC6
prerank,actin filament network formation (GO:0051639),0.6141861146042149,1.2380700998737293,0.24964131994261118,0.5915764030441336,1.0,4/11,10.23%,LCP1;PLS1;FHOD1;ACTN1
prerank,positive regulation of protein processing (GO:0010954),0.5811893135383625,1.2379354241938316,0.23809523809523808,0.5914363029335006,1.0,5/19,15.46%,BAG2;ADAM8;MYH9;CCBE1;PLGRKT
prerank,aromatic amino acid family metabolic process (GO:0009072),0.6334213466528751,1.2378080419389454,0.2503597122302158,0.5912505759190478,1.0,3/10,8.93%,ATP7A;KYNU;QDPR
prerank,cellular response to chemical stress (GO:0062197),0.48904254243977824,1.2374716860511095,0.13715455475946775,0.5916835755667965,1.0,29/96,18.60%,CYBB;NCF4;NFE2L2;LRRC8D;NCF2;ATG7;SNCA;PKD2;FOXO3;TXNRD1;AIF1;LONP1;PPARGC1A;PRDX1;PYCR2;MSRA;PRDX3;PRDX6;PRDX2;LRRK2;CPEB2;PRDX5;ERO1A;NOX1;GPX8;PYROXD1;STX2;KEAP1;GSR
prerank,negative regulation of myoblast differentiation (GO:0045662),0.602766198546622,1.2374618101853663,0.22814207650273224,0.5911736280368773,1.0,3/13,11.27%,TGFB1;SOX9;SRA1
prerank,negative regulation of potassium ion transport (GO:0043267),0.6061140812348003,1.2374348564335873,0.23119015047879618,0.5907103677704585,1.0,1/13,0.33%,PTK2B
prerank,organic hydroxy compound transport (GO:0015850),0.5312536579171557,1.2374057739076196,0.2056818181818182,0.5902535491921576,1.0,9/36,18.47%,SLCO2B1;NR1H4;ABCC3;NPC2;SLC16A1;OSBP;SLCO1B1;STARD5;RXRA
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.5158005126040623,1.2373667591037645,0.20044052863436124,0.5898432362281937,1.0,9/46,14.11%,PTK2B;CCR2;DGKZ;TNF;CLN3;MEF2C;CCL2;DGKI;LRRK2
prerank,glycerophospholipid catabolic process (GO:0046475),0.5427861523462737,1.237308721555992,0.2109004739336493,0.5894867522911587,1.0,12/27,23.92%,ABHD12;LIPC;PLA2G7;PRDX6;GDE1;ABHD16A;GDPD3;PLA2G5;GPCPD1;PLA2G4E;PLA2G6;INPP5F
prerank,regulation of mRNA metabolic process (GO:1903311),0.6154772797266754,1.237145732594621,0.2566995768688293,0.5894305159593031,1.0,4/11,13.39%,DHX9;CDK11B;SRPK3;SAFB2
prerank,protein localization to membrane (GO:0072657),0.4813540574436635,1.2370975886570474,0.06412825651302605,0.5890583208871337,1.0,34/187,10.73%,MRAP;ITGAL;FYB1;RFTN1;ITGB2;RAB8B;SH3PXD2B;ITGA4;RAB34;MYO5A;THY1;RAB32;RABEP1;FGF13;RAP2A;PKP2;TNF;TTC7A;NPC1;AP3D1;TSPAN32;AGRN;PACS1;TNIK;RAMP1;TSPAN14;ARL5B;RAB11A;RAB40C;F11R;DENND4C;TM9SF2;ZDHHC3;CACNB2
prerank,positive regulation of establishment of protein localization (GO:1904951),0.5683213773767293,1.2367018783779513,0.23941798941798942,0.5896304084697841,1.0,3/18,8.55%,TREM2;TNF;CCT8
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.6146355618585443,1.2365926955677748,0.2247191011235955,0.5894229460622303,1.0,2/12,3.79%,TGFB1;TNF
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.6217088791234031,1.236467091849151,0.2528248587570621,0.5892566500923521,1.0,3/12,9.63%,APOBEC1;RESF1;ATF7IP
prerank,positive regulation of protein catabolic process (GO:0045732),0.4904727292520477,1.2364575966750315,0.1499482936918304,0.5887507289406098,1.0,33/84,21.05%,ADAM8;SNX9;TNF;ATG7;APOE;SNX33;TNFAIP3;RAB7A;PLK2;CSNK2A1;VPS11;AMER1;NEDD4L;FZR1;TNFRSF1B;ITCH;STX5;SORL1;TIPARP;HUWE1;AREL1;GSK3A;SMURF1;IDE;FAF1;HSP90AA1;FURIN;VPS28;DACT1;SEC22B;GSK3B;WWP1;PRKN
prerank,calcium import into the mitochondrion (GO:0036444),-0.5277403031639578,-1.2356492048925591,0.22115384615384615,0.8490631193312284,1.0,4/10,17.66%,AFG3L2;MICU1;MCUR1;SLC25A23
prerank,regulation of lipid catabolic process (GO:0050994),0.5738478722608475,1.2354981901323556,0.25251256281407036,0.5909867326458779,1.0,3/19,7.38%,ANGPTL3;TNF;ABCD1
prerank,positive regulation of organelle organization (GO:0010638),0.5323334686095818,1.2352956095847918,0.20530565167243367,0.5910099342587553,1.0,11/32,20.32%,TREM2;P2RX7;RAB3GAP2;ANXA1;PPARGC1A;UVRAG;SYNJ1;IRGM;PLA2G5;ATL3;GSK3B
prerank,regulation of intracellular signal transduction (GO:1902531),0.4763218817439729,1.2340322869478322,0.011,0.5941100154315391,1.0,102/420,19.09%,ARHGAP45;ARHGAP30;FGD2;VAV1;TREM2;LYN;ARHGAP25;PREX1;ARHGAP9;ABR;ARHGAP15;ARHGAP39;PRKAR2B;TAOK3;ARHGAP22;PLCG2;MTOR;ARHGAP24;VAV2;RFFL;ARHGEF18;MAPK14;MAP2K6;ARAP1;TNF;PRKD2;PIP5K1C;TRAF2;PIP4K2A;RMI1;VAV3;PYCARD;AKAP5;EXO1;TRAF3;FAM13B;WWC2;TAGAP;BRIP1;TAF1;MYO9B;GNA13;TP53;GNA12;TMSB4X;TNIK;CHEK2;CSNK2A1;CSNK2A2;FLCN;ITSN1;ARHGAP21;ARHGAP10;ARHGAP1;ATP6AP2;TRAF5;CMKLR1;ARHGDIB;ARHGEF17;NF2;USP7;RBBP7;DNA2;DDIT4;PIP4P1;IKBKG;RRS1;ARHGDIA;ARHGEF3;STK3;LRRK2;NOC2L;ARHGAP18;BRD7;ARHGEF11;LBH;TMEM127;CAPN3;PHLPP1;A2M;TAF3;TTI1;RPL11;ARHGEF26;PTEN;STK4;ARHGAP23;ARHGEF2;SGMS1;CDC42;MEAF6;RHOA;PDPK1;TAOK1;PPP2R5C;PTPMT1;BIRC2;MINK1;CHD4;RHOD;TAF11;CHN2
prerank,positive regulation of dendrite extension (GO:1903861),0.5794193861795112,1.234015340890098,0.23596938775510204,0.5936366148699442,1.0,9/17,21.94%,SYT17;SYT2;NEDD4L;SMURF1;RASAL1;PLAA;UNC13A;RIMS1;ITSN2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.48457548119487537,1.2332942469926331,0.12170385395537525,0.5951483399769141,1.0,25/114,15.82%,PTK2B;AIM2;TNFRSF11A;TNF;TRAF2;TNFSF8;FOXO3;PYCARD;MAP3K14;TRAF3;PSMB10;ACTN4;TP53;TMSB4X;ST18;TRAF5;LIMS1;PSMA2;TNFRSF1B;PSME3;PSMB5;TRADD;PSMD8;PSMD7;PSMB9
prerank,entry into host (GO:0044409),0.6195153216490921,1.2331356079287414,0.2446236559139785,0.5950709864264465,1.0,4/13,6.34%,CBL;GRB2;CXCR4;CTNNB1
prerank,phosphatidic acid metabolic process (GO:0046473),0.5073489348000293,1.2328931454542997,0.1873661670235546,0.5952266339027487,1.0,8/48,9.06%,DGKZ;DDHD1;LPCAT1;PLD2;DGKE;DGKD;DGKG;ABHD4
prerank,actin filament polymerization (GO:0030041),0.5397127458978499,1.2328713420556823,0.22273781902552203,0.5947548503901771,1.0,6/29,10.96%,PREX1;PSTPIP1;MICALL2;AIF1;WASHC3;DIAPH1
prerank,apical junction assembly (GO:0043297),-0.301931584943387,-1.232800838854249,0.09433962264150944,0.8519360810444326,1.0,11/53,10.43%,CDH5;AFDN;PRKCI;PARD3;CLDN5;CLDN11;MPP7;WDR1;PARD6G;CLDN14;DLG1
prerank,pentose-phosphate shunt (GO:0006098),0.6223989461502075,1.2324043506992335,0.2545968882602546,0.5955692476216561,1.0,5/11,19.61%,RPE;SHPK;PGLS;PGD;RBKS
prerank,RNA catabolic process (GO:0006401),0.5153251111600198,1.232152590682079,0.1967741935483871,0.5957965466163075,1.0,24/46,26.91%,SLFN14;ERN1;SND1;ZC3H12D;AGO4;AGO3;RNASEH1;METTL3;DNA2;HNRNPD;PABPC4;RNASEH2A;DIS3L2;RNASE6;NUDT12;ZPR1;DCP2;SIDT2;XRN2;NCBP1;DXO;RNASE3;LSM6;SUPV3L1
prerank,endomembrane system organization (GO:0010256),0.48523693072424867,1.23208108216804,0.06813627254509018,0.5954970190484927,1.0,63/178,20.74%,HOOK3;PLEKHM2;SPTBN5;ATP8B4;SRGN;LMAN1L;TMED3;REEP6;SNX33;PI4K2A;VPS18;ARFGEF1;AP3D1;SYNE1;USP6NL;VMP1;DNAJC13;VPS11;ARHGAP21;ARFGEF2;WASHC4;VAPB;SYNGR1;SYNGR2;BNIP1;TMCC1;DYSF;ATL1;SEC16B;SEC16A;EXOC8;PI4K2B;CSNK1A1;TOR1AIP2;TOR1A;HOOK2;LRRK2;HUWE1;TRAPPC11;GAK;USP8;ALS2;LMAN2;LAMTOR1;CDC42;SNX10;UBXN2A;LYSMD3;VPS33B;GOLGB1;GOLPH3;ATL2;TMEM170A;SEC31A;LAPTM4B;RAB29;OPTN;DNM1L;TRAPPC12;ATL3;COG7;SPTSSB;NSFL1C
prerank,actin filament depolymerization (GO:0030042),-0.48210908312286754,-1.231753718976958,0.24814814814814815,0.8485682517020895,1.0,5/11,8.39%,GSN;CFL2;WDR1;MICAL3;MICAL2
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.5606355797587189,1.2316047210162862,0.23627075351213284,0.5963085671204434,1.0,6/21,13.63%,ADCY7;GUCY2F;ADCY6;NPR2;ADCY8;ADCY3
prerank,retinoic acid metabolic process (GO:0042573),-0.43954050304257686,-1.2311526806577402,0.17142857142857143,0.8442353965527267,1.0,8/14,50.61%,SCPEP1;ALDH1A2;ADH1A;CYP2S1;BCO2;ALDH8A1;CYP26C1;CYP26B1
prerank,cellular response to organonitrogen compound (GO:0071417),0.4874431156061662,1.2306182223826063,0.13993871297242083,0.5986401727352971,1.0,35/99,21.39%,P2RY6;AQP1;HCN4;NR1H4;P2RX7;MTOR;P2RY2;PKD2;RAP1B;P2RX4;TAF1;CTNNB1;ACTB;P2RY12;MEF2C;LARP1;IMPACT;CPEB3;DIAPH1;RAPGEF1;SOX9;GLRA2;LAMTOR3;CAPN2;RAP1A;CPEB4;LAMTOR1;AKAP9;GOLPH3;RPTOR;P2RY1;ZFP36L1;INPP5K;HCN1;RRAGA
prerank,positive regulation of autophagy (GO:0010508),0.4907005404862354,1.230482758404206,0.16632231404958678,0.5985108628620274,1.0,24/81,16.24%,PIK3CB;TRIM5;FOXO3;HMGB1;SCOC;TFEB;PIM2;SVIP;PLK2;TICAM1;FLCN;TRIM27;LARP1;PAFAH1B2;TRIM8;MID2;IKBKG;CAMKK2;LRRK2;GNAI3;RNF152;MTDH;GSK3A;IRGM
prerank,positive regulation of protein import into nucleus (GO:0042307),0.5279356711886876,1.2304086475020033,0.22531939605110338,0.5981999305634557,1.0,5/28,10.17%,TGFB1;HCLS1;PRKCD;SMAD3;TPR
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6328158416075611,1.2302514677952858,0.2451523545706371,0.5981123294776829,1.0,3/10,6.25%,ITGB3;PRKD2;PRKCB
prerank,skeletal muscle contraction (GO:0003009),0.566550610556308,1.230093431377733,0.228643216080402,0.5980349186852099,1.0,4/19,15.31%,STAC;TNNT3;STAC3;RCSD1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.5434557093306508,1.2289720710174108,0.22380952380952382,0.6007693015608064,1.0,11/26,22.12%,PIK3CB;TNF;APOE;ATP7A;GCH1;NOS1AP;POR;HIF1A;GDNF;TERF2;CDH3
prerank,synaptic vesicle membrane organization (GO:0048499),0.5840022462069097,1.2289326231626088,0.24281984334203655,0.6003245217958635,1.0,9/17,17.81%,STX11;AP3D1;SNAP29;SYNGR1;SYNGR2;STX3;SNAP23;TOR1A;STX2
prerank,positive regulation of ERAD pathway (GO:1904294),0.6008569970032157,1.2287908486440864,0.23055555555555557,0.6002044126396304,1.0,3/13,6.54%,NFE2L2;HERPUD1;ATXN3
prerank,negative regulation of biosynthetic process (GO:0009890),0.5909520136214569,1.2287270479282828,0.26613965744400525,0.5998763625736371,1.0,3/16,7.85%,CIITA;ABCD1;TRAP1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.6300319517071417,1.228309168021766,0.26500732064421667,0.600010501218903,1.0,2/10,6.82%,REEP6;CNGB1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.6300319517071417,1.228309168021766,0.26500732064421667,0.600010501218903,1.0,2/10,6.82%,REEP6;CNGB1
prerank,response to tumor necrosis factor (GO:0034612),0.4905456187397688,1.2281387189454733,0.16276703967446593,0.5999763114324531,1.0,26/91,21.53%,NFE2L2;TNFRSF11A;DHX9;CCL8;OCSTAMP;GCH1;TANK;PYCARD;ERBIN;CCL14;TNFRSF21;CCL13;GBP3;CCL2;CASP8;PID1;TRADD;CXCL16;CCL25;ASAH1;ARHGEF2;SMPD1;ZFP36L1;INPP5K;BAG4;CX3CL1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.4306908970116201,-1.2280968044262364,0.21008403361344538,0.8481637784904168,1.0,6/17,8.52%,PIK3R3;EPHB4;EFNB2;ROBO1;SLIT2;GPLD1
prerank,heart morphogenesis (GO:0003007),-0.3149884052567965,-1.2275658271830994,0.109375,0.8434809405716456,1.0,14/50,13.52%,BMPR1A;RYR2;NIPBL;EPHB4;ACVR1;TGFBR3;ACVRL1;TBX3;FKBP1A;HES1;OLFM1;TBX1;NOS3;SOX17
prerank,transcription by RNA polymerase I (GO:0006360),0.5224248793846066,1.2275545394916545,0.20296465222348917,0.6010580721910337,1.0,8/34,10.95%,GTF2H1;TAF1A;POLR1E;TAF1;TTF1;CDK7;POLR1B;POLR2L
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.6233062559938338,1.2275368634410964,0.2510822510822511,0.600583209360368,1.0,2/10,4.11%,MAD2L2;RGCC
prerank,positive regulation of protein secretion (GO:0050714),0.49963755158332845,1.2274007587049005,0.16856256463288521,0.6005006843513858,1.0,7/69,4.35%,TREM2;TGFB1;IL1A;TLR2;ADAM8;ABCG1;TTN
prerank,protein localization to microtubule organizing center (GO:1905508),0.5964810653387462,1.2272734527666413,0.2529335071707953,0.6003108051964129,1.0,2/15,6.47%,HOOK3;CEP192
prerank,basement membrane organization (GO:0071711),0.6130775104502815,1.2267019233712093,0.250334672021419,0.6013992896283349,1.0,1/14,0.14%,CTSS
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.5232606918073394,1.22591872492474,0.19383259911894274,0.6030774177469064,1.0,6/39,5.20%,PIK3CG;PIK3CD;PIK3CB;PIP4K2A;PI4K2A;TTC7A
prerank,presynapse assembly (GO:0099054),-0.42890310850078395,-1.2257698837857003,0.2345679012345679,0.8431291477282455,1.0,5/16,8.45%,NLGN1;IL1RAPL1;WNT5A;BSN;LRRTM3
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.5776015173179614,1.2255901960963362,0.2563758389261745,0.6034903277155202,1.0,3/15,11.96%,SLFN14;ZC3H12D;RNASEH1
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.6358005707165895,1.2252299372048245,0.26138032305433184,0.6040186356806205,1.0,2/10,11.73%,TGFB1;TNFRSF1B
prerank,regulation of ERAD pathway (GO:1904292),0.597836474631006,1.2246581208015668,0.2669491525423729,0.6051252251864817,1.0,3/11,8.26%,HERPUD1;ATXN3;AQP11
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5736631933184417,1.2245908311864946,0.25,0.604766046995806,1.0,7/17,20.04%,LPL;ANGPTL3;LIPC;ANGPTL4;HDAC9;FURIN;SORT1
prerank,primary alcohol metabolic process (GO:0034308),0.5475347406486653,1.2243249213876324,0.22128174123337363,0.6050629045695453,1.0,5/25,15.61%,CYP1A1;DHRS3;RETSAT;GDE1;GDPD3
prerank,embryonic eye morphogenesis (GO:0048048),-0.4892471637927345,-1.2242618457692034,0.24912280701754386,0.8421025860764588,1.0,3/11,8.80%,EFEMP1;MFAP5;FBN1
prerank,fatty acid metabolic process (GO:0006631),0.478928383004221,1.2241407304252379,0.13883299798792756,0.6050901331011062,1.0,24/115,17.96%,CYP1A1;LPL;LPIN2;SGPL1;ALOX12;ANGPTL3;CEL;HPGD;NUDT19;LIPC;PON3;ACSF2;PPARGC1A;ADIPOR1;NDUFAB1;FASN;CD36;ACACA;CPT2;ADIPOR2;PNPLA3;PPARD;ACOT2;ABCD2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.5812197107681707,1.2240583597817363,0.25161290322580643,0.6048018355017889,1.0,5/16,9.16%,PIK3CB;TNF;APOE;GCH1;NOS1AP
prerank,digestive tract development (GO:0048565),-0.35222354985524407,-1.223829900501244,0.15503875968992248,0.8372599262363298,1.0,13/32,14.56%,COBL;PCSK5;NIPBL;SALL1;GLI2;GLI3;SMO;GLI1;CCDC39;PKDCC;CHD8;STRA6;RARB
prerank,tight junction assembly (GO:0120192),-0.30399314699820074,-1.2237673077491595,0.12857142857142856,0.8312284658018031,1.0,11/49,11.48%,CDH5;AFDN;PRKCI;PARD3;CLDN5;CLDN11;MPP7;PARD6G;CLDN14;DLG1;CLDN12
prerank,regulation of transport (GO:0051049),0.5204907081726922,1.2236084074499607,0.22085201793721973,0.6055572554636554,1.0,11/36,14.73%,SNCA;REEP6;ACTB;GAPVD1;ACTG1;RAB11A;EPB41;NRP1;ICA1L;LRRK2;YRDC
prerank,positive regulation of protein metabolic process (GO:0051247),0.47931050042870654,1.2233002351619295,0.1243680485338726,0.6058908562174966,1.0,35/110,20.39%,CD86;TGFB1;TNF;ATG7;APOE;SLC25A37;TNFAIP3;IL18;RAB7A;CD80;PLK2;CSNK2A1;NEDD4L;RAB1B;INHBA;FZR1;RANBP9;ITCH;STX5;SORL1;TIPARP;HUWE1;AREL1;WFS1;GSK3A;SMURF1;IDE;VPS28;DACT1;MAP2K5;ROCK2;SEC22B;ABCA2;GSK3B;WWP1
prerank,detection of visible light (GO:0009584),0.5832055679324127,1.2232640638564163,0.24489795918367346,0.6054676357868833,1.0,4/16,12.98%,GNAQ;REEP6;CNGB1;ABCA4
prerank,cartilage development (GO:0051216),0.5000520668823644,1.2231071768217283,0.21405405405405406,0.6054024013855245,1.0,9/49,11.67%,RUNX1;TGFB1;ATP7A;CD44;MEF2C;SULF2;CREB3L2;SOX9;SNX19
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.48654875305575646,1.2229017228383123,0.1748971193415638,0.6054595315132906,1.0,21/80,15.20%,VAMP3;TBC1D10C;SNX5;TMEM87B;HEATR5A;RBSN;RAB7A;RAB7B;TMEM87A;TBC1D10A;TRIM27;VPS54;TBC1D17;CLTC;YKT6;STX5;VPS29;VTI1A;SNX2;HEATR5B;TBC1D14
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.6026253644215399,1.2226680704828867,0.24362606232294617,0.6056012609267262,1.0,5/11,18.60%,VAPB;BNIP1;ATL1;RTN4;ATL2
prerank,protein localization to centrosome (GO:0071539),0.5830474736949919,1.222607119207444,0.2635561160151324,0.6052439012902503,1.0,6/17,18.46%,HOOK3;CEP192;PCM1;NUDCD3;SNX10;GOLGB1
prerank,regulation of melanin biosynthetic process (GO:0048021),0.6214989325780781,1.2219276309463307,0.2614942528735632,0.6066511750453301,1.0,5/10,22.12%,ZEB2;ATP7A;CTNS;GIPC1;CDH3
prerank,epithelial tube morphogenesis (GO:0060562),0.5315891374265721,1.2218082271868191,0.22701475595913734,0.6064713731974837,1.0,9/32,9.88%,SHH;CSF1R;CCM2;PRKD2;PKD2;CTNNB1;MTSS1;MEF2C;PODXL
prerank,protein localization to organelle (GO:0033365),-0.26157100748473405,-1.2210675580870853,0.0,0.8342636671760583,1.0,42/133,17.36%,APP;ANK2;RAB6A;UBAC2;BMP4;LMBRD1;SSB;ZNF423;ARL3;CEP250;ATP6V1D;YBX1;TOLLIP;PAF1;CALR;GCC2;BBS4;ARL6;EHD1;TRAM1;SCG3;ALDH3A2;ARL1;SIX1;TOPORS;SEC61G;BBS2;XPA;GBP2;CTDNEP1;WDR35;EMD;DNAJA1;SERP1;SEC61B;IFT20;AUP1;LMNA;MTCH2;COL1A1;LAMP2;GET4
prerank,fatty acid biosynthetic process (GO:0006633),0.4973968536193439,1.220881584538622,0.18803418803418803,0.6086028003071756,1.0,12/63,15.95%,CYP1A1;LPL;ALOX12;HPGD;LIPC;ABCD1;HACD4;ABHD3;NDUFAB1;ACACA;DEGS1;FADS1
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.5759104579242773,1.220689309817879,0.25611325611325614,0.6086337798201729,1.0,3/18,5.89%,PYCARD;IL18;HMGB1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.5580272076053507,1.2204544686372056,0.25925925925925924,0.608791537259254,1.0,3/21,6.30%,LPIN2;CEL;NUDT19
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.5476296010663152,1.2201786046636836,0.24600246002460024,0.6090039641040439,1.0,4/22,7.31%,THY1;TNF;CD44;WNK1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.5377228670407799,1.2198529862903658,0.259478672985782,0.6094090411413303,1.0,5/26,9.25%,LGMN;SMOC2;DUSP3;TAL1;HSF1
prerank,regulation of intracellular protein transport (GO:0033157),0.5324976345356408,1.2194869991468977,0.21169590643274855,0.6098656121054673,1.0,7/32,12.28%,TGFB1;LCP1;PTPN1;RIPOR1;KIF20B;TPR;PCM1
prerank,dopamine metabolic process (GO:0042417),0.5777966211479031,1.2189322728289638,0.24433249370277077,0.6109286159677131,1.0,5/18,15.09%,SNCA;ATP7A;GCH1;COMT;MAOA
prerank,positive regulation of vasculature development (GO:1904018),0.48325551901813496,1.2187596776676226,0.16191446028513237,0.6108797164545281,1.0,16/94,11.82%,RUNX1;ITGAX;IL1A;SMOC2;PIK3CD;AQP1;ANGPT4;ANGPTL3;PRKD2;PDCL3;PRKCB;VEGFB;PDCD6;THBS1;ANGPTL4;GRN
prerank,regulation of brown fat cell differentiation (GO:0090335),0.582457979338196,1.218660562298893,0.2675496688741722,0.6105926665650367,1.0,7/16,19.40%,METRNL;RREB1;PIM1;FLCN;VSTM2A;ZBTB7B;FTO
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5296322904191623,1.2185584802137477,0.23910482921083628,0.6103325584697632,1.0,10/30,20.32%,RFFL;TRAF2;TNFAIP3;CFLAR;BCL2L1;CASP8;TRADD;ARHGEF2;TNFSF10;GSK3B
prerank,regulation of keratinocyte migration (GO:0051547),0.615800839507626,1.2177064446529673,0.2610497237569061,0.6121948244964873,1.0,6/12,19.76%,MTOR;ARF6;PTEN;MAPRE2;IQSEC1;MAP4K4
prerank,negative regulation of viral entry into host cell (GO:0046597),0.6068060160653701,1.2175839392749768,0.2543352601156069,0.6120288351405834,1.0,2/12,3.66%,CIITA;TRIM5
prerank,negative regulation of programmed cell death (GO:0043069),0.46920984712785246,1.2175335940639171,0.025,0.6116468178060316,1.0,74/355,16.61%,NCKAP1L;TREM2;PTK2B;ASCL1;SHH;HCK;CLEC5A;GATA1;PCID2;CD74;CBL;LAPTM5;AQP1;ANGPT4;NR1H4;TNFAIP8;DSTYK;NUP62;SEMA4D;SNCA;DNAJC3;CLN3;RAB7A;CCND2;CD44;CFLAR;ANXA1;CTNNB1;BCL2L1;TP53;PIM1;TAX1BP1;PIM2;PLK2;MALT1;KIF14;TPT1;TFAP2B;ARHGAP10;MGMT;BABAM2;ANXA4;SON;BNIP1;SOX9;THBS1;ANGPTL4;PHIP;PRDX3;ITCH;PRDX2;PRLR;NFKB1;BRAF;ARHGDIA;RNF144B;GAS6;ATAD3A;AREL1;BAG1;WFS1;MIEN1;CAPN3;VDAC1;SRC;ERCC5;AHI1;MTDH;RASA1;TXNDC5;FANK1;NAA38;YME1L1;PRDX5
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.6215048953512421,1.2172733782629537,0.2531824611032532,0.6118716667939633,1.0,2/11,7.51%,IL12RB2;STAT4
prerank,positive regulation of hydrolase activity (GO:0051345),0.4745979742727165,1.2171899438017177,0.1383838383838384,0.6116019212034397,1.0,38/137,18.44%,DOCK8;RGS10;FZD10;THY1;SNX9;ARAP1;PSAP;CCL8;SEMA4D;ITGA6;RASGRP2;USP6NL;DOCK11;DOCK10;AGRN;FLCN;CCL14;F11R;TBC1D2;LIMS1;RAPGEF1;CCL13;CCL2;ARHGAP27;MMUT;RAP1A;BCAR3;NF1;GNB5;ALS2;RGS1;SNX13;CCL25;SNX18;RHOA;PICALM;MAPRE2;ITGB1
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.5593161742916153,1.2170166833044977,0.2669220945083014,0.6115869855905136,1.0,3/18,4.10%,GSAP;TNF;ABCG1
prerank,organic cation transport (GO:0015695),-0.3917490245767856,-1.2168682855684234,0.19047619047619047,0.8423214414649621,1.0,9/20,28.08%,SLC47A1;RALBP1;SEC14L1;SLC25A42;SLC5A7;SLC25A19;SLC22A2;SLC25A29;SLC25A26
prerank,regulation of cardiac muscle contraction (GO:0055117),0.5195568173183882,1.2167051039738106,0.21764032073310424,0.6119541476029444,1.0,5/34,7.13%,PIK3CG;HCN4;SLC8A1;P2RX4;SLC9A1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.49041271413497567,1.2166307173620705,0.2142099681866384,0.6116324893848641,1.0,14/59,13.20%,CSF1R;MED17;MITF;CDK8;CTNNB1;TP53;TNRC6A;CEBPB;MOV10;AGO4;MED27;SOX9;AGO3;NFKB1
prerank,regulation of myoblast differentiation (GO:0045661),0.5323805203831675,1.2164151601609945,0.22811059907834103,0.6117461637955566,1.0,7/32,11.27%,TGFB1;MAPK14;RIPOR2;MEF2C;AKIRIN1;SOX9;SRA1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.5897341118758594,1.216379505237213,0.2591145833333333,0.6113343287696462,1.0,4/16,9.00%,MAPK14;RIPOR2;MEF2C;AKIRIN1
prerank,positive regulation of organelle assembly (GO:1902117),0.5019791447804878,1.2163667432098102,0.2110497237569061,0.6108428501436268,1.0,10/44,12.21%,LCP1;NUP62;KCTD17;TNF;ASAP1;PIP4K2A;RAB3GAP2;PLK4;DYNC1H1;SDCBP
prerank,positive regulation of calcium ion transport (GO:0051928),0.5215631322410017,1.2162490589159158,0.2290249433106576,0.6106375424263505,1.0,8/36,16.85%,LGALS3;P2RX7;P2RX4;ATP2B1;CACNB2;CCL2;WFS1;CACNA1D
prerank,cAMP biosynthetic process (GO:0006171),0.6217245649328947,1.2161000764636802,0.27521613832853026,0.6105624879278893,1.0,4/10,13.63%,ADCY7;ADCY6;ADCY8;ADCY3
prerank,negative regulation of blood coagulation (GO:0030195),0.5193460524571444,1.2157754723196539,0.23798882681564246,0.6109832146684576,1.0,3/38,4.04%,GP1BA;F10;APOE
prerank,negative regulation of heart contraction (GO:0045822),0.6241232077937587,1.2156292884666442,0.25889046941678523,0.6109193086420716,1.0,1/11,0.67%,PIK3CG
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.5899752333469883,1.2156216961538793,0.25630810092961487,0.6104311380144347,1.0,5/13,16.20%,METRNL;RREB1;PIM1;VSTM2A;ZBTB7B
prerank,negative regulation of actin filament polymerization (GO:0030837),0.5583991648465301,1.2155070140687594,0.25584255842558423,0.610248772173014,1.0,9/22,13.36%,CYRIB;PRKCD;ARFGEF1;TMSB4X;PFN2;PFN1;TWF2;TMSB10;SSH2
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.5773399389942233,1.215374959151711,0.27214377406931967,0.6101049137218467,1.0,4/16,10.88%,PTPRJ;PTPN1;BCAR1;NRP1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.503778174011103,1.214292354802679,0.21018418201516792,0.6126858273901417,1.0,10/47,13.20%,PLEK;WDTC1;SIRPA;ERLIN2;ERLIN1;ACADL;SNAI1;PRMT3;FYN;NFKB1
prerank,carboxylic acid metabolic process (GO:0019752),0.5241017533721449,1.2136269806636284,0.21818181818181817,0.6140914972633738,1.0,5/33,11.68%,TBXAS1;SLC2A3;PON3;ST3GAL1;CYB5A
prerank,regulation of apoptotic process (GO:0042981),0.465870230977372,1.213123637918934,0.01,0.6149734938826237,1.0,143/676,16.61%,NCKAP1L;FGD2;VAV1;PTK2B;LILRB1;IRF5;ASCL1;SHH;HCK;PREX1;CD3E;CTSB;CLEC5A;ABR;PCSK9;FLT3;GATA1;PCID2;CD74;PLEKHN1;CTSD;CBL;AQP1;ANGPT4;NR1H4;TNFAIP8;DSTYK;VAV2;NUP62;ARHGEF18;MTCH1;SEMA4D;TNF;ATG7;TMEM219;SNCA;ITGA6;TRAF2;DNAJC3;CLN3;FOXO3;VAV3;PYCARD;CASP1;CCND2;CD44;ANP32A;FZD9;HMGB1;CFLAR;APAF1;ANXA1;CTNNB1;BCL2L1;CCAR1;DNM2;GNA13;ACTN4;TP53;CRADD;KCNMA1;PIM1;MAP3K5;TAX1BP1;PIM2;PLK2;MALT1;MEF2C;KIF14;FLCN;TPT1;GADD45B;ITSN1;TFAP2B;NTF3;ARHGAP10;BAK1;MGMT;BABAM2;BCAR1;ANXA4;STK17B;ACTN1;SON;ARHGEF17;NF2;LGALS1;BNIP1;TRIM24;IAPP;SOX9;SRA1;THBS1;TRIM35;ANGPTL4;PHIP;PRDX3;UTP11;CTNNBL1;CASP8;ITCH;LRP8;PRDX2;PRLR;NFKB1;BRAF;ARHGDIA;ARHGEF3;RNF144B;GAS6;STK3;TRADD;ATAD3A;AREL1;BAG1;WFS1;ARHGEF11;MIEN1;BMF;SOX4;CAPN3;VDAC1;STEAP3;PHLPP1;SRC;PTPA;ERCC5;AHI1;MTDH;NF1;RASA1;RPS6KA2;TXNDC5;FANK1;TOP2A;MAP3K11;RTN4;ARHGEF26;FAF1;NAA38;YME1L1;STK4;PRDX5
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5880578314843858,1.2123454646161087,0.25824175824175827,0.6166430723142581,1.0,4/14,6.47%,CREB3;HERPUD1;CREB3L1;BCL2L1
prerank,embryonic heart tube development (GO:0035050),-0.45108279759629694,-1.211150613043991,0.22007722007722008,0.8559213860200757,1.0,6/14,24.86%,RYR2;ACVR1;HES1;SOX17;SOX18;IFT122
prerank,regulation of JNK cascade (GO:0046328),0.47179870809665186,1.2106589423106207,0.17911975435005117,0.6210000947484697,1.0,20/101,13.46%,PTK2B;SLAMF1;FCGR2B;SIRPA;TAOK3;DUSP3;RAP2A;TRAF2;PYCARD;TRAF3;HMGB1;MAP3K5;GADD45B;DUSP10;TRAF5;DUSP19;SDCBP;NOD2;ITCH;GPS2
prerank,embryonic hemopoiesis (GO:0035162),0.6078177039040988,1.2106281391787965,0.2599431818181818,0.6205689072702085,1.0,4/12,11.03%,TGFBR2;TAL1;FLT3LG;SH2B3
prerank,positive regulation of cell division (GO:0051781),0.5146407932924885,1.2103272973243415,0.21984216459977451,0.6208633860074596,1.0,9/38,17.69%,SHH;TAL1;KIF14;KIF20B;KIF23;CDC6;CDC42;RHOA;GIPC1
prerank,pulmonary valve morphogenesis (GO:0003184),-0.41437906173188166,-1.2097312242938065,0.20270270270270271,0.854215363843576,1.0,8/17,14.33%,ROBO2;BMP4;ROBO1;SLIT2;NOS3;SMAD6;JAG1;STRA6
prerank,protein transport (GO:0015031),0.46592755100121636,1.2095119150412852,0.027,0.6226620772553395,1.0,104/332,20.11%,IL10RA;ATP6V0D2;TBC1D9;RAB8B;CD74;ABCA1;LAPTM5;TBC1D10C;ATP6V0E1;UNC93B1;RAB34;CTSA;TCIRG1;RAB32;ATP6V1C1;SNX9;TMED3;APOE;ABCG1;ATP6V1E1;SEL1L;SNX33;ATP6V0A2;RAB14;RAB3GAP2;MYH9;TBC1D16;RAB7A;STX11;TBC1D22A;AP3D1;TLK1;USP6NL;PRKCB;MACF1;DNM2;VMP1;STXBP3;ATP6V0D1;RAMP1;TBC1D10A;HFE;RAB28;PPY;SNX27;RAB31;ARHGAP1;PDCD6;SYNRG;ARL5B;ARL4A;RAB1B;COPA;ATP6V0A1;TBC1D2;TBC1D17;CLTC;ARRDC4;ATP6AP1;HDAC6;TBC1D2B;WDR11;TBC1D8;STX5;STX3;SAR1A;RPGR;GGA2;STX8;ARF6;LRP1;SCAMP2;VPS29;NEURL1B;ATP6V0B;LTBP2;STEAP3;TBC1D14;CD36;TBC1D22B;SVBP;YWHAH;SNX13;ARFIP2;ARHGEF2;IFT27;MON1A;VLDLR;STX2;ATP6V1F;VPS33B;SLU7;GOLPH3;LRP1B;TBC1D12;SEC13;SEC31A;MCOLN1;TBC1D5;RAB29;OPTN;KIF3A;ARCN1;USO1
prerank,cellular response to starvation (GO:0009267),0.47182350815736696,1.2093257279323189,0.12977867203219315,0.6226958286767962,1.0,44/147,19.29%,ATP6V0D2;PCSK9;ATP6V0E1;GAS2L1;TCIRG1;MTOR;ATP6V1C1;ATG7;FNIP1;SREBF2;MAP1LC3B;ATP6V1E1;FOXO3;TFEB;TP53;RIPOR1;MAP3K5;SEH1L;ATP6V0D1;MTMR3;CEBPB;FLCN;XPR1;IMPACT;DAP;BECN1;TBL2;STK24;LAMTOR3;LRRK2;SREBF1;ATP6V0B;NIM1K;CPEB4;RNF152;FADS1;GCN1;PIK3R4;LAMTOR1;SIK2;ATP6V1F;ATG14;RPTOR;SEC13
prerank,regulation of dopamine secretion (GO:0014059),0.5346688107537162,1.2087526597376117,0.26321974148061106,0.6238047222278645,1.0,5/25,10.99%,SYT17;SNCA;SYT2;SYT10;DTNBP1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.5421280057411108,1.2085516817686437,0.2502994011976048,0.6238615410713304,1.0,3/25,2.11%,PCSK9;ITGB3;RIN3
prerank,regulation of macrophage activation (GO:0043030),0.5257943099911839,1.2083092726973628,0.24447031431897556,0.6239947514825667,1.0,4/30,4.65%,FCGR2B;CD74;GPR137B;CEBPA
prerank,regulation of RNA metabolic process (GO:0051252),0.4990162996181747,1.2078487591634826,0.20405982905982906,0.6247846310801227,1.0,20/59,16.21%,RBM38;MITF;ZNF326;RC3H2;GRSF1;METTL4;RC3H1;PCBP3;HNRNPL;SON;TNFRSF1B;PTBP2;TRA2B;PRX;BRDT;FAM50A;PCBP1;IGF2BP3;RASA1;AHNAK2
prerank,regulation of cell migration (GO:0030334),0.4668172436436689,1.2078024111811207,0.037,0.6244003510135153,1.0,72/382,12.94%,PTK2B;FERMT3;GPNMB;FGR;SHH;ITGAX;TGFB1;CASS4;F10;TMIGD3;CD74;VSIR;PIK3CD;CYRIB;CSF1R;TGFBR1;MGAT5;THY1;PTPRJ;DUSP3;SLURP1;ARSB;PLXNC1;RFFL;MDK;ANGPTL3;RAP2A;SEMA4D;ITGA6;MITF;CLN3;PLXNB2;FOXO3;MCTP1;LGR6;ADGRG3;ANXA1;MACF1;AIF1;DOCK10;CCAR1;MAPRE1;ACTN4;NKX2-1;RIPOR1;GNA12;YTHDF3;SNAI1;NEDD9;TMSB4X;RAP2B;KIF14;FLCN;FAM89B;NTF3;PODN;PTP4A1;DUSP10;BCAR1;ACTG1;VCL;PODXL;NF2;SEMA4A;THBS1;PTPRU;GRN;SDCBP;NUMB;TMSB10;SORL1;ADARB1
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.3077424702599427,-1.2073622612778847,0.16666666666666666,0.8562443569444624,1.0,10/51,9.57%,FSTL1;CRIM1;BMPR1A;BMPER;NBL1;SMAD9;SMAD4;SMAD5;FBN1;SMAD1
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.5627090007099735,1.2072544182359028,0.26329113924050634,0.6243750464556578,1.0,4/20,10.17%,IK;MAD2L2;TRIP13;TPR
prerank,spindle assembly checkpoint signaling (GO:0071173),0.5627090007099735,1.2072544182359028,0.26329113924050634,0.6243750464556578,1.0,4/20,10.17%,IK;MAD2L2;TRIP13;TPR
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.5627090007099735,1.2072544182359028,0.26329113924050634,0.6243750464556578,1.0,4/20,10.17%,IK;MAD2L2;TRIP13;TPR
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.5270172187463033,1.207164683419329,0.26198830409356727,0.6240984236516931,1.0,10/28,19.54%,ERN1;TRAF2;DDIT3;MAP3K5;CEBPB;BAK1;ATP2A3;SELENOK;ERO1A;QRICH1
prerank,regulation of ion transmembrane transport (GO:0034765),0.5242766181448777,1.207062723364893,0.2410196987253766,0.6238624184131449,1.0,4/33,10.19%,KCNJ11;P2RX7;WNK1;NEDD4L
prerank,alcohol catabolic process (GO:0046164),0.6236750517314272,1.2069864737974958,0.2761627906976744,0.6235627809643652,1.0,2/10,4.52%,APOE;CEL
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.5079711351433692,1.2069033032495575,0.2205071664829107,0.6232525539735538,1.0,7/41,11.26%,PTPRC;PLCG2;SLC8A1;PKD2;ITPR2;IBTK;CHERP
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.471547670408242,1.2069021585117452,0.16956077630234934,0.6227357455406919,1.0,24/108,13.86%,SYK;CTSD;LAPTM5;MTCH1;TNF;SNCA;TRAF2;PYCARD;CASP1;XDH;HMGB1;CFLAR;APAF1;CRADD;MAP3K5;ST18;MALT1;SMAD3;GRAMD4;PDCD6;DAP;CASP8;ATP2A3;TRADD
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5516179835572803,1.2066967353983713,0.26741293532338306,0.622833760373126,1.0,5/21,6.47%,CREB3;HERPUD1;DDIT3;CREB3L1;BCL2L1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.6126720522336528,1.2056726533998163,0.2911931818181818,0.6251812278090988,1.0,2/10,5.67%,PLS1;WHRN
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.5958795918661904,1.2050424163411835,0.2652777777777778,0.6263941237199858,1.0,3/12,9.69%,MDK;WNK1;FUT9
prerank,positive regulation of glial cell differentiation (GO:0045687),0.5730201450775033,1.2046471573306592,0.2544757033248082,0.627081761226851,1.0,3/17,4.42%,TGFB1;MDK;CXCR4
prerank,positive regulation of apoptotic process (GO:0043065),0.4630364478918728,1.2045789972553858,0.06,0.6267557326051018,1.0,62/293,16.57%,FGD2;VAV1;LILRB1;IRF5;PREX1;ABR;PCSK9;PLEKHN1;CTSD;TGFBR1;TNFAIP8;VAV2;ARHGEF18;MTCH1;TNF;ATG7;SNCA;ITGA6;FOXO3;DDIT3;VAV3;PYCARD;FZD9;HMGB1;APAF1;CTNNB1;CCAR1;DNM2;GNA13;TP53;CRADD;KCNMA1;MAP3K5;FLCN;GADD45B;ITSN1;TFAP2B;BAK1;STK17B;ARHGEF17;IAPP;TRIM35;GRN;UTP11;CTNNBL1;CASP8;ARHGEF3;STK3;TRADD;ARHGEF11;BMF;SOX4;TLE5;PTPA;NF1;RPS6KA2;FANK1;TOP2A;MAP3K11;ARHGEF26;FAF1;STK4
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5510618462306613,1.2045051698906033,0.2608173076923077,0.626439571992001,1.0,3/21,4.37%,P2RY6;ERN1;LDLRAP1
prerank,regulation of sensory perception of pain (GO:0051930),-0.46571697503854254,-1.204386252450877,0.21660649819494585,0.8601429265203034,1.0,7/11,38.87%,ATPSCKMT;CCN3;ZFHX2;ACP3;SPX;F2R;TMEM100
prerank,positive regulation of fat cell differentiation (GO:0045600),0.4985365276432032,1.2042842671204044,0.23510292524377033,0.6265603037462655,1.0,15/47,18.50%,LPL;METRNL;RREB1;PIM1;ASXL2;CEBPB;LRP5;CMKLR1;VSTM2A;CREB1;WDFY2;SYAP1;ZBTB7B;PPARD;CREBL2
prerank,iron ion homeostasis (GO:0055072),0.49085246613165684,1.2039463746515415,0.21729957805907174,0.6270203301121183,1.0,11/58,14.15%,SLC11A1;FRRS1;ATP6V0A2;IREB2;ATP6V0D1;HFE;FTL;ATP6AP1;ACO1;B2M;FTH1
prerank,protein-containing complex disassembly (GO:0032984),0.49128048801044283,1.2027818180443246,0.210752688172043,0.6298549394348812,1.0,17/54,20.66%,RPL23;LIX1;FRAT2;MAP1LC3B;CLN3;CTNNB1;TECPR1;SNAP29;UVRAG;AMER1;CSNK1A1;SNX14;VPS33B;PYM1;GSK3B;FZD2;EPG5
prerank,L-glutamate transmembrane transport (GO:0015813),-0.48665504387864744,-1.202706276487657,0.24838709677419354,0.8600786780591538,1.0,3/10,6.17%,SLC25A12;ARL6IP5;SLC25A13
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.5138040148021515,1.202335355072865,0.2545454545454545,0.6306554936127229,1.0,9/35,18.35%,CBL;BMP2K;PIK3CB;LDLRAP1;HFE;B2M;ARF6;PICALM;FLOT1
prerank,cellular response to oxygen levels (GO:0071453),0.613770335202977,1.2017770786186177,0.2653958944281525,0.6316658590855588,1.0,4/10,15.05%,ATP6V0A2;ATP6V0D1;ATP6AP1;CPEB4
prerank,glycoprotein metabolic process (GO:0009100),0.5033799381405556,1.200788545679045,0.22008547008547008,0.6339369287501647,1.0,18/53,19.26%,HPSE;MAN1C1;GCNT1;ST8SIA4;OGA;MAN2B1;ST8SIA1;MAN2A2;B4GALT7;STT3B;LARGE1;HIF1A;MGAT4B;ERP44;GOLPH3;FBXO44;MAN1A2;GANC
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.3483094836698054,-1.2001367851786098,0.2014388489208633,0.8625875399314417,1.0,11/31,12.71%,DLG2;PRKCI;LIN7A;SYNJ2BP;PARD3;MYO9A;WDR1;LIN7C;DLG1;MTCL1;EZR
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4783219881091989,1.2001067086295933,0.1962809917355372,0.6354049681953851,1.0,15/80,9.03%,SYK;CTSD;AQP1;TNF;FNIP1;SNCA;PYCARD;CASP1;CD44;HMGB1;MAP3K5;MALT1;CSNK2A1;GRAMD4;PDCD6
prerank,homeostasis of number of cells (GO:0048872),0.5900929466825207,1.199913962406789,0.2886002886002886,0.6353963205162836,1.0,2/12,7.79%,CX3CR1;OCIAD1
prerank,regulation of postsynapse organization (GO:0099175),0.5256065902026464,1.199905546359451,0.245593419506463,0.6348969472361485,1.0,8/28,16.70%,FCGR2B;ARHGAP22;ABHD17B;ABHD17C;LZTS3;LRRK2;TANC2;EPHA4
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.5747340510538889,1.1997798726788709,0.2729693741677763,0.6347465920224897,1.0,6/15,22.98%,TGFB1;LRP1;DPP4;CLASP1;DDR1;PDPN
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5316260039098326,1.1995805955112169,0.26537997587454765,0.634799852599575,1.0,2/27,0.98%,TREM2;FCGR2B
prerank,endocardial cushion morphogenesis (GO:0003203),-0.3900461705114553,-1.1992837185547303,0.22966507177033493,0.8594051048288316,1.0,4/18,5.30%,BMPR1A;BMP4;ACVR1;ACVRL1
prerank,regulation of cholesterol transport (GO:0032374),0.554609129244853,1.1991609188004855,0.2683544303797468,0.635491182188762,1.0,9/20,20.15%,TSPO;ABCB4;TTC39B;NFKB1;LRP1;ARV1;LAMTOR1;NAXE;ABCA2
prerank,positive regulation of cholesterol transport (GO:0032376),0.5313933774572062,1.19894332049078,0.2611311672683514,0.6356007971389658,1.0,7/27,15.52%,TREM2;APOE;ABCB4;EEPD1;GPS2;LRP1;ABCA3
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.5772284048309855,1.198202045591111,0.27636849132176233,0.6372007391610297,1.0,2/15,5.66%,CD74;CD44
prerank,stabilization of membrane potential (GO:0030322),0.5751359214157389,1.1981688952788434,0.26587301587301587,0.6367785637755624,1.0,3/16,7.61%,KCNN4;KCNK6;KCNK13
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5720807585322283,1.1979828448656766,0.2920469361147327,0.636793958458352,1.0,5/18,11.36%,ITGA4;MDK;HMGB1;MEF2C;CCL2
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.2880792936303038,-1.1978995087141797,0.14705882352941177,0.8584182945107772,1.0,25/61,22.07%,CAV1;PANK2;PSME4;PSMD11;PSMA5;PSMA4;PPARA;PSMD14;AZIN1;PSMC6;PSMC3;PSMB3;PSMC1;PSMD5;PSMA3;PSMD3;PSMD6;PSMC5;ODC1;PSME2;FGFR4;PSMB4;PSMC4;PDK2;PSMB6
prerank,piRNA metabolic process (GO:0034587),-0.4061420586572882,-1.1974979945758666,0.2511013215859031,0.8538760240905807,1.0,19/19,59.44%,MYBL1;TDRKH;EXD1;TEX15;PIWIL2;TDRD9;DDX4;TDRD12;PIWIL4;FKBP6;MAEL;MOV10L1;HENMT1;ASZ1;GPAT2;BTBD18;TDRD1;PIWIL1;PLD6
prerank,sensory perception (GO:0007600),0.5039857275432855,1.197151097817294,0.23344191096634093,0.6386323576102969,1.0,10/45,13.58%,CCR2;P2RX7;PRDM12;P2RX4;WHRN;MYO7A;CCL2;SCN9A;CDH23;RETREG1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.5358676259702508,1.1969813006424088,0.25616921269095183,0.6385885607817202,1.0,8/25,16.75%,TNF;PKD2;P2RX4;SMAD3;NOS1AP;DDAH1;CD36;HSP90AA1
prerank,synaptic vesicle recycling (GO:0036465),0.5136543541389837,1.196806520257723,0.26432748538011697,0.6385381562293971,1.0,8/31,12.60%,SNCA;PIP5K1C;CEL;PLD2;SYT2;STON2;STON1;SYNJ1
prerank,ceramide metabolic process (GO:0006672),0.49047931647209,1.1962757869244038,0.23721436343852012,0.6395464451810812,1.0,16/49,20.72%,CERS6;SGPL1;CLN8;CERK;AGK;ACER3;ORMDL2;PPP2CA;NSMAF;DEGS1;ASAH1;SGMS1;SPTSSA;SMPD1;ABCA2;SPTSSB
prerank,autophagosome maturation (GO:0097352),0.5172455765870151,1.1959055357089805,0.24799081515499427,0.6400504744855282,1.0,12/32,21.80%,LIX1;MAP1LC3B;CLN3;VMP1;TECPR1;SNAP29;UVRAG;SNX14;VPS33B;ATG14;EPG5;VAMP8
prerank,cellular response to sterol (GO:0036315),-0.44171997179758093,-1.1947348575720307,0.2397003745318352,0.8567625283643785,1.0,6/13,21.34%,GPLD1;RORA;SMO;INSIG1;INSIG2;PTCH1
prerank,regulation of catecholamine secretion (GO:0050433),0.5188566493465788,1.194687876239538,0.25968109339407747,0.6430730636863268,1.0,5/29,10.99%,SYT17;SNCA;SYT2;SYT10;DTNBP1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.5189996946419533,1.1944703176661868,0.2494172494172494,0.6431797899388734,1.0,7/30,10.95%,GTF2H1;TAF1A;POLR1E;TTF1;CDK7;POLR1B;POLR2L
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.5460907424796667,1.1942511956143536,0.27921279212792127,0.6432838484324789,1.0,10/21,22.85%,PCID2;AIM2;PYCARD;FYN;SOX2;PSMB9;BIRC2;BIRC3;MT3;DELE1
prerank,modulation by symbiont of entry into host (GO:0052372),0.5717991583105735,1.1935795116767722,0.26632522407170295,0.6446730264341468,1.0,6/16,16.77%,TRIM25;TRIM5;TRIM27;EXOC7;EXOC2;TRIM62
prerank,proteolysis (GO:0006508),0.46202878784313395,1.1926966080924692,0.071,0.6466767566316738,1.0,49/252,17.12%,CTSS;KLK3;MMP12;CTSB;NAPSA;LGMN;FAM111A;CTSD;SRGN;CTSC;CTSA;CTSK;CTSL;ECE2;EEF1AKMT4-ECE2;CLN3;CAPN15;CASP1;DDI2;LONP1;MALT1;ZMPSTE24;CTSZ;SPPL3;NLN;TINAGL1;SPCS1;CTSE;TBL1X;MMP19;CASP7;PARL;CASP8;LRP8;PCSK7;PSMB5;ERAP1;CAPN2;ECEL1;CAPN3;SPPL2A;METAP2;PRCP;SVBP;IDE;YME1L1;ATG4A;FURIN;PITRM1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.5508869438831997,1.1925730800996717,0.2812887236679058,0.6465031726417712,1.0,4/21,10.17%,IK;MAD2L2;TRIP13;TPR
prerank,chromosome condensation (GO:0030261),0.5148604239227368,1.192285895666267,0.25143513203214696,0.6467915165564323,1.0,11/36,20.00%,ACIN1;TTN;NCAPG2;CSNK2A1;CSNK2A2;RB1;AKAP8L;INCENP;TOP2A;SMC4;MCPH1
prerank,miRNA metabolic process (GO:0010586),0.5496135545457219,1.1920905982130248,0.2788339670468948,0.6467978267667127,1.0,10/20,21.46%,TENT4B;SND1;BCDIN3D;PRKRA;TUT7;TARBP2;AGO2;DIS3L2;DICER1;LIN28B
prerank,negative regulation of transposition (GO:0010529),0.5649176630431136,1.1920718246617465,0.28512960436562074,0.6463275036083503,1.0,2/16,8.37%,SMYD5;MOV10
prerank,Ras protein signal transduction (GO:0007265),0.4633018533789026,1.1917090513619106,0.1407035175879397,0.6468525835790504,1.0,33/137,15.04%,GRAP2;LAT;RREB1;GRB2;ELMO1;MAPK14;RAP2A;RASGRP2;RAP1B;RGL2;SHC2;MYO9B;AIF1;GNA13;TP53;RIPOR1;GNA12;PLK2;RAP2B;RASGRP3;RB1;ARHGAP1;ARHGDIB;RASSF1;RAPGEF1;CYFIP1;ADGRG1;RRAS2;ARHGDIA;ARHGEF3;ARHGEF11;RAP1A;USP8
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5366564759788296,1.19113568218708,0.25886524822695034,0.6480063323994681,1.0,5/25,10.36%,STAP1;PRKCD;ARHGAP24;CAPZB;PFN2
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.3266459412788427,-1.1910121046976851,0.1796875,0.8632200819492083,1.0,13/37,16.27%,EFNA5;PHLDB2;CYLD;EPHA3;STMN2;PHLDB1;ROCK1;MAP6;MAPT;TPPP;STMN4;TRIM36;STMN3
prerank,regulation of oxidoreductase activity (GO:0051341),0.5896240949943903,1.190983588282038,0.276797829036635,0.647905157680963,1.0,4/13,12.42%,SLAMF8;ATP7A;HDAC6;NOD2
prerank,tRNA modification (GO:0006400),-0.29347504030530625,-1.190969015748502,0.14,0.8575540245536206,1.0,23/62,23.30%,NSUN6;DTWD2;METTL6;SSB;THADA;TYW5;THUMPD3;TPRKB;NSUN2;TRMT6;TARBP1;PUS10;QTRT2;DUS2;TYW1;URM1;MTO1;ANKRD16;TRMT5;LCMT2;WDR4;DTWD1;WDR6
prerank,negative regulation of protein phosphorylation (GO:0001933),0.4658806349233476,1.1908344253265024,0.15045135406218657,0.6477942482147897,1.0,39/150,18.72%,PTPRC;LYN;UBASH3B;TGFB1;SIRPA;NIBAN1;THY1;PRKCD;GNAQ;MLXIPL;NCK2;SEMA4D;SNCA;DNAJC3;XDH;SAMSN1;TRIM27;RB1;NTF3;IBTK;QARS1;IMPACT;DUSP19;DTNBP1;SNX25;DDIT4;PID1;RTRAF;LRRK2;NF1;PTEN;TARBP2;CORO1C;LDLRAD4;PDPK1;GREM1;PAQR3;CNKSR3;ATG14
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.5818115839204347,1.1906851089567168,0.29349269588313415,0.6477197794628149,1.0,2/13,2.11%,TGFB1;TGFBR1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.41479972180139396,-1.1904647149786105,0.24789915966386555,0.8534643742563832,1.0,8/17,20.71%,SPRED2;PARD3;CALM3;SPRY2;DGKQ;DMTN;PPEF2;SMAD7
prerank,response to exogenous dsRNA (GO:0043330),0.5536019660620963,1.190147083128463,0.27784730913642053,0.648709366301326,1.0,3/18,7.56%,RFTN1;DHX9;TICAM1
prerank,mRNA catabolic process (GO:0006402),0.49815994280848264,1.1898868304215608,0.2599118942731278,0.6488827732827738,1.0,9/44,16.51%,SLFN14;ERN1;ZC3H12D;RC3H1;AGO4;AGO3;METTL3;THRAP3;TUT7
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.2910753274527584,-1.1898605560897755,0.15384615384615385,0.8497754363575688,1.0,21/53,22.07%,PSME4;PSMD11;PSMA5;PSMA4;PSMD14;AZIN1;PSMC6;PSMC3;PSMB3;PSMC1;PSMD5;PSMA3;PSMD3;PSMD6;PSMC5;BCKDK;ODC1;PSME2;PSMB4;PSMC4;PSMB6
prerank,nucleoside salvage (GO:0043174),0.613542811865569,1.1893768383661358,0.2956521739130435,0.6498320190506697,1.0,4/10,16.16%,UCK1;CDA;UCK2;DCK
prerank,mitotic chromosome condensation (GO:0007076),0.5351897953281209,1.18924248233662,0.2800953516090584,0.6497257595827467,1.0,8/26,20.00%,TTN;NCAPG2;CSNK2A1;CSNK2A2;RB1;AKAP8L;SMC4;MCPH1
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.5666660153981825,1.188724968583339,0.2660300136425648,0.6507113881531191,1.0,5/15,13.52%,PRKCD;TNF;SMPD3;ORMDL2;NSMAF
prerank,regulation of amyloid fibril formation (GO:1905906),0.5640939552744698,1.1886086130127886,0.2818181818181818,0.6505143746241816,1.0,2/15,4.04%,TREM2;APOE
prerank,lipid transport (GO:0006869),0.4740829864850262,1.1884423185407313,0.20612244897959184,0.6504733864600738,1.0,25/97,18.47%,ABCA1;SLCO2B1;NR1H4;ABCC3;ATP8A1;GM2A;NPC2;MFSD2B;CLN8;APOE;ABCG1;CLN3;PRELID3B;ABCD1;FABP5;ABCA4;OSBP;SLCO1B1;CD36;OSBPL8;ABCA3;PPARD;STARD5;ABCD2;RXRA
prerank,nuclear membrane reassembly (GO:0031468),-0.31424262844261724,-1.1882884899117363,0.22807017543859648,0.8493061512660257,1.0,20/54,21.42%,SPAST;NUP93;IST1;NUP188;NUP98;PPP2R2A;AHCTF1;NDC1;NUP37;VPS4A;RCC1;EMD;CHMP4A;CHMP4B;NUP133;LMNA;CHMP2A;RAN;NUP43;LBR
prerank,protein localization to mitochondrion (GO:0070585),-0.46212375527173194,-1.1882278309749716,0.24381625441696114,0.8439154815611919,1.0,6/11,16.42%,HK1;PINK1;COX18;DNAJA1;AKT1;MTCH2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.5574570441429111,1.1880311121615166,0.28076923076923077,0.6511121275612081,1.0,6/18,15.81%,MDK;CXCR4;TMEM98;TNFRSF21;TNFRSF1B;NF1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.5478365188913502,1.187994244999957,0.28553299492385786,0.650703347588552,1.0,13/20,25.60%,PUM2;AGO4;SNIP1;AGO3;PRKRA;TARBP2;AGO2;ZC3H7A;DICER1;ZC3H7B;AGO1;DROSHA;PUM1
prerank,RNA interference (GO:0016246),0.5547118246360497,1.1873739545828583,0.2646276595744681,0.6519818565146417,1.0,10/17,25.10%,DHX9;AGO4;AGO3;PRKRA;NRDE2;TARBP2;AGO2;DICER1;AGO1;DROSHA
prerank,regulation of aerobic respiration (GO:1903715),0.5736494147904352,1.1871507258442346,0.27466666666666667,0.6520844224453249,1.0,3/15,7.38%,CBFA2T3;ATP7A;ABCD1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4606375519777143,1.1871153433231263,0.18391959798994975,0.6516774774230334,1.0,30/128,16.98%,ARRB2;TGFB1;NRROS;CBL;ITGB5;TGFBR1;ARHGEF18;SKI;HPGD;ZMIZ2;RNF111;TGFBR2;TGFBRAP1;HFE;ZFYVE9;SMAD3;F11R;INHBA;NLK;BAMBI;STUB1;MEGF8;USP9X;ZYX;LTBP2;SRC;SMURF1;APPL2;LPXN;FURIN
prerank,tRNA aminoacylation (GO:0043039),0.5047016359843022,1.1869404777632824,0.2711864406779661,0.6516471775948334,1.0,17/37,22.53%,VARS1;FARSB;GATB;GARS1;PPA2;RARS1;QARS1;EPRS1;LARS2;DARS1;DARS2;FARS2;AIMP1;YARS1;TARS1;SARS2;SARS1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.45401406631639246,1.1868868085202595,0.026,0.6512860508867148,1.0,118/476,18.53%,RUNX1;CD86;NFE2;SHH;CIITA;IRF4;TGFB1;GATA1;PCID2;CD74;SNX5;TGFBR1;NFATC1;MED17;RREB1;GTF2H1;MAD2L2;NR1H4;NSD1;MLXIPL;ELF4;SS18L1;NUP62;YAF2;RXRB;TNF;CXXC1;SPP1;APOE;MITF;UBE2V1;FOXO3;DDIT3;NDP;HIVEP3;RNF111;TEAD1;FLI1;CTNNB1;MAP2K3;TFEB;DNM2;KLF6;CD80;TP53;TBL1XR1;NKX2-1;TAL1;MAP3K5;MYOCD;SNAI1;PIM2;ZFP90;EPO;CEBPB;CHEK2;MEF2C;MDFIC;TFAP2B;MMS19;SMAD3;BICRA;ARID1A;PPARGC1A;ATF7IP;RNF4;LRP5;HDAC4;ARID1B;TRIM56;TBL1X;RNF10;SEC14L2;INHBA;ATAD2;CREB3L2;MAP2K2;ELF2;SOX9;PHIP;MAP3K12;CREB1;SMARCD3;BAMBI;NFKB1;CAMKK2;IRF1;FOXK1;GPATCH3;HCFC1;ZFHX3;SOX2;BRD7;HNRNPD;ARHGEF11;LBH;SOX4;CAPN3;THRAP3;YWHAH;FANK1;USP21;USP16;HIF1A;PPP3CB;RSF1;TRIP4;PPARD;VHL;NPAS2;CASZ1;NFYA;CNBP;PICALM;MAFB;RXRA;CREBL2;TESC
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5527221617236803,1.1866313094403758,0.2927461139896373,0.651541120787489,1.0,4/18,10.69%,TGFB1;TNF;TP53;MAP2K2
prerank,regulation of intracellular transport (GO:0032386),0.5001119099003819,1.1861906363145256,0.2786516853932584,0.6523108377524821,1.0,4/38,4.72%,LCP1;NEFH;PTPN1;REEP6
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.4774412480966753,1.1861842564024683,0.2074688796680498,0.6518069521274599,1.0,19/77,15.26%,LGALS3;CX3CR1;TGFBR1;TNF;ITGA6;HERPUD1;FZD9;CFLAR;BCL2L1;CSNK2A1;CSNK2A2;RB1;QARS1;THBS1;PHIP;PSME3;NOC2L;PIH1D1;SRC
prerank,negative regulation of cellular component organization (GO:0051129),0.4764513816493447,1.1861743997569645,0.22140608604407136,0.6513176761150266,1.0,15/74,12.90%,LILRB1;LGALS3;NR1H4;TNF;MCTP1;SNX33;XRCC5;DNM2;TFIP11;SVIP;HSF1;IMPACT;IAPP;HDAC6;SORL1
prerank,sterol metabolic process (GO:0016125),0.48026726785952073,1.1859597235693533,0.2288135593220339,0.6514225533606578,1.0,15/60,18.52%,ABCA1;ANGPTL3;CLN8;APOE;ABCG1;LDLRAP1;LIPA;SOAT2;PIP4P1;ARV1;FDXR;PPARD;FDX1;RXRA;GBA2
prerank,mitochondrial fusion (GO:0008053),-0.38900961638086273,-1.1854710676977895,0.21428571428571427,0.8476324106687677,1.0,9/18,25.94%,AFG3L2;SPG7;GDAP1;BAX;MFN2;MIGA2;MIEF1;STOML2;MIEF2
prerank,regulation of gluconeogenesis (GO:0006111),-0.3490344695785387,-1.1853345355593499,0.2028985507246377,0.8425740832844095,1.0,11/27,23.05%,OGT;DDB1;SIK1;SELENOS;ZNF692;DGKQ;ARPP19;C1QTNF3;NNMT;PDK2;CRY1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.4879606264830943,1.1851995566098854,0.24919441460794844,0.6530959159077563,1.0,5/50,5.97%,ARRB2;BAG2;IVNS1ABP;TNFAIP3;TAF1
prerank,negative regulation of viral life cycle (GO:1903901),0.5703961074120631,1.1849070883163269,0.2966442953020134,0.6533742775793769,1.0,2/15,3.66%,CIITA;TRIM5
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.463959447583363,1.1843865710794987,0.19556451612903225,0.6543243409198881,1.0,29/112,16.98%,ARRB2;TGFB1;NRROS;CBL;ITGB5;TGFBR1;ARHGEF18;SKI;HPGD;ZMIZ2;TGFBR2;TGFBRAP1;MEF2C;ZFYVE9;SMAD3;F11R;LIMS1;SOX9;NLK;BAMBI;SOX6;USP9X;ZYX;LTBP2;SRC;SMURF1;APPL2;LPXN;FURIN
prerank,regulation of phosphorylation (GO:0042325),0.46342300845981654,1.1843620989281642,0.17038539553752535,0.6538689939456952,1.0,21/120,12.38%,NCKAP1L;LYN;STAP1;FNIP2;NLRC5;SLAMF8;PTGES3;NUP62;FNIP1;ITGA6;PLXNB2;SEH1L;FLCN;TPR;INHBA;NRP1;THBS1;NUP205;PHIP;SDCBP;PPP2CA
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5232028885502408,1.1839564144135342,0.2699167657550535,0.6545018400096683,1.0,18/29,25.60%,SMAD3;ADAR;PUM2;AGO4;SNIP1;AGO3;METTL3;PRKRA;TUT7;TARBP2;AGO2;ZC3H7A;DICER1;LIN28B;ZC3H7B;AGO1;DROSHA;PUM1
prerank,positive regulation of blood coagulation (GO:0030194),0.5584858703316427,1.1837479687471955,0.2955729166666667,0.6545899756325921,1.0,3/17,11.47%,HPSE;USF1;THBS1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.5211863659536957,1.1832557530545913,0.271461716937355,0.6554755420352228,1.0,8/29,12.11%,NLRC5;PTPN1;SAMHD1;YTHDF3;RNASEL;TTLL12;USP18;METTL3
prerank,genitalia development (GO:0048806),0.5942972328424672,1.182908695382032,0.2998624484181568,0.6559854416401761,1.0,2/12,5.96%,SHH;CHD7
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.5197420753454943,1.182711031918205,0.28846153846153844,0.6560165888931285,1.0,10/27,22.09%,SLFN14;ERN1;ZC3H12D;RNASEH1;ZC3H12C;PCF11;TRIR;DICER1;TOE1;RNASE6
prerank,myelin maintenance (GO:0043217),0.6178398567638138,1.1824211049760955,0.2922636103151863,0.6563029840287372,1.0,6/10,17.96%,CXCR4;ABCD1;PRX;DEGS1;PTEN;ABCD2
prerank,negative regulation of hippo signaling (GO:0035331),0.6027463916353896,1.182373057154518,0.2859135285913529,0.6559145736690949,1.0,3/12,6.35%,MAPK14;WWC2;MAP2K3
prerank,regulation of inclusion body assembly (GO:0090083),-0.47208222832624114,-1.1822438821317462,0.2852233676975945,0.8476088069797404,1.0,9/11,38.86%,SNCAIP;SACS;DNAJB2;BAG5;DNAJA4;DNAJB1;HSPA1A;HSPA1B;HSPA2
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.49600238497166044,1.182076977633005,0.2677165354330709,0.6562745754278844,1.0,13/41,21.53%,CD3E;THY1;MDK;TNF;CD44;PODXL;PTPRU;DENND6A;CD47;FLOT1;PIEZO1;MEGF10;CX3CL1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.508191354349201,1.180339374929925,0.24632768361581922,0.660741289319904,1.0,5/33,8.24%,CBL;NUP62;ARAP1;DOK1;DGKD
prerank,response to chemokine (GO:1990868),0.5827115913659678,1.1802825874410479,0.30674002751031637,0.6604000892060808,1.0,4/13,11.03%,DOCK8;RIPOR2;WNK1;SH2B3
prerank,organelle fission (GO:0048285),0.5308260960651893,1.180185435444526,0.2929782082324455,0.6601677204103366,1.0,13/24,25.24%,PEX11A;MTFR2;DNM2;TMCC1;SEC16B;CORO1C;FIS1;DNM1L;PRKN;ACOT8;MTFR1;MFF;WASHC5
prerank,cellular response to ketone (GO:1901655),0.5010249385252603,1.1801369899296568,0.2690531177829099,0.6598178841956498,1.0,12/35,19.50%,MAP4K1;AQP1;SPP1;ADCY6;LARP1;ADCY8;ADCY3;GNG2;SRC;NCOA4;GOLPH3;ROCK2
prerank,action potential (GO:0001508),0.4895039931294069,1.1799183326326628,0.2579933847850055,0.6599155224167155,1.0,3/44,4.47%,GNA15;GNAQ;CLN3
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.3279688872902136,-1.1795919886490112,0.1652892561983471,0.8509879821003541,1.0,15/33,26.14%,WDR33;SCAF8;CPSF7;FIP1L1;CSTF2;PAPOLA;SNRPD3;MAZ;CSTF3;SNRPG;SNRPF;CSTF2T;NCBP2;CPSF1;CLP1
prerank,cellular response to cAMP (GO:0071320),0.5126818263561354,1.1793309065288151,0.27147766323024053,0.6610454201088318,1.0,10/30,21.25%,AQP1;HCN4;PKD2;RAP1B;RAPGEF1;RAP1A;AKAP9;ZFP36L1;INPP5K;HCN1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.5262366949948443,1.1783554481407266,0.2782503037667072,0.6633475054488341,1.0,13/24,24.08%,SMYD5;DNMT3A;SPI1;TRIM27;RBBP7;MTF2;TASOR;PHF1;RBBP4;EED;AEBP2;H3-3A;DNMT3B
prerank,peptidyl-amino acid modification (GO:0018193),0.602043827213689,1.1783041810532433,0.29004329004329005,0.6629707101678797,1.0,5/10,28.67%,ATP7A;METAP2;TTLL4;METAP1D;FKBP10
prerank,smooth muscle tissue development (GO:0048745),0.6170515058714272,1.1777529903433013,0.28714285714285714,0.6639798096042253,1.0,1/10,0.65%,SHH
prerank,regulation of cell-cell adhesion (GO:0022407),0.5004101177500052,1.1765099076688503,0.28207964601769914,0.6670146136007495,1.0,7/39,10.66%,FERMT3;TGFB1;ADAM8;SPINT2;FUT9;PODXL;NF2
prerank,negative regulation of response to wounding (GO:1903035),0.5567330793613972,1.1763330870159123,0.3112244897959184,0.6669810341205709,1.0,7/19,23.92%,MDK;RTN4RL1;CASK;EPHA4;CRK;FGF2;INPP5F
prerank,lipoprotein biosynthetic process (GO:0042158),0.5901876612799777,1.176295443320901,0.3170731707317073,0.6665747048918452,1.0,2/11,4.04%,ATG7;APOE
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.5048463599505928,1.1758171986191217,0.2708333333333333,0.667471208231383,1.0,7/32,10.95%,GTF2H1;TAF1A;POLR1E;TAF1;CDK7;POLR1B;POLR2L
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.4944464619011405,1.1748192110016114,0.27547592385218367,0.6698313513772759,1.0,5/41,9.16%,CTSS;KCNN4;STAC;KCNMA1;NOS1AP
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.49719006422303863,1.1747332913479098,0.2645381984036488,0.6695731660831784,1.0,12/36,17.98%,PLCB2;NFATC1;FZD3;CTNNB1;TNRC6A;MOV10;AGO4;NLK;AGO3;GNG2;PPP3CB;AGO2
prerank,regulation of exit from mitosis (GO:0007096),0.5032587737141897,1.1745877706549432,0.27896512935883017,0.6694599100750297,1.0,4/38,6.50%,ANAPC15;RGCC;CDC23;UBE2S
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5907582568903353,1.174349862766841,0.31393775372124494,0.6696372506170443,1.0,3/12,12.42%,MUC13;SOX9;NOD2
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.5756124783445741,1.1742783099850294,0.3058823529411765,0.6693147983972737,1.0,4/14,11.47%,ITGA4;RGCC;CCL2;THBS1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.4654606708395149,1.173968984185408,0.1771255060728745,0.669682914623934,1.0,18/119,9.67%,INPP5D;PIK3CG;PIK3R5;PIK3CD;PIGM;PLCG2;PIK3CB;PIP5K1C;INPP4B;PIP4K2A;PI4K2A;RAB14;TTC7A;PIGL;MTMR3;PIGV;SMG1;PIGH
prerank,regulation of protein secretion (GO:0050708),0.462545724618962,1.1735556701593588,0.2119071644803229,0.6703402096773264,1.0,26/119,16.94%,TREM2;KCNJ11;TGFB1;IL1A;ADAM8;TNF;APOE;ABCG1;TTN;RHBDF2;CACNA1A;TFAP2B;SYTL4;ITPR2;ENSA;SLC8B1;EXOC1;KCNA5;ARF6;MYH10;RAP1A;CD33;RHBDF1;GCK;CACNA1D;PPP3CB
prerank,generation of neurons (GO:0048699),0.4545212071387952,1.1734620448553603,0.14114114114114115,0.6700693798297462,1.0,28/190,13.04%,RUNX1;ASCL1;SHH;CX3CR1;PCSK9;FZD10;HES7;FGF13;IER2;PLXNB2;MYT1L;BHLHE41;THOC2;FZD3;CTNNB1;LRP12;DISC1;MEF2C;PEX13;FUT9;MAP1B;NRP1;OLIG1;ARTN;CDK6;DDIT4;NAV1;TAFA1
prerank,positive regulation of cell cycle (GO:0045787),0.4701826048829747,1.1729102016723492,0.2463157894736842,0.6711893499848751,1.0,10/62,9.25%,LGMN;SMOC2;DUSP3;CCND3;PKD2;RGCC;CCND2;RPS15A;TAL1;HSF1
prerank,negative regulation of macroautophagy (GO:0016242),-0.33989765209506867,-1.1728946540020562,0.20714285714285716,0.8678960223924935,1.0,16/26,23.71%,MTM1;FEZ1;NRBP2;TMEM39A;LZTS1;PINK1;AKT1;CHMP4A;CHMP4B;NUPR1;CLEC16A;PHF23;USP36;SMCR8;FEZ2;UBQLN4
prerank,regulation of macromolecule metabolic process (GO:0060255),0.4537462282706321,1.1728636687407512,0.14614614614614616,0.6708156052341432,1.0,48/170,21.50%,PTPRC;TREM2;ASCL1;SHH;CAVIN4;SIRPA;SLC8A1;PRDM12;TRIM5;APOE;TBC1D16;ZUP1;AIF1;TFEB;NFKBID;MTMR3;TRIM27;PCBP3;NELL1;AFF1;TXK;CDK6;ZFP64;ZNF445;COQ7;MEGF8;PCBP1;SOX2;C1D;HNRNPD;RO60;IGF2BP3;RASA1;HIF1A;MARF1;LAMTOR1;FLOT1;PRDM10;FUBP3;ROCK2;GDNF;ATRAID;SORT1;ZFP36L1;NPAT;CIAO3;SCARB2;PIN1
prerank,vesicle transport along microtubule (GO:0047496),-0.3617426880509208,-1.172641426954014,0.1813186813186813,0.8631605882287758,1.0,12/23,23.78%,KIF5B;DYNC1I1;PAFAH1B1;NDEL1;KIF3B;NDE1;KIF5A;KIFAP3;KIF13A;TRAK2;KIF1A;FYCO1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.4642843245411302,1.1725256995435982,0.2236842105263158,0.6712087699363932,1.0,31/104,20.73%,CSF1R;THY1;GTF2H1;SLC8A1;CCND3;SNCA;BCCIP;PYCARD;CCND2;ACTB;RB1;UVRAG;CDK7;LRP5;MAP2K2;DUSP19;PARP16;PPP2CA;CCNE2;CDC6;PIH1D1;SRC;INCENP;SYAP1;IRGM;KSR1;RHOA;RPTOR;CNPPD1;CDK5R1;TELO2
prerank,regulation of angiogenesis (GO:0045765),0.45574743986569216,1.172011640962923,0.14844533600802406,0.6721509928601979,1.0,20/192,7.45%,RUNX1;KLK3;GPNMB;PF4;ITGAX;CCR2;IL1A;SMOC2;PIK3CD;AQP1;ANGPT4;ANGPTL3;PRKD2;RGCC;PDCL3;TNFAIP3;PRKCB;CTNNB1;STAB1;VEGFB
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.5546742910993371,1.1717022627389402,0.304177545691906,0.6725448894928169,1.0,1/18,0.65%,KCNJ11
prerank,cellular response to nitrogen compound (GO:1901699),0.5368561521622974,1.1715292438065745,0.29839704069050554,0.672538180835408,1.0,10/20,24.70%,NR1H4;DDI2;HSF1;ATRX;RIOK3;ROCK2;SPIDR;EPG5;DDX11;ATP2B4
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5063456619428685,1.1713425251581937,0.28339140534262486,0.6725464316136462,1.0,4/31,3.74%,TGFB1;TGFBR1;MYL3;PKP2
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.480635897541329,1.1711437149715422,0.25556733828207845,0.6725790416953247,1.0,12/54,17.10%,ARRB2;BAG2;IVNS1ABP;TNFAIP3;CTNNB1;PRMT3;SOX4;CAPN3;SVBP;RPL11;COPS9;VPS28
prerank,transcription by RNA polymerase III (GO:0006383),0.519080475412566,1.1710970198709254,0.29531812725090034,0.6722148790141855,1.0,10/27,18.96%,IVNS1ABP;GTF3C4;GTF3A;POLR2L;SNAPC3;ELL;RO60;SNAPC4;ICE2;CRCP
prerank,negative regulation of blood pressure (GO:0045776),-0.42959814137883523,-1.1710208270850018,0.24579124579124578,0.8631123111588197,1.0,6/13,26.57%,SCPEP1;NOS3;NOS1;DRD2;BMPR2;GPR37L1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.47586405294718204,1.170904676601863,0.2528497409326425,0.6722445532315644,1.0,20/65,18.29%,CBL;PTPRJ;DUSP3;GRB2;NUP62;ARAP1;DOK1;ZFYVE28;RHBDF2;SH3KBP1;DGKD;EPS15;MVB12B;BCAR3;RHBDF1;EPN1;PTPN12;PDE6H;CDC42;PTPN3
prerank,ncRNA catabolic process (GO:0034661),0.5178136751619686,1.170878145283063,0.2959905660377358,0.6718051188480229,1.0,3/28,6.79%,SLFN14;TENT4B;SND1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.47073344762178526,-1.1708489060351415,0.2736156351791531,0.8584494657150805,1.0,3/11,15.73%,MLLT3;RSPO3;WNT5B
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.5398987402841416,1.1706433773995308,0.29523809523809524,0.6719400885480749,1.0,5/21,10.22%,HPSE;SULF2;HS3ST4;XYLT1;EXTL3
prerank,metanephros development (GO:0001656),0.512746714617907,1.1698423621554177,0.28354725787631274,0.6736944829690493,1.0,3/26,4.08%,SHH;BASP1;PKD2
prerank,collagen fibril organization (GO:0030199),-0.28901440190538824,-1.169447807475777,0.14814814814814814,0.8576055882122419,1.0,33/88,18.02%,COL5A2;COL8A1;COL12A1;COL25A1;SERPINH1;PLOD2;COL4A1;COL4A5;TLL1;COL3A1;COL6A3;PLOD1;COL4A3;COL4A2;PPIB;ITGB4;PLEC;COL4A6;COL5A3;COL20A1;LOXL1;COL1A2;ADAMTS2;COL6A2;COL6A1;COL16A1;COL9A2;COL26A1;COL14A1;COL1A1;PLOD3;DPT;CD151
prerank,regulation of MAPK cascade (GO:0043408),0.4544742074026893,1.1692524180565902,0.16649949849548645,0.6748209083683334,1.0,38/157,19.76%,PTPRC;LYN;SYK;FLT3;CD74;TAOK3;LAPTM5;PLCG2;PTPRJ;DUSP3;P2RX7;OSM;TRIM5;HMGB1;TNIK;ATP6AP2;MAP2K2;DUSP19;GPR37;IAPP;STK3;TMEM106A;SOX2;LBH;PHLPP1;BCAR3;NF1;STK4;EPHA8;IQGAP1;KSR1;LAMTOR1;TAOK1;GREM1;MINK1;PTPN6;ROCK2;MAP4K4
prerank,positive regulation of vascular permeability (GO:0043117),0.5750080959452422,1.1691902390860023,0.3258426966292135,0.6744715600973556,1.0,2/12,5.48%,TGFB1;FGFBP3
prerank,positive regulation of phosphorylation (GO:0042327),0.45317907187161016,1.1690139048495791,0.12,0.6744181120833022,1.0,23/240,5.63%,NCKAP1L;TREM2;GPNMB;LYN;TGFB1;FLT3;CD74;ITGB3;CSF1R;NIBAN1;P2RX7;DSTYK;MLXIPL;PTGES3;RAP2A;SEMA4D;CCND3;TNF;FNIP1;ITGA6;BRAT1;PFKFB4;CCND2
prerank,protein export from nucleus (GO:0006611),0.5081785940180377,1.168989598014315,0.29759036144578316,0.6739587298473938,1.0,11/27,22.04%,TGFB1;XPO1;CSE1L;STRADB;TPR;XPO6;STRADA;SMURF1;DESI1;XPO7;CHP1
prerank,regulation of actin filament-based movement (GO:1903115),-0.4714406449708552,-1.1687281601340147,0.2753623188405797,0.8547021979977434,1.0,2/10,5.83%,ANK2;SRI
prerank,ventricular septum development (GO:0003281),-0.3273572293761333,-1.1683924904071081,0.1875,0.8504089486197536,1.0,9/37,7.20%,ZFPM2;BMPR1A;ROBO2;ACVR1;SALL1;TGFBR3;ROBO1;SLIT2;SMAD4
prerank,neuron projection fasciculation (GO:0106030),-0.4666566826693959,-1.1674255705644756,0.2684563758389262,0.8482717768172949,1.0,3/10,4.87%,SEMA5A;ARHGAP35;EPHB2
prerank,neuron projection organization (GO:0106027),0.5601802749010332,1.1670338910785267,0.2896825396825397,0.6790605666091072,1.0,3/15,7.38%,LGMN;PLS1;ABCD1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.3568528471647188,-1.1666834237987136,0.20725388601036268,0.8455150828384874,1.0,7/22,8.19%,SCAF8;CDK12;THOC1;THOC5;BRD4;CCNK;CCNT1
prerank,response to amino acid starvation (GO:1990928),0.4661391922108807,1.1660908212917434,0.2776617954070981,0.6811765240482568,1.0,23/72,19.29%,ATP6V0D2;ATP6V0E1;TCIRG1;MTOR;ATP6V1C1;ATP6V1E1;TFEB;MAP3K5;SEH1L;ATP6V0D1;CEBPB;FLCN;LARP1;IMPACT;DAP;LAMTOR3;ATP6V0B;RNF152;GCN1;LAMTOR1;ATP6V1F;RPTOR;SEC13
prerank,regulation of stem cell population maintenance (GO:2000036),-0.40138146332082414,-1.165894059187365,0.26666666666666666,0.8429453593625797,1.0,3/18,6.03%,PTN;CNOT3;REST
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6078216808097353,1.1657465603902646,0.31024531024531027,0.6816681265793286,1.0,5/10,19.76%,MTOR;ARF6;MAPRE2;IQSEC1;MAP4K4
prerank,positive regulation of protein import (GO:1904591),0.497546712783662,1.1656837130166822,0.28835063437139563,0.6813330718301289,1.0,5/30,10.17%,TGFB1;HCLS1;PRKCD;SMAD3;TPR
prerank,negative regulation of cellular catabolic process (GO:0031330),0.47462121665608875,1.1651502370791935,0.26277372262773724,0.6824219641429811,1.0,15/63,16.11%,TREM2;IL10RA;MTOR;TIMP1;EIF4G3;NELL1;DAP;TAB2;SORL1;FOXK1;BMF;TAB3;TBC1D14;GSK3A;NRDE2
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.37477327718079634,-1.1646472259344574,0.23008849557522124,0.8418715344778757,1.0,6/20,8.24%,SEMA6A;SEMA5A;SEMA6D;SEMA3A;SEMA3C;SEMA3D
prerank,brain morphogenesis (GO:0048854),0.579762305284531,1.1642958785978914,0.308,0.6843455196756362,1.0,1/12,0.41%,SLC6A4
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.4366290705349759,-1.1638682266815426,0.25,0.8391864472842547,1.0,6/13,16.45%,RHOT1;BNIP3;BCL2L11;BLOC1S2;BAD;BAX
prerank,phosphate ion transport (GO:0006817),0.5619296331115876,1.1634302662602576,0.3198959687906372,0.6862847982568253,1.0,4/16,13.11%,SLC37A2;XPR1;SLC20A2;SLC25A30
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.46996845580205837,1.1630253183645254,0.2575599582898853,0.6869344189528116,1.0,12/75,10.88%,STAT5A;ITGA4;PIK3CD;ITGB3;TGFBR1;MDK;PRKD2;PDCL3;HMGB1;VEGFB;PDCD6;NRP1
prerank,placenta development (GO:0001890),-0.46180100219043924,-1.1627433269628045,0.28776978417266186,0.8376632416098908,1.0,8/12,44.98%,SOD1;PPARG;PTK2;ADAM19;ANG;E2F7;PLAC1;E2F8
prerank,cytoskeleton organization (GO:0007010),0.46272482241738416,1.1624979121312535,0.21327967806841047,0.6879304710776131,1.0,32/114,18.96%,FGD2;THY1;NCKIPSD;MDK;APOE;TNFAIP3;PLD2;FMNL3;FGD6;CAPZB;SH3KBP1;NEDD9;RANBP10;TNIK;MICAL1;SIPA1;ARHGAP10;DIAPH1;CCL13;CCL2;PHIP;RANBP9;DES;SIPA1L3;PDZD8;DST;WDPCP;BIN1;RHOA;ANK1;PALLD;RHOD
prerank,neuron differentiation (GO:0030182),0.4522900617853654,1.1611014166334634,0.1782477341389728,0.6913620554923389,1.0,18/165,11.28%,RUNX1;ASCL1;SHH;PCSK9;FZD10;TGFBR1;IER2;ATP8A2;MYT1L;THOC2;FZD3;CTNNB1;WNK1;MYO7A;MEF2C;FUT9;INHBA;OLIG1
prerank,regulation of neuron migration (GO:2001222),-0.34752174774200206,-1.1605758294390935,0.20634920634920634,0.8400822919793611,1.0,8/26,4.17%,SEMA6A;NIPBL;NTNG1;SEMA3A;COL3A1;ULK4;DAB2IP;NEXMIF
prerank,negative regulation of JNK cascade (GO:0046329),0.49920104588913067,1.1602763441244905,0.318448883666275,0.6931856357794233,1.0,11/31,21.05%,SIRPA;TAOK3;DUSP3;DUSP10;DUSP19;ITCH;GPS2;DACT1;PER1;ZMYND11;PRKN
prerank,cAMP metabolic process (GO:0046058),0.5630575891403259,1.15949169960125,0.32450331125827814,0.6948524905989213,1.0,4/13,13.63%,ADCY7;ADCY6;ADCY8;ADCY3
prerank,positive regulation of sodium ion transport (GO:0010765),0.5746042769834209,1.1594288216241162,0.3342857142857143,0.694520585172316,1.0,5/12,18.55%,SCN4B;PKP2;PRSS8;SCN5A;CNKSR3
prerank,positive regulation of ATPase activity (GO:0032781),0.4929629010093409,1.1593682972557877,0.2825361512791991,0.6941667762423833,1.0,12/41,13.88%,MYL3;DHX9;ALDOB;VMP1;TNNT3;AHSA1;PFN2;PFN1;TOR1AIP2;ATP1B3;ATP1B2;DNAJC9
prerank,cardiac muscle cell development (GO:0055013),0.5336405942127124,1.1590236135011733,0.32,0.6945939657689677,1.0,3/20,4.48%,SLC8A1;TTN;MYLK3
prerank,negative regulation of viral release from host cell (GO:1902187),0.5728507015825878,1.1586059461414167,0.31424581005586594,0.6952503868123396,1.0,4/13,11.50%,TRIM5;TRIM8;MID2;TRIM35
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.5169335397546304,1.1581894732256712,0.3087719298245614,0.6958742167312623,1.0,3/27,2.86%,CD74;AQP1;DHX9
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4855063174538464,1.1580492014705908,0.2834051724137931,0.6957407405317557,1.0,4/48,3.90%,PTK2B;UBASH3B;THY1;SNCA
prerank,organophosphate biosynthetic process (GO:0090407),-0.3099677489234639,-1.1575723787855008,0.20192307692307693,0.8447016778802581,1.0,12/37,20.56%,PPIP5K2;IP6K1;AGPAT4;GK5;AGPAT3;AGPAT5;IP6K2;GPHN;MBOAT1;ITPKC;IPMK;NFS1
prerank,phosphate ion transmembrane transport (GO:0035435),0.5764545617470254,1.1573846300982946,0.3287101248266297,0.6970397901005149,1.0,4/12,13.11%,SLC37A2;XPR1;SLC20A2;SLC25A30
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.4585301328921565,1.1568823257926,0.24539877300613497,0.6979215882646389,1.0,8/87,2.95%,PTK2B;IQGAP2;CORO1A;FZD10;CSF1R;PRKCD;MTOR;MDK
prerank,regulation of microtubule-based movement (GO:0060632),0.5836536350260094,1.1563789119501207,0.3319027181688126,0.6988420253358759,1.0,2/11,11.44%,NEFH;HDAC6
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.5311592533789555,1.1559336506319517,0.30666666666666664,0.6996604845722145,1.0,7/25,17.75%,CALCR;THY1;SNCA;CACNB2;CAPN3;CEMIP;PDPK1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.45653274640712277,1.1559227590606684,0.19477911646586346,0.6991586473974529,1.0,26/142,14.13%,CALCR;CX3CR1;CCR2;CD52;SLC8A1;CXCR4;CLN3;S1PR4;FZD9;HMGB1;CCKBR;CACNA1A;TMEM178A;ATP2B1;SMAD3;SPPL3;CMKLR1;CYSLTR1;SLC8B1;IAPP;ATP2B3;TACR1;NPTN;CDH23;ADCY8;C3AR1
prerank,regulation of macroautophagy (GO:0016241),0.46002390274216653,1.1558606568729832,0.22912423625254583,0.698804015134492,1.0,24/105,14.74%,ATP6V0D2;SNX5;ATP6V0E1;MTOR;ATP6V1C1;ERN1;ATP6V1E1;CLN3;ATP6V0A2;SCOC;ATP6V0D1;LARP1;PAFAH1B2;SMG1;ATP6V0A1;HDAC6;EXOC8;EXOC7;EXOC1;IKBKG;LAMTOR3;LRRK2;GNAI3;ATP6V0B
prerank,glycosaminoglycan metabolic process (GO:0030203),0.47992975193582743,1.1556667939499605,0.2682154171066526,0.6988038975664428,1.0,9/54,9.42%,HPSE;GUSB;GNS;IDS;HEXA;FUCA1;AGRN;NDST1;XYLT1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5529132698584878,1.155439346091616,0.32655654383735705,0.6989415930221218,1.0,7/17,19.43%,CBFA2T3;MLXIPL;FLCN;HDAC4;PID1;TIGAR;FIS1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4704485727248372,1.1543193925109372,0.27666314677930304,0.7016381922626886,1.0,14/60,13.20%,CSF1R;MED17;CDK8;CTNNB1;TP53;TNRC6A;CEBPB;MOV10;AGO4;ATF7IP;MED27;SOX9;AGO3;NFKB1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.5121220415392335,1.1542310260589561,0.3033292231812577,0.700862177604731,1.0,5/23,12.21%,ZEB2;RNF111;FLCN;THBS1;SDCBP
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.5121220415392335,1.1542310260589561,0.3033292231812577,0.700862177604731,1.0,5/23,12.21%,ZEB2;RNF111;FLCN;THBS1;SDCBP
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.5488798406399678,1.154014437114167,0.32914572864321606,0.700939151344844,1.0,2/16,4.08%,SHH;PKD2
prerank,regulation of synapse organization (GO:0050807),0.5032481365547032,1.1539452108597466,0.29797377830750893,0.7006330966534448,1.0,6/26,11.35%,ARHGAP22;TNF;CLN3;ABHD17B;MEF2C;ABHD17C
prerank,membrane lipid catabolic process (GO:0046466),0.5850963440947968,1.1534626918697752,0.3309143686502177,0.7014479445657528,1.0,2/10,6.84%,SGPL1;FUCA1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.4561081560137845,1.1533601142634853,0.24004085801838612,0.7012036597122252,1.0,31/101,17.24%,TGFB1;NIBAN1;MTOR;ATG7;AURKAIP1;PLXNB2;ASPH;CIRBP;YTHDF3;TBC1D10A;VPS11;LARP4B;BAK1;AMER1;CPEB3;INHBA;RPL26;THBS1;ZCCHC4;METTL3;CASP8;STUB1;PCIF1;POLDIP3;UPF3B;HNRNPD;SOX4;CAPN3;FAF1;HSP90AA1;RPS4X
prerank,transition metal ion homeostasis (GO:0055076),0.5129085335374512,1.153102952234643,0.30213270142180093,0.7014019232270854,1.0,10/28,22.13%,SLC11A1;IREB2;HFE;FTL;B2M;PICALM;ATP13A2;HMOX2;PRKN;MT3
prerank,carboxylic acid transmembrane transport (GO:1905039),0.48662949780506715,1.1529699940285774,0.28202247191011237,0.7012203971825096,1.0,10/40,13.29%,SLC7A7;SLC7A8;SLC38A6;SLC36A1;SLC38A4;SLC36A4;ABCC1;SLC16A1;SLC25A30;SLC38A10
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.4714832987380102,1.152957920019415,0.3,0.7007351615811055,1.0,14/51,19.76%,NCKAP1L;TAOK3;ATP7A;DNM2;TNIK;KIF20B;NTF3;DTNBP1;LRRK2;SNX2;ALS2;TAOK1;MINK1;MAP4K4
prerank,cellular response to insulin stimulus (GO:0032869),0.45696652299246326,1.1528978549614808,0.21717171717171718,0.7003956876987666,1.0,32/124,16.55%,ATP6V0D2;PCSK9;RAB8B;LPIN2;ATP6V0E1;MYO5A;TCIRG1;GRB2;ATP6V1C1;ATP6V1E1;ATP6V0A2;HDAC5;USF1;ATP6V0D1;ZDHHC7;RAB31;AP3S1;EPRS1;BCAR1;DENND4C;ATP6V0A1;ATP6AP1;ZNF106;PHIP;HDAC9;ATP6V0B;BCAR3;GSK3A;SYAP1;IDE;CPEB2;GCK
prerank,regulation of cellular protein metabolic process (GO:0032268),0.47282339853933564,1.152814901223493,0.29360780065005415,0.7000969342728067,1.0,10/47,14.63%,TGFB1;EDNRB;WDR91;APOE;FOXO3;INHBA;CYFIP1;NFKB1;PCIF1;PUM3
prerank,cGMP-mediated signaling (GO:0019934),0.5626971495017212,1.1526456995629386,0.324585635359116,0.7000814539800473,1.0,2/13,4.04%,AQP1;APOE
prerank,nuclear migration (GO:0007097),0.5629924529628081,1.1524690605477743,0.319672131147541,0.7000523580079421,1.0,1/13,0.16%,HOOK3
prerank,regulation of actin filament bundle assembly (GO:0032231),0.5161894292813168,1.1524287101722321,0.3042959427207637,0.6996424642140089,1.0,11/26,21.53%,PLEK;FHOD1;SLC9A1;ACTG1;PFN2;PFN1;SYNPO;CDC42;ROCK2;PRKN;CX3CL1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.5653933884370647,1.152135750744063,0.3315143246930423,0.6999352817849775,1.0,1/13,1.90%,CYRIB
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.450317230155772,1.1520735945079947,0.1981981981981982,0.6996115098082855,1.0,48/166,17.69%,SMOC2;PPP1R3E;NIBAN1;MTOR;MLXIPL;ZEB2;DHX9;TNF;SNCA;ATP7A;PRKD2;PKD2;RGCC;PLXNB2;SLC25A37;P2RX4;CIRBP;YTHDF3;LARP4B;SMAD3;NOS1AP;PPARGC1A;CPEB3;BRPF3;RPL26;THBS1;STN1;ZCCHC4;METTL3;DNA2;KAT7;PCIF1;DDAH1;POLDIP3;UPF3B;HNRNPD;SREBF1;SOX4;STARD4;CD36;BCAR3;PAOX;HIF1A;FAF1;GCK;HSP90AA1;RPS4X;GIPC1
prerank,alanine transport (GO:0032328),0.5881492723753509,1.151628841826483,0.35399449035812675,0.7003337771929458,1.0,3/10,15.22%,SLC36A1;SLC36A4;SLC1A4
prerank,macrophage differentiation (GO:0030225),0.5562679899074271,1.1511361765512265,0.3203342618384401,0.7012112458262683,1.0,6/13,24.56%,CSF1R;CASP8;CDC42;PARP1;VEGFA;IL15
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.3326805704528757,-1.1509081009486701,0.2571428571428571,0.8608778773619679,1.0,11/33,13.27%,TJP1;SEMA6A;BMPER;EPN2;SYNJ2BP;KLF2;KLF4;SMAD1;RHOJ;ADAMTS9;GLUL
prerank,regulation of anoikis (GO:2000209),-0.38643806407051856,-1.1507643470918518,0.23809523809523808,0.856329050106735,1.0,4/19,7.43%,ANKRD13C;CAV1;TLE1;SIK1
prerank,activin receptor signaling pathway (GO:0032924),0.5520366120243685,1.150121257998755,0.32138114209827356,0.7035734938933904,1.0,3/15,10.48%,TGFBR1;SMAD3;INHBA
prerank,organic substance transport (GO:0071702),0.4543264858676255,1.149581149314487,0.20689655172413793,0.7045098523570895,1.0,21/121,15.52%,SLC6A3;SLC6A4;ABCA1;SLCO2B1;ATP8A1;GM2A;MFSD2B;CLN8;ABCG1;MYH9;RAB7A;ABCD1;RAMP1;TAP1;ARRDC4;ABCA4;CUBN;SCAMP2;SLCO1B1;SLC18A1;ABCA3
prerank,regulation of hippo signaling (GO:0035330),0.5411347233328019,1.1493438884774012,0.32564102564102565,0.7046569429089127,1.0,4/17,10.66%,MAPK14;WWC2;MAP2K3;NF2
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.4608229222274696,1.1486318418871542,0.2922422954303932,0.706227903657648,1.0,9/60,8.55%,SMOC2;PTGES3;PKIB;PRKD2;RGCC;XRCC5;CTNNB1;PRKCQ;CCT8
prerank,regulation of protein localization to cell surface (GO:2000008),0.4909092263542264,1.1486134138058506,0.31874298540965207,0.7057680475531014,1.0,13/33,21.82%,TNF;SNX33;CTNNB1;TYROBP;HFE;NEDD4L;RAB11FIP5;STX3;TOR1A;PICALM;LEPROTL1;ABCA2;GPM6B
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.5328069146473301,1.148551201064228,0.315527950310559,0.7054313743924996,1.0,5/20,9.64%,WDTC1;ERLIN2;ERLIN1;ACADL;PRMT3
prerank,negative regulation of chemokine production (GO:0032682),0.5554573200355178,1.1482645838839367,0.33835616438356164,0.7057005273819926,1.0,1/14,1.37%,SIRPA
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.5378647985659093,1.1482281169337458,0.3225388601036269,0.7052923506449555,1.0,8/18,20.44%,CAMK1D;PRKD2;RPS6KA4;LRP8;ADCY8;RPS6KA5;RELN;CRTC3
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.2938603130212731,-1.1479663740883597,0.19047619047619047,0.8598952911284802,1.0,20/50,22.07%,PSME4;PSMD11;PSMA5;PSMA4;PSMD14;AZIN1;PSMC6;PSMC3;PSMB3;PSMC1;PSMD5;PSMA3;PSMD3;PSMD6;PSMC5;ODC1;PSME2;PSMB4;PSMC4;PSMB6
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.5760721219789579,1.147822565038281,0.3429355281207133,0.7058866823701083,1.0,3/12,9.03%,PTPN1;ERN1;BAK1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.4905035569347329,1.1474787056691753,0.31758241758241756,0.7063917171631579,1.0,7/36,8.17%,TGFB1;ANGPT4;TNF;APOE;RGCC;HMGB1;MEF2C
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.511864198558818,1.1473854935137646,0.3143534994068802,0.7061561627747166,1.0,6/27,8.15%,PRKCD;PTPN1;PTPRE;PIP4K2A;PRKCB;PRKCQ
prerank,negative regulation of angiogenesis (GO:0016525),0.459939775432599,1.147119729515725,0.2520833333333333,0.7064529866124951,1.0,10/84,6.76%,KLK3;PF4;CCR2;ANGPT4;PIK3CB;TNF;RGCC;CTNNB1;CREB3L1;STAB1
prerank,mRNA destabilization (GO:0061157),0.4834011534460263,1.146991776975364,0.3063063063063063,0.7062947489755216,1.0,14/38,20.38%,PLEKHN1;YTHDF3;RC3H2;ZC3H12D;MOV10;RC3H1;CPEB3;METTL3;TUT7;MEX3D;FTO;ROCK2;ZFP36L1;DIS3L2
prerank,regulation of protein import into nucleus (GO:0042306),0.48047320041783087,1.1468410640805122,0.3114382785956965,0.7061651357084023,1.0,6/36,10.17%,TGFB1;HCLS1;PRKCD;MDFIC;SMAD3;TPR
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.47192565715997525,1.1467272546849976,0.28068303094983993,0.7059670192441654,1.0,13/52,14.23%,TREM2;LGALS3;PLS1;TNF;CLN3;AKAP5;STAC;ATP2C1;PRKCH;STX3;STAC3;ARF6;LRP1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.45866603582515675,1.1464020285783065,0.2553191489361702,0.7064048769691682,1.0,25/102,16.55%,PCSK9;ADCY7;RAB8B;LPIN2;PRKAR2B;MYO5A;CYSLTR2;PRKCD;ADCY6;HDAC5;USF1;RAB31;EPRS1;DENND4C;PRKACB;HDAC9;NR4A1;NFKB1;ADCY8;ADCY3;SRC;GSK3A;SYAP1;CPEB2;GCK
prerank,positive regulation of dephosphorylation (GO:0035306),0.5081552556696222,1.146335384942671,0.31547619047619047,0.7060957849408805,1.0,13/27,24.71%,TGFB1;PRKCD;SPPL3;SRC;PTPA;SMPD1;ANKLE2;PTBP1;PIN1;MTMR9;PPP1R16B;CAMTA1;PPIA
prerank,copper ion transport (GO:0006825),0.5832880446244113,1.1463227795900908,0.3247863247863248,0.7056210020132947,1.0,4/11,15.17%,ATP7A;ATOX1;SLC31A2;STEAP3
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.6017495734268591,1.14606340143259,0.3357664233576642,0.7058668243989189,1.0,4/10,16.91%,TLR2;CCL2;NOD2;IL33
prerank,regulation of oxidative phosphorylation (GO:0002082),0.5477064768283053,1.1459421265238134,0.33157199471598414,0.7056852667431076,1.0,3/16,7.38%,MLXIPL;ATP7A;ABCD1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.5981279110861594,1.1455694408333994,0.32296296296296295,0.706267447106627,1.0,3/10,8.23%,DIP2B;MYOCD;FLCN
prerank,renal filtration (GO:0097205),0.5721519947702532,1.1455264145412203,0.3242857142857143,0.7058756318669203,1.0,2/10,8.92%,MYO1E;SULF2
prerank,regulation of microtubule-based process (GO:0032886),-0.31921387067964013,-1.145492642500517,0.21818181818181817,0.8628323465944543,1.0,11/36,14.87%,EFNA5;PHLDB2;CYLD;EPHA3;PHLDB1;ROCK1;MAP6;MAPT;TPPP;MARK4;TRIM36
prerank,membrane protein proteolysis (GO:0033619),0.4831545984654489,1.1448655850976244,0.30201342281879195,0.7072184562453951,1.0,9/37,15.03%,TGFB1;NAPSA;MYH9;PRKCQ;SPPL3;PARL;NFKB1;ERAP1;SPPL2A
prerank,response to endoplasmic reticulum stress (GO:0034976),0.4490071964111615,1.1448067282763796,0.2692307692307692,0.7068851210342493,1.0,33/107,21.05%,NIBAN1;ERN1;HERPUD1;TRAF2;ATF3;SEL1L;DDIT3;CREB3L1;TP53;MAP3K5;P4HB;CEBPB;TMX1;BAK1;DERL1;CREB3L2;THBS1;SEC16A;ATF6B;ATP2A3;WFS1;CCDC47;SELENOK;PDIA3;ERO1A;ERP44;FLOT1;ERLEC1;OS9;QRICH1;GSK3B;TMEM259;PRKN
prerank,negative regulation of lymphocyte migration (GO:2000402),0.6060271246712794,1.1445958537559784,0.33084947839046197,0.7069377187214567,1.0,2/10,5.98%,CD200R1;RIPOR2
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.4797831533383018,1.1445045923786024,0.29633740288568255,0.7067080279327637,1.0,18/42,22.53%,VARS1;FARSB;GARS1;PPA2;RARS1;QARS1;EPRS1;LARS2;CARS2;DARS1;DARS2;TARS2;FARS2;AIMP1;YARS1;TARS1;SARS2;SARS1
prerank,cellular biogenic amine metabolic process (GO:0006576),0.5733446300297425,1.144444849201549,0.34492350486787204,0.7063602402999232,1.0,4/12,15.09%,ATP7A;DDC;AMD1;MAOA
prerank,positive regulation of angiogenesis (GO:0045766),0.4518630964625181,1.1443096983394287,0.25656565656565655,0.7062259727539024,1.0,17/108,11.82%,RUNX1;ITGAX;IL1A;SMOC2;PIK3CD;AQP1;ANGPT4;MDK;ANGPTL3;PRKD2;PDCL3;PRKCB;VEGFB;PDCD6;THBS1;ANGPTL4;GRN
prerank,regulation of sister chromatid cohesion (GO:0007063),0.5708273024028578,1.1437771035652926,0.340365682137834,0.7072057403103712,1.0,3/12,8.59%,ESPL1;CTNNB1;RB1
prerank,extracellular matrix organization (GO:0030198),0.44383651282187153,1.1436608701179887,0.15015015015015015,0.7070304349482446,1.0,34/276,7.77%,CTSS;ITGAL;MMP12;ITGA2B;ITGAX;TGFB1;ITGB2;LCP1;SMOC2;SH3PXD2B;ITGA4;ITGB3;ITGB5;TGFBR1;ADAM8;ITGA2;CTSK;CTSL;ADAMTS8;SPP1;ATP7A;ITGA6;COLGALT1;TTR;TGFBI;CRTAP;TIMP1;CD44;ITGAE;CREB3L1;TNR;AGRN;P4HB;LOX
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.5079695298971285,1.142738297379025,0.330188679245283,0.7090850213054972,1.0,9/28,16.59%,PRKCD;PTPN1;PTPRE;PIP4K2A;PRKCB;PRKCQ;PID1;GSK3A;APPL2
prerank,cellular response to amino acid starvation (GO:0034198),0.4582645451639916,1.1424466709030139,0.3023012552301255,0.7094005381347533,1.0,22/71,19.29%,ATP6V0D2;ATP6V0E1;TCIRG1;MTOR;ATP6V1C1;ATP6V1E1;TFEB;MAP3K5;SEH1L;ATP6V0D1;CEBPB;FLCN;IMPACT;DAP;LAMTOR3;ATP6V0B;RNF152;GCN1;LAMTOR1;ATP6V1F;RPTOR;SEC13
prerank,quinone biosynthetic process (GO:1901663),0.5572402876616722,1.1422914952504815,0.3297442799461642,0.7093146812655622,1.0,8/14,21.58%,COQ9;PDSS1;COQ7;COQ8B;FDXR;COQ6;COQ3;UBIAD1
prerank,organelle organization (GO:0006996),0.4430638952128969,1.142229877980145,0.091,0.709002856172691,1.0,109/388,20.04%,FGD2;PLEKHM2;SPTBN5;ATP8B4;LMAN1L;PEX11A;RAB34;THY1;RAB32;NCKIPSD;MTFR2;MDK;TMED3;APOE;ATXN7;ATP7A;PKD2;PYROXD2;REEP6;TNFAIP3;PI4K2A;RAB14;VPS18;ARFGEF1;PLD2;RAB7A;NDP;FMNL3;SYNE1;TTC29;FGD6;USP6NL;CAPZB;LONP1;VMP1;YTHDF3;SH3KBP1;IRAG2;NEDD9;RANBP10;ABCD1;TNIK;MICAL1;MSTO1;VPS11;RAB31;SIPA1;ARHGAP21;ARHGAP10;PPARGC1A;VAPB;BNIP1;TMCC1;DIAPH1;CCL13;ATL1;CCL2;SEC16B;PEX7;SEC16A;PHIP;PI4K2B;PRDX3;CSNK1A1;WDR81;RANBP9;SAR1A;TOR1AIP2;FNBP1L;HCFC1;TOR1A;DES;ATAD3A;LRRK2;HUWE1;TRAPPC11;GAK;EPS15;SIPA1L3;AGTPBP1;TWNK;ABCA3;PDZD8;PDCD6IP;DST;YME1L1;WDPCP;PLAAT3;BIN1;PNPLA3;LMAN2;CDC42;ANK1;ABCD2;UBXN2A;LYSMD3;GOLGB1;GOLPH3;PALLD;ATL2;SEC31A;MCOLN1;RAB29;OPTN;DNM1L;TRAPPC12;ATL3;KIF3A;SORT1
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.5030780726237694,1.1422039895880736,0.3231850117096019,0.708564163925675,1.0,3/24,5.85%,LPCAT1;PGS1;CDS2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5129619760144815,1.142202605465336,0.3155940594059406,0.7080584449532565,1.0,9/24,19.76%,THY1;PTPRJ;DUSP3;NRP1;LIMS1;ARF6;MAPRE2;IQSEC1;MAP4K4
prerank,cellular component assembly (GO:0022607),0.442540836883409,1.1421132307263504,0.169,0.7077937540493869,1.0,59/253,19.73%,NCKAP1L;PTK2B;TGFB1;CD3E;LCP1;NEFH;CD74;VAMP3;SKAP2;SNX9;WIPF1;PLS1;PKP2;MITF;TRAF2;TEAD1;AIF1;ACTB;TP53;VMP1;YTHDF3;NEDD9;MICAL1;CAPZA1;HFE;TRIP13;PPARGC1A;EPRS1;ACTG1;TUBGCP4;LIMS1;PARVB;SOX9;CYFIP1;DET1;MDN1;RANBP9;IKBKG;TSPAN4;DARS1;GAS6;NOC2L;JHY;CAPN3;ABCA3;RTN4;LPXN;CDC42;RHOA;PPIH;PICALM;ADD1;RHOD;ELOB;TINF2;FBLIM1;RBBP4;DNM1L;AIF1L
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.34849434132679386,-1.1418467730126858,0.2459016393442623,0.8693815571152429,1.0,10/23,26.11%,FAR1;ACSL1;HACD1;ELOVL5;ACSL6;ELOVL1;ACSBG1;HACD2;ACSL4;ACSL3
prerank,protein phosphorylation (GO:0006468),0.4412223243764316,1.1415811617943619,0.091,0.7087947160541203,1.0,108/478,17.75%,PTK2B;BTK;FGR;LYN;GMFG;HCK;TGFB1;SYK;FLT3;MAPKAPK3;RSKR;FNIP2;PIK3CD;MAP4K1;TAOK3;CSF1R;TLR2;TGFBR1;TYK2;GTF2H1;PRKCD;CAMK1D;MTOR;TEC;BMP2K;TLR7;MAPK14;GRK3;NEK6;MAP2K6;CDK14;ERN1;PRKD2;MYLK3;CDK8;MORC3;TLK1;TAF1;PRKCB;MKNK1;CDK11B;STK10;TGFBR2;PIM1;MAP3K5;WNK1;PLK4;CDK17;PIM2;PLK2;CSNK1G2;TNIK;CHEK2;PRKCQ;CSNK2A1;CSNK2A2;MAP3K1;STRADB;ABI1;SMG1;CDK7;PRKCH;STK17B;FAM20C;STK32C;RNASEL;PKN1;TXK;RPS6KA4;CCL2;NLK;PRKACB;CSNK1A1;CDK6;GRK4;FYN;MAP3K12;CREB1;MERTK;LIPE;CAMKK2;BRAF;GAS6;STK24;STK3;LRRK2;BMX;WNK4;NIM1K;TESK2;SRC;SGK3;STRADA;GSK3A;INCENP;RPS6KA2;CDK15;COQ8B;MAP3K11;STK4;EPHA4;EPHA8;PPP3CB;PIK3R4;CDK18;RPS6KA5;SIK2;PDPK1
prerank,positive regulation of signaling (GO:0023056),0.48735866403603256,1.141364403246638,0.31905298759864714,0.7089011884612065,1.0,5/37,6.70%,CLSTN1;VAMP3;TNF;SNCA;CD80
prerank,lung epithelium development (GO:0060428),0.5872512237799715,1.1410715486121954,0.34051724137931033,0.7092069638452275,1.0,1/10,0.62%,ASCL1
prerank,apical protein localization (GO:0045176),-0.47134428048141175,-1.140728662785195,0.3323262839879154,0.8679555020647449,1.0,6/10,21.20%,SHROOM3;SHROOM2;ATP8B1;JAM3;GOPC;VANGL2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.32812696571612154,-1.1406965282194537,0.2578125,0.8631782383589326,1.0,7/35,9.43%,RBFOX2;UBR5;NR3C2;AR;KDM3A;TADA3;CALCOCO1
prerank,protein kinase B signaling (GO:0043491),0.5127513758270864,1.1405338101038482,0.3345280764635603,0.7101622664734654,1.0,9/23,25.06%,TGFB1;TNF;CCL2;GAS6;PTEN;ZFP36L1;MT3;IGF1;KDR
prerank,proteoglycan metabolic process (GO:0006029),0.5054653881254342,1.1405322746068571,0.3130952380952381,0.7096605030740518,1.0,5/26,12.55%,HPSE;SULF2;HS3ST4;XYLT1;B4GALT7
prerank,response to UV-B (GO:0010224),-0.43062142183625934,-1.139924499489339,0.30976430976430974,0.8609128103411964,1.0,5/12,22.48%,MSH2;MME;RELA;HYAL1;CDKN1A
prerank,amino acid transmembrane transport (GO:0003333),0.47710949957771026,1.1395175601916598,0.31933701657458563,0.7119721904569278,1.0,10/45,13.29%,LRRC8D;SLC7A7;SLC7A8;SLC38A6;SLC36A1;SLC38A4;SLC16A2;SLC36A4;SLC25A18;SLC38A10
prerank,regulation of cytoplasmic transport (GO:1903649),0.5825019073899246,1.1395118475577828,0.3468208092485549,0.7114808194453561,1.0,5/11,15.26%,DNAJC13;MAP2K2;USP7;LRRK2;SRC
prerank,regulation of endothelial cell migration (GO:0010594),0.45691839002519874,1.1391546463114046,0.2802874743326489,0.7119948299548492,1.0,16/85,11.82%,PTK2B;PIK3CG;RIN2;SMOC2;PIK3CD;ITGB3;ANGPT4;PIK3CB;APOE;PRKD2;PDCD6;BCAR1;NRP1;GPI;THBS1;GRN
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.46058830587901295,1.1390727198664814,0.3040254237288136,0.7117107774060865,1.0,10/67,12.33%,PTK2B;CD3E;CASS4;RREB1;MDK;NEDD9;P4HB;NRP1;LIMS1;CDK6
prerank,ubiquinone biosynthetic process (GO:0006744),0.549724805236902,1.1389052772380766,0.3413654618473896,0.7116708278890663,1.0,8/15,21.58%,COQ9;PDSS1;COQ7;COQ8B;FDXR;COQ6;COQ3;UBIAD1
prerank,retinoid metabolic process (GO:0001523),0.45640813763732224,1.1387098461123737,0.3049421661409043,0.7117271786321766,1.0,10/71,14.55%,CYP1A1;LPL;DHRS3;APOE;TTR;AGRN;LRP8;ABCA4;LRP1;RETSAT
prerank,regulation of biomineral tissue development (GO:0070167),0.4954321589795,1.138587036180022,0.3258026159334126,0.7115830847582254,1.0,5/26,13.65%,TGFB1;BMP2K;CEBPB;SOX9;GAS6
prerank,glycogen metabolic process (GO:0005977),-0.3349141142159826,-1.1385202750796979,0.2129032258064516,0.8603985827841699,1.0,11/27,21.83%,PGM1;PHKA2;PYGB;PHKG2;UGP2;PHKB;PYGM;PER2;AGL;PPP1R3C;PHKA1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.5664957417347831,1.1382144992458219,0.34806629834254144,0.7121410650181478,1.0,2/13,2.86%,CD74;DHX9
prerank,positive regulation of metabolic process (GO:0009893),0.4516194410571838,1.1381549514116824,0.2818181818181818,0.7117924366401054,1.0,24/103,17.07%,IRF4;SYK;CCR2;FABP4;CAMK1D;TNF;CXCR4;IL18;ACADL;CEBPB;FABP5;HSF1;PPARGC1A;CMKLR1;ADIPOR1;DYNC1H1;PRLR;FASN;CD36;ACACA;ZBTB7B;APPL2;CPT2;ADIPOR2
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5154248542335943,1.1376009364747124,0.33875,0.7128467762555455,1.0,2/22,3.34%,GPNMB;RAP2A
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.5137953283175849,1.1375512112691621,0.34169653524492233,0.7124763459487207,1.0,7/23,20.74%,PLEK;CBFA2T3;HDAC4;GSK3A;GCK;TIGAR;CLK2
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.46232028545146325,1.1371668893713196,0.29771784232365145,0.7130226731277728,1.0,20/66,19.36%,GPNMB;CCND3;PKD2;RGCC;CCND2;ANXA1;AIF1;KIF14;RB1;LSM11;CCL2;CDK6;PSME3;INO80;BRD7;PTEN;APPL2;DACT1;RPTOR;PTPN6
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.4941349712875614,1.1370697552771336,0.3329532497149373,0.7127854098045626,1.0,7/33,8.79%,PLCG2;CCND3;RGCC;CCND2;ANXA1;AIF1;LSM11
prerank,negative regulation of myotube differentiation (GO:0010832),0.5653089395046316,1.1370293886293166,0.34206896551724136,0.7123889848271167,1.0,3/12,10.06%,HDAC5;BHLHE41;HDAC4
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.5022113574618049,1.1367134654608417,0.32926829268292684,0.7127784523736981,1.0,7/24,14.48%,CREB3;HERPUD1;CREB3L1;BCL2L1;AQP11;LRRK2;WFS1
prerank,regulation of organelle assembly (GO:1902115),0.45260148633253466,1.1365183477485776,0.2890295358649789,0.7128176949003251,1.0,27/72,19.92%,HCK;TBC1D10C;TBC1D16;TBC1D22A;USP6NL;PLK2;MTMR3;TBC1D10A;CEP76;VPS11;RNF4;RAB1B;TBC1D2;TBC1D17;TBC1D2B;TBC1D8;ATXN2L;TBC1D14;TBC1D22B;PDCD6IP;ATG3;DYNC2LI1;RABEP2;TBC1D12;TBC1D5;SENP6;TRAPPC12
prerank,cellular response to metal ion (GO:0071248),0.44445447555474626,1.1359913059333173,0.2515151515151515,0.7137749433088465,1.0,42/123,22.40%,SLFN14;SYT17;ADCY7;LGMN;AQP1;PLCG2;RASA4;SNCA;PKD2;RASGRP2;P2RX4;MEF2A;SYT2;HFE;MEF2C;SYT10;HSF1;GLRA2;B2M;BRAF;ADCY8;LRRK2;CAPN3;IQGAP1;SCN5A;HVCN1;ADD1;TIGAR;MCOLN1;SMPD1;ATP13A2;PRKN;ITPKB;MT3;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.4570674769944657,1.1359704852987087,0.28512820512820514,0.7133290560566445,1.0,21/82,18.37%,TUBB;PRKAR2B;HAUS2;TUBA4A;CNTRL;CEP192;MAPRE1;TP53;CEP70;PLK4;CEP76;KIF14;HAUS1;DYNC1H1;PCM1;CEP152;HAUS8;NINL;HSP90AA1;AKAP9;CEP63
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.4404960060176652,1.1359053116316544,0.25835866261398177,0.7130131130613395,1.0,33/124,17.98%,ARRB2;PLCB2;FZD10;NFATC1;FZD9;FZD3;CTNNB1;PSMB10;TNRC6A;AP2S1;MOV10;DAAM1;AGO4;CLTC;PSMA2;PFN1;NLK;AGO3;PSME3;PSMB5;GNG2;PSMD8;PSMD7;AP2M1;PSMB9;VANGL1;SMURF1;FZD8;PPP3CB;CDC42;RHOA;PSMD2;AGO2
prerank,respiratory system development (GO:0060541),0.48854931120064243,1.135783369932015,0.3213885778275476,0.7128614919067178,1.0,5/32,6.88%,SHH;BASP1;CEBPA;CHD7;NKX2-1
prerank,sphingolipid metabolic process (GO:0006665),0.4478862653512543,1.1354355728255978,0.27715736040609135,0.7133528647773348,1.0,32/108,20.72%,HEXB;CERS6;SGPL1;CTSA;GM2A;PSAP;CLN8;PRKD2;SMPD3;HEXA;CERK;CSNK1G2;HACD4;B3GALNT1;AGK;ACER3;VAPB;ORMDL2;PPP2CA;ARSA;SUMF2;NSMAF;ARV1;DEGS1;ASAH1;B4GALNT1;SGMS1;GBA2;SPTSSA;SMPD1;ABCA2;SPTSSB
prerank,cellular response to reactive oxygen species (GO:0034614),0.46266431189819845,1.1351365902419894,0.3001049317943337,0.7136885510570731,1.0,12/59,13.25%,SIRPA;NFE2L2;AQP1;PRKCD;PKD2;TNFAIP3;ANXA1;MAP3K5;IMPACT;HDAC6;PRDX3;CAMKK2
prerank,regulation of cellular pH (GO:0030641),0.4954039532075367,1.1346955259491227,0.3100686498855835,0.714370998016661,1.0,10/29,22.04%,SLC9A4;CLN3;SLC9A9;SLC9A1;ATP6AP1;LACC1;SLC9A8;SLC9B1;SLC9A7;CHP1
prerank,regulation of peptide hormone secretion (GO:0090276),0.45675486421488554,1.1342497909333253,0.2914466737064414,0.7150474465533564,1.0,16/67,16.94%,KCNJ11;FFAR2;TNF;RASL10B;CHD7;CACNA1A;HFE;TFAP2B;ITPR2;ENSA;SLC8B1;KCNA5;RAP1A;GCK;CACNA1D;PPP3CB
prerank,neuropeptide signaling pathway (GO:0007218),0.46268617018864255,1.134105556438739,0.30434782608695654,0.7149524802296473,1.0,9/58,12.90%,CYSLTR2;GALR1;SORCS3;PPY;CYSLTR1;GPR37;GLRA2;LTB4R2;SORL1
prerank,regulation of regulated secretory pathway (GO:1903305),0.48930467722680654,1.133897881458398,0.3091732729331823,0.7150172393055189,1.0,7/34,14.11%,SYT17;UNC13D;VPS18;SYT2;SYT10;DTNBP1;LRRK2
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.32281814324250224,-1.1334049519816902,0.20535714285714285,0.8715845573671478,1.0,6/39,3.68%,UTRN;ANK2;FHL1;TCAF1;AHCYL1;FGF12
prerank,striated muscle contraction (GO:0006941),0.4651968858299699,1.1333253505099998,0.3011789924973205,0.7161048796333945,1.0,10/53,15.31%,SCN4B;MYL3;SLC8A1;TTN;STAC;TNNT3;DTNA;STAC3;ARHGEF11;RCSD1
prerank,regulation of amyloid-beta formation (GO:1902003),0.48089118711929607,1.1330750675010959,0.318955732122588,0.7162857541422251,1.0,18/34,25.41%,GSAP;TNF;APOE;ABCG1;SORL1;RTN1;GSK3A;RTN4;EPHA4;BIN1;PICALM;ROCK2;ABCA2;PIN1;EFNA1;IGF1;IFNGR1;GGA3
prerank,camera-type eye development (GO:0043010),-0.35764722639563384,-1.1330245020242629,0.2641509433962264,0.8681303310164282,1.0,7/25,15.17%,CACNA1C;EFEMP1;SHROOM2;FBN1;TENM3;STRA6;PAX2
prerank,protein localization to cell periphery (GO:1990778),0.44315460947184315,1.1329302679192212,0.2542713567839196,0.7161837303102354,1.0,40/133,20.24%,MRAP;FYB1;RAB8B;RAB34;MYO5A;RABEP1;FGF13;RAP2A;PKP2;TNF;TTC7A;TSPAN32;PACS1;TNIK;RAMP1;TSPAN14;RAB11A;RAB40C;F11R;DENND4C;ZDHHC3;CACNB2;SEC16A;ATP1B3;GAS6;GAK;PDZD11;RAP1A;EFR3A;SMURF1;SPTBN4;ANK1;FLOT1;TESC;PACS2;RAB29;ROCK2;FCHO2;P2RY1;INPP5K
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.4356719741414301,1.132759180068474,0.041,0.7161370483453504,1.0,145/834,13.81%,RUNX1;LILRB1;NPAS4;IRF5;MMP12;PF4;ASCL1;SHH;CIITA;IRF4;IRF8;SLC11A1;TGFB1;HCLS1;GATA1;NFE2L2;POU2F2;BRD8;LPIN2;NLRC5;TLR2;NFATC1;MED17;RREB1;NR1H4;MLXIPL;ELF4;SS18L1;ZEB2;DHX9;SP7;IER2;OSM;MAML3;CREB3L4;CREB3;NCK2;BARX2;RXRB;FOXD2;TNF;SREBF2;TET3;MLXIP;PRKD2;PKD2;ITGA6;RGCC;MITF;BPTF;SKI;ATF3;FOXO3;CDK8;CEBPA;DDIT3;SPI1;FHOD1;ZMIZ2;IL18;FIZ1;HDAC5;GALR1;HMGB1;MRTFA;RNF111;TEAD1;USF1;CTNNB1;TFEB;KLF6;TP53;MEF2A;AKNA;TBL1XR1;NKX2-1;NRL;TAL1;MYOCD;YY1;SLC9A1;AGRN;LEO1;TCF20;ASXL2;CEBPB;ST18;LMO2;MEF2C;DOT1L;NKRF;FLCN;CDC5L;TFAP2B;SMAD3;AKIRIN1;IRF2;HSF1;PPARGC1A;CDK7;ATRX;RNF4;LITAF;STAT5B;LRP5;ACTR2;CREBRF;MCRS1;HDAC4;TBL1X;NFIC;RNF10;INHBA;ATAD2;ACTR3;RNASEL;PTOV1;TXK;RPS6KA4;SOX9;NRIP1;NR2C2;PHIP;LAGE3;ATF6B;MTF2;NOD2;ELL;CREB1;SMARCD3;KAT7;ZFP64;SMARCB1;MAX;IKBKG;NR4A1;NFKB1;IRF1;GPS2;INO80;PID1;PCBP1;HCFC1;ZFHX3;RTRAF
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.458578933365967,-1.1323188706181395,0.3024054982817869,0.8658440749457952,1.0,4/10,12.99%,OGT;SELENOS;ZNF692;DGKQ
prerank,limb morphogenesis (GO:0035108),0.5213045382516266,1.1319007503216556,0.33374844333748444,0.7180210483237721,1.0,4/20,13.47%,SHH;SKI;TFAP2B;MEGF8
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.5243929765335235,1.13181565035946,0.33877038895859474,0.7177211617015746,1.0,10/19,21.05%,SREBF2;CSNK2A2;HDAC6;CAMKK2;SREBF1;VDAC1;GSK3A;DNM1L;ATP13A2;PRKN
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.5276299378385424,1.1316206458649951,0.34088050314465407,0.7177872476274326,1.0,3/17,11.25%,GMFG;WASF2;CYFIP1
prerank,purine ribonucleotide transport (GO:0015868),0.5357128406090886,1.1316077332046237,0.3446969696969697,0.7173270969338293,1.0,2/16,2.50%,ABCC6;LRRC8D
prerank,negative regulation of cell motility (GO:2000146),0.44832622154566487,1.1314149582938924,0.2769857433808554,0.7173826499171246,1.0,27/108,17.31%,SHH;TMIGD3;CD74;THY1;PTPRJ;DUSP3;SLURP1;RAP2A;MITF;FOXO3;MCTP1;NKX2-1;RAP2B;FLCN;PODN;SPINT2;DUSP10;VCL;NF2;PTPRU;ADARB1;STK24;PTPRT;NF1;PTEN;EPHA4;LDLRAD4
prerank,pyruvate metabolic process (GO:0006090),0.47392944619370503,1.1314048884173014,0.3183279742765273,0.7169048617805545,1.0,15/52,16.93%,HK3;PFKL;ALDOB;ENO3;SLC16A1;GPI;PDHA1;HK2;VDAC1;ME3;GCK;PGAM4;PGAM1;GAPDHS;LDHA
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.4828869593007866,1.1313364185588668,0.3234624145785877,0.7166067966205116,1.0,7/34,10.90%,CASS4;RREB1;MDK;NEDD9;P4HB;NRP1;LIMS1
prerank,I-kappaB phosphorylation (GO:0007252),0.5846986115823065,1.131332461619189,0.3676056338028169,0.7161195201728896,1.0,2/10,2.88%,TLR2;TLR7
prerank,microtubule-based transport (GO:0099111),-0.4464316246777879,-1.1309552409192207,0.29225352112676056,0.8656442739431579,1.0,11/12,47.21%,DYNC1I1;SPEF2;CABYR;ROPN1L;DYNC1I2;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,transition metal ion transport (GO:0000041),0.48716200182460745,1.1309303307927352,0.3174061433447099,0.7167228696453641,1.0,7/35,14.36%,SLC11A1;ATP7A;ATOX1;IREB2;ATP2C1;FTH1;SLC31A2
prerank,organonitrogen compound catabolic process (GO:1901565),0.4566284089372085,1.1306798617361613,0.2997881355932203,0.7169188917066363,1.0,16/57,18.72%,SGPL1;NPL;MTOR;CLN8;RENBP;NAGK;LIPC;PLA2G7;TXN2;NAALADL1;TRIM24;ERAP1;CAPN3;IDE;USE1;PLA2G5
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.43292097144091946,1.1298106293347487,0.029,0.718825546551397,1.0,199/1082,14.67%,RUNX1;CD86;NFE2;LILRB1;NPAS4;IRF5;MMP12;PF4;ASCL1;SHH;CIITA;IRF4;IRF8;SLC11A1;TGFB1;HCLS1;GATA1;PCID2;CD74;NFE2L2;POU2F2;BRD8;LPIN2;NLRC5;SNX5;TLR2;TGFBR1;NFATC1;MED17;RREB1;GTF2H1;MAD2L2;NR1H4;MTOR;NSD1;MLXIPL;ELF4;SS18L1;ZEB2;DHX9;NUP62;SP7;IER2;OSM;MAML3;CREB3L4;CREB3;NCK2;BARX2;YAF2;RXRB;FOXD2;TNF;CXXC1;SPP1;SREBF2;TET3;APOE;MLXIP;PRKD2;PKD2;ITGA6;RGCC;MITF;UBE2V1;BPTF;SKI;ATF3;FOXO3;CDK8;CEBPA;DDIT3;SPI1;FHOD1;ZMIZ2;IL18;FIZ1;NDP;HIVEP3;HDAC5;GALR1;HMGB1;MRTFA;RNF111;TEAD1;FLI1;USF1;CTNNB1;MAP2K3;TFEB;DNM2;KLF6;CD80;TP53;MEF2A;AKNA;TBL1XR1;NKX2-1;NRL;TAL1;MAP3K5;MYOCD;YY1;SLC9A1;AGRN;SNAI1;TCF20;PIM2;ZFP90;ASXL2;EPO;CEBPB;ST18;CHEK2;LMO2;MEF2C;DOT1L;NKRF;FLCN;CDC5L;MDFIC;TFAP2B;MMS19;SMAD3;BICRA;ARID1A;AKIRIN1;IRF2;HSF1;PPARGC1A;CDK7;ATRX;ATF7IP;RNF4;LITAF;STAT5B;LRP5;ACTR2;CREBRF;MCRS1;HDAC4;ARID1B;TRIM56;TBL1X;NFIC;RNF10;SEC14L2;INHBA;DDX39B;ATAD2;CREB3L2;ACTR3;MAP2K2;RNASEL;ELF2;PTOV1;TXK;RPS6KA4;SOX9;NRIP1;NR2C2;PHIP;LAGE3;ATF6B;MTF2;NOD2;MAP3K12;ELL;HEATR1;CREB1;SMARCD3;KAT7;ZFP64;SMARCB1;MAX;IKBKG;BAMBI;NR4A1;NFKB1;CAMKK2;IRF1;GPS2;FOXK1;INO80;GPATCH3;PID1;PCBP1;HCFC1;ZFHX3;RTRAF;SOX2;BRD7;HNRNPD;MEIS1;ARHGEF11;LBH;ELOF1;SREBF1;SOX4
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.5889348148211243,1.1296381162388482,0.3285302593659942,0.7187674673926349,1.0,5/10,22.13%,SNCA;HDAC6;ETFBKMT;PRKN;MT3
prerank,regulation of dephosphorylation (GO:0035303),0.5420659849116003,1.129276476149429,0.35723771580345287,0.7192174107557747,1.0,7/15,25.88%,MTMR3;SRC;SMG7;INPP5K;MTMR9;PPP1R16B;CDK5RAP3
prerank,cardiac myofibril assembly (GO:0055003),0.5482588017693002,1.1291956876341056,0.33992094861660077,0.7189447458904427,1.0,3/15,6.81%,TTN;MYLK3;MEF2A
prerank,response to estradiol (GO:0032355),0.4852802526041264,1.1289615039264131,0.35079726651480636,0.7191101735334179,1.0,5/31,11.49%,TGFB1;ANXA1;CTNNB1;STAT5B;NRIP1
prerank,carbohydrate homeostasis (GO:0033500),0.45861143876085664,1.128657803818496,0.3002092050209205,0.7194157410341004,1.0,19/67,20.24%,MLXIPL;FFAR2;TENT4B;CEBPA;USF1;TFAP2B;VGF;SLC8B1;ADIPOR1;ADCY8;MBD5;WFS1;SOX4;GCK;APPL2;ADIPOR2;KLF7;PYGL;INPP5K
prerank,smooth muscle cell differentiation (GO:0051145),0.5568769411475556,1.1281987685472876,0.36044880785413747,0.720179957076417,1.0,4/12,8.17%,EDNRB;MRTFA;MYOCD;MEF2C
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5367148998050308,1.1281985518309527,0.35331632653061223,0.7196836674154614,1.0,6/15,23.23%,TNF;TICAM1;NOD2;HIF1A;GBP5;STAT3
prerank,response to ethanol (GO:0045471),0.554353611876136,1.1279532386228965,0.34081902245706736,0.7198361008717504,1.0,2/14,3.00%,ADCY7;SDF4
prerank,epithelium development (GO:0060429),0.4464788128467252,1.1278396629236407,0.2777777777777778,0.7196468543176494,1.0,7/107,5.18%,LGALS3;SHH;MEOX1;TGFB1;CTSB;PKD2;DMBT1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.49356942920061464,1.1276149997799922,0.33983926521239954,0.7197687238885632,1.0,4/32,4.08%,P2RY6;THY1;SNCA;PKD2
prerank,regulation of lymphocyte migration (GO:2000401),0.5852221690436755,1.127557310785789,0.3565459610027855,0.7194421142379276,1.0,2/10,10.78%,STK10;SLC8B1
prerank,regulation of p38MAPK cascade (GO:1900744),0.4792869796394661,1.1274704625847265,0.3474770642201835,0.7191907391299883,1.0,6/35,10.71%,TREM2;SPI1;XDH;GADD45B;DUSP10;RELL1
prerank,negative regulation of defense response (GO:0031348),0.4527387788029108,1.1273782409178248,0.3017689906347555,0.7189580408148714,1.0,9/77,4.87%,SIRPA;METRNL;PRKCD;NR1H4;NLRC3;APOE;OTULIN;TNFAIP3;TRAFD1
prerank,positive regulation of chromatin organization (GO:1905269),0.5629285091244447,1.1272151966065171,0.34156378600823045,0.7189144807149368,1.0,7/12,22.96%,TAL1;ATRX;UBE2N;TINF2;TERF2;TERF2IP;H3-3A
prerank,positive regulation of signaling receptor activity (GO:2000273),0.47962988553652586,1.127145288184926,0.3333333333333333,0.7186238550607109,1.0,11/36,20.19%,CCR2;TAF1;HFE;NRP1;CCL2;HDAC6;BUD31;HIF1A;ITGB1;GREM1;RELN
prerank,central nervous system neuron differentiation (GO:0021953),0.4896772286397284,1.1269526008002837,0.3344671201814059,0.7186685315064809,1.0,3/33,6.34%,DRAXIN;ATP7A;CTNNB1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.5176053602255898,1.126951748050034,0.3496932515337423,0.7181752792542457,1.0,2/21,2.13%,SHH;RAB34
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.4512392982580801,1.126783936887492,0.31030927835051547,0.7181555617424953,1.0,17/78,15.66%,BAG2;NFE2L2;CBFA2T3;RNF180;RNF19B;HERPUD1;CEBPA;TAF1;HECTD1;FZR1;CSNK1A1;DET1;STUB1;RNF144B;LRRK2;PIAS1;GSK3A
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.4879641975123104,1.1256965252751177,0.3416572077185017,0.7206551165688028,1.0,11/36,16.75%,IL1A;PIK3CB;TNF;APOE;GCH1;DNM2;NOS1AP;SPR;DDAH1;HIF1A;HSP90AA1
prerank,respiratory chain complex IV assembly (GO:0008535),-0.3580166323291364,-1.125639005668137,0.3005464480874317,0.8781585374955181,1.0,13/21,30.00%,COX16;OXA1L;COX18;COX15;COA8;COX14;COX17;TIMM21;COA5;SCO1;COA3;COX10;SURF1
prerank,transcription preinitiation complex assembly (GO:0070897),0.5588754935066782,1.125534733275819,0.35636856368563685,0.720586015356238,1.0,5/12,18.98%,POLR1E;TAF1;BDP1;GTF2B;TAF11
prerank,regulation of protein localization to membrane (GO:1905475),-0.33850582896103487,-1.1252597770382207,0.24203821656050956,0.8747243241167798,1.0,6/28,4.08%,SPTBN1;GPC6;GPC5;GSN;MMP14;AR
prerank,limb development (GO:0060173),-0.33801248217921853,-1.1251320469814123,0.25,0.8705031909813224,1.0,13/28,26.06%,PCSK5;KREMEN1;SALL1;GLI3;MAP3K20;RSPO2;PTCH1;FGF10;KAT2B;SMOC1;LRP4;IFT122;KAT2A
prerank,glucose metabolic process (GO:0006006),0.46416188084563215,1.1251240078111804,0.32312565997888065,0.7212329029354123,1.0,14/58,17.29%,KCNJ11;AKR1A1;ALDOB;BRAT1;SORD;ENO3;TFAP2B;PPARGC1A;LRP5;GPI;PGAM1;GAPDHS;GALM;PPARD
prerank,plasma membrane organization (GO:0007009),0.46378612431402044,1.1244238263183384,0.32275132275132273,0.7226412563416788,1.0,20/61,17.96%,BIN2;P2RX7;SNX9;CXCR4;CLN3;SNX33;MYH9;MICALL1;ABCD1;SYTL4;BIN3;DYSF;FNBP1L;ARV1;DEGS1;AHNAK2;ARL8B;BIN1;STX2;ABCD2
prerank,regulation of microtubule nucleation (GO:0010968),-0.46423705484483113,-1.1240469323593016,0.31802120141342755,0.8694589088009702,1.0,2/10,4.54%,EML2;PAK1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.5780104545669483,1.1237591362724915,0.35344827586206895,0.7239503551101335,1.0,2/10,10.19%,PCSK9;NEDD4L
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.5172959357973409,1.123701800304495,0.3204633204633205,0.7236146928497704,1.0,5/18,15.66%,HDAC5;BHLHE41;HDAC4;SOX6;GSK3A
prerank,glycerolipid metabolic process (GO:0046486),0.5682749102505191,1.1236391532778973,0.3522727272727273,0.7232913761694383,1.0,2/11,8.30%,DGKZ;DGKG
prerank,positive regulation of peptidase activity (GO:0010952),0.5118123782210056,1.123048355197893,0.3615676359039191,0.7244226580038435,1.0,4/20,12.57%,VSIR;TANK;GRN;PSME3
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.3697099833101297,-1.122913923621323,0.2727272727272727,0.868481558376273,1.0,6/19,9.50%,APP;MAPK8;MTPN;KLF2;CHRNA7;KLF4
prerank,muscle tissue development (GO:0060537),0.5532960089915187,1.1229022715197299,0.36141304347826086,0.724336653983836,1.0,5/13,15.81%,SHH;SRPK3;POGLUT1;CSRP1;NF1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5471488332135825,1.1227048403280422,0.36388508891928867,0.7243833541102995,1.0,3/13,11.72%,SULT4A1;BPNT1;TPST1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.4377211845713728,1.1216629905064004,0.28197381671701915,0.7266768560554867,1.0,46/110,25.96%,RPL23;RPL17;RPL10A;PNRC2;RPS2;RPL18A;RPS15A;GSPT1;CASC3;SMG1;RPL6;CTIF;RPLP2;RPL26;RPS20;RPS16;PPP2CA;RPS14;RPL19;UPF3B;RPL9;SMG7;RPS11;RPL11;RPS23;RPS4X;UPF2;RPS27;RPL4;PYM1;RPL7A;RPL15;RPL29;RPL22;RPS7;RPS13;EIF3E;RPLP1;RPS15;RPS5;RPL41;RPL10;NCBP1;RPS8;RPL18;RPL5
prerank,positive regulation of vacuole organization (GO:0044090),0.571107651944281,1.1212771921093938,0.3589001447178003,0.7272382863490903,1.0,3/10,11.82%,PIP4K2A;RAB3GAP2;GRN
prerank,protein localization to cell junction (GO:1902414),-0.35462949929771787,-1.1211029353280586,0.27325581395348836,0.869663861368571,1.0,6/22,12.26%,TJP1;NLGN1;BSN;SHANK1;JAM3;HEG1
prerank,regulation of gene expression (GO:0010468),0.4294005934184877,1.120915394770671,0.058,0.7277397590548556,1.0,154/903,13.76%,RUNX1;PTPRC;TREM2;LILRB1;LYN;PF4;CALCR;ASCL1;SHH;ITGAX;SLC11A1;TGFB1;CD3E;HCLS1;STAP1;LGMN;CD74;CAVIN4;SIRPA;NFE2L2;IL1A;VSIR;PIK3CD;RPL23;RBM38;HAVCR2;PLCG2;TLR2;TGFBR1;RREB1;P2RX7;MTOR;NSD1;PIK3CB;MLXIPL;MAPK14;MSR1;SLC8A1;YAF2;PRDM12;TRIM5;TNF;CXXC1;APOE;RGCC;MITF;UBE2V1;ZNF326;PDCL3;TTN;PPIE;NFXL1;CEBPA;DDIT3;SPI1;TRAF3;XDH;WWC2;ZUP1;HDAC5;BACH1;CHD7;TAF1;BTN3A3;SBNO1;AIF1;CREB3L1;CCAR1;CDK11B;TFEB;TYROBP;DNM2;TP53;NKX2-1;TNRC6A;YY1;GCFC2;NFKBID;TICAM1;HINT1;CEBPB;FOXN2;TGFBRAP1;HFE;GRSF1;CHEK2;PRKCQ;MEF2C;FLCN;MOV10;TRIM27;RB1;METTL4;SMAD3;LARP1;GTF2IRD1;RC3H1;NOS1AP;IRF2;TDRD7;PPARGC1A;PCBP3;PUM2;RPL6;AGO4;ATRX;HNRNPL;ACTG1;NFX1;HDAC4;SON;INHBA;MAP2K2;NELL1;LIMS1;HCFC2;DTNBP1;AFF1;ZSCAN26;TXK;RPS6KA4;SOX9;HDAC6;NLK;NR2C2;SEC16B;PTBP2;AGO3;DENND4A;VSTM2A;ZNF628;TRA2B;GZF1;CDK6;PRX;PPP2CA;MTF2;CASP8;BRDT;KAT7;ZFP64;COQ7;FAM50A;NFKB1;TIPARP;FOXN3;BRAF;MEGF8;PID1;PCBP1;GAS6;SOX6;HCFC1;ZFHX3
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.44766983637062174,1.1205690767628507,0.31092436974789917,0.7281695655603775,1.0,16/73,13.86%,LAPTM5;MTCH1;TNF;SNCA;TRAF2;PYCARD;CASP1;XDH;CFLAR;APAF1;CRADD;SMAD3;DAP;CASP8;ATP2A3;TRADD
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.40356162866728507,-1.1202868043067815,0.2979591836734694,0.8677279917960472,1.0,5/15,19.95%,RSPO3;NPHP3;GPC3;WNT5B;SPEF1
prerank,sensory perception of light stimulus (GO:0050953),0.4477901968755506,1.1197821846638767,0.28512820512820514,0.7298520028267849,1.0,14/87,14.48%,CABP4;DRAM2;DHRS3;ATXN7;GUCY2F;WHRN;RP2;CNGB1;MYO7A;CRYBB1;RPGR;CDH23;OAT;WFS1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.4496833390298717,1.119606129580697,0.33756613756613757,0.7298273574941136,1.0,10/55,13.64%,GRB2;MAPK14;SNCA;XDH;TGFBR2;TP53;THBS1;PARL;COQ7;PID1
prerank,synaptic vesicle endocytosis (GO:0048488),0.4805924998905167,1.1194461116576557,0.34321550741163054,0.7297985784920489,1.0,10/33,14.57%,SNCA;PIP5K1C;CEL;DNM2;SYT2;STON2;ITSN1;STON1;SYNJ1;GAK
prerank,N-glycan processing (GO:0006491),0.5281006187100353,1.1192844589310453,0.3780025284450063,0.7297767789251952,1.0,8/18,19.26%,MAN1C1;ST8SIA4;ST8SIA1;MAN2A2;GNPTAB;MGAT4B;MAN1A2;GANC
prerank,AMP metabolic process (GO:0046033),-0.41331775200399956,-1.1189840826257218,0.32616487455197135,0.867091223708137,1.0,10/13,29.34%,ADSS2;NT5E;AK3;AMPD3;AMPD2;ADSL;NUDT2;AK4;NT5C1A;ADSS1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.34639482615146105,-1.1186105761439706,0.28823529411764703,0.8637705071460614,1.0,10/25,11.01%,CACNA1C;ANK2;CAV1;RYR2;CXADR;JUP;CTNNA3;CALM3;DLG1;TBX18
prerank,protein localization to plasma membrane (GO:0072659),0.4373791716491116,1.1185473518073716,0.27181544633901705,0.7313183247321621,1.0,37/129,20.24%,MRAP;FYB1;RAB8B;RAB34;MYO5A;FGF13;RAP2A;PKP2;TNF;TTC7A;TSPAN32;PACS1;TNIK;RAMP1;TSPAN14;RAB11A;RAB40C;F11R;DENND4C;ZDHHC3;CACNB2;SEC16A;ATP1B3;GAS6;GAK;RAP1A;EFR3A;SMURF1;SPTBN4;ANK1;FLOT1;TESC;PACS2;ROCK2;FCHO2;P2RY1;INPP5K
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.4403891576943022,1.118162296552325,0.31237322515212984,0.7319026861895797,1.0,26/88,16.79%,MYO5A;RABEP1;AP1S3;EXOC6;CCDC93;RAB14;RP2;DNM2;VPS35L;CLINT1;AP1B1;FTL;ARFGEF2;DTNBP1;CLTC;EXOC8;EXOC1;SORL1;EXOC2;SNAP23;EXOC5;FTH1;SCAMP2;EPS15;TXNDC5;MON2
prerank,epithelial cell differentiation (GO:0030855),0.44737674546374206,1.1181315007055246,0.29754601226993865,0.7314867834993823,1.0,9/88,9.73%,LGALS3;ASCL1;CTSB;BASP1;DMBT1;ANXA1;ZDHHC7;TDRD7;ANXA4
prerank,positive regulation of cell cycle process (GO:0090068),0.44115916340800226,1.1179517737819187,0.31568228105906315,0.7315137382767888,1.0,16/91,13.79%,PCID2;IL1A;NUP62;RGCC;PLK4;KIF14;KIF20B;KIF23;ATRX;LRP5;DBF4;TPR;PHIP;DYNC1H1;INO80;CDC6
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5679235012478705,1.1179495207889885,0.3564625850340136,0.7310294897861995,1.0,5/11,15.90%,PCBP3;ZNF445;PCBP1;IGF2BP3;RASA1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.45085370493861904,1.1177319853277001,0.3294491525423729,0.7311424297727246,1.0,6/64,7.38%,CYP1A1;ALOX12;DAGLB;HPGD;ACADL;ABCD1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.46041690069987967,-1.1176433619700903,0.31666666666666665,0.8622941851902015,1.0,2/10,5.09%,UPP2;NT5E
prerank,negative regulation of signal transduction (GO:0009968),0.43619248374636305,1.1173262836313502,0.208,0.7317615503373701,1.0,40/249,14.43%,PTPRC;SLAMF1;LYN;UBASH3B;PLEK;CX3CR1;LGMN;NFATC1;PTPRJ;PRKCD;PTPN1;PIK3CB;PTPN18;TNF;SNCA;PTPRE;PIP4K2A;TNFAIP3;MGRN1;XDH;PRKCB;CREB3L1;YWHAB;PRKCQ;CSNK2A1;CSNK2A2;RB1;SULF2;PDCD6;QARS1;NLK;THBS1;METTL3;DDIT4;GPS2;MEGF8;PID1;LRRK2;LRP1;PTPRT
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.4547803611680564,1.1172112703879253,0.33796791443850266,0.7315728729429378,1.0,20/52,25.48%,EDEM1;ERN1;CXXC1;DNAJC3;ATP6V0D1;VAPB;EXTL3;PARP16;TLN1;TATDN2;WFS1;GSK3A;ADD1;SEC31A;DDX11;HYOU1;PPP2R5B;PDIA6;XBP1;EXTL2
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.4870771559153996,1.1169273178922225,0.3380447585394582,0.7318431916638033,1.0,5/30,13.42%,LPAR6;GPR17;F11R;ADGRG1;ARHGEF3
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.4448523848534407,1.116804442594781,0.32298136645962733,0.7316802200839213,1.0,16/74,13.42%,TGFB1;TGFBR1;MAD2L2;MTOR;MDK;RGCC;CTNNB1;TGFBR2;NKX2-1;SNAI1;SMAD3;ADIPOR1;SDCBP;PPP2CA;BAMBI;VASN
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.5189114377540969,1.1167652609881618,0.36917098445595853,0.7312963276611125,1.0,5/19,11.72%,SULT4A1;SLC35B3;BPNT1;PAPSS1;TPST1
prerank,regulation of protein phosphorylation (GO:0001932),0.43385033058680833,1.11569308902103,0.2022022022022022,0.733719748821779,1.0,57/256,18.90%,TREM2;GPNMB;FGR;LYN;TGFB1;ITGB2;CD74;SIRPA;FNIP2;ITGB3;CSF1R;NIBAN1;NSD1;RAP2A;SEMA4D;CCND3;TNF;FNIP1;PDCL3;TTN;PLXNB2;ATF3;BRAT1;XDH;CCND2;VEGFB;TNIK;CEBPB;FLCN;IBTK;IMPACT;SOX9;PHIP;PPP2CA;FYN;NPTN;PPIL4;CAMKK2;PID1;GAS6;MOB1B;LRRK2;AKAP8L;WDFY2;IRGM;PTEN;STK4;HSP90AA1;CORO1C;PECAM1;SPTBN4;ANGPT1;FLOT1;PPP2R5C;PAQR3;ATG14;VEGFD
prerank,cardiac muscle tissue development (GO:0048738),-0.29790729543655264,-1.1156362597747558,0.23684210526315788,0.8642767883657378,1.0,12/50,11.01%,SGCD;BMPR1A;BMP4;SGCZ;AKAP13;CACNA1G;BMP5;SMAD4;SIK1;SMAD5;SMAD1;TBX18
prerank,regulation of vasculogenesis (GO:2001212),0.5461586237384318,1.1155007877902021,0.3746594005449591,0.7337443530503905,1.0,2/14,5.36%,RIN2;XDH
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.5508719122536547,1.1154885588025705,0.37534246575342467,0.7332835332204841,1.0,3/12,16.03%,CTPS1;CDA;DPYSL5
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.45052877152905096,1.1154347796616666,0.3305526590198123,0.732937383750442,1.0,17/72,15.69%,TREM2;CORO1A;CYRIB;PRKCD;FGF13;SNCA;APOE;ATXN7;ARFGEF1;MAPRE1;PFN2;IAPP;PFN1;TWF2;SSH2;PFDN1;CAMSAP2
prerank,peptidyl-serine phosphorylation (GO:0018105),0.4373270612886957,1.1151747274626884,0.2851365015166835,0.733147158575211,1.0,48/153,21.26%,MAPKAPK3;MAP4K1;TGFBR1;PRKCD;CAMK1D;MTOR;MAPK14;NEK6;ERN1;PRKD2;MORC3;TLK1;TAF1;PRKCB;MKNK1;TGFBR2;WNK1;PLK2;CSNK1G2;PRKCQ;CSNK2A1;CSNK2A2;SMG1;PRKCH;STK32C;MAP2K2;PKN1;RPS6KA4;NLK;CSNK1A1;MAP3K12;GAS6;LRRK2;SGK3;RPS6KA2;STK4;RPS6KA5;PDPK1;VRK1;TOP1;ROCK2;DCLK3;TLK2;GSK3B;CDK5R1;MARK1;CSNK1G3;BRSK1
prerank,positive regulation of response to stimulus (GO:0048584),0.48062401336759714,1.1151115376498948,0.35706340378198,0.7328550831593219,1.0,7/40,15.37%,FCGR2B;PRKCD;DHX9;CD80;YPEL3;B2M;IER5
prerank,negative regulation of insulin secretion (GO:0046676),0.52600457349476,1.115050128143432,0.35667963683527887,0.7325291146436974,1.0,1/17,0.65%,KCNJ11
prerank,regulation of protein dephosphorylation (GO:0035304),0.48004286263399015,1.1147065561711675,0.35738068812430634,0.7329909037805404,1.0,6/37,9.11%,TGFB1;PRKCD;PPP6R1;YWHAB;ENSA;SPPL3
prerank,cytosolic calcium ion transport (GO:0060401),-0.33001320224414415,-1.1145490837363832,0.3076923076923077,0.8630509416809594,1.0,9/28,13.22%,CACNA1C;RYR2;AFG3L2;MICU1;JPH1;ITPR3;SLC35G1;MCUR1;CACNA2D1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.3294420769289192,-1.1144149917849835,0.26,0.8590720614233693,1.0,10/29,17.03%,RAB6A;GOSR1;COG2;TRAPPC3;COG1;COPZ2;RAB6B;COPB1;VTI1B;COPG2
prerank,intracellular lipid transport (GO:0032365),0.5087668944943361,1.1140485389674626,0.37192118226600984,0.7343128254905795,1.0,7/21,17.96%,SLC25A20;NPC2;ABCD1;ARV1;ACACA;CPT2;ABCD2
prerank,cellular response to purine-containing compound (GO:0071415),0.5697918378880045,1.1131879577545403,0.38686131386861317,0.7361585295274,1.0,2/10,3.21%,P2RY6;SLC8A1
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.5394582281892284,1.1130759250222095,0.37622377622377623,0.7359673125379469,1.0,4/13,9.06%,CNOT8;GTPBP1;MOV10;RC3H1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.49545114045589134,1.1127699999253569,0.38238993710691827,0.7363319506640665,1.0,6/23,11.65%,TSPAN6;NLRC3;SPI1;ADGRG3;TMSB4X;ADIPOR1
prerank,BMP signaling pathway (GO:0030509),-0.26408742806515195,-1.11217146556797,0.2413793103448276,0.8618810208070129,1.0,14/62,13.19%,BMPR1A;SLC33A1;RGMA;BMP4;ACVR1;TGFBR3;ACVRL1;SMAD9;BMP5;SMAD4;SMAD5;SMAD1;RGMB;SMAD6
prerank,endodermal cell differentiation (GO:0035987),0.49253372087139685,1.1113914987104603,0.36257309941520466,0.7396040578238945,1.0,6/31,10.48%,ITGB2;ITGA4;ITGB5;LEO1;SETD2;INHBA
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.5396914515370425,1.11131247819432,0.3622795115332429,0.7393003650790254,1.0,3/14,13.65%,RFFL;GPS2;GAS6
prerank,regulation of cell differentiation (GO:0045595),0.4354313961799883,1.1110535425196615,0.25851703406813625,0.7395106451967068,1.0,30/148,18.48%,RUNX1;LGALS3;SHH;TGFB1;SMYD5;TGFBR1;MDK;TNF;TRPS1;PRKCB;CEBPB;OCIAD1;TFAP2B;NTF3;TAF8;CDK6;PPP2CA;GPS2;ZFHX3;YWHAH;NF1;FADS1;MCRIP1;BIN1;TRIP4;VHL;CASZ1;MAFB;BIRC2;GREM1
prerank,regulation of monooxygenase activity (GO:0032768),0.5044258703059361,1.1107742356997823,0.358695652173913,0.7397431375109129,1.0,10/23,20.85%,IL1A;SNCA;DNM2;NOS1AP;SPR;DDAH1;POR;HSP90AA1;GDNF;ZDHHC21
prerank,DNA replication initiation (GO:0006270),0.4765578986834264,1.1103051809926177,0.3721198156682028,0.7405426960328126,1.0,10/37,16.65%,MCM5;ORC3;MCM2;MCM6;DBF4;ORC4;CDC34;CDC6;NOC3L;LRWD1
prerank,melanosome organization (GO:0032438),0.4962475073553379,1.10980343063931,0.3742621015348288,0.7414664353579785,1.0,5/26,13.27%,LYST;RAB32;AP3D1;DTNBP1;TRAPPC6A
prerank,glutamate receptor signaling pathway (GO:0007215),0.46659601975090614,1.1096986885482174,0.35825892857142855,0.7412400591427099,1.0,4/37,4.47%,PTK2B;DAGLB;GNAQ;CLN3
prerank,glutamate metabolic process (GO:0006536),0.5148339767373715,1.109577236615899,0.3706467661691542,0.7410561289130467,1.0,2/19,2.80%,DGLUCY;MTHFS
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.4433668374072456,1.1095684313361138,0.3265720081135903,0.7405939229787407,1.0,20/90,17.07%,IRF4;SYK;CCR2;FABP4;CXCR4;IL18;ACADL;CEBPB;FABP5;HSF1;PPARGC1A;CMKLR1;ADIPOR1;DYNC1H1;PRLR;CD36;ZBTB7B;APPL2;CPT2;ADIPOR2
prerank,ion transport (GO:0006811),0.44361094863565415,1.1095170945907997,0.28789420142421157,0.740236875011781,1.0,21/111,15.01%,P2RX1;SLC15A3;TSPO;HCN4;SLC9A4;KCNN4;SLC8A1;SLC36A1;SLC9A9;CNGB1;SLC9A1;WNK1;AQP11;SLC8B1;SLC20A2;SLC25A18;CTNS;SLC9A8;VDAC2;WNK4;VDAC1
prerank,secretion (GO:0046903),0.5397137442887763,1.1094026969690158,0.3657219973009447,0.7400709349779714,1.0,1/14,1.62%,TPD52
prerank,regulation of cell population proliferation (GO:0042127),0.4269433418539742,1.1090714597944247,0.112,0.7404360631104294,1.0,104/691,13.79%,RUNX1;CD86;PTK2B;SLAMF1;GPNMB;LYN;PF4;CXCL5;SHH;HCK;ITGAX;TGFB1;HCLS1;FLT3;TMIGD3;LGMN;STAT5A;IL1A;TSPO;CBFA2T3;RPL23;CSF1R;TGFBR1;PTPRJ;TCIRG1;SLURP1;MLXIPL;S100B;TNFRSF11A;ADAMTS8;NUP62;OSM;NCK2;UTP20;IL12RB2;PKD2;RGCC;SKI;IL6R;CNOT8;CEBPA;ATP8A2;TIMP1;CCND2;XRCC5;SPEG;CTNNB1;AIF1;GAB2;CCAR1;TGFBR2;TP53;RPS15A;MYOCD;CCKBR;PIM2;STAT4;EPO;ST18;FLT3LG;CSNK2A1;KIF14;DOT1L;AQP11;KIF20B;TFAP2B;NTF3;GID8;PODN;ABI1;CCL14;HSF1;STRN;STAT5B;LRP5;ACER3;P3H2;HDAC4;NAP1L1;INHBA;NF2;LIMS1;SH2B3;SOX9;CHERP;THBS1;PTPRU;AGO3;PHIP;PRDX3;SDCBP;CIAO1;CDK6;ADGRG1;NRG1;TBC1D8;STX3;ADARB1;BAMBI;PRLR;IRF1;DDAH1;RAB33B;CDC6
prerank,protein deneddylation (GO:0000338),0.5747067798762046,1.1087175220102226,0.3791606367583213,0.7408826880768687,1.0,3/10,13.76%,COPS6;COPS4;TOR1A
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.5554030021752523,1.1086804188789632,0.36962750716332377,0.7404925396372938,1.0,6/12,19.28%,ACTB;ZDHHC7;ACTG1;AHI1;LAMA3;SCRIB
prerank,cellular response to calcium ion (GO:0071277),0.4436575305235987,1.1083623239021232,0.3577405857740586,0.7408282475846795,1.0,10/67,8.73%,SYT17;LGMN;PLCG2;RASA4;PKD2;RASGRP2;MEF2A;SYT2;MEF2C;SYT10
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.5467895213156596,1.1083296492642085,0.3875338753387534,0.740427155110218,1.0,1/13,2.14%,TYK2
prerank,anion transport (GO:0006820),0.4845855825432596,1.1079578254722442,0.3596881959910913,0.7408807162997281,1.0,8/33,17.22%,TSPO;SLCO2B1;LRRC8D;VDAC2;SLCO1B1;VDAC1;LRRC8C;SLC13A3
prerank,negative regulation of hormone secretion (GO:0046888),0.5627196184653436,1.1078209323804777,0.36934306569343067,0.7407853472995168,1.0,2/10,12.59%,OSM;RAB11FIP5
prerank,cation transmembrane transport (GO:0098655),0.46641508214909827,1.107517435439359,0.35300546448087433,0.7411327997320449,1.0,6/44,10.24%,KCNJ11;SLC25A20;SLC7A8;PKD2;SLC25A38;SLC36A4
prerank,regulation of vasculature development (GO:1901342),0.49195355330979235,1.1071698170789586,0.3555291319857313,0.7415890469813511,1.0,2/26,6.34%,GPNMB;CTNNB1
prerank,chloride transport (GO:0006821),-0.2635023810691788,-1.107058190104798,0.23529411764705882,0.8735735995176481,1.0,17/74,18.08%,SLC12A2;CLIC4;SLC12A7;SLC4A10;GABRB2;CLCN6;GABRB1;SLC26A7;GABRA2;CLIC5;CLCN2;GABRB3;TTYH3;ANO4;TTYH1;SLC12A8;GLRB
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.48431159121933537,1.1068565342549772,0.3646080760095012,0.7419537102257507,1.0,5/27,10.69%,TGFB1;DHX9;TP53;PUM2;MAP2K2
prerank,positive regulation of telomerase activity (GO:0051973),0.46718542349710773,1.1063744945802385,0.36395759717314485,0.7427536549894656,1.0,5/33,8.15%,PTGES3;PKIB;XRCC5;CTNNB1;PRKCQ
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.53590307079706,1.1062192661514492,0.3814713896457766,0.7426701569972763,1.0,5/13,13.22%,EDEM1;SEC16B;SEC16A;SORL1;SAR1A
prerank,regulation of centrosome cycle (GO:0046605),-0.35485073603170525,-1.105810194696977,0.2717391304347826,0.8732191157541362,1.0,12/21,38.20%,NAT10;CHMP5;MARK4;CHMP4B;CHMP2A;NPM1;ATF5;CHMP4C;CHMP1B;GEN1;CEP131;XRCC3
prerank,calcium-ion regulated exocytosis (GO:0017156),0.49258184265955723,1.1053382327068262,0.3460166468489893,0.7445481449958301,1.0,4/27,8.73%,SYT17;SDF4;SYT2;SYT10
prerank,positive regulation of protein modification process (GO:0031401),0.428279934154296,1.1053026028293724,0.254,0.7441543743271841,1.0,25/203,9.16%,TREM2;GPNMB;LYN;TGFB1;CD74;ITGB3;CSF1R;NIBAN1;PRKCD;RAP2A;SEMA4D;CCND3;TNF;ATG7;FNIP1;BRAT1;RAB3GAP2;CCND2;VEGFB;SVIP;TNIK;RAMP1;FLCN;SPPL3;NOS1AP
prerank,glial cell development (GO:0021782),0.49643820213604467,1.1051454280140476,0.3762135922330097,0.7440855721893449,1.0,7/25,15.81%,NRROS;TLR2;MDK;EIF2B2;CDK6;SOX4;NF1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.3366451061855382,-1.1050603484355275,0.2934131736526946,0.8713881427491186,1.0,4/26,4.52%,ANK2;FHL1;ATP1B1;ACTN2
prerank,primary neural tube formation (GO:0014020),0.4781710562818583,1.1049665510815356,0.3669724770642202,0.7440947314075586,1.0,3/30,4.57%,TGFB1;SKI;PLXNB2
prerank,regulation of protein catabolic process (GO:0042176),0.43539251019004366,1.1046842542003241,0.3323108384458078,0.7443326431437094,1.0,38/99,22.59%,CTSA;MAD2L2;WDR91;TNF;ATG7;TNFAIP3;RAB7A;PLK2;CHEK2;CSNK2A1;NEDD4L;GFAP;FZR1;ITCH;STX5;SORL1;TIPARP;HUWE1;AREL1;GSK3A;SMURF1;IDE;FAF1;FURIN;VPS28;DACT1;SF3B3;SEC22B;ATP13A2;GSK3B;WWP1;PRKN;AZIN2;ZDHHC2;PIN1;FLNA;MDM4;NKD1
prerank,regulation of cellular catabolic process (GO:0031329),0.45016726369821475,1.1042792529500616,0.3595744680851064,0.7449523855169453,1.0,21/62,22.01%,DRAM2;WDR91;PSAP;PIP4K2A;GPR137B;DDIT3;DCAF12;ABCD1;MTMR3;RAB39B;HDAC6;LRRK2;VPS29;KEAP1;RPTOR;HSPB1;OSBPL7;PRKN;SCARB2;RRAGA;RRAGB
prerank,negative regulation of protein modification process (GO:0031400),0.4474624218470168,1.1042159370612752,0.33264248704663213,0.7446279767280699,1.0,24/79,21.05%,LYN;TGFB1;SIRPA;DBI;NIBAN1;CRTAP;XDH;YWHAB;ENSA;IBTK;IMPACT;CDYL;PID1;LRRK2;PTPA;PTEN;CORO1C;PAQR3;ATG14;TINF2;INPP5K;GSK3B;FXYD1;PRKN
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.4943326137595298,1.103973817446591,0.3802469135802469,0.7447740148810019,1.0,4/22,13.10%,CYRIB;TRAF2;MALT1;B2M
prerank,Golgi organization (GO:0007030),0.4372629210451415,1.1038394940922238,0.3080040526849038,0.744658908995637,1.0,36/112,20.74%,PLEKHM2;SPTBN5;ATP8B4;LMAN1L;TMED3;PI4K2A;ARFGEF1;SYNE1;USP6NL;VMP1;ARHGAP21;SEC16B;SEC16A;PI4K2B;CSNK1A1;STX5;LRRK2;HUWE1;TRAPPC11;VTI1A;GAK;LMAN2;CDC42;UBXN2A;LYSMD3;VRK1;GOLGB1;GOLPH3;ATL2;RAB29;OPTN;TRAPPC12;ATL3;SEC22B;COG7;NSFL1C
prerank,cardiac muscle contraction (GO:0060048),0.47535347721802,1.1037278891162372,0.36605080831408776,0.7444750799389845,1.0,4/34,4.35%,SCN4B;MYL3;SLC8A1;TTN
prerank,nucleosome organization (GO:0034728),0.4494235434383257,1.1035290306340055,0.3468516542155816,0.7445333928634221,1.0,13/55,15.26%,NFE2;BPTF;SRCAP;ARID1A;ATRX;SETD2;NAP1L1;SOX9;SMARCD3;BRDT;SMARCB1;INO80;SPTY2D1
prerank,positive regulation of vasculogenesis (GO:2001214),0.5697575709389009,1.103257717059991,0.37554585152838427,0.7447979806931413,1.0,1/10,1.10%,RIN2
prerank,cell-substrate junction assembly (GO:0007044),-0.3095371756976592,-1.1031678526565534,0.29365079365079366,0.8730348116970085,1.0,9/33,8.41%,SORBS1;PEAK1;TAOK2;ACTN2;PTPRK;BCR;WHAMM;ITGB4;PLEC
prerank,negative regulation of peptidase activity (GO:0010466),-0.2874978615617057,-1.1029248490616372,0.22077922077922077,0.8694321802480715,1.0,12/47,18.44%,SERPINH1;SERPINE2;SERPING1;SPOCK2;TIMP2;TIMP3;SERPINB9;ECM1;SERPINF1;AKT1;PARK7;GAPDH
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.4728491631210324,1.1024411498304436,0.3803317535545024,0.7465724760289648,1.0,4/29,9.10%,SLC11A1;CIRBP;LARP1;TENT5C
prerank,nucleoside catabolic process (GO:0009164),-0.4290631539520188,-1.1022018630231631,0.3626760563380282,0.8673101771501298,1.0,2/11,5.09%,UPP2;NT5E
prerank,response to muscle stretch (GO:0035994),0.5361724437456963,1.101807573307227,0.3885941644562334,0.7478124484205271,1.0,4/15,7.13%,SLC8A1;TTN;CTNNB1;SLC9A1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.4462606057014872,-1.1017261299644285,0.33024691358024694,0.8646121067219747,1.0,4/10,15.88%,SOX5;ACVRL1;PKDCC;ZBTB16
prerank,inner dynein arm assembly (GO:0036159),-0.44455786551627774,-1.1016575295361986,0.33935018050541516,0.8606328563699112,1.0,9/10,52.82%,DNAAF5;CCDC39;CFAP100;CCDC40;DNAAF4;DNAH1;DNAAF1;DNAI3;CFAP73
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5581496083748384,1.1016339525880368,0.3669064748201439,0.7477837928723265,1.0,3/11,13.66%,PRKCD;MAP3K5;STK24
prerank,anterior/posterior pattern specification (GO:0009952),0.4520290216817569,1.1015745263445453,0.3590568060021436,0.7474521147561043,1.0,9/53,10.44%,BASP1;TGFBR1;HES7;SKI;DDIT3;BHLHE41;ATP6AP2;LRP5;HOXA6
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.4009182351747982,-1.101196801730078,0.32421875,0.8578740606965113,1.0,4/15,7.38%,ATF2;RAD17;TIPIN;MRE11
prerank,regulation of stem cell differentiation (GO:2000736),0.43665511124103806,1.1008774983592609,0.3282208588957055,0.7487995935225827,1.0,18/89,16.32%,RUNX1;SMYD5;GATA1;SP7;OSM;PSMB10;TAL1;OCIAD1;LMO2;PSMA2;METTL3;PSME3;ITCH;PSMB5;PSMD8;PSMD7;PSMB9;PUS7
prerank,rRNA metabolic process (GO:0016072),0.42908562942982187,1.100871926544353,0.29158316633266534,0.7483339812371386,1.0,45/160,21.18%,SLFN14;RPL23;RPL17;EMG1;RPL10A;UTP20;NOB1;TEX10;FBL;EXOSC1;RPS2;LAS1L;RPL18A;KRR1;RPL6;DDX27;RPLP2;RPL26;RPS16;MDN1;UTP11;HEATR1;RPS14;RPL19;C1D;PES1;RPL9;IMP3;PIH1D1;RPL11;WDR12;RPS27;RPL4;FCF1;WDR75;EXOSC3;RPL7A;UTP3;RPL15;RPL29;RRP7A;TRIR;RPL22;IMP4;RPS7
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.4409969595733913,1.1006012352364518,0.33962264150943394,0.7485516908854369,1.0,26/73,22.96%,SMYD5;TAF1A;POLR1E;DNMT3A;SF3B1;SPI1;HDAC5;ACTB;TRIM27;HDAC4;POLR1B;POLR2L;HDAC6;RBBP7;MTF2;ERCC6;TASOR;MYO1C;PHF1;POLR2E;RBBP4;EED;TAF1C;SMARCA5;AEBP2;H3-3A
prerank,regulation of execution phase of apoptosis (GO:1900117),0.5518869718657565,1.100413357197089,0.37518248175182484,0.7485910756390911,1.0,3/11,6.80%,FZD3;BCL2L1;TP53
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.4691194590597773,1.1003765145312054,0.38333333333333336,0.7482048448166895,1.0,8/39,13.65%,NFE2L2;ITGA4;TNF;RGCC;TNFAIP3;CCL2;THBS1;GAS6
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.4166559836978861,-1.1003662222677821,0.3271375464684015,0.8564027446940545,1.0,7/13,23.30%,NOS3;GLUL;GAD1;NOS1;GLS;ALDH4A1;GLS2
prerank,negative regulation of gene expression (GO:0010629),0.4252875854625892,1.10014339711955,0.22,0.7483392804383581,1.0,48/302,13.44%,RUNX1;SLFN14;GPNMB;SLC11A1;TGFB1;SMYD5;CD3E;FCGR2B;LGMN;SRGN;HAVCR2;MSR1;ERN1;TNF;DNMT3A;APOE;RGCC;CNOT8;SPI1;XDH;PPP1R11;TAF1;CREB3L1;TNRC6A;YY1;ZC3H12D;MEF2C;FLCN;ATP2B1;MOV10;TRIM27;RB1;LARP1;AGO4;EPRS1;CPEB3;MAP2K2;RPS6KA4;PTBP2;AGO3;RBBP7;METTL3;MTF2;HDAC9;NPTN;NFKB1;TIPARP;PCIF1
prerank,regulation of cellular protein localization (GO:1903827),0.46048881273697956,1.0998658872233384,0.3693304535637149,0.7486174234039285,1.0,13/45,20.25%,SHH;LCP1;PTPN1;CTNNB1;HFE;SETD2;RAB11FIP5;TOR1A;HSP90AA1;CCDC66;ABCA2;ATP13A2;SPIDR
prerank,glucan catabolic process (GO:0009251),0.5270815231041811,1.0992856120640837,0.37745740498034075,0.7496823978132953,1.0,1/15,0.77%,MGAM
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.4443855394910052,1.0987634656559988,0.3295336787564767,0.7505744880355041,1.0,22/76,21.09%,BAG2;CBFA2T3;LAPTM5;RNF180;RNF19B;CEBPA;TAF1;HECTD1;CSNK1A1;DET1;STUB1;RNF144B;LRRK2;PIAS1;GSK3A;SMURF1;PTEN;KEAP1;ELOB;GSK3B;PRKN;PABIR1
prerank,negative regulation of nuclear division (GO:0051784),0.5584457619336909,1.0986227545337772,0.3717201166180758,0.7504661638365806,1.0,2/11,4.05%,AURKAIP1;NME6
prerank,tube closure (GO:0060606),0.4754461666223825,1.0985650431066962,0.3755707762557078,0.7501258507071884,1.0,3/31,4.57%,TGFB1;SKI;PLXNB2
prerank,protein stabilization (GO:0050821),0.42828461894943515,1.0982981613379867,0.3092369477911647,0.7503484101883251,1.0,63/168,22.44%,BAG2;RPL23;PRKCD;GNAQ;PTGES3;PDCL3;SEL1L;CRTAP;MORC3;TAF1;OTUD3;TYROBP;PIM2;CHEK2;CCT8;PPARGC1A;CDK7;ATF7IP;TBL1X;PFN2;USP7;PFN1;NLK;GRN;SEC16A;WDR81;CREB1;ATP1B3;STK3;ATP1B2;HCFC1;USP9X;BAG1;CCT5;WFS1;SOX4;PRKRA;IRGM;RTN4;RPL11;PTEN;STK4;EPHA4;STXBP4;HSP90AA1;VHL;FLOT1;CREBL2;TESC;COG7;NAA15;TELO2;BAG4;PRKN;RPS7;CRYAB;PIN1;FLNA;CHP1;MT3;MTMR9;WIZ;MDM4
prerank,negative regulation of response to external stimulus (GO:0032102),0.435582568740728,1.0974675411277988,0.33537206931702346,0.7521109285916424,1.0,13/105,8.80%,SIRPA;METRNL;PRKCD;DUSP3;NR1H4;NLRC3;RTN4RL1;APOE;OTULIN;TNFAIP3;TRAFD1;RB1;CASK
prerank,V(D)J recombination (GO:0033151),0.5629828700828914,1.0971987159617314,0.3808139534883721,0.7523438032546181,1.0,2/11,6.20%,HMGB1;LIG3
prerank,adenine nucleotide transport (GO:0051503),0.5164033613079289,1.0966980727342366,0.3780025284450063,0.7532096249452431,1.0,2/17,2.50%,ABCC6;LRRC8D
prerank,sodium ion homeostasis (GO:0055078),0.5009691808411272,1.096435883594482,0.3864795918367347,0.7534362192244525,1.0,6/21,13.68%,SLC8A1;SLC9A1;TFAP2B;NEDD4L;ATP1B3;ATP1B2
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.5108762174738869,1.0962059565441504,0.3676268861454047,0.7535656808428524,1.0,4/15,9.62%,EDEM1;RAB3GAP2;SPCS2;SPCS1
prerank,ceramide transport (GO:0035627),0.5504436042748245,1.0961384870753001,0.3813443072702332,0.7532709919380558,1.0,2/12,6.05%,PSAP;ABCB4
prerank,pteridine-containing compound metabolic process (GO:0042558),0.5363226844387678,1.0956539340614826,0.39864864864864863,0.754135967611381,1.0,5/13,17.33%,GCH1;QDPR;SPR;HSP90AA1;FPGS
prerank,regulation of signal transduction (GO:0009966),0.4269247607395037,1.0956299501077542,0.2935871743486974,0.7537268832980154,1.0,26/190,12.40%,RUNX1;TREM2;UBASH3B;TGFB1;CD3E;IRAK2;PTPN1;LFNG;NUP62;DHRS3;GRK3;NCK2;MTCH1;TRIM5;SREBF2;TIMP1;CD80;ZDHHC7;MDFIC;ZDHHC3;DTNBP1;CD63;WDR11;GRK4;PPP2CA;FYN
prerank,regulation of small molecule metabolic process (GO:0062012),0.4767477661563658,1.0951783072587633,0.3824561403508772,0.7543907004536536,1.0,8/28,14.97%,NR1H4;APOE;FMO5;ACADL;ADIPOR1;TTC39B;FOXK1;ARV1
prerank,visual perception (GO:0007601),0.43685755868451703,1.095101682934362,0.35354573484069884,0.7540962383027087,1.0,10/84,8.45%,CABP4;DRAM2;DHRS3;ATXN7;GUCY2F;REEP6;RP2;CNGB1;MYO7A;CRYBB1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.45188731543048166,1.0950594619271614,0.35859124866595515,0.7537201219683621,1.0,10/56,9.82%,ESPL1;CCND3;RGCC;CDC23;CCND2;ANXA1;AIF1;RB1;LSM11;RAB11A
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.42565757479237415,1.0949600547631106,0.281563126252505,0.7534927051409109,1.0,21/182,8.59%,RUNX1;APOBEC1;TGFB1;CD3E;PCSK9;LGMN;HAVCR2;RIN3;MSR1;TNF;APOE;SPI1;XDH;TAF1;CREB3L1;TNRC6A;YY1;MEF2C;FLCN;MOV10;RB1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.43889861482526454,1.0948569100619912,0.3420229405630866,0.753301626969682,1.0,7/75,6.76%,KLK3;PF4;CCR2;ANGPT4;RGCC;CTNNB1;STAB1
prerank,cholesterol metabolic process (GO:0008203),0.43831761878134157,1.0946221390059974,0.35640495867768596,0.7534762791611386,1.0,8/68,5.61%,ABCA1;ANGPTL3;CLN8;APOE;ABCG1;LDLRAP1;CEL;SOAT2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.26844331367564905,-1.0944095168149874,0.273972602739726,0.8701856215324698,1.0,24/55,22.07%,FBXL7;FHL1;PSME4;PSMD11;PSMA5;PSMA4;RBX1;PSMD14;PSMC6;PSMC3;PINX1;PSMB3;PSMC1;PSMD5;PSMA3;PSMD3;PSMD6;PSMC5;USP47;PSME2;PSMB4;PSMC4;SKP1;PSMB6
prerank,embryonic axis specification (GO:0000578),-0.39499204063434207,-1.0942404132680534,0.28695652173913044,0.8665909127819226,1.0,10/15,43.91%,COBL;TBX3;SMAD6;PTCH1;STIL;FZD5;CXXC4;RIPPLY2;WNT7A;HOXD8
prerank,regulation of receptor binding (GO:1900120),0.5694844290494763,1.0936665617438106,0.3903133903133903,0.7555640289407048,1.0,3/10,13.62%,HFE;B2M;ATP2A3
prerank,positive regulation of synaptic transmission (GO:0050806),0.4377244705837229,1.0935697475800128,0.3454356846473029,0.7553294739727492,1.0,12/72,13.62%,PTK2B;CCR2;LGMN;CLSTN1;TNF;AKAP5;PLK2;ZDHHC3;DTNBP1;CCL2;NPTN;ADCY8
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.4756894177677727,1.093021396497895,0.3879210220673635,0.7563222862648359,1.0,6/30,10.49%,CD74;CD44;BCL2L1;SNAI1;TPT1;DDX39B
prerank,response to cAMP (GO:0051591),0.46384147924409425,1.0929588856040564,0.3655555555555556,0.7560117615440427,1.0,11/37,21.25%,AQP1;HCN4;PKD2;RAP1B;VGF;RAPGEF1;RAP1A;AKAP9;ZFP36L1;INPP5K;HCN1
prerank,negative regulation of transmembrane transport (GO:0034763),0.5601113441172224,1.0929261380827515,0.3840782122905028,0.7556278543190371,1.0,4/10,20.24%,PRKCB;THBS1;CTTNBP2NL;INPP5K
prerank,protein K11-linked ubiquitination (GO:0070979),0.4777253038199618,1.0927887637834064,0.3881656804733728,0.7555086944783164,1.0,7/27,11.04%,CDC23;UBE2D3;UBE2S;UBE2E3;RNF4;UBE2H;FZR1
prerank,regulation of muscle contraction (GO:0006937),-0.3348511456634433,-1.092783085935699,0.2754491017964072,0.8670388227151206,1.0,7/26,12.24%,CHRM2;CAV1;SRI;KCNA1;ATP1A2;PLCE1;KCNB2
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.4392839520073299,1.0924836729338727,0.3682572614107884,0.7558787421151464,1.0,13/70,13.86%,TGFB1;P2RX7;TNF;TRAF2;IL6R;BCL2L1;CRADD;SMAD3;BAK1;INHBA;TNFRSF1B;CASP8;TRADD
prerank,regulation of lipid kinase activity (GO:0043550),0.550791683273075,1.0923261388018293,0.3894878706199461,0.7557954155555362,1.0,3/11,12.45%,WDR91;RB1;WDR81
prerank,intermediate filament organization (GO:0045109),0.518160300796582,1.0923122019657383,0.4020618556701031,0.7553514050528672,1.0,5/17,17.42%,BFSP2;PKP2;GFAP;DES;DNAJB6
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.4364551958080379,1.0920038018083233,0.36610878661087864,0.7557156406667119,1.0,16/73,16.32%,RUNX1;GATA1;OSM;SPI1;PSMB10;TAL1;LMO2;PSMA2;METTL3;PSME3;ITCH;PSMB5;PSMD8;PSMD7;PSMB9;PUS7
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.5323672358460214,1.0918171125976839,0.3921832884097035,0.7557346920553522,1.0,3/15,15.76%,DDC;SMOX;PAOX
prerank,nuclear body organization (GO:0030575),-0.4168464337811832,-1.0914759260512346,0.32342007434944237,0.8670839584995869,1.0,4/12,22.78%,AFF2;PML;WRAP53;USP50
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5561158618607435,1.0913836021629058,0.3813559322033898,0.7564641753956253,1.0,4/11,14.55%,ZMIZ2;ARID1A;ARID1B;ELOF1
prerank,regulation of glycogen metabolic process (GO:0070873),0.5573254037062688,1.0912145958570398,0.4,0.7564457011398776,1.0,1/12,1.66%,PPP1R3E
prerank,oligodendrocyte differentiation (GO:0048709),0.5096208731640587,1.0910392115918883,0.37468030690537085,0.7564136174816837,1.0,4/19,13.72%,SHH;EIF2B2;SOX9;SOX6
prerank,positive regulation of telomere capping (GO:1904355),0.5198611274699703,1.0908508049111425,0.37017310252996005,0.7564483978371059,1.0,4/17,14.40%,PKIB;PRKCQ;TNKS2;HNRNPD
prerank,O-glycan processing (GO:0016266),0.45075779704381885,1.090747730261876,0.3742004264392324,0.7562406475180666,1.0,8/54,8.38%,GCNT1;GALNT10;MUC13;GALNT15;GALNT7;ST6GALNAC4;GALNT6;ST3GAL1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.4289619406006653,1.0905883829398295,0.3659531090723751,0.756170525392592,1.0,38/87,25.96%,RPL23;RPL17;RPL10A;RPS2;RPL18A;RPS15A;RPL6;RPLP2;RPL26;RPS20;RPS16;RPS14;RPL19;SRP19;RPL9;RPS11;RPL11;RPS23;RPS4X;SEC63;RPS27;RPL4;RPL7A;RPL15;RPL29;RPL22;RPS7;SRP14;RPS13;RPLP1;RPS15;SRP9;RPS5;RPL41;RPL10;RPS8;RPL18;RPL5
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5453230509041586,1.0902852196229647,0.3819918144611187,0.7565129751212581,1.0,3/13,10.88%,PLXNC1;PLXNB2;NRP1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.44836920398479285,1.0901027198292477,0.3665594855305466,0.7564925986667098,1.0,13/50,18.56%,AQP1;RFFL;TNF;FNIP1;SNCA;CD44;CSNK2A1;THBS1;GAS6;PIH1D1;SRC;DNAJB6;MAP2K5
prerank,carnitine metabolic process (GO:0009437),0.5387078662007783,1.0898931825939806,0.4008207934336525,0.7565653760160748,1.0,5/12,23.73%,ALDH9A1;ACADL;CPT2;CROT;CPT1A
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4518584494712443,1.0895588995920642,0.3695652173913043,0.7570161556460651,1.0,13/52,14.23%,TREM2;LGALS3;PLS1;TNF;AKAP5;STAC;PRKCH;EPB41;EPB41L2;STX3;STAC3;ARF6;LRP1
prerank,carboxylic acid transport (GO:0046942),0.4444093266689165,1.0894188151169197,0.3814102564102564,0.7568772994511108,1.0,14/55,17.61%,PSAP;SLC7A8;SLC38A6;CLN3;SLC36A1;SLC16A2;SLC6A15;SLC36A4;SLC16A1;SLC66A1;SLC1A4;SLC16A6;SLC13A3;SLC16A13
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.5506706891997216,1.089361426906162,0.3907380607814761,0.756555941688163,1.0,2/11,4.62%,FBL;TENT4B
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.5560890788685736,1.088869861728001,0.39680232558139533,0.7573709987092297,1.0,3/11,9.06%,ANXA1;RC3H2;RC3H1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.4330735810852364,1.0884618886941086,0.3696537678207739,0.7579716382104719,1.0,23/85,21.09%,TREM2;BAG2;CBFA2T3;RNF180;RNF19B;CEBPA;TAF1;HECTD1;ATXN3;CSNK1A1;DET1;STUB1;RNF144B;LRRK2;PIAS1;GSK3A;KEAP1;ELOB;GSK3B;OSBPL7;TMEM259;PRKN;PABIR1
prerank,positive regulation of bone mineralization (GO:0030501),0.46501162355512776,1.0880541803859396,0.39599555061179087,0.7586082462807023,1.0,7/35,10.88%,TGFB1;P2RX7;SLC8A1;FZD9;MEF2C;ATP2B1;NELL1
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.4276434718974544,1.0878584839380203,0.32196589769307926,0.7586542624523852,1.0,23/151,10.48%,CERS6;LPIN2;SGPL1;LPCAT1;ESD;AKR1A1;HPGDS;GCNT1;APOE;PRKD2;GCH1;PCYT1A;CHKB;LPCAT2;CSNK1G2;CSNK2A1;CSNK2A2;SLC44A2;HACD4;ACER3;VAPB;STARD10;INHBA
prerank,cellular polysaccharide catabolic process (GO:0044247),0.5144595116158119,1.0874070767086943,0.3992248062015504,0.7593263199342436,1.0,1/16,0.77%,MGAM
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.48233444731370234,1.0867127074388487,0.38141809290953543,0.7607409213585383,1.0,6/25,16.84%,PTGES3;SDF2L1;DNAJC7;BAG1;GAK;ERO1A
prerank,regulation of transferase activity (GO:0051338),0.5122522498465338,1.0866453241802279,0.38089171974522296,0.7604359029437868,1.0,2/17,1.97%,NLRC5;SLAMF8
prerank,cellular response to light stimulus (GO:0071482),0.44217406993664077,1.086383921118034,0.37604166666666666,0.7606579223239894,1.0,14/66,16.33%,AQP1;PRKCD;SAG;TAF1;TP53;CNGB1;YY1;BAK1;RPL26;METTL3;INO80;NOC2L;BMF;COPS9
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.48086225615201794,1.0858690963158966,0.383054892601432,0.7615279422595438,1.0,6/26,8.79%,CCND3;RGCC;CCND2;ANXA1;AIF1;LSM11
prerank,positive regulation of nervous system process (GO:0031646),0.5158384873134381,1.0858370312100505,0.3909677419354839,0.7611267852780004,1.0,4/18,11.73%,ITGAX;CST7;RNF10;TNFRSF1B
prerank,fat cell differentiation (GO:0045444),0.4480660796653818,1.0857972363127306,0.40471092077087795,0.7607485673598164,1.0,13/57,15.36%,METRNL;SDF4;FFAR2;CEBPA;OSBPL11;BBS9;TFAP2B;PPARGC1A;TMEM120A;NR4A1;PID1;ERAP1;OSBPL8
prerank,cardiac cell development (GO:0055006),0.5586046493501724,1.0850318751949648,0.39913544668587897,0.7622876650609858,1.0,2/11,4.35%,SLC8A1;TTN
prerank,response to interferon-beta (GO:0035456),0.4923935094787725,1.084912499504648,0.38179519595448796,0.7621749004073632,1.0,7/22,20.69%,AIM2;CDC34;IRF1;UBE2G2;IRGM;UBE2K;IFITM2
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.5510524351001469,1.0847681336926063,0.4201438848920863,0.7621038672363737,1.0,2/11,6.80%,MAD2L2;TP53
prerank,organic acid transport (GO:0015849),0.4356478536927428,1.084632797082751,0.3516819571865443,0.7619875213556048,1.0,21/94,18.47%,SLC16A10;SLCO2B1;NR1H4;LRRC8D;ABCC3;SLC7A7;SLC7A8;SLC36A1;SLC38A4;SLC43A2;SLC6A15;SLC16A1;SLC25A30;SLC25A45;SLCO1B1;SLC1A4;SLC43A1;SLC13A3;PPARD;STARD5;RXRA
prerank,positive regulation of biomineral tissue development (GO:0070169),0.4626288552910459,1.084277700026843,0.3759733036707453,0.7624713954308278,1.0,8/40,10.88%,TGFB1;P2RX7;SLC8A1;FZD9;CEBPB;MEF2C;ATP2B1;NELL1
prerank,regulation of histone acetylation (GO:0035065),0.47002172324995584,1.0837981761881812,0.4011494252873563,0.7632580291377831,1.0,13/33,21.86%,SNCA;SPI1;HDAC5;MYOCD;FLCN;PPARGC1A;RPS6KA4;NOC2L;BRD7;RPS6KA5;SETD5;IWS1;CTBP1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.4601497792865101,1.0832312413373175,0.39578713968957874,0.7642447348174221,1.0,8/41,16.04%,TGFB1;MYL3;PKP2;TGFBR2;MEF2C;SOX4;GSK3A;RBPJ
prerank,positive regulation of lipid metabolic process (GO:0045834),0.500226573622133,1.0831729712189573,0.39081885856079407,0.7639040934342155,1.0,4/22,4.04%,MTOR;MLXIPL;ANGPTL3;APOE
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.45444859913579144,1.0829408312456614,0.3881578947368421,0.7640560002182307,1.0,7/43,6.36%,P2RY6;ERN1;TNF;LDLRAP1;IL6R;IL18;AIF1
prerank,cellular protein-containing complex assembly (GO:0034622),0.41755272174934316,1.0828887197809678,0.3316582914572864,0.7637127145397391,1.0,39/159,18.32%,TGFB1;CD3E;VAMP3;TBCEL;DHX9;PTGES3;NCK2;SNX9;SNCA;TRAF2;DNAI4;FMOD;LONP1;AP2S1;TBCC;PSMG3;CHCHD4;SMAD3;HSF1;UVRAG;EIF4H;TPR;IMMP2L;CLTC;NUP205;NRG1;PRLR;SRP19;BBS12;EPS15;SRC;AP2M1;RTN4;HSP90AA1;GTF2B;BIN1;MIS12;PICALM;ANGPT1
prerank,diol biosynthetic process (GO:0034312),0.5217240594355369,1.0826666998470498,0.39090909090909093,0.7638479979151598,1.0,6/15,20.15%,GCH1;QDPR;ACER3;SPR;ASAH1;ABCA2
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.43256424734015747,1.082359376768185,0.37591623036649213,0.7641988117433145,1.0,15/70,16.32%,RUNX1;GATA1;OSM;PSMB10;TAL1;LMO2;PSMA2;METTL3;PSME3;ITCH;PSMB5;PSMD8;PSMD7;PSMB9;PUS7
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.3736747632997839,-1.0817906045513157,0.33170731707317075,0.8927970079893984,1.0,8/17,23.03%,SOD2;PRKG1;TGFB3;PPARG;TAFA5;PDCD4;CDKN1A;GPER1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.31933728644833737,-1.0816376755165036,0.2865853658536585,0.8890815744076134,1.0,12/27,26.85%,ANK2;DMD;JPH1;FKBP1A;SELENON;AHNAK;NOS1;JPH2;JPH4;PDE4D;CACNB3;CALM2
prerank,regulation of protein metabolic process (GO:0051246),0.44750027281910815,1.0815797088920884,0.40352811466372657,0.7658762795842615,1.0,13/44,19.50%,GSAP;SHH;APOE;TRAF3;CHEK2;NEDD4L;SPOP;PARL;WFS1;FAF1;FURIN;MAP2K5;ROCK2
prerank,insulin receptor signaling pathway (GO:0008286),0.4364812217317245,1.0813532439458606,0.3775933609958506,0.7659896333703855,1.0,18/69,16.27%,ATP6V0D2;ATP6V0E1;TCIRG1;GRB2;ATP6V1C1;ATP6V1E1;ATP6V0A2;ATP6V0D1;AP3S1;BCAR1;ATP6V0A1;ATP6AP1;ZNF106;PHIP;ATP6V0B;BCAR3;GSK3A;IDE
prerank,negative regulation of cell population proliferation (GO:0008285),0.4199668346182979,1.0810647373134818,0.245,0.7662660661171222,1.0,62/351,14.94%,TREM2;PTK2B;GPNMB;LYN;TGFB1;TMIGD3;IL1A;CD300A;CBFA2T3;PTPRJ;SLURP1;ADAMTS8;NUP62;OSM;NCK2;UTP20;NLRC3;PKD2;RGCC;SKI;CEBPA;TNFAIP3;ATP8A2;MORC3;SPEG;CTNNB1;AIF1;MTSS1;TP53;MYOCD;PIM2;SLC16A2;ST18;FLCN;AQP11;TFAP2B;PODN;DUSP10;ABI1;STRN;P3H2;INHBA;NF2;NELL1;SH2B3;SOX9;CHERP;PTPRU;CDK6;ADGRG1;B4GALT7;ADARB1;B2M;IRF1;DDAH1;CDC6;FTH1;SOX2;BRD7;SOX4;TMEM127;PRKRA
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.4398523822008853,1.081012230443512,0.37323177366702937,0.7659245913894872,1.0,5/53,6.96%,TREM2;BAG2;APOE;XPO1;GNA12
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.33305531644757375,-1.0806726599377925,0.39226519337016574,0.887832312785546,1.0,8/22,18.43%,GDI1;SP100;LMAN1;RAB23;INSIG1;DMTN;PARK7;CABP1
prerank,muscle filament sliding (GO:0030049),0.4548073175241003,1.0804786124566086,0.3908685968819599,0.7663535312475366,1.0,6/38,13.83%,MYL3;TTN;TNNT3;TPM4;TPM3;DES
prerank,actin-myosin filament sliding (GO:0033275),0.4548073175241003,1.0804786124566086,0.3908685968819599,0.7663535312475366,1.0,6/38,13.83%,MYL3;TTN;TNNT3;TPM4;TPM3;DES
prerank,GPI anchor biosynthetic process (GO:0006506),0.47128794284026404,1.0799653831405926,0.38346727898966704,0.7672017611244798,1.0,13/30,24.23%,PIGM;PIGL;PIGX;PIGV;PGAP1;PIGH;PGAP2;PIGC;PIGU;PIGN;DPM2;PIGP;PIGK
prerank,determination of left/right symmetry (GO:0007368),0.45677286526219385,1.0797554464830055,0.3986409966024915,0.7673176741496416,1.0,3/36,5.58%,SHH;PKD2;ODAD2
prerank,DNA strand elongation (GO:0022616),-0.3671808553894777,-1.0789903800131115,0.34977578475336324,0.8891249867500552,1.0,12/18,35.10%,MRE11;POLA1;GINS3;TERT;MCM4;DCLRE1B;MCMDC2;POLD2;RFC3;GINS1;RFC4;MCM3
prerank,macroautophagy (GO:0016236),0.42067537527021664,1.0781829184226592,0.3603238866396761,0.7710103328993303,1.0,40/118,22.83%,LIX1;TCIRG1;VTA1;ATG7;MAP1LC3B;CLN3;PIP4K2A;PLEKHM1;MTMR3;FUNDC1;CSNK2A1;CSNK2A2;TECPR1;SNAP29;UVRAG;VPS37C;BECN1;TOMM40;VPS39;VDAC1;SRC;SNX14;ATG3;ARL8B;VPS28;PIK3R4;VPS33B;ATG14;PLAA;TBC1D5;TOMM20;MFN1;ATP13A2;EPG5;STAM2;PRKN;VAMP8;RB1CC1;ATG10;MTMR14
prerank,positive regulation of neuron differentiation (GO:0045666),0.45553132871712115,1.0779931981701667,0.3811659192825112,0.7710206786169534,1.0,5/40,9.89%,ASCL1;GPRC5B;MMD;MEF2C;IMPACT
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.5036506535047165,1.0778952493816545,0.40102827763496146,0.770801609714484,1.0,4/17,10.88%,MDK;AIF1;DOCK4;NRP1
prerank,negative regulation of cellular process (GO:0048523),0.4148621199556829,1.0775649948811719,0.216,0.7712118560642911,1.0,88/521,14.94%,TREM2;PTK2B;LILRB1;GPNMB;LYN;SHH;TGFB1;SMYD5;FCGR2B;TMIGD3;SIRPA;IL1A;CBFA2T3;VAMP3;TLR2;PTPRJ;SLURP1;PLXNC1;ADAMTS8;MDK;NUP62;OSM;CD9;NCK2;UTP20;SEMA4D;NME6;PKD2;RGCC;TGFBI;SKI;PLXNB2;HPGD;CEBPA;ATP8A2;MYH9;RIPOR2;SPEG;CTNNB1;CDA;TP53;MYOCD;PIM2;EPO;ST18;FLCN;AQP11;TFAP2B;RB1;SMAD3;CASK;SIPA1;PODN;ABI1;TMEM98;STRN;TNFRSF21;P3H2;PODXL;IMPACT;ARHGDIB;ACTN1;INHBA;NF2;DYSF;SH2B3;CHERP;BECN1;PTPRU;PARP16;TNFRSF1B;RBBP7;CDK6;PPP2CA;ADGRG1;ADARB1;NR4A1;ARHGDIA;IRF1;DDAH1;CTTNBP2NL;CDC6;FTH1;BRD7;WFS1;SOX4;TMEM127;PRKRA
prerank,neural tube closure (GO:0001843),0.46163838914820826,1.077414538346016,0.3934240362811791,0.7711387424308563,1.0,3/34,4.57%,TGFB1;SKI;PLXNB2
prerank,modulation of chemical synaptic transmission (GO:0050804),0.42022695240992863,1.0772491935113655,0.3800813008130081,0.7711187055028111,1.0,14/107,8.75%,NPAS4;CX3CR1;ABR;DGKZ;CLSTN1;TNF;CLN3;CEL;MCTP1;BTBD9;CACNA1A;MEF2C;EIF4EBP2;NTF3
prerank,negative regulation of cell differentiation (GO:0045596),0.4204076881168949,1.0769145279827894,0.32898696088264795,0.7715380858258797,1.0,31/181,14.42%,PTK2B;ASCL1;SHH;TGFB1;ABCA1;ITGB3;TGFBR1;MAD2L2;SEMA4D;PKP2;TNF;ABCG1;SKI;XDH;NKX2-1;MYOCD;LEO1;RB1;SMAD3;LRP5;SOX9;SRA1;ADIPOR1;CDK6;PPP2CA;BAMBI;VASN;GPS2;SOX2;BBS12;MEIS1
prerank,epiboly involved in wound healing (GO:0090505),0.5013804261821091,1.0767949656587186,0.3900804289544236,0.7713974945575176,1.0,8/16,22.98%,LCP1;CD44;MRTFA;TOR1A;RHOA;FLNA;DDR1;PDPN
prerank,ubiquinone metabolic process (GO:0006743),0.5156801593478981,1.0766872635322686,0.38603425559947296,0.7712092241932398,1.0,8/15,21.58%,COQ9;PDSS1;COQ7;COQ8B;FDXR;COQ6;COQ3;UBIAD1
prerank,neurotrophin signaling pathway (GO:0038179),0.4815279653713419,1.0757362214293633,0.40359897172236503,0.7731675355751717,1.0,8/21,20.04%,GRB2;NTF3;BCAR1;RAPGEF1;DDIT4;RAP1A;KIDINS220;SORT1
prerank,regulation of TOR signaling (GO:0032006),0.43038121184762845,1.075575588567813,0.4016649323621228,0.7730840578347624,1.0,23/67,22.17%,TREM2;RFFL;FNIP1;GNA12;SEH1L;FLCN;PDCD6;DDIT4;GAS6;LAMTOR3;TMEM127;PIH1D1;GSK3A;TTI1;LAMTOR1;GOLPH3;RPTOR;SEC13;TELO2;RRAGA;PIK3CA;RRAGB;NPRL3
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.5115157409653752,1.07543409349719,0.4057217165149545,0.7729805714273015,1.0,4/16,11.44%,TNF;CLN3;GSPT1;HDAC6
prerank,peptidyl-serine modification (GO:0018209),0.41984657294598693,1.0754066695826658,0.349748743718593,0.7725725900394596,1.0,51/166,21.26%,MAPKAPK3;MAP4K1;TGFBR1;PRKCD;CAMK1D;MTOR;MAPK14;NEK6;PRKD2;MORC3;TLK1;TAF1;PRKCB;MKNK1;TGFBR2;WNK1;PLK2;CSNK1G2;POGLUT2;PRKCQ;CSNK2A1;CSNK2A2;POGLUT1;SMG1;PRKCH;HPF1;STK32C;PKN1;RPS6KA4;CSNK1A1;MAP3K12;GAS6;GALNT2;LRRK2;SGK3;MGAT5B;RPS6KA2;STK4;RPS6KA5;PDPK1;GALNT1;VRK1;TOP1;ROCK2;DCLK3;TLK2;GSK3B;CDK5R1;MARK1;CSNK1G3;BRSK1
prerank,protein targeting to ER (GO:0045047),0.41932316658620183,1.0749968637951741,0.37678207739307534,0.7731888897640498,1.0,41/99,25.96%,RPL23;RPL17;EDEM1;RPL10A;RPS2;RPL18A;RPS15A;SPCS2;RPL6;SPCS1;RPLP2;RPL26;RPS20;RPS16;RPS14;RPL19;SRP19;RPL9;RPS11;RPL11;RPS23;RPS4X;SEC63;RPS27;RPL4;RPL7A;RPL15;RPL29;RPL22;RPS7;SRP14;RPS13;RPLP1;RPS15;SRP9;RPS5;RPL41;RPL10;RPS8;RPL18;RPL5
prerank,sulfate transport (GO:0008272),-0.39725875822133794,-1.0738576780964955,0.3852140077821012,0.9011173520554566,1.0,7/14,30.45%,SLC26A2;SLC26A7;SLC25A14;SLC25A11;SLC26A6;RACGAP1;SLC26A8
prerank,anterograde axonal transport (GO:0008089),-0.2906839475784084,-1.073761581378124,0.29906542056074764,0.8972785080224962,1.0,8/37,10.56%,DLG2;KIF5B;SPAST;SOD1;NEFL;KIF3B;MAPK8IP3;KIF5A
prerank,artery morphogenesis (GO:0048844),0.46900268220403324,1.0735187569368578,0.41656942823803966,0.7765771762975295,1.0,8/30,15.81%,TGFBR1;ANGPTL3;PKD2;HPGD;TFAP2B;NRP1;LRP1;NF1
prerank,positive regulation of heart contraction (GO:0045823),-0.3629813289136544,-1.0735110999746378,0.31443298969072164,0.8938846446126396,1.0,8/19,29.44%,RYR2;ATP1A2;EDN1;EDN3;CHGA;TGFB2;ATP2A2;SCN3B
prerank,negative regulation of chemotaxis (GO:0050922),-0.30668814631388064,-1.0734562794982825,0.3288590604026846,0.8900375640396796,1.0,9/31,8.24%,SEMA6A;ROBO2;SEMA5A;SEMA6D;SEMA3A;ROBO1;SLIT2;SEMA3C;SEMA3D
prerank,fatty acid oxidation (GO:0019395),0.44277988340864805,1.073430973269077,0.39403620873269435,0.7763539420111584,1.0,16/57,18.76%,ALOX12;EHHADH;ACAD10;ACADL;ABCD1;PEX13;PPARGC1A;ECHS1;ILVBL;ECI1;ADIPOR1;CPT2;ADIPOR2;PPARD;ABCD2;ECHDC1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.5504475298191853,1.0733921039065426,0.415014164305949,0.7759900071011222,1.0,7/11,23.34%,RREB1;CD44;SRC;CORO1C;ARPIN;PDPN;ARHGEF7
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.4637785963465829,1.072948365617147,0.40843507214206437,0.7766471689353996,1.0,6/35,11.87%,CD300A;MTOR;PPP6R1;PPP1R11;BOD1L1;PPP4R4
prerank,cell cycle checkpoint signaling (GO:0000075),0.5291759809626846,1.0728515812998975,0.4180790960451977,0.7764299330544969,1.0,7/12,27.58%,NABP1;PLK2;PRCC;ZWINT;BUB1B;WEE1;ZWILCH
prerank,positive regulation of mitochondrion organization (GO:0010822),0.4403740622751587,1.0727903890969737,0.40523560209424087,0.7761060186392111,1.0,14/57,21.05%,TREM2;DDHD1;PYCARD;TP53;BAK1;PPARGC1A;CAMKK2;BMF;GSK3A;TNFSF10;FIS1;DNM1L;GSK3B;PRKN
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.3411984243531358,-1.0724946115690879,0.33014354066985646,0.8889174552824901,1.0,11/22,21.67%,NTRK3;STMN2;NGF;EHD1;MAPT;RAPGEF2;AKT1;MAGI2;WASF1;BDNF;NTRK2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.4948879388464968,1.0724857674023272,0.4206451612903226,0.7764068951066148,1.0,10/20,22.33%,KCTD17;HERPUD1;BAK1;WFS1;CCDC47;SELENOK;PACS2;FIS1;RAP1GDS1;TGM2
prerank,histone H2A acetylation (GO:0043968),0.5081054017199782,1.0720912084684335,0.39841688654353563,0.776992240279272,1.0,7/16,24.82%,BRD8;EP400;NAA40;MEAF6;MORF4L2;MORF4L1;SPHK2
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.48365644931456225,1.0717055659772174,0.3997569866342649,0.7775431620713512,1.0,5/24,9.03%,ITGB3;PTPN1;PRKD2;PRKCB;PDCD6
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.42868884928536166,1.0712640838591807,0.37755102040816324,0.7782300422627363,1.0,23/94,18.37%,TUBB;MKS1;PRKAR2B;HAUS2;TUBA4A;CNTRL;CEP192;MAPRE1;CEP70;PLK4;CEP76;HAUS1;RAB11A;DYNC1H1;PCM1;CEP152;HAUS8;CEP162;AHI1;NINL;HSP90AA1;AKAP9;CEP63
prerank,regulation of cellular localization (GO:0060341),0.4490468817304143,1.0712263198575172,0.4155701754385965,0.7778505265549361,1.0,9/46,16.75%,LYN;UNC13D;NR1H4;REEP6;LRP5;DYNC1H1;LRRK2;STXBP4;HSP90AA1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.49140844523953636,1.0708295761947986,0.3969658659924147,0.7784229763733578,1.0,5/22,7.15%,P2RY6;PKD2;STAC;SLC9A1;VMP1
prerank,vasodilation (GO:0042311),-0.3993433999690506,-1.0704163498464354,0.3613138686131387,0.8912922692114263,1.0,7/13,26.60%,SOD2;SOD1;KLF2;NOS3;NOS1;GPER1;ADRB2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.4579313602968665,1.0700646696413576,0.41114982578397213,0.7800135343724849,1.0,4/31,8.73%,SYT17;SYT2;STXBP3;SYT10
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.41207840448166777,-1.0699474507662212,0.40794223826714804,0.8848902433082758,1.0,3/12,7.18%,EFNA5;KANK1;AP1AR
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.41207840448166777,-1.0699474507662212,0.40794223826714804,0.8848902433082758,1.0,3/12,7.18%,EFNA5;KANK1;AP1AR
prerank,proteasome assembly (GO:0043248),-0.43049764034039883,-1.0697452278163653,0.3695652173913043,0.881579354988327,1.0,8/11,40.35%,PSMD11;PSMD5;OTUD6B;PSMG1;ADRM1;PSMD10;PSMD9;POMP
prerank,error-free translesion synthesis (GO:0070987),-0.32935805770853305,-1.0691926850263385,0.37209302325581395,0.8792713596197802,1.0,15/22,39.68%,REV1;RFC1;RCHY1;RFC2;UBC;RPA3;UBA52;RPA2;RFC3;RPS27A;RFC4;PCNA;POLD1;UFD1;RFC5
prerank,neuron development (GO:0048666),0.41931017743562876,1.0690368804361892,0.3800403225806452,0.7822344801371794,1.0,19/141,9.82%,RUNX1;LYN;ASCL1;PRDM12;MICALL2;APOE;ATP7A;ATP8A2;MYT1L;THOC2;HMGB1;GPRIN3;MICALL1;LRP12;WNK1;MEF2C;RB1;ATCAY;RAB11A
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.4369440344986079,1.0688368592446635,0.3934065934065934,0.782301905775003,1.0,7/46,10.17%,TGFB1;HCLS1;PRKCD;DHX9;TP53;SMAD3;TPR
prerank,regulation of viral release from host cell (GO:1902186),0.4940528843295952,1.0687366223408223,0.4192740926157697,0.7820957423719046,1.0,5/21,11.50%,TRIM25;TRIM5;TRIM8;MID2;TRIM35
prerank,peptide cross-linking (GO:0018149),0.4771379492152539,1.0685953933234145,0.3973902728351127,0.7819898471007171,1.0,3/25,11.47%,F13A1;ANXA1;THBS1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.4184558371216302,1.0685894294502238,0.38071065989847713,0.7815326769137421,1.0,21/108,14.23%,RUNX1;TLR2;NFATC1;GNAQ;CDK14;OTULIN;SKI;TNFAIP3;LGR6;MACF1;CTNNB1;DISC1;CSNK2A1;MDFIC;SULF2;ATP6AP2;AMER1;NLK;PPP2CA;LRRK2;LRP1
prerank,long-chain fatty acid transport (GO:0015909),0.47438389542090464,1.068452022521156,0.40022935779816515,0.7814167028453259,1.0,9/30,17.96%,FABP4;SLC25A20;APOE;ABCD1;FABP5;CD36;ACACA;CPT2;ABCD2
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5331368955826385,1.0684096132269287,0.4074585635359116,0.7810584092205987,1.0,3/13,14.48%,PTPN1;ATF6B;WFS1
prerank,histone lysine methylation (GO:0034968),0.4626587592326024,1.0680769126529879,0.43714609286523215,0.7814646725728482,1.0,10/33,18.63%,WDR5B;CXXC1;SETD6;DPY30;DOT1L;RBBP5;SMYD3;SUV39H1;SETD1B;WDR82
prerank,regulation of cell cycle (GO:0051726),0.4139474664189594,1.0678212793551582,0.321,0.7816474778187322,1.0,48/271,14.41%,PTPRC;LILRB1;TGFB1;RPL23;GAS2L1;TGFBR1;MLXIPL;NEK6;MAP2K6;ERN1;PKD2;RGCC;HPGD;FBXL22;FZD9;CDK11B;SND1;TP53;RPS15A;PIM2;CSNK2A1;CSNK2A2;GADD45B;KIF20B;RB1;SMAD3;SIPA1;CDK7;SON;INHBA;NF2;RASSF1;MAEA;RNF40;SOX9;SRA1;TTLL12;THBS1;METTL3;SDCBP;CDK6;FBXL3;ADARB1;NR4A1;IRF1;HCFC1;SOX2;PES1
prerank,autophagosome organization (GO:1905037),0.44244482771376015,1.067594409048552,0.408207343412527,0.7817625935336823,1.0,18/50,22.21%,ATG7;MAP1LC3B;RAB7A;VMP1;EMC6;RAB1B;BECN1;ATG2B;ATG3;IRGM;UBXN2A;ATG14;PACS2;TMEM41B;ATP13A2;NSFL1C;TP53INP2;RB1CC1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.4492371976640427,1.067567819769063,0.40522875816993464,0.781377737889024,1.0,7/43,7.29%,CBL;PTPRJ;DUSP3;GRB2;ZFYVE28;RAB7A;SH3KBP1
prerank,striated muscle cell differentiation (GO:0051146),0.5032141884133656,1.0675049068561469,0.39923954372623577,0.781073716800832,1.0,5/16,12.65%,SKI;PLD3;MYOCD;MEF2C;NRG1
prerank,establishment of spindle orientation (GO:0051294),-0.3237089100864174,-1.067355183247771,0.38666666666666666,0.8806709318031769,1.0,6/28,10.99%,PAFAH1B1;MAP4;GPSM2;NDEL1;NDE1;CDK5RAP2
prerank,regulation of interleukin-1 production (GO:0032652),0.5059136779445783,1.0671078737519748,0.3984375,0.7816332103007549,1.0,3/15,6.22%,SIRPA;HMGB1;ANXA1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5036389714820365,1.0667154110142465,0.41581632653061223,0.7821654774191349,1.0,1/18,0.33%,PTK2B
prerank,regulation of DNA biosynthetic process (GO:2000278),0.46483158791479506,1.066695126640236,0.41379310344827586,0.7817430453834018,1.0,3/27,4.11%,SMOC2;PRKD2;RGCC
prerank,pulmonary valve development (GO:0003177),-0.3645587669268444,-1.0666693477213665,0.35071090047393366,0.8789816388233779,1.0,8/18,14.33%,ROBO2;BMP4;ROBO1;SLIT2;NOS3;SMAD6;JAG1;STRA6
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5566836351144959,1.0665921869954746,0.43577981651376146,0.781530197609995,1.0,3/10,14.11%,NFE2L2;GPR37;LRRK2
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3191744105947759,-1.066176374099663,0.3416666666666667,0.8765845488964875,1.0,10/30,10.66%,FSTL1;LTBP4;LATS1;TGFBR3;XIAP;PCSK6;SMAD4;FKBP1A;TWSG1;LATS2
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.5049543760904792,1.0654599678238972,0.3944020356234097,0.7839427306616175,1.0,1/17,2.54%,LPCAT1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.33045235816359736,-1.0644667342384095,0.34104046242774566,0.8778550949680793,1.0,13/24,30.12%,DMD;JPH1;SRI;FKBP1A;CALM3;SELENON;NOS1;JPH2;JPH4;PDE4D;CALM2;GSTO1;CASQ2
prerank,positive regulation of vasoconstriction (GO:0045907),-0.398677300162669,-1.0638678374485397,0.38515901060070673,0.8757579615280187,1.0,1/13,1.07%,CAV1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.46416287833375747,1.0637643307099982,0.43453070683661643,0.7879040675578763,1.0,11/32,17.62%,RREB1;ARPC2;WASF2;AKIRIN1;ACTR2;ACTR3;CYFIP1;TWF2;SRC;CORO1C;CDC42
prerank,negative regulation of protein polymerization (GO:0032272),0.4703817050729922,1.0637174876193938,0.41947115384615385,0.7875419966034839,1.0,9/27,13.36%,CYRIB;PRKCD;SNCA;ARFGEF1;MAPRE1;PFN2;PFN1;TWF2;SSH2
prerank,positive regulation of potassium ion transport (GO:0043268),-0.3054099890505068,-1.063426266041834,0.3391304347826087,0.8732426364194522,1.0,8/38,10.43%,ANK2;KCNN2;FHL1;KIF5B;ACTN2;GABBR2;KCNJ3;DLG1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.4905342823968946,1.0631204642209529,0.41875,0.7885985361659572,1.0,5/19,11.61%,SMOC2;PIK3CB;XDH;CD63;CCBE1
prerank,regulation of vasoconstriction (GO:0019229),-0.32067872805888087,-1.062849494203851,0.35443037974683544,0.8710548693712263,1.0,11/27,27.64%,CAV1;ECE1;ACE;CHRM3;PER2;TBXA2R;KCNMB2;BMPR2;AGTR1;ACE2;AGT
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.3762302369849276,-1.0627109921112048,0.34051724137931033,0.8676934908682072,1.0,4/15,10.13%,KCNN2;ATP1B1;KCND3;KCNJ3
prerank,regulation of sodium ion transport (GO:0002028),0.4566525826163438,1.062047763750393,0.4160090191657272,0.7908719069567893,1.0,12/34,18.93%,SCN4B;P2RX7;PKP2;P2RX4;WNK1;PRSS8;WNK4;YWHAH;SCN5A;SPTBN4;CNKSR3;PER1
prerank,autophagosome assembly (GO:0000045),0.43689378003945345,1.0619320059702984,0.4115755627009646,0.7906758573443621,1.0,18/52,22.21%,ATG7;MAP1LC3B;RAB7A;VMP1;EMC6;RAB1B;BECN1;ATG2B;SMURF1;ATG3;IRGM;UBXN2A;ATG14;PACS2;TMEM41B;NSFL1C;TP53INP2;RB1CC1
prerank,protein oxidation (GO:0018158),0.5463572866653913,1.0617951807030996,0.45718432510885343,0.7905912046735859,1.0,5/11,21.65%,LOX;CHCHD4;PRDX3;LOXL3;SUMF1
prerank,cellular response to oxidative stress (GO:0034599),0.4165429963430166,1.0615592513361805,0.3869653767820774,0.7907349818366062,1.0,30/118,18.60%,CYBB;NCF4;NFE2L2;PRKCD;NCF2;SNCA;PKD2;FOXO3;TXNRD1;AIF1;TP53;LONP1;PPARGC1A;PRDX1;PYCR2;MSRA;PRDX3;PRDX6;PRDX2;CAMKK2;LRRK2;HIF1A;CPEB2;PRDX5;ERO1A;GPX8;PYROXD1;STX2;KEAP1;GSR
prerank,positive regulation of exocytosis (GO:0045921),0.4541621745359273,1.0608951589554203,0.4118967452300786,0.7919802863747457,1.0,11/35,20.19%,UNC13D;SNCA;SMPD3;RAB7A;SYTL4;ATP6AP1;SDCBP;PDCD6IP;RAB27B;STXBP5;ATP13A2
prerank,regulation of membrane depolarization (GO:0003254),0.5043000183857747,1.0608342505609822,0.40597758405977585,0.7916620455358205,1.0,6/18,18.29%,HCN4;ABCD1;NEDD4L;LRRK2;SCN5A;PTPN3
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.37843120829868815,-1.0605028146417887,0.3464566929133858,0.8707613111594996,1.0,7/14,21.38%,AUTS2;SMAD4;DNMT1;SNW1;PAXIP1;KMT2E;PRDM9
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.45491943005208146,1.0603675921456819,0.41776315789473684,0.7924139328731008,1.0,7/39,10.88%,SHH;PKD2;CTNNB1;TGFBR2;NKX2-1;LRP5;NRP1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.526238199269943,1.0602467117919883,0.420391061452514,0.7922329726167266,1.0,4/12,16.16%,UCK1;CDA;UCK2;DCK
prerank,regulation of centriole replication (GO:0046599),0.49457303545811737,1.0601396747979668,0.41719342604298354,0.7920191831150293,1.0,5/17,7.78%,NUP62;MDM1;PLK4;PLK2;CEP76
prerank,regulation of lysosomal lumen pH (GO:0035751),0.5195010545377341,1.0600734872832451,0.42448979591836733,0.7917243077648051,1.0,5/12,17.46%,CLN3;ATP6AP2;GRN;LRRK2;TMEM165
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.2583993257648901,-1.059972791652853,0.3548387096774194,0.8685745752349581,1.0,21/84,15.52%,RBFOX2;FXR2;YTHDC1;DAZAP1;MBNL2;RBFOX3;REST;NUP98;U2AF2;SRRM4;KHDRBS3;FMR1;NOVA2;HNRNPA1;METTL16;QKI;HNRNPU;SNW1;KHDRBS2;PUF60;LARP7
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.4572076891520309,1.0598374404330495,0.42044134727061555,0.7918570287914175,1.0,7/32,14.31%,PKIB;XRCC5;CTNNB1;PRKCQ;CCT8;TNKS2;CCT5
prerank,extracellular matrix assembly (GO:0085029),0.48437545114784375,1.059772933770605,0.4294478527607362,0.7915387783430368,1.0,6/23,15.88%,TGFB1;ATP7A;PXDN;GAS6;LTBP3;MFAP4
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.3871008216918554,-1.0594415518665798,0.3794466403162055,0.8665882601956613,1.0,7/14,29.92%,UPP2;NT5E;DHODH;NT5C1A;UPB1;UMPS;CAD
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.44297798313252645,1.0592978770474342,0.40825190010857765,0.7922471475343743,1.0,8/50,13.79%,GTF2H1;CCND3;BCCIP;CCND2;ACTB;CDK7;CCNE2;CDC6
prerank,C21-steroid hormone metabolic process (GO:0008207),0.48784811898203434,1.0592805890739492,0.43236409608091025,0.7918247115416651,1.0,4/20,20.71%,TSPO;FDXR;FDX1;STARD3
prerank,actin polymerization or depolymerization (GO:0008154),0.4409694203155302,1.0591162653998587,0.41862955032119914,0.7917655899119571,1.0,10/50,12.41%,PREX1;PSTPIP1;MICALL2;FLII;AIF1;MICAL1;WASHC3;ABI1;DIAPH1;TWF2
prerank,regulation of axon guidance (GO:1902667),0.5427029616423138,1.0587656988963263,0.40114613180515757,0.7921739518164758,1.0,5/10,28.55%,NRP1;ZSWIM6;MYCBP2;VEGFA;ZSWIM5
prerank,SNARE complex assembly (GO:0035493),0.5467769145091375,1.0586543188563233,0.4177777777777778,0.7919807035868291,1.0,3/10,9.39%,VAMP3;SNCA;UVRAG
prerank,cellular biogenic amine catabolic process (GO:0042402),0.5497904533932791,1.058618577636607,0.44028776978417267,0.7916014288523806,1.0,4/10,20.05%,SMOX;ALDH7A1;COMT;SLC44A1
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.48884696309295783,1.0584504725701018,0.43702770780856426,0.791556571576861,1.0,3/21,8.52%,TGFB1;TGFBR1;FAM89B
prerank,eye photoreceptor cell development (GO:0042462),0.5131115063660228,1.0579914632503928,0.42302543507362783,0.7922893455278898,1.0,3/15,7.95%,THY1;NRL;MYO7A
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.3496039637321287,-1.05779729336579,0.3347457627118644,0.8675548626292885,1.0,6/18,12.64%,SLC25A12;FOLH1;MTHFD1;SLC25A13;SMS;GOT1
prerank,regulation of cell communication (GO:0010646),0.4556180325026473,1.0577232989921976,0.4125714285714286,0.7924920330941633,1.0,6/35,6.22%,PTPN1;NUP62;SLC8A1;GRK3;MTCH1;ANXA1
prerank,gland development (GO:0048732),0.4285023921917459,1.057474480896919,0.42177589852008457,0.7926501520651705,1.0,14/59,15.81%,SHH;PCSK9;TGFBR1;MDK;PKD2;CEBPA;ANXA1;NKX2-1;SOX9;NRG1;SOX2;TG;IGSF3;NF1
prerank,cellular response to alcohol (GO:0097306),0.44186888893089465,1.0573702738574564,0.4251968503937008,0.792445171082203,1.0,13/42,20.57%,ADCY7;MAP4K1;ADCY6;CTNNB1;LARP1;GLRA2;ADCY8;ADCY3;GNG2;GOLPH3;GRAMD1C;SPIDR;OSBPL7
prerank,thyroid hormone generation (GO:0006590),0.5432282374052652,1.057110556779206,0.4291845493562232,0.7926455868220921,1.0,2/10,14.45%,CTSK;TG
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.49265167931267406,1.056678509011075,0.41245136186770426,0.7932706828951592,1.0,3/18,5.79%,PCID2;NXF1;THOC2
prerank,muscle cell development (GO:0055001),-0.30169082183176466,-1.0563236461641556,0.34328358208955223,0.8682187727843053,1.0,5/30,2.92%,ANK2;NEBL;DMD;CXADR;SGCZ
prerank,negative regulation of neuron differentiation (GO:0045665),0.48257996429160877,1.0560262770543727,0.4369645042839657,0.7945014460607306,1.0,6/22,20.36%,ASCL1;SOX9;B2M;SOX2;GSK3B;CNTN4
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.4299393356792579,-1.0559764151431912,0.3881578947368421,0.8656720171122054,1.0,4/11,11.27%,BMPR1A;CD200;CD46;PTGS2
prerank,negative regulation of phosphorylation (GO:0042326),0.42657904054747475,1.055670827568105,0.4134419551934827,0.7949473117315826,1.0,14/85,14.11%,LYN;TGFB1;STAP1;SIRPA;CBFA2T3;NIBAN1;XDH;IBTK;IMPACT;HDAC4;INHBA;PRDX3;PID1;LRRK2
prerank,endoderm formation (GO:0001706),0.45675115849416975,1.0556620666812906,0.435632183908046,0.7945013605401477,1.0,5/35,10.48%,ITGB2;ITGA4;ITGB5;SETD2;INHBA
prerank,polarized epithelial cell differentiation (GO:0030859),0.5087620572052161,1.0555567235092729,0.43081312410841655,0.7943189924339329,1.0,5/13,19.28%,RAP2A;ZDHHC7;CDC42;RHOA;SCRIB
prerank,'de novo' posttranslational protein folding (GO:0051084),0.45717947366736517,1.0554208836134578,0.42452830188679247,0.7941996940948172,1.0,7/30,16.84%,PTGES3;SDF2L1;DNAJC7;CHCHD4;BAG1;GAK;ERO1A
prerank,"transcription, DNA-templated (GO:0006351)",0.4094433265338118,1.055325916596294,0.35135135135135137,0.7939802700067508,1.0,70/207,25.32%,ARRB2;IVNS1ABP;RREB1;GTF2H1;TAF1A;FOXO3;EAF1;TAF1;GTF3C4;BTF3;TP53;MEF2A;TTF1;LEO1;GTF3A;TRIP13;MMS19;GMEB2;HSF1;CDK7;NFX1;NFIC;KLF13;POLR2L;TRIM24;MBD1;SNAPC3;PMF1;ELL;MLLT1;NFKB1;RO60;TWNK;MAF;TAF3;ERCC6;ZBTB7B;GTF2B;RSF1;TCEA1;NFYA;GTF2H5;CREBL2;FUBP3;CRCP;TAF11;POLR2E;MED4;ELOB;GLIS3;IWS1;IRF9;TAF1C;SMARCA5;ELOC;POLR3A;GTF2A1;NELFE;PARP1;CTR9;MNT;TFAM;MRPL12;PAX8;NFIX;THRA;PWP1;XBP1;NCBP1;XAB2
prerank,fatty acid catabolic process (GO:0009062),0.4236592618517863,1.055280148134191,0.4089958158995816,0.793627695945354,1.0,27/67,25.71%,LPIN2;EHHADH;CEL;ACAD10;NUDT19;ACADL;ABCD1;PEX13;ECHS1;ILVBL;ECI1;ABHD3;MMUT;CPT2;PPARD;PCCA;ABCD2;ECHDC1;LPIN1;CROT;ACOT8;MMAA;ABHD2;HADHA;HADH;LPIN3;HADHB
prerank,DNA geometric change (GO:0032392),0.47415708612044327,1.055108352515605,0.42011834319526625,0.7935964944689191,1.0,6/24,14.11%,DHX9;HMGB1;ANXA1;DNA2;MCM9;DDX1
prerank,cellular sodium ion homeostasis (GO:0006883),0.5018745323145483,1.0544658741138095,0.41823056300268097,0.7948086087219127,1.0,5/15,13.68%,SLC8A1;SLC9A1;NEDD4L;ATP1B3;ATP1B2
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.5488328502900819,1.054433968053243,0.4507042253521127,0.7944284502940331,1.0,2/10,9.58%,PRDM12;ATRX
prerank,positive regulation of dendritic spine development (GO:0060999),-0.34017735640186486,-1.0543767446771841,0.3490566037735849,0.8668202921520607,1.0,10/20,19.06%,NLGN1;CAPRIN1;DLG5;FMR1;SHANK3;SHANK1;DBN1;DHX36;CAPRIN2;CAMK1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.4800607231559815,1.0537268241516329,0.42375,0.7957825854333572,1.0,2/21,4.18%,MED17;MITF
prerank,negative regulation of axonogenesis (GO:0050771),0.4663159511621933,1.0536229928559109,0.4299175500588928,0.7955828670707917,1.0,8/27,17.66%,THY1;FGF13;DIP2B;ARHGDIA;EFNB3;RTN4;PTEN;RHOA
prerank,microtubule depolymerization (GO:0007019),-0.3545079176445565,-1.0535032637447888,0.36324786324786323,0.8659369647719236,1.0,7/17,20.99%,NCKAP5;STMN2;KIF24;STMN4;STMN3;KIF18A;STMN1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.5502705504118713,1.051940298766902,0.43641618497109824,0.7994467312853639,1.0,4/10,15.26%,FZD9;ABCD1;LRRK2;SRC
prerank,renal absorption (GO:0070293),-0.4261585131528087,-1.0518984802444291,0.375,0.8670746986688186,1.0,2/10,5.24%,GSN;KLHL3
prerank,pseudouridine synthesis (GO:0001522),-0.3915491146265422,-1.0516863513991639,0.41263940520446096,0.8641018541151052,1.0,10/13,40.05%,PUS10;TRUB2;GAR1;NOP10;PUS1;PUS7L;NHP2;TRUB1;PUSL1;RPUSD2
prerank,potassium ion transport (GO:0006813),0.4152339064414641,1.0516077275831919,0.399592252803262,0.7998162169637435,1.0,13/120,7.61%,KCNJ11;AQP1;HCN4;SLC9A4;KCNN4;KCNK6;PKD2;KCNIP2;SLC9A9;CCDC51;KCNMA1;SLC9A1;KCNK13
prerank,extracellular transport (GO:0006858),-0.3977415730413122,-1.051313654039393,0.38175675675675674,0.861649023315986,1.0,9/12,47.21%,SPEF2;CABYR;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.38309771651592767,-1.0512892124302158,0.36666666666666664,0.8582143623850619,1.0,8/14,25.94%,ECE1;ACE;NOS3;ENPEP;EDN1;AGTR1;ACE2;EDN3
prerank,actin filament bundle assembly (GO:0051017),0.4582266034329419,1.051050909090909,0.45109321058688145,0.8007272145479165,1.0,5/33,7.67%,LCP1;PLS1;AIF1;NEDD9;MICAL1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.47407669705420946,1.0505774741140477,0.4441747572815534,0.8014786189737859,1.0,3/22,4.60%,EDEM1;MAN1C1;SEL1L
prerank,peptide hormone secretion (GO:0030072),-0.3141361976202384,-1.050571224807051,0.38011695906432746,0.856856393728344,1.0,10/26,27.31%,LTBP4;CDK16;RIMS2;CAMK2G;PARK7;PTPRN;EDN1;ADCYAP1;EDN3;CYB5R4
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5412425938661432,1.0505009346668641,0.42613636363636365,0.8012203373636843,1.0,4/11,17.02%,NOS1AP;CACNB2;CACNB1;BIN1
prerank,ephrin receptor signaling pathway (GO:0048013),0.42271212519580453,1.0498558667827678,0.4369230769230769,0.8023706204560842,1.0,25/82,17.66%,LYN;VAV2;NCK2;VAV3;ARPC2;EFNA2;ACTB;AP2S1;ARPC3;ITSN1;ACTG1;ACTR2;ACTR3;YES1;ARPC4;SDCBP;FYN;EFNB3;SRC;AP2M1;RASA1;EPHA4;EPHA8;CDC42;RHOA
prerank,regulation of transforming growth factor beta production (GO:0071634),0.48915795139962936,1.048905810503732,0.4383735705209657,0.8042820196831483,1.0,1/18,0.36%,LILRB1
prerank,regulation of intracellular pH (GO:0051453),0.44751610118716556,1.0486980382748403,0.42251950947603123,0.8043544362833812,1.0,11/34,22.04%,SLC9A4;CLN3;SLC9A9;SLC9A1;LRRK2;SLC9A8;NOX1;TMEM165;SLC9B1;SLC9A7;CHP1
prerank,protein polymerization (GO:0051258),0.42766991655226017,1.0483096376633247,0.41331923890063427,0.804866228250629,1.0,9/55,12.82%,PREX1;FGF13;PSTPIP1;MICALL2;AIF1;UBE2S;WASHC3;DIAPH1;RNF135
prerank,regulation of response to interferon-gamma (GO:0060330),0.5193134177290455,1.0476848378689778,0.4435374149659864,0.8060254566584425,1.0,9/14,29.54%,IFNGR2;PIAS1;SOCS3;IFNGR1;PARP9;HSP90AB1;CDC37;SUMO1;JAK2
prerank,positive regulation of T cell cytokine production (GO:0002726),0.48598575079829875,1.0475930552593755,0.424968474148802,0.8057690135217773,1.0,5/20,13.10%,TRAF2;IL18;MALT1;DENND1B;B2M
prerank,negative regulation of cell migration (GO:0030336),0.41157219356329494,1.0474867143747837,0.4150753768844221,0.8055708437476772,1.0,34/137,17.31%,SHH;TMIGD3;CD74;THY1;PTPRJ;DUSP3;SLURP1;RAP2A;MITF;FOXO3;MCTP1;TIMP1;NKX2-1;RAP2B;FLCN;PODN;DUSP10;VCL;ARHGDIB;PFN2;NF2;PTPRU;ADIPOR1;ADGRG1;ADARB1;STK24;ATP1B2;LRP1;PTPRT;NF1;PTEN;EPHA4;CORO1C;LDLRAD4
prerank,cardiac muscle cell action potential (GO:0086001),0.45875084184789894,1.0474831010920036,0.44638694638694637,0.805109485660194,1.0,5/30,4.29%,SCN4B;HCN4;SLC8A1;PKP2;KCNIP2
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.4428910849642673,1.04744473916767,0.43293347873500543,0.8047513449597118,1.0,12/38,15.66%,SREBF2;MICALL2;UBE2D3;CSNK2A2;VPS11;ATP5IF1;PARL;LRRK2;HUWE1;SREBF1;UBE2J2;GSK3A
prerank,cotranslational protein targeting to membrane (GO:0006613),0.4129293111328977,1.047432719034213,0.43743641912512715,0.8043100936268812,1.0,38/91,25.96%,RPL23;RPL17;RPL10A;RPS2;RPL18A;RPS15A;RPL6;RPLP2;RPL26;RPS20;RPS16;RPS14;RPL19;SRP19;RPL9;RPS11;RPL11;RPS23;RPS4X;SEC63;RPS27;RPL4;RPL7A;RPL15;RPL29;RPL22;RPS7;SRP14;RPS13;RPLP1;RPS15;SRP9;RPS5;RPL41;RPL10;RPS8;RPL18;RPL5
prerank,positive regulation of cilium assembly (GO:0045724),-0.35327310126167044,-1.0470298381348897,0.39316239316239315,0.8637889688006243,1.0,10/18,22.40%,ARHGAP35;CEP135;CCP110;BBS4;MARK4;CEP120;FUZ;CCDC88A;WRAP73;CROCC
prerank,regulation of wound healing (GO:0061041),0.44256779051597284,1.0469259399823212,0.42905405405405406,0.8051835568335317,1.0,6/42,9.75%,GP1BA;TNFAIP3;ARFGEF1;ANXA1;CASK;ACTG1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.4551105125976306,1.0468305230824044,0.43458475540386804,0.804957103332008,1.0,6/33,13.99%,DGLUCY;MTHFS;ART4;PYCR2;DDAH1;OAT
prerank,regulation of histone modification (GO:0031056),0.5138309034979889,1.0466345343059458,0.4311050477489768,0.8049810594923629,1.0,6/13,21.33%,MYOCD;FLCN;HPF1;AKAP8L;UBE2N;SETD5
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.2733992346384815,-1.0461634374226878,0.38095238095238093,0.862970925115204,1.0,26/57,24.80%,DLG2;APP;DLGAP1;NLGN1;GRIA3;GRIA2;DLGAP2;ACTN2;NEFL;GRIN2B;DLG1;SHANK1;PRRT1;GRIN1;CACNG8;CAMK2A;OPRM1;DLG3;SHISA9;GSG1L;DLGAP3;SHISA7;GRIA4;CACNG2;LRRC7;CAMK2B
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.5193403743062754,1.0459085544246933,0.4404432132963989,0.806349040778241,1.0,2/12,7.59%,SOAT2;P4HB
prerank,cell junction maintenance (GO:0034331),0.5120865470942048,1.0458741651654502,0.4546684709066306,0.805970011907586,1.0,1/14,2.06%,CSF1R
prerank,cytoplasmic translation (GO:0002181),0.4150694317489812,1.0458268936140547,0.44114636642784033,0.8056282850715325,1.0,40/91,25.96%,RPL23;RPL17;RPL10A;RPS2;RPL18A;RPS15A;GSPT1;EIF4A1;RPL6;RPL26;RPS20;RPS16;RPS14;RWDD1;RPL19;RPL9;TMA7;RPS11;RPL11;RPS23;RPS4X;RPS27;RPL4;RPL7A;RPL15;RPL29;RPL22;RPS7;RPS13;RPL22L1;RPLP1;EIF3M;RPS15;RPS5;DRG2;RPL41;RPL10;RPS8;RPL18;RPL5
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.267283675924955,-1.0458210198986329,0.3333333333333333,0.8569958298044356,1.0,29/56,23.76%,NDUFAF7;TIMMDC1;NDUFS5;NDUFS1;NDUFA7;NDUFS4;NDUFAF2;NDUFS3;OXA1L;NDUFAF6;NUBPL;NDUFAF5;NDUFAF4;NDUFB5;NDUFB2;TMEM126B;NDUFA8;NDUFS2;NDUFB7;ACAD9;NDUFA10;NDUFB6;NDUFB10;NDUFB3;NDUFS7;NDUFC1;NDUFA3;FOXRED1;TIMM21
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.267283675924955,-1.0458210198986329,0.3333333333333333,0.8569958298044356,1.0,29/56,23.76%,NDUFAF7;TIMMDC1;NDUFS5;NDUFS1;NDUFA7;NDUFS4;NDUFAF2;NDUFS3;OXA1L;NDUFAF6;NUBPL;NDUFAF5;NDUFAF4;NDUFB5;NDUFB2;TMEM126B;NDUFA8;NDUFS2;NDUFB7;ACAD9;NDUFA10;NDUFB6;NDUFB10;NDUFB3;NDUFS7;NDUFC1;NDUFA3;FOXRED1;TIMM21
prerank,positive regulation of filopodium assembly (GO:0051491),0.47178786785334026,1.0455444083466292,0.4392523364485981,0.8058977970625297,1.0,8/24,17.62%,ARAP1;RIPOR2;DOCK11;AGRN;NRP1;FNBP1L;MIEN1;CDC42
prerank,ceramide biosynthetic process (GO:0046513),0.43919136372335243,1.0451781765146615,0.43688254665203075,0.8063873187082783,1.0,14/40,22.94%,CERS6;CLN8;ST8SIA4;ST6GALNAC4;AGK;DEGS1;ASAH1;B4GALNT1;SGMS1;SPTSSA;SMPD1;SPTSSB;B4GALT6;CERS4
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.5566662499105259,1.0451736367730284,0.4492131616595136,0.8049950475038528,1.0,4/10,19.00%,EXO1;DNA2;SLX4;ERCC1
prerank,t-circle formation (GO:0090656),0.5566662499105259,1.0451736367730284,0.4492131616595136,0.8049950475038528,1.0,4/10,19.00%,EXO1;DNA2;SLX4;ERCC1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.5566662499105259,1.0451736367730284,0.4492131616595136,0.8049950475038528,1.0,4/10,19.00%,EXO1;DNA2;SLX4;ERCC1
prerank,positive regulation of cell projection organization (GO:0031346),0.4097977656743641,1.0449604574174167,0.41919191919191917,0.8050579611156882,1.0,20/115,14.64%,PTK2B;LYN;CAMK1D;ARSB;SS18L1;PLXNC1;MDK;SLITRK1;APOE;ITGA6;PLXNB2;CBFA2T2;FUT9;RAPGEF1;TWF2;NPTN;ARHGDIA;ATP1B2;CUX1;RAP1A
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.2791283655566499,-1.0448514028923088,0.3263157894736842,0.8564100656620982,1.0,30/42,35.85%,REV1;RFC1;WRNIP1;PRIMPOL;ZBTB1;WRN;USP10;RFC2;POLN;POLA1;UBC;POLK;POLI;UBE2L6;ISG15;FAAP20;RPA3;UBA52;USP43;POLD2;RPA2;RFC3;RPS27A;PCLAF;POLE;RFC4;PCNA;POLD4;CDKN2D;POLD1
prerank,regulation of chromosome segregation (GO:0051983),0.49570302471419936,1.0438319861886198,0.43609022556390975,0.8073881207440737,1.0,4/16,13.79%,CSNK2A1;CSNK2A2;PUM2;CDC6
prerank,regulation of biosynthetic process (GO:0009889),0.5137364905239494,1.0433770550262085,0.41935483870967744,0.8080585431904184,1.0,1/11,3.90%,SNCA
prerank,positive regulation of cell killing (GO:0031343),0.5126515940263554,1.0430413704316346,0.43291839557399725,0.8084673575871715,1.0,1/13,0.97%,SYK
prerank,chordate embryonic development (GO:0043009),0.42225778604363473,1.0427169844015096,0.4350580781414995,0.8087758011113326,1.0,7/55,9.42%,TGFB1;TGFBR1;PKD2;CHD7;FLCN;SULF2;XYLT1
prerank,extracellular structure organization (GO:0043062),0.4069021263026218,1.0426502540559826,0.4288577154308617,0.8084883847770877,1.0,22/204,7.77%,ITGAL;MMP12;ITGA2B;ITGAX;ITGB2;SMOC2;ITGA4;ITGB3;ITGB5;TGFBR1;ITGA2;ADAMTS8;SPP1;ATP7A;ITGA6;TTR;TGFBI;CD44;ITGAE;TNR;AGRN;LOX
prerank,regulation of Rho protein signal transduction (GO:0035023),0.41419956755347265,1.0418187702418704,0.4176285414480588,0.8101414769559133,1.0,14/72,13.42%,LPAR6;ABCA1;ARHGEF18;APOE;RIPOR2;GPR17;MYO9B;FLCN;ARHGDIB;F11R;NRP1;ADGRG1;ARHGDIA;ARHGEF3
prerank,mitotic cell cycle phase transition (GO:0044772),0.4044039053159379,1.0416027474959233,0.41,0.810212974295859,1.0,36/203,13.71%,TUBB;GPR132;PRKAR2B;HAUS2;CDK14;CCND3;CDC23;TUBA4A;FBXL22;CCND2;CNTRL;CEP192;UBE2S;MAPRE1;DNM2;CEP70;GSPT1;PLK4;PIM2;PLK2;CEP76;CHEK2;RB1;ENSA;HAUS1;CDK7;DBF4;INHBA;CDC34;DYNC1H1;PCM1;CDK6;FBXL3;MAX;CEP152;CCNE2
prerank,positive regulation of neurogenesis (GO:0050769),0.4226996150844579,1.0415933957244787,0.4365904365904366,0.809776608076157,1.0,14/68,13.82%,CX3CR1;SS18L1;PLXNC1;SLITRK1;PLXNB2;FZD3;CTNNB1;DISC1;NAP1L1;NUMB;SMARCD3;NPTN;ARHGDIA;CUX1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.4129581878123668,1.0405741430703908,0.442051282051282,0.8118793682041272,1.0,17/94,13.66%,FNIP2;PRKCD;ERN1;TRAF2;DDIT3;PYCARD;APAF1;BCL2L1;TP53;MAP3K5;HINT1;CEBPB;CHEK2;BAK1;TNFRSF1B;ATP2A3;STK24
prerank,regulation of protein sumoylation (GO:0033233),0.4916515925838655,1.0404533889520287,0.4529032258064516,0.8117235364028572,1.0,6/17,19.85%,CTNNB1;HDAC4;UBA2;CAPN3;PIAS1;RWDD3
prerank,intracellular protein transport (GO:0006886),0.4012953561004491,1.0403977731259613,0.391,0.8113889065425272,1.0,84/304,20.41%,MMP12;TBC1D9;TGFB1;SYK;CD74;LAPTM5;TBC1D10C;UNC93B1;CTSA;RAB32;NUP62;AP1S3;SNX9;TMED3;XPO1;RAB14;RAB3GAP2;TBC1D16;RAB7A;STX11;TBC1D22A;AP3D1;TLK1;USP6NL;STXBP3;TBC1D10A;RAB28;SNX27;RAB31;CSE1L;STRADB;PDCD6;SYNRG;ARL5B;ARL4A;TPR;RAB1B;COPA;TBC1D2;TBC1D17;CLTC;HDAC6;TBC1D2B;SEC16A;WDR11;XPO6;TBC1D8;STX5;SORL1;STX3;SAR1A;RPGR;GGA2;STX8;ARF6;VPS29;LTBP2;TBC1D14;STRADA;TBC1D22B;YWHAH;SMURF1;RPL11;APPL2;SNX13;ARFIP2;VPS28;ARHGEF2;IFT27;GIPC1;MYO1C;STX2;VPS33B;SLU7;TBC1D12;SEC13;SEC31A;TBC1D5;RAB29;DESI1;ARCN1;USO1;IPO9;COG7
prerank,maintenance of blood-brain barrier (GO:0035633),-0.3035400094703607,-1.0389832650573747,0.36486486486486486,0.8702031984618779,1.0,9/30,14.85%,SLC12A2;TJP1;CDH5;DMD;CLDN5;CLDN12;JAM3;OCLN;LAMC1
prerank,establishment of protein localization to organelle (GO:0072594),0.41522240688886813,1.0378485146741294,0.45134575569358176,0.8173034961571191,1.0,8/72,10.17%,MMP12;IL10RA;SYK;NUP62;CD68;CSE1L;RAB11A;TPR
prerank,rRNA transcription (GO:0009303),0.4905897855458652,1.0378478192108846,0.44903225806451613,0.8168360849805134,1.0,3/17,7.73%,POLR1E;GTF3C4;GTF3A
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3971806190420196,1.037652275704676,0.242,0.8168723047772858,1.0,266/1668,13.85%,RUNX1;BATF3;SPIC;NFE2;LILRB1;NPAS4;IRF5;MMP12;AHRR;PF4;ASCL1;SHH;CIITA;MEOX1;IRF4;IRF8;SLC11A1;TGFB1;IKZF1;HCLS1;TOX4;UXT;GATA1;STAT5A;NFE2L2;POU2F2;BRD8;FNIP2;LPIN2;NLRC5;RPL23;CSF1R;TLR2;NFATC1;HES7;MED17;RREB1;GTF2H1;MAD2L2;EDNRB;NR1H4;BCL11A;NSD1;MLXIPL;ELF4;SS18L1;ZEB2;DHX9;MED13L;SP7;MAPK14;IER2;OSM;MAML3;CREB3L4;CREB3;NCK2;BARX2;PRDM12;SEMA4D;RXRB;FOXD2;TNF;DNMT3A;CRYM;FNIP1;SNCA;SREBF2;TET3;APOE;MLXIP;PRKD2;PKD2;ITGA6;RGCC;RFX1;MITF;CIR1;BPTF;UBE2D3;ZFP30;SKI;ATF3;FOXO3;CDK8;CEBPA;SRCAP;DDIT3;SPI1;FHOD1;LRRFIP1;ZMIZ2;ZBTB12;IL18;PGBD1;MYT1L;FIZ1;MAFG;WWC2;HIVEP3;MAFK;ZBTB39;HDAC5;HOXC8;BHLHE41;GALR1;BRIP1;BACH1;HMGB1;TRPS1;MRTFA;RNF111;TAF1;TEAD1;FLI1;PCGF6;PRKCB;USF1;CTNNB1;CREB3L1;MTA3;TFEB;ZFP69;ZNF177;KLF6;PHF21A;RCOR1;TP53;MEF2A;AKNA;TBL1XR1;NKX2-1;NRL;TAL1;MYOCD;KDM7A;TNRC6A;YY1;SLC9A1;AGRN;SNAI1;HSBP1;TCF20;ZFP90;STAT4;ASXL2;EPO;CEBPB;DBX2;ST18;LMO2;MEF2C;DOT1L;NKRF;FLCN;CDC5L;MOV10;TFAP2B;TRIM27;RB1;SMAD3;GMEB2;ARID1A;AKIRIN1;GTF2IRD1;ZNF32;ZFP14;TADA1;IRF2;HSF1;PPARGC1A;CDK7;ARID3B;AGO4;ATRX;ARID4A;ANXA4;RNF4;LITAF;STAT5B;LRP5;ACTR2;CREBRF;IMPACT;GMEB1;CCNL1;NFE2L1;NFX1;MCRS1;MIDEAS;HDAC4;CPEB3;ARID1B;TPR;NEDD4L;RPAP2;ZNF83;BAZ1A;TBL1X;NFIC;RNF10;HOXA6;INHBA;TGIF1;ATAD2;MED27;CREB3L2;ACTR3;CHD1;RNASEL;KLF13;HCFC2;PKN1;ELF2;PTOV1;ZSCAN26;TXK;RPS6KA4;SOX9;SRA1;OLIG1;ETV6;NRIP1;NR2C2;JDP2;ZNF740;E2F6;AGO3;PHIP;HSF5;LAGE3;SDCBP;CIAO1;GZF1;ATF6B;MTF2;NOD2;HDAC9;CREB1;RPS14;SMARCD3;KAT7;ZFP64;SMARCB1;MAX;ZNF445;IKBKG;PPIL4;ZFX;ZSCAN18;NR4A1;NFKB1;IRF1;SAFB2;GPS2;FOXK1;RFX7;INO80;PID1;PCBP1;SOX6;HCFC1;ZFHX3;RTRAF;CUX1;USP9X
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.4589699951921662,1.0369971501833468,0.43614457831325304,0.8180198256517576,1.0,6/25,14.80%,CTSS;STAC;WNK1;ATP1B3;ATP1B2;WNK4
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.4307641966949195,1.0366076420506747,0.4502212389380531,0.8185237944866097,1.0,8/43,11.24%,TGFB1;TNF;FOXO3;SPI1;TEAD1;TP53;SMAD3;SOX9
prerank,negative regulation of cell division (GO:0051782),-0.4080798195860594,-1.0362919534200348,0.4068965517241379,0.8744627298596842,1.0,7/11,44.98%,ZFYVE19;VPS4A;CHMP4C;ORC6;E2F7;MYC;E2F8
prerank,positive regulation of translation (GO:0045727),0.4093101352604957,1.0360589242910647,0.4334016393442623,0.819462530457308,1.0,24/94,17.99%,NIBAN1;MTOR;DHX9;PLXNB2;CIRBP;FASTKD3;YTHDF3;LARP4B;LARP1;CPEB3;RPL26;THBS1;ZCCHC4;METTL3;PCIF1;POLDIP3;UPF3B;RCC1L;HNRNPD;SOX4;USP16;RPS4X;AGO2;CNBP
prerank,regulation of heart contraction (GO:0008016),0.4111857533004331,1.035935302216968,0.4451282051282051,0.8193153855923451,1.0,15/90,13.83%,KCNJ11;TMIGD3;HCN4;SLC8A1;KCNIP2;P2RX4;ASPH;ATP2B1;ITPR2;NPR2;ATP2B3;ATP1B3;ATP2A3;ATP1B2;DES
prerank,response to histamine (GO:0034776),-0.4259148859606006,-1.035897941982507,0.4101694915254237,0.8721724535861076,1.0,3/10,10.75%,GABRB2;GABRB1;GABRB3
prerank,polyol biosynthetic process (GO:0046173),-0.3594076013205594,-1.0357101005088882,0.39148936170212767,0.869270916009059,1.0,7/16,23.51%,PPIP5K2;IP6K1;IP6K2;ITPKC;IPMK;ISYNA1;CYP2R1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.46447820059617445,1.0356528792544524,0.45085995085995084,0.8195956367981541,1.0,7/24,12.41%,ARPC2;WASF2;AKIRIN1;ACTR2;ACTR3;CYFIP1;TWF2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.4755503494840013,1.0355768012156545,0.43429286608260326,0.8193103562544718,1.0,3/20,10.19%,PCSK9;EPO;NEDD4L
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.31675747290832207,-1.0354380404757417,0.38311688311688313,0.8667241469259419,1.0,18/24,35.85%,RFC1;XRCC1;RFC2;UBC;LIG1;POLK;RPA3;UBA52;POLD2;RPA2;RFC3;RPS27A;LIG4;POLE;RFC4;PCNA;POLD4;POLD1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.45111091575229084,1.0352054190400535,0.45649717514124294,0.8197541954609732,1.0,8/31,18.41%,GPNMB;PKD2;RB1;CCL2;CDK6;BRD7;PTEN;DACT1
prerank,cGMP biosynthetic process (GO:0006182),0.5243768331515024,1.0351402081428964,0.4595808383233533,0.8194393130622089,1.0,2/10,10.26%,GUCY2F;NPR2
prerank,outer dynein arm assembly (GO:0036158),0.5075670728115125,1.035040228407329,0.46802721088435373,0.8192078186883379,1.0,3/14,13.15%,ODAD2;ODAD1;CCDC63
prerank,mitochondrial genome maintenance (GO:0000002),0.518543539562798,1.0348476323617852,0.45702592087312416,0.8192237789218183,1.0,7/11,26.99%,MEF2A;LONP1;MGME1;MPV17;PARP1;AKT3;TOP3A
prerank,regulation of cellular component organization (GO:0051128),0.40410304131844343,1.0343605804544336,0.4391959798994975,0.8199703569057477,1.0,35/135,18.86%,CD22;MAD2L2;PTPN1;MTOR;SEMA4D;TNF;APOE;TRAF2;RASGRP2;RAP1B;CDK11B;AP2S1;STON2;PRKCQ;KIF14;METTL4;BCAR1;GFAP;RAPGEF1;STON1;ITCH;HCFC1;RAB33B;ATAD3A;ARHGEF11;RAP1A;CD36;SGK3;CAMSAP2;IRGM;HSP90AA1;LAMTOR1;PICALM;DCUN1D5;RPTOR
prerank,peroxisome organization (GO:0007031),0.4637671359343643,1.034118438360923,0.45072115384615385,0.8200850949418265,1.0,12/25,26.68%,PEX11A;ABCD1;SEC16B;PEX7;PLAAT3;ABCD2;FIS1;DNM1L;ACOT8;TMEM135;MFF;PEX1
prerank,cellular transition metal ion homeostasis (GO:0046916),0.41166925680376365,1.034027238058194,0.4635149023638232,0.8198537601326573,1.0,25/91,22.40%,SLC11A1;FRRS1;ATP7A;ATOX1;ATP6V0A2;IREB2;ATP6V0D1;HFE;FTL;ATP6AP1;ACO1;FTH1;SLC31A2;ATP13A2;SLC39A6;HMOX2;MT3;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,negative regulation of proteolysis (GO:0045861),0.44093959777590175,1.0339216572237462,0.4452054794520548,0.8196710813297872,1.0,9/34,19.25%,CST7;CLN8;CLN3;TIMP1;HDAC6;LRRK2;EPHA4;PTPN3;TMEM59
prerank,regulation of filopodium assembly (GO:0051489),0.4424882662958398,1.0338903732227325,0.45615982241953384,0.8192904880520112,1.0,10/38,14.56%,PRKCD;ARAP1;RIPOR2;DOCK11;CAPZB;AGRN;NRP1;FNBP1L;ARF6;MIEN1
prerank,fatty acid transport (GO:0015908),0.5024081335553114,1.0334742295725534,0.46387832699619774,0.8198928048902823,1.0,5/17,17.29%,FABP4;APOE;FABP5;CD36;PPARD
prerank,negative regulation of DNA binding (GO:0043392),0.45773764130700295,1.033363247124624,0.444047619047619,0.8197121614386399,1.0,2/28,2.41%,GATA1;MAD2L2
prerank,cellular respiration (GO:0045333),-0.27931153478770454,-1.0331054942705264,0.39473684210526316,0.8699418324737769,1.0,27/41,33.42%,UQCRC2;UQCRH;NDUFS1;SLC25A13;NDUFS4;OXA1L;SLC25A14;COQ10B;MTFR1L;COX15;ATP5F1D;UQCRC1;ETFA;ETFRF1;NDUFS7;ETFB;SDHAF4;UQCRFS1;LYRM7;MDH2;COX10;MTLN;CYCS;SURF1;NR4A3;NDUFS8;SIRT3
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.339939203390047,-1.0329401958286986,0.3793103448275862,0.8669737741784087,1.0,4/21,3.85%,AFG3L2;BCAP31;MICU1;SLC8A3
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.42778608877037005,1.0328533235014212,0.4439608269858542,0.8204915610690617,1.0,8/48,10.90%,CASS4;RREB1;SS18L1;MDK;NEDD9;P4HB;NRP1;LIMS1
prerank,mitotic sister chromatid segregation (GO:0000070),0.41049777611127836,1.0327337816244253,0.4404883011190234,0.8203258989797803,1.0,26/98,20.63%,NUP62;ESPL1;CDC23;TTN;NCAPG2;SEH1L;CSNK2A1;CSNK2A2;KIF14;RB1;KIF23;RAB11A;BECN1;PDS5A;RRS1;INO80;AKAP8L;PDCD6IP;EML4;NAA50;CENPK;MIS12;SMC4;MCPH1;DIS3L2;CUL3
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5277328713704631,1.03270226816044,0.4304932735426009,0.8199378788302089,1.0,3/10,9.63%,HMGB1;TP53;ATF7IP
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4081341745230572,1.0326270449015753,0.45060483870967744,0.8196681869312931,1.0,16/113,13.20%,MMP12;STAT5A;PIK3CD;ITGB3;TGFBR1;RREB1;MDK;PRKD2;PDCL3;VEGFB;PDCD6;NRP1;SOX9;GRN;NOD2;NR4A1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3957393546096376,1.0320660171146177,0.365,0.82064144047331,1.0,99/572,14.48%,RUNX1;BATF3;ASCL1;SHH;CIITA;IRF8;UXT;GATA1;FNIP2;RPL23;RREB1;MAD2L2;EDNRB;NR1H4;BCL11A;NSD1;ZEB2;PRDM12;SEMA4D;TNF;DNMT3A;CRYM;FNIP1;SNCA;SREBF2;MITF;CIR1;BPTF;UBE2D3;SKI;ATF3;FOXO3;DDIT3;SPI1;LRRFIP1;MYT1L;WWC2;MAFK;HDAC5;BHLHE41;BACH1;HMGB1;TRPS1;TAF1;MTA3;ZFP69;ZNF177;PHF21A;TP53;MEF2A;TBL1XR1;NKX2-1;YY1;SNAI1;HSBP1;ZFP90;EPO;CEBPB;MEF2C;FLCN;TFAP2B;TRIM27;RB1;SMAD3;GTF2IRD1;IRF2;HSF1;ATRX;IMPACT;NFX1;HDAC4;CPEB3;TPR;NEDD4L;TBL1X;NFIC;TGIF1;HCFC2;SOX9;ETV6;NRIP1;NR2C2;JDP2;E2F6;SDCBP;GZF1;MTF2;HDAC9;RPS14;MAX;NFKB1;GPS2;HCFC1;ZFHX3;CUX1;USP9X;SOX2;NOC2L;WFS1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.43608936312994573,1.0319607202996637,0.44733861834654587,0.8204569263326923,1.0,9/36,12.97%,UXT;YAF2;APAF1;PCGF6;RING1;PHC1;E2F6;RBBP7;MAX
prerank,ncRNA export from nucleus (GO:0097064),-0.2931728017649805,-1.0318014780413067,0.4322033898305085,0.8669363550098331,1.0,17/36,22.37%,NUP93;NUP188;RANBP2;SSB;NUP98;NUP42;PHAX;NDC1;RAE1;NUP153;NUP37;NUP133;NUP50;RAN;NUP43;NPM1;NCBP2
prerank,cellular response to catecholamine stimulus (GO:0071870),0.46315429418573667,1.0317472306268622,0.4455324357405141,0.8205300276713002,1.0,13/23,28.08%,SNCA;ADCY6;SLC9A1;LRRK2;GNG2;PRKN;TGM2;GABPA;ATP2B4;MAPK1;MAPK3;APLP1;PRKACA
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.4612378788243499,1.0316931550059816,0.44537815126050423,0.8201876044971161,1.0,4/24,11.83%,PRKAR2B;MGRN1;PDE11A;CDC34
prerank,sodium-independent organic anion transport (GO:0043252),0.5337657125501689,1.0316523833249471,0.45294117647058824,0.8198322494083499,1.0,3/10,14.69%,SLCO2B1;SLC16A2;SLCO1B1
prerank,mesenchymal to epithelial transition (GO:0060231),0.5312390412801038,1.0313280677633088,0.4542974079126876,0.8201822280333235,1.0,1/10,1.64%,BASP1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.4093556365104579,1.0310083552099478,0.4516785350966429,0.8204861150403683,1.0,30/100,21.09%,BAG2;CBFA2T3;RNF180;RNF19B;HERPUD1;CEBPA;XPO1;TAF1;HECTD1;GNA12;HFE;USP7;CSNK1A1;DET1;SDCBP;STUB1;RNF144B;LRRK2;PIAS1;GSK3A;RPL11;GIPC1;KEAP1;ELOB;TLK2;DESI1;RAD23B;GSK3B;PRKN;PABIR1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.4372960265816557,1.0309236726387954,0.46258503401360546,0.8202508616355337,1.0,9/39,18.49%,RAB8B;ABCA1;SEL1L;PPY;LTBP2;STEAP3;SVBP;MON1A;GOLPH3
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.5016149875505564,1.02991720817942,0.4636118598382749,0.8222946488166494,1.0,2/14,5.23%,LPIN2;CHKB
prerank,epithelial to mesenchymal transition (GO:0001837),0.42648060752649114,1.0294104944984241,0.447939262472885,0.8230732332354761,1.0,13/47,20.32%,TGFB1;TGFBR1;CTNNB1;AKNA;SNAI1;LIMS1;SOX9;RBPJ;HIF1A;TASOR;LOXL3;ROCK2;GSK3B
prerank,regulation of endothelial cell proliferation (GO:0001936),0.4090696331626269,1.029303075146129,0.4548254620123203,0.8228802047910778,1.0,16/88,13.20%,STAT5A;PIK3CD;ITGB3;TGFBR1;APOE;PRKD2;RGCC;PDCL3;XDH;VEGFB;ATP5IF1;PDCD6;NRP1;THBS1;ATP5F1A;NR4A1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5399690278786755,1.0290734888455448,0.47604790419161674,0.8229752203029965,1.0,2/10,10.19%,PCSK9;NEDD4L
prerank,long-term synaptic potentiation (GO:0060291),0.46996669638944544,1.0283751146949265,0.453646477132262,0.8242594116163554,1.0,2/21,7.55%,PTK2B;PLK2
prerank,positive regulation of neuron projection development (GO:0010976),0.40754510219241324,1.0283546088860045,0.4554759467758444,0.8238350023864801,1.0,16/85,14.64%,PTK2B;LYN;CAMK1D;ARSB;MDK;APOE;ITGA6;PLXNB2;CBFA2T2;FUT9;RAPGEF1;TWF2;LRP8;NPTN;ATP1B2;RAP1A
prerank,positive regulation of cell differentiation (GO:0045597),0.3996431700240877,1.0283199559902803,0.445,0.8234565611816533,1.0,38/237,13.72%,PF4;ASCL1;TGFB1;RIN2;LPL;TGFBR1;GPRC5B;MMD;MTOR;MDK;SP7;MAPK14;MSR1;RGCC;IL6R;IL18;RIPOR2;CTNNB1;TGFBR2;MEF2A;SNAI1;ASXL2;CEBPB;MEF2C;SMAD3;AKIRIN1;PRKCH;LRP5;IMPACT;CMKLR1;NELL1;ATP6AP1;SOX9;SDCBP;CREB1;BAMBI;NFKB1;SOX6
prerank,heart looping (GO:0001947),0.4334107410547273,1.0281014180555457,0.45494505494505494,0.8235395291681942,1.0,4/39,8.17%,SHH;PKD2;TGFBR2;MEF2C
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.3228222082575716,-1.0280834878300098,0.42105263157894735,0.8740549002557292,1.0,11/20,23.56%,ADSS2;NT5C2;GMPS;PFAS;AK3;AMPD3;AMPD2;PAICS;ADSL;IMPDH1;AK4
prerank,regulation of osteoblast proliferation (GO:0033688),0.4853273964886502,1.0279989315112434,0.45525291828793774,0.8233227313265982,1.0,5/17,19.60%,HPSE;NELL1;RHOA;GREM1;ATRAID
prerank,apoptotic process (GO:0006915),0.4021908139860463,1.0277347668797274,0.43043043043043044,0.8234804137029578,1.0,38/203,15.21%,PTK2B;ITGB2;IL1A;TLR2;PRKCD;MTOR;ELMO1;ESPL1;CXCR4;BRAT1;PYCARD;CASP1;CD14;CFLAR;APAF1;BCL2L1;CDK11B;TGFBR2;BAK1;ATCAY;TNFRSF21;MCM2;BNIP1;IAPP;DAP;CASP7;PPP2CA;DDIT4;CASP8;IKBKG;IRF1;STK3;TRADD;HK2;BMF;CAPN3;VDAC1;RNF152
prerank,triglyceride biosynthetic process (GO:0019432),0.4776820452094084,1.0269768986444998,0.4387755102040816,0.8249547700496161,1.0,7/18,20.95%,LPIN2;AGMO;GK;PNPLA3;DGAT2;MOGAT1;LPIN1
prerank,nuclear membrane disassembly (GO:0051081),0.5101631411167067,1.0267780141719018,0.4521857923497268,0.824988477709307,1.0,5/14,20.95%,NEK6;PRKCB;AKAP8L;VRK1;LPIN1
prerank,amino acid import (GO:0043090),0.4764996566627102,1.0262635159566955,0.4784217016029593,0.8257980583840936,1.0,4/21,9.28%,SLC7A8;SLC36A1;SLC16A2;SLC25A38
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.47749302416317463,1.025922600762679,0.44963144963144963,0.8262350544633856,1.0,4/20,11.47%,ITGA4;RGCC;CCL2;THBS1
prerank,protein deacetylation (GO:0006476),0.42418542278268917,1.0258730410905843,0.45098039215686275,0.8259011051208925,1.0,10/41,14.10%,HDAC5;MTA3;RCOR1;TBL1XR1;MIDEAS;HDAC4;TBL1X;HDAC6;HDAC9;HDAC11
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.41368851211313284,-1.0255393974576335,0.4121212121212121,0.8783174762503677,1.0,2/10,13.29%,CAV1;ANK3
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.3168524845558859,-1.0250407760246856,0.4226190476190476,0.8763767008835995,1.0,12/24,20.99%,NCKAP5;STMN2;MAPT;KIF24;TPPP;STMN4;STMN3;HDGFL3;MAP7D3;KIF18A;TRPV4;STMN1
prerank,acute-phase response (GO:0006953),0.5153664368081698,1.024722306204332,0.47018030513176146,0.8282568889877486,1.0,2/12,7.75%,IL6R;CEBPB
prerank,protein import into peroxisome membrane (GO:0045046),0.46238001735790857,1.0238149935315943,0.4554334554334554,0.8300362786555318,1.0,4/22,9.08%,RAB8B;ABCD1;PEX13;PXMP2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.4258776860857528,1.0237039236661796,0.4511930585683297,0.8298507068208932,1.0,17/48,22.31%,TAF1A;POLR1E;SF3B1;ZMIZ2;ACTB;ARID1A;ARID1B;ATAD2;POLR1B;POLR2L;ELOF1;ERCC6;MYO1C;POLR2E;PADI2;TAF1C;SMARCA5
prerank,regulation of G0 to G1 transition (GO:0070316),0.42868653705335946,1.02354924676358,0.4484304932735426,0.8297900329594975,1.0,9/38,12.97%,UXT;YAF2;APAF1;PCGF6;RING1;PHC1;E2F6;RBBP7;MAX
prerank,regulation of protein acetylation (GO:1901983),-0.403626801293578,-1.0232199073478032,0.41637010676156583,0.8783111903480425,1.0,2/12,1.78%,CEP295;RAPGEF3
prerank,mRNA metabolic process (GO:0016071),0.40550512865105537,1.0222258431116416,0.478844169246646,0.8325751339513304,1.0,16/90,12.11%,SLFN14;ERN1;SF3B2;AURKAIP1;SCAF11;TP53;ZC3H12D;LSM11;HSF1;PPARGC1A;PCBP3;AGO4;SON;AGO3;PRPF8;METTL3
prerank,regulation of fat cell differentiation (GO:0045598),0.4106554843744365,1.021731283754349,0.48293691830403307,0.8333220227410267,1.0,18/74,20.22%,TGFB1;LPL;TNF;ASXL2;CEBPB;SMAD3;LRP5;CMKLR1;TAF8;CREB1;GPS2;BBS12;WDFY2;SYAP1;PPARD;CREBL2;FTO;ZFP36L1
prerank,odontogenesis (GO:0042476),-0.27986229926798345,-1.021495785173481,0.37404580152671757,0.8798358525468694,1.0,8/35,11.97%,FOXC1;EDA;BMP4;GLI2;WNT6;HDAC2;COL1A2;TBX1
prerank,actin filament bundle organization (GO:0061572),0.4434169805278793,1.0213753916399004,0.4781609195402299,0.8337237541694467,1.0,5/33,7.67%,LCP1;PLS1;AIF1;NEDD9;MICAL1
prerank,cellular protein modification process (GO:0006464),0.3927358037368029,1.0210018216230885,0.391,0.8341826788177287,1.0,206/982,18.57%,PTPRC;PTPN7;PTK2B;BTK;FGR;LYN;GMFG;PPM1H;HCK;DAPP1;TGFB1;SYK;PCSK9;WDTC1;RSKR;FNIP2;PIK3CD;MAP4K1;TAOK3;COPS6;F13A1;TGFBR1;TYK2;PPP2CB;PTPRJ;PRKCD;PTPN1;MTOR;TEC;DUSP29;BMP2K;GRK3;NEK6;PTPN18;CDK14;ERN1;ATG7;PTPRE;SPP1;ART4;APOE;PRKD2;UBE2D3;ST8SIA4;DNAJC3;MYLK3;CEL;CDK8;FBXL22;TIMP1;RNF7;OARD1;NPC1;PARP8;MORC3;FBXL18;TLK1;TAF1;PTP4A2;ANXA1;PRKCB;KLHL21;MKNK1;UBE2S;CDK11B;PSMB10;STK10;TGFBR2;PIM1;MAP3K5;OGA;WNK1;PLK4;CDK17;PIM2;PLK2;CSNK1G2;TNIK;P4HB;MTMR3;LOX;CHEK2;CSNK2A1;ST3GAL1;MAP3K1;CHML;STRADB;DUSP10;MAN2B1;B3GALNT1;CDK7;PRKCH;PGAP1;PIGH;FUT9;RAB11A;MCRS1;STK17B;FAM20C;RAB1B;ST8SIA1;VGF;LGALS1;RNASEL;MSRA;RBBP5;FBXO40;CHGB;PKN1;YES1;PSMA2;TXK;RPS6KA4;TIMM50;CCL2;NLK;THBS1;PRKACB;PTPRO;PTPRU;PARP16;CDC34;KLHL11;RBBP7;FBXO32;MAN2A2;CSNK1A1;TNKS2;CDK6;GRK4;PPP2CA;FYN;MAP3K12;F5;CREB1;B4GALT7;PSME3;STT3B;SUMF2;ILKAP;MERTK;FBXL3;LIPE;COPS4;CAMKK2;TIPARP;BRAF;SSH2;GAS6;STK24;STK3;CTTNBP2NL;PSMB5;LRRK2;PTPRT;BMX;WFS1;PSMD8;PPP1CC;WNK4;NIM1K;CCDC8;TESK2;DCAF17;LARGE1;PTPRA;PSMD7;METAP2;GAN;SGK3;STRADA;GSK3A;PSMB9;CDK15;WSB2;ATG3;COQ8B;HIF1A;MAP3K11;PTEN;STK4;APLP2;PTPN12;MACROD1;ERO1A;DCAF5;PPP3CB;PIK3R4;FEM1B;CDK18;DDOST;VHL;PPM1M;RPS6KA5;SIK2;PDPK1;PSMD2;KEAP1;TAOK1;IGFBP4;PTPN3;PPP2R5C;VRK1;FBXO44;PPP4R2;MXRA8
prerank,regulation of AMPA receptor activity (GO:2000311),-0.3132764101611425,-1.02093072270545,0.38,0.8781197088397207,1.0,10/25,26.60%,NLGN1;SHANK3;SHANK1;PRRT1;CACNG8;SHISA9;GSG1L;SHISA7;CACNG2;ADRB2
prerank,cellular protein localization (GO:0034613),0.3942661458763592,1.0207678719176754,0.451,0.834306847659985,1.0,97/285,23.20%,TBC1D9;CD74;SH3PXD2B;LAPTM5;TBC1D10C;UNC93B1;CTSA;RAB32;RAP2A;SNX9;TMED3;RAB14;RAB3GAP2;TBC1D16;STX11;TBC1D22A;AP3D1;TLK1;USP6NL;CTNNB1;STXBP3;TBC1D10A;MYO7A;RAB28;SNX27;RAB31;ITSN1;PDCD6;SYNRG;ARL5B;ARL4A;VCL;RAB1B;COPA;TBC1D2;TM9SF2;TBC1D17;CLTC;CD63;HDAC6;PTPRU;TBC1D2B;WDR11;BICD2;TBC1D8;STX5;STX3;SAR1A;RPGR;GGA2;STX8;LAMTOR3;LRRK2;ARF6;VPS29;CAPN3;TBC1D14;AHI1;TBC1D22B;YWHAH;SMURF1;MESD;SNX13;ARFIP2;ARHGEF2;IFT27;LAMTOR1;STX2;VPS33B;ANGPT1;SLU7;TBC1D12;PACS2;SEC13;SEC31A;TBC1D5;RAB29;ARCN1;USO1;HHEX;COG7;AMOT;PIGU;HERC2;RRAGA;ERP29;FLNA;RRAGB;UNC50;ADPRH;NPHP1;NAPA;ABHD17A;ARL5A;TBC1D9B;STX7;CEP68
prerank,regulation of smooth muscle contraction (GO:0006940),-0.3383710903422426,-1.0207347990649915,0.3853658536585366,0.8753846594598464,1.0,6/20,14.54%,CHRM2;CAV1;SETD3;PLCE1;KCNB2;CHRM3
prerank,neuron projection development (GO:0031175),0.3988003345015902,1.0207235001609616,0.467,0.8339520227568092,1.0,42/168,20.37%,NCKAP1L;LYN;NEFH;TAOK3;PRDM12;MICALL2;APOE;ATP7A;WHRN;HMGB1;DOCK10;DNM2;GPRIN3;MICALL1;LRP12;TNIK;KIF20B;RB1;NTF3;ATCAY;RAB11A;DTNBP1;STX3;TOR1A;LRRK2;CAMSAP2;SVBP;ERCC6;ALS2;PTEN;EPHA4;EPHA8;TBC1D23;CDC42;MANF;TAOK1;MINK1;GDNF;MAP4K4;GSK3B;CNTN4;CDK5R1
prerank,artery development (GO:0060840),0.461003051110894,1.0205497474110972,0.46228710462287104,0.8339138032786576,1.0,5/23,10.88%,TGFBR1;ANGPTL3;PKD2;HECTD1;NRP1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.4733434182906986,1.0205217752641638,0.4636942675159236,0.8335191616254983,1.0,6/21,17.68%,SCN4B;NOS1AP;KCNA5;CACNA1D;SCN5A;AKAP9
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.31813782386202083,-1.020482583811666,0.4022346368715084,0.8728867688664622,1.0,5/23,10.99%,PAFAH1B1;GPSM2;NDEL1;NDE1;CDK5RAP2
prerank,response to estrogen (GO:0043627),0.44548469641209726,1.020441653301897,0.4588100686498856,0.8332598389599012,1.0,6/31,15.44%,TRIM25;OCSTAMP;RBBP5;TRIM24;SRA1;NCOA4
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.5099875681659125,1.0203286275628094,0.47639484978540775,0.8330667850729785,1.0,4/12,20.71%,TSPO;FDXR;FDX1;STARD3
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.44867157947985337,1.0197480461553166,0.46987951807228917,0.8340302426631321,1.0,4/26,7.85%,PLCG2;SNCA;ABCD1;TRAP1
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.23453665792922934,-1.0196296726700538,0.48,0.8721317158240872,1.0,12/85,7.29%,PIEZO2;ROR1;GRM7;NIPBL;DCDC2;GSDME;EML2;COL4A3;EYA1;SOD1;USP53;WDR1
prerank,cardiac muscle cell differentiation (GO:0055007),0.46851357459416815,1.0195773600002724,0.4629861982434128,0.8339727680419053,1.0,5/21,12.65%,SLC8A1;TTN;MYOCD;MEF2C;NRG1
prerank,protein insertion into ER membrane (GO:0045048),-0.27864656285805134,-1.0194856528058434,0.3709677419354839,0.8693514416201762,1.0,13/37,19.60%,APP;EMC7;TRAM1;ALDH3A2;SEC61G;EMC10;EMC4;EMD;SERP1;SEC61B;EMC1;GET4;VAPA
prerank,protein catabolic process (GO:0030163),0.41801173713660494,1.0193408913006723,0.49209694415173866,0.8340908240635798,1.0,15/59,18.54%,CTSD;MTOR;CLN8;APOE;DDI2;OGA;CHEK2;TRIM24;STT3B;UBE2G2;CAPN3;IDE;HSP90AA1;USE1;FBXO44
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.5215308522031016,1.0189317833162657,0.4682651622002821,0.8346429170093864,1.0,4/11,16.75%,GCH1;QDPR;SPR;HSP90AA1
prerank,long-chain fatty acid import into cell (GO:0044539),-0.4168649475305898,-1.0187956690829594,0.42953020134228187,0.868241520309748,1.0,7/10,35.54%,ACSL1;SLC27A1;SLC27A4;ACSL3;SLC2A1;SLC27A2;SPX
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.2746597016207954,-1.0184329252279123,0.3883495145631068,0.8660816649805249,1.0,6/43,4.14%,SUCO;BMPR1A;WNT4;PRKD1;BMP4;ACVR1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.41136697790307686,1.01841214673125,0.4712041884816754,0.8354451121257049,1.0,15/64,19.14%,PCID2;GTF2H1;POLR1E;EAF1;LEO1;CDK7;SETD2;POLR2L;ELL;MLLT1;ELOF1;TCEA1;GTF2H5;POLR2E;ELOB
prerank,regulation of humoral immune response (GO:0002920),0.423991903508449,1.0183062320277587,0.4453125,0.8352367502257223,1.0,6/44,14.78%,FCGR2B;C1QC;C1QA;C1QB;C3AR1;C4B
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.4103942303318491,1.018209711408799,0.47102212855637515,0.8350008555219784,1.0,16/66,14.18%,TGFB1;NLRC3;APOE;RGCC;XDH;MTSS1;AQP11;ATP5IF1;CASK;DUSP10;SOX9;THBS1;CDK6;ATP5F1A;B2M;SOX2
prerank,external encapsulating structure organization (GO:0045229),0.39704956151017157,1.0179655547189566,0.4759519038076152,0.8351457648689218,1.0,25/205,10.75%,ITGAL;MMP12;ITGA2B;ITGAX;ITGB2;SMOC2;ITGA4;ITGB3;ITGB5;ITGA2;ADAMTS8;SPP1;ATP7A;ITGA6;TTR;TGFBI;CD44;ITGAE;TNR;AGRN;LOX;BCAN;ITGAM;F11R;MMP19
prerank,liver development (GO:0001889),0.43961016334920666,1.0177435363504836,0.4822451317296678,0.8352259933174775,1.0,5/32,7.75%,PCSK9;PKD2;CEBPA;ANXA1;CEBPB
prerank,negative regulation of locomotion (GO:0040013),0.5055608760113385,1.0176443811349623,0.4779516358463727,0.8350074650997202,1.0,2/12,8.98%,DUSP3;SPINT2
prerank,protein import (GO:0017038),0.40332676137941453,1.0171998893625867,0.49229188078108943,0.8356208035791327,1.0,11/84,10.17%,MMP12;SYK;RAB8B;NUP62;APOE;SNX33;ABCD1;CSE1L;PEX13;PXMP2;TPR
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.30260074008113247,-1.017060265307711,0.3958333333333333,0.8667230931957755,1.0,13/29,20.71%,ARRDC3;ABL1;DCUN1D4;PINK1;TOPORS;FBXW7;DTX3L;UBE2L3;FEM1A;DCUN1D3;PARK7;BMI1;SMAD7
prerank,negative regulation of fat cell differentiation (GO:0045599),0.44067189845997656,1.0170536813460949,0.47011494252873565,0.8355283015151348,1.0,6/34,14.36%,TGFB1;TNF;FLCN;SMAD3;GPS2;BBS12
prerank,positive regulation of transferase activity (GO:0051347),0.3923787929296391,1.017042959403266,0.4798387096774194,0.8350987613742886,1.0,12/142,6.34%,TREM2;TGFB1;FLT3;CD74;DBI;CSF1R;DSTYK;PTGES3;PKIB;RPS2;XRCC5;CTNNB1
prerank,substantia nigra development (GO:0021762),0.4210550835681155,1.016927384636777,0.4547537227949599,0.8348999748894588,1.0,12/37,22.72%,BASP1;CKB;ACTB;SEC16A;YWHAH;GNB4;CDC42;RHOA;COX6B1;PADI2;RAD1;NDRG2
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.35505391395422237,-1.0165986773673426,0.3644067796610169,0.8648832745565984,1.0,3/16,1.20%,SOX5;FOXC1;PTN
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.4074309294565768,1.0161638115065095,0.48459958932238195,0.8363028922925464,1.0,19/80,14.56%,P2RX7;KCTD17;ARAP1;ARPC2;PLEKHM1;RIPOR2;DOCK11;AGRN;P2RY12;WASF2;AKIRIN1;ACTR2;ACTR3;NRP1;CYFIP1;PFN1;TWF2;FNBP1L;MIEN1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5113436814869807,1.0160379555387982,0.4803370786516854,0.836156658296822,1.0,2/10,7.38%,MLXIPL;ABCD1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.4560141744481876,1.0157886891055066,0.48592411260709917,0.8363374042754084,1.0,7/23,16.89%,P2RX7;MLXIPL;PFKFB4;NFKB1;HIF1A;PFKFB3;GAPDHS
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.45557488745435243,1.0157868126791973,0.45985401459854014,0.8358832573177898,1.0,6/24,12.65%,MAPK14;CTNNB1;MEF2A;MYOCD;MEF2C;NRG1
prerank,bone morphogenesis (GO:0060349),0.5032686060573501,1.014305798275115,0.49519890260631,0.8390324890732767,1.0,2/14,9.80%,SKI;LRP5
prerank,regulation of histone methylation (GO:0031060),0.5034772569082886,1.0141067190634592,0.47455295735900965,0.8390459674699234,1.0,3/13,15.15%,NSD1;TTLL12;PIH1D1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.47108043673430106,1.0139980693043842,0.48320413436692505,0.8388446538070609,1.0,4/19,10.90%,THY1;PTPRJ;NRP1;LIMS1
prerank,negative regulation of neuron projection development (GO:0010977),0.4090364740807628,1.0139405831836823,0.47291666666666665,0.838512068043008,1.0,18/56,19.48%,MYLIP;THY1;BCL11A;RTN4RL1;APOE;ADCY6;CBFA2T2;PTPRO;ARHGDIA;EFNB3;GAK;RTN4;PTEN;EPHA4;RHOA;DENND5A;PAQR3;RAB29
prerank,regulation of RNA export from nucleus (GO:0046831),0.5146207241948147,1.0138761727791186,0.484375,0.8381989422964864,1.0,5/11,16.11%,DHX9;SETD2;TPR;AKAP8L;NRDE2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.39976489224847095,1.0137648669268366,0.4768611670020121,0.8380113340415182,1.0,23/128,14.41%,TUBB;PRKAR2B;HAUS2;CDK14;TUBA4A;FBXL22;BACH1;CNTRL;CEP192;MAPRE1;DNM2;CEP70;PLK4;CEP76;CHEK2;ENSA;HAUS1;CDK7;DYNC1H1;PCM1;FBXL3;CEP152;HAUS8
prerank,regulation of urine volume (GO:0035809),0.5176765090010664,1.013745742780844,0.476056338028169,0.8375944771569145,1.0,4/10,20.24%,ADCY6;TFAP2B;ADM;INPP5K
prerank,cellular senescence (GO:0090398),0.454440764962878,1.0135342925184925,0.48693586698337293,0.8376412192941561,1.0,3/27,4.86%,PRKCD;MAPK14;SPI1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.5015425601092416,1.013393164718063,0.46825396825396826,0.8375214718751701,1.0,4/13,16.91%,TLR2;CCL2;NOD2;IL33
prerank,protein maturation (GO:0051604),0.3992849744108868,1.0133556490922178,0.4750762970498474,0.837157095059347,1.0,22/95,17.12%,CTSS;SRGN;ECE2;EEF1AKMT4-ECE2;CLN3;DDI2;TSPAN32;TSPAN14;MMS19;CIAO2A;NAA40;CIAO1;SORL1;STUB1;NDUFAB1;PCSK7;GALNT2;ECEL1;METAP2;NAA50;FURIN;PITRM1
prerank,regulation of cytoplasmic translation (GO:2000765),0.49606538765868424,1.0132532015022913,0.48344370860927155,0.8369414598256911,1.0,6/14,20.61%,DHX9;CPEB3;CPEB4;CPEB2;CNBP;PKM
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.44983046145351735,1.0130694593412592,0.4664310954063604,0.836960482469184,1.0,8/29,13.36%,CORO1A;CYRIB;PRKCD;ARFGEF1;PFN2;PFN1;TWF2;SSH2
prerank,adipose tissue development (GO:0060612),0.5028061208102425,1.0124137020227457,0.4853146853146853,0.8380782634745195,1.0,2/11,9.80%,SH3PXD2B;LRP5
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.45682297969666946,1.0122801404844086,0.47342398022249693,0.8379396026853563,1.0,6/21,20.35%,FRAT2;CTNNB1;AMER1;CSNK1A1;GSK3B;FZD2
prerank,T-helper cell differentiation (GO:0042093),0.49271738760344014,1.0122525429119225,0.478796169630643,0.8375502972690857,1.0,4/14,9.47%,ATP7A;HMGB1;TMEM98;GPR183
prerank,miRNA mediated inhibition of translation (GO:0035278),0.5077923888458259,1.0121754176835267,0.4659248956884562,0.836794718994894,1.0,4/11,17.98%,TNRC6A;AGO4;AGO3;AGO2
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.5077923888458259,1.0121754176835267,0.4659248956884562,0.836794718994894,1.0,4/11,17.98%,TNRC6A;AGO4;AGO3;AGO2
prerank,cellular potassium ion homeostasis (GO:0030007),-0.3757480150860887,-1.011820710447644,0.43866171003717475,0.8755898608668892,1.0,3/13,7.17%,SLC12A2;ATP1B1;ATP1A2
prerank,sphingoid metabolic process (GO:0046519),-0.39806396653991205,-1.0114345697055354,0.45357142857142857,0.8735112162466366,1.0,7/12,40.67%,SGPP1;SPHK1;PLPP3;PLPP1;PLPP2;ASAH2;SPTLC3
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.39965976728275293,1.0113803881662489,0.47494780793319413,0.8382173723662203,1.0,18/69,19.92%,EDEM1;TRIM25;HERPUD1;SEL1L;ERLIN2;ERLIN1;DERL1;UBE4B;STT3B;STUB1;UBE2G2;WFS1;UBE2J2;FAM8A1;FBXO44;OS9;EDEM2;TMEM67
prerank,COPII-coated vesicle budding (GO:0090114),0.41213124971979415,1.0112681269324617,0.49007314524555906,0.8380294089701935,1.0,27/68,24.50%,CTSC;PPP6R1;TRAPPC9;MCFD2;CTSZ;PDCD6;VAPB;RAB1B;SEC24D;SEC16B;SEC16A;F5;STX5;SAR1A;TRAPPC6A;GRIA1;TRAPPC2L;SEC13;SEC31A;SEC22B;USO1;CUL3;NAPA;TRAPPC10;NSF;TRAPPC4;SEC24C
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.39735880346818886,1.0109373026049822,0.485456369107322,0.8383246094611928,1.0,27/124,17.83%,LYN;PLEK;CSF1R;PRDM12;MICALL2;APOE;PKD2;TTC29;HMGB1;GPRIN3;MICALL1;LRP12;RB1;ATCAY;RAB11A;DTNBP1;CYFIP1;STX3;ATP1B2;TOR1A;PLEKHA1;ERCC6;EPHA8;ARFIP2;WDPCP;TBC1D23;MANF
prerank,regulation of viral life cycle (GO:1903900),0.46644303948452864,1.0101361958416208,0.4718826405867971,0.8398181587698591,1.0,3/21,8.54%,TRIM25;TRIM5;TRIM27
prerank,acute inflammatory response (GO:0002526),0.4582847167472399,1.0100769033254657,0.47630619684082626,0.8394933039771916,1.0,3/23,7.75%,MYLK3;IL6R;CEBPB
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.4743634849701325,1.0098780403221093,0.46941323345817726,0.8395080469586792,1.0,3/17,3.21%,SCN4B;HCN4;SLC8A1
prerank,regulation of protein modification process (GO:0031399),0.4190204558602221,1.009657151326951,0.47986942328618065,0.839575578520485,1.0,21/50,24.62%,LYN;FNIP2;ATG7;FNIP1;PLXNB2;FLCN;HPF1;PHIP;PPP2CA;PUM3;CORO1C;ATG14;ABCA2;HSPB1;PIN1;MT3;ATG10;FKTN;PPP1R16B;SPRED1;SPRED3
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.44910540120794973,1.009561167042633,0.4830917874396135,0.8393508247725048,1.0,2/25,3.68%,LYST;VTA1
prerank,positive regulation of natural killer cell activation (GO:0032816),0.49854948079032807,1.0094631262342684,0.48364153627311524,0.8391396403034282,1.0,4/13,13.65%,IL18;TYROBP;TICAM1;GAS6
prerank,neuron apoptotic process (GO:0051402),-0.331195882443227,-1.0091021551495685,0.4271356783919598,0.8768999259431648,1.0,9/19,32.93%,APP;BNIP3;ATN1;NAE1;GAPDH;ERBB3;CIT;LIG4;DIABLO
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4260755691422747,1.0086802244699986,0.4760845383759733,0.8405773946333094,1.0,10/39,18.66%,PCSK9;SCN4B;FGF13;WNK1;NEDD4L;WNK4;FXYD5;YWHAH;PTPN3;FXYD6
prerank,Golgi to plasma membrane transport (GO:0006893),0.41590892257805373,1.008372392261316,0.49075081610446136,0.8408876852668017,1.0,13/47,13.71%,RAB34;RABEP1;EXOC6;CCDC93;MACF1;VPS35L;RAB31;ARFGEF2;EXOC8;EXOC1;EXOC2;EXOC5;GGA2
prerank,COPII vesicle coating (GO:0048208),0.4151614903992511,1.0083647935283877,0.4978768577494692,0.8395467867297777,1.0,25/61,24.50%,CTSC;PPP6R1;TRAPPC9;MCFD2;CTSZ;PDCD6;RAB1B;SEC24D;SEC16B;SEC16A;F5;STX5;TRAPPC6A;GRIA1;TRAPPC2L;SEC13;SEC31A;SEC22B;USO1;CUL3;NAPA;TRAPPC10;NSF;TRAPPC4;SEC24C
prerank,vesicle coating (GO:0006901),0.4151614903992511,1.0083647935283877,0.4978768577494692,0.8395467867297777,1.0,25/61,24.50%,CTSC;PPP6R1;TRAPPC9;MCFD2;CTSZ;PDCD6;RAB1B;SEC24D;SEC16B;SEC16A;F5;STX5;TRAPPC6A;GRIA1;TRAPPC2L;SEC13;SEC31A;SEC22B;USO1;CUL3;NAPA;TRAPPC10;NSF;TRAPPC4;SEC24C
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.4151614903992511,1.0083647935283877,0.4978768577494692,0.8395467867297777,1.0,25/61,24.50%,CTSC;PPP6R1;TRAPPC9;MCFD2;CTSZ;PDCD6;RAB1B;SEC24D;SEC16B;SEC16A;F5;STX5;TRAPPC6A;GRIA1;TRAPPC2L;SEC13;SEC31A;SEC22B;USO1;CUL3;NAPA;TRAPPC10;NSF;TRAPPC4;SEC24C
prerank,MAPK cascade (GO:0000165),0.38955153161774636,1.0082360649055218,0.492,0.8394191962479336,1.0,69/295,18.77%,PTPN7;TGFB1;RASAL3;FLT3;SPTBN5;LAT;CSF2RB;TAOK3;GRB2;PIK3CB;FGF13;CCM2;RASA4;TNF;RASA3;IL18;RGL2;SHC2;BCL2L1;PSMB10;YWHAB;MEF2A;ABHD17B;MAP3K5;TNIK;PRKCQ;FLT3LG;MEF2C;RASGRP3;HSF1;MAP2K2;PSMA2;SOX9;ARTN;ABHD17C;CCL2;SYNGAP1;FYN;PSME3;NRG1;RANBP9;IKBKG;NFKB1;CAMKK2;BRAF;PSMB5;LAMTOR3;LRRK2;IL2RG;PSMD8;PPP1CC;WDR83;IL3RA;PTPRA;PSMD7;NF1;PSMB9;RASA1;RASAL1;RASGRP4;KSR1;SPTBN4;PSMD2;TAOK1;PTPN3;ANGPT1;CSF2RA;PAQR3;MINK1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.24204516859208486,-1.0078353838322671,0.4375,0.8773959252171055,1.0,27/65,22.07%,FBXL7;FHL1;PSME4;PSMD11;PSMA5;PSMA4;RBX1;PSMD14;PSMC6;NABP2;PSMC3;ZFYVE19;PINX1;PSMB3;PSMC1;VPS4A;PSMD5;PSMA3;PSMD3;PSMD6;PSMC5;USP47;PSME2;PSMB4;PSMC4;SKP1;PSMB6
prerank,regulation of telomere capping (GO:1904353),0.4529034601323213,1.0066671670473295,0.4801488833746898,0.8427045958868318,1.0,5/23,14.40%,PKIB;PRKCQ;USP7;TNKS2;HNRNPD
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.44065835570445894,1.006516041259054,0.4912485414235706,0.8425992109914887,1.0,8/32,17.14%,MMP12;CASK;NF2;THBS1;SRC;RASA1;PTEN;CORO1C
prerank,regulation of programmed cell death (GO:0043067),0.3919295631579594,1.0063458360992839,0.5025025025025025,0.8425475361430462,1.0,34/161,16.95%,CD3E;CTSB;FLT3;NUP62;TNF;TMEM219;TRAF2;CASP1;ANP32A;APAF1;ACTN4;TP53;CRADD;MALT1;TPT1;NTF3;BCAR1;ACER3;ACTN1;NF2;LGALS1;TRIM24;SOX9;SRA1;LRP8;PRDX2;LRRK2;WFS1;STEAP3;PHLPP1;FANK1;RTN4;HSP90AA1;ASAH1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.41046551340022247,1.0062109129453511,0.48854166666666665,0.8424031403593616,1.0,12/65,13.43%,TGFB1;NRROS;TGFBR1;SKI;TGFBR2;NKX2-1;FAM89B;SMAD3;SNX25;BAMBI;VASN;STUB1
prerank,muscle cell migration (GO:0014812),0.5207684695296187,1.006183328390022,0.4922425952045134,0.8420116290760598,1.0,1/10,1.71%,ITGB3
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.33005448200832815,-1.0061670080453724,0.4028436018957346,0.8789893177378506,1.0,11/18,30.00%,COX16;OXA1L;COX18;COA8;COX14;COX17;TIMM21;COA5;SCO1;COA3;SURF1
prerank,synapse assembly (GO:0007416),0.4054890424418529,1.0060883325174776,0.49056603773584906,0.841784930316136,1.0,5/67,4.57%,NPAS4;PCDHB6;FGF13;SLITRK1;PLXNB2
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.27859686638819026,-1.0059526604973164,0.40707964601769914,0.876472446488996,1.0,8/33,8.02%,NR2F2;MCC;DAB2IP;SYNJ2BP;ACVRL1;SP100;SLIT2;KRIT1
prerank,cell cycle G1/S phase transition (GO:0044843),0.40678051516807645,1.0055888872133054,0.5042462845010616,0.8425084521284476,1.0,14/61,16.29%,GPR132;GSPT1;PIM2;PLK2;RB1;CDK7;DBF4;INHBA;CDC34;CDK6;MAX;CCNE2;USP29;MAP3K11
prerank,monocarboxylic acid metabolic process (GO:0032787),0.3921579733570411,1.005502080346078,0.5075681130171544,0.8422596878607229,1.0,22/117,17.70%,CYP1A1;LPL;SGPL1;ALOX12;MTHFS;ANGPTL3;CKB;NPC1;KYNU;ACSF2;SLC16A1;MCCC2;PDHA1;FASN;PDZD11;VDAC1;CD36;ME3;LDHA;PPARD;PCCA;ACOT2
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.4592110453442227,1.0053739970572044,0.4731585518102372,0.8421180380246446,1.0,11/21,22.76%,DUSP3;MACF1;SLC9A1;ACTG1;VCL;PTPRA;CORO1C;RHOA;ROCK2;GPM6B;CLASP1
prerank,positive regulation of ossification (GO:0045778),0.4244950119239994,1.0053490017260411,0.4856828193832599,0.8417189244400872,1.0,7/39,10.88%,TGFB1;P2RX7;SLC8A1;FZD9;MEF2C;ATP2B1;NELL1
prerank,negative regulation of cell cycle (GO:0045786),0.4058737878787703,1.0053191157952932,0.49483471074380164,0.8413356441931223,1.0,20/73,20.29%,LILRB1;TGFB1;HPGD;CEBPA;MYOCD;RB1;SMAD3;SIPA1;ANGEL2;INHBA;TRIM35;CDK6;NR4A1;RPS6KA2;PTEN;PTPN3;SCRIB;NPPC;HEXIM1;HHEX
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.3552939434568988,-1.005228300363101,0.4666666666666667,0.8753672861176104,1.0,3/15,7.15%,PIEZO2;SCN1A;KCNA1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.4600874630668834,1.0050629840668472,0.4751592356687898,0.8414921984224488,1.0,8/20,25.40%,PTGES3;LONP1;PSMG3;BBS12;HSP90AA1;PSMG2;HSPA4;HSP90AB1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.48705462143497336,1.0048785246473706,0.4878361075544174,0.8410325143074692,1.0,3/15,10.99%,AP3D1;AP3S1;DTNBP1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.48705462143497336,1.0048785246473706,0.4878361075544174,0.8410325143074692,1.0,3/15,10.99%,AP3D1;AP3S1;DTNBP1
prerank,manganese ion transport (GO:0006828),0.49414691158663543,1.0048591921501824,0.48738379814077026,0.8406268170997011,1.0,2/14,7.97%,SLC11A1;ATP2C1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.5132440095696671,1.0041704712582975,0.47345132743362833,0.8418303208044774,1.0,3/10,13.59%,ATRX;DBF4;INO80
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.36899089236853827,-1.0039411259998756,0.4300341296928328,0.8760021308106918,1.0,3/13,4.67%,ZFPM2;BMPR1A;TGFBR3
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.4242741478956444,1.0039049962337163,0.49286498353457736,0.8420201918968229,1.0,12/43,17.60%,SNX5;PRKCD;PTPN1;PTPRE;PIP4K2A;PRKCB;PRKCQ;SORL1;PID1;GSK3A;ZBTB7B;SIK2
prerank,hydrogen peroxide metabolic process (GO:0042743),0.4719261802153357,1.0025878339550194,0.5051150895140665,0.8446544095218866,1.0,7/19,21.24%,PRDX1;PRDX3;PXDN;PRDX2;PRDX5;NOX1;CYBA
prerank,organic anion transport (GO:0015711),0.40554548307477867,1.002523467687048,0.5159958720330238,0.844353371030218,1.0,12/76,15.28%,AQP1;ABCC6;SLC52A1;SLCO2B1;LRRC8D;CYB5R1;SLC16A2;CYB5RL;MGST1;SLCO1B1;SLC35A3;LRRC8C
prerank,regulation of multicellular organismal development (GO:2000026),0.4544289959990014,1.0022164186331364,0.48292682926829267,0.8446280972442638,1.0,2/25,4.98%,HPSE;RAB14
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.44508141873287943,1.0020631922164127,0.4865497076023392,0.8445402657113297,1.0,12/27,27.28%,CHSY3;BCAN;XYLT1;CHSY1;CHST15;PXYLP1;CHPF;CSPG4;B3GAT2;CHST3;CHST11;CHST9
prerank,myofibril assembly (GO:0030239),0.4221847667115951,1.0018492534174053,0.4972796517954298,0.8445865269856917,1.0,7/42,15.00%,TTN;MYLK3;CFLAR;FLII;TNNT3;CSRP1;CAPN3
prerank,regulation of water loss via skin (GO:0033561),0.48210824610922987,1.0014119783593405,0.4799465240641711,0.8446985701480031,1.0,1/15,2.01%,ALOX12
prerank,establishment of skin barrier (GO:0061436),0.48210824610922987,1.0014119783593405,0.4799465240641711,0.8446985701480031,1.0,1/15,2.01%,ALOX12
prerank,regulation of feeding behavior (GO:0060259),-0.39301703740749466,-1.0013285083250323,0.45422535211267606,0.8802120913287538,1.0,5/11,36.11%,LEPR;EIF2AK4;NR4A3;AGRP;CFAP20
prerank,cellular response to inorganic substance (GO:0071241),0.4575232907021911,1.0011793754139378,0.5061881188118812,0.8448549772095512,1.0,7/21,24.14%,AQP1;DDI2;ATRX;MTR;SPIDR;MT3;DDX11
prerank,regulation of cellular protein catabolic process (GO:1903362),0.4777557493069293,1.0010523152318973,0.5103626943005182,0.8446946714637315,1.0,8/18,19.60%,WDR91;VPS11;AMER1;NELL1;FAF1;HSP90AA1;DACT1;ATRAID
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.38246793503223464,1.001037098058015,0.51,0.8442748886173823,1.0,340/1646,18.94%,RUNX1;CD86;BATF3;SPIC;NFE2;NPAS4;IRF5;AHRR;ASCL1;SHH;CIITA;MEOX1;IRF4;IRF8;TGFB1;IKZF1;HCLS1;TOX4;UXT;GATA1;PCID2;STAT5A;CD74;NFE2L2;POU2F2;BASP1;CBFA2T3;SNX5;TGFBR1;NFATC1;HES7;MED17;RREB1;GTF2H1;MAD2L2;NR1H4;BCL11A;NSD1;MLXIPL;ELF4;SS18L1;ZEB2;DHX9;NUP62;MED13L;SP7;MAPK14;CREB3L4;CREB3;BARX2;YAF2;CDK14;RXRB;FOXD2;TNF;CXXC1;SPP1;SREBF2;APOE;MLXIP;RFX1;MITF;CIR1;UBE2V1;BPTF;ZNF326;ZFP30;PPIE;NFXL1;ATF3;FOXO3;CEBPA;SRCAP;DDIT3;SPI1;LRRFIP1;ZMIZ2;ZBTB12;PGBD1;MYT1L;NDP;MAFG;WWC2;HIVEP3;MAFK;TSC22D4;ZBTB39;HDAC5;HOXC8;BHLHE41;BRIP1;BACH1;HMGB1;TRPS1;RNF111;XRCC5;CHD7;TEAD1;FLI1;PCGF6;SBNO1;PRKCB;USF1;CTNNB1;MAP2K3;CREB3L1;MTA3;CCAR1;CDK11B;TFEB;ZFP69;ZNF177;DNM2;KLF6;CD80;RCOR1;TP53;MEF2A;TBL1XR1;NKX2-1;NRL;TAL1;MAP3K5;MYOCD;KDM7A;YY1;SNAI1;TCF20;GCFC2;CDK17;PIM2;ZFP90;STAT4;CBFA2T2;HINT1;EPO;CEBPB;FOXN2;TGFBRAP1;DBX2;ST18;CHEK2;PRKCQ;MEF2C;NKRF;CDC5L;MDFIC;TFAP2B;CIART;RBM15B;RB1;MMS19;METTL4;SMAD3;BICRA;GMEB2;ARID1A;GTF2IRD1;ZNF32;ZFP14;TADA1;IRF2;HSF1;PPARGC1A;RPL6;ARID3B;QARS1;ATRX;ATF7IP;ARID4A;RING1;ANXA4;RNF4;LITAF;STAT5B;LRP5;CREBRF;GMEB1;CCNL1;NFE2L1;NFX1;MIDEAS;HDAC4;ARID1B;ZNF83;BAZ1A;TRIM56;TBL1X;NFIC;RNF10;SEC14L2;HOXA6;INHBA;TGIF1;ATAD2;MED27;CREB3L2;PHC1;MAP2K2;ZMYND15;CHD1;KLF13;LIMS1;POLR2L;HCFC2;PKN1;ELF2;ZSCAN26;RPS6KA4;DAP;SOX9;SRA1;OLIG1;ETV6;HDAC6;NLK;NR2C2;JDP2;ZNF740;E2F6;DENND4A;PHIP;ZNF628;HSF5;CIAO1;GZF1;MBD1;ATF6B;PPP2CA;MTF2;MAP3K12;HDAC9;CREB1;SMARCD3;NRG1;BRDT;KAT7;SMARCB1;MAX;ZNF445;ZFX;BAMBI;ZSCAN18;NR4A1;NFKB1;CAMKK2;FOXN3;IRF1;SAFB2;FOXK1;RFX7;GPATCH3;GAS6;SOX6;HCFC1;ZFHX3;CDC6;CUX1;SOX2;KDM3B;BRD7;HNRNPD;MEIS1;ARHGEF11;LBH;SREBF1;SOX4;POU6F1;ZBTB11;CAPN3;PIAS1;IFRD1;TLE5;SPTY2D1;EID1;SBNO2;NR2C1;MTDH;MAF;THRAP3;YWHAH;REXO4;FOSL2;ERCC6;FADS1;CDK15;RBPJ;FANK1;USP21;USP16;ZBTB7B;OGG1;MED29;HIF1A;REL;SUV39H1;SIX5;PPP3CB;PBXIP1;RSF1;TRIP4;ZNF568;ZGPAT;PPARD;BACH2;CDK18;ZSCAN2;VHL;ZKSCAN2;PCGF1;RPS6KA5;NPAS2;CASZ1;HSF2;ZNF35;SFMBT1;NFYA;CNBP;KDM4C;PROX2;LOXL3;JUNB;PICALM;MAFB;PHF1;RXRA;CREBL2;TESC;ZIC4;SP140;CIPC;KLF5;POU2F3;MAMLD1;CHD4;CUX2;KLF7;TULP3;PER1;FUBP3
prerank,regulation of cytokinesis (GO:0032465),0.40101529765764315,1.0008456811816326,0.49126413155190135,0.8442611726897259,1.0,20/78,17.69%,ZFYVE26;KLHL21;BCL2L1;PLK4;PLK2;KIF14;FLCN;MYO19;KIF20B;KIF23;UVRAG;RAB11A;SETD2;BECN1;CDC6;PIK3R4;CDC42;ENTR1;RHOA;GIPC1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5011340569806576,1.0008067398171971,0.4811715481171548,0.8438987364303382,1.0,2/12,10.17%,TGFB1;TPR
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.24974586893417253,-1.00023745721407,0.4852941176470588,0.8801281215079738,1.0,12/53,12.27%,SMCHD1;EYA2;EGFR;FXR2;SPRED2;NACC2;EYA1;FMR1;CEBPG;EYA4;CCAR2;ATM
prerank,membrane organization (GO:0061024),0.38714396628397035,1.0001932974545142,0.511,0.8448807796401577,1.0,64/227,21.38%,ARRB2;CBL;VAMP3;GRB2;RABEP1;SNX9;MTCH1;PIP5K1C;LDLRAP1;CLN3;ARPC2;NPC1;STX11;AP3D1;LPCAT2;DNM2;ACTB;GAPVD1;SYT2;AP2S1;SH3KBP1;ARPC3;STON2;ATP2C1;ITSN1;SNAP29;ACTG1;ACTR2;VAPB;SYNGR1;SYNGR2;ACTR3;TMCC1;DYSF;CLTC;TIMM50;ARPC4;SYNJ1;SNAP23;SAR1A;TOR1AIP2;FNBP1L;TOR1A;HUWE1;GAK;EPS15;AP2M1;PDCD6IP;EPN1;BIN1;CORO1C;UBXN2A;VPS33B;PICALM;TMEM170A;DNM1L;FNBP1;FCHO2;USO1;STAM2;NSFL1C;AZIN2;RIMS1;SCARB2
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.347773791584731,-0.9999280294562046,0.4117647058823529,0.8779293452886276,1.0,8/16,26.58%,PSIP1;DCPS;SRSF1;SNRPC;NCBP2;DDX23;SRSF12;CACTIN
prerank,establishment of protein localization to membrane (GO:0090150),0.4028358104945921,0.9997943311163098,0.5,0.8453593725616004,1.0,18/66,17.78%,RFTN1;RAB3GAP2;NPC1;MICALL1;ZDHHC14;AQP11;ZDHHC7;RAB11A;ZDHHC3;VPS37C;SDCBP;BRAF;ZDHHC1;ZDHHC24;ATG3;RABGEF1;SEC63;MYO1C
prerank,purine nucleotide catabolic process (GO:0006195),0.4974570781032759,0.9995966393931266,0.5180555555555556,0.8453728553755476,1.0,3/13,8.32%,XDH;HINT1;PNP
prerank,positive regulation of DNA replication (GO:0045740),0.47643761713935767,0.9992786491745546,0.48711340206185566,0.8456848379165326,1.0,7/16,16.45%,DHX9;BRPF3;STN1;DNA2;KAT7;BCAR3;FAF1
prerank,positive regulation of protein binding (GO:0032092),0.40288870621100725,0.9988167798568833,0.5149253731343284,0.8462932147597857,1.0,23/56,21.84%,PPP2CB;APOE;TAF1;HFE;SPPL3;DERL1;EPB41;PPP2CA;BAMBI;B2M;STK3;LRRK2;LRP1;IDE;RPL11;STK4;ADD1;FLOT1;DACT1;GSK3B;PRKN;PIN1;VTN
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.48761847984620527,0.9986916499236471,0.5128205128205128,0.8461356272315405,1.0,8/13,23.80%,ATG7;UBA2;SENP6;DESI1;DESI2;ATG10;UBA7;UBA5
prerank,tRNA transport (GO:0051031),-0.28076597613976845,-0.9986342768687139,0.464,0.8784232579439339,1.0,11/35,12.17%,NUP93;NUP188;RANBP2;SSB;NUP98;NUP42;YBX1;NDC1;RAE1;NUP153;NUP37
prerank,mesenchymal cell differentiation (GO:0048762),0.40908268825197586,0.9984210022434108,0.4887459807073955,0.8462816749522573,1.0,13/51,20.32%,TGFB1;TGFBR1;CTNNB1;AKNA;SNAI1;MEF2C;LIMS1;SOX9;RBPJ;HIF1A;LOXL3;ROCK2;GSK3B
prerank,aortic valve development (GO:0003176),0.42405170866282704,0.9984038494375681,0.4982973893303065,0.845877924872628,1.0,6/34,11.73%,TGFB1;NFATC1;SNAI1;RB1;SOX9;TNFRSF1B
prerank,regulation of epithelial cell migration (GO:0010632),0.415087037554975,0.9979365886156364,0.5016111707841031,0.8465722219003092,1.0,15/51,17.14%,PLCG2;RREB1;ARSB;MACF1;DUSP10;RAB11A;PFN2;SOX9;PFN1;HDAC6;ADIPOR1;SRC;HIF1A;RTN4;CORO1C
prerank,embryonic digit morphogenesis (GO:0042733),0.462927356333999,0.9961647398593348,0.4880503144654088,0.8501796582466299,1.0,1/18,0.65%,SHH
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.5000896447155494,0.9961151387158221,0.4882108183079057,0.8498562883897881,1.0,2/11,9.42%,DHX9;PUM2
prerank,regulation of secretion (GO:0051046),-0.3760842597746622,-0.9960932543088875,0.4377358490566038,0.8825017074523891,1.0,7/13,27.74%,MYO6;GPLD1;FGF10;EGF;ERBB3;ACSL3;POFUT2
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.4345438845418126,0.9960133472244639,0.5046403712296984,0.8496323443029444,1.0,10/28,22.91%,TNF;SPI1;CRADD;ZDHHC3;CASP8;TRADD;SORT1;DEDD;DELE1;BID
prerank,endocrine system development (GO:0035270),0.45361612816300195,0.9959077226491133,0.48695652173913045,0.8494167541626009,1.0,6/21,15.81%,TGFBR1;MDK;NKX2-1;SOX2;TG;NF1
prerank,response to reactive oxygen species (GO:0000302),-0.2536611776116727,-0.9958058725983385,0.4,0.8802411935235842,1.0,16/54,16.85%,MAPK8;EGFR;SOD2;AGAP3;MAPK9;PTPRK;SOD1;PDGFRA;STK25;CHUK;MAPT;AKT1;HYAL1;GLRX2;ERCC6L2;COA8
prerank,endothelial cell migration (GO:0043542),-0.26890873512588076,-0.9953991800643794,0.4925373134328358,0.8783008658923862,1.0,10/37,16.70%,FSTL1;CDH5;STARD13;ID1;ABL1;FAP;CCN3;NOS3;SCG2;STAT1
prerank,negative regulation of histone acetylation (GO:0035067),0.5081017973521829,0.9948166602972179,0.4907010014306152,0.8515173994072504,1.0,3/11,14.29%,SNCA;SPI1;NOC2L
prerank,nuclear membrane organization (GO:0071763),-0.31793967565918546,-0.9944916717975179,0.4801980198019802,0.8777396358816745,1.0,8/19,23.03%,SPAST;VPS4A;EMD;CHMP4B;TARDBP;TMEM43;CHMP2A;GPER1
prerank,myoblast differentiation (GO:0045445),-0.36776130555271336,-0.9941563990378759,0.4370629370629371,0.8756972359478048,1.0,6/14,13.87%,TCF7L2;REST;HINFP;EPAS1;MAPK12;JAG1
prerank,negative regulation of RNA metabolic process (GO:0051253),0.4629643940800312,0.9938177535496987,0.48516129032258065,0.8533287769037231,1.0,2/18,3.79%,TGFB1;TNF
prerank,phasic smooth muscle contraction (GO:0014821),0.5147083889826966,0.9930153516614687,0.5160349854227405,0.8547454455503547,1.0,1/10,2.44%,EDNRB
prerank,axonal transport of mitochondrion (GO:0019896),-0.38292661038804077,-0.9922816402835332,0.411214953271028,0.8779730132652402,1.0,4/11,11.34%,SPAST;NEFL;SYBU;MAPT
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.4741026907520246,0.9920931990567657,0.5100671140939598,0.8564651891820281,1.0,3/15,9.65%,HERPUD1;SEL1L;DERL1
prerank,nuclear export (GO:0051168),0.390230496587632,0.9912163603419591,0.5265901981230449,0.8580195822526935,1.0,24/80,20.37%,TGFB1;NUP62;DHX38;XPO1;NXF1;THOC2;CASC3;MALT1;CSE1L;STRADB;WASHC4;TPR;DDX39B;XPO6;POLDIP3;THOC3;UPF3B;STRADA;SMURF1;SLU7;SRSF2;SRSF6;DESI1;SRSF3
prerank,response to calcium ion (GO:0051592),0.38874374001611967,0.991123811881963,0.5268490374873354,0.857774363191196,1.0,15/102,9.04%,SYT17;LGMN;PLCG2;RASA4;PKD2;KCNIP2;TTN;RASGRP2;MEF2A;KCNMA1;SYT2;MEF2C;SYT10;PDCD6;ALG2
prerank,cytoplasmic microtubule organization (GO:0031122),0.41349618479962363,0.991089773328564,0.5185577942735949,0.8574145606328033,1.0,13/54,16.09%,HOOK3;CCDC88B;CLIP2;RAB11A;TUBGCP4;TUBGCP6;DYNC1H1;PCM1;KATNA1;HOOK2;CAMSAP2;DST;FIGN
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.47696508620496947,0.9907077793601214,0.5,0.8578370499351251,1.0,2/14,9.42%,TLR2;PUM2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.4254220267787622,0.9900883906247827,0.5113500597371565,0.8587858414791509,1.0,5/30,13.97%,KLK3;PKN1;HDAC6;SAFB2;KLK2
prerank,cellular response to interleukin-1 (GO:0071347),0.38584195263344917,0.990046489947663,0.5226130653266332,0.8584357642431167,1.0,34/143,17.93%,SIRPA;IL1A;IRAK2;CCL8;UBE2V1;TANK;MYLK3;PYCARD;PSMB10;ST18;RC3H1;CCL14;PSMA2;CCL13;RPS6KA4;GBP3;SOX9;CCL2;NOD2;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;TAB3;PSMD7;PSMB9;HIF1A;CD47;CCL25;UBE2N;RPS6KA5;PSMD2
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.3619156640178438,-0.9897971618540564,0.46558704453441296,0.8816781082339058,1.0,9/14,29.38%,IRS1;PPARA;LONP2;AKT1;IRS2;MFSD2A;TWIST1;TYSND1;MTLN
prerank,cellular protein metabolic process (GO:0044267),0.38108876935630653,0.9893139223029471,0.5455455455455456,0.8596818512740081,1.0,89/396,18.77%,KLK3;PCSK9;NAPSA;LGMN;CSF2RB;RPL23;RPL17;RPL10A;SFTPA1;SFTPA2;SPP1;APOE;UBE2D3;ST8SIA4;DNAJC3;RPS2;RRBP1;TIMP1;DMBT1;FARSB;RPL18A;UBE2S;MRPL41;TTF1;RPS15A;GSPT1;SPCS2;P4HB;ATP23;LOX;SEC11C;CHEK2;EIF4EBP2;ST3GAL1;MRPL51;MAN2B1;SPPL3;RPL6;SPCS1;PIGH;MCRS1;FAM20C;RPLP2;RPL26;VGF;LGALS1;RPS20;MSRA;CHGB;YES1;RPS16;CDC34;PARL;LMCD1;F5;B4GALT7;RPS14;UBE2G2;DARS1;GAS6;RPL19;WFS1;RPL9;IGF2BP3;ABCA3;ATG3;IDE;RPS11;RPL11;YME1L1;APLP2;ERO1A;RPS23;FURIN;FDXR;MRPS21;RPS4X;MRPS14;PABPC4;AGO2;FDX1;RPS27;RPL4;IGFBP4;CSF2RA;MRPL3;PPP4R2;MXRA8;MSRB2
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.44576290277655667,0.9891560789205109,0.5227848101265823,0.8596075356536808,1.0,12/24,19.36%,FCER1G;HFE;TAPBPL;TAP1;SEC24D;B2M;ERAP1;PDIA3;IDE;TAP2;SEC13;SEC31A
prerank,regulation of protein ubiquitination (GO:0031396),0.39204111765956895,0.9890701804667796,0.5309017223910841,0.8593575468652679,1.0,22/108,18.44%,ARRB2;BAG2;IVNS1ABP;LAPTM5;TGFBR1;TNFAIP3;MALT1;PRMT3;DERL1;AMER1;STUB1;LRRK2;HUWE1;WFS1;SOX4;GSK3A;SVBP;HSP90AA1;VPS28;UBE2N;ANGPT1;BIRC2
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.4078191137775416,-0.9890684211141371,0.4696485623003195,0.8807927080487042,1.0,5/10,29.78%,MAPT;PPM1F;DNAJA1;TERF1;NDFIP2
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.48241254201907513,0.9890664542772146,0.5138504155124654,0.8589160457658233,1.0,4/13,17.83%,FCGR2B;AQP11;WFS1;MANF
prerank,cardiac conduction system development (GO:0003161),-0.3070995373759007,-0.9889016151686032,0.44886363636363635,0.8782574763141247,1.0,7/24,11.01%,BMPR1A;BMP4;CACNA1G;SMAD4;SMAD5;SMAD1;TBX18
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.4499833527452095,0.988628316214324,0.5055079559363526,0.859469349785787,1.0,10/23,25.42%,NLRC5;IFNGR2;TXK;PIAS1;IRGM;SOCS3;IFNGR1;PARP9;HSP90AB1;CDC37
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.4848800979035252,0.9884096138067473,0.4920424403183024,0.8595240901553949,1.0,4/13,14.21%,UTP20;NOP9;RRS1;TSR1
prerank,cell junction organization (GO:0034330),0.39793549669541506,0.9880214771770344,0.514047866805411,0.8599987271943343,1.0,12/71,10.90%,TGFB1;RAB8B;SNCA;ACTB;AGRN;VMP1;C1QA;CAPZA1;RAB39B;SMAD3;ACTG1;LIMS1
prerank,signal transduction in response to DNA damage (GO:0042770),0.40860322448799735,0.9876890057693991,0.5151515151515151,0.8603050810098434,1.0,9/49,9.58%,MAD2L2;GRB2;MAPK14;BRIP1;TP53;CHEK2;DOT1L;CDC5L;ATRX
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.4088253951370617,0.9874755554662098,0.5124324324324324,0.8603416176953794,1.0,12/47,19.76%,SCIMP;TAOK3;RAP2A;QARS1;MAP2K2;NOD2;KLHDC10;PHLPP1;TAOK1;GREM1;PER1;MAP4K4
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.45551814598624674,0.9870003258059981,0.5091145833333334,0.8609859071024639,1.0,2/17,7.22%,TGFB1;SNAI1
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3823566734080109,0.9862330432219052,0.5466399197592778,0.8623033637752928,1.0,30/144,15.76%,TGFB1;ITGB2;HCLS1;PRKCD;SREBF2;MICALL2;UBE2D3;AKAP5;YWHAB;TP53;RIPOR1;CSNK2A2;VPS11;KIF20B;SMAD3;ITGAM;TPR;SEC16B;SEC16A;PCM1;FYN;CASP8;SORL1;SAR1A;GAS6;HUWE1;UBE2J2;CEMIP;GSK3A;YWHAH
prerank,positive regulation of neuron migration (GO:2001224),-0.38497688490066995,-0.9862119754252687,0.4602076124567474,0.8830866602947995,1.0,6/11,11.94%,SEMA6A;NIPBL;SEMA3A;DAB2IP;RAPGEF2;NSMF
prerank,proteasomal protein catabolic process (GO:0010498),0.38291977206823646,0.986024558964724,0.547,0.8623195419172546,1.0,58/201,21.05%,ARRB2;NFE2L2;RFFL;KCTD17;UBE2D3;SEL1L;FBXL22;DDIT3;DDI2;CTNNB1;ATXN3;PSMB10;TBL1XR1;KIF14;GID8;DERL1;UBE4B;RNF4;APPBP2;NEDD4L;TBL1X;MAEA;PSMA2;SPOP;CDC34;PSME3;RNF216;ITCH;RMND5B;STUB1;PSMB5;HUWE1;AREL1;PSMD8;ZNRF1;PSMD7;CCDC47;GSK3A;PSMB9;SMURF1;FAF1;FEM1B;UBE2K;PSMD2;UBXN2A;PPP2R5C;BIRC2;KCTD5;FBXO44;SPSB2;ERLEC1;PLAA;FBXW11;RAD23B;WWP1;CUL3;NSFL1C;PRKN
prerank,positive regulation of protein depolymerization (GO:1901881),0.5046735436368607,0.9857088366689769,0.5055555555555555,0.862601963923731,1.0,1/11,0.92%,PLEK
prerank,negative regulation of catalytic activity (GO:0043086),0.4416301533424651,0.9852390139025908,0.5125748502994012,0.8632351797547884,1.0,5/24,11.44%,CLN3;TIMP1;TP53;ATP5IF1;HDAC6
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.43818103084760557,0.985002179076416,0.5203836930455635,0.8633421783142039,1.0,9/25,20.56%,BCAS2;SF3B1;SCAF11;PRPF8;TRA2B;WDR83;SLU7;SF3B3;SRSF10
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.3871974369191049,-0.98487298959185,0.45896656534954405,0.8838382912323104,1.0,9/10,45.67%,GAR1;NOP10;TSR3;RPUSD1;NAF1;NHP2;RPUSD2;RPUSD3;DKC1
prerank,mRNA methylation (GO:0080009),-0.3512867146742252,-0.9848388234610316,0.45,0.8810052961794096,1.0,6/15,14.53%,CBLL1;NSUN2;METTL14;TRMT6;METTL16;CMTR1
prerank,ERAD pathway (GO:0036503),0.3874311591442525,0.9846867390854906,0.5351966873706004,0.8636049420550721,1.0,23/83,21.34%,EDEM1;TRIM25;HERPUD1;SEL1L;ERLIN2;ATXN3;ERLIN1;DERL1;UBE4B;STT3B;STUB1;UBE2G2;TOR1A;WFS1;UBE2J2;FAM8A1;CCDC47;FBXO44;ERLEC1;OS9;TMEM67;PRKN;DNAJB14
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.4627679035611261,0.9844709407815678,0.5142150803461063,0.8636641509551709,1.0,6/21,15.36%,PPP1R11;YWHAB;ENSA;BOD1L1;PPP4R4;PTPA
prerank,sensory perception of chemical stimulus (GO:0007606),-0.3451130803287043,-0.9843801034950543,0.46987951807228917,0.8793510184174116,1.0,7/15,22.83%,GNAS;GNAL;UBR3;BBS4;SLC24A4;DRD2;MKKS
prerank,GPI anchor metabolic process (GO:0006505),0.43589270931266966,0.9836968920696086,0.51357733175915,0.8649727463657684,1.0,11/26,23.09%,PIGM;PIGL;PIGV;PGAP1;PIGH;PGAP2;PIGC;PIGU;PIGN;DPM2;PIGP
prerank,response to hexose (GO:0009746),0.4460247415197978,0.9835748622642805,0.5187878787878788,0.8648003968639854,1.0,4/25,11.47%,LPL;PFKL;EIF2B2;THBS1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.399868125523508,0.9835137778027138,0.5162644281217209,0.864491319139614,1.0,13/63,15.26%,LGALS3;TGFBR1;TNF;ITGA6;TRAF2;PYCARD;CFLAR;THBS1;PHIP;PSME3;CASP8;TRADD;SRC
prerank,response to metal ion (GO:0010038),0.4024752701008414,0.9834084762335726,0.5241090146750524,0.8642863879217976,1.0,12/67,12.38%,IL1A;PPP2CB;SNCA;TTN;HAAO;KCNMA1;HFE;PDCD6;ALG2;NEDD4L;THBS1;PPP2CA
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.447798809043296,0.9829128995626398,0.5280095351609059,0.8649964534067252,1.0,7/22,16.10%,STAC;CACNB4;NOS1AP;CACNB2;CACNB1;STAC3;GNB5
prerank,regulation of pH (GO:0006885),0.5004226443155746,0.9828495255513198,0.5148936170212766,0.8646983929997811,1.0,4/11,20.82%,SLC9A1;ATP6AP1;LACC1;SLC9A7
prerank,inorganic cation transmembrane transport (GO:0098662),0.38108647517538724,0.9826917690280291,0.558,0.8645973369469655,1.0,22/268,7.97%,SLC6A3;SLC6A4;KCNJ11;SLC11A1;SCN4B;ATP6V0E1;HCN4;SLC9A4;KCNN4;P2RX7;SLC8A1;KCNK6;PKD2;SLC36A1;P2RX4;SLC9A9;CCDC51;SLC9A1;CACNA1A;ATP6V0D1;KCNK13;ATP2C1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.441688752958738,0.9825392349791581,0.5116564417177915,0.8644974483888488,1.0,4/22,10.71%,SPI1;XDH;GADD45B;RELL1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3912214772249351,0.9825318317859972,0.5606995884773662,0.8640668149224016,1.0,23/83,20.69%,GPR132;CDK14;BACH1;GSPT1;CDK17;PIM2;PLK2;RB1;CDK7;DBF4;INHBA;CDC34;CDK6;MAX;CCNE2;CDC6;USP29;CDK15;CDK18;CRLF3;CDC45;CUL3;NPAT
prerank,muscle cell differentiation (GO:0042692),0.4278884685230524,0.9824897289058934,0.5238636363636363,0.8637013830854955,1.0,8/32,13.23%,DUSP29;SYNE1;MRTFA;SPEG;MYOCD;MEF2C;FBXO40;NINJ1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.38867596135363736,0.9823490139044312,0.5530839231547017,0.8635739968324999,1.0,22/118,15.81%,GPNMB;TGFB1;CYRIB;LFNG;RAP2A;SEMA4D;TNFAIP3;CTNNB1;CAPZB;TNIK;MEF2C;MYO19;RC3H1;POGLUT1;NEDD4L;PHIP;LZTS3;PID1;LRRK2;TANC2;PDZD8;NF1
prerank,regulation of lamellipodium assembly (GO:0010591),0.42073366364845544,0.9820335942914031,0.5148741418764302,0.863812602748165,1.0,8/34,12.41%,ARPC2;CAPZB;WASF2;AKIRIN1;ACTR2;ACTR3;CYFIP1;TWF2
prerank,ameboidal-type cell migration (GO:0001667),0.40187275587627713,0.981482510493014,0.5081788440567067,0.8646238463982732,1.0,4/51,3.64%,SHH;ITGA4;SGPL1;SEMA4D
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.506436406373151,0.9811544835690678,0.5064935064935064,0.86491198270592,1.0,3/10,11.83%,MGRN1;PDE11A;CDC34
prerank,ncRNA processing (GO:0034470),0.38042514741398936,0.9811524334871682,0.5535535535535535,0.8644702938716365,1.0,71/200,25.19%,RPL23;RPL17;EMG1;RPL10A;UTP20;NOB1;TEX10;FBL;EXOSC1;RPS2;LAS1L;RPL18A;SMAD3;INTS8;ADAR;KRR1;RPL6;AGO4;DDX27;RPLP2;RPL26;RPS16;AGO3;METTL3;MDN1;UTP11;HEATR1;RPS14;INTS6;RPL19;C1D;PES1;RPL9;PRKRA;IMP3;PIH1D1;RPL11;TUT7;TARBP2;FARS2;INTS1;WDR12;AGO2;RPS27;RPL4;FCF1;WDR75;EXOSC3;RPL7A;UTP3;RPL15;RPL29;RRP7A;RPL22;DICER1;IMP4;RPS7;LIN28B;EXOSC2;SARS1;RPLP1;ZCCHC8;RPS15;ADAT1;INTS3;DDX10;RPL41;XRN2;AGO1;DROSHA;RPL10
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.49640849340103144,0.981096775212908,0.511204481792717,0.8641512919273088,1.0,2/12,6.25%,NEK6;PRKCB
prerank,cation transport (GO:0006812),0.3834328349388102,0.9807242296255151,0.5621242484969939,0.8645381234326929,1.0,19/167,12.19%,SLC6A3;SCN4B;AQP1;HCN4;KCNN4;FGF13;SLC8A1;KCNK6;SLC7A8;KCNIP2;CLN3;SLC36A1;CNGB1;KCNMA1;NEDD4L;SLC36A4;SLC8B1;SLC66A1;SCN9A
prerank,cellular response to UV-A (GO:0071492),0.5053200889967209,0.9807046226493543,0.5216783216783217,0.8641364269511929,1.0,1/11,4.99%,TIMP1
prerank,microtubule anchoring (GO:0034453),0.4910440737610129,0.9806797369802145,0.5056022408963585,0.8637562775281934,1.0,3/12,12.28%,BCCIP;BICD2;PCM1
prerank,regulation of trophoblast cell migration (GO:1901163),0.47772501965403896,0.9800988737766818,0.5098814229249012,0.8646623115156546,1.0,7/14,25.55%,TIMP1;YTHDF3;ARHGDIB;AGO2;VEGFA;GJA1;C1QBP
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.4779020341872532,0.9799958802054237,0.5033921302578019,0.8644775591477161,1.0,4/14,18.48%,TGFBR1;SOX9;RFLNA;GREM1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4064200729179789,0.9799944898045334,0.5355249204665959,0.8640361035878341,1.0,2/53,6.22%,CNR2;ANXA1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.37689671471177466,0.9797362427689755,0.575,0.864180855505426,1.0,76/327,18.50%,HCLS1;TGFBR1;RREB1;NSD1;MLXIPL;YAF2;CXXC1;MITF;UBE2V1;PPIE;NFXL1;CEBPA;DDIT3;SPI1;WWC2;BACH1;CHD7;SBNO1;CCAR1;CDK11B;TFEB;DNM2;ACTN4;TP53;GCFC2;HINT1;CEBPB;FOXN2;TGFBRAP1;CHEK2;PRKCQ;MEF2C;RB1;GTF2IRD1;IRF2;PPARGC1A;RPL6;ATRX;NFX1;HCFC2;ZSCAN26;RPS6KA4;NLK;NR2C2;DENND4A;ZNF628;GZF1;PPP2CA;MTF2;BRDT;KAT7;FOXN3;SOX6;HCFC1;ZFHX3;SOX2;HNRNPD;SOX4;ZBTB11;SPTY2D1;SBNO2;REXO4;FADS1;OGG1;HIF1A;TRIP4;VHL;PCGF1;RPS6KA5;CASZ1;ZNF35;NFYA;CNBP;MAFB;PHF1;CREBL2
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.3165414116406251,-0.9795564549709833,0.45408163265306123,0.889965020146028,1.0,5/19,13.19%,BMPR1A;ACVR1;SMAD4;OLFM1;SMAD6
prerank,spindle assembly (GO:0051225),0.3999568945751834,0.979388090630897,0.542016806722689,0.8645177986378189,1.0,18/67,18.37%,HAUS2;NEK6;BCCIP;CEP192;MAPRE1;STARD9;CHEK2;HAUS1;RAB11A;TUBGCP4;TUBGCP6;STAG2;INO80;KIF2A;HAUS8;RHOA;MAPRE2;CEP63
prerank,cellular response to estrogen stimulus (GO:0071391),0.4778624810478285,0.979367590062991,0.5020689655172413,0.8641170316120147,1.0,5/14,20.62%,OCSTAMP;TRIM24;SRA1;NCOA4;SFR1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.4863200591138426,0.9793063125135342,0.5333333333333333,0.863795112710941,1.0,2/13,4.62%,CBL;ZFYVE28
prerank,aortic valve morphogenesis (GO:0003180),0.42060461625740203,0.9790566470292265,0.528604118993135,0.8639149620953435,1.0,5/30,11.24%,TGFB1;NFATC1;SNAI1;RB1;SOX9
prerank,axon extension (GO:0048675),-0.29904816985241267,-0.9787546645679386,0.4647058823529412,0.889163323818471,1.0,5/23,6.20%,SEMA5A;AUTS2;SEMA3A;ULK2;SLIT2
prerank,carbohydrate biosynthetic process (GO:0016051),-0.32110598842025767,-0.9782943704230732,0.5,0.8873789783500661,1.0,7/21,16.20%,B3GALT5;ST3GAL4;ST6GALNAC6;MPDU1;ST8SIA6;ST3GAL3;B3GALT1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4422683020262115,0.97817673809164,0.5043804755944932,0.865405124482703,1.0,2/20,3.26%,NFE2L2;CREB3
prerank,positive regulation of cell development (GO:0010720),0.4278241563192261,0.9771471833229474,0.5366705471478463,0.8672474914992817,1.0,5/31,12.58%,CX3CR1;TYROBP;NAP1L1;ATP6AP1;NUMB
prerank,zinc ion transport (GO:0006829),-0.3045736348923532,-0.9771275764154824,0.455,0.8875758063381601,1.0,7/21,26.09%,SLC39A13;SLC39A8;SLC30A1;SLC39A1;SLC39A14;SLC39A3;TRPM2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.38249174895198595,-0.9771026441479124,0.4555160142348754,0.8847285280378296,1.0,6/12,18.76%,ANKRD13C;RER1;KDELR3;INSIG1;INSIG2;KDELR1
prerank,cell cycle G2/M phase transition (GO:0044839),0.3846125205388214,0.9770342290859546,0.5553319919517102,0.8670659434663096,1.0,25/129,16.75%,TUBB;PRKAR2B;HAUS2;CDK14;TUBA4A;FBXL22;CNTRL;CEP192;MAPRE1;DNM2;CEP70;PLK4;CEP76;CHEK2;ENSA;HAUS1;CDK7;DYNC1H1;PCM1;FBXL3;CEP152;HAUS8;AKAP8L;NINL;HSP90AA1
prerank,detection of mechanical stimulus (GO:0050982),0.45146728804534164,0.9767160325988951,0.5049875311720698,0.867369219857926,1.0,3/19,6.34%,PKD2;TTN;CTNNB1
prerank,regulation of secretion by cell (GO:1903530),0.39799266881223894,0.9760752589396472,0.5188374596340151,0.8683822393864882,1.0,6/54,8.17%,RAB8B;VAMP3;MCTP1;RHBDF2;ANXA1;MEF2C
prerank,supramolecular fiber organization (GO:0097435),0.3788072164449708,0.9759818340460097,0.588,0.8681400681481843,1.0,75/333,18.48%,MYO1F;HOOK3;ARHGAP25;MYO1G;MYO1E;CORO1A;BFSP2;TGFBR1;MYO5A;MAD2L2;FGF13;ELMO1;SNCA;ATP7A;ITGA6;COLGALT1;TTR;TGFBI;CRTAP;CCDC88B;FLII;CLIP2;P4HB;LOX;MYO7A;KIF14;MYO19;TSPAN14;TPM4;BCAR1;P3H2;TUBGCP4;TUBGCP6;ACTN1;GFAP;BIN3;IAPP;DYNC1H1;PCM1;ITM2B;B4GALT7;TPM3;SORL1;PXDN;B2M;KATNA1;GGA2;DES;USP9X;HOOK2;KIF2A;LTBP2;LTBP3;CAPN3;CD36;COL23A1;CAMSAP2;NF1;DST;MFAP4;LAMA3;FIGN;COL22A1;FURIN;CORO1C;ARHGEF2;DNAJB6;MARCKS;CDC42;RHOA;MYO1C;MYO15A;LOXL3;ELMO2;GREM1
prerank,carbohydrate derivative catabolic process (GO:1901136),0.45940268247268357,0.9759803756990034,0.5082592121982211,0.8676994493118022,1.0,4/18,12.68%,SAMHD1;FUCA1;OGA;STT3B
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3744591338997761,0.9753458934966712,0.626,0.8687091734365027,1.0,137/807,14.54%,RUNX1;BATF3;ASCL1;SHH;CIITA;IRF8;TGFB1;IKZF1;UXT;GATA1;FNIP2;BASP1;CBFA2T3;RPL23;RREB1;MAD2L2;EDNRB;NR1H4;BCL11A;NSD1;MLXIPL;ZEB2;YAF2;PRDM12;SEMA4D;TNF;DNMT3A;CRYM;FNIP1;SNCA;SREBF2;MITF;CIR1;BPTF;UBE2D3;SKI;ATF3;FOXO3;CEBPA;DDIT3;SPI1;LRRFIP1;MYT1L;WWC2;MAFK;TSC22D4;HDAC5;BHLHE41;BACH1;HMGB1;TRPS1;XRCC5;TAF1;PCGF6;CTNNB1;CREB3L1;MTA3;ZFP69;ZNF177;PHF21A;RCOR1;TP53;MEF2A;TBL1XR1;NKX2-1;YY1;SNAI1;HSBP1;GCFC2;ZFP90;CBFA2T2;EPO;CEBPB;MEF2C;NKRF;FLCN;MDFIC;TFAP2B;TRIM27;CIART;RBM15B;RB1;SMAD3;GTF2IRD1;IRF2;HSF1;QARS1;ATF7IP;ARID4A;RING1;IMPACT;NFX1;MIDEAS;HDAC4;CPEB3;TPR;NEDD4L;TBL1X;NFIC;TGIF1;PHC1;ZMYND15;LIMS1;HCFC2;DAP;SOX9;ETV6;HDAC6;NRIP1;NR2C2;JDP2;E2F6;SDCBP;GZF1;MBD1;MTF2;HDAC9;CREB1;RPS14;NRG1;KAT7;MAX;NFKB1;FOXN3;IRF1;GPS2;FOXK1;GAS6;HCFC1;ZFHX3;CUX1;USP9X;SOX2;NOC2L;BRD7;WFS1;LBH
prerank,histone H3-K4 methylation (GO:0051568),0.4366186813367975,0.9753414162241727,0.5379229871645275,0.8682708090826005,1.0,8/26,19.33%,WDR5B;CXXC1;TET3;DPY30;RBBP5;SETD1B;WDR82;TET2
prerank,negative regulation of cell cycle process (GO:0010948),0.39875367303041404,0.9749274917924073,0.5425867507886435,0.8687473752174479,1.0,12/61,12.97%,UXT;YAF2;ESPL1;AURKAIP1;NME6;APAF1;PCGF6;RING1;PHC1;E2F6;RBBP7;MAX
prerank,neuromuscular process controlling balance (GO:0050885),0.4911945244756181,0.9749099246488597,0.5273492286115007,0.868344492946788,1.0,3/12,13.41%,CLN3;MYO7A;CDH23
prerank,negative regulation of receptor internalization (GO:0002091),0.489030496155213,0.9747156828486965,0.5212620027434842,0.8683300318713287,1.0,3/12,15.47%,RIN3;SDCBP;ANKRD13A
prerank,cardiocyte differentiation (GO:0035051),0.5019842244473899,0.9743332894229702,0.5129310344827587,0.8687457327319834,1.0,3/10,12.65%,EEF1AKMT4-ECE2;MYOCD;NRG1
prerank,ribosome biogenesis (GO:0042254),0.3781490658452191,0.9742943392609217,0.5825825825825826,0.8683920500080412,1.0,50/187,21.18%,RPL23;RPL17;EMG1;RPL10A;UTP20;NOB1;TEX10;FBL;EXOSC1;RPS2;XPO1;LAS1L;URB2;RPL18A;GTF3A;KRR1;RPL6;SURF6;DDX27;RPLP2;RPL26;RPS16;MDN1;UTP11;HEATR1;RPS14;RRS1;RPL19;C1D;NOC2L;PES1;RPL9;IMP3;PIH1D1;RPL11;WDR12;DDX31;RPS27;RPL4;FCF1;WDR75;EXOSC3;RPL7A;UTP3;RPL15;RPL29;RRP7A;RPL22;IMP4;RPS7
prerank,central nervous system myelination (GO:0022010),0.5003833194875599,0.9738888811068817,0.5232067510548524,0.8688652513585122,1.0,6/11,26.87%,PTEN;ABCA2;TENM4;B4GALT6;CNTNAP1;B4GALT5
prerank,positive regulation of protein sumoylation (GO:0033235),0.4996427870304201,0.973874474071074,0.5137085137085137,0.8684638570878773,1.0,4/10,19.85%,HDAC4;UBA2;PIAS1;RWDD3
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.42165574798158645,0.9738523996583521,0.5331088664421998,0.8680764329894908,1.0,8/30,15.66%,SREBF2;MICALL2;UBE2D3;CSNK2A2;VPS11;HUWE1;UBE2J2;GSK3A
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.4239081274941049,0.9734145733017586,0.5076023391812865,0.8686058972285986,1.0,3/27,7.22%,CD74;CD44;SNAI1
prerank,determination of heart left/right asymmetry (GO:0061371),0.4056627379920862,0.9732475741196407,0.5289617486338798,0.868546543306388,1.0,4/42,8.17%,SHH;PKD2;TGFBR2;MEF2C
prerank,protein localization to Golgi apparatus (GO:0034067),0.4265934495517097,0.9730373990391663,0.5319396051103368,0.868600262808385,1.0,14/27,22.90%,RIPOR1;ARL5B;BICD2;SORL1;RAB33B;GAK;GOLPH3;PAQR3;OPTN;COG7;VPS13C;GBP5;VPS13A;ARL5A
prerank,protein lipidation (GO:0006497),0.399884346085803,0.9726110529310932,0.55,0.869148954548558,1.0,21/59,23.09%,PIGM;ATG7;PIGL;PIGV;ZDHHC14;ZDHHC7;ZDHHC13;ZDHHC16;PIGH;ZDHHC3;ZDHHC1;SELENOK;PGAP2;PIGC;ZDHHC21;PIGU;PIGN;ZDHHC2;ATG10;DPM2;PIGP
prerank,positive regulation of cellular protein localization (GO:1903829),0.39475674372975733,0.9724551439847385,0.5691987513007284,0.8690415505458331,1.0,16/69,21.05%,TGFB1;NUP62;TNF;GPR137B;SNX33;TYROBP;FYN;KAT7;STX3;CENPQ;RTN4;VPS28;ENTR1;TRAPPC12;GSK3B;PRKN
prerank,protein O-linked glycosylation via serine (GO:0018242),0.4912359046385068,0.9721288063398709,0.5126676602086438,0.8693039787720035,1.0,6/10,23.03%,POGLUT2;POGLUT1;GALNT2;MGAT5B;GALNT1;GALNT3
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.3996852568160306,0.97211026865639,0.5584826132771338,0.8689024318886043,1.0,13/59,18.97%,CD84;PCDHB6;PLXNB2;EMB;TRO;NPTN;PTPRT;CADM1;KIRREL3;PECAM1;ITGB1;PALLD;VSTM2L
prerank,response to progesterone (GO:0032570),0.4598463997831889,0.9720438188703228,0.5359897172236504,0.8686051876731122,1.0,3/18,15.26%,TGFB1;THBS1;SRC
prerank,regulation of mitotic cell cycle (GO:0007346),0.3768376752393663,0.9719339642864462,0.5791583166332666,0.8684094914614695,1.0,37/171,18.29%,ANAPC15;TGFB1;LGMN;SMOC2;DUSP3;NEK6;CDC23;UBE2S;CDK11B;PSMB10;TAL1;PIM2;KIF20B;RB1;SMAD3;HSF1;ANGEL2;MAEA;FZR1;PSMA2;RNF40;SRA1;TTLL12;TRIM35;SDCBP;PSME3;PSMB5;PSMD8;CCDC8;INTS13;PSMD7;PSMB9;DYNLT3;ANAPC11;IQGAP1;PSMD2;PTPN3
prerank,regulation of catabolic process (GO:0009894),0.4526106856347216,0.9718262422875307,0.5272020725388601,0.8681958302463503,1.0,8/18,21.45%,HPGD;CHEK2;ZDHHC7;NEDD4L;FAF1;FURIN;ITGB1;ZDHHC2
prerank,positive regulation of glycolytic process (GO:0045821),0.4499907890967838,0.9713871650026497,0.530690537084399,0.8682606239823644,1.0,6/20,16.89%,P2RX7;MLXIPL;PFKFB4;HIF1A;PFKFB3;GAPDHS
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.4499907890967838,0.9713871650026497,0.530690537084399,0.8682606239823644,1.0,6/20,16.89%,P2RX7;MLXIPL;PFKFB4;HIF1A;PFKFB3;GAPDHS
prerank,sulfation (GO:0051923),0.4866345573433369,0.9709793786242731,0.5084985835694051,0.8687282288585922,1.0,1/11,4.88%,SULT4A1
prerank,histone modification (GO:0016570),0.38091261318595165,0.9709778594178274,0.5564598168870803,0.8682905873002766,1.0,24/109,17.58%,BRD8;PRKCD;NSD1;ATXN7;HDAC5;MTA3;RCOR1;TBL1XR1;MIDEAS;HDAC4;TBL1X;PHC1;RPS6KA4;HDAC6;MAP3K12;HDAC9;HDAC11;HUWE1;INCENP;USP21;USP16;NAA50;UBE2N;RPS6KA5
prerank,histone methylation (GO:0016571),0.42044433822100974,0.9706181596673298,0.5105140186915887,0.8686609058573841,1.0,5/26,16.55%,NSD1;FBL;SETD6;SMYD3;SUV39H1
prerank,positive regulation of DNA binding (GO:0043388),0.42304594872462575,0.9704820300581811,0.5300925925925926,0.8685212328279776,1.0,4/31,8.59%,TGFB1;SKI;HMGB1;RB1
prerank,chromosome organization (GO:0051276),-0.22258183335022025,-0.9704309554264755,0.6190476190476191,0.9002181280061329,1.0,19/99,11.39%,SMARCA4;COPS5;LATS1;DDB2;TCF7L2;HMG20A;DDB1;EZH1;NUCKS1;ABL1;MSH2;HDAC2;HMGN3;RBX1;EZH2;PWWP3A;TOP2B;SETD7;RAE1
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.35425765400206616,-0.9701930117330168,0.4881889763779528,0.8979032580796055,1.0,8/15,21.30%,NTRK3;F3;VEGFC;CXCL12;IL16;SCG2;PGF;CDH13
prerank,modulation by symbiont of host process (GO:0044003),0.5016219436827603,0.9700261724165506,0.5260989010989011,0.8690973907809532,1.0,3/10,19.63%,TLR2;B2M;ENO1
prerank,regulation of myotube differentiation (GO:0010830),0.4340356504230549,0.9698521711577809,0.5132211538461539,0.8690279309013604,1.0,5/24,12.48%,MAPK14;HDAC5;BHLHE41;HDAC4;HDAC9
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.30136095409043845,-0.969276296234083,0.5027027027027027,0.8976217429980117,1.0,3/23,1.32%,MTM1;SACM1L;MTMR7
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.39152508535246283,0.9689700459081756,0.5604626708727655,0.8705310577180757,1.0,20/67,18.20%,TBC1D10C;TBC1D16;P2RX4;TBC1D22A;USP6NL;CAPZB;TBC1D10A;PODXL;TBC1D2;TBC1D17;TBC1D2B;TWF2;TBC1D8;ARF6;TBC1D14;TBC1D22B;ATG3;CDC42;DYNC2LI1;RABEP2
prerank,protein localization to vacuole (GO:0072665),-0.35933062772807967,-0.9685404489654494,0.45491803278688525,0.8967876895222318,1.0,5/13,20.82%,LMBRD1;KPTN;CD81;LAMTOR5;GLMP
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3990921083845668,0.9684704341329865,0.5388768898488121,0.8711734876809808,1.0,8/45,13.20%,TGFB1;ERN1;TP53;GRSF1;ZC3H18;MAP2K2;HEATR1;NFKB1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.5020791414642685,0.96840786798242,0.55,0.8708780781942961,1.0,4/10,17.08%,ATP5MC2;ATP5F1A;ATP5PD;ATP5MG
prerank,histone H2A monoubiquitination (GO:0035518),-0.32739740294981795,-0.9679854971186325,0.5041322314049587,0.8953153161483637,1.0,6/17,11.01%,DDB2;RYBP;DDB1;TRIM37;PCGF2;PCGF3
prerank,neurotransmitter transport (GO:0006836),0.3828621330139031,0.967555328822291,0.5503634475597092,0.872251628126448,1.0,6/73,9.12%,SLC6A3;SLC6A4;APBA1;STXBP3;CASK;SLC6A15
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.36723753406819043,-0.9668124072217236,0.5054151624548736,0.8956865153978566,1.0,7/12,35.52%,BDH2;GSS;CHAC2;OPLAH;GGCT;HAGH;GGT1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.3971441350149671,-0.9666821180875261,0.5368098159509203,0.8930894938440075,1.0,2/10,3.59%,DLGAP1;DLGAP2
prerank,regulation of cell cycle process (GO:0010564),0.3784190049640671,0.9658759182982501,0.5892494929006086,0.8755870309777845,1.0,19/104,11.87%,ZFYVE26;KLHL21;CTNNB1;BCL2L1;SND1;PLK4;PLK2;CSNK2A1;CSNK2A2;FLCN;MYO19;KIF20B;UVRAG;RAB11A;SETD2;DBF4;SOX9;BECN1;DYNC1H1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.39832816971930096,0.9654871419493034,0.5464362850971922,0.8759839511632549,1.0,12/51,17.66%,PLEK;TGFBR1;RGCC;FHOD1;PFN2;NF2;NRP1;PFN1;SYNPO;CD47;CDC42;RHOA
prerank,glycerolipid catabolic process (GO:0046503),0.44539921532295346,0.965486165196234,0.5428226779252111,0.8755461120948892,1.0,7/19,23.97%,ABHD12;PRDX6;GDE1;GDPD3;GPCPD1;PLA2G4E;ABHD2
prerank,respiratory tube development (GO:0030323),0.41830914340322783,0.9654214856858205,0.5212888377445339,0.8752641761153828,1.0,3/28,6.88%,SHH;CEBPA;NKX2-1
prerank,modification-dependent protein catabolic process (GO:0019941),0.37398824115608875,0.9654053113273225,0.5901803607214429,0.8748616112033434,1.0,33/193,13.51%,ANAPC15;CBL;MYLIP;TRIM25;RFFL;PTTG1;RNF149;WDR91;RNF19B;CDC23;HERPUD1;RNF7;RNF111;PPP1R11;TAF1;UBE2S;ATXN3;RNF150;LONP1;RC3H2;RNF114;RC3H1;UBE4B;UBE2H;NEDD4L;FZR1;RNF40;CDC34;WDR81;ITCH;STUB1;UBE2G2;RNF144B
prerank,cellular response to radiation (GO:0071478),0.41118286209385324,0.965325634768233,0.531986531986532,0.874604986467318,1.0,4/40,6.80%,GRB2;MAPK14;TANK;TP53
prerank,stress-activated MAPK cascade (GO:0051403),0.3934682741600252,0.9648031373919088,0.5745798319327731,0.8752815354834977,1.0,18/61,20.23%,IRAK2;MAPK14;CCM2;UBE2V1;MAP2K3;MAP3K5;NOD2;MAP3K12;TAB2;IKBKG;NFKB1;GPS2;TAB3;MAP3K11;UBE2N;MINK1;ZFP36L1;FBXW11
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.48706254475543326,0.9645866112288422,0.5543175487465181,0.875303407695668,1.0,5/12,17.81%,STX11;SNAP29;STX3;SNAP23;STX2
prerank,RNA 3'-end processing (GO:0031123),-0.23178547894638923,-0.9643583294466149,0.54,0.8968364511992933,1.0,18/69,15.27%,WDR33;SARNP;SRRM1;RPRD2;CPSF7;FIP1L1;THOC7;CSTF2;THOC1;PAPOLA;THOC5;U2AF2;SRSF11;RPRD1B;EIF4A3;TUT1;SRSF1;CSTF3
prerank,regulation of tau-protein kinase activity (GO:1902947),0.492699372712511,0.9641038327285174,0.5192878338278932,0.87592347166241,1.0,3/10,16.75%,RB1;SORL1;HSP90AA1
prerank,steroid biosynthetic process (GO:0006694),-0.24301749664031255,-0.9640473916443465,0.5333333333333333,0.8947922370148876,1.0,25/56,34.29%,OSBPL9;OSBPL1A;HMGCR;CYP51A1;INSIG1;INSIG2;CYP7B1;SQLE;CYP39A1;AMACR;LSS;PMVK;LBR;SCP2;HSD17B4;DHCR7;EBP;SLC27A2;STAR;TM7SF2;SC5D;SRD5A1;HSD11B1;OSBPL2;CH25H
prerank,connective tissue development (GO:0061448),0.4068637100106342,0.9636680901688588,0.551605504587156,0.8764228182966224,1.0,8/35,13.72%,SH3PXD2B;ATP7A;CD44;SULF2;LRP5;CREB3L2;SOX9;SOX6
prerank,nuclear pore complex assembly (GO:0051292),-0.39137363256244545,-0.9634930709160757,0.48089171974522293,0.8935598857062738,1.0,5/10,11.57%,NUP93;NUP98;AHCTF1;NDC1;NUP153
prerank,lysine metabolic process (GO:0006553),0.4828335535547049,0.9630211729570036,0.5402298850574713,0.8769411342210455,1.0,3/12,12.73%,CRYM;OGDH;ALDH7A1
prerank,lysine catabolic process (GO:0006554),0.4828335535547049,0.9630211729570036,0.5402298850574713,0.8769411342210455,1.0,3/12,12.73%,CRYM;OGDH;ALDH7A1
prerank,protein targeting to lysosome (GO:0006622),0.44793778483771884,0.9625077286068829,0.5455696202531646,0.8776416443310202,1.0,5/20,16.42%,LAPTM5;RAB7A;SORL1;NCOA4;GNPTAB
prerank,negative regulation of glycolytic process (GO:0045820),0.49662837624755884,0.9619214890624406,0.5487465181058496,0.8780499438314588,1.0,2/10,10.06%,CBFA2T3;HDAC4
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.49662837624755884,0.9619214890624406,0.5487465181058496,0.8780499438314588,1.0,2/10,10.06%,CBFA2T3;HDAC4
prerank,negative regulation of viral process (GO:0048525),0.39938153802923565,0.9615816642305735,0.5712754555198285,0.8783379611163395,1.0,8/57,11.50%,FAM111A;TRIM5;TNF;TRIM27;TRIM8;RNASEL;MID2;TRIM35
prerank,cellular response to glucose stimulus (GO:0071333),0.42017013607250053,0.9614424188959307,0.531322505800464,0.8782083580091361,1.0,7/30,14.67%,MLXIPL;ERN1;TRA2B;RAB11FIP5;ADCY8;GAS6;SOX4
prerank,cristae formation (GO:0042407),-0.2966885364256387,-0.9611500258628562,0.4966442953020134,0.8972026070652286,1.0,10/27,16.00%,AFG3L2;APOOL;IMMT;ATP5PF;ATP5MC3;ATP5PO;SPG7;DMAC2L;SAMM50;ATP5F1D
prerank,response to ketone (GO:1901654),0.4361934520992229,0.96069480510943,0.5608272506082725,0.8793277020049047,1.0,3/24,11.47%,TGFB1;ABCB4;THBS1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.37131127494646143,0.9604304235758492,0.6082164328657315,0.879493050405411,1.0,63/168,25.96%,RPL23;RPL17;RPL10A;PNRC2;RPS2;CNOT8;TENT4B;RPL18A;RPS15A;GSPT1;RC3H2;CASC3;RC3H1;SMG1;RPL6;CTIF;RPLP2;RPL26;RPS20;RPS16;PPP2CA;RPS14;RPL19;UPF3B;RPL9;THRAP3;SMG7;RPS11;RPL11;TUT7;RPS23;RPS4X;UPF2;RPS27;RPL4;PYM1;RPL7A;ZFP36L1;RPL15;DIS3L2;RPL29;RPL22;RPS7;DCP1B;CNOT7;PNLDC1;RPS13;CNOT1;EIF3E;RPLP1;DCP2;RPS15;RPS5;CNOT2;RPL41;XRN2;AGO1;RPL10;NCBP1;DXO;RPS8;RPL18;RPL5
prerank,clathrin-dependent endocytosis (GO:0072583),0.42438715825172285,0.9604131657590471,0.5473684210526316,0.8790903662419841,1.0,12/26,21.94%,PIP5K1C;AP2S1;GPR107;ITSN1;CLTC;FNBP1L;SIGLEC1;GAK;AP2M1;PICALM;FCHO2;ITSN2
prerank,keratan sulfate biosynthetic process (GO:0018146),0.43101911751301514,0.9602999183913312,0.5574572127139364,0.8789080734970723,1.0,4/26,8.38%,PRELP;B4GALT1;FMOD;ST3GAL1
prerank,ion homeostasis (GO:0050801),0.42480914323884605,0.9598889353956033,0.5616438356164384,0.8793774414443914,1.0,5/30,10.19%,HCN4;P2RY2;AP3D1;WNK1;NEDD4L
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.37559028057925464,0.9598856176452238,0.6296296296296297,0.8789473711064653,1.0,38/184,18.37%,TUBB;ANAPC15;PRKAR2B;HAUS2;NEK6;RGCC;CDC23;TUBA4A;CNTRL;CEP192;UBE2S;MAPRE1;PSMB10;CEP70;PLK4;CEP76;KIF14;HAUS1;FZR1;PSMA2;DYNC1H1;PCM1;PSME3;INO80;CEP152;PSMB5;CDC6;HAUS8;PSMD8;PSMD7;PSMB9;NINL;APPL2;HSP90AA1;ANAPC11;AKAP9;PSMD2;CEP63
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.4989225915370749,0.958733411587275,0.5361271676300579,0.8809712133460094,1.0,1/10,0.92%,PLEK
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.3955684247312089,0.958674315673639,0.5474137931034483,0.8806772981234585,1.0,7/46,6.36%,TNF;IL6R;TNFAIP3;IL18;XRCC5;CTNNB1;AIF1
prerank,heart contraction (GO:0060047),0.4039084810041894,0.9579687830432643,0.5574324324324325,0.8817945283865115,1.0,4/41,4.35%,SCN4B;MYL3;SLC8A1;TTN
prerank,ERBB2 signaling pathway (GO:0038128),0.4131243203461699,0.957908129055223,0.5428240740740741,0.8815040584581791,1.0,8/31,16.75%,GRB2;PTPN18;ERBIN;NRG1;STUB1;SRC;PTPN12;HSP90AA1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.35304705067607556,-0.9578579596382747,0.5217391304347826,0.9034153089254681,1.0,3/14,4.52%,ANK2;ATP1B1;ACTN2
prerank,hepaticobiliary system development (GO:0061008),0.4367136293551549,0.9578439560257079,0.5356265356265356,0.8812128596927974,1.0,3/20,4.65%,PCSK9;PKD2;CEBPA
prerank,regulation of acrosome reaction (GO:0060046),-0.3951795129299523,-0.9578069880356761,0.4923547400611621,0.9006792519666553,1.0,8/10,60.50%,CACNA1H;PLCB1;SPINK13;SERPINA10;FAM170B;PRSS37;PLA2G10;GLRA1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.3491577077962872,-0.9577991103471888,0.502262443438914,0.897871836561394,1.0,4/14,6.16%,CPSF6;CPSF7;FIP1L1;CSTF2
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.4138489273509617,0.9576724015622734,0.5536912751677853,0.8811441170361916,1.0,8/33,18.41%,GPNMB;PKD2;RB1;CCL2;CDK6;BRD7;PTEN;DACT1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.3256567321232948,-0.9574351590293841,0.4977168949771689,0.895962150628144,1.0,4/17,15.48%,VEZF1;BMP4;ATOH8;BAD
prerank,peptide catabolic process (GO:0043171),-0.2993052437574514,-0.9573494483542742,0.519774011299435,0.8933823009378081,1.0,9/23,23.60%,LTA4H;ECE1;CPQ;ACE;NPEPPS;CHAC2;ENPEP;GGT7;TPP1
prerank,linoleic acid metabolic process (GO:0043651),0.45628862560906236,0.9573321470024967,0.535483870967742,0.8814219935819501,1.0,4/17,17.80%,ALOX12;ABCD1;FADS1;GSTM2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3932325745361749,0.9573214108829381,0.5633802816901409,0.8810098835370408,1.0,8/48,12.62%,FNIP2;PYCARD;BCL2L1;TP53;CHEK2;BAK1;TNFRSF1B;DDIT4
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.39653187949391855,0.9572348761465224,0.5695509309967142,0.8807667169777044,1.0,8/47,10.90%,CASS4;RREB1;MDK;ACTN4;NEDD9;P4HB;NRP1;LIMS1
prerank,in utero embryonic development (GO:0001701),0.42538212313391055,0.9569064184407944,0.5640394088669951,0.8810200131105147,1.0,3/25,8.23%,TGFBR1;CHD7;FLCN
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.36823593194957954,0.9567291546125604,0.651,0.8809571145415671,1.0,77/341,18.54%,ARRB2;ANAPC15;NFE2L2;CBL;MYLIP;TRIM25;RFFL;PTTG1;RNF149;WDR91;KCTD17;RNF19B;CDC23;HERPUD1;UBE2D3;FBXL22;DDIT3;TNFAIP3;RNF7;RNF111;PPP1R11;TAF1;CTNNB1;UBE2S;ATXN3;PSMB10;RNF150;TBL1XR1;RC3H2;KIF14;RNF114;GID8;RC3H1;UBE4B;RNF4;APPBP2;UBE2H;NEDD4L;TBL1X;MAEA;VPS37C;FZR1;PSMA2;RNF40;SPOP;CDC34;WDR81;PSME3;RNF216;ITCH;RMND5B;STUB1;UBE2G2;RNF144B;PSMB5;USP9X;HUWE1;AREL1;PSMD8;ZNRF1;MVB12B;PSMD7;GSK3A;PSMB9;SMURF1;FAF1;VPS28;ANAPC11;ZNRF3;FEM1B;UBE2K;PSMD2;KEAP1;UBXN2A;PPP2R5C;BIRC2;KCTD5
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.41046226598894114,0.9567119581477339,0.5655172413793104,0.88055770846621,1.0,7/35,14.31%,PKIB;XRCC5;CTNNB1;PRKCQ;CCT8;TNKS2;CCT5
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3782112714090189,0.956704815489146,0.6065573770491803,0.8801353924035438,1.0,19/98,15.76%,TREM2;LGALS3;ITGB2;PLS1;TNF;AKAP5;STAC;YWHAB;TP53;ITGAM;PRKCH;FYN;CASP8;STX3;STAC3;ARF6;LRP1;CEMIP;YWHAH
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.4119040272103263,0.9566485827288949,0.5601799775028121,0.8798213530162852,1.0,8/37,12.21%,RPL23;PDCL3;TAF1;HFE;CSNK2A1;CSNK2A2;USP7;SDCBP
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.45134623837368604,0.9558432383999251,0.5441988950276243,0.8811150955184747,1.0,3/15,12.62%,GRB2;BCAR1;DDIT4
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.4606657165249203,0.9556216396433375,0.5290237467018469,0.8811342580072987,1.0,4/16,16.07%,RMI1;HFM1;SLX4;TOP2A
prerank,potassium ion homeostasis (GO:0055075),-0.3009713797294319,-0.9555690456862522,0.5222222222222223,0.895476897907356,1.0,4/23,7.17%,SLC12A2;SLC12A7;ATP1B1;ATP1A2
prerank,membrane depolarization (GO:0051899),0.4132015869228656,0.9553929069443233,0.5504694835680751,0.8811817169274554,1.0,9/32,17.57%,P2RX7;P2RX4;CACNA1A;CACNB4;ATP5IF1;SCN9A;CACNA1B;YWHAH;SCN5A
prerank,protein import into nucleus (GO:0006606),0.3879014474802887,0.9551562326735513,0.5850052798310454,0.8812528819637868,1.0,4/66,2.97%,MMP12;SYK;RPL23;NUP62
prerank,regulation of monocyte differentiation (GO:0045655),0.45590768183068575,0.9551142877011728,0.5257301808066759,0.8808991603325804,1.0,2/14,3.59%,CD74;ACIN1
prerank,positive regulation of developmental growth (GO:0048639),0.39347723709895355,0.9551009912315667,0.5580645161290323,0.8804882306362559,1.0,14/49,22.88%,SYT17;SEMA4D;MACF1;AGRN;SYT2;NEDD4L;TWF2;SMURF1;RASAL1;PLAA;UNC13A;RIMS1;ITSN2;GOLGA4
prerank,regulation of focal adhesion assembly (GO:0051893),0.390693543141098,0.9546023397264431,0.5508021390374331,0.8810955543798749,1.0,17/54,19.76%,THY1;PTPRJ;DUSP3;MACF1;SLC9A1;ACTG1;VCL;NRP1;LIMS1;THBS1;SRC;PTPRA;PTEN;CORO1C;RHOA;ROCK2;MAP4K4
prerank,positive regulation of exosomal secretion (GO:1903543),0.45913686443875096,0.9545720275776937,0.5548128342245989,0.8807323449671535,1.0,5/15,20.19%,SMPD3;RAB7A;SDCBP;PDCD6IP;ATP13A2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.33419120172318084,-0.9544340790307996,0.4875,0.8956588295402977,1.0,3/16,4.67%,ZFPM2;BMPR1A;TGFBR3
prerank,response to interleukin-6 (GO:0070741),0.49484288634463414,0.9542820439633893,0.5411255411255411,0.8809255574863926,1.0,5/10,15.78%,NFKB1;PID1;PTPRT;SBNO2;SELPLG
prerank,ether lipid metabolic process (GO:0046485),0.4658079449055911,0.9542512737079316,0.5597897503285151,0.8805506956406347,1.0,7/14,16.90%,DHRS7B;PLA2G7;PEX7;AGMO;LIPE;NCEH1;PLAAT3
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3857716082202732,0.9541222772127672,0.559748427672956,0.8803942795913361,1.0,14/62,19.14%,PCID2;GTF2H1;EAF1;LEO1;CDK7;SETD2;POLR2L;ELL;MLLT1;ELOF1;TCEA1;GTF2H5;POLR2E;ELOB
prerank,RNA stabilization (GO:0043489),0.40464321466411646,0.953961081510271,0.5667828106852497,0.8802954042985419,1.0,4/33,9.10%,SLC11A1;CIRBP;LARP1;TENT5C
prerank,regulation of telomerase activity (GO:0051972),0.3903551657867363,0.953849413918598,0.5668508287292817,0.8800748643751463,1.0,6/45,8.15%,PTGES3;PKIB;XRCC5;CTNNB1;TP53;PRKCQ
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.40049771163512515,0.9531793295895516,0.5585284280936454,0.8810534563843091,1.0,16/38,23.59%,CENPO;ASF1B;ATRX;RBBP7;CENPI;CENPQ;CENPK;RSF1;UBN1;RBBP4;IPO4;ITGB3BP;SMARCA5;H3-3A;KNL1;CENPT
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.45714751707941387,0.9528705586353627,0.5448460508701473,0.8812650433634418,1.0,6/15,22.48%,TENT4B;TNRC6A;CPEB3;AGO2;CNOT7;CNOT1
prerank,cell differentiation in hindbrain (GO:0021533),0.48298576861050924,0.9527630788881435,0.5544692737430168,0.881061434230215,1.0,2/11,15.29%,ATP7A;AGTPBP1
prerank,positive regulation of viral life cycle (GO:1903902),0.4313689827395986,0.9525946651396696,0.5558343789209536,0.8809715131437376,1.0,3/22,10.76%,CD74;P4HB;LGALS1
prerank,dicarboxylic acid transport (GO:0006835),-0.28432313518805996,-0.951874672254426,0.5276073619631901,0.899760700812819,1.0,11/28,30.45%,SLC25A12;SLC26A7;ARL6IP5;SLC25A13;SLC22A6;SLC19A1;SLC25A22;SLC26A6;SLC1A6;PRAF2;SLC26A8
prerank,positive regulation of hormone secretion (GO:0046887),0.4514227220385986,0.9518672662630052,0.558408215661104,0.8820852727200046,1.0,4/17,14.20%,SPP1;RASL10B;HFE;NMB
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.4658348609718205,0.9518317091913351,0.5352862849533955,0.8817260435371479,1.0,5/14,20.26%,PKD2;TMSB4X;FAF1;KEAP1;NFKBIE
prerank,regulation of osteoblast differentiation (GO:0045667),-0.2145270713819163,-0.9516297548214382,0.5555555555555556,0.8975948616971597,1.0,30/82,26.41%,SUCO;CRIM1;BMPR1A;TMEM64;WNT4;PRKD1;BMP4;ACVR1;RORB;REST;CTNNBIP1;CCN1;ATF4;SMAD6;PPARG;HDAC7;TWIST2;FERMT2;RANBP3L;PTK2;TMEM119;PTCH1;CHRD;BMPR2;MEN1;SMOC1;TWIST1;ACVR2B;FGFR2;HGF
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.36552811680120856,-0.9510694158560503,0.4925925925925926,0.8963603921551084,1.0,4/12,4.68%,CDH5;STMN2;EML2;DYRK1A
prerank,RNA transport (GO:0050658),0.3786938637039323,0.9509298439902132,0.568041237113402,0.8831803145070062,1.0,20/71,20.37%,RFTN1;NUP62;DHX38;NXF1;THOC2;TGFBR2;CASC3;TPR;DDX39B;POLDIP3;RTRAF;THOC3;UPF3B;FLOT1;SLU7;SRSF2;SRSF6;SLBP;ZFP36L1;SRSF3
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.4094323887371007,0.9505510499052101,0.5733333333333334,0.8835706641090482,1.0,2/37,2.23%,ITGAL;CRTAM
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.36587534139384725,0.9492594731613865,0.667,0.8858782050694352,1.0,80/314,21.35%,ARRB2;ANAPC15;NFE2L2;EDEM1;TRIM25;RFFL;PTTG1;KCTD17;CDC23;HERPUD1;UBE2D3;SEL1L;FBXL22;DDIT3;DCAF12;FBXL18;TAF1;CTNNB1;UBE2S;ERLIN2;ATXN3;ERLIN1;PSMB10;TBL1XR1;KIF14;RB1;GID8;DERL1;UBE4B;RNF4;APPBP2;NEDD4L;TBL1X;MAEA;FZR1;PSMA2;SPOP;CDC34;PSME3;RNF216;STT3B;ITCH;FBXL3;RMND5B;STUB1;UBE2G2;PSMB5;HUWE1;AREL1;WFS1;PSMD8;UBE2J2;ZNRF1;FAM8A1;PSMD7;GSK3A;PSMB9;SMURF1;FAF1;ANAPC11;FEM1B;UBE2K;PSMD2;UBXN2A;PPP2R5C;BIRC2;KCTD5;FBXO44;SPSB2;PLAA;OS9;TMEM67;FBXW11;RAD23B;WWP1;CUL3;NSFL1C;PRKN;DNAJB14;CDC16
prerank,membrane depolarization during action potential (GO:0086010),0.4191458075403258,0.9491749580736324,0.5501165501165501,0.8856475027062735,1.0,3/26,3.21%,SCN4B;HCN4;SLC8A1
prerank,negative regulation of protein secretion (GO:0050709),0.40111099001287565,0.9488824957077449,0.5725534308211474,0.8858343960317111,1.0,3/38,4.79%,KCNJ11;APOE;RHBDF2
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.3390138393321789,-0.9488166365184533,0.5080645161290323,0.8996475273929512,1.0,2/15,2.36%,FOXC1;BMP4
prerank,nucleotide catabolic process (GO:0009166),0.4570072332952432,0.9486278962782869,0.5458115183246073,0.885956080892585,1.0,3/16,8.32%,XDH;SAMHD1;PNP
prerank,response to nitric oxide (GO:0071731),0.45975799185931693,0.948119503060697,0.5406896551724137,0.8865946009742796,1.0,1/13,1.89%,AQP1
prerank,positive regulation of response to wounding (GO:1903036),0.42455477750839654,0.9480732655204536,0.5509708737864077,0.8862650563983737,1.0,5/24,11.82%,MDK;ARFGEF1;ANXA1;ACTG1;GRN
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3859470330699404,0.9479404366103209,0.595213319458897,0.8861246320708528,1.0,19/78,21.27%,GTF2H1;CCND3;PKD2;RGCC;BCCIP;CEBPA;CCND2;ACTB;MYOCD;CDK7;CCNE2;CDC6;PTEN;CCNYL1;CNPPD1;HEXIM1;HHEX;CDK5R1;TFAP4
prerank,regulation of dendritic spine development (GO:0060998),-0.3184661754550122,-0.9477249541967461,0.5492227979274611,0.8995986011134437,1.0,7/19,11.18%,NLGN1;GRIN3A;DLG5;FMR1;SHANK3;SHANK1;PPFIA2
prerank,intracellular protein transmembrane transport (GO:0065002),-0.26797910474513076,-0.9475008502917308,0.4811320754716981,0.8974328357018911,1.0,24/42,33.57%,DNAJC19;TIMM17A;PEX5;GRPEL2;PEX6;SEC61G;C2CD5;PEX14;TOMM70;SEC61B;TIMM23;SEC61A1;PAM16;PEX26;TIMM21;ROMO1;PEX10;GRPEL1;ZFAND2B;HSPD1;PEX16;DNLZ;AIFM1;TOMM40L
prerank,regulation of viral genome replication (GO:0045069),0.39125239642683096,0.9468433398556236,0.5848452508004269,0.8879717576593622,1.0,17/56,24.71%,FAM111A;TNF;PPIE;LARP1;ADAR;VAPB;RNASEL;ADARB1;TARBP2;PPIH;PARP10;IFITM2;CNOT7;ILF3;IFITM1;IFIT1;PPIA
prerank,regulation of dendrite morphogenesis (GO:0048814),0.40829778310997794,0.9468110138930677,0.5311438278595696,0.8876036022683633,1.0,9/32,20.32%,SS18L1;RAP2A;SEMA4D;TNIK;NEDD4L;CUX1;YWHAH;CUX2;GSK3B
prerank,signal peptide processing (GO:0006465),0.4781129408549636,0.946730635411966,0.5479651162790697,0.8873295681880209,1.0,6/11,16.98%,SPCS2;SEC11C;SPPL3;SPCS1;PARL;FURIN
prerank,regulation of actin filament depolymerization (GO:0030834),0.4781223402104328,0.9464785769645802,0.5347885402455662,0.88741721025113,1.0,1/12,0.92%,PLEK
prerank,protein deacylation (GO:0035601),0.41835997324785534,0.9464573171748237,0.5444579780755177,0.8870309281469916,1.0,5/23,11.44%,HDAC5;ABHD17B;HDAC4;ABHD17C;HDAC6
prerank,DNA double-strand break processing (GO:0000729),0.4444310714802292,0.9456210518611532,0.5432569974554707,0.8882969244461862,1.0,5/18,17.21%,UBE2V2;DNA2;SLX4;SMARCAD1;UBE2N
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.4334441507382639,0.9455937985079929,0.5653798256537983,0.8879185545827677,1.0,5/22,15.82%,NFE2L2;PSMB10;PSMA2;PSMB5;PSMB9
prerank,spliceosomal snRNP assembly (GO:0000387),-0.2601698858307679,-0.9455148878606757,0.5510204081632653,0.9000313227967862,1.0,16/38,24.79%,PRPF3;SNRPD3;SNRPD1;TGS1;SNRPC;SNRPG;WDR77;COIL;SNRPF;PRPF19;LSM2;PRPF6;CD2BP2;PRMT7;PRPF31;SRSF12
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.36293209859699566,0.9453294478889143,0.678,0.8880276315337686,1.0,81/366,18.50%,HCLS1;GATA1;ORC3;TGFBR1;RREB1;NSD1;MLXIPL;YAF2;CXXC1;MITF;UBE2V1;PPIE;NFXL1;FOXO3;CEBPA;DDIT3;SPI1;WWC2;BACH1;CHD7;SBNO1;CCAR1;CDK11B;TFEB;DNM2;TP53;GCFC2;HINT1;CEBPB;FOXN2;TGFBRAP1;CHEK2;PRKCQ;MEF2C;RB1;GTF2IRD1;IRF2;PPARGC1A;RPL6;ATRX;NFX1;HCFC2;ZSCAN26;RPS6KA4;CYFIP1;NLK;NR2C2;DENND4A;ZNF628;GZF1;PPP2CA;MTF2;BRDT;KAT7;FOXN3;PCIF1;SOX6;HCFC1;ZFHX3;SOX2;HNRNPD;PUM3;SOX4;ZBTB11;SPTY2D1;SBNO2;REXO4;FADS1;OGG1;HIF1A;TRIP4;VHL;PCGF1;RPS6KA5;CASZ1;ZNF35;NFYA;CNBP;MAFB;PHF1;CREBL2
prerank,positive regulation of viral genome replication (GO:0045070),0.41649840118769277,0.945061841381364,0.5444711538461539,0.8881410781574046,1.0,13/29,26.60%,PPIE;LARP1;ADAR;VAPB;ADARB1;TOP2A;TARBP2;PPIH;CNOT7;IFIT1;PPIA;PKN2;HACD3
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.45629407979154896,0.9448279501257851,0.5378266850068776,0.8881927811667746,1.0,1/13,1.74%,NEIL2
prerank,monocyte differentiation (GO:0030224),0.48637538760436944,0.9447679923355451,0.5312954876273653,0.8878867355008453,1.0,2/10,5.13%,CSF1R;MYH9
prerank,sarcomere organization (GO:0045214),0.41838479587239086,0.9447423175189505,0.5442739079102715,0.8875194127605467,1.0,5/27,15.00%,TTN;MYLK3;TNNT3;CSRP1;CAPN3
prerank,regulation of chondrocyte differentiation (GO:0032330),0.42433423022301364,0.9446287883598394,0.5479951397326853,0.8873405520331374,1.0,5/24,13.72%,TGFBR1;MDK;TRPS1;SOX9;SOX6
prerank,negative regulation of developmental process (GO:0051093),0.37931834266295433,0.9441242887903933,0.5873180873180873,0.8879526188636986,1.0,18/69,21.21%,SHH;TGFB1;THY1;BCL11A;SPI1;RC3H1;SOX9;CDK6;GAS6;HUWE1;VAT1;SFMBT1;GREM1;KLF7;ROCK2;PARP3;PRKN;ARPIN
prerank,positive regulation of cell communication (GO:0010647),0.4167687665286214,0.9439996878281709,0.5650118203309693,0.8877786800161145,1.0,3/28,6.70%,CLSTN1;TNF;CD80
prerank,sensory organ development (GO:0007423),0.3837539360450171,0.9438263472395448,0.573735199138859,0.8877055166264657,1.0,9/51,15.54%,ASCL1;SH3PXD2B;CHD7;MYO7A;ZDHHC16;SOX2;MEIS1;SIPA1L3;AHI1
prerank,heterocycle biosynthetic process (GO:0018130),0.4510200079268234,0.9435974962380447,0.5478142076502732,0.8877542830727045,1.0,2/14,10.34%,GCH1;PYCR2
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.4502274719713787,0.9434279429799546,0.5454545454545454,0.887678726584718,1.0,4/17,17.68%,SCN4B;NOS1AP;SCN5A;AKAP9
prerank,potassium ion import across plasma membrane (GO:1990573),0.39467235318970073,0.9433297229102632,0.5666666666666667,0.8874463650299348,1.0,2/41,2.28%,KCNJ11;HCN4
prerank,ATP transport (GO:0015867),0.48858360486895086,0.9433248291164337,0.5636623748211731,0.8870272522355688,1.0,1/10,1.92%,ABCC6
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.48485048141360926,0.9432584603116263,0.5625899280575539,0.8867405503412977,1.0,5/10,25.55%,TSPAN6;GPATCH3;RIOK3;RNF125;C1QBP
prerank,proton transmembrane transport (GO:1902600),0.3972573393159223,0.9432581428445905,0.553932584269663,0.8863127932017215,1.0,4/36,7.51%,ATP6V0E1;SLC36A1;SLC9A1;ATP6V0D1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.41931697372615684,0.943159036104751,0.5497572815533981,0.8860795626711695,1.0,7/24,22.04%,ITGB2;ITGAM;FYN;CEMIP;MYO1C;FIS1;CHP1
prerank,regulation of fatty acid oxidation (GO:0046320),0.4513306820754185,0.9429847839336367,0.5615183246073299,0.8860045380629386,1.0,5/16,16.59%,ACADL;ABCD1;PPARGC1A;SOX9;APPL2
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.29534897423889944,-0.9428153659195756,0.543010752688172,0.9042729696413425,1.0,6/24,8.24%,SEMA6A;SEMA5A;SEMA6D;SEMA3A;SEMA3C;SEMA3D
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.44700449768448847,0.9427475149540634,0.5681233933161953,0.886053442485168,1.0,6/20,17.58%,DIP2B;PPARGC1A;RPS6KA4;BRD7;SOX4;RPS6KA5
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.40352320495582217,0.9427088830665967,0.5701559020044543,0.8857027951661368,1.0,9/35,16.50%,PCDHB6;ATP2C1;CDH8;CDH9;CDH12;CDH23;DCHS1;CDH19;PCDHGB4
prerank,regulation of neuron projection arborization (GO:0150011),-0.34038583581483367,-0.9421153687041505,0.5306122448979592,0.9034528462266079,1.0,5/15,11.84%,NTNG1;WNT5A;MYO9A;FZD4;GRIP1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.3879544466368122,0.9420293897381836,0.5898268398268398,0.8867052176943804,1.0,8/55,6.97%,TGFBR1;TNF;TRAF2;DDIT3;PYCARD;BCL2L1;TP53;CRADD
prerank,amyloid precursor protein catabolic process (GO:0042987),0.451690444551336,0.9417225352439031,0.5370611183355006,0.8869222319911962,1.0,2/14,4.47%,ABCG1;CLN3
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.3861668372451764,0.9411938526754087,0.5750551876379691,0.887581798939758,1.0,13/48,20.20%,ADCY7;SLC25A16;GUCY2F;ADCY6;SLC35B3;NPR2;PAPSS1;ADCY8;ADCY3;IMPDH2;PPCDC;ADCY9;NPPC
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.4685511927586994,0.9404398232333102,0.5546334716459198,0.8887300459699228,1.0,3/13,14.11%,NFE2L2;GPR37;LRRK2
prerank,glucose import (GO:0046323),0.4720108052670484,0.9403127473457447,0.5571808510638298,0.8885403413653772,1.0,2/13,8.27%,SLC2A3;ZDHHC7
prerank,fatty acid transmembrane transport (GO:1902001),0.44066023820684125,0.940125835005793,0.5636822194199244,0.8885116358481198,1.0,6/19,17.96%,SLC25A20;ABCD1;CD36;ACACA;CPT2;ABCD2
prerank,neuron projection morphogenesis (GO:0048812),0.3697543285724188,0.9397559520479043,0.6492985971943888,0.8888452368201655,1.0,19/137,11.23%,NCKAP1L;NEFH;TAOK3;S100B;SLITRK1;ATP7A;CTNNB1;DOCK10;DNM2;ACTB;MEF2A;TNIK;KIF20B;NTF3;IMPACT;FLRT1;MAP1B;DTNBP1;ATL1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.43009249297410507,0.9395003772431507,0.5655940594059405,0.8889716707311995,1.0,11/21,29.66%,CHSY3;BCAN;CHSY1;CHST15;CHPF;CSPG4;CHST3;CHST11;CHST9;CHST12;CHPF2
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.3857427352369595,0.9394171639016591,0.5771739130434783,0.8887178815801748,1.0,16/51,24.11%,PKIB;TENT4B;XRCC5;CTNNB1;PRKCQ;CCT8;STN1;TNKS2;CCT5;SRC;TINF2;TERF2;TEN1;FBXO4;DCP2;ATR
prerank,DNA methylation (GO:0006306),0.4197189570643093,0.939319489612566,0.5806060606060606,0.8885124391681545,1.0,4/23,9.63%,DNMT3A;METTL4;ATRX;ATF7IP
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.38879684221603006,0.9392104132422703,0.5815991237677984,0.8882998342811691,1.0,5/45,12.21%,TGFB1;TGFBR1;HFE;INHBA;SDCBP
prerank,phosphatidylcholine catabolic process (GO:0034638),0.48033217205004286,0.9389721385197617,0.5625942684766214,0.8883453740844164,1.0,4/10,23.55%,LIPC;PLA2G7;PLA2G5;PLA2G6
prerank,oogenesis (GO:0048477),0.4563750663236024,0.9389228245943018,0.5539661898569571,0.8880389442109262,1.0,4/15,17.06%,MDK;TRIP13;METTL3;MARF1
prerank,histone exchange (GO:0043486),0.39631764198646735,0.9382413815143904,0.5683122847301951,0.8890109913889839,1.0,14/37,23.59%,CENPO;SRCAP;RBBP7;CENPI;CENPQ;SPTY2D1;CENPK;RSF1;RBBP4;ITGB3BP;VPS72;SMARCA5;KNL1;CENPT
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.4481354717717151,0.9378858015672271,0.5611979166666666,0.8893014552126358,1.0,4/15,14.11%,TSEN15;ERN1;RTRAF;DDX1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.4262532537990308,0.9378555432112267,0.5674698795180723,0.8889308904375116,1.0,10/22,25.88%,RPL23;RPS20;HEXIM1;RPS7;RPS15;CHD5;ATR;SPRED1;SPRED3;CDK5RAP3
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.3672955981994015,0.9377537073991489,0.6237424547283702,0.8887059754016711,1.0,58/148,28.48%,RPL23;MTOR;RFFL;MAPK14;MAP2K6;PIP4K2A;RMI1;EXO1;BRIP1;TAF1;TP53;CHEK2;CSNK2A1;CSNK2A2;RPS20;USP7;RBBP7;DNA2;PIP4P1;RRS1;NOC2L;BRD7;TAF3;RPL11;MEAF6;PDPK1;PPP2R5C;CHD4;TAF11;RBBP4;HEXIM1;CDK5R1;TTC5;PHF20;PIN1;NUAK1;RAD1;MDM4;SGK1;RPS15;CHD5;ATR;RPA1;PRKAG1;CDK5RAP3;RPL5;ING5;MTA2;TAF6;TOP3A;PAK1IP1;TAF15;PRKAA1;HDAC1;KAT5;RHNO1;RAD9B;TAF5
prerank,nuclear transport (GO:0051169),0.4411437223104291,0.9376171135979947,0.5578673602080624,0.8885624454240499,1.0,4/16,11.84%,XPO1;ANP32A;RBM15B;NUP205
prerank,regulation of exosomal secretion (GO:1903541),0.4335333559611497,0.9375133431979588,0.5728900255754475,0.8883589368076107,1.0,6/19,21.05%,SMPD3;RAB7A;SDCBP;PDCD6IP;ATP13A2;PRKN
prerank,response to interferon-alpha (GO:0035455),0.4463454973380976,0.937363473907166,0.5568783068783069,0.8882455084215918,1.0,5/16,14.51%,IFNAR1;ADAR;TPR;GAS6;RO60
prerank,regulation of cell motility (GO:2000145),0.3685521480375735,0.9372554085676137,0.6305668016194332,0.8880462511039748,1.0,29/121,21.99%,TGFB1;CYRIB;CSF1R;PLXNC1;PLXNB2;ADGRG3;MACF1;DOCK10;TMSB4X;KIF14;SPINT2;DIAPH1;PKN1;CDK6;NRG1;TMSB10;KIF2A;ARHGAP18;SGK3;RHOA;MINK1;ROCK2;MEMO1;CRK;AMOT;SPATA13;PIN1;FGF2;FLNA
prerank,regulation of DNA metabolic process (GO:0051052),0.3952048536436036,0.9363531977016517,0.5863586358635864,0.8894123475996224,1.0,14/44,22.68%,UBE2V2;UBE2V1;XRCC5;POLH;SMG1;KAT7;HNRNPD;SMARCAD1;KPNA1;UBE2N;MPV17;TERF2;WDR70;TERF2IP
prerank,regulation of muscle cell differentiation (GO:0051147),0.4073256266069499,0.9361696041587725,0.5669745958429562,0.8893561416503182,1.0,10/31,22.12%,MAPK14;CTNNB1;MEF2A;MYOCD;MEF2C;HDAC9;CDC42;MEGF10;PTBP1;CDH15
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.28066798908387797,-0.9359948613266438,0.5194805194805194,0.9167303172117707,1.0,13/25,26.82%,ADK;DGUOK;GMPS;MTHFD1;PRPS2;AMPD3;GMPR;AMPD2;PAICS;ADSL;PPAT;PRPS1;PRPS1L1
prerank,snRNA metabolic process (GO:0016073),-0.31970381352048904,-0.9359158249995702,0.5319148936170213,0.9142020306445527,1.0,7/17,19.32%,INTS9;INTS10;MTREX;TUT1;INTS4;INTS2;MEPCE
prerank,histone monoubiquitination (GO:0010390),-0.2819623454199852,-0.935676182684685,0.5654761904761905,0.9120340834697059,1.0,7/24,12.39%,DDB2;RYBP;DDB1;TRIM37;PAF1;WAC;DTX3L
prerank,endothelial tube morphogenesis (GO:0061154),0.4792108487442993,0.9356644841686149,0.5652777777777778,0.8899670007655316,1.0,3/10,6.34%,CCM2;PRKD2;CTNNB1
prerank,energy reserve metabolic process (GO:0006112),-0.30999996904034216,-0.9355631507754973,0.5512820512820513,0.909587454721314,1.0,10/19,26.26%,LEPR;PHKG2;UGP2;PHKB;PYGM;GFPT1;PPP1R3C;PHKA1;MRAP2;GFPT2
prerank,carnitine shuttle (GO:0006853),0.4707631231281604,0.9350440575902912,0.5483870967741935,0.8907868389871033,1.0,3/11,16.66%,SLC25A20;ACACA;CPT2
prerank,skeletal muscle organ development (GO:0060538),0.419409472159775,0.9349920614658774,0.574793875147232,0.8904679902286204,1.0,3/26,8.17%,BASP1;CFLAR;MEF2C
prerank,mRNA modification (GO:0016556),-0.29217427928692474,-0.9348293794073499,0.5561797752808989,0.9087401437437822,1.0,7/22,15.10%,CBLL1;NSUN2;METTL14;TRMT6;METTL16;CMTR1;TRUB2
prerank,regulation of axon regeneration (GO:0048679),0.4780977861506018,0.9345658826841947,0.5775623268698061,0.8908968150737043,1.0,4/12,16.70%,RTN4RL1;GRN;STK24;EPHA4
prerank,peptide biosynthetic process (GO:0043043),0.36299659503272186,0.934078906714354,0.6388329979879276,0.891448356206676,1.0,57/153,25.96%,RPL23;RPL17;RPL10A;RPS2;RRBP1;FARSB;RPL18A;MRPL41;RPS15A;GSPT1;EIF4EBP2;MRPL51;RPL6;RPLP2;RPL26;RPS20;GGTA1;RPS16;RPS14;DARS1;RPL19;RPL9;IGF2BP3;RPS11;RPL11;RPS23;FURIN;MRPS21;RPS4X;MRPS14;PABPC4;AGO2;RPS27;RPL4;MRPL3;RPL7A;MRPL10;RPL15;RPL29;RPL22;RPS7;RPS13;SARS1;RPLP1;RPS15;MRPL52;MRPL18;RPS5;RPL41;RPL10;MRPL37;MRPS12;ABCF1;RPS8;RPL18;EEF1A1;RPL5
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4166153580673076,0.9340572002044619,0.5731272294887039,0.8910746816317188,1.0,3/26,4.62%,CBL;NCK2;ZFYVE28
prerank,cellular glucan metabolic process (GO:0006073),-0.3610303043903629,-0.9337983567838607,0.5596026490066225,0.908574280260095,1.0,6/11,21.83%,PHKG2;UGP2;PHKB;PYGM;PPP1R3C;PHKA1
prerank,modulation by host of symbiont process (GO:0051851),0.4036781022374719,0.9329327995314383,0.5868544600938967,0.892897009741072,1.0,2/31,1.89%,CX3CR1;AQP1
prerank,positive regulation of histone acetylation (GO:0035066),0.42427651036095093,0.9327581136258594,0.5738705738705738,0.8928213834210345,1.0,11/23,27.30%,PPARGC1A;RPS6KA4;KAT7;SMARCB1;BRD7;PIH1D1;RPS6KA5;ARRB1;SPHK2;GLYR1;MAPK3
prerank,regulation of cellular response to stress (GO:0080135),0.36325418249508284,0.9323539281041245,0.6440849342770475,0.8931781303192677,1.0,34/115,21.88%,BAG2;MTOR;PTGES3;NUP62;NEK6;DNAJC7;CLN3;ATF3;HSBP1;ABCD1;SEH1L;CEBPB;HSF1;SMG1;TPR;NUP205;ADCY8;CHORDC1;BAG1;HSP90AA1;DNAJB6;NPAS2;MANF;CORO2B;RPTOR;SEC13;ROCK2;GSK3B;BAG4;NEK4;NUP54;PRKN;CRYAB;NUAK1
prerank,rRNA processing (GO:0006364),0.36329215238709783,0.9322766781845333,0.6566566566566566,0.8929116402358299,1.0,46/172,21.18%,RPL23;RPL17;EMG1;RPL10A;UTP20;NOB1;TEX10;FBL;EXOSC1;RPS2;LAS1L;RPL18A;KRR1;RPL6;DDX27;RPLP2;RPL26;RPS16;MDN1;UTP11;HEATR1;RPS14;RPL19;C1D;PES1;RPL9;IMP3;PIH1D1;RPL11;WDR12;RPS27;RPL4;FCF1;RIOK3;WDR75;EXOSC3;RPL7A;UTP3;SART1;RPL15;RPL29;RRP7A;RPL22;SRFBP1;IMP4;RPS7
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.48481674724509044,0.9321793449847673,0.5734664764621968,0.8926890770948234,1.0,2/10,5.36%,PIK3CB;XDH
prerank,regulation of protein localization to nucleus (GO:1900180),0.3938941090311976,0.9311739367746686,0.5958605664488017,0.894330741361891,1.0,2/43,0.89%,SHH;TGFB1
prerank,heme biosynthetic process (GO:0006783),0.4224919893305152,0.9309731232656385,0.587088915956151,0.8942938852812073,1.0,4/22,9.94%,TSPO;ATP5IF1;SLC25A38;NFE2L1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.43859420790586323,0.9306311828484968,0.56575682382134,0.8945696202184303,1.0,2/18,6.22%,AQP1;ANXA1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.282715229208672,-0.9304577497529812,0.55,0.9146588286657171,1.0,6/26,10.38%,SRI;THADA;ATP1A2;FKBP1A;FMR1;CALM3
prerank,histone H4 deacetylation (GO:0070933),0.4726198952782672,0.9304013291995329,0.5615835777126099,0.8946237446080119,1.0,4/10,16.45%,RCOR1;HDAC4;HDAC9;SMARCAD1
prerank,regulation of synapse maturation (GO:0090128),-0.37379534869853037,-0.9299729961427292,0.5363636363636364,0.913323750303257,1.0,5/10,28.56%,DAB2IP;ARHGEF15;ANAPC2;CAMK2B;YWHAZ
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.39246842734020027,0.9298060984895202,0.57847533632287,0.8953977119519623,1.0,9/35,15.81%,APOE;RGCC;XDH;MEF2C;ATP5IF1;CCL2;THBS1;ATP5F1A;NF1
prerank,UV protection (GO:0009650),0.4816060563637435,0.9297623358411785,0.588495575221239,0.8950618573835448,1.0,3/10,15.88%,SDF4;ERCC5;MFAP4
prerank,sensory perception of sound (GO:0007605),-0.21533690665309035,-0.9295725152658412,0.6190476190476191,0.9116548285428139,1.0,14/88,11.97%,ROR1;GRM7;NIPBL;DCDC2;GSDME;EML2;COL4A3;EYA1;SOD1;USP53;WDR1;CLIC5;ATP6V0A4;TBX1
prerank,tRNA export from nucleus (GO:0006409),-0.2729963140939532,-0.9295562598678592,0.6165413533834586,0.9063543954444877,1.0,14/32,21.17%,NUP93;NUP188;RANBP2;SSB;NUP98;NUP42;NDC1;RAE1;NUP153;NUP37;NUP133;NUP50;RAN;NUP43
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.2729963140939532,-0.9295562598678592,0.6165413533834586,0.9063543954444877,1.0,14/32,21.17%,NUP93;NUP188;RANBP2;SSB;NUP98;NUP42;NDC1;RAE1;NUP153;NUP37;NUP133;NUP50;RAN;NUP43
prerank,inorganic cation import across plasma membrane (GO:0098659),0.37278456200542665,0.9295476432902546,0.6224279835390947,0.8950590835463881,1.0,6/75,7.13%,KCNJ11;HCN4;SLC9A4;SLC8A1;SLC9A9;SLC9A1
prerank,regulation of spindle organization (GO:0090224),0.43546326361461546,0.929400414130161,0.5774111675126904,0.8949204657566838,1.0,6/18,20.46%,NUP62;RNF4;CLTC;DYNC1H1;SENP6;PARP3
prerank,regulation of NMDA receptor activity (GO:2000310),0.40135273588010795,0.929232221293788,0.5892448512585813,0.8947964750899425,1.0,2/32,1.17%,PTK2B;CCR2
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.42005754430832676,0.9286358313288046,0.5817958179581796,0.8955477681542224,1.0,11/24,23.57%,TENT4B;STN1;TNKS2;SLX4;SRC;TINF2;TERF2;ERCC4;TEN1;PARP1;DCP2
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.38525528833890615,0.9286282384420261,0.6073825503355704,0.8951382897666639,1.0,15/44,22.48%,CNOT8;GTPBP1;TNRC6A;YTHDF3;MOV10;RC3H1;CPEB3;METTL3;MEX3D;AGO2;FTO;ROCK2;ZFP36L1;CNOT7;CNOT1
prerank,cellular response to topologically incorrect protein (GO:0035967),0.3977285979502821,0.928119687337584,0.5787631271878646,0.8957212765345933,1.0,7/31,13.43%,PTPN1;ERN1;ATXN3;BAK1;HSF1;HDAC6;STUB1
prerank,regulation of mitochondrial fission (GO:0090140),0.41800470528278105,0.9281073575500617,0.5661057692307693,0.8953174073492941,1.0,8/24,21.05%,CYRIB;DDHD1;MYO19;LRRK2;FIS1;INF2;DNM1L;PRKN
prerank,cellular response to decreased oxygen levels (GO:0036294),0.37861373105654766,0.9276991902553996,0.6052356020942409,0.8957382660930239,1.0,13/65,16.55%,AQP1;ADAM8;ANGPT4;MTOR;RGCC;TP53;P4HB;TBL2;STUB1;CPEB4;HIF1A;CPEB2;SUV39H1
prerank,transcription by RNA polymerase II (GO:0006366),0.35741048280209575,0.9276326485995996,0.721,0.8954508942165041,1.0,73/305,20.43%,ARRB2;PCID2;POU2F2;MED17;RREB1;GTF2H1;TAF1A;NR1H4;MAML3;RXRB;NABP1;EAF1;HDAC5;ELL2;TAF1;TEAD1;BTF3;TBL1XR1;CSTF1;LEO1;TRIP13;INTS8;GMEB2;LSM11;PPARGC1A;CDK7;NFX1;SETD2;RPAP2;TBL1X;NFIC;MED27;KLF13;POLR2L;TRIM24;TAF8;NR2C2;MBD1;SNAPC3;PMF1;HDAC9;ELL;MLLT1;NR4A1;NFKB1;INTS6;ELOF1;INTS13;NR2C1;MAF;TAF3;ERCC6;RBPJ;ZBTB7B;SNAPC4;GTF2B;ICE2;PPARD;INTS1;TCEA1;NFYA;PCF11;GTF2H5;RXRA;TAF11;POLR2E;MED4;ELOB;PABPN1;SLBP;POU2F1;HNF4G;GLIS3
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.4619067468324168,0.9273609272178327,0.5766129032258065,0.8955861745701532,1.0,3/13,7.10%,RENBP;NAGK;OGA
prerank,cellular response to glucose starvation (GO:0042149),0.3911862412144525,0.9273044383052368,0.5793025871766029,0.8952745930999316,1.0,22/41,28.94%,FOXO3;TP53;MTMR3;IMPACT;BECN1;TBL2;NIM1K;CPEB4;PIK3R4;SIK2;ATG14;BRSK1;NUAK1;XBP1;NUAK2;PRKAG1;SH3GLB1;PRKAA1;ITFG2;SESN1;SESN2;PMAIP1
prerank,regulation of protein binding (GO:0043393),0.36571062055367687,0.9272901989517732,0.6629667003027245,0.894880062091986,1.0,39/114,24.14%,BAG2;PRKCD;LDLRAP1;HDAC5;TAF1;ACTB;TFIP11;DISC1;HFE;CTSZ;SPPL3;DERL1;HDAC4;EPB41;PPP2CA;PSME3IP1;SORL1;BAMBI;B2M;STK3;LRRK2;LRP1;TLE5;IDE;RPL11;STK4;ADD1;FLOT1;DACT1;GSK3B;CRK;PRKN;PIN1;VTN;MITD1;RACK1;AMFR;IFIT1;DDX11
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.37832734040995775,0.9271516006196288,0.6175847457627118,0.8947326253541157,1.0,17/58,22.09%,UBE2V2;HMGB1;XRCC5;LIG3;ATP23;UVRAG;BABAM2;ERCC6;MDC1;BABAM1;UBE2N;ERCC1;POLM;DCLRE1C;HERC2;NSMCE2;ERCC4
prerank,regulation of necroptotic process (GO:0060544),0.41497247943681304,0.9270904054199269,0.5782227784730913,0.894418518042397,1.0,11/23,20.18%,FZD9;CFLAR;SDCBP;CASP8;STUB1;PDCD6IP;HSP90AA1;ARHGEF2;FLOT1;BIRC2;BIRC3
prerank,protein localization to kinetochore (GO:0034501),0.4601063520746463,0.9268873908778956,0.5843293492695883,0.8943901176085599,1.0,5/14,23.87%,IK;MIS12;KNL1;CENPT;BUB3
prerank,DNA replication (GO:0006260),0.36307205392474506,0.9265692277114234,0.6312056737588653,0.8945937126126087,1.0,18/105,13.79%,MCM5;FAM111A;ORC3;RMI1;EXO1;BRIP1;MCM2;MCM6;DBF4;NAP1L1;BAZ1A;WDHD1;ORC4;DNA2;MCM9;KAT7;MCMBP;CDC6
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.4226376933481712,0.9259656229229547,0.5692695214105793,0.895388048051527,1.0,2/20,8.59%,TGFB1;RB1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3666124509236755,0.9250348409592437,0.6275510204081632,0.8968178764396874,1.0,21/95,17.75%,TGFB1;TGFBR1;ZEB2;SKI;RNF111;TGFBR2;NKX2-1;FLCN;FAM89B;SMAD3;SNX25;THBS1;SDCBP;BAMBI;VASN;STUB1;SMURF1;BCL9;LDLRAD4;GIPC1;PDPK1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.35497156542509994,-0.9248428764693087,0.5719298245614035,0.9157591975874482,1.0,3/12,5.14%,SORBS1;IRS1;EPM2AIP1
prerank,keratinocyte differentiation (GO:0030216),-0.2710766713283253,-0.9241536443864042,0.5645161290322581,0.9148573631398029,1.0,6/29,15.92%,CLIC4;WNT5A;BCR;CASP3;JAG1;UGCG
prerank,mitochondrion disassembly (GO:0061726),0.397511061870197,0.9237612944343588,0.5882352941176471,0.8988923766660056,1.0,10/34,22.21%,CTSK;ATG7;MAP1LC3B;FUNDC1;BECN1;ATG2B;ATG3;FIS1;PRKN;RB1CC1
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.4003058216845248,0.9236190384366773,0.574095682613769,0.8987651168772436,1.0,4/28,6.64%,LGMN;APOE;AKAP5;TYROBP
prerank,dorsal/ventral pattern formation (GO:0009953),0.41981534344023635,0.923570259926708,0.5832274459974587,0.8984338609963994,1.0,1/20,0.65%,SHH
prerank,positive regulation of TORC1 signaling (GO:1904263),0.4413837388700376,0.9234427168769744,0.5735294117647058,0.8982719734330538,1.0,8/16,22.01%,GPR137B;SEH1L;FLCN;PIP4P1;PIH1D1;TELO2;RRAGA;RRAGB
prerank,sphingolipid biosynthetic process (GO:0030148),0.3750600204401467,0.9231165669428858,0.6436058700209644,0.8984515472135014,1.0,20/71,22.94%,CERS6;SGPL1;CLN8;PRKD2;CSNK1G2;HACD4;AGK;ACER3;VAPB;ST8SIA1;LARGE1;DEGS1;ASAH1;SGMS1;SPTSSA;SMPD1;SPTSSB;B4GALT6;PRKD3;CERS4
prerank,protein neddylation (GO:0045116),-0.34186465794532683,-0.922883807849774,0.5471014492753623,0.9153587573283364,1.0,6/13,18.16%,DCUN1D4;RBX1;NAE1;UBA3;DCUN1D3;UBE2M
prerank,cellular response to UV (GO:0034644),0.3724454346585755,0.9226497425367683,0.6372141372141372,0.8989151656933698,1.0,15/76,16.33%,AQP1;PRKCD;TIMP1;TAF1;TP53;YY1;BAK1;IMPACT;RPL26;METTL3;INO80;NOC2L;BMF;MFAP4;COPS9
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.4542650768331099,0.9225614486874724,0.5814917127071824,0.8986681518858851,1.0,3/12,16.47%,UBE2S;FZR1;PTEN
prerank,regulation of vacuole organization (GO:0044088),0.4304894012236722,0.9219163480010543,0.5684754521963824,0.8994959701328071,1.0,11/20,23.86%,ENO3;MTMR3;RAB1B;TBC1D14;TBC1D12;LAPTM4B;ENO1;SCARB2;NPRL3;ADPRH;IFT88
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.2549137330624738,-0.9218937347449506,0.5798319327731093,0.9152416723440896,1.0,17/37,26.45%,KIF3C;IFT46;IFT57;IFT172;KIF3B;IFT81;IFT74;KIFAP3;WDR35;IFT20;DYNC2I2;IFT43;DYNLL2;IFT22;IFT122;WDR19;TRAF3IP1
prerank,nucleotide-excision repair (GO:0006289),0.3612520899786439,0.92182775129082,0.6474747474747474,0.8992298037458942,1.0,23/101,19.03%,COPS6;GTF2H1;PPIE;BRIP1;RNF111;LIG3;UVSSA;ATXN3;TP53;MMS19;CDK7;USP7;POLR2L;COPS4;SLX4;POLD3;ERCC5;ERCC6;OGG1;TCEA1;GTF2H5;ERCC1;POLR2E
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.38146289128262656,-0.9214408235724784,0.5534591194968553,0.913803801822848,1.0,6/10,24.80%,APP;SHANK3;RAB5A;SYP;DRD2;CAMK2B
prerank,regulation of cell-substrate adhesion (GO:0010810),0.38648967607579815,0.9213721271065304,0.6015712682379349,0.8997136859400755,1.0,10/42,18.77%,THY1;PIK3CB;ATXN3;LIMS1;PTPRO;NF1;CORO1C;RHOA;CORO2B;MINK1
prerank,diterpenoid metabolic process (GO:0016101),0.37874049259689113,0.9211326899352746,0.6056034482758621,0.8997464918498832,1.0,8/55,14.23%,LPL;DHRS3;APOE;TTR;AGRN;LRP8;ABCA4;LRP1
prerank,autophagy of mitochondrion (GO:0000422),0.38988367898849796,0.9210216427460779,0.6057471264367816,0.8995449939168142,1.0,11/38,22.21%,CTSK;ATG7;MAP1LC3B;FUNDC1;BECN1;ATG2B;ATG3;ATG14;FIS1;PRKN;RB1CC1
prerank,cellular calcium ion homeostasis (GO:0006874),0.36286316925091067,0.9207640876066477,0.6539235412474849,0.8996412772267567,1.0,27/133,15.63%,CCR2;KCTD17;SLC8A1;CCL8;HERPUD1;CLN3;FZD9;TMEM178A;ATP2C1;TPT1;ATP2B1;BAK1;CCL14;VAPB;ATP13A1;SLC8B1;CCL13;CHERP;ATP2B3;NPTN;CDH23;ATP2A3;ADCY8;WFS1;CCDC47;PDZD8;SELENOK
prerank,lamellipodium organization (GO:0097581),0.39935465416514976,0.9204002045957282,0.5757931844888367,0.8999372044343128,1.0,12/29,20.86%,ABLIM2;P2RY12;VCL;PARVB;CYFIP1;PTPRO;SNX2;ARFIP2;ITGB1;GOLPH3;RHOD;SPATA13
prerank,pre-replicative complex assembly (GO:0036388),0.36934555004861735,0.9189261029475114,0.6239495798319328,0.9023636267411529,1.0,13/64,15.82%,MCM5;ORC3;PSMB10;MCM2;MCM6;PSMA2;ORC4;PSME3;PSMB5;CDC6;PSMD8;PSMD7;PSMB9
prerank,protein localization to condensed chromosome (GO:1903083),0.46615782404658224,0.9185074047960144,0.6021505376344086,0.9027699313883664,1.0,1/12,2.37%,IK
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.37510916740705647,0.9184750085530574,0.6197478991596639,0.9024070757750684,1.0,8/62,8.29%,NFE2L2;CREB3;HERPUD1;CREB3L1;BCL2L1;SNAI1;EPO;TPT1
prerank,chloride transmembrane transport (GO:1902476),-0.24042407737895397,-0.918468519105742,0.5466666666666666,0.9185907320593912,1.0,15/48,29.16%,SLC12A2;SLC12A7;GABRB2;GABRB1;GABRA2;GABRB3;ANO4;SLC12A8;GLRB;ANO5;SLC12A4;CLCN1;GABRE;ANO2;CFTR
prerank,stress granule assembly (GO:0034063),0.42425613072634305,0.9180846356737021,0.5739570164348925,0.9027301926861371,1.0,6/20,21.44%,CIRBP;YTHDF3;DYNC1H1;ATXN2L;RPS23;LSM14A
prerank,cellular response to virus (GO:0098586),0.39166078007646854,0.9179664892279594,0.6143024618991794,0.9025469877605724,1.0,2/30,3.07%,POU2F2;MAPK14
prerank,negative regulation of viral genome replication (GO:0045071),0.3935587096870017,0.9177454806687148,0.6219512195121951,0.9025640809928346,1.0,12/40,24.09%,FAM111A;TNF;RESF1;RNASEL;TASOR;PARP10;INPP5K;IFITM2;SETDB1;ILF3;IFITM1;IFIT1
prerank,positive regulation of protein acetylation (GO:1901985),-0.3572075135331839,-0.9171728478496926,0.5785953177257525,0.9192976057007012,1.0,3/12,6.26%,CEP295;RAPGEF3;DIP2A
prerank,JNK cascade (GO:0007254),0.388349251507533,0.9170958331664347,0.6033519553072626,0.9034235873424739,1.0,12/40,18.77%,IRAK2;UBE2V1;MAP3K5;NOD2;MAP3K12;TAB2;IKBKG;GPS2;TAB3;MAP3K11;UBE2N;MINK1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.360162088035274,0.9162386033235042,0.6897590361445783,0.9046836066519377,1.0,31/145,18.37%,TUBB;GPR132;PRKAR2B;HAUS2;TUBA4A;CNTRL;CEP192;MAPRE1;PSMB10;CEP70;PLK4;CEP76;KIF14;HAUS1;RAB11A;PSMA2;DYNC1H1;PCM1;PSME3;CEP152;PSMB5;HAUS8;PSMD8;RAD51B;PSMD7;PSMB9;NINL;HSP90AA1;AKAP9;PSMD2;CEP63
prerank,protein localization to cell-cell junction (GO:0150105),0.43647277541613416,0.916153061071738,0.5828804347826086,0.9044181872156309,1.0,4/15,10.07%,ARHGEF18;ACTB;ACTG1;F11R
prerank,peptidyl-lysine trimethylation (GO:0018023),0.4094978368851191,0.9160329312471991,0.58698224852071,0.9042322523159647,1.0,9/26,21.33%,SMYD5;TET3;SETD2;ETFBKMT;SUV39H1;SETD1B;WDR82;TET2;SETD5
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.3468053207998007,-0.9157737122316479,0.5880281690140845,0.920284595714719,1.0,3/12,7.35%,UNC13B;RIMS2;SYT7
prerank,epithelial cell-cell adhesion (GO:0090136),0.46914989317057565,0.9156319624009935,0.6023054755043228,0.9046042232782426,1.0,2/11,9.85%,ITGB5;VCL
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.4577637034605628,0.9155351940471461,0.5972413793103448,0.9043505860972642,1.0,1/12,2.04%,PLCG2
prerank,cellular response to pH (GO:0071467),0.42514618755299116,0.915421420999736,0.5844155844155844,0.9041559378016311,1.0,6/17,22.04%,SLC9A1;IMPACT;RAB11FIP5;HVCN1;MCOLN1;CHP1
prerank,regulation of mRNA stability (GO:0043488),0.3572438641749995,0.9153639588252219,0.6893787575150301,0.9038577498672308,1.0,36/145,20.34%,SLC11A1;PCID2;PRKCD;EXOSC1;XPO1;ANP32A;CIRBP;PSMB10;YWHAB;FASTKD3;YTHDF3;RC3H2;LARP1;RC3H1;TENT5C;PUM2;FASTKD1;PSMA2;METTL3;PSME3;PSMB5;HNRNPD;PSMD8;IGF2BP3;PSMD7;THRAP3;PSMB9;MEX3D;PSMD2;FTO;ROCK2;GDNF;SERBP1;EXOSC3;ZFP36L1;HSPB1
prerank,peroxisomal membrane transport (GO:0015919),0.40264211453028986,0.9151268549062146,0.5824561403508772,0.9039248186745084,1.0,5/27,11.62%,RAB8B;ABCD1;PEX13;PXMP2;PEX7
prerank,RNA processing (GO:0006396),0.3554308139724543,0.9148051422973502,0.6941649899396378,0.9041333027725799,1.0,45/176,21.79%,APOBEC1;IVNS1ABP;BCAS2;SF3B2;SF3B1;AURKAIP1;RBM39;TENT4B;SNRNP25;SCAF11;ZMAT5;TFIP11;SNRPD2;ADAR;PPARGC1A;HNRNPL;SON;DDX39B;RNASEL;LUC7L3;PRPF8;METTL3;PPP2CA;ADARB1;ALKBH5;HNRNPD;PPIG;AKAP8L;NUFIP1;NRDE2;TUT7;PABPC4;SLU7;RBMS2;SNRNP35;SRSF2;HNRNPF;PABPN1;TSEN2;SF3B3;DICER1;PTBP1;HNRNPA0;LIN28B;PDCD7
prerank,epidermal cell differentiation (GO:0009913),-0.246243887391547,-0.9140039995721676,0.550561797752809,0.9220683578622256,1.0,8/41,15.92%,CLIC4;WNT5A;BCR;HDAC2;GLI1;CASP3;JAG1;UGCG
prerank,calcium ion homeostasis (GO:0055074),0.36201446890321065,0.913622790610623,0.6548223350253807,0.9059633385479211,1.0,18/95,14.48%,CCR2;SLC8A1;CCL8;SNCA;ATP2C1;TPT1;ATP2B1;TFAP2B;CCL14;VAPB;ATP13A1;SLC8B1;CCL13;CHERP;ATP2B3;NPTN;ATP2A3;WFS1
prerank,regulation of translation (GO:0006417),0.3546497035558313,0.9129531272614617,0.7028112449799196,0.9068046222592789,1.0,34/173,15.02%,NIBAN1;MTOR;DHX9;PLXNB2;FOXO3;CNOT8;EIF5B;CIRBP;GSPT1;YTHDF3;TRAP1;LARP4B;LARP1;EIF1;EPRS1;EIF4H;IMPACT;CPEB3;CTIF;EIF2B2;RPL26;EIF4G3;CYFIP1;THBS1;ZCCHC4;METTL3;PCIF1;POLDIP3;UPF3B;DDX1;HNRNPD;PUM3;SOX4;IGF2BP3
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.46168219153477236,0.9126936311103928,0.5986013986013986,0.9068909986501336,1.0,2/12,5.36%,PIK3CB;XDH
prerank,histone deacetylation (GO:0016575),0.37683350367804713,0.9116422114394668,0.6039603960396039,0.9084721105022527,1.0,11/43,16.45%,HDAC5;MTA3;RCOR1;TBL1XR1;MIDEAS;HDAC4;TBL1X;HDAC6;HDAC9;HDAC11;SMARCAD1
prerank,RNA destabilization (GO:0050779),0.42821965551936153,0.9115006131953208,0.5989650711513583,0.9083319856650043,1.0,9/18,25.63%,YTHDF3;ZC3H18;METTL3;MEX3D;FTO;ROCK2;LIN28B;PUM1;DXO
prerank,RNA splicing (GO:0008380),0.3626347103475901,0.9113975808142036,0.6612244897959184,0.9081131892358351,1.0,24/95,21.79%,IVNS1ABP;BCAS2;SF3B2;SF3B1;SNRNP25;SCAF11;ZMAT5;SNRPD2;PPARGC1A;DDX39B;LUC7L3;PRPF8;TRA2B;PPP2CA;WDR83;PPIG;NRDE2;SLU7;SNRNP35;SRSF2;SF3B3;SRSF10;PTBP1;PDCD7
prerank,translation (GO:0006412),0.35265042658697615,0.9113868565677433,0.7177177177177178,0.9077158415376676,1.0,77/208,25.96%,RPL23;RPL17;VARS1;RPL10A;RPS2;RRBP1;FARSB;RPL18A;MRPL41;GTPBP1;RPS15A;GSPT1;GATB;GARS1;EIF4EBP2;PPA2;MRPL51;RARS1;RPL6;QARS1;EPRS1;LARS2;RPLP2;RPL26;RPS20;RPS16;RPS14;RWDD1;DARS1;RPL19;DARS2;RPL9;IGF2BP3;TMA7;RPS11;RPL11;FARS2;RPS23;MRPS21;RPS4X;MRPS14;PABPC4;AGO2;RPS27;RPL4;MRPL3;RPL7A;MRPL10;RPL15;RPL29;AIMP1;RPL22;YARS1;TARS1;RPS7;RPS13;SARS2;SARS1;EEF1G;RPL22L1;RPLP1;RPS15;MRPL52;MRPL18;RPS5;DRG2;RPL41;GATC;RPL10;MRPL37;MRPS12;MRPS34;ABCF1;RPS8;RPL18;EEF1A1;RPL5
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.291971451028252,-0.9106059577942223,0.5934579439252337,0.928277630700812,1.0,5/20,16.31%,WNT4;NCOR1;SIK1;C1QTNF3;BCKDK
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.353632382051124,0.9098722829219122,0.6987951807228916,0.9101870157254128,1.0,34/152,15.82%,TGFB1;TLR2;GPRC5B;ZEB2;DKK2;SKI;TNFAIP3;LGR6;FZD9;MACF1;PSMB10;TBL1XR1;WNK1;CSNK1G2;DISC1;CSNK2A1;GID8;SULF2;ATP6AP2;AMER1;TBL1X;PSMA2;TNKS2;PSME3;BAMBI;NFKB1;PSMB5;LRRK2;PSMD8;SOX4;USP8;PSMD7;LGR4;PSMB9
prerank,regulation of viral transcription (GO:0046782),0.37958976040356446,0.9096696590352916,0.6104783599088838,0.9101585076762365,1.0,12/39,24.01%,DHX9;MDFIC;TRIM27;POLR2L;MID2;TARBP2;TRIM62;RSF1;POLR2E;HEXIM1;NELFE;UBP1
prerank,rRNA methylation (GO:0031167),0.41563109734973125,0.9094967988247864,0.6002430133657352,0.9100565510006545,1.0,3/22,12.10%,EMG1;FBL;ZCCHC4
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.34786944519803265,-0.9092814737738758,0.5344827586206896,0.9290213579464196,1.0,2/11,4.52%,CAV1;ACTN2
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.4263453479462635,0.9090737639644024,0.614569536423841,0.9104249933789552,1.0,3/17,9.65%,HERPUD1;SEL1L;DERL1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.38883648030106277,0.9086111030189442,0.6037296037296037,0.9108745041284082,1.0,5/31,17.09%,GCH1;DHRS11;PYCR2;PRLR;FDXR
prerank,protein complex oligomerization (GO:0051259),0.3634512296582462,0.9084635578942649,0.6553846153846153,0.9107206213286453,1.0,18/85,16.57%,CARD11;LRRC8D;SNCA;PKD2;PYCARD;SLC9A1;AQP11;ATL1;RNF135;TMEM120A;NINJ1;ADCY8;LRRC8C;TWNK;PDCD6IP;ALS2;ZNHIT6;YME1L1
prerank,regulation of cilium assembly (GO:1902017),0.3662960222680751,0.9082666372023367,0.631413612565445,0.9106735988187117,1.0,18/62,19.47%,TBC1D10C;KCTD17;TBC1D16;TBC1D22A;USP6NL;TBC1D10A;TBC1D2;TBC1D17;TBC1D2B;TBC1D8;TBC1D14;TBC1D22B;ATG3;ENTR1;DYNC2LI1;RABEP2;TAPT1;TBC1D5
prerank,pharyngeal system development (GO:0060037),-0.3232011407511753,-0.9082627866496227,0.5799086757990868,0.9290373881924509,1.0,5/15,11.97%,BMPR1A;BMP4;BMP5;HES1;TBX1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.36603566028635537,0.9082148958579459,0.6432374866879659,0.9103559499578885,1.0,9/62,11.84%,TGFB1;DHX9;NUP62;TNRC6A;SEH1L;PUM2;TPR;POLR2L;NUP205
prerank,Rho protein signal transduction (GO:0007266),0.3748597528662645,0.9081869379122923,0.6440129449838188,0.909991153002252,1.0,19/53,23.93%,MYO9B;GNA13;RIPOR1;GNA12;ARHGAP1;ARHGDIB;ADGRG1;ARHGDIA;ARHGEF3;ARHGEF11;CDC42;RHOA;CDC42EP3;RHOD;ROCK2;CFL1;RHOG;PDPN;EPS8L1
prerank,myelin assembly (GO:0032288),0.47238234278319013,0.907949593832813,0.5859598853868195,0.9100201159912049,1.0,7/10,28.61%,CD9;ABCA2;DICER1;TENM4;CNTNAP1;PMP22;GPC1
prerank,synaptic vesicle localization (GO:0097479),-0.3396562524727922,-0.9077439153694951,0.5799256505576208,0.9276500816011142,1.0,5/13,15.21%,NLGN1;KIF5B;SYNDIG1;KIF5A;RAB27A
prerank,regulation of dendrite development (GO:0050773),0.3899936001553344,0.9077396863678934,0.602017937219731,0.9099927404614285,1.0,8/37,12.97%,CAMK1D;BCL11A;RAP2A;SEMA4D;TNIK;NEDD4L;CSMD3;LRP8
prerank,protein acetylation (GO:0006473),-0.26147112289321073,-0.9074791110830375,0.6211180124223602,0.9256945299560454,1.0,10/30,21.67%,ESCO1;CLOCK;NAT10;HAT1;MAPT;NAA60;ING4;NAA35;SPHK1;KAT2B
prerank,positive regulation of actin nucleation (GO:0051127),-0.3472916379266416,-0.9072477993795598,0.5498281786941581,0.9237080229194485,1.0,3/11,5.31%,GSN;BRK1;WHAMM
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.3957954928190831,0.9070997319404918,0.6106508875739645,0.9108078067914666,1.0,14/27,30.21%,BRD8;KAT7;NAA50;PHF20;MORF4L2;MORF4L1;TAF6;CREBBP;KAT5;EP300;SGF29;MRGBP;KAT6A;BAG6
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.3340478042943335,-0.906771333008412,0.5773584905660377,0.9223103514209174,1.0,3/13,5.14%,SORBS1;IRS1;EPM2AIP1
prerank,epithelial cell migration (GO:0010631),-0.25332812502506685,-0.9056519799058569,0.6173913043478261,0.922501755079405,1.0,7/37,9.41%,FSTL1;STARD13;KANK1;KANK2;ABL1;FAP;ROCK1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.39744175801316006,0.9055466252876672,0.6169212690951822,0.9133887048671132,1.0,3/29,4.61%,NT5C3B;EXOSC1;CNOT8
prerank,tRNA wobble base modification (GO:0002097),-0.3316243755915377,-0.9053193680837424,0.569811320754717,0.9207484791159043,1.0,5/14,21.19%,ELP3;ELP4;URM1;MTO1;DPH3
prerank,cellular metal ion homeostasis (GO:0006875),0.3599631661824428,0.9052653575072267,0.6836215666327569,0.9135065047735725,1.0,20/102,13.68%,CCR2;SLC8A1;CCL8;KCNMA1;SLC9A1;ATP2C1;TPT1;ATP2B1;CCL14;VAPB;NEDD4L;ATP13A1;SLC8B1;CCL13;CHERP;ATP2B3;NPTN;ATP1B3;ATP2A3;ATP1B2
prerank,regulation of striated muscle contraction (GO:0006942),0.39931813540285666,0.9048931626874219,0.6009334889148191,0.913798913228861,1.0,4/27,8.27%,HCN4;MYL3;P2RX4;TNNT3
prerank,mitochondrion localization (GO:0051646),0.41463338564408614,0.9047336339470364,0.59375,0.9136846618636756,1.0,9/19,25.34%,BRAT1;MEF2A;MSTO1;ATCAY;LRRK2;MFN1;MARK1;TRAK1;MARK2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.26146319002508234,-0.9046183718191063,0.6265822784810127,0.9198972348543396,1.0,12/29,26.11%,ACSL1;HACD1;ELOVL5;ACSL6;ACLY;PPT1;CBR4;ELOVL1;ACSBG1;HACD2;ACSL4;ACSL3
prerank,response to UV (GO:0009411),0.3580053339666008,0.9046095341266837,0.670442842430484,0.9134984459219138,1.0,21/95,16.33%,AQP1;PRKCD;SDF4;TAF1;USF1;CIRBP;UVSSA;TP53;POLH;YY1;BAK1;UBE4B;RPL26;METTL3;INO80;NOC2L;BMF;ERCC5;MFAP4;ERCC6;COPS9
prerank,isotype switching (GO:0045190),-0.3787268865081812,-0.9043826020924985,0.5870307167235495,0.9179590429738966,1.0,6/10,37.39%,MSH2;MSH6;HSPD1;BATF;LIG4;RNF8
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.4470410453438858,0.903961666863384,0.5991678224687933,0.9143162271470539,1.0,3/12,16.24%,TNF;UVRAG;IRGM
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.36850900726343516,0.9039355085871922,0.6323060573857598,0.913940066375938,1.0,10/57,16.35%,ADCY7;PSAP;ADCY6;AKAP5;P2RY12;GPR37;ADCY8;ADCY3;GNAI3;RGS1
prerank,monocarboxylic acid transport (GO:0015718),0.37821993854787794,0.903889544966702,0.6457204767063922,0.913612852156174,1.0,12/51,18.47%,SLCO2B1;NR1H4;ABCC3;ABCB4;SLC16A2;SLC16A1;SLCO1B1;CD36;SLC16A6;SLC16A13;STARD5;RXRA
prerank,apoptotic nuclear changes (GO:0030262),0.40756341694827125,0.9037072417193994,0.6206467661691543,0.9135531328215224,1.0,11/24,27.16%,ACIN1;HMGB1;TOP2A;KPNA1;DICER1;DNASE2;DFFB;CDK5RAP3;CECR2;KPNB1;HMGB2
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.4422087743800639,0.9034678666378119,0.6141732283464567,0.9135723763547272,1.0,3/15,7.10%,RENBP;NAGK;OGA
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.41592796193510295,0.9028744149392375,0.6025316455696202,0.9143089218902075,1.0,1/20,0.89%,TGFB1
prerank,muscle contraction (GO:0006936),0.35095721492790505,0.9028098986565486,0.6774193548387096,0.9140152564085003,1.0,18/126,14.52%,ITGB5;HCN4;MYL3;SLC8A1;KCNIP2;TTN;ASPH;MYL12A;TNNT3;TPM4;VCL;DTNA;DYSF;TLN1;TPM3;SMTN;DES;ARHGEF11
prerank,peptidyl-threonine modification (GO:0018210),0.362947247142146,0.9025893214386317,0.646379853095488,0.9140062867489921,1.0,19/66,20.37%,TGFBR1;PRKCD;PRKD2;TAF1;TGFBR2;WNK1;CSNK2A1;CSNK2A2;NLK;MAP3K12;GALNT2;LRRK2;GSK3A;GALNTL6;PDPK1;GALNT1;ROCK2;GSK3B;CDK5R1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.35993324467413923,0.9021849602758462,0.6496881496881497,0.9143962760992944,1.0,9/66,14.31%,TGFB1;HCLS1;PRKCD;CCT8;SMAD3;MCRS1;TPR;KAT7;CCT5
prerank,endoplasmic reticulum organization (GO:0007029),0.35800757262733673,0.9020721972062113,0.6514522821576764,0.9141877566160054,1.0,23/72,20.72%,LMAN1L;REEP6;VAPB;BNIP1;TMCC1;ATL1;SEC16B;CYB5A;SEC16A;STX5;TOR1AIP2;LRRK2;GAK;UBE2J2;CCDC47;RTN4;LMAN2;ATL2;TMEM170A;SEC31A;DNM1L;ATL3;SPTSSB
prerank,primary miRNA processing (GO:0031053),-0.3699203487335313,-0.9015908034107551,0.5777027027027027,0.9225803619473211,1.0,4/10,11.18%,DGCR8;HNRNPA2B1;SMAD1;PUS10
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.43647184413734774,0.9015322042680038,0.6193724420190996,0.9147654276578865,1.0,2/14,7.38%,EHHADH;ABCD1
prerank,atrioventricular valve development (GO:0003171),-0.3317754859500215,-0.901434304597345,0.5903614457831325,0.9204254162141603,1.0,2/14,4.14%,BMPR1A;ACVR1
prerank,regulation of blood circulation (GO:1903522),0.38399792415646855,0.9008645281854742,0.6234357224118316,0.9155752881937628,1.0,2/34,4.29%,TMIGD3;KCNIP2
prerank,protein targeting to peroxisome (GO:0006625),0.39478477687233415,0.9007726127056658,0.6078886310904872,0.9153227869283223,1.0,5/29,11.62%,RAB8B;ABCD1;PEX13;PXMP2;PEX7
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3585190300999361,0.9004133677920668,0.6584107327141383,0.9155829518184024,1.0,16/72,19.03%,COPS6;GTF2H1;PPIE;LIG3;UVSSA;CDK7;USP7;POLR2L;COPS4;POLD3;ERCC5;ERCC6;TCEA1;GTF2H5;ERCC1;POLR2E
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.3348436538042828,-0.9004102428348689,0.5853658536585366,0.920353593625771,1.0,7/13,24.79%,PRPF3;PRPF19;LSM2;PRPF6;CD2BP2;PRPF31;SRSF12
prerank,"base-excision repair, AP site formation (GO:0006285)",0.4248575213151775,0.9002506226799984,0.6142668428005285,0.9154863826306444,1.0,6/17,22.68%,NEIL2;ERCC5;OGG1;TINF2;TERF2;TERF2IP
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.34936001014750484,0.899851652231441,0.765,0.9158145312728867,1.0,67/259,20.24%,FGD2;MKS1;RAB8B;P2RX7;RAP2A;ASAP1;EXOC6;IFT52;RAP1B;FGD6;RP2;AIF1;MTSS1;CNGB1;ABLIM2;BBS9;PLK4;ATP6V0D1;P2RY12;TNIK;DISC1;RAP2B;SNAP29;ACTR2;RAB11A;VCL;ACTR3;NRP1;PARVB;CYFIP1;HDAC6;PTPRO;WDR11;EXOC8;EXOC7;EXOC1;SDCBP;DYNC2I1;PCM1;IFT80;EXOC2;EXOC5;TXNDC15;RPGR;FNBP1L;ARF6;EXOC3;RAP1A;CEP162;FXYD5;WDR90;AHI1;ARFIP2;WDPCP;NUDCD3;SNX10;ITGB1;GOLPH3;MINK1;RHOD;CLUAP1;CCDC66;AIF1L;MAP4K4;TMEM67;KIF3A;INPP5K
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.3583988506542855,-0.899797052182595,0.584375,0.9193226795748002,1.0,4/11,18.32%,REST;PINK1;ATF4;PARK7
prerank,regulation of organelle organization (GO:0033043),0.3563112957075543,0.8997105481821299,0.6611570247933884,0.9156510748169652,1.0,24/80,21.38%,MYO5A;ZEB2;ARMH3;RBSN;CLN3;USP6NL;VPS11;F11R;DIAPH1;PARL;STX5;SAR1A;RAB33B;CAPN2;CAMSAP2;AKAP9;TAOK1;GOLPH3;FIS1;DNM1L;ATP13A2;PDE4DIP;PRKN;SCARB2
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3559104963605849,0.8996165087859521,0.6559251559251559,0.9154167494715517,1.0,19/69,20.04%,POU2F2;NABP1;ELL2;INTS8;CDK7;RPAP2;POLR2L;TAF8;SNAPC3;ELL;INTS6;INTS13;SNAPC4;GTF2B;ICE2;INTS1;TAF11;POLR2E;POU2F1
prerank,response to ionizing radiation (GO:0010212),0.36300286264753906,0.899359741308138,0.6823027718550106,0.9155018362322814,1.0,18/70,22.16%,GRB2;MAPK14;NABP1;TANK;BRAT1;ANXA1;TP53;BABAM2;INO80;IKBIP;BABAM1;SWI5;SMPD1;SPIDR;CLK2;BRSK1;RAD1;RFWD3
prerank,response to glucose (GO:0009749),0.3771665146651201,0.8993057502255244,0.6266233766233766,0.9151843168165483,1.0,10/46,16.55%,LPL;PFKL;ERN1;EIF2B2;THBS1;TRA2B;ADCY8;GAS6;SOX4;GCK
prerank,heterochromatin assembly (GO:0031507),-0.29051294994840715,-0.8988095783511354,0.547945205479452,0.9193214018616654,1.0,2/20,4.81%,SMCHD1;EZH1
prerank,cellular copper ion homeostasis (GO:0006878),0.44123354999358344,0.898459759504902,0.6027027027027027,0.9163119183885672,1.0,2/14,4.55%,ATP7A;ATOX1
prerank,potassium ion export across plasma membrane (GO:0097623),-0.33945687853742296,-0.8984058860826457,0.6167883211678832,0.9178301315825709,1.0,3/13,6.61%,KCNK5;KCND3;KCNT2
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.35311855197467773,0.8981836413462845,0.678125,0.9164150177789985,1.0,19/85,17.93%,ARRB2;FZD3;PSMB10;AP2S1;DAAM1;CLTC;PSMA2;PFN1;PSME3;PSMB5;PSMD8;PSMD7;AP2M1;PSMB9;VANGL1;SMURF1;CDC42;RHOA;PSMD2
prerank,regulation of centrosome duplication (GO:0010824),-0.2623125893307091,-0.8981359637461872,0.6492537313432836,0.91602017563386,1.0,15/29,31.93%,CEP295;SPICE1;NAT10;CHMP5;CENATAC;CHMP4B;ALMS1;CEP120;CHMP2A;NPM1;STIL;CHMP4C;CCNF;CEP295NL;CHMP1B
prerank,regulation of cell aging (GO:0090342),0.4619091169274514,0.898134331143193,0.6184971098265896,0.9160873276500159,1.0,1/11,3.32%,NEK6
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.4509248239803211,0.8979703938240493,0.6008344923504868,0.9159728699860832,1.0,2/11,6.02%,RENBP;NAGK
prerank,circulatory system development (GO:0072359),0.35323954239057404,0.897959245177948,0.7063572149344097,0.9155855251051925,1.0,22/118,14.82%,SHH;TGFB1;SH3PXD2B;TGFBR1;EEF1AKMT4-ECE2;PKP2;PKD2;ADAP2;TGFBR2;MEF2A;LDB3;MEF2C;ZDHHC16;SMYD4;SOX9;WDR11;HDAC9;TAB2;CASP8;SOX4;PDLIM1;POU6F1
prerank,cell-cell junction maintenance (GO:0045217),0.45156204706784897,0.897596335330348,0.6141843971631206,0.9158497117511113,1.0,1/11,2.06%,CSF1R
prerank,snRNA transcription (GO:0009301),0.3550602664997896,0.8975404700299403,0.6555671175858481,0.9155311892329613,1.0,19/70,20.04%,POU2F2;NABP1;ELL2;INTS8;CDK7;RPAP2;POLR2L;TAF8;SNAPC3;ELL;INTS6;INTS13;SNAPC4;GTF2B;ICE2;INTS1;TAF11;POLR2E;POU2F1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.32303967765808606,-0.8969434440433556,0.5965665236051502,0.9164060511866715,1.0,3/16,8.93%,RBFOX2;AR;TADA3
prerank,Rac protein signal transduction (GO:0016601),0.4134472711631483,0.8967053419222389,0.6066411238825032,0.9166333567505162,1.0,3/18,11.25%,ELMO1;AIF1;CYFIP1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.4397889257287886,0.8959299415445183,0.6312247644683715,0.917651857218111,1.0,2/14,9.60%,MAPK14;ANGEL2
prerank,regulation of fibrinolysis (GO:0051917),0.4499934638898901,0.8958161372308348,0.6135135135135135,0.9174548296774219,1.0,2/13,11.47%,USF1;THBS1
prerank,spliceosomal complex assembly (GO:0000245),0.37027224322263197,0.895567261033149,0.6415929203539823,0.9174965469221708,1.0,12/46,20.56%,SF3B1;SCAF11;GCFC2;SRPK3;SNRPD2;DDX39B;LUC7L3;DDX1;CRNKL1;SNRNP200;SRSF6;SRSF10
prerank,regulation of cellular metabolic process (GO:0031323),0.37309199722426367,0.8953934389498968,0.6531284302963776,0.9173984715905936,1.0,14/45,21.05%,NPC2;ABCG1;TBC1D16;PARL;COQ7;STUB1;PID1;FASN;ACACA;LAMTOR1;FLOT1;MPV17;ABCA2;PRKN
prerank,regulation of exocytosis (GO:0017157),0.37248407324058375,0.8944232246186851,0.6390134529147982,0.9187909947827904,1.0,6/46,11.17%,RAB8B;UNC13D;SNCA;ANXA1;SYTL4;ATP6AP1
prerank,negative regulation of DNA replication (GO:0008156),-0.33504154067971637,-0.8935132116258013,0.6074074074074074,0.9223410589584128,1.0,5/13,18.57%,RAD17;WAPL;TSPYL2;CDAN1;S100A11
prerank,gliogenesis (GO:0042063),0.4301570576309172,0.8934912268772932,0.6075778078484438,0.9200656770023922,1.0,4/15,12.33%,CD9;ANXA1;METTL3;CDK6
prerank,aorta morphogenesis (GO:0035909),-0.30459173125452266,-0.8929514375404878,0.605,0.9211605462695673,1.0,5/17,13.87%,BMPR1A;ACVRL1;TBX1;ADAMTS9;JAG1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.423370398334884,0.8928354596843869,0.6104060913705583,0.9208661608228191,1.0,2/17,8.59%,IK;RB1
prerank,regulation of mRNA processing (GO:0050684),0.38304438627706366,0.8927648301451104,0.6400911161731208,0.9205779799021924,1.0,15/32,25.95%,DHX9;RBM39;CDK11B;SRPK3;SON;SAFB2;PABPN1;ZFP36L1;SRSF3;SRSF10;IWS1;HNRNPK;NCBP1;JMJD6;CPSF4
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.3463686795043107,-0.8924822769267443,0.570446735395189,0.9198093939460424,1.0,7/12,25.77%,RAD17;TOPBP1;STK33;NAE1;CLSPN;SETMAR;ORC1
prerank,positive regulation of axonogenesis (GO:0050772),0.37204414018446297,0.8920805439261121,0.6372549019607843,0.9213802755745867,1.0,5/43,6.28%,PLXNC1;SLITRK1;SEMA4D;PLXNB2;MACF1
prerank,CENP-A containing chromatin organization (GO:0061641),0.390119776042125,0.8918351117702252,0.6184834123222749,0.9209761892095268,1.0,11/29,23.59%,CENPO;RBBP7;CENPI;CENPQ;CENPK;RSF1;RBBP4;ITGB3BP;SMARCA5;KNL1;CENPT
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.390119776042125,0.8918351117702252,0.6184834123222749,0.9209761892095268,1.0,11/29,23.59%,CENPO;RBBP7;CENPI;CENPQ;CENPK;RSF1;RBBP4;ITGB3BP;SMARCA5;KNL1;CENPT
prerank,regulation of actin filament-based process (GO:0032970),0.35958544171765094,0.8917028387260639,0.6552440290758048,0.9208208357632273,1.0,16/70,19.59%,IQGAP2;CORO1A;FZD10;PRKCD;MTOR;F11R;TWF2;LRP1;ARHGAP18;IQGAP1;RHOA;TAOK1;CORO2B;RHOD;ROCK2;ARHGEF19
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.3431189235719729,0.8916231434878454,0.805,0.9205645588921795,1.0,64/306,19.03%,MCM5;FAM111A;ORC3;RPL23;RPL17;RPL10A;GCNT1;APOE;RPS2;RMI1;RRBP1;EXO1;BRIP1;FARSB;RPL18A;MRPL41;MEF2A;GTPBP1;RPS15A;GSPT1;EIF4EBP2;MMS19;MRPL51;RPL6;FUT9;MCM2;MCM6;DBF4;NAP1L1;RPLP2;INHBA;RPL26;RPS20;POLR2L;ORC4;RPS16;DNA2;MCM9;RPS14;KAT7;DARS1;CDC6;RPL19;POLD3;RPL9;IGF2BP3;LARGE1;RPS11;RPL11;RPS23;MRPS21;RPS4X;MRPS14;PABPC4;AGO2;RPS27;RPL4;RNASEH2A;MRPL3;GOLPH3;CREBL2;TOP1;FUBP3;POLR2E
prerank,synaptic vesicle exocytosis (GO:0016079),0.37393320601508834,0.8906301007878531,0.6423766816143498,0.9219587696558089,1.0,12/40,21.31%,SNCA;PIP5K1C;STX11;SYT2;SYT10;SNAP29;STX3;SNAP23;DNAJC5;STX2;UNC13A;RIMS1
prerank,mitochondrion transport along microtubule (GO:0047497),0.4397045169861742,0.890502618682608,0.6135135135135135,0.9217857441414524,1.0,1/13,1.15%,UXT
prerank,cellular amide metabolic process (GO:0043603),0.34673311334457924,0.8904425560256061,0.688708036622584,0.9214747871408315,1.0,21/102,17.70%,DBI;SGPL1;MTHFS;CLN8;SMPD3;CERK;ST3GAL1;ACSF2;ABHD4;NLN;MCCC2;DNPEP;ORMDL2;PPP2CA;NSMAF;PDZD11;ACOT9;PLAAT3;FPGS;PCCA;ACOT2
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.4376292854853273,0.8904350420918271,0.6126373626373627,0.9210792761022542,1.0,8/14,25.06%,PIK3CD;VEGFB;NRP1;MYO1C;VEGFD;PIK3CA;VEGFA;KDR
prerank,negative regulation of cartilage development (GO:0061037),0.43958750707486105,0.8903553058878134,0.6002747252747253,0.9208156650002406,1.0,3/13,18.48%,TGFBR1;SOX9;GREM1
prerank,regulation of protein polymerization (GO:0032271),0.3839633666347366,0.8902262759874533,0.6185567010309279,0.9206425439532543,1.0,9/35,18.52%,HCLS1;PFN2;PFN1;COTL1;ARHGAP18;CAMSAP2;RASA1;HSP90AA1;GBA2
prerank,protein palmitoylation (GO:0018345),0.39172589787061324,0.8900099162303818,0.6320093457943925,0.9206280244706861,1.0,8/30,15.63%,ZDHHC14;ZDHHC7;ZDHHC13;ZDHHC16;ZDHHC3;ZDHHC1;ZDHHC24;SELENOK
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.45270363904986327,0.8898532469449765,0.6120300751879699,0.9205068659264587,1.0,3/10,17.66%,RAP2A;CDC42;RHOA
prerank,negative regulation of cell death (GO:0060548),0.3530673654009761,0.8896875544516915,0.680327868852459,0.9203903909040962,1.0,25/88,22.13%,GPNMB;CD200R1;NUP62;SNCA;TRAF2;PPARGC1A;IMPACT;BECN1;PARP16;TNFRSF1B;FYN;SORL1;IKBKG;LRRK2;WFS1;SOX4;NPAS2;TIGAR;SRSF6;NENF;ATP13A2;GSK3B;PRKN;FGF2;MT3
prerank,oligosaccharide metabolic process (GO:0009311),0.3696346144614323,0.8896875041632972,0.6390403489640131,0.9199795023367284,1.0,7/46,10.43%,ST8SIA4;B4GALT1;ST6GALNAC4;MAN2B1;MAN2B2;FUT9;ST8SIA1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.37041009223655746,-0.8896477078559111,0.6166134185303515,0.9241204078808885,1.0,3/10,25.45%,FBXW7;HBEGF;EGF
prerank,aspartate family amino acid catabolic process (GO:0009068),0.4150100737919139,0.8890858418332424,0.6222222222222222,0.9206409299225407,1.0,3/19,12.73%,CRYM;OGDH;ALDH7A1
prerank,oxoacid metabolic process (GO:0043436),0.38649229967408694,0.8889888006929986,0.6284023668639053,0.9204011832566245,1.0,4/27,11.72%,SULT4A1;BPNT1;PPA2;TPST1
prerank,regulation of cardiac conduction (GO:1903779),0.3677832279606387,0.8888194673978728,0.6483870967741936,0.9203014047571697,1.0,10/54,13.68%,KCNJ11;SLC8A1;ASPH;ATP2B1;ITPR2;NPR2;ATP2B3;ATP1B3;ATP2A3;ATP1B2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.40068580021496675,0.888392092758051,0.6289537712895377,0.9206723771791373,1.0,4/24,9.94%,TSPO;ATP5IF1;SLC25A38;NFE2L1
prerank,adherens junction organization (GO:0034332),-0.23825378877545986,-0.8882620382590652,0.6557377049180327,0.9249677155384002,1.0,18/48,21.30%,TJP1;CDH5;AFDN;CTNND1;CDH10;CDH1;JUP;CDH4;CDH11;CADM3;JAM3;NECTIN2;PVR;FERMT2;CDH2;CDH22;SMAD7;CDH13
prerank,negative regulation of cellular component movement (GO:0051271),0.42682765356208563,0.887896244153848,0.6153846153846154,0.921122416502106,1.0,3/15,10.23%,CD9;SPINT2;ACTN1
prerank,heart trabecula morphogenesis (GO:0061384),-0.2952657294223278,-0.8875676404007713,0.6120689655172413,0.9241134606868472,1.0,8/18,19.27%,BMPR1A;ADGRG6;TGFBR3;BMP5;FKBP1A;S1PR1;TEK;RBP4
prerank,purine-containing compound salvage (GO:0043101),-0.33442671724192696,-0.8870807935411954,0.5938566552901023,0.9228155026797862,1.0,5/12,18.27%,ADK;DGUOK;AMPD3;GMPR;AMPD2
prerank,glutathione metabolic process (GO:0006749),0.37171018453596705,0.8869302646413801,0.6449438202247191,0.9223944099898062,1.0,2/38,3.22%,GSTT4;HPGDS
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.3722145932809999,0.8868840438046643,0.6485587583148559,0.9220682512113484,1.0,11/41,25.11%,ALOX12;DAGLB;ABCD1;DEGS1;FADS1;GSTM2;GPX4;ACOT8;SCD;FADS2;PTGS1
prerank,negative regulation of cell projection organization (GO:0031345),0.3665028130433937,0.8860777061172505,0.6605405405405406,0.9231017293890901,1.0,14/48,19.48%,MYLIP;RTN4RL1;APOE;ADCY6;CBFA2T2;PTPRO;FYN;GAK;YWHAH;PTEN;EPHA4;DENND5A;PAQR3;RAB29
prerank,positive regulation of viral transcription (GO:0050434),0.3879876832433159,0.8859923066980816,0.6393244873341375,0.9228493363864034,1.0,5/25,19.03%,DHX9;MDFIC;POLR2L;RSF1;POLR2E
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.20183572797283772,-0.8856180076037271,0.8,0.9239249732687277,1.0,30/88,23.88%,FBXL7;PSME4;PSMD11;PSMA5;PSMA4;RBX1;PSMD14;FBXL2;PSMC6;SKP2;PSMC3;FBXW7;PSMB3;PSMC1;CUL2;PSMD5;PSMA3;PSMD3;PSMD6;PSMC5;PSME2;FBXO31;FBXO17;PSMB4;PSMC4;FBXO38;SKP1;PSMB6;CUL1;FBXL14
prerank,response to insulin (GO:0032868),0.35829072806452045,0.8854851534226835,0.6967213114754098,0.9232846598857053,1.0,21/80,20.95%,PCSK9;RAB8B;LPIN2;MYO5A;HDAC5;USF1;RAB31;EPRS1;DENND4C;HDAC9;GSK3A;SYAP1;ZBTB7B;CPEB2;GCK;PDPK1;SORT1;ZFP36L1;INPP5K;PKM;LPIN1
prerank,motile cilium assembly (GO:0044458),-0.33007288730088136,-0.8852209530705196,0.6094276094276094,0.922395171480445,1.0,4/12,17.50%,BBOF1;BBS5;CCDC39;E2F4
prerank,DNA alkylation (GO:0006305),0.4043348669387893,0.884702666034541,0.6144278606965174,0.9238243529111172,1.0,3/19,9.63%,DNMT3A;ATRX;ATF7IP
prerank,DNA methylation or demethylation (GO:0044728),0.4043348669387893,0.884702666034541,0.6144278606965174,0.9238243529111172,1.0,3/19,9.63%,DNMT3A;ATRX;ATF7IP
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.364565305158956,0.8846419509239574,0.6630785791173305,0.9235157061368964,1.0,16/59,20.37%,TGFBR1;PRKCD;PRKD2;TAF1;TGFBR2;WNK1;CSNK2A1;CSNK2A2;NLK;MAP3K12;LRRK2;GSK3A;PDPK1;ROCK2;GSK3B;CDK5R1
prerank,regulation of actomyosin structure organization (GO:0110020),0.43693773653238427,0.8845882230476527,0.6167341430499326,0.9232127870466105,1.0,5/13,19.50%,FHOD1;SLC9A1;ACTG1;CDC42;ROCK2
prerank,negative regulation of cellular senescence (GO:2000773),-0.3305583389341691,-0.8841008662868046,0.6276595744680851,0.9226614710431644,1.0,6/13,24.46%,ZKSCAN3;YBX1;MAP3K3;HMGA2;TERT;TWIST1
prerank,ncRNA transcription (GO:0098781),0.433303881443623,0.884034462612636,0.6159217877094972,0.9237878119522231,1.0,3/13,12.31%,GTF3A;RPAP2;SNAPC3
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.4318269077869924,0.8838827133238272,0.6267217630853994,0.9236525970255546,1.0,2/13,4.97%,LGMN;AKAP5
prerank,cellular response to growth factor stimulus (GO:0071363),0.34264706306935705,0.8838060671956763,0.7244488977955912,0.9233708984372058,1.0,27/151,13.72%,TGFB1;LGMN;TGFBR1;DUSP3;DSTYK;MAPK14;ERN1;PRKD2;CD44;ANXA1;CTNNB1;MAP2K3;TGFBR2;MEF2C;SMAD3;ACAP2;BCAR1;STAT5B;NRP1;LIMS1;RAPGEF1;SOX9;CCL2;VSTM2A;TWF2;NR4A1;SOX6
prerank,regulation of neuron projection development (GO:0010975),0.3439808578094433,0.8833545911892069,0.7464929859719439,0.923765885842102,1.0,42/163,22.13%,PTK2B;LYN;MYLIP;CAMK1D;ARSB;MDK;RTN4RL1;APOE;ITGA6;PLXNB2;ADCY6;CBFA2T2;DISC1;FUT9;RAPGEF1;PTPRO;TWF2;CSMD3;NPTN;LZTS3;ATP1B2;LRRK2;TANC2;GAK;RAP1A;GSK3A;CAMSAP2;PTEN;EPHA4;DENND5A;PAQR3;KIDINS220;RAB29;RELN;GSK3B;CDK5R1;MARK1;BRSK1;SCARB2;CX3CL1;CFL1;MT3
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.42393633857564705,0.8827943446450952,0.6240105540897097,0.9243673099246172,1.0,3/16,8.29%,BCL2L1;SNAI1;TPT1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.41581884343185466,0.8826573557417781,0.618229854689564,0.9242062410413293,1.0,8/17,25.20%,FZD9;BCL2L1;BAK1;TIMM50;FIS1;DNM1L;BID;MFF
prerank,regulation of cation channel activity (GO:2001257),0.3531945959714774,0.8821836824868007,0.6965944272445821,0.9246397526673567,1.0,7/89,8.17%,CTSS;PTK2B;FGF13;STAC;EPO;CACNB4;MEF2C
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.41241025114685403,0.8821542624335083,0.6103404791929382,0.924277175279505,1.0,4/18,14.50%,TNF;ATP7A;NOD2;POR
prerank,positive regulation of ion transport (GO:0043270),0.36255882254789606,0.8818925459362229,0.6548004314994607,0.9243150851061689,1.0,12/48,19.55%,SCN4B;P2RX7;PKP2;P2RX4;PRSS8;ATP2B1;CACNB2;WFS1;CACNA1D;SCN5A;CNKSR3;GDNF
prerank,positive regulation of ruffle assembly (GO:1900029),0.43216934942938506,0.8817002381659583,0.6338418862690708,0.9242303400678116,1.0,3/13,11.33%,PLEKHM1;P2RY12;PFN1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.34626270043738927,0.8816702041178283,0.753259779338014,0.9238733987249785,1.0,24/159,16.50%,CD84;ITGAL;ITGB2;PCDHB6;CRTAM;SLITRK1;PLXNB2;EMB;TGFBR2;TRO;ATP2C1;ITGAM;CDH8;CDH9;CDH12;NPTN;CDH23;PTPRT;CADM1;KIRREL3;MPZ;DCHS1;CDH19;PCDHGB4
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.38567787424367306,0.8816125445717493,0.64075382803298,0.9235683093195123,1.0,5/29,11.47%,TNF;TRAF2;PYCARD;INHBA;THBS1
prerank,regulation of pseudopodium assembly (GO:0031272),-0.3669171104164699,-0.8814497254660065,0.610223642172524,0.9243372796113638,1.0,4/10,23.11%,CDC42EP5;CDC42EP4;APC;WASHC1
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.3669171104164699,-0.8814497254660065,0.610223642172524,0.9243372796113638,1.0,4/10,23.11%,CDC42EP5;CDC42EP4;APC;WASHC1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.4067054677615211,0.8814041963678654,0.6294416243654822,0.9235237711574382,1.0,8/19,23.05%,MTOR;CEBPA;ELL;PRDX5;ICE2;RPTOR;ZC3H8;TENM1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.43952792787594164,0.8813101612791557,0.6396276595744681,0.9232773715872091,1.0,6/13,19.67%,EDEM1;SVIP;UBE2G2;ERLEC1;OS9;EDEM2
prerank,epidermis development (GO:0008544),-0.2229455937344227,-0.8811997005969224,0.6875,0.9225098524347924,1.0,19/56,31.97%,PLOD1;EMP1;YBX1;HDAC2;ALDH3A2;GLI1;FLOT2;UGCG;PTHLH;GATA6;FGF7;LAMC2;FGFR2;SCEL;ATP2A2;KRTDAP;CCN2;EDAR;DSP
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.3846732420891843,0.8803267340493843,0.6436781609195402,0.9246425224521693,1.0,9/33,19.36%,PLCG2;TAF1;KIF14;PSME3;INO80;PTEN;APPL2;STXBP4;PTPN6
prerank,regulation of protein autophosphorylation (GO:0031952),0.3765700484056432,0.8801445459056497,0.6636466591166478,0.9245569546011295,1.0,2/36,3.34%,GPNMB;RAP2A
prerank,purine ribonucleotide catabolic process (GO:0009154),0.3990584754418329,0.8801146201560658,0.6322981366459627,0.9242116384655202,1.0,4/21,8.32%,XDH;NUDT4;HINT1;PNP
prerank,axonemal dynein complex assembly (GO:0070286),0.38505087336542343,0.8799271307392167,0.6572104018912529,0.9241150634836575,1.0,4/27,13.15%,DNAI4;ODAD2;ODAD1;CCDC63
prerank,protein secretion (GO:0009306),0.3591170920809139,0.879350834991992,0.6637837837837838,0.924695052872187,1.0,11/56,18.49%,RAB8B;ABCA1;SEL1L;ANXA1;PPY;SNX19;LTBP2;STEAP3;SVBP;MON1A;GOLPH3
prerank,protein modification by small protein conjugation (GO:0032446),0.3402923445037638,0.8793349850667015,0.848,0.9243167954860136,1.0,106/361,24.66%,ARRB2;NFE2L2;CBL;MYLIP;BCL11A;UBE2V2;NUP62;TRIM5;ATG7;MKRN1;CDC23;UBE2D3;OTULIN;MSL2;VPS18;MGRN1;RNF7;HLTF;RNF111;KLHL21;UVSSA;UBE2S;KLHL7;LEO1;SEH1L;VPS11;TRIM27;PEX13;UBE2E3;DERL1;NFX1;UBE2H;TPR;NEDD4L;USP7;ARRDC4;TRIM24;RNF40;TRIM35;CDC34;NUP205;FBXO32;DET1;ITCH;RNF135;FBXL3;STUB1;UBE2G2;USP9X;DTX4;UBA2;HUWE1;AREL1;UBE2J2;PIAS1;RNF152;GAN;SMURF1;ATG3;HIF1A;TRIM62;ANAPC11;UBE2N;ZNRF3;VHL;UBE2Z;UBE2K;KEAP1;DCUN1D5;SPSB2;ELOB;OS9;FBXW11;WWP1;LZTR1;CUL3;UBE2R2;NUP54;PRKN;HERC2;NSMCE2;CDC16;RRAGA;UBE2E1;SPSB1;RFWD3;TNFAIP1;ELOC;ATG10;EIPR1;UBA7;RNF181;FBXO4;MYCBP2;RACK1;UBE2I;CTR9;NUP85;UBA5;AMFR;NUP155;MIB1;KCTD13;CAND1;ARRB1;UBE2F
prerank,organelle assembly (GO:0070925),0.3411003261253426,0.8792314781666658,0.848,0.9240784604093615,1.0,86/384,19.98%,BIN2;MKS1;RAB8B;SH3PXD2B;CORO1A;RAB32;NUP62;HAUS2;NEK6;VTA1;ATG7;ASAP1;MAP1LC3B;EXOC6;IFT52;RAB7A;CDS2;FLII;CIRBP;RP2;MAPRE1;CNGB1;VMP1;YTHDF3;BBS9;PLK4;ATP6V0D1;STARD9;DISC1;RC3H1;SNAP29;HAUS1;ACTR2;RAB11A;TUBGCP4;EMC6;TUBGCP6;RAB1B;ACTR3;VPS37C;BECN1;HDAC6;WDR11;DYNC1H1;EXOC8;EXOC7;EXOC1;DYNC2I1;PCM1;IFT80;EXOC2;EXOC5;TRAPPC6A;TXNDC15;RPGR;FNBP1L;INO80;SYNPO;EXOC3;HAUS8;CEP162;CAPN3;ATXN2L;WDR90;ABCA3;AHI1;PDCD6IP;ATG2B;ATG3;IRGM;WDPCP;RPS23;VPS28;NUDCD3;MIS12;SNX10;UBXN2A;MAPRE2;CEP63;ATG14;PACS2;CLUAP1;TMEM41B;CCDC66;TMEM67;KIF3A
prerank,regulation of RNA splicing (GO:0043484),0.35272762344943187,0.8792207721860595,0.6898002103049422,0.9236913543947453,1.0,13/69,13.18%,RBM38;ERN1;ZNF326;RBM39;GRSF1;METTL4;HNRNPL;SON;PTBP2;TRA2B;PRX;BRDT;FAM50A
prerank,regulation of establishment of planar polarity (GO:0090175),0.34648856448299403,0.8786415162575579,0.6993736951983298,0.9243074023147403,1.0,20/88,18.41%,ARRB2;FZD3;PSMB10;AP2S1;DAAM1;CLTC;PSMA2;PFN1;PSME3;PSMB5;PSMD8;PSMD7;AP2M1;PSMB9;VANGL1;SMURF1;CDC42;RHOA;PSMD2;DACT1
prerank,positive regulation of viral process (GO:0048524),0.3536584861637307,0.8785052609892474,0.696068012752391,0.9241372894210327,1.0,13/60,19.03%,DHX9;PPIE;RAB7A;MDFIC;LARP1;ADAR;VAPB;POLR2L;ADARB1;TARBP2;RSF1;PPIH;POLR2E
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.3979442351032921,0.8778441776968411,0.6630824372759857,0.9248798093330987,1.0,1/26,0.33%,PTK2B
prerank,cellular modified amino acid catabolic process (GO:0042219),0.42320189795364277,0.8777291363655232,0.6337837837837837,0.9246691574145942,1.0,1/15,2.38%,ABHD12
prerank,cellular response to cadmium ion (GO:0071276),-0.2776200089260265,-0.8773588955285859,0.6395939086294417,0.9287666602228716,1.0,4/24,9.25%,MAPK8;EGFR;MAPK9;CHUK
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.3524808685317619,-0.8772738114430078,0.6159420289855072,0.9265600235234243,1.0,3/11,10.13%,ATP1B1;KCND3;KCNJ3
prerank,cellular response to unfolded protein (GO:0034620),0.3851390233430271,0.8770026691224684,0.6462093862815884,0.9255257640230153,1.0,4/26,9.25%,PTPN1;ERN1;BAK1;HSF1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.3758976448439455,0.8769328345574755,0.6360619469026548,0.9252369036082599,1.0,4/37,8.17%,P2RY6;ERN1;LDLRAP1;MEF2C
prerank,regulation of cellular response to heat (GO:1900034),0.35081384883295674,0.8765978753779602,0.7006237006237006,0.9253907259941393,1.0,21/77,21.41%,BAG2;MTOR;PTGES3;NUP62;DNAJC7;HSBP1;SEH1L;HSF1;TPR;NUP205;CHORDC1;BAG1;IER5;HSP90AA1;DNAJB6;RPTOR;SEC13;GSK3B;BAG4;NUP54;CRYAB
prerank,lamellipodium assembly (GO:0030032),0.388356018574095,0.8765797493658346,0.6396614268440145,0.9250183052932145,1.0,13/26,24.60%,ABLIM2;P2RY12;VCL;PARVB;CYFIP1;PTPRO;ARFIP2;ITGB1;GOLPH3;RHOD;SPATA13;ARHGEF7;SRGAP2
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.39467565080700007,0.8755142541031157,0.6431137724550898,0.9264556259080274,1.0,3/26,4.87%,NLRC3;TNFAIP3;TRAFD1
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.3148844713660098,-0.8754949125302591,0.6627450980392157,0.9284485234535618,1.0,4/15,6.99%,RAPGEF3;TCF7L2;ANP32B;BAG3
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.42038807634262426,0.875472137109515,0.6130790190735694,0.9261301180983297,1.0,1/13,1.24%,NRROS
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3617022679556011,0.8749672992360081,0.6779475982532751,0.9265775688627403,1.0,14/49,19.58%,HERPUD1;DDIT3;PYCARD;BCL2L1;TP53;P4HB;BECN1;NOC2L;BMF;SRC;SGMS1;PTPMT1;FIS1;DNM1L
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.3547004498584957,-0.8749395940914598,0.6215277777777778,0.9272706947140171,1.0,2/11,0.43%,TJP1;AFDN
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.35936227414955946,-0.874710106050055,0.6226993865030674,0.9254388411655041,1.0,3/10,12.21%,NEXMIF;ACER2;JAM3
prerank,necroptotic process (GO:0070266),0.41107799157854613,0.8740717714987216,0.632,0.9276769727624626,1.0,3/16,8.58%,CD14;TICAM1;LY96
prerank,amino sugar biosynthetic process (GO:0046349),0.4379651158803861,0.8740405943544127,0.6356050069541029,0.9273276386129778,1.0,2/12,6.02%,RENBP;NAGK
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.3813225424040523,0.8738919238294631,0.6643518518518519,0.927179017925133,1.0,3/31,4.61%,NT5C3B;EXOSC1;CNOT8
prerank,mRNA splice site selection (GO:0006376),-0.25160428375850225,-0.8735533250355044,0.7,0.925752243796427,1.0,16/30,34.32%,YTHDC1;PSIP1;SF3A1;SRSF1;SNRPC;PUF60;SRSF12;CELF4;CELF6;LUC7L;SF3A2;CELF5;SF3A3;LUC7L2;CELF2;SRSF9
prerank,glycerol metabolic process (GO:0006071),0.4470783566581467,0.8735066696260259,0.6401799100449775,0.9274579974508607,1.0,3/10,19.87%,ANGPTL3;GK;COQ3
prerank,response to prostaglandin E (GO:0034695),0.4475957796959142,0.8734301714617724,0.6236722306525038,0.9271860914417241,1.0,2/10,14.33%,ADCY6;GNG2
prerank,mitotic metaphase plate congression (GO:0007080),0.35969209946062813,0.8731962105894159,0.6509635974304069,0.9271722001342074,1.0,10/51,17.63%,NUP62;CDC23;SEH1L;KIF14;RAB11A;BECN1;RRS1;PDCD6IP;EML4;MIS12
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.34561804297326926,0.8727410909500829,0.7360970677451971,0.9275718355770965,1.0,30/107,22.40%,SLC11A1;CCR2;SLC8A1;CCL8;ATP2C1;TPT1;ATP2B1;CCL14;VAPB;ATP13A1;SLC8B1;CCL13;CHERP;ATP2B3;NPTN;ATP2A3;TMEM165;ATP13A5;ATP13A2;SLC39A6;SLC10A7;MT3;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,smoothened signaling pathway (GO:0007224),0.3758638585148741,0.87243738157014,0.6482122260668973,0.9276850024643288,1.0,2/32,7.46%,SHH;PTCHD1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.39386464412915945,0.8722386206815219,0.6217948717948718,0.9275959552675822,1.0,10/20,20.18%,CFLAR;SDCBP;CASP8;STUB1;PDCD6IP;HSP90AA1;ASAH1;FLOT1;BIRC2;BIRC3
prerank,embryonic heart tube morphogenesis (GO:0003143),0.36471432263142795,0.8721819568640031,0.6710526315789473,0.9272947006211658,1.0,4/43,8.17%,SHH;PKD2;TGFBR2;MEF2C
prerank,phospholipid biosynthetic process (GO:0008654),-0.24255452398967908,-0.8714407323763449,0.6956521739130435,0.9282959538809641,1.0,12/36,16.43%,FAR1;SAMD8;AGPAT4;AGPAT3;SGMS2;AGPAT5;NUS1;CPNE3;HDHD5;MBOAT1;SRD5A3;CRLS1
prerank,cellular response to acid chemical (GO:0071229),0.383432226352231,0.8710841571829763,0.653755868544601,0.9287977910885684,1.0,12/27,25.09%,MTOR;CPEB3;GLRA2;LAMTOR3;CAPN2;CPEB4;LAMTOR1;RPTOR;RRAGA;RRAGB;VEGFA;XBP1
prerank,regulation of potassium ion transport (GO:0043266),0.3796952794794364,0.871019648693332,0.6405152224824356,0.928490483096608,1.0,2/31,4.29%,PTK2B;KCNIP2
prerank,tRNA methylation (GO:0030488),-0.2502142273712391,-0.8709445738342674,0.6838235294117647,0.9271688311838656,1.0,17/34,32.65%,NSUN6;METTL6;THADA;THUMPD3;NSUN2;TARBP1;DALRD3;MTO1;TRMT5;LCMT2;WDR6;TRMT44;TRMT13;TRMT10C;TYW3;TRMT12;TRMT112
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3360401806490592,0.870396565041038,0.7805611222444889,0.9291682109976925,1.0,32/166,19.03%,MED17;GTF2H1;TAF1A;NR1H4;MAML3;POLR1E;RXRB;HDAC5;TAF1;TEAD1;TBL1XR1;PPARGC1A;CDK7;TBL1X;MED27;POLR1B;POLR2L;TAF8;NR2C2;HDAC9;NR4A1;NR2C1;TAF3;RBPJ;GTF2B;RSF1;PPARD;GTF2H5;RXRA;CRCP;TAF11;POLR2E
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.4495862072127575,0.8702765357615561,0.6428571428571429,0.928982994364854,1.0,3/10,10.08%,LEO1;HSF1;CPEB3
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.4524697715259465,0.870196706387092,0.6491994177583698,0.928714277111668,1.0,5/10,20.24%,PRKCB;PID1;GSK3A;APPL2;INPP5K
prerank,regulation of protein targeting to membrane (GO:0090313),0.38131127620953037,0.869805627535292,0.6524317912218268,0.928965337086364,1.0,8/28,22.04%,ITGB2;ITGAM;FYN;CEMIP;MYO1C;FIS1;INPP5K;CHP1
prerank,regulation of response to oxidative stress (GO:1902882),0.4382684756475667,0.8697437080609655,0.6124137931034482,0.9286741850419936,1.0,2/11,7.38%,MCTP1;ABCD1
prerank,gene expression (GO:0010467),0.3332534261934075,0.8695299665870193,0.856,0.9286339435781034,1.0,126/348,26.63%,APOBEC1;RPL23;RPL17;NUP62;RPL10A;RBM39;RPS2;DHX38;RRBP1;NXF1;THOC2;FARSB;RPL18A;MRPL41;MEF2A;TSPAN32;RPS15A;GSPT1;TFIP11;SEH1L;CASC3;EIF4EBP2;TSPAN14;RBM15B;MMS19;ADAR;MRPL51;SMG1;RPL6;HNRNPL;TPR;RPLP2;DDX39B;RPL26;RNASEL;RPS20;POLR2L;RPS16;NUP205;RPS14;SORL1;ADARB1;STUB1;DARS1;POLDIP3;THOC3;RPL19;GALNT2;UPF3B;ALKBH5;HNRNPD;RPL9;IGF2BP3;NUFIP1;SMG7;RPS11;RPL11;RPS23;MRPS21;RPS4X;UPF2;MRPS14;PABPC4;AGO2;RPS27;RPL4;FYTTD1;SLU7;MRPL3;GOLPH3;CREBL2;TESC;RBMS2;FUBP3;POLR2E;SRSF2;SRSF6;HNRNPF;SEC13;PABPN1;SLBP;RPL7A;MRPL10;HHEX;RPL15;SRSF3;RPL29;RPL22;NUP54;RPS7;RPS13;SARS1;POLR3A;ATXN1;RPLP1;TASP1;RPS15;NUP85;MRPL52;MRPL18;RPS5;NUP155;PAX8;DDX20;RPL41;XRN2;PWP1;HNRNPK;DROSHA;RPL10;MRPL37;NCBP1;XAB2;MRPS12;ABCF1;RPS8;RPL18;EEF1A1;CPSF4;RPL5;MCM3AP;ANGPT2;RPL28;NOVA1;PTMA;MRPS15
prerank,clathrin coat assembly (GO:0048268),0.4137272902057048,0.8694781176315185,0.6282225237449118,0.9283338587982713,1.0,5/15,19.97%,AP2S1;CLTC;EPS15;PICALM;FCHO2
prerank,protein glycosylation (GO:0006486),0.3430564049765011,0.8694604533882252,0.7525252525252525,0.92796565143877,1.0,35/125,20.46%,MGAT5;MAN1C1;GALNT10;TET3;ST8SIA4;NPC1;B4GALT1;GALNT7;OGA;GALNT6;AQP11;ST3GAL1;ALG2;POGLUT1;B3GALNT1;FUT9;ST8SIA1;POMK;DPAGT1;B4GALT7;STT3B;GALNT2;LARGE1;PMM1;MGAT5B;TMEM165;DDOST;ALG11;MGAT4B;GALNT1;TET2;STT3A;MGAT1;COG7;TUSC3
prerank,nucleic acid metabolic process (GO:0090304),-0.20918187608704092,-0.8693856807810251,0.8723404255319149,0.9284610757725201,1.0,26/69,27.42%,RBFOX2;NT5E;TOPBP1;HNRNPR;DUSP11;HNRNPA2B1;DDX24;METTL14;ATXN2;HNRNPA1;HNRNPU;WRN;EXD2;RBMX;HNRNPH2;RAN;POLG;POLR2C;DDX54;GTF2F1;NCBP2;PCBP2;SETMAR;POLR2J;PDE12;POLR2D
prerank,negative regulation of protein processing (GO:0010955),0.43234726896153075,0.8693255126499602,0.6262482168330956,0.9277695336089633,1.0,4/12,19.25%,CTSZ;THBS1;LRRK2;TMEM59
prerank,regulation of lipid biosynthetic process (GO:0046890),0.37697948284653776,0.8692612298913099,0.6720554272517321,0.9274857411520392,1.0,8/32,18.50%,MTOR;MLXIPL;APOE;ADIPOR1;CREB1;ASAH1;ADIPOR2;CREBL2
prerank,chromatin remodeling at centromere (GO:0031055),0.3794283849103544,0.8687515723262947,0.6579881656804734,0.9279223848577862,1.0,11/31,23.59%,CENPO;RBBP7;CENPI;CENPQ;CENPK;RSF1;RBBP4;ITGB3BP;SMARCA5;KNL1;CENPT
prerank,steroid hormone biosynthetic process (GO:0120178),0.383174164821068,0.8683490814811406,0.6473372781065089,0.928213699711511,1.0,8/29,26.54%,TSPO;HSD17B11;FDXR;FDX1;STARD3;HSD17B8;MED1;STARD3NL
prerank,acylglycerol biosynthetic process (GO:0046463),0.388766489441849,0.8681357430068417,0.6477132262051916,0.9282039089294876,1.0,7/23,20.95%,LPIN2;AGMO;GK;PNPLA3;DGAT2;MOGAT1;LPIN1
prerank,bicarbonate transport (GO:0015701),0.39514145316994803,0.8681185372452125,0.6622114216281896,0.9278278550577904,1.0,3/25,12.24%,AQP1;CYB5R1;CYB5RL
prerank,sodium ion export across plasma membrane (GO:0036376),0.4210313425474996,0.8678389325549999,0.628032345013477,0.9279001390644503,1.0,3/13,13.68%,SLC9A1;ATP1B3;ATP1B2
prerank,ganglioside biosynthetic process (GO:0001574),0.41774250263002677,0.8674554029354098,0.6335078534031413,0.9281546744200179,1.0,3/15,8.38%,ST8SIA4;ST6GALNAC4;ST3GAL1
prerank,regulation of astrocyte differentiation (GO:0048710),-0.32357108951321034,-0.8673984983089804,0.667953667953668,0.9306582253389775,1.0,2/12,10.82%,SERPINE2;HES1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.25549043656620596,-0.8670356698551227,0.6756756756756757,0.9291047942594011,1.0,19/31,33.57%,DNAJC19;TIMM17A;PEX5;GRPEL2;PEX6;PEX14;TOMM70;TIMM23;PAM16;PEX26;TIMM21;ROMO1;PEX10;GRPEL1;HSPD1;PEX16;DNLZ;AIFM1;TOMM40L
prerank,aorta development (GO:0035904),0.41544779819477734,0.8665153303771947,0.6244952893674294,0.9293108766786039,1.0,4/14,14.23%,PKD2;HECTD1;TFAP2B;LRP1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3341222457089033,0.8664100969799676,0.829,0.9290826647573628,1.0,48/248,15.82%,DRAXIN;TGFB1;TMEM131L;GPRC5B;MAD2L2;GNAQ;ZEB2;MDK;TLE3;CDK14;DKK2;APOE;OTULIN;TPBGL;DDIT3;LGR6;FZD9;CTNNB1;PSMB10;TBL1XR1;WNK1;CSNK1G2;GID8;SCYL2;ATP6AP2;AMER1;TBL1X;PSMA2;SOX9;PTPRO;PTPRU;CSNK1A1;TNKS2;PSME3;BAMBI;NFKB1;STK3;PSMB5;LRRK2;SOX2;PSMD8;SOX4;USP8;TLE5;PSMD7;LGR4;GSK3A;PSMB9
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.4341257350964526,0.8663885504146129,0.6246376811594203,0.9287211849134076,1.0,5/11,20.18%,FZD9;CASP8;ARHGEF2;BIRC2;BIRC3
prerank,cellular response to gamma radiation (GO:0071480),0.413124626303896,0.8663658552996263,0.6532988357050453,0.928354715873095,1.0,4/17,10.53%,XRCC5;TP53;HSF1;RPL26
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.41186197359264,0.8662239880549862,0.6518424396442185,0.9281916782995835,1.0,5/18,21.05%,NFE2L2;TRAP1;HIF1A;HSPB1;PRKN
prerank,female gamete generation (GO:0007292),0.3764659983966159,0.8661798112811522,0.6504629629629629,0.9278654760580649,1.0,6/29,17.06%,MDK;TRIP13;METTL3;MCM9;USP9X;MARF1
prerank,spinal cord development (GO:0021510),0.43331388995872966,0.8660253514875629,0.6448863636363636,0.9277447012556349,1.0,6/12,23.03%,PKD2;SOX4;NF1;LOXL3;RELN;ZPR1
prerank,regulation of cellular component biogenesis (GO:0044087),0.3697883059239462,0.8659715164745996,0.6621773288439955,0.9274366116852296,1.0,14/39,19.53%,APOE;TRAF2;RAP1B;VPS11;GFAP;RAPGEF1;HCFC1;RAP1A;SPTY2D1;CD36;IRGM;HSP90AA1;ROCK2;PARP10
prerank,negative regulation of cell aging (GO:0090344),-0.30573605238568824,-0.8658466415281675,0.6307053941908713,0.9293796455530681,1.0,7/16,27.73%,ZKSCAN3;YBX1;MAP3K3;HMGA2;TERT;TWIST1;MIF
prerank,positive regulation of synapse assembly (GO:0051965),0.3787212523284235,0.8649002563856211,0.6458583433373349,0.9288068958758349,1.0,4/27,10.91%,CLSTN1;SEMA4D;AGRN;SEMA4A
prerank,membrane lipid metabolic process (GO:0006643),0.39548170784948866,0.8647402453468094,0.6491885143570537,0.9286801441227435,1.0,5/22,14.97%,CERK;ST6GALNAC4;AGK;AGMO;ARV1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3528257025603237,0.8645810555941081,0.7015873015873015,0.9285543821895919,1.0,12/52,15.76%,SREBF2;MICALL2;UBE2D3;YWHAB;TP53;CSNK2A2;VPS11;CASP8;HUWE1;UBE2J2;GSK3A;YWHAH
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.3720151891905228,0.8644321836980657,0.6659012629161883,0.9284353317546857,1.0,8/34,13.20%,MAPK14;ERN1;PRKD2;ANXA1;MAP2K3;VEGFB;NRP1;NR4A1
prerank,ether lipid biosynthetic process (GO:0008611),0.4430942961708556,0.8643633984668225,0.6401137980085349,0.9281566497446658,1.0,3/10,11.62%,DHRS7B;LPCAT2;PEX7
prerank,cellular response to ionizing radiation (GO:0071479),0.36013038429375704,0.8641509652089863,0.6666666666666666,0.928109127890638,1.0,7/47,10.53%,GRB2;MAPK14;TANK;XRCC5;TP53;HSF1;RPL26
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.41633509060888074,0.8637034900469446,0.6223684210526316,0.9284322805829944,1.0,5/14,21.78%,CREB3L1;SULF2;THBS1;SPRY4;FGF2
prerank,response to hydroxyurea (GO:0072710),0.43254565179803617,0.8625990374247157,0.6349862258953168,0.9298340593537714,1.0,5/11,24.14%,DDI2;ATRX;KAT7;SPIDR;DDX11
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3373481280845504,0.8621850792014367,0.794383149448345,0.9301522416703223,1.0,51/173,20.63%,SPTBN5;F10;LMAN1L;CTSC;TMED3;KDELR2;CAPZB;CAPZA1;ACTR10;MCFD2;CTSZ;PDCD6;PGAP1;VAPB;RAB1B;COG6;COPA;SEC24D;SEC16B;YKT6;SEC16A;DYNC1H1;DCTN5;F5;STX5;SAR1A;TRAPPC6A;GAS6;TRAPPC11;VTI1A;GRIA1;LMAN2;SPTBN4;ANK1;USE1;ERGIC1;DCTN6;GOLGB1;ATL2;TRAPPC2L;SEC13;COG5;SEC31A;RAB29;TRAPPC12;ATL3;SEC22B;ARCN1;USO1;COG7;CUL3
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.3928267821281008,0.8619406351537551,0.656441717791411,0.9297510901225046,1.0,7/22,21.45%,ZDHHC14;ZDHHC7;ZDHHC3;ZDHHC1;ZDHHC24;ZDHHC21;ZDHHC2
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.3928267821281008,0.8619406351537551,0.656441717791411,0.9297510901225046,1.0,7/22,21.45%,ZDHHC14;ZDHHC7;ZDHHC3;ZDHHC1;ZDHHC24;ZDHHC21;ZDHHC2
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.3934158629347363,0.8616193194141784,0.6396508728179551,0.9298727917847778,1.0,9/21,23.30%,ABCD1;TRAP1;HDAC6;ABCD2;PRKN;SIRT5;MT3;AATF;SLC30A10
prerank,cell-cell junction assembly (GO:0007043),0.3476249663057487,0.860844428908799,0.7013669821240799,0.9307749747510158,1.0,13/63,12.13%,CD9;PKP2;PIP5K1C;CTNNB1;ACTB;GJB6;FLCN;CDH8;ACTG1;VCL;CDH9;CDH12;TLN1
prerank,neuromuscular process (GO:0050905),0.40925531485445216,0.8604917979006461,0.6446499339498019,0.9309741592909038,1.0,2/16,4.47%,GCH1;CLN3
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.4133517726271847,0.8603510916503847,0.6272108843537415,0.9308130091717344,1.0,7/14,24.11%,XRCC5;ATRX;TNKS2;TINF2;TERF2;TERF2IP;ATR
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.2691396182940442,-0.8594232370171251,0.7105263157894737,0.9416837489152586,1.0,12/23,27.19%,GLIS2;GLI3;HHIP;GPC3;KCTD21;GPR161;PTCH1;KIF7;RFX4;IFT122;ULK3;PTCH2
prerank,maintenance of protein localization in organelle (GO:0072595),-0.2855800536266538,-0.8592499214687043,0.6745283018867925,0.9397706576614474,1.0,10/19,21.73%,PML;HK1;BBS4;PINK1;TOPORS;HNRNPU;AKT1;SUPT7L;BCL3;SKP1
prerank,error-prone translesion synthesis (GO:0042276),-0.27743637688980394,-0.8590657872427039,0.6847290640394089,0.937800838615833,1.0,16/21,34.69%,REV3L;REV1;RFC1;PRIMPOL;RFC2;POLE2;UBC;POLK;POLI;RPA3;UBA52;RPA2;RFC3;RPS27A;RFC4;PCNA
prerank,positive regulation of cytokinesis (GO:0032467),0.37158677513226074,0.8590643551883735,0.6808755760368663,0.9325260650006733,1.0,8/32,20.63%,KIF14;KIF20B;KIF23;CDC6;CDC42;RHOA;GIPC1;CUL3
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.44560758786114807,0.8588446006904852,0.6375358166189111,0.9324909082782326,1.0,2/10,6.77%,RXRB;ACTN4
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.33432802733931116,0.8587282919847453,0.7847082494969819,0.9322733046649445,1.0,27/138,19.03%,MED17;GTF2H1;NR1H4;MAML3;RXRB;HDAC5;TAF1;TEAD1;TBL1XR1;PPARGC1A;CDK7;TBL1X;MED27;POLR2L;TAF8;NR2C2;HDAC9;NR4A1;NR2C1;TAF3;RBPJ;GTF2B;PPARD;GTF2H5;RXRA;TAF11;POLR2E
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.21152605861406198,-0.8585892558753566,0.8656716417910447,0.936489408807849,1.0,18/57,18.69%,RINT1;ATF2;RAD17;TAOK2;TIPIN;TOPBP1;TRIM39;MRE11;WAC;STK33;ATM;NOP53;MRNIP;SDE2;PRKDC;FBXO31;HMGA2;CDK2
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.3134300870334614,-0.8585416722779251,0.659919028340081,0.9342427990588915,1.0,4/14,16.10%,CAV1;SPRED2;SPRY2;NOTCH4
prerank,negative regulation of axon extension (GO:0030517),-0.2571068131638816,-0.8585093220460935,0.6739130434782609,0.9319920305135434,1.0,6/30,8.24%,SEMA6A;SEMA5A;SEMA6D;SEMA3A;SEMA3C;SEMA3D
prerank,regulation of lamellipodium organization (GO:1902743),0.4173883349808418,0.858283428379699,0.6543715846994536,0.9326127068827369,1.0,4/14,17.62%,CD44;CAPZB;TWF2;CDC42
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.33815987883017845,0.8580962712698271,0.780241935483871,0.9325128494861384,1.0,25/125,18.40%,ERCC6L;NEK6;CENPO;ESPL1;BCCIP;XPO1;MAPRE1;SEH1L;PLK2;SETD2;DYNC1H1;PMF1;CENPI;KIF2A;PPP1CC;CENPQ;PTPA;INTS13;INCENP;EML4;CENPK;MIS12;RPS27;TAOK1;DCTN6
prerank,peripheral nervous system development (GO:0007422),-0.2641010382340061,-0.8580524321757577,0.7172774869109948,0.9307179735071897,1.0,5/23,11.25%,ADGRG6;NFASC;NGF;ALDH3A2;SCN8A
prerank,regulation of cellular amide metabolic process (GO:0034248),0.3675044309057212,0.8578401770434537,0.6504629629629629,0.9325411283966887,1.0,9/32,18.74%,PRKCD;NR1H4;FOXO3;CYFIP1;PCIF1;PUM3;PGAM1;PICALM;TIGAR
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.38045009281147363,0.8575917478559265,0.6861143523920653,0.9325685094925291,1.0,7/26,18.49%,GCNT1;ALG2;LARGE1;RRM2B;GK;ALG11;GOLPH3
prerank,glucan biosynthetic process (GO:0009250),0.4283357028819026,0.8575005019742145,0.6581920903954802,0.9319191661280841,1.0,2/12,9.08%,GYG1;GBE1
prerank,glycogen biosynthetic process (GO:0005978),0.4283357028819026,0.8575005019742145,0.6581920903954802,0.9319191661280841,1.0,2/12,9.08%,GYG1;GBE1
prerank,establishment of apical/basal cell polarity (GO:0035089),0.41085221505327146,0.8572890601437667,0.6422651933701657,0.9318747892856452,1.0,4/14,19.28%,RAP2A;CDC42;RHOA;SCRIB
prerank,dicarboxylic acid catabolic process (GO:0043649),0.4229387831253182,0.8571463587079092,0.6532033426183844,0.9317065966254334,1.0,1/13,2.80%,MTHFS
prerank,microtubule bundle formation (GO:0001578),-0.22627675852624715,-0.8568235297458288,0.7888888888888889,0.9310117569993244,1.0,18/42,30.73%,NCKAP5;SPAST;CLIP1;MAP1S;CDK5RAP2;MTCL1;TPPP;MARK4;CFAP74;RP1;SPEF1;NUMA1;SPAG16;GAS8;CFAP46;TTLL3;AAAS;LRGUK
prerank,ribosomal small subunit assembly (GO:0000028),0.4105005211932472,0.8562828466140622,0.6437086092715232,0.9327669658746849,1.0,7/16,24.16%,XRCC5;ERAL1;RPS14;RPS27;RRP7A;RPS15;RPS5
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.2862267653724101,-0.8561967897288161,0.6822429906542056,0.9300862850783224,1.0,6/20,16.20%,B3GALT5;ST3GAL4;ST6GALNAC6;MPDU1;ST3GAL3;B3GALT1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.3026010968080832,-0.8561658551286561,0.6411290322580645,0.9278549704081174,1.0,4/14,6.89%,ADK;ADSS2;GMPS;PFAS
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.40319112112415983,0.8559288208778496,0.6717752234993615,0.932946251930103,1.0,5/18,17.02%,SLC43A2;EPO;NEDD4L;SLC43A1;BIN1
prerank,protein modification by small protein removal (GO:0070646),0.3317173615690104,0.8556480395434889,0.8438438438438438,0.9329847035355314,1.0,61/252,21.05%,ARRB2;OTULINL;COPS6;TGFBR1;ATXN7;TRAF2;TNFAIP3;USP35;TRAF3;OTUD3;ATXN3;PSMB10;ACTB;TP53;STAMBPL1;YY1;ASXL2;SMAD3;BABAM2;MCRS1;USP7;PSMA2;USP48;USP31;BECN1;USP18;PSME3;IKBKG;COPS4;FOXK1;INO80;HCFC1;PSMB5;TOR1A;USP9X;MBD5;PSMD8;JOSD2;USP8;PSMD7;USP29;PSMB9;USP21;USP16;HIF1A;PTEN;BABAM1;IL33;RHOA;PSMD2;KEAP1;BIRC2;TOMM20;SENP6;DESI1;DESI2;BIRC3;RAD23B;STAM2;SENP7;PRKN
prerank,membrane lipid biosynthetic process (GO:0046467),0.3538839093683889,0.8555627750899834,0.7085106382978723,0.9327444902201265,1.0,7/58,9.87%,CERS6;SGPL1;PRKD2;CSNK1G2;HACD4;ACER3;VAPB
prerank,lung development (GO:0030324),0.3690935889671447,0.8549274453062624,0.6909920182440137,0.9333700498881093,1.0,3/33,6.88%,SHH;CEBPA;NKX2-1
prerank,nuclear envelope organization (GO:0006998),-0.285094698713226,-0.8546614282610163,0.6887755102040817,0.9288885201214686,1.0,5/20,16.59%,NUP93;VPS4A;CTDNEP1;EMD;TMEM43
prerank,ovarian follicle development (GO:0001541),0.4174925741038919,0.8545341096525143,0.6508795669824087,0.9336101093693215,1.0,3/13,10.48%,CEBPB;EIF2B2;INHBA
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.3661423214217718,0.8540526717804736,0.6701149425287356,0.9339891037863538,1.0,9/32,20.69%,CDK14;BACH1;CDK17;RB1;CDC6;CDK15;CDK18;CDC45;NPAT
prerank,myoblast fusion (GO:0007520),-0.3292178819405153,-0.8537995321289968,0.6563573883161512,0.9283448702186945,1.0,7/12,23.97%,ADAMTS5;ADAM12;ADAMTS15;CD81;KCNH1;NOS1;CACNA1H
prerank,histone H4-K16 acetylation (GO:0043984),0.39969366402979395,0.8536991165932216,0.6654320987654321,0.9341721957997522,1.0,8/19,21.42%,MSL2;MCRS1;KAT7;HCFC1;JADE2;MEAF6;MSL1;PHF20
prerank,mammary gland epithelium development (GO:0061180),0.411631540284208,0.8536858401124479,0.6524064171122995,0.9337986152500112,1.0,1/14,2.06%,CSF1R
prerank,negative regulation of metabolic process (GO:0009892),0.3469872043496046,0.853522873121327,0.7112068965517241,0.9336654947459732,1.0,7/54,8.59%,PLCL2;TLE3;MAP2K6;DDIT3;FLCN;ZDHHC7;RB1
prerank,sister chromatid segregation (GO:0000819),0.366331247642602,0.8534800370311327,0.6609977324263039,0.9333345504332304,1.0,8/31,19.60%,ESPL1;NCAPG2;RB1;INO80;TOP2A;CENPK;MIS12;SMC4
prerank,mucosal immune response (GO:0002385),0.41273125198659577,0.8533834104102143,0.6590909090909091,0.933109321171717,1.0,2/15,12.50%,FFAR2;DEFA6
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.30963279488447004,-0.8532241828345667,0.644,0.9273983360339646,1.0,8/14,32.89%,ENPP3;AK3;AK4;SMPDL3A;CMPK2;NME2;CMPK1;AK7
prerank,morphogenesis of an epithelium (GO:0002009),0.37916451274977714,0.8528032878346581,0.6485207100591716,0.9336272175646695,1.0,6/25,15.97%,ACTB;ACTG1;VCL;SOX9;AHI1;LAMA3
prerank,protein K48-linked ubiquitination (GO:0070936),0.34846231072886635,0.8527453076893221,0.7024972855591748,0.9333183856310875,1.0,19/54,21.89%,RFFL;UBE2D3;TNFAIP3;UBE2E3;RNF4;UBE2H;NEDD4L;CDC34;RNF216;ITCH;UBE2G2;ZNRF1;RNF152;UBE2K;CUL3;UBE2R2;PRKN;RNF146;UBE2E1
prerank,centromere complex assembly (GO:0034508),0.36261895652920173,0.8525395127980834,0.683371298405467,0.9332624504892497,1.0,12/36,23.59%,CENPO;RBBP7;CENPI;CENPQ;CENPK;RSF1;MIS12;RBBP4;ITGB3BP;SMARCA5;KNL1;CENPT
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.38726920338454734,0.852411644147802,0.6456494325346784,0.9326896081851719,1.0,6/19,22.68%,ATRX;POLR2L;POLR2E;TINF2;TERF2;TERF2IP
prerank,regulation of DNA recombination at telomere (GO:0072695),0.38726920338454734,0.852411644147802,0.6456494325346784,0.9326896081851719,1.0,6/19,22.68%,ATRX;POLR2L;POLR2E;TINF2;TERF2;TERF2IP
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.356269141602912,0.8523622574196386,0.6974697469746974,0.9323769335984041,1.0,13/44,21.99%,KCNN4;KCNIP2;KCNMA1;WNK1;NOS1AP;ATP1B3;ATP1B2;GNG2;WNK4;AKAP9;KCNJ2;KCNJ10;FLNA
prerank,protein auto-ADP-ribosylation (GO:0070213),0.4300795562445334,0.8519845770819523,0.65283540802213,0.9325983577674234,1.0,7/12,23.36%,PARP8;PARP16;TNKS2;TIPARP;PARP10;PARP3;PARP1
prerank,lipid biosynthetic process (GO:0008610),0.3401802913758959,0.8517762099329668,0.7312049433573635,0.9325424121970233,1.0,12/77,17.09%,LPL;LPCAT1;CLN8;DHRS11;LIPC;PDSS1;PRLR;NDUFAB1;SREBF1;ACACA;FADS1;FDXR
prerank,amino acid import across plasma membrane (GO:0089718),0.383367704959471,0.8512344356625743,0.6730083234244947,0.9330259493774187,1.0,3/24,7.46%,SLC7A8;SLC36A1;SLC16A2
prerank,protein targeting to mitochondrion (GO:0006626),0.3513009988931845,0.8509492012541018,0.71875,0.9330657874684632,1.0,18/52,23.89%,TSPO;AIP;CHCHD4;TIMM22;AGK;IMMP2L;TIMM50;TOMM40;PMPCB;HSP90AA1;PITRM1;FIS1;TOMM20;PMPCA;DNAJC15;TIMM29;HSPA4;TIMM8B
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.2558924429422108,-0.8508897133250023,0.6691729323308271,0.9302373230664938,1.0,11/30,20.11%,OGT;RYBP;N4BP1;USP14;TRIM39;WAC;CCAR2;NOP53;UCHL5;PARK7;DDRGK1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.4331248638293125,0.8507392033042712,0.6694796061884669,0.9330105793452317,1.0,6/11,21.45%,NF2;SH2B3;ADIPOR1;PTPRT;VHL;SOCS3
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.4363047980447059,0.8503639280124473,0.6466275659824047,0.9331988929245557,1.0,5/11,21.82%,SNX33;NEDD4L;PICALM;LEPROTL1;GPM6B
prerank,antibacterial humoral response (GO:0019731),0.40300718264314744,0.8503286465213432,0.6546854942233633,0.9328636241339904,1.0,5/16,26.03%,DMBT1;DEFA6;RNASE6;PLA2G6;RNASE3
prerank,regulation of isotype switching (GO:0045191),0.4241509925861086,0.8498653697061941,0.6552197802197802,0.933244645535661,1.0,4/14,20.46%,MAD2L2;SHLD1;SHLD2;PARP3
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.3603805461569652,0.84982286290437,0.6863181312569522,0.9329199872657401,1.0,5/40,9.27%,PRKCD;UBE2V2;UBE2V1;POLH;SMG1
prerank,nerve growth factor signaling pathway (GO:0038180),0.4262744660715513,0.8496829727598889,0.6409155937052933,0.9327339426067288,1.0,4/10,19.43%,NTF3;RAPGEF1;RAP1A;KIDINS220
prerank,response to unfolded protein (GO:0006986),0.34796587442174437,0.8496639948084546,0.7072905331882481,0.9323727245636835,1.0,13/48,21.05%,PTPN1;ERN1;HERPUD1;DDIT3;BAK1;HSF1;DERL1;STT3B;HSP90AA1;ERP44;OPTN;HSPB1;PRKN
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.3689500499276371,0.8493068870208027,0.6732101616628176,0.9325362868481826,1.0,9/29,20.17%,UTP20;RPS16;NOP9;HEATR1;RPS14;RRS1;TSR1;NGDN;UTP3
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.3707751410794623,0.8487893318255644,0.6725768321513003,0.9329738916975686,1.0,10/30,22.57%,MGAT5;OSTC;MCFD2;STT3B;DDOST;STT3A;MGAT1;TUSC3;MAGT1;DPM2
prerank,nervous system development (GO:0007399),0.3274076348942368,0.8484919025996146,0.916,0.9330385384359464,1.0,64/429,16.47%,PCDHA6;ASCL1;SHH;TGFB1;PCSK9;PCDHB6;TGFBR1;DAGLB;MYLIP;EDNRB;S100B;FGF13;ZEB2;MDK;NAV2;SLITRK1;PRDM12;CLN8;SREBF2;PKD2;ST8SIA4;CXCR4;NRGN;MYT1L;NDP;FZD9;CHD7;TEAD1;APAF1;ATXN3;APBA1;MEF2C;BPNT1;NTF3;BCAN;HDAC4;EIF2B2;INHBA;NELL1;CHERP;ARTN;SNTG2;NR2C2;UTP11;PRX;ITM2B;NRG1;NAV1;MERTK;SH3GL3;NINJ1;SOX6;EFNB3;MBD5;KIRREL3;IGF2BP3;MPZ;AHI1;NF1;MTR;ERCC6;DPYSL5;DCHS1;PTEN
prerank,cellular response to leucine starvation (GO:1990253),0.44473651419926946,0.8484842376954528,0.6612665684830633,0.932656726036622,1.0,4/10,22.01%,MTOR;IMPACT;GCN1;RRAGB
prerank,heart development (GO:0007507),0.33000654211241043,0.8484055934483025,0.8040201005025126,0.9323917321096238,1.0,25/150,14.82%,SHH;TGFB1;SH3PXD2B;TGFBR1;EEF1AKMT4-ECE2;PKP2;PKD2;CHD7;ADAP2;TGFBR2;MEF2A;MYOCD;LDB3;MEF2C;ZDHHC16;SMYD4;SOX9;WDR11;HDAC9;TAB2;CASP8;MEGF8;SOX4;PDLIM1;POU6F1
prerank,ketone body metabolic process (GO:1902224),0.4280710823149051,0.8477720267715217,0.662807525325615,0.9330001143336734,1.0,1/10,3.38%,OXCT1
prerank,regulation of gastrulation (GO:0010470),-0.3050519081745292,-0.8477293019192257,0.6778242677824268,0.9347626113140701,1.0,2/14,6.37%,PHLDB2;PHLDB1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.34505863279511534,0.847475028089245,0.7292759706190975,0.9330917015110972,1.0,14/61,18.74%,SMOC2;DHX9;PRKD2;RGCC;HMGB1;BABAM2;ATRX;USP7;USP9X;ERCC6;BABAM1;UBE2N;NPAS2;TIGAR
prerank,sulfur compound biosynthetic process (GO:0044272),0.33375939049901,0.8474217647560552,0.7652439024390244,0.9327817776085958,1.0,25/104,21.90%,PRELP;ESD;AKR1A1;HPGDS;SLC35B3;CHSY3;B4GALT1;FMOD;ST3GAL1;BCAN;GGTA1;PAPSS1;CHSY1;CHST15;MGST1;CBS;GSTM2;ANGPT1;CHPF;CSPG4;CNDP2;SLC10A7;B4GALT2;B4GALT6;GCLM
prerank,regulation of peptidase activity (GO:0052547),-0.3005114947503379,-0.8473415619811161,0.6733668341708543,0.9333191249389631,1.0,6/19,13.37%,CAV1;NRDC;PINK1;MAPK12;ECM1;PSMA3
prerank,DNA modification (GO:0006304),0.3808459239163307,0.8460742821962289,0.651219512195122,0.9345127769848864,1.0,8/22,23.36%,NEIL2;OGG1;TINF2;EXOSC3;PARP3;TERF2;TERF2IP;PARP1
prerank,protein K63-linked deubiquitination (GO:0070536),0.3640161436276626,0.8459035709146622,0.6780660377358491,0.9344002782273039,1.0,8/31,16.60%,TNFAIP3;ATXN3;STAMBPL1;BABAM2;USP7;USP8;USP16;BABAM1
prerank,embryonic limb morphogenesis (GO:0030326),0.3616490426601636,0.8456482377178138,0.6835016835016835,0.9344238039982936,1.0,3/34,6.34%,SHH;SKI;CTNNB1
prerank,homologous chromosome segregation (GO:0045143),0.38553546756894913,0.8451649287389951,0.6788413098236776,0.9347906370607822,1.0,1/20,2.87%,PTTG1
prerank,phosphatidylserine metabolic process (GO:0006658),0.3644435915783566,0.8448078183940539,0.6859410430839002,0.9349720756090116,1.0,6/32,18.72%,ABHD12;OSBPL10;ABHD16A;OSBPL8;PLAAT3;PLA2G5
prerank,positive regulation by host of viral transcription (GO:0043923),-0.3018960040309684,-0.8447408495904207,0.6557377049180327,0.9365973126825897,1.0,4/15,13.00%,SMARCA4;NUCKS1;CCNT1;SNW1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.3366338168835914,0.84458017013419,0.7627811860940695,0.9349370888480238,1.0,18/87,18.41%,GPNMB;GPR132;PKD2;RGCC;PSMB10;RB1;PSMA2;CCL2;CDK6;PSME3;PSMB5;BRD7;PSMD8;PSMD7;PSMB9;PTEN;PSMD2;DACT1
prerank,neuron projection extension (GO:1990138),0.36418008736335666,0.8445362486040282,0.6925714285714286,0.9346161701482911,1.0,10/32,17.26%,CTNNB1;IMPACT;FLRT1;MAP1B;NRP1;CYFIP1;USP9X;HSP90AA1;PPP3CB;IQGAP1
prerank,apoptotic DNA fragmentation (GO:0006309),0.39953717131011834,0.844492340407406,0.6618037135278515,0.9342843939747257,1.0,8/16,27.16%,HMGB1;KPNA1;DICER1;DNASE2;DFFB;CECR2;KPNB1;HMGB2
prerank,negative regulation of phosphatase activity (GO:0010923),0.3761635139071057,0.8443057201063466,0.6706586826347305,0.9341791630316318,1.0,7/25,22.04%,SEMA4D;PPP1R11;BOD1L1;PPP4R4;PTPA;GSK3B;CHP1
prerank,RNA methylation (GO:0001510),-0.20701110653533064,-0.8437416078563421,0.7708333333333334,0.9364030447638116,1.0,30/60,32.65%,NSUN6;METTL6;THADA;CBLL1;THUMPD3;NSUN2;METTL14;METTL5;TRMT6;METTL16;TARBP1;TGS1;CMTR1;MTO1;MTERF4;MEPCE;NOP2;TRMT5;LCMT2;NSUN5;WDR6;NSUN3;METTL8;TRMT44;TRMT13;TRMT10C;TYW3;MRM2;TRMT12;TRMT112
prerank,telomere organization (GO:0032200),0.35227933851610804,0.8433404828300506,0.7059471365638766,0.9353318708446143,1.0,16/43,24.89%,PTGES3;XRCC5;DOT1L;STN1;DNA2;POLD3;TINF2;RAD51D;PARP3;TERF2;ERCC4;TERF2IP;H3-3A;PARP1;ATR;RPA1
prerank,Notch signaling pathway (GO:0007219),0.3375925246449013,0.8432587425655997,0.7209302325581395,0.935071154952535,1.0,4/59,7.22%,ASCL1;MDK;MAML3;SNAI1
prerank,DNA replication checkpoint signaling (GO:0000076),-0.298019534199326,-0.84299465598765,0.6770428015564203,0.9356017041230198,1.0,4/16,12.74%,RAD17;TIPIN;TOPBP1;NAE1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.4230638748932488,0.8426687675304391,0.6550218340611353,0.9356159153277734,1.0,6/11,24.95%,MTOR;SMARCB1;PIH1D1;DDX11;SIRT7;PWP1
prerank,microtubule nucleation (GO:0007020),-0.27287822024887276,-0.8424924336573545,0.6865671641791045,0.9344797443947361,1.0,6/19,14.15%,SLAIN2;TUBGCP2;NDEL1;NDE1;GOLGA2;TPPP
prerank,establishment of vesicle localization (GO:0051650),0.3947831867661491,0.842464318350752,0.669609079445145,0.9355619736183873,1.0,5/18,13.76%,DNM2;RAB11A;SYNJ1;IKBKG;TOR1A
prerank,protein O-linked glycosylation (GO:0006493),0.33433226891231715,0.8423829433202106,0.7617586912065439,0.9353130123444304,1.0,15/96,11.32%,SDF2L1;GCNT1;GALNT10;TET3;MUC13;GALNT15;GALNT7;OGA;ST6GALNAC4;GALNT6;POGLUT2;ST3GAL1;POGLUT1;TMTC4;POMK
prerank,nitric oxide mediated signal transduction (GO:0007263),0.40896946089113284,0.8422919605524497,0.6827309236947792,0.9350659650887557,1.0,3/16,15.32%,APOE;DDAH1;CD36
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.3613549027417473,0.8422405235200281,0.6833144154370034,0.9347517394393704,1.0,3/33,4.82%,NFE2L2;MDK;TNFAIP3
prerank,stress fiber assembly (GO:0043149),0.4085269632661596,0.842157562208243,0.6644562334217506,0.9341091579594893,1.0,10/15,24.61%,ITGB5;ZYX;PDLIM1;SRC;RHOA;ITGB1;CUL3;TNFAIP1;KCTD13;ARRB1
prerank,contractile actin filament bundle assembly (GO:0030038),0.4085269632661596,0.842157562208243,0.6644562334217506,0.9341091579594893,1.0,10/15,24.61%,ITGB5;ZYX;PDLIM1;SRC;RHOA;ITGB1;CUL3;TNFAIP1;KCTD13;ARRB1
prerank,protein import into mitochondrial matrix (GO:0030150),-0.2901304035822788,-0.8417905734425867,0.7033492822966507,0.9337905486087629,1.0,11/18,33.57%,DNAJC19;TIMM17A;GRPEL2;TOMM70;TIMM23;PAM16;TIMM21;ROMO1;GRPEL1;DNLZ;TOMM40L
prerank,regulation of actin nucleation (GO:0051125),0.41756658156912746,0.8412629821006665,0.6567967698519516,0.9351272406293177,1.0,1/12,1.77%,CORO1A
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.4107005022553952,0.8405340458843326,0.6729986431478969,0.9358834784187398,1.0,6/14,22.04%,ACTN4;SLC9A1;WNK1;WNK4;TESC;CHP1
prerank,negative regulation of cellular protein localization (GO:1903828),0.3598763121235839,0.8398648160537918,0.6864988558352403,0.9365292841535475,1.0,12/34,21.82%,SNX33;SPI1;RIPOR2;FLCN;NEDD4L;ANKRD13A;PICALM;ROCK2;LEPROTL1;GSK3B;NSFL1C;GPM6B
prerank,regulation of mRNA catabolic process (GO:0061013),0.3297597061106265,0.8397703674234513,0.7889447236180904,0.9362896820844198,1.0,22/121,15.82%,PCID2;PRKCD;EXOSC1;CNOT8;XPO1;ANP32A;PSMB10;YWHAB;GTPBP1;YTHDF3;RC3H2;MOV10;RC3H1;PUM2;PSMA2;PSME3;PSMB5;HNRNPD;PSMD8;IGF2BP3;PSMD7;PSMB9
prerank,cGMP metabolic process (GO:0046068),0.41548923130510607,0.83975704685757,0.639367816091954,0.935917178080149,1.0,2/12,10.26%,GUCY2F;NPR2
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.2594005440187203,-0.8395142582857503,0.7267441860465116,0.9363254629067059,1.0,9/24,22.27%,SORBS1;IRS1;EPM2AIP1;SELENOS;AKT1;IRS2;PPP1R3C;PPP1R3F;IGF2
prerank,negative regulation of T cell differentiation (GO:0045581),0.42911519994575087,0.8394168329526043,0.6603221083455344,0.9360516617694034,1.0,2/10,13.35%,MDK;IRF1
prerank,negative regulation of protein catabolic process (GO:0042177),0.353304351351882,0.839402573929094,0.6991150442477876,0.9356804152707305,1.0,4/40,4.99%,CTSA;MAD2L2;SNCA;TIMP1
prerank,regulation of telomere maintenance (GO:0032204),0.3716291497454666,0.8389918541228002,0.6810551558752997,0.9359291335257032,1.0,10/26,22.68%,XRCC5;SMG1;ATRX;USP7;HNRNPD;ERCC1;TINF2;TERF2;ERCC4;TERF2IP
prerank,protein targeting to membrane (GO:0006612),0.3320814150929544,0.8389543021417254,0.7543679342240494,0.9356036710165752,1.0,23/83,21.62%,RAB8B;MICALL1;ABCD1;ZDHHC14;AQP11;ZDHHC7;PEX13;PXMP2;ZDHHC3;VPS37C;SDCBP;SRP19;ZDHHC1;ZDHHC24;ATG3;RABGEF1;SEC63;MYO1C;ABCD2;FIS1;ZDHHC21;ZDHHC2;SRP14
prerank,chromatin remodeling (GO:0006338),0.33037114832329023,0.8384717152178245,0.7778904665314401,0.935971036240077,1.0,28/100,20.02%,NPM3;BPTF;SRCAP;HDAC5;ACTB;RB1;ARID1A;ATRX;HDAC4;ARID1B;BAZ1A;HCFC2;SOX9;SMARCD3;BRDT;SMARCB1;INO80;HCFC1;PIH1D1;ERCC6;SMARCAD1;RSF1;KDM4C;CHD4;TOP1;RBBP4;KDM5A;KDM5B
prerank,visual system development (GO:0150063),0.3482249776318519,0.8383595776100092,0.6894618834080718,0.9357433886604535,1.0,7/37,15.07%,SH3PXD2B;C1QA;ITGAM;ZDHHC16;SOX2;MEIS1;SIPA1L3
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.36471518269311065,0.8379703552489562,0.6792452830188679,0.9359382437697976,1.0,3/27,9.06%,LPIN2;CHKB;ABHD4
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.32057236892238217,-0.837029461663074,0.664179104477612,0.9393346350215688,1.0,3/12,9.45%,SORBS1;IRS1;PRKCZ
prerank,programmed necrotic cell death (GO:0097300),0.386764649077211,0.8370262780339356,0.6829896907216495,0.9369937462259309,1.0,3/18,8.58%,CD14;TICAM1;LY96
prerank,tetrahydrofolate metabolic process (GO:0046653),0.4429812823530958,0.8364759835291693,0.6794117647058824,0.9374586415250556,1.0,1/10,2.80%,MTHFS
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.3772626830385837,0.8356157133238475,0.6666666666666666,0.9384203231754527,1.0,2/23,8.62%,TGFB1;SMAD3
prerank,myotube differentiation (GO:0014902),0.3916716378246789,0.8351956061798825,0.6531645569620254,0.9386946021413523,1.0,3/17,8.17%,SKI;PLD3;MEF2C
prerank,protein deubiquitination (GO:0016579),0.32446252201295,0.8351158464184087,0.8617234468937875,0.9384359280781811,1.0,50/242,17.95%,ARRB2;OTULINL;TGFBR1;ATXN7;OTULIN;TRAF2;TNFAIP3;USP35;TRAF3;OTUD3;ATXN3;PSMB10;ACTB;TP53;STAMBPL1;YY1;ASXL2;SMAD3;BABAM2;MCRS1;USP7;PSMA2;USP48;USP31;BECN1;USP18;PSME3;IKBKG;FOXK1;INO80;HCFC1;PSMB5;MINDY1;USP9X;MBD5;PSMD8;JOSD2;USP8;PSMD7;USP29;PSMB9;USP21;USP16;HIF1A;PTEN;BABAM1;IL33;RHOA;PSMD2;KEAP1
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.42788112953339136,0.8349247351408567,0.6777777777777778,0.9383263494975271,1.0,6/11,25.64%,VPS11;SORL1;PRKN;EIPR1;PTPN23;RAB21
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.28611317587991725,-0.8348624373660022,0.6666666666666666,0.9415900519025402,1.0,2/17,1.19%,ANK2;RYR2
prerank,negative regulation of catabolic process (GO:0009895),0.34768964568784005,0.8343264798302061,0.7029379760609358,0.938841315287083,1.0,5/47,10.06%,CBFA2T3;MAD2L2;TNF;ZDHHC7;HDAC4
prerank,positive regulation of macroautophagy (GO:0016239),0.3498429021708583,0.8342338019629356,0.7152173913043478,0.9386124836032909,1.0,10/48,16.24%,PIP4K2A;RAB3GAP2;SCOC;LARP1;PAFAH1B2;UVRAG;IKBKG;GNAI3;VDAC1;IRGM
prerank,magnesium ion transport (GO:0015693),-0.3215169528303475,-0.8337868389452412,0.6630434782608695,0.9416260262267703,1.0,5/12,19.39%,SLC41A1;NIPA2;NIPAL2;MRS2;CNNM4
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.342974454329822,0.8336376726560788,0.7232635060639471,0.9391476060803993,1.0,6/46,8.59%,PLCL2;TLE3;MAP2K6;DDIT3;FLCN;RB1
prerank,polyamine metabolic process (GO:0006595),0.4047005715177874,0.8335623579457463,0.6648793565683646,0.9388736547045398,1.0,4/13,15.76%,SMOX;AMD1;HDAC6;PAOX
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.3564192048841845,0.8328374659862675,0.7123442808607021,0.9396154740595964,1.0,9/38,17.68%,SCN4B;HCN4;PKP2;CACNB2;KCNA5;CACNA1D;BIN1;SCN5A;AKAP9
prerank,ribosomal large subunit biogenesis (GO:0042273),0.3406866960727521,0.832552906897282,0.7292110874200426,0.9396546163376205,1.0,12/54,17.86%,RPL10A;LAS1L;GTF3A;RPL6;SURF6;RPL26;MDN1;RRS1;NOC2L;PES1;RPL11;WDR12
prerank,regulation of synapse assembly (GO:0051963),0.34658090672069003,0.8320996047384596,0.7276736493936052,0.9399598449439371,1.0,5/46,8.17%,CLSTN1;TLR2;SLITRK1;SNCA;MEF2C
prerank,potassium ion transmembrane transport (GO:0071805),0.32702395537611084,0.8316862004755677,0.8164300202839757,0.9401876754949721,1.0,11/135,7.61%,KCNJ11;HCN4;SLC9A4;KCNN4;KCNK6;PKD2;KCNIP2;SLC9A9;CCDC51;SLC9A1;KCNK13
prerank,epithelial structure maintenance (GO:0010669),0.4241492215376872,0.8307579812689091,0.6830985915492958,0.9411927905555392,1.0,3/11,20.97%,MUC13;NOD2;STRAP
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.4074806392456924,0.8303898641794507,0.6944818304172274,0.9413529526806881,1.0,5/13,23.88%,RENBP;NAGK;SLC35A3;GNPNAT1;GNPDA2
prerank,leukotriene metabolic process (GO:0006691),0.3885840779835541,0.8296894897378618,0.6823529411764706,0.9419917142810186,1.0,4/19,19.64%,ALOX12;ABCC1;PLA2G5;ABCC10
prerank,negative regulation of defense response to virus (GO:0050687),0.43532315595716414,0.8296470210055561,0.6836158192090396,0.9416648855009743,1.0,3/10,16.52%,TSPAN6;ITCH;TARBP2
prerank,negative regulation of translational initiation (GO:0045947),0.4111945534718047,0.8294731374617801,0.6928281461434371,0.9415545658788934,1.0,5/13,22.59%,EIF4EBP2;LARP1;TPR;AGO2;EIF3E
prerank,protein N-linked glycosylation (GO:0006487),0.3345859816937971,0.829293263155998,0.7655755015839493,0.9414590553489843,1.0,20/66,21.49%,MGAT5;MAN1C1;B4GALT1;OSTC;ST3GAL1;MCFD2;ALG2;DPAGT1;B4GALT7;STT3B;PMM1;MGAT5B;TMEM165;DDOST;ALG11;MGAT4B;STT3A;MGAT1;TUSC3;MAGT1
prerank,L-amino acid transport (GO:0015807),0.36267330062137826,0.8290963623372174,0.7044392523364486,0.9413816985330838,1.0,6/28,15.22%,SLC7A8;SLC36A1;SLC36A4;SLC25A18;CTNS;SLC1A4
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.2826786500472013,-0.8284087857887813,0.7317073170731707,0.9504840165227704,1.0,5/18,14.29%,UBTF;EIF2AK3;ATF4;DHX33;UTP15
prerank,mitotic cytokinesis (GO:0000281),0.3465375766086708,0.8279922302026391,0.7287581699346405,0.9426884916030878,1.0,12/47,16.99%,SNX9;ESPL1;SNX33;CNTROB;KIF23;SON;MYH10;USP8;PDCD6IP;INCENP;RASA1;SNX18
prerank,metal ion transport (GO:0030001),0.328600407276704,0.8279064430114953,0.7571428571428571,0.942440169346295,1.0,14/86,14.00%,SLC11A1;KCNN4;SLC8A1;CCL8;PKD2;CACNA1A;RAMP1;ATP2C1;TPT1;NIPAL3;FYN;CDH23;ATP2A3;CACNA1B
prerank,protein ubiquitination (GO:0016567),0.3191786639416005,0.8276281610007888,0.954,0.942485938413366,1.0,91/471,17.95%,ARRB2;NFE2L2;CBL;MYLIP;TRIM25;UBE2V2;ZNRF2;RNF19B;TRIM5;MKRN1;CDC23;UBE2V1;UBE2D3;OTULIN;TRAF2;FBXL22;MSL2;VPS18;MGRN1;RNF7;FBXL18;HLTF;RNF111;TAF1;KLHL21;CTNNB1;UVSSA;UBE2S;PSMB10;LONRF1;KLHL7;LEO1;RC3H2;VPS11;TRIM27;RNF114;PEX13;UBE2E3;RC3H1;DERL1;UBE4B;RNF4;NFX1;UBE2H;NEDD4L;RNF10;PHC1;USP7;FBXO40;PSMA2;ARRDC4;TRIM24;RNF40;TRIM35;SPOP;CDC34;FBXO32;DET1;TNKS2;PSME3;ITCH;RNF135;FBXL3;STUB1;UBE2G2;RNF144B;PSMB5;USP9X;DTX4;HUWE1;AREL1;PSMD8;UBE2J2;ZNRF1;RNF152;PSMD7;GAN;PSMB9;SMURF1;ATG3;HIF1A;TRIM62;FANCL;ANAPC11;UBE2N;ZNRF3;VHL;UBE2Z;UBE2K;PSMD2;KEAP1
prerank,histone mRNA catabolic process (GO:0071044),-0.29076480195305016,-0.8271770891758768,0.6768558951965066,0.9507198194432354,1.0,5/15,14.25%,SSB;ERI1;UPF1;ATM;TUT1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.3996336008232006,0.827039329419262,0.6794520547945205,0.9429987601216298,1.0,5/14,21.99%,TIMP1;LIMS1;CD63;LOXL3;FLNA
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.3371020913121596,0.8270305076547082,0.7266881028938906,0.9426260256100221,1.0,13/57,17.89%,EMG1;XPO1;URB2;GTF3A;SURF6;RPL26;RPS16;RRS1;NOC2L;PES1;RPL11;WDR12;DDX31
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3820042304833839,0.8269418752421303,0.7036569987389659,0.9423777161842499,1.0,6/20,21.05%,TGFBR1;ITCH;HIF1A;HSP90AA1;DCUN1D5;PRKN
prerank,glutathione biosynthetic process (GO:0006750),-0.32425025948867137,-0.8263055777663483,0.6996587030716723,0.9501763327105446,1.0,6/11,35.52%,GSS;CHAC2;OPLAH;GGCT;HAGH;GGT1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.3626772887520866,0.8258529658828306,0.6922169811320755,0.9436025120249001,1.0,3/27,3.74%,HCN4;FGF13;PKP2
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.371405259403368,0.8255400769643352,0.694344163658243,0.9436988277954752,1.0,5/24,18.32%,NFE2L2;TNFAIP3;GAS6;PDPK1;ANGPT1
prerank,methylguanosine-cap decapping (GO:0110156),0.42564255976845616,0.825477929231678,0.663323782234957,0.9434034776241502,1.0,1/10,4.13%,PNRC2
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.32239234408070594,0.8254303970988851,0.8088978766430738,0.9430799014207227,1.0,27/129,15.82%,TGFB1;GPRC5B;ZEB2;DKK2;LGR6;FZD9;PSMB10;TBL1XR1;WNK1;CSNK1G2;GID8;ATP6AP2;AMER1;TBL1X;PSMA2;TNKS2;PSME3;BAMBI;NFKB1;PSMB5;LRRK2;PSMD8;SOX4;USP8;PSMD7;LGR4;PSMB9
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.3817813191811127,0.8253893262992926,0.6924050632911393,0.9427557526416142,1.0,9/18,25.60%,PUM2;GPATCH3;BIRC2;BIRC3;RNF125;DDX60;USP15;C1QBP;PUM1
prerank,dendritic spine morphogenesis (GO:0060997),-0.2917850702723585,-0.8247143440821211,0.7049180327868853,0.9512545132142727,1.0,4/15,10.98%,EPHB2;DIP2A;SHANK3;SHANK1
prerank,mRNA processing (GO:0006397),0.3184291264769862,0.8246931978431151,0.899,0.9433834937772173,1.0,75/287,21.79%,GTF2H1;IK;SNRNP27;DHX9;ERN1;BCAS2;SF3B2;SF3B1;AURKAIP1;PPIE;DHX38;SNRNP25;SCAF11;CWF19L1;THOC2;CCAR1;CSTF1;DNAJC8;ZMAT5;TFIP11;GCFC2;CASC3;SNRPD2;CDC5L;RBM15B;CWC27;PPARGC1A;CDK7;HNRNPL;RBMX2;SON;DDX39B;SNIP1;POLR2L;CHERP;PRPF8;METTL3;TRA2B;CTNNBL1;RBM41;PCBP1;POLDIP3;THOC3;UPF3B;ALKBH5;HNRNPD;WDR83;BUD31;AKAP8L;CWF19L2;LSM8;CRNKL1;PCF11;PPIH;DDX41;SLU7;GTF2H5;SNRNP35;SNRNP200;POLR2E;SNRPB2;SRSF2;SRSF6;HNRNPF;PNN;PABPN1;SF3B3;SART1;SRSF3;SRSF10;PTBP1;HNRNPA0;UBL5;PRCC;PDCD7
prerank,skeletal muscle tissue development (GO:0007519),0.36046420732254847,0.8242161342140409,0.7267573696145124,0.9437151073496197,1.0,3/32,8.17%,SKI;CFLAR;MEF2C
prerank,regulation of stress fiber assembly (GO:0051492),0.3272975564523443,0.8237634854454379,0.7565308254963428,0.9439971315830257,1.0,13/74,11.33%,TGFBR1;ARHGEF18;ARAP1;RGCC;FHOD1;SLC9A1;WASF2;ACTG1;F11R;PFN2;NF2;NRP1;PFN1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.4220967435161901,0.8234133774189455,0.6821378340365682,0.9441335365979773,1.0,4/11,17.96%,ABCD1;TRAP1;FYN;ABCD2
prerank,endothelial cell proliferation (GO:0001935),0.39101381585609746,0.8232927372358579,0.6929133858267716,0.9439323977278448,1.0,2/17,3.71%,ANGPT4;ERN1
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.22722105815047422,-0.8228461439057334,0.7391304347826086,0.9527666485433002,1.0,10/41,12.17%,OGT;NUP93;NUP188;RANBP2;NUP98;NUP42;NDC1;RAE1;NUP153;NUP37
prerank,regulation of embryonic development (GO:0045995),-0.2269757383360716,-0.8225714428760484,0.7948717948717948,0.9510755386267152,1.0,10/34,20.22%,PHLDB2;NIPBL;PHLDB1;TDG;NPHP3;ZBED3;SOX17;DHX36;RBM19;RPS6KA6
prerank,protein targeting (GO:0006605),0.32205102455801987,0.8225627641337941,0.8058943089430894,0.944647296048232,1.0,26/118,17.78%,TSPO;EDEM1;AP1S3;AIP;MICALL1;SPCS2;ZDHHC14;AQP11;ZDHHC7;TIMM22;SPCS1;ZDHHC3;VPS37C;SDCBP;SORL1;TOMM40;ZDHHC1;ZDHHC24;LTBP2;ATG3;RABGEF1;RPL11;PITRM1;SEC63;GIPC1;MYO1C
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.3418070868873614,-0.8225133548885575,0.6838709677419355,0.9489409489940247,1.0,4/10,12.19%,THOC1;THOC5;WDR76;CCAR2
prerank,regulation of protein localization to centrosome (GO:1904779),0.4234016932813652,0.822358252887915,0.6813793103448276,0.9445537685826486,1.0,1/10,2.97%,NUP62
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.3889548654355812,0.8221067708915935,0.6711051930758988,0.9445324763710089,1.0,8/17,25.41%,APOE;SORL1;RTN1;RTN4;BIN1;PIN1;IGF1;GGA3
prerank,regulation of protein localization to cell periphery (GO:1904375),0.3840825191021442,0.8220018460755473,0.6826424870466321,0.9442977308667422,1.0,9/18,23.12%,LDLRAP1;CLN3;ACTB;ZDHHC7;STX8;ABCA2;ZDHHC2;VAMP8;STX7
prerank,ribosomal small subunit biogenesis (GO:0042274),0.3481639691889077,0.821981061556882,0.7085650723025584,0.9439460653494104,1.0,16/39,27.19%,EMG1;NOB1;ERAL1;SURF6;RPS16;RPS14;RPS27;RIOK3;RRP7A;SRFBP1;RPS7;RPS15;RPS5;NOP14;LSM6;RPS6
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.3647280936194058,0.8217014800235122,0.6810035842293907,0.9439662892234579,1.0,8/25,21.33%,ZNF326;EAF1;DDX39B;ELL;KAT7;ERCC6;ZMYND11;SETD5
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.36297048070259547,0.8213169612277944,0.7094117647058824,0.9441593135932358,1.0,7/29,17.31%,MAD2L2;NKX2-1;ADIPOR1;PPP2CA;VASN;PTEN;LDLRAD4
prerank,protein localization to lysosome (GO:0061462),0.36809122034779845,0.821289979267511,0.7239336492890995,0.9438168744064187,1.0,13/28,27.32%,LAPTM5;RAB7A;SORL1;NCOA4;RTN4;ATP13A2;SCARB2;RNF128;MFSD1;GGA3;HGS;SNX16;NAGPA
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.2634164820090013,-0.8212758678057689,0.7966101694915254,0.9490947965994094,1.0,2/23,0.98%,SLC12A2;SLC12A7
prerank,mitochondrial RNA metabolic process (GO:0000959),0.39609577211272684,0.8210098771099754,0.7013333333333334,0.943854185722232,1.0,3/14,15.43%,FOXO3;FASTKD1;TWNK
prerank,canonical Wnt signaling pathway (GO:0060070),0.32715447381408413,0.8204657001538229,0.7596656217345873,0.9442736964283527,1.0,13/68,16.58%,FZD10;FRAT2;FZD9;FZD3;CTNNB1;SCYL2;LRP5;AMER1;CSNK1A1;LRRK2;BCL9;PTEN;FZD8
prerank,peptidyl-asparagine modification (GO:0018196),0.35504136284793886,0.8204622195550947,0.7066356228172294,0.9438942102201959,1.0,10/31,22.57%,MGAT5;OSTC;MCFD2;STT3B;DDOST;STT3A;MGAT1;TUSC3;MAGT1;DPM2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.3244001645673526,0.8200978303876427,0.7917525773195876,0.9440648464718431,1.0,19/86,17.93%,NFE2L2;ATF3;DDIT3;BACH1;PSMB10;TP53;EPO;IMPACT;PSMA2;PSME3;INO80;PSMB5;PSMD8;PSMD7;PSMB9;HIF1A;GCN1;VHL;PSMD2
prerank,RNA metabolic process (GO:0016070),0.32011794844594016,0.8200007999305129,0.819838056680162,0.9438265777892445,1.0,42/127,25.24%,APOBEC1;DHX9;RBM39;SND1;TFIP11;ADAR;PCBP3;AGO4;FASTKD1;HNRNPL;DDX39B;RNASEL;POLR2L;AGO3;RNASEH1;METTL3;LAGE3;ADARB1;PCBP1;HNRNPD;NUFIP1;LSM8;PABPC4;AGO2;RNASEH2A;RBMS2;POLR2E;HNRNPF;FTO;PABPN1;DICER1;PTBP1;HNRNPA0;RNASE6;ATXN1;SIDT2;DDX20;XRN2;AGO1;HNRNPK;DROSHA;NCBP1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.38545038543709376,0.8198836635037616,0.6974025974025974,0.9436192303840204,1.0,2/17,8.73%,UNC13D;SYT10
prerank,regulation of mitochondrial fusion (GO:0010635),0.41469191623929585,0.8198543346695911,0.7025495750708215,0.943277151140414,1.0,4/11,21.05%,PID1;HUWE1;VAT1;PRKN
prerank,regulation of epithelial cell differentiation (GO:0030856),0.3888037344796468,0.819097278187664,0.6975,0.9439941952300732,1.0,3/17,11.24%,MAFG;CEBPB;SOX9
prerank,double-strand break repair via homologous recombination (GO:0000724),0.3260494418160541,0.819003220892533,0.7957532861476239,0.9437530230880731,1.0,27/95,23.42%,MCM5;ZFYVE26;NABP1;RMI1;SAMHD1;LIG3;YY1;RAD54L;MCM2;MCM6;MCM9;INO80;SLX4;RAD51B;ERCC5;UBE2N;SWI5;RAD51D;SPIDR;CDC45;SFR1;NSMCE2;ERCC4;RFWD3;SEM1;PARP1;MORF4L1
prerank,protein localization to chromosome (GO:0034502),0.35148284754933,0.8186386007234334,0.7265446224256293,0.9439104503942258,1.0,12/34,24.89%,XRCC5;RB1;ATRX;TNKS2;MCM9;SLF2;TINF2;PARP3;TERF2;TERF2IP;ATR;RPA1
prerank,interstrand cross-link repair (GO:0036297),-0.20632799171720728,-0.8182165324657756,0.8484848484848485,0.9529879585877736,1.0,28/53,33.97%,NUCKS1;FAN1;FANCM;ATRIP;XPA;FANCI;ERCC6L2;POLN;DCLRE1A;MSH6;UBC;DCLRE1B;MUS81;FAAP20;RPA3;FANCB;UBA52;FANCD2;FANCC;FANCG;NEIL3;MCM8;RPA2;EXO5;RAD51;RPS27A;RAD51AP2;CENPX
prerank,purine-containing compound catabolic process (GO:0072523),0.4032685142275958,0.8181195270453157,0.6909340659340659,0.9442985738441683,1.0,2/13,8.32%,XDH;PNP
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.36829720804843125,0.8179123470113272,0.713939393939394,0.9442149813607897,1.0,1/23,0.89%,TGFB1
prerank,establishment of epithelial cell polarity (GO:0090162),0.3743784001994599,0.816995333210452,0.7047496790757382,0.9451765687839933,1.0,6/19,18.49%,RAP2A;CYTH1;SIPA1L3;CDC42;RHOA;GOLPH3
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.37680360743275604,0.816835661210235,0.6936936936936937,0.945027292500139,1.0,9/19,25.41%,APOE;SORL1;RTN1;RTN4;BIN1;PICALM;PIN1;IGF1;GGA3
prerank,sphingolipid catabolic process (GO:0030149),0.3865591692364449,0.8168303605947232,0.6783310901749664,0.9446543059464522,1.0,4/15,19.94%,SGPL1;ACER3;ASAH1;SMPD1
prerank,neuron cell-cell adhesion (GO:0007158),-0.29719008969547767,-0.8162251288148761,0.6991869918699187,0.9547363776872462,1.0,3/14,8.29%,NLGN1;ASTN1;NINJ2
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.2596270140025622,-0.8157945547202653,0.776595744680851,0.9533135315931809,1.0,4/22,12.33%,VPS37A;UBAP1;SNF8;VPS4A
prerank,regulation of epithelial cell proliferation (GO:0050678),0.32762859014195267,0.8157096788766738,0.7799385875127943,0.9458999135595996,1.0,19/85,20.22%,TGFB1;NLRC3;MTSS1;AQP11;DUSP10;LIMS1;SOX9;GRN;CDK6;NOD2;B2M;NR4A1;RAB33B;SOX2;SCN5A;ANGPT1;SRSF6;TINF2;ZFP36L1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.34282137761246434,0.8156850283811999,0.7191011235955056,0.945551266583562,1.0,4/35,8.23%,RASAL3;ARHGAP24;RIPOR2;FLCN
prerank,axon guidance (GO:0007411),0.3175682452699596,0.8155821415001989,0.8667334669338678,0.9453297639426718,1.0,45/201,20.37%,SHH;DRAXIN;SPTBN5;PIK3CD;GRB2;PIK3CB;PLXNC1;SEMA4D;TUBB3;DOK1;CXCR4;PLXNB2;EMB;LGR6;GAB2;TNR;EFNA2;SH3KBP1;PRKCQ;NRP1;SEMA4A;CYFIP1;ARTN;PTPRO;FYN;RANBP9;NPTN;EFNB3;SRC;PTPRA;LAMA3;EPHA4;EPHA8;SEMA4B;RPS6KA5;SPTBN4;VLDLR;TMEFF1;PALLD;KLF7;VSTM2L;GDNF;RELN;CNTN4;CDK5R1
prerank,protein localization to cell surface (GO:0034394),0.3609498807315831,0.8154248265552484,0.7302158273381295,0.9451629649194145,1.0,13/26,25.41%,CTNNB1;VCL;PTPRU;GGA2;ARF6;SMURF1;MESD;ANGPT1;PIGU;FLNA;UNC50;PIGK;GGA3
prerank,negative regulation by host of viral transcription (GO:0043922),-0.31913390293908417,-0.8153446063422473,0.6666666666666666,0.952045998103417,1.0,4/12,18.62%,REST;PSMC3;TARDBP;HMGA2
prerank,NAD biosynthetic process (GO:0009435),0.38150754068556836,0.8152613106699346,0.7064676616915423,0.945028919582634,1.0,7/20,19.53%,HAAO;KYNU;NMNAT3;PARP16;NAXD;NAXE;PARP10
prerank,snRNA processing (GO:0016180),-0.27972076786186306,-0.8150539334460175,0.7051282051282052,0.9504184461496995,1.0,6/16,18.65%,INTS9;INTS14;INTS10;TUT1;INTS4;INTS2
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.34418832224351087,0.8142917259864855,0.734304932735426,0.9460461008116577,1.0,17/37,26.91%,SND1;ADPRM;ENTPD1;RNASEH1;HNRNPD;ENTPD2;PABPC4;RNASEH2A;ENTPD3;RNASE6;SIDT2;DNASE1L1;XRN2;NCBP1;DFFB;RNASE3;SUPV3L1
prerank,negative regulation of interleukin-8 production (GO:0032717),0.38290971878752594,0.8142350600084285,0.7049608355091384,0.9457451298948292,1.0,5/17,18.56%,ANXA1;TMSB4X;ANXA4;CD33;MAP2K5
prerank,maturation of LSU-rRNA (GO:0000470),0.3670415975971585,0.8139696664959678,0.7127403846153846,0.9457396817915817,1.0,7/26,20.07%,RPL10A;LAS1L;DDX18;PES1;ZNHIT6;WDR12;RPL7A
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.2674000540267453,-0.8136823108378703,0.7617021276595745,0.9508993454351288,1.0,5/18,12.26%,KANK1;ARHGAP35;SCAI;MET;HEG1
prerank,UV-damage excision repair (GO:0070914),-0.3116625351704996,-0.8135086950631475,0.7201365187713311,0.949085654007364,1.0,5/12,20.73%,DDB2;DDB1;XPA;POLA1;ACTR5
prerank,regulation of neuron differentiation (GO:0045664),0.32614276313118457,0.8134846177727587,0.7796257796257796,0.9460718601404438,1.0,17/76,20.37%,ASCL1;GPRC5B;MMD;MEF2C;NTF3;IMPACT;ZFHX3;LRRK2;SOX2;YWHAH;BIN1;ARHGEF2;RHOA;CASZ1;BEND6;CNTN4;CDK5R1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.3731991850624046,0.813205411170528,0.7090012330456227,0.9460778229838535,1.0,5/21,18.19%,FGF13;ATXN7;CAMSAP2;ARHGEF2;TAOK1
prerank,mitochondrial transcription (GO:0006390),0.41722304747335326,0.8126931855294646,0.7120115774240231,0.946438431618474,1.0,4/10,24.50%,FOXO3;TWNK;TFAM;MRPL12
prerank,cellular response to DNA damage stimulus (GO:0006974),0.31406819175729433,0.8125204660667826,0.925,0.9463046625113941,1.0,58/336,16.82%,LYN;EID3;FAM111A;FNIP2;TAOK3;GTF2H1;GRB2;MAPK14;MAP2K6;NABP1;TANK;BRAT1;DDIT3;VAV3;EXO1;OARD1;BACH1;XRCC5;TAF1;SAMHD1;BCL2L1;TP53;POLH;YY1;CHEK2;ENDOV;DOT1L;MMS19;BAK1;UVRAG;MGMT;BABAM2;RAD54L;ZDHHC16;HPF1;RBBP5;APTX;WDHD1;BOD1L1;TNFRSF1B;METTL3;PDS5A;MCM9;IKBKG;RNF169;INO80;SLX4;RAD51B;SLF2;REXO4;TOP2A;NRDE2;USP16;OGG1;SUV39H1;STXBP4;MACROD1;FANCL
prerank,calcineurin-mediated signaling (GO:0097720),0.4247270071671543,0.8124494994229128,0.6686746987951807,0.945641259600394,1.0,1/10,2.21%,NFATC1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.4247270071671543,0.8124494994229128,0.6686746987951807,0.945641259600394,1.0,1/10,2.21%,NFATC1
prerank,positive regulation of cellular senescence (GO:2000774),0.42973371535458643,0.8123272731128183,0.6973684210526315,0.9454339476947301,1.0,2/10,13.10%,YPEL3;B2M
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.302464277541715,-0.8123207596041736,0.7093023255813954,0.9492282722587524,1.0,3/13,9.45%,SORBS1;IRS1;PRKCZ
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.38135075789718287,0.8122795935901876,0.6962025316455697,0.9451273210560492,1.0,9/18,29.01%,DNAJC13;VPS11;MAP2K2;SRC;PTPN23;RAB21;MAPK1;MAPK3;MSN
prerank,acyl-CoA metabolic process (GO:0006637),0.3417092248537994,0.8121241646330742,0.7315968289920725,0.9449696913095365,1.0,6/35,17.70%,DBI;OGDH;ACSF2;ACOT9;ACACA;ACOT2
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.4256161523605345,0.8119902276774003,0.6925373134328359,0.9447772742768852,1.0,7/10,25.88%,NELL1;EPHA4;FURIN;ATRAID;EFNA1;RIC1;CDK5RAP3
prerank,gonad development (GO:0008406),0.3448208632145199,0.8119236481974271,0.7317073170731707,0.9444877029114723,1.0,2/41,1.64%,GATA1;BASP1
prerank,skeletal system morphogenesis (GO:0048705),0.34019681528276235,0.8115608488480799,0.7266739846322722,0.9446387444565346,1.0,8/42,13.83%,TGFBR1;SKI;LRP5;DYNC2I1;MEGF8;ANKRD11;RAB33B;RFLNA
prerank,regulation of microtubule depolymerization (GO:0031114),0.3627617077906058,0.8115338216384188,0.727164887307236,0.9442998195481926,1.0,6/25,18.19%,FGF13;ATXN7;MAP1B;CAMSAP2;ARHGEF2;TAOK1
prerank,oligodendrocyte development (GO:0014003),-0.2886606837556971,-0.8109429255477274,0.7380952380952381,0.9496058785049089,1.0,7/15,30.63%,EIF2B3;TPPP;EIF2B5;EIF2B4;NSUN5;SOX10;EIF2B1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.21453379721333116,-0.8102532895077497,0.7840909090909091,0.948685681438588,1.0,25/44,37.65%,OSBPL9;OSBPL1A;HMGCR;INSIG1;INSIG2;CYP7B1;SQLE;PER2;PARK7;CYP39A1;AMACR;PMVK;LBR;SCP2;HSD17B4;DHCR7;EBP;SLC27A2;TM7SF2;SC5D;OSBPL2;CH25H;PNPO;CYP46A1;HSD3B7
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.2720885218744131,-0.8100038137160949,0.7767441860465116,0.9469737520941215,1.0,12/19,39.00%,DRG1;CEP97;HNRNPU;CHMP5;CHMP4B;CHMP2A;CHMP4C;CHMP1B;HSPA1A;EML3;HSPA1B;CCSAP
prerank,protein methylation (GO:0006479),-0.21279895141380203,-0.809921632500198,0.8415841584158416,0.9449775617336296,1.0,19/40,30.64%,RAB6A;SETD3;FAM98B;SNRPD3;ATPSCKMT;EZH2;PCMT1;PRMT8;PRMT1;EEF2KMT;LCMT1;METTL22;PRMT7;EEF1AKMT2;N6AMT1;ICMT;CAMKMT;NTMT1;VCPKMT
prerank,bile acid biosynthetic process (GO:0006699),-0.25029957567646177,-0.8098395463950522,0.7115384615384616,0.9430083861890436,1.0,12/24,37.65%,OSBPL9;OSBPL1A;CYP7B1;CYP39A1;AMACR;SCP2;HSD17B4;SLC27A2;OSBPL2;CH25H;CYP46A1;HSD3B7
prerank,protein acylation (GO:0043543),0.34252163602017294,0.809582776146547,0.7410714285714286,0.9467243632514329,1.0,12/38,21.45%,ZDHHC14;ZDHHC7;NAT9;ZDHHC13;ZDHHC16;ZDHHC3;ZDHHC1;SELENOK;GTF2B;ZDHHC21;NAA80;ZDHHC2
prerank,positive regulation of nervous system development (GO:0051962),0.3388862650889629,0.8089758394503593,0.7447973713033954,0.9471846435737792,1.0,2/42,1.61%,CX3CR1;CLSTN1
prerank,double-strand break repair (GO:0006302),0.3187202919007659,0.808893700590572,0.861,0.9469176351613212,1.0,44/158,23.42%,ZFYVE26;MAD2L2;UBE2V2;NABP1;RMI1;BRIP1;HMGB1;XRCC5;SAMHD1;LIG3;YY1;ATP23;CHEK2;TRIP13;BABAM2;HPF1;APTX;DNA2;MCM9;INO80;SLX4;DDX1;RAD51B;ERCC5;MDC1;SMARCAD1;BABAM1;UBE2N;SWI5;ERCC1;RAD51D;POLM;SPIDR;PARP3;SFR1;DCLRE1C;HERC2;NSMCE2;ERCC4;RFWD3;SMARCA5;SEM1;PARP1;MORF4L1
prerank,protein localization to chromatin (GO:0071168),-0.2719795178857145,-0.808889114820959,0.7323943661971831,0.9427207626199233,1.0,3/18,6.23%,NIPBL;WAPL;MSH2
prerank,development of primary male sexual characteristics (GO:0046546),0.35250772040072936,0.808583985758778,0.7381228273464658,0.9469674608342772,1.0,4/34,11.24%,GATA1;LHFPL2;INHBA;SOX9
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.38794202915124504,0.808400963763009,0.7139107611548556,0.9468600232599701,1.0,6/16,21.11%,ATP5MC2;ATP5F1E;ATP5F1A;ATP5PD;ATP5MG;ATP5MF
prerank,neuron remodeling (GO:0016322),-0.32915228249521233,-0.8079977502667013,0.7459807073954984,0.94218808117286,1.0,1/10,0.14%,APP
prerank,axonogenesis (GO:0007409),0.3133422071384627,0.8077099092997491,0.9019019019019019,0.9474635777050623,1.0,45/237,17.76%,SHH;DRAXIN;SPTBN5;NEFH;PIK3CD;GRB2;PIK3CB;S100B;SLITRK1;SEMA4D;TUBB3;DOK1;CXCR4;EMB;LGR6;GAB2;TNR;EFNA2;ACTB;SH3KBP1;PRKCQ;MAP1B;NRP1;SEMA4A;ATL1;CYFIP1;ARTN;PTPRO;FYN;RANBP9;NPTN;USP9X;EFNB3;SRC;PTPRA;LAMA3;PTEN;EPHA4;HSP90AA1;EPHA8;PPP3CB;SEMA4B;RPS6KA5;SPTBN4;VLDLR
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.37048635814549186,0.8076490141902971,0.7146371463714637,0.9471690650188903,1.0,9/22,26.52%,UTP20;NOP9;RRS1;PES1;WDR12;EXOSC3;EXOSC2;URB1;NOP14
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.2808141716586175,-0.8067450984719791,0.7043478260869566,0.942460618762069,1.0,10/16,26.32%,ADSS2;GMPS;PFAS;AMPD3;AMPD2;PAICS;ADSL;IMPDH1;NUDT2;PPAT
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.3704250970526861,0.8064382841718695,0.7083854818523154,0.948465994971084,1.0,5/19,18.35%,MAD2L2;RGCC;PTPRU;DENND6A;FLOT1
prerank,regulation of glycolytic process (GO:0006110),0.32486067259832996,0.8062114242580807,0.7904066736183525,0.9483847017665088,1.0,14/68,16.89%,CBFA2T3;P2RX7;MLXIPL;NUP62;PFKFB4;SEH1L;HDAC4;TPR;NUP205;HIF1A;PFKFB3;GCK;PGAM1;GAPDHS
prerank,actin filament capping (GO:0051693),0.38112920629810215,0.8061659415797113,0.706700379266751,0.947693358704909,1.0,4/18,12.41%,FLII;CAPZB;CAPZA1;TWF2
prerank,barbed-end actin filament capping (GO:0051016),0.38112920629810215,0.8061659415797113,0.706700379266751,0.947693358704909,1.0,4/18,12.41%,FLII;CAPZB;CAPZA1;TWF2
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.3710123681266553,0.8052453771958591,0.7095959595959596,0.9486046242843691,1.0,5/21,15.03%,MYH9;PRKCQ;SPPL3;ERAP1;SPPL2A
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.39584790218368815,0.8051000019705117,0.6918767507002801,0.9484172913371463,1.0,5/12,22.66%,SREBF2;SEC14L2;SREBF1;ABCA2;MBTPS2
prerank,gluconeogenesis (GO:0006094),-0.2240540850698406,-0.8042352912116635,0.8020833333333334,0.9448580836668793,1.0,15/39,23.05%,SLC25A12;PGM1;MDH1;SLC25A13;PGK1;GOT1;ATF4;SLC25A11;PER2;GAPDH;SLC39A14;RBP4;ALDOC;ENO2;CRY1
prerank,positive regulation of protein deacetylation (GO:0090312),-0.29342778202167624,-0.8041809676057502,0.6993243243243243,0.942842183619013,1.0,6/14,29.85%,NIPBL;DYRK1A;NNMT;AKAP8;APLNR;BRMS1
prerank,protein polyubiquitination (GO:0000209),0.3107715900561023,0.8041304334497646,0.924,0.9493973054021859,1.0,57/297,16.01%,MYLIP;RFFL;UBE2V2;ZNRF2;RNF19B;TRIM5;MKRN1;CDC23;UBE2V1;UBE2D3;TRAF2;FBXL22;TNFAIP3;TRAF3;FBXL18;TAF1;HECTD1;CTNNB1;UBE2S;PSMB10;LONRF1;RC3H2;TRIM27;RNF114;UBE2E3;RC3H1;UBE4B;RNF4;TRAF5;UBE2H;NEDD4L;TRIM56;FBXO40;FZR1;PSMA2;SPOP;CDC34;FBXO32;TNKS2;PSME3;RNF216;ITCH;RNF135;FBXL3;STUB1;UBE2G2;RNF144B;PSMB5;HUWE1;AREL1;PSMD8;UBE2J2;ZNRF1;RNF152;PSMD7;PSMB9;SMURF1
prerank,ribosomal subunit export from nucleus (GO:0000054),0.3879090163993019,0.8038157103942623,0.6989100817438693,0.9494781424387798,1.0,3/13,13.01%,XPO1;NOP9;RRS1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.340054536391888,0.8037936903963089,0.7516629711751663,0.9491329273828706,1.0,8/38,15.29%,NDUFB8;NDUFA11;NDUFA2;NDUFB4;NDUFV1;NDUFS6;NDUFAB1;NDUFB11
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.3389914911015327,0.8033654778569869,0.7425414364640884,0.9493462368044625,1.0,8/40,14.11%,BCL2L1;ABCD1;ATP5IF1;PPA2;BAK1;PRDX3;PID1;LRRK2
prerank,L-serine metabolic process (GO:0006563),0.4113301085254031,0.8030188921577056,0.6910919540229885,0.9494392173092828,1.0,5/10,25.00%,CBS;PHGDH;PSAT1;SERINC3;PSPH
prerank,negative regulation of cell junction assembly (GO:1901889),0.36170309282073204,0.8026818328312271,0.7217496962332929,0.949526830852304,1.0,7/25,19.50%,TLR2;TNF;THBS1;SRC;PTEN;CORO1C;ROCK2
prerank,ATP synthesis coupled proton transport (GO:0015986),0.38101621684389636,0.8025334181947767,0.7195902688860435,0.9493469784307562,1.0,6/17,21.11%,ATP5MC2;ATP5F1E;ATP5F1A;ATP5PD;ATP5MG;ATP5MF
prerank,positive regulation of heart rate (GO:0010460),-0.2705415549519577,-0.802345106089473,0.7327586206896551,0.9440329052029689,1.0,6/17,29.44%,RYR2;EDN1;PDE4D;EDN3;ATP2A2;SCN3B
prerank,regulation of rRNA processing (GO:2000232),-0.2709909721299093,-0.8022622006165429,0.7333333333333333,0.9420769609175964,1.0,8/16,32.65%,RIOK2;UTP15;SHQ1;USP36;KAT2B;RIOK1;NUDT16;TRMT112
prerank,nitric oxide biosynthetic process (GO:0006809),0.40080896207494693,0.8019202352228233,0.7089136490250696,0.949820644792623,1.0,2/13,11.67%,GCH1;SPR
prerank,regulation of cartilage development (GO:0061035),0.3737950921023263,0.8019084945804317,0.720626631853786,0.9494602557960028,1.0,4/18,13.72%,MDK;TRPS1;SOX9;SOX6
prerank,nitric oxide metabolic process (GO:0046209),0.39607118118400536,0.8018643853666501,0.7268965517241379,0.9491464951269144,1.0,2/14,11.67%,GCH1;SPR
prerank,sensory perception of smell (GO:0007608),-0.3110909515162681,-0.8015355602090538,0.6959459459459459,0.9413058468359558,1.0,5/11,22.83%,UBR3;BBS4;SLC24A4;DRD2;MKKS
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.22040724804255848,-0.8009244439797845,0.8333333333333334,0.940303459095609,1.0,23/37,35.96%,RFC1;DDB2;DDB1;RBX1;CHD1L;XPA;RFC2;GTF2H3;UBC;POLK;RPA3;GTF2H4;UBA52;POLD2;RPA2;RFC3;RPS27A;RFC4;CUL4B;PCNA;POLD4;POLD1;NTHL1
prerank,C4-dicarboxylate transport (GO:0015740),0.3851151615397992,0.800605907927166,0.7186629526462396,0.9505140541241921,1.0,3/14,13.11%,LRRC8D;SLC25A18;SLC25A30
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.24446648093002635,-0.8005630582689799,0.7821229050279329,0.9389113128074487,1.0,10/24,29.66%,DACH1;ACVRL1;MSH2;MSH6;H1-0;CDKN1A;BMPR2;NIBAN2;MSH3;RTEL1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.39692279857351037,0.8001162769278877,0.726027397260274,0.9508260617899246,1.0,4/14,17.86%,DDX18;PES1;ZNHIT6;WDR12
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.3983766259122315,0.800000293548393,0.700139470013947,0.9506083615133529,1.0,6/11,22.96%,ASF1B;ATRX;UBN1;RBBP4;IPO4;H3-3A
prerank,synaptic membrane adhesion (GO:0099560),-0.2924705043938133,-0.7998838092797323,0.7176470588235294,0.9380724857553947,1.0,2/14,2.84%,GPC6;NTNG1
prerank,neural crest cell migration (GO:0001755),0.34511987410272,0.7994860620610834,0.7453917050691244,0.9509367251377168,1.0,4/36,10.91%,SHH;SEMA4D;NRP1;SEMA4A
prerank,mitochondrial fission (GO:0000266),0.3840308365091431,0.7991837832123696,0.7229551451187335,0.9509775884913255,1.0,7/16,25.20%,MTFR2;DNM2;FIS1;DNM1L;PRKN;MTFR1;MFF
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.29077834120119567,-0.7991756378294644,0.7589285714285714,0.9371441035251328,1.0,4/15,15.17%,BMP4;SIX1;SMO;PAX2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.3862299575715411,0.798403554312074,0.7230169050715215,0.9513024493979567,1.0,3/17,14.18%,STAT5A;STAT5B;IL2RG
prerank,cellular response to interleukin-7 (GO:0098761),0.3862299575715411,0.798403554312074,0.7230169050715215,0.9513024493979567,1.0,3/17,14.18%,STAT5A;STAT5B;IL2RG
prerank,positive regulation of cyclase activity (GO:0031281),0.38678670395239884,0.7983936199769104,0.7046070460704607,0.9509423520498836,1.0,4/14,16.85%,MAPK14;AKAP5;NF1;CACNA1D
prerank,relaxation of muscle (GO:0090075),0.39286221102737695,0.7982106559004551,0.700960219478738,0.9508243631518805,1.0,2/13,5.60%,SLC8A1;P2RX4
prerank,monoacylglycerol metabolic process (GO:0046462),0.3905580454530735,0.7977101622361054,0.7172131147540983,0.9511449792926042,1.0,3/13,19.01%,ABHD12;ABHD16A;DGAT2
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.34800407231243896,0.7975626530246227,0.7549591598599766,0.9509788389520809,1.0,8/27,20.42%,SCN4B;NEDD4L;FXYD5;YWHAH;SCN5A;PTPN3;FXYD6;FXYD1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.37055030942672723,0.7972119717341815,0.72400513478819,0.951084306277486,1.0,6/17,20.85%,TNF;VCL;F11R;ADD1;ROCK2;ZDHHC21
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.40878189540684123,0.7967576125324297,0.7214285714285714,0.9513182975173916,1.0,4/11,16.68%,RESF1;ATF7IP;TPR;TASOR
prerank,import into nucleus (GO:0051170),0.3195732297634978,0.7964685205288469,0.7972972972972973,0.9513584608901798,1.0,6/73,10.17%,MMP12;SYK;NUP62;SNRPD2;CSE1L;TPR
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.3085602360308361,-0.7964193848646508,0.7412587412587412,0.939914798308207,1.0,3/11,7.91%,AHCYL1;PAPOLA;PAF1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.35818556112003885,0.7963674054092666,0.7098765432098766,0.9511246086739933,1.0,2/22,6.80%,MED17;TP53
prerank,response to amino acid (GO:0043200),0.34312856110152773,0.7959549267698494,0.7557077625570776,0.9512839810250678,1.0,10/31,22.01%,MTOR;CPEB3;GLRA2;LAMTOR3;CAPN2;CPEB4;LAMTOR1;RPTOR;RRAGA;RRAGB
prerank,positive regulation of telomere maintenance (GO:0032206),0.3421513055489326,0.7955651942558075,0.7399770904925544,0.9514525148497504,1.0,6/31,14.40%,PKIB;PRKCQ;ATRX;TNKS2;SLX4;HNRNPD
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.27361508638814996,-0.7955161653457679,0.768,0.9395299994934427,1.0,9/16,32.03%,DIP2A;ACLY;MLYCD;PPT1;CBR4;ACSS1;PPCS;GCDH;SLC25A1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.39168452533231907,0.7954441412916736,0.7250341997264022,0.9512540176656696,1.0,4/13,13.22%,SEC16B;SEC16A;SORL1;SAR1A
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.34137801623575087,0.7944530446465672,0.7511574074074074,0.9522039507863207,1.0,6/31,13.07%,SEMA4D;SKI;LRP5;SOX9;CDK6;BAMBI
prerank,negative regulation of stress fiber assembly (GO:0051497),0.3496135257712641,0.7942974889967397,0.7444168734491315,0.952028302760557,1.0,6/24,13.39%,ARHGEF18;ARAP1;WASF2;F11R;PFN1;PPFIA1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.34204171156099666,0.7942606948433987,0.7201834862385321,0.951711286688496,1.0,4/32,6.61%,FGF13;SNCA;ATXN7;MAPRE1
prerank,glycine metabolic process (GO:0006544),-0.3012904870300316,-0.7938055993251387,0.7364341085271318,0.9405423546906956,1.0,6/12,41.51%,DLD;RIDA;GCSH;SHMT2;SHMT1;GLDC
prerank,mitotic sister chromatid cohesion (GO:0007064),0.3720303601172418,0.7937923894385268,0.7213333333333334,0.9519780542622787,1.0,6/16,24.86%,RB1;PDS5A;NAA50;MAU2;SMC1A;PDS5B
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.2938219152783194,-0.7935025857509849,0.7269230769230769,0.9390177444827459,1.0,4/13,14.78%,D2HGDH;ADHFE1;GOT1;DLST
prerank,negative regulation of vascular permeability (GO:0043116),0.3960574639794806,0.7931422650251413,0.7206703910614525,0.9525080659745109,1.0,6/12,25.15%,PTPRJ;DDAH1;ANGPT1;RAMP2;VEGFA;SH3GL2
prerank,positive regulation of DNA recombination (GO:0045911),0.35337895099780964,0.7923236699832381,0.731995277449823,0.9532478581070852,1.0,6/27,19.30%,MAD2L2;MMS19;ACTR2;ERCC6;SHLD1;SHLD2
prerank,fatty acid elongation (GO:0030497),0.3996099075920252,0.7920915894879527,0.7318059299191375,0.9531759946835556,1.0,2/13,8.88%,ABCD1;HACD4
prerank,amyloid fibril formation (GO:1990000),0.3291810403975326,0.7915840559869316,0.7727759914255091,0.953455850447046,1.0,12/51,16.98%,SNCA;TTR;TGFBI;TSPAN14;IAPP;ITM2B;SORL1;B2M;GGA2;USP9X;CD36;FURIN
prerank,myotube cell development (GO:0014904),0.41274415954055177,0.7912476079154394,0.7282127031019202,0.9535170906982183,1.0,1/10,4.38%,SKI
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.3896954405658871,0.7911151499653738,0.7219917012448133,0.9533322317780472,1.0,5/13,23.84%,RAMP1;IL33;ABCA2;CHP1;IGF1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3137142952444205,0.7905469724633661,0.815843621399177,0.9537624043361199,1.0,15/84,17.93%,ANAPC15;PTTG1;CDC23;UBE2S;PSMB10;RB1;FZR1;PSMA2;PSME3;PSMB5;PSMD8;PSMD7;PSMB9;ANAPC11;PSMD2
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3216175669634407,0.7904976632230759,0.7835820895522388,0.953458682431058,1.0,6/56,12.21%,TGFB1;TGFBR1;HFE;INHBA;SNX25;SDCBP
prerank,neural crest cell differentiation (GO:0014033),0.3650381118809098,0.789486478702155,0.7167919799498746,0.9544321959413726,1.0,4/18,19.01%,MEF2C;PDCD6;NRG1;TAPT1
prerank,replication fork processing (GO:0031297),0.3349180024760069,0.7887490524506481,0.7588888888888888,0.9550721742037744,1.0,5/38,12.45%,FAM111A;SAMHD1;ATRX;BOD1L1;DNA2
prerank,regulation of DNA binding (GO:0051101),0.33222739715487454,0.7886027883882855,0.7599557522123894,0.9549083348211835,1.0,4/44,8.22%,TGFB1;SKI;HMGB1;DOT1L
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3251138210916374,0.7881329976099672,0.7916219119226638,0.955199069788939,1.0,7/54,10.53%,RGCC;CNOT8;TP53;CRADD;PLK2;CHEK2;RPL26
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.27746785435261406,-0.7879380090698824,0.7402597402597403,0.9466585051209161,1.0,7/16,17.94%,SMCHD1;KMT5B;DTX3L;KMT5C;WRAP53;KDM4D;PRKDC
prerank,atrial septum morphogenesis (GO:0060413),-0.3155739599378493,-0.787838046864786,0.7366666666666667,0.9447302926228435,1.0,4/10,26.66%,ACVR1;HEY2;BMPR2;TGFB2
prerank,midbody abscission (GO:0061952),-0.27180923840664045,-0.7877398196713645,0.7828054298642534,0.9428276835554006,1.0,5/17,19.93%,VPS4A;CHMP5;CHMP4A;CHMP4B;CHMP2A
prerank,cellular macromolecule catabolic process (GO:0044265),0.3259708381699985,0.7876041628178923,0.7793478260869565,0.9555132328003076,1.0,20/49,26.91%,SND1;OGA;CHEK2;RNASEH1;STT3B;UBE2G2;HNRNPD;IDE;PABPC4;RNASEH2A;FBXO44;PRKN;RNASE6;SIDT2;DNASE1L1;XRN2;NCBP1;DFFB;RNASE3;SUPV3L1
prerank,DNA metabolic process (GO:0006259),0.30365287776386574,0.787328065204877,0.922,0.955527362112185,1.0,59/270,20.60%,MCM5;EID3;ORC3;GTF2H1;UBE2V2;PTGES3;NABP1;EXO1;BACH1;HMGB1;XRCC5;SAMHD1;LIG3;POLH;LONP1;ENDOV;DOT1L;MMS19;UVRAG;MGMT;RAD54L;MCM2;MCM6;DBF4;USP7;WDHD1;ORC4;CDC34;STN1;RNASEH1;PDS5A;DNA2;SMARCB1;ZNF445;INO80;CDC6;SLX4;POLD3;RAD51B;NOC3L;ERCC5;REXO4;TOP2A;OGG1;SMARCAD1;LRWD1;FANCL;CBS;UBE2N;CNBP;RNASEH2A;TOP1;ERCC1;TINF2;RAD51D;PARP3;FANCA;TERF2;CDC45
prerank,positive regulation of lyase activity (GO:0051349),-0.2945526517726104,-0.7866907963937833,0.7626459143968871,0.9425083953521204,1.0,6/14,20.93%,CACNA1C;NOS3;PARK7;NOS1;FXN;ISCU
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.2711619180967379,-0.7865246688644583,0.7863636363636364,0.9407331343424612,1.0,5/16,17.18%,AUTS2;SMAD4;DNMT1;SNW1;PAXIP1
prerank,histone H3-K9 demethylation (GO:0033169),-0.310884431963565,-0.7862029860012171,0.7665505226480837,0.9392715907185085,1.0,5/11,17.22%,JMJD1C;KDM3A;KDM4B;KDM4A;KDM4D
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.31042963218639436,0.7861948099620145,0.829393627954779,0.9566652452482377,1.0,10/87,13.53%,CBL;GRB2;DSTYK;RAB14;CD44;FLRT1;POLR2L;CCL2;NR4A1;FIBP
prerank,negative regulation of centrosome duplication (GO:0010826),-0.30407010524950484,-0.7861872861141167,0.708185053380783,0.937287131881942,1.0,9/11,32.74%,TRIM37;CDK5RAP2;RBM14;CENATAC;KAT2B;NPM1;KAT2A;CCNF;BRCA1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.2476025727507129,-0.7857172464185339,0.7361111111111112,0.9360985917899356,1.0,10/21,28.16%,PAN2;CNOT3;SAMD4B;SAMD4A;TNKS1BP1;PAN3;PARN;CNOT6L;CNOT9;ZFP36
prerank,synaptic vesicle cycle (GO:0099504),0.3374772466896929,0.7856161811698932,0.7613504074505238,0.9570537554827545,1.0,4/30,8.73%,SNCA;PIP5K1C;PLD2;SYT10
prerank,negative regulation of JUN kinase activity (GO:0043508),0.39889944318134696,0.7855242933064578,0.718887262079063,0.9568022569866849,1.0,2/10,10.72%,DUSP10;DUSP19
prerank,striated muscle cell development (GO:0055002),0.38622768012346576,0.7853741733530846,0.7254901960784313,0.9566441921843462,1.0,2/14,15.00%,FLII;CAPN3
prerank,activation of protein kinase B activity (GO:0032148),0.339850169328154,0.7853126185872981,0.747072599531616,0.9563602497350078,1.0,7/29,17.75%,MTOR;IL18;NTF3;NRG1;GAS6;OSBPL8;PDPK1
prerank,mitochondrion organization (GO:0007005),0.30696366505687694,0.785001136603238,0.8853118712273642,0.956392808173552,1.0,38/165,19.90%,TSPO;RAB32;MTFR2;AIP;ATP7A;PYROXD2;BCL2L1;DNM2;MEF2A;LONP1;ATP23;MSTO1;CHCHD4;TIMM22;PPARGC1A;ATCAY;IMMP2L;MGME1;TIMM50;PRDX3;WDR81;PID1;HCFC1;TOMM40;HK2;ATAD3A;LRRK2;MIGA1;AGTPBP1;TWNK;YME1L1;PITRM1;FIS1;RAB29;TOMM20;DNM1L;MFN1;MPV17
prerank,nucleotide metabolic process (GO:0009117),-0.2417835982657411,-0.7845996658714878,0.8072289156626506,0.936010591162862,1.0,11/23,29.07%,ME1;NUDT5;RNASEH2B;ENPP3;NMNAT1;PARK7;GUK1;AK4;CMPK2;NME2;CMPK1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.3091144830478536,0.784404204935241,0.8259067357512954,0.9568342254193932,1.0,9/86,12.21%,TGFB1;TGFBR1;ZEB2;RNF111;HFE;FLCN;INHBA;THBS1;SDCBP
prerank,glial cell differentiation (GO:0010001),0.3476587276555704,0.7843738418938656,0.7444831591173054,0.9564974028681933,1.0,4/28,14.67%,SHH;SOX9;SOX2;SOX4
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.3780582914382577,0.7843140357340125,0.7440318302387268,0.9562119635435838,1.0,2/14,8.05%,TRAF2;MALT1
prerank,GTP metabolic process (GO:0046039),0.3789608003886533,0.7840026234524607,0.7273954116059379,0.9562429321212902,1.0,6/15,23.61%,GTPBP1;LRRK2;GNAI3;IMPDH2;MFN1;EFL1
prerank,negative regulation of double-strand break repair (GO:2000780),0.342962541790967,0.7838319268685892,0.7561837455830389,0.956098685499744,1.0,8/30,19.30%,MAD2L2;TFIP11;HSF1;RNF169;ERCC6;OGG1;SHLD1;SHLD2
prerank,alpha-amino acid catabolic process (GO:1901606),0.3416095870754927,0.7837953787249954,0.7482435597189696,0.9557766359779095,1.0,5/29,17.04%,HAAO;KYNU;KMO;THNSL2;CBS
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.21565531002712793,-0.7836635042818332,0.8691588785046729,0.9354838456727108,1.0,24/39,35.96%,RFC1;DDB2;DDB1;FAN1;RBX1;CHD1L;XPA;RFC2;GTF2H3;UBC;POLK;RPA3;GTF2H4;UBA52;POLD2;RPA2;RFC3;RPS27A;RFC4;CUL4B;PCNA;POLD4;POLD1;NTHL1
prerank,regulation of chromatin organization (GO:1902275),0.3823698877169406,0.7835907270475033,0.7356948228882834,0.9556745527340368,1.0,3/14,10.32%,TLK1;METTL4;HPF1
prerank,cellular response to superoxide (GO:0071451),0.4026441137800192,0.7830439657234498,0.729106628242075,0.9560157950905285,1.0,3/10,13.07%,ATP7A;PRDX1;PRDX2
prerank,copper ion homeostasis (GO:0055070),0.37149184943625735,0.7826759456433903,0.7363636363636363,0.9561216878949446,1.0,2/17,4.55%,ATP7A;ATOX1
prerank,relaxation of cardiac muscle (GO:0055119),0.3846938846724657,0.7826439579454799,0.7142857142857143,0.9557977405281145,1.0,2/13,5.60%,SLC8A1;P2RX4
prerank,protein localization to phagophore assembly site (GO:0034497),-0.3029027813348183,-0.7825876167856239,0.7582781456953642,0.935248966040877,1.0,8/11,44.82%,MFN2;WDR45B;WDR45;WIPI1;ATG9A;ATG13;STX17;WIPI2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.35705972284846965,0.7822242314356384,0.7120481927710843,0.9559737080407387,1.0,4/22,12.31%,P2RX4;MEF2A;SLC9A1;LMCD1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.30285947016049014,0.7819307817894314,0.92992992992993,0.9559895495675846,1.0,62/241,21.79%,IK;SNRNP27;DHX9;BCAS2;SF3B2;SF3B1;PPIE;DHX38;SNRNP25;CWF19L1;CCAR1;CSTF1;DNAJC8;ZMAT5;TFIP11;GCFC2;CASC3;SNRPD2;CDC5L;RBM15B;CWC27;HNRNPL;RBMX2;DDX39B;SNIP1;POLR2L;CHERP;PRPF8;METTL3;TRA2B;CTNNBL1;RBM41;PCBP1;UPF3B;HNRNPD;WDR83;BUD31;CWF19L2;LSM8;CRNKL1;PCF11;PPIH;DDX41;SLU7;SNRNP35;SNRNP200;POLR2E;SNRPB2;SRSF2;SRSF6;HNRNPF;PNN;PABPN1;SF3B3;SART1;SRSF3;SRSF10;PTBP1;HNRNPA0;UBL5;PRCC;PDCD7
prerank,neural crest cell development (GO:0014032),0.32826369815710965,0.7817977979629631,0.7763012181616833,0.9558036796523811,1.0,9/44,19.55%,SHH;SEMA4D;PDCD6;SEMA4A;NRG1;CORO1C;SEMA4B;TAPT1;GDNF
prerank,selective autophagy (GO:0061912),0.31861770629750014,0.7815757957056044,0.7870074547390842,0.955724530741865,1.0,23/56,27.29%,MAP1LC3B;UBE2V1;RAB7A;BECN1;HDAC6;DYNC1H1;WDR81;TEX264;RETREG1;ATG2B;UBE2N;WDFY3;ATG14;PRKN;RB1CC1;UBA5;IFT88;DYNC1LI1;AMBRA1;NBR1;ATG2A;DYNLL1;UFM1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.33096121009057,0.7811951612952684,0.7767955801104972,0.9558481784182932,1.0,11/35,25.56%,ALOX12;HPGD;GGTA1;FASN;ACACA;PPT2;FAR2;HMGCL;SCD;HSD17B8;ACSS3
prerank,cilium assembly (GO:0060271),0.30435060083465604,0.780920185121626,0.951,0.9558576862066316,1.0,55/296,17.84%,TUBB;MKS1;RAB8B;PRKAR2B;HAUS2;ASAP1;EXOC6;TUBA4A;IFT52;RP2;CNTRL;CEP192;MAPRE1;CNGB1;CEP70;SPATA6;BBS9;PLK4;ATP6V0D1;DISC1;CEP76;SNAP29;HAUS1;ACTR2;RAB11A;ACTR3;HDAC6;WDR11;DYNC1H1;EXOC8;EXOC7;EXOC1;DYNC2I1;PCM1;IFT80;EXOC2;EXOC5;TXNDC15;RPGR;FNBP1L;CEP152;EXOC3;HAUS8;CEP162;JHY;WDR90;AHI1;NINL;HSP90AA1;WDPCP;IFT27;NUDCD3;AKAP9;DYNC2LI1;SNX10
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.2684688582368235,-0.7806742740298852,0.7735042735042735,0.9364469382554701,1.0,7/16,31.97%,UPP2;NT5E;CRMP1;DPYSL2;NT5C1A;UPB1;DPYSL3
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.30187650787313774,0.7806285847519054,0.942,0.9558826778759533,1.0,67/264,21.79%,IK;SNRNP27;DHX9;BCAS2;SF3B2;SF3B1;PPIE;DHX38;SNRNP25;SCAF11;CWF19L1;CCAR1;CSTF1;DNAJC8;ZMAT5;TFIP11;GCFC2;CASC3;SRPK3;SNRPD2;CDC5L;RBM15B;CWC27;HNRNPL;RBMX2;DDX39B;SNIP1;POLR2L;CHERP;PRPF8;METTL3;TRA2B;CTNNBL1;RBM41;PCBP1;UPF3B;DDX1;HNRNPD;WDR83;BUD31;CWF19L2;LSM8;CRNKL1;PCF11;PPIH;DDX41;SLU7;SNRNP35;SNRNP200;POLR2E;SNRPB2;SRSF2;SRSF6;HNRNPF;PNN;CLNS1A;PABPN1;SF3B3;SART1;SRSF3;SRSF10;STRAP;PTBP1;HNRNPA0;UBL5;PRCC;PDCD7
prerank,mitotic nuclear division (GO:0140014),0.31572236958370803,0.7802158411358536,0.8190376569037657,0.9560589291512662,1.0,14/71,17.66%,NUP62;ESPL1;BCCIP;NCAPG2;CEP192;UBE2S;CHEK2;RAB11A;STAG2;INO80;KIF2A;CENPK;MIS12;RHOA
prerank,calcium ion transport (GO:0006816),0.30909051800770065,0.7801368870554353,0.8446014127144299,0.9557956712887196,1.0,22/113,17.46%,KCNN4;P2RX7;SLC8A1;CCL8;PKD2;ORAI2;P2RX4;CACNA1A;RAMP1;ATP2C1;TPT1;CACNB2;FYN;CDH23;ATP2A3;GAS6;CACNA1B;TRPV3;SELENOK;CACNA1D;CRACR2B;TMEM165
prerank,negative regulation of anoikis (GO:2000811),-0.28913487075495614,-0.778509461417492,0.7310924369747899,0.9378570358267989,1.0,2/14,6.97%,CAV1;TLE1
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.28743569982050643,-0.7783508526008387,0.7796610169491526,0.9361199665883665,1.0,2/12,4.87%,ARHGAP35;EPHB2
prerank,mitochondrion morphogenesis (GO:0070584),-0.30581614675858265,-0.7781433147823443,0.7508305647840532,0.9344760330110912,1.0,6/11,28.57%,MTM1;NUBPL;WASF1;SLIRP;MYH14;PNPT1
prerank,replicative senescence (GO:0090399),0.3862294332323264,0.778115990728857,0.7279102384291725,0.9580769759303178,1.0,2/12,8.05%,TP53;CHEK2
prerank,transport across blood-brain barrier (GO:0150104),0.3146614571603712,0.777896855185625,0.84,0.9579983512058667,1.0,14/83,15.32%,SLCO2B1;ABCC3;ATP8A1;SLC7A8;SLC2A3;SLC16A2;FABP5;ABCC1;SLC16A1;ATP2A3;ATP1B2;LRP1;SLC1A4;CD36
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.3973518891596793,0.7776334931557393,0.7408450704225352,0.9579677569453066,1.0,3/11,11.24%,TGFBR2;LRP5;SOX9
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.3468288591716577,0.7775767848792067,0.7380352644836272,0.9576712759764568,1.0,10/23,27.16%,HMGB1;REXO4;KPNA1;DICER1;DNASE2;DNASE1L1;DFFB;CECR2;KPNB1;HMGB2
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.40641852053229877,0.7774736935931511,0.7348148148148148,0.9574399906809107,1.0,2/10,14.29%,SNCA;NOC2L
prerank,protein K48-linked deubiquitination (GO:0071108),0.34999236405764667,0.7770290103347821,0.7248484848484849,0.9576492176377955,1.0,5/23,15.04%,TNFAIP3;OTUD3;ATXN3;MINDY1;USP8
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.3700575540939768,0.7767869617666043,0.7447089947089947,0.9576057431681929,1.0,1/15,2.24%,DAGLB
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.21707204406668026,-0.7766225009379357,0.8739495798319328,0.9349491251356015,1.0,22/35,39.68%,RFC1;TDG;XRCC1;SMUG1;RFC2;POLG;LIG1;RPA3;POLD2;NEIL1;RPA2;RFC3;POLE;RFC4;MUTYH;PCNA;POLD4;POLD1;NTHL1;MPG;POLL;RFC5
prerank,positive regulation of cell growth (GO:0030307),0.308772983902688,0.7764003605546755,0.8439716312056738,0.9577470836370583,1.0,24/96,22.96%,SYT17;TGFBR1;SEMA4D;BRAT1;MACF1;SYT2;CSNK2A1;NEDD4L;SDCBP;TWF2;INO80;SMURF1;CXCL16;RASAL1;CDC42;RPTOR;PLAA;UNC13A;PABIR1;RIMS1;ITSN2;EXOSC2;GOLGA4;H3-3A
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.3744421744078749,0.7763443311741602,0.7612551159618008,0.9574536333752253,1.0,2/15,6.74%,TGFBR1;TGFBR2
prerank,inorganic anion transport (GO:0015698),0.31772336423951175,0.7755088274944056,0.7963558413719185,0.9581721665613765,1.0,6/53,15.41%,SLC11A1;PACC1;CLIC1;XPR1;SLC25A30;CLCN4
prerank,negative regulation of cell growth (GO:0030308),0.3040980320472199,0.7754933809991489,0.8693009118541033,0.9578238432244252,1.0,14/121,12.38%,TGFB1;PTPRJ;FGF13;NME6;DIP2B;CDA;TP53;FLCN;RB1;SMAD3;SIPA1;INHBA;RBBP7;PPP2CA
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.3370996641757849,0.775471204774308,0.7464285714285714,0.9571126005579972,1.0,6/29,22.26%,DBI;ACSF2;ACOT9;ACOT2;CROT;ACOT8
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.3370996641757849,0.775471204774308,0.7464285714285714,0.9571126005579972,1.0,6/29,22.26%,DBI;ACSF2;ACOT9;ACOT2;CROT;ACOT8
prerank,protein-DNA complex assembly (GO:0065004),0.30423117114761006,0.7750928539791084,0.861648016276704,0.9572538042637786,1.0,23/116,18.39%,MCM5;ORC3;GTF2H1;PSMB10;CDK7;ATRX;MCM2;MCM6;NAP1L1;PSMA2;SOX9;ORC4;PSME3;PSMB5;CDC6;PSMD8;SPTY2D1;ERCC5;PSMD7;PSMB9;RSF1;PSMD2;GTF2H5
prerank,negative regulation of telomere maintenance (GO:0032205),0.37365986154837944,0.7737477613356363,0.748993288590604,0.9586544958738145,1.0,7/15,23.36%,TNKS2;SLX4;ERCC1;TERF2;ERCC4;TERF2IP;PARP1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.3972346388621867,0.7734478774506939,0.7018284106891702,0.9586778429268282,1.0,2/10,10.12%,SETD6;SETD2
prerank,cellular response to leucine (GO:0071233),0.40460486246853594,0.7729714266795196,0.7453237410071942,0.958545142610758,1.0,1/10,2.55%,MTOR
prerank,response to leucine (GO:0043201),0.40460486246853594,0.7729714266795196,0.7453237410071942,0.958545142610758,1.0,1/10,2.55%,MTOR
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.33663813384547453,0.772261240359966,0.7453051643192489,0.9590818912123752,1.0,8/28,20.46%,MAD2L2;TFIP11;HSF1;ACTR2;ERCC6;SHLD1;SHLD2;PARP3
prerank,amide biosynthetic process (GO:0043604),0.32025111011285573,0.7722078060280532,0.7911255411255411,0.9587836548765669,1.0,10/47,20.72%,CERS6;CLN8;AGK;DEGS1;ASAH1;FURIN;SGMS1;SPTSSA;SMPD1;SPTSSB
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.39471795582626007,0.7716671258125917,0.723589001447178,0.9590761986052374,1.0,5/10,23.92%,NF2;SH2B3;PPP2CA;SOCS3;INPP5F
prerank,protein modification process (GO:0036211),0.30914203355709036,0.7709456241645211,0.8224974200206399,0.9596510859594621,1.0,23/76,24.63%,UBE2D3;ST8SIA4;UBE2S;LOX;ST3GAL1;MAN2B1;PIGH;MCRS1;MSRA;YES1;CDC34;B4GALT7;ATG3;ERO1A;PPP4R2;CSNK1G3;UBL5;ADPRH;UBA7;PARP1;UBE2I;BAP1;ABL2
prerank,electron transport chain (GO:0022900),0.3827879120690626,0.7706447567346121,0.7506561679790026,0.9596586450078334,1.0,5/15,20.59%,PPARGC1A;POR;SDHB;ETFDH;SDHA
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.37383268646673146,0.7704605007008481,0.7430555555555556,0.9595108656267969,1.0,3/13,12.25%,MMS19;CIAO2A;CIAO1
prerank,cellular response to hydroxyurea (GO:0072711),0.39470982190930004,0.7700555916835746,0.7307692307692307,0.9596694216419915,1.0,2/10,9.58%,DDI2;ATRX
prerank,positive regulation of intracellular transport (GO:0032388),0.3252455182879075,0.7695776782176561,0.7660753880266076,0.9599119463487975,1.0,7/38,12.90%,RIPOR1;KIF20B;PGAP1;TPR;DYNC1H1;PCM1;SORL1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.37483266879966937,0.7694061575472925,0.7524339360222532,0.9597677749878274,1.0,2/14,9.03%,PTPN1;BAK1
prerank,phospholipid dephosphorylation (GO:0046839),-0.21319992703238744,-0.7690730995318714,0.8532110091743119,0.9451591915492686,1.0,3/37,1.32%,MTM1;SACM1L;MTMR7
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.28485109101903844,-0.768730151110768,0.767175572519084,0.9437474879331871,1.0,4/13,17.11%,PTGIS;NAMPT;PTGS2;NNMT
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.32619709705380007,0.7683593837318549,0.7833698030634574,0.9606979888012638,1.0,13/42,24.65%,MAD2L2;MMS19;ACTR2;SETD2;ERCC6;PPP4C;PPP4R2;SHLD1;SHLD2;SPIDR;TERF2IP;PARP1;KLHL15
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.27144286403604834,-0.7682359738492032,0.7877551020408163,0.9406263203507483,1.0,4/16,15.66%,PHLDB2;ACVRL1;ARHGAP6;DMTN
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.27144286403604834,-0.7682359738492032,0.7877551020408163,0.9406263203507483,1.0,4/16,15.66%,PHLDB2;ACVRL1;ARHGAP6;DMTN
prerank,cilium movement (GO:0003341),0.31306910803470744,0.7679981817700968,0.7785016286644951,0.9608162051077438,1.0,4/47,7.92%,DNAI4;ODAD2;TTC29;ODAD1
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.36558128109331445,0.7671677768645978,0.7410714285714286,0.9615118604701639,1.0,5/16,17.41%,ST8SIA4;ST6GALNAC4;ST8SIA1;LARGE1;B4GALNT1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.2993254638072244,0.7667500301458536,0.8816449348044132,0.9616586969717572,1.0,41/132,25.40%,DHX9;PTGES3;SF3B1;SCAF11;XRCC5;GCFC2;SRPK3;SNRPD2;ERAL1;RPL6;EIF4H;DDX39B;LUC7L3;MDN1;RPS14;RRS1;DDX1;RPL11;TARBP2;HSP90AA1;CRNKL1;RPS27;SNRNP200;SRSF6;CLNS1A;SART1;SRSF10;RRP7A;DICER1;STRAP;EIF2S2;SNRPB;RPS15;GEMIN8;RPS5;DDX20;NUDT21;RPL10;NCBP1;XAB2;HSP90AB1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.3959606631346629,0.7665326504363006,0.755223880597015,0.9615498089289367,1.0,4/10,22.68%,TFIP11;TERF2;DCLRE1C;TERF2IP
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3380454005626364,0.7662481398271129,0.7469586374695864,0.9615507342948272,1.0,6/26,18.91%,NR1H4;LRP5;ADCY8;STXBP4;PPP3CB;KLF7
prerank,DNA repair (GO:0006281),0.29745631363378067,0.7660715067967688,0.967,0.9613996625366702,1.0,51/284,17.21%,EID3;FAM111A;NEIL2;GTF2H1;MAD2L2;UBE2V2;NABP1;UBE2V1;EXO1;BRIP1;BACH1;XRCC5;LIG3;ATXN3;TP53;POLH;FAAP100;CHEK2;ENDOV;DOT1L;TRIP13;MMS19;UVRAG;MGMT;BABAM2;RAD54L;SETD2;HPF1;MGME1;APTX;WDHD1;PDS5A;DNA2;PMS1;TEX264;INO80;SLX4;DDX1;HUWE1;POLD3;ALKBH5;RAD51B;ERCC5;REXO4;ERCC6;OGG1;MDC1;BABAM1;FANCL;FANCE;UBE2N
prerank,protein localization to cilium (GO:0061512),-0.22069456371376384,-0.7656524661735373,0.8717948717948718,0.9426835039349861,1.0,15/32,26.74%,ZNF423;ARL3;ATP6V1D;BBS4;ARL6;EHD1;WDR35;IFT20;TCTN2;BBS1;IFT122;TUB;WDR19;TULP2;NPHP4
prerank,cardiac muscle cell contraction (GO:0086003),0.3558139234045836,0.7656172218350425,0.7450738916256158,0.9616093639750531,1.0,2/19,3.74%,SCN4B;PKP2
prerank,ERK1 and ERK2 cascade (GO:0070371),0.3517663150512982,0.7653328590243622,0.7431077694235589,0.9615946077648592,1.0,10/21,27.51%,MAP2K2;SOX9;ZFP36L1;MT3;IGF1;KDR;PTGER4;MAPK1;MAPK3;CTSH
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.3470687257006649,0.7646697449486582,0.7623888182973316,0.9620595898076281,1.0,7/21,20.24%,MLXIPL;NCK2;DDIT4;PTEN;PAQR3;CNKSR3;INPP5K
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.3412284111002878,0.7640185303373617,0.7628361858190709,0.9625019214999657,1.0,4/23,11.82%,HERPUD1;SEL1L;DERL1;SEC16A
prerank,regulation of axon extension (GO:0030516),0.3268476923645089,0.7623455115014809,0.7867564534231201,0.9642549242480994,1.0,10/37,22.88%,APOE;DIP2B;MACF1;DNM2;TWF2;RTN4;GSK3B;MT3;NRCAM;GOLGA4
prerank,regulation of steroid biosynthetic process (GO:0050810),0.3771643718330774,0.7616209269306599,0.7455882352941177,0.9648188066374649,1.0,1/11,2.45%,NR1H4
prerank,mRNA export from nucleus (GO:0006406),0.29852363618898814,0.7613915619559319,0.8543788187372708,0.9647528452431696,1.0,29/102,21.54%,PCID2;NUP62;DHX38;NXF1;THOC2;SEH1L;CASC3;RBM15B;SMG1;TPR;DDX39B;NUP205;POLDIP3;THOC3;UPF3B;ALKBH5;SMG7;UPF2;FYTTD1;SLU7;SRSF2;SRSF6;SEC13;PABPN1;SLBP;HHEX;SRSF3;NUP54;IWS1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.33849410565383276,0.7612208618828878,0.7599517490952955,0.9646221030848222,1.0,7/25,16.57%,ATXN3;LONP1;DERL1;HDAC6;STUB1;TOR1A;YME1L1
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.3479538861911603,0.7612009580652035,0.75875,0.9642802543348755,1.0,2/19,10.17%,APOE;RAPSN
prerank,regulation of autophagosome maturation (GO:1901096),0.372156781811615,0.7605902169600783,0.7553763440860215,0.9646883381841158,1.0,3/13,16.24%,CLN3;UVRAG;IRGM
prerank,aminoglycan metabolic process (GO:0006022),0.39889785723769244,0.7605633294645919,0.7676767676767676,0.9643541365134907,1.0,3/10,21.21%,XYLT1;B4GALT7;B3GAT2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.3497083473938582,0.7604451370151953,0.7619647355163728,0.964130156272367,1.0,3/19,12.62%,PYCARD;TP53;DDIT4
prerank,DNA duplex unwinding (GO:0032508),0.31366507726985,0.7604280613021274,0.8010695187165775,0.9637878456180451,1.0,8/50,15.43%,GTF2H1;DHX9;ANXA1;MCM2;MCM6;MCM9;DDX1;TWNK
prerank,synapse organization (GO:0050808),0.2999443142212616,0.7603009696916566,0.8791878172588833,0.9635704856860753,1.0,17/125,14.92%,CX3CR1;PCDHB6;ARHGAP39;C1QC;SLITRK1;SNCA;AGRN;C1QA;CACNB4;RAB39B;C1QB;CACNB2;CYFIP1;CACNB1;PPFIA1;LRRK2;KIRREL3
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.39137310715562423,0.7600802934047843,0.7542134831460674,0.9634798814924332,1.0,4/11,16.48%,PIK3CB;CREB3L1;THBS1;EPN1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.33343699092333234,0.7600394692760385,0.7720763723150358,0.9631670210322053,1.0,5/29,11.39%,TLE3;CTNNB1;LEO1;RBBP5;PYGO2
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.3775573818013548,0.759627917187197,0.7546099290780142,0.9633198971561927,1.0,5/13,23.61%,GTPBP1;LRRK2;GNAI3;MFN1;EFL1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.3920092090569773,0.7594680523234194,0.7496318114874816,0.9631438970100361,1.0,1/10,3.81%,DNMT3A
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.3777463376991017,0.7593476830344036,0.7725988700564972,0.9629279719930024,1.0,2/13,9.03%,PTPN1;PDCD6
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.29915042039620066,0.7593321399606177,0.8673469387755102,0.9625811953904103,1.0,20/94,17.93%,IL1A;IRAK2;UBE2V1;PSMB10;ST18;PSMA2;RPS6KA4;NOD2;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;TAB3;PSMD7;PSMB9;UBE2N;RPS6KA5;PSMD2
prerank,cochlea morphogenesis (GO:0090103),-0.3081062514814493,-0.7586153009228479,0.7668918918918919,0.951368888787947,1.0,3/10,15.17%,TBX18;TBX1;PAX2
prerank,protein destabilization (GO:0031648),0.3285701035368257,0.7581739613058313,0.779976717112922,0.9636667557060928,1.0,16/32,29.14%,SNCA;DERL1;FBXL3;CAPN3;IRGM;FBXW11;CUL3;PRKN;HTT;GGA3;CTSH;CREBBP;PRNP;SENP2;CDC73;EP300
prerank,mitotic spindle organization (GO:0007052),0.2973335296261941,0.7580827615969962,0.9127382146439318,0.9634096996991693,1.0,29/153,18.40%,ERCC6L;NEK6;CENPO;BCCIP;XPO1;CEP192;MAPRE1;SEH1L;PLK2;CHEK2;KIF23;RAB11A;DYNC1H1;PMF1;STAG2;CENPI;KIF2A;PPP1CC;CENPQ;PTPA;INTS13;INCENP;EML4;CENPK;MIS12;RHOA;RPS27;TAOK1;DCTN6
prerank,protein monoubiquitination (GO:0006513),0.3257821698351874,0.7579092241608429,0.8097949886104784,0.9632526388336614,1.0,11/36,21.89%,TRIM25;UBE2D3;MGRN1;LEO1;RNF40;HUWE1;FANCL;CUL3;UBE2R2;PRKN;UBE2E1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.36250139482115085,0.7577286725126343,0.7642276422764228,0.9630976379021873,1.0,5/14,21.80%,HDAC5;THBS1;RHOA;MAP2K5;MMRN2
prerank,dendrite self-avoidance (GO:0070593),0.36036346692065657,0.7574958804832912,0.7556440903054449,0.9630122124190611,1.0,5/16,20.36%,EMB;NPTN;PALLD;VSTM2L;CNTN4
prerank,mitochondrial protein processing (GO:0034982),0.3878674138142899,0.7567696857442059,0.7570621468926554,0.9635443672914996,1.0,5/11,19.63%,ATP23;IMMP2L;PMPCB;YME1L1;PMPCA
prerank,hexose transmembrane transport (GO:0008645),0.3511013989167139,0.7567385796985084,0.7756653992395437,0.9632126225465455,1.0,3/21,17.29%,SLC2A3;SLC2A12;PPARD
prerank,C-terminal protein amino acid modification (GO:0018410),-0.2965322316769354,-0.7559559126322386,0.7722772277227723,0.9533987876235126,1.0,8/11,28.18%,AGBL4;FOLH1;GPLD1;TTL;LCMT1;AGBL1;ATG5;ICMT
prerank,response to growth factor (GO:0070848),0.31426816838307997,0.7554774154309618,0.8085808580858086,0.9644004941956467,1.0,7/41,14.18%,TGFBR1;CTNNB1;TGFBR2;STAT5B;HDAC6;TWF2;SOX2
prerank,mitochondrial transport (GO:0006839),0.30862665706703446,0.7553814666601517,0.827807486631016,0.9641442286813084,1.0,6/53,9.03%,TSPO;SLC25A16;AIP;BCL2L1;TIMM22;BAK1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.3357001481895449,0.7543081283797354,0.7629987908101572,0.9650752318307206,1.0,6/28,18.52%,GAS2L1;MAPRE1;MAP1B;CAMSAP2;MAPRE2;GBA2
prerank,cell part morphogenesis (GO:0032990),-0.28135459314302824,-0.754204462200642,0.7818181818181819,0.9538777346833978,1.0,6/13,28.57%,MTM1;NUBPL;WASF1;SLIRP;MYH14;PNPT1
prerank,regulation of cell growth (GO:0001558),0.2940116464686794,0.7540493335010201,0.933,0.9650333881942903,1.0,34/204,17.62%,TGFB1;TGFBR1;PTPRJ;MAD2L2;MTOR;NME6;BRAT1;RASGRP2;CDA;CDK11B;TP53;PRKCQ;CSNK2A1;KIF14;FLCN;RB1;SMAD3;SIPA1;BCAR1;INHBA;RBBP7;SDCBP;PPP2CA;ITCH;INO80;RAB33B;ATAD3A;ARHGEF11;SGK3;CXCL16;RTN4;DCBLD2;LAMTOR1;CDC42
prerank,cellular response to amino acid stimulus (GO:0071230),0.3280681456747489,0.7540095150379978,0.7907239819004525,0.9647102217255848,1.0,11/33,22.01%,MTOR;CPEB3;GLRA2;FYN;LAMTOR3;CAPN2;CPEB4;LAMTOR1;RPTOR;RRAGA;RRAGB
prerank,tRNA wobble uridine modification (GO:0002098),0.37210176844371373,0.7539162613710235,0.7655826558265583,0.9644557737980572,1.0,3/14,11.59%,ELP1;TRMU;CTU1
prerank,cardiac ventricle development (GO:0003231),-0.24952914108474367,-0.7538514298663302,0.8010204081632653,0.9524775746830545,1.0,9/20,30.23%,SALL1;HES1;STRA6;PDE2A;HEY2;MATR3;DAND5;TMEM65;HEY1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.2908692632207487,0.7535264298799966,0.9077231695085256,0.9645804989757976,1.0,33/161,18.48%,DRAXIN;TMEM131L;MAD2L2;MDK;TLE3;DKK2;APOE;TPBGL;DDIT3;PSMB10;SCYL2;AMER1;PSMA2;SOX9;PTPRO;PTPRU;CSNK1A1;PSME3;STK3;PSMB5;SOX2;PSMD8;TLE5;PSMD7;GSK3A;PSMB9;STK4;INVS;ZNRF3;PSMD2;IGFBP4;DACT1;GREM1
prerank,cytoplasmic sequestering of protein (GO:0051220),0.3733091892215846,0.7531647627565249,0.7669902912621359,0.9646564222804118,1.0,5/13,21.99%,PKD2;YWHAB;KEAP1;NFKBIE;FLNA
prerank,regulation of DNA repair (GO:0006282),0.31704430201923917,0.7531307399040691,0.8085339168490153,0.96433697701219,1.0,11/44,18.74%,DHX9;UBE2V2;UBE2V1;POLH;BABAM2;KAT7;ERCC6;BABAM1;UBE2N;NPAS2;TIGAR
prerank,regulation of cilium movement (GO:0003352),0.3845698559438615,0.7526838383551722,0.7460087082728593,0.9645168436246611,1.0,1/10,5.58%,ODAD2
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.3675387905939142,0.7526344786218806,0.7647058823529411,0.9642011669763875,1.0,7/13,28.52%,TNRC6A;CPEB3;AGO2;CNOT7;CNOT1;BTG2;TNRC6C
prerank,protein heterotetramerization (GO:0051290),0.3786240980013271,0.7524329030606842,0.7534435261707989,0.9640733177764746,1.0,2/13,5.98%,PKD2;FARSB
prerank,glycolipid biosynthetic process (GO:0009247),0.32132049596036527,0.7517390098792536,0.7967032967032966,0.9645478632630184,1.0,13/38,23.09%,PIGM;PIGL;PIGV;PIGH;ST8SIA1;LARGE1;PGAP2;PIGC;PIGU;PIGN;B4GALT6;DPM2;PIGP
prerank,purine ribonucleotide metabolic process (GO:0009150),0.30088969106607,0.7515486475914274,0.837696335078534,0.9644234510667369,1.0,17/68,23.61%,DBI;SULT4A1;GTPBP1;HINT1;BPNT1;ACSF2;TPST1;LRRK2;GNAI3;ACOT9;ACOT2;MFN1;GMPR2;CROT;ACOT8;TPST2;EFL1
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.2854170996155396,-0.7515295280747228,0.8198529411764706,0.9537873742113212,1.0,2/13,5.98%,RANBP2;IPO5
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.25698644691006,-0.7514300351231091,0.827433628318584,0.9519494857374756,1.0,4/18,10.66%,OTUD7B;LATS1;RAB23;LATS2
prerank,"DNA-templated transcription, termination (GO:0006353)",0.29839914200752454,0.7510482186096611,0.8285123966942148,0.9646812134965732,1.0,9/68,10.95%,GTF2H1;TAF1A;POLR1E;TTF1;CSTF1;LSM11;CDK7;POLR1B;POLR2L
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.20013943397133108,-0.7503627782516955,0.8690476190476191,0.9515128636023226,1.0,10/48,12.17%,OGT;NUP93;NUP188;RANBP2;NUP98;NUP42;NDC1;RAE1;NUP153;NUP37
prerank,cellular response to arsenic-containing substance (GO:0071243),0.36306577084976754,0.7499061763390683,0.7670299727520435,0.9656910942576534,1.0,3/15,16.54%,ATF3;HSF1;CPEB2
prerank,organelle transport along microtubule (GO:0072384),0.32507067497689524,0.7496552104368739,0.791907514450867,0.9656280342311616,1.0,5/31,11.88%,UXT;CLN3;ARHGAP21;BORCS5;BICD2
prerank,hemidesmosome assembly (GO:0031581),0.381524900566637,0.7496040963184867,0.7670454545454546,0.965330100794762,1.0,3/11,15.97%,ITGA6;DST;LAMA3
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.29346391975417685,-0.7493006541638929,0.7625418060200669,0.9511540987210247,1.0,2/11,5.84%,GSN;CAAP1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.2996473913933807,0.7492860455126032,0.8687179487179487,0.9653634666693223,1.0,14/88,16.32%,EDNRB;CLN8;APOE;CLN3;CNOT8;LARP1;EPRS1;CPEB3;NELL1;HDAC6;NFKB1;PCIF1;IGF2BP3;PUS7
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.31665900198367564,0.7492101328674168,0.7945516458569807,0.965092794334728,1.0,5/35,11.24%,AQP1;APOE;NUDT4;CAP1;SOX9
prerank,determination of bilateral symmetry (GO:0009855),0.33405117894771835,0.7489535731743543,0.7730582524271845,0.9650219753726214,1.0,2/24,5.58%,PKD2;ODAD2
prerank,chromatin organization (GO:0006325),0.2914540223220774,0.7486374453476347,0.8926038500506586,0.9650373460566681,1.0,34/132,20.02%,NPM3;BPTF;SPI1;HDAC5;SNAI1;RB1;ARID1A;ATRX;HDAC4;SETD2;BAZ1A;CHD1;HCFC2;SOX9;MTF2;SMARCD3;BRDT;SMARCB1;FAM50A;INO80;HCFC1;HDAC11;SOX2;PIH1D1;SMARCAD1;SUV39H1;LRWD1;RSF1;KDM4C;PHF1;TOP1;RBBP4;KDM5A;KDM5B
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3296744740531237,0.7482380381062959,0.7938751472320377,0.9651649481249392,1.0,7/28,18.52%,HCLS1;PFN2;PFN1;COTL1;ARHGAP18;RASA1;GBA2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.3168211269249779,-0.7480688359805538,0.7891156462585034,0.9510733156310067,1.0,3/10,19.88%,FMR1;CALM3;DRD2
prerank,zinc ion homeostasis (GO:0055069),0.32820380210266836,0.747806933547268,0.7937062937062938,0.9653108984377817,1.0,13/28,23.30%,ATP13A2;SLC39A6;PRKN;MT3;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;SLC30A10
prerank,postsynaptic membrane organization (GO:0001941),0.35889130518062795,0.747480186753358,0.7798165137614679,0.9653484216067978,1.0,2/17,4.52%,APOE;CEL
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.37951546287411314,0.7461527563158431,0.7386363636363636,0.9665735090508069,1.0,2/11,15.66%,P2RX4;GSK3A
prerank,cardiolipin metabolic process (GO:0032048),0.36197969212184977,0.7456416648556529,0.7552742616033755,0.9668154895678428,1.0,7/13,25.71%,PGS1;LCLAT1;PTPMT1;PLA2G5;PLA2G6;HADHA;HADHB
prerank,regulation of insulin secretion (GO:0050796),0.29700645945393905,0.7455644756591027,0.8724489795918368,0.9665420150179244,1.0,16/101,16.94%,KCNJ11;NR1H4;TNF;CACNA1A;TFAP2B;ITPR2;ENSA;LRP5;SLC8B1;KCNA5;RAP1A;SOX4;GCK;STXBP4;CACNA1D;PPP3CB
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.29815529052971934,0.7450560267998803,0.8601036269430051,0.9667930308569672,1.0,19/76,20.63%,LAPTM5;TANK;MALT1;DERL1;AMER1;HDAC4;STUB1;LRRK2;UBA2;HUWE1;WFS1;PIAS1;GSK3A;ANGPT1;BIRC2;DCUN1D5;RWDD3;BIRC3;CUL3
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.3549347212465833,0.7448350577013475,0.7838179519595448,0.966691909965546,1.0,2/17,3.74%,SLC8A1;PKP2
prerank,positive regulation of chromosome organization (GO:2001252),-0.2624880788608777,-0.7448220546445486,0.8142292490118577,0.9536296409012852,1.0,4/15,17.77%,PML;MRE11;GNL3;DHX36
prerank,negative regulation of protein transport (GO:0051224),0.334475954354858,0.7444731314081094,0.7932692307692307,0.9667782706165661,1.0,2/25,4.79%,APOE;RHBDF2
prerank,protein ADP-ribosylation (GO:0006471),0.33099540716253784,0.7441901837424392,0.7862149532710281,0.9667404423429775,1.0,9/28,21.28%,ART4;PARP8;HPF1;PARP16;TNKS2;TIPARP;PARP10;PARP3;SIRT5
prerank,regulation of protein kinase C signaling (GO:0090036),-0.2777600457277007,-0.7431946163473535,0.8262548262548263,0.9539922891533025,1.0,3/14,6.36%,WNT5A;ULK4;MYADM
prerank,neuromuscular synaptic transmission (GO:0007274),0.3475342547234329,0.7426971646375794,0.7816537467700259,0.968172429685065,1.0,4/18,18.71%,RIMBP2;DTNA;STAC3;KIF1B
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3098306051623137,0.7424107831170654,0.8275084554678692,0.9681490384227286,1.0,17/42,26.19%,SRCAP;ACTB;ARID1A;ARID1B;SMARCB1;INO80;SPTY2D1;ERCC6;SMARCAD1;CHD4;RBBP4;VPS72;SMARCA5;MBD2;SMARCC1;CECR2;MTA2
prerank,regulation of cell cycle phase transition (GO:1901987),0.2934178999912227,0.7422056323277773,0.86414708886619,0.9680127768487331,1.0,16/91,17.93%,ANAPC15;CDC23;TAF1;UBE2S;PSMB10;TP53;DBF4;FZR1;PSMA2;PSME3;PSMB5;PSMD8;PSMD7;PSMB9;ANAPC11;PSMD2
prerank,cellular response to hypoxia (GO:0071456),0.2904094835105482,0.7418908198011666,0.9014084507042254,0.9680449291699246,1.0,25/126,19.14%,AQP1;ADAM8;ANGPT4;MTOR;RGCC;BACH1;PSMB10;TP53;P4HB;EPO;PSMA2;TBL2;PSME3;STUB1;PSMB5;PSMD8;PSMD7;PSMB9;HIF1A;CPEB2;SUV39H1;VHL;PSMD2;TIGAR;ELOB
prerank,positive regulation of binding (GO:0051099),0.2940673181249339,0.7417149028859773,0.8502564102564103,0.9678740111675072,1.0,24/84,21.84%,DHX9;APOE;SKI;HMGB1;TAF1;HFE;SPPL3;DERL1;EPB41;BAMBI;B2M;STK3;LRRK2;LRP1;IDE;RPL11;STK4;ADD1;FLOT1;DACT1;GSK3B;PRKN;PIN1;VTN
prerank,reticulophagy (GO:0061709),0.36343919160874977,0.7407730646294686,0.7667597765363129,0.9686209840057628,1.0,7/12,27.29%,TEX264;RETREG1;ATG2B;RB1CC1;UBA5;ATG2A;UFM1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.30449059424845054,0.7404704654429584,0.8310454065469906,0.9686127530401293,1.0,13/56,17.66%,SNX9;ESPL1;SNX33;KIF23;SON;BIN3;MYH10;USP8;PDCD6IP;INCENP;RASA1;SNX18;RHOA
prerank,dicarboxylic acid metabolic process (GO:0043648),0.308744993340193,0.7404051982057804,0.8352816153028693,0.9683337206564075,1.0,4/52,6.93%,DGLUCY;MTHFS;HAAO;OGDH
prerank,actomyosin structure organization (GO:0031032),0.29881799081348276,0.740008999984468,0.8561151079136691,0.968434038268826,1.0,15/75,15.26%,ITGB5;TTN;MYLK3;MYH9;FLII;TNNT3;F11R;EPB41;EPB41L2;ZYX;MYH10;CSRP1;PDLIM1;CAPN3;SRC
prerank,protein O-linked mannosylation (GO:0035269),-0.2570369203878882,-0.7397415664461645,0.8360655737704918,0.9568968478615468,1.0,9/18,23.06%,DPM1;RXYLT1;POMT2;TMTC1;TMTC3;CRPPA;FKRP;DPM3;TMTC2
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.30529870954736693,0.7397391857241151,0.8226164079822617,0.9683972607219252,1.0,18/45,25.60%,FOXO3;LARP1;RC3H1;TDRD7;PUM2;CYFIP1;PCIF1;PUM3;MEX3D;ATG14;PER1;ZC3H7A;NUDT21;ZC3H7B;EIF2A;RPL10;PARP9;PUM1
prerank,regulation of presynapse assembly (GO:1905606),0.34281912217922034,0.7396342100157962,0.7923566878980892,0.9677974719984097,1.0,2/18,3.90%,SLITRK1;SNCA
prerank,regulation of presynapse organization (GO:0099174),0.34281912217922034,0.7396342100157962,0.7923566878980892,0.9677974719984097,1.0,2/18,3.90%,SLITRK1;SNCA
prerank,chromatin assembly or disassembly (GO:0006333),0.3706328463478548,0.7394890046804842,0.7831149927219796,0.9676145738358058,1.0,3/11,19.48%,TP53;NOC2L;RBBP4
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.3261087393620319,0.7394478809765626,0.7824561403508772,0.967299949608773,1.0,7/27,23.78%,CTPS1;TXNRD1;RRM2B;AK8;GSR;AK5;AK1
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.37205416692144166,0.7394008298001191,0.7692307692307693,0.9669950834588588,1.0,1/12,1.97%,SLAMF8
prerank,cellular response to exogenous dsRNA (GO:0071360),0.3702894364497387,0.7391189969376655,0.776551724137931,0.966973394073998,1.0,1/12,2.86%,DHX9
prerank,regulation of axonogenesis (GO:0050770),0.30421202163011896,0.7385111148471855,0.8301486199575372,0.9672874802271415,1.0,10/51,17.66%,THY1;PLXNC1;SLITRK1;PLXNB2;ARHGDIA;EFNB3;RTN4;PTEN;EPHA4;RHOA
prerank,sulfur amino acid metabolic process (GO:0000096),0.33002580564803435,0.7382499061308742,0.79375,0.9672322109776332,1.0,5/24,17.04%,TXN2;MSRA;MMUT;MTR;CBS
prerank,regulation of ossification (GO:0030278),0.30723108689448725,0.7366957105737066,0.8162100456621004,0.9686749857450424,1.0,5/36,12.06%,BMP2K;MDK;MEF2C;SOX9;CHSY1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.342246432780853,0.7363937789928044,0.7864197530864198,0.9686698164986025,1.0,7/18,21.31%,VPS18;RAP1B;DTNBP1;LRRK2;RAP1A;GSK3B;RIMS1
prerank,endothelial cell development (GO:0001885),-0.227903097684601,-0.7363235926687209,0.8780487804878049,0.9596587212942584,1.0,8/25,16.96%,RAPGEF3;MYADM;RDX;MET;RAPGEF2;EZR;PDE2A;ROBO4
prerank,regulation of cell death (GO:0010941),0.28924960902250035,0.7353870724167468,0.8756423432682425,0.9694933009080344,1.0,22/94,22.13%,CALCR;SNCA;CTSZ;ACER3;IMPACT;BECN1;PARP16;TNFRSF1B;RRAS2;LRRK2;LRP1;SOX4;CD36;FAF1;NPAS2;SRSF6;RAB29;PRKN;CRYAB;FGF2;CHP1;MT3
prerank,response to gamma radiation (GO:0010332),0.3300806952137804,0.7351481464560486,0.7956469165659008,0.9694179168238242,1.0,4/24,10.53%,XRCC5;TP53;HSF1;RPL26
prerank,spermatid development (GO:0007286),-0.21106859456022903,-0.7349560448714407,0.9069767441860465,0.959527484664745,1.0,8/32,23.67%,BBS4;RFX2;CEP57;NECTIN2;ACRBP;TDRD5;MKKS;NME5
prerank,regulation of tube diameter (GO:0035296),-0.2782421186673349,-0.7346841499642229,0.8075601374570447,0.9560258097189853,1.0,4/13,12.19%,SCPEP1;ROCK1;ACE;NOS3
prerank,vascular process in circulatory system (GO:0003018),-0.2782421186673349,-0.7346841499642229,0.8075601374570447,0.9560258097189853,1.0,4/13,12.19%,SCPEP1;ROCK1;ACE;NOS3
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.3335606043145924,0.7344471572249239,0.7936117936117936,0.9698777729395126,1.0,10/23,27.58%,NABP1;PLK2;PABIR1;PRCC;INTS3;ZWINT;BUB1B;CDK5RAP3;WEE1;ZWILCH
prerank,DNA-dependent DNA replication (GO:0006261),0.28693887071499496,0.7341371992743684,0.902834008097166,0.9698695077063918,1.0,24/128,16.65%,MCM5;ORC3;PSMB10;MCM2;MCM6;DBF4;BAZ1A;MGME1;PSMA2;WDHD1;ORC4;CDC34;DNA2;PSME3;MCMBP;PSMB5;CDC6;POLD3;PSMD8;NOC3L;TWNK;PSMD7;PSMB9;LRWD1
prerank,cellular response to hexose stimulus (GO:0071331),0.33030044812421083,0.7341367889380062,0.7911318553092183,0.9695101636872342,1.0,5/23,14.67%,ERN1;TRA2B;ADCY8;GAS6;SOX4
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.36566281274551615,0.7339118803669699,0.7949790794979079,0.9694007380764504,1.0,5/12,20.15%,APOE;RANBP9;PICALM;ROCK2;ABCA2
prerank,cell junction assembly (GO:0034329),0.28768242770446945,0.733867378956871,0.8943089430894309,0.9690873461187799,1.0,20/100,17.66%,PCDHB6;SLITRK1;PKP2;ITGA6;ACTB;VMP1;CAPZA1;FLCN;CDH8;ACTG1;LIMS1;CDH9;CDH12;TLN1;KIRREL3;DCHS1;CDH19;PTEN;CDC42;RHOA
prerank,intestinal absorption (GO:0050892),0.36807013270968564,0.733708458946022,0.7861035422343324,0.9689114311347632,1.0,2/13,15.32%,F11R;CD36
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.34955519475168406,0.7332853333966295,0.7789613848202397,0.9690411119155916,1.0,2/15,9.33%,MLXIPL;PPARGC1A
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.3543581502732437,0.7329879060765788,0.7777777777777778,0.9690237032029975,1.0,3/14,14.11%,TSEN15;RTRAF;DDX1
prerank,embryonic organ development (GO:0048568),0.29658785111376723,0.7321129864898247,0.8354700854700855,0.9696955584091764,1.0,7/61,11.03%,TGFB1;TNF;TEAD1;TGFBR2;TAL1;FLT3LG;SH2B3
prerank,cytoplasmic translational initiation (GO:0002183),-0.2382694022326041,-0.7317412630263991,0.8333333333333334,0.95796878621807,1.0,4/17,12.58%,EIF2B3;EIF4B;EIF2D;DHX29
prerank,kidney development (GO:0001822),0.2971048031071536,0.7317386637755336,0.8569948186528498,0.969764991678615,1.0,11/65,17.31%,SHH;PCSK9;TGFBR1;TFAP2B;SULF2;PYGO2;WFS1;SOX4;NF1;IFT27;ITGA8
prerank,coenzyme A biosynthetic process (GO:0015937),0.37587100666015016,0.7317348592114719,0.7691154422788605,0.9686974833638083,1.0,1/11,3.27%,SLC25A16
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.37587100666015016,0.7317348592114719,0.7691154422788605,0.9686974833638083,1.0,1/11,3.27%,SLC25A16
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.37587100666015016,0.7317348592114719,0.7691154422788605,0.9686974833638083,1.0,1/11,3.27%,SLC25A16
prerank,nucleosome assembly (GO:0006334),0.3161324676032707,0.731666604824419,0.8023121387283237,0.968423192758907,1.0,11/31,22.96%,ASF1B;ATRX;NAP1L1;SOX9;SPTY2D1;RSF1;UBN1;RBBP4;IPO4;SMARCA5;H3-3A
prerank,negative regulation of protein depolymerization (GO:1901880),0.33012005392265875,0.731614242288099,0.7940119760479042,0.9681264322355276,1.0,7/24,22.76%,FGF13;ATXN7;CAMSAP2;ARHGEF2;TAOK1;PIK3CA;CLASP1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.3015793161757726,-0.7314704215834976,0.808641975308642,0.9563905134558967,1.0,5/10,27.78%,FOXC1;TRIM16;NUMA1;NME2;ETV4
prerank,mitochondrial membrane organization (GO:0007006),-0.2166821460341859,-0.7310985745095613,0.8636363636363636,0.9549549497699414,1.0,11/32,22.80%,APOOL;IMMT;SLC25A4;BNIP3;SPG7;SAMM50;BAD;MFN2;MTX3;SLC25A5;APOO
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.2948469444233062,0.7307838247030256,0.865424430641822,0.9686967852082221,1.0,9/75,11.23%,NEFH;S100B;SLITRK1;ACTB;MEF2A;MEF2C;RB1;MAP1B;ATL1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.30520002878491065,0.730748525073974,0.8398220244716351,0.968380130199126,1.0,10/44,19.50%,TGFBR1;RGCC;FHOD1;PFN2;NF2;NRP1;CD47;CDC42;RHOA;ROCK2
prerank,positive regulation of behavior (GO:0048520),-0.29463729701222874,-0.7305035501781401,0.8184615384615385,0.9538079234872257,1.0,1/10,0.40%,NLGN1
prerank,telomere capping (GO:0016233),0.3468072179496625,0.7299534664646538,0.781718963165075,0.9689050524218277,1.0,7/16,23.05%,TFIP11;STN1;TINF2;TERF2;DCLRE1C;TERF2IP;TEN1
prerank,positive regulation of tissue remodeling (GO:0034105),0.3729739700399465,0.7298219908098017,0.7618364418938307,0.9686926927651233,1.0,1/10,5.21%,IL18
prerank,positive regulation of transmembrane transport (GO:0034764),0.36893805091846865,0.7295798034709098,0.7764060356652949,0.9686290966581194,1.0,2/13,13.33%,P2RX7;BRAF
prerank,photoperiodism (GO:0009648),-0.21961910046462868,-0.7293397932065477,0.8590604026845637,0.9533269134332292,1.0,10/28,23.05%,PPP1CB;CLOCK;PML;SIK1;RBM4B;USP2;PER2;PPP1CA;RBM4;CRY1
prerank,sprouting angiogenesis (GO:0002040),0.30043230725805203,0.7292687164077927,0.8435814455231931,0.9686292665745319,1.0,14/51,21.78%,PTK2B;OTULIN;VEGFB;NRP1;THBS1;CCBE1;NR4A1;ANGPT1;GREM1;NAXE;VEGFD;RAMP2;ESM1;FGF2
prerank,negative regulation of synaptic transmission (GO:0050805),-0.22849250870490617,-0.7291173978648358,0.8659217877094972,0.9517054211177312,1.0,7/23,22.99%,ATAD1;SLC24A2;PRRT1;SLC30A1;SHANK2;DRD2;ARF1
prerank,positive regulation of catalytic activity (GO:0043085),0.3082803467430339,0.7287838081016002,0.8325892857142857,0.9688435144451134,1.0,4/37,6.73%,MAPK14;ATP7A;XRCC5;YWHAB
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.3774186674231167,0.7286385982604981,0.7903930131004366,0.9686552256723068,1.0,3/10,15.15%,HDAC5;SMARCB1;PIH1D1
prerank,Wnt signaling pathway (GO:0016055),0.28756411769180956,0.7283886754391001,0.8843813387423936,0.9685838278248431,1.0,15/92,16.58%,FZD10;PLCG2;FZD9;FZD3;CTNNB1;CSNK1G2;STRN;LRP5;AMER1;CSNK1A1;LRRK2;VPS29;BCL9;PTEN;FZD8
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.2877656802705393,-0.7277370353960637,0.8042704626334519,0.9516556596223823,1.0,6/12,22.21%,WAC;SDE2;PRKDC;FBXO31;CDK2;PLK5
prerank,positive regulation of reproductive process (GO:2000243),0.3144500301622977,0.7275375139603566,0.8045714285714286,0.9691920333386438,1.0,5/31,17.98%,LHFPL2;INHBA;TACR1;PGAM4;AGO2
prerank,histone H3-K4 trimethylation (GO:0080182),0.36877782806721443,0.7274537081900552,0.7741007194244605,0.968937587472582,1.0,5/11,23.67%,TET3;SETD1B;WDR82;TET2;CTR9
prerank,negative regulation of TOR signaling (GO:0032007),0.3139263712752951,0.7271610564080853,0.8240635641316686,0.9689304958105108,1.0,7/36,15.66%,FNIP1;FLCN;PDCD6;DDIT4;TMEM127;RNF152;GSK3A
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.24390140108133007,-0.7270139085321884,0.8543689320388349,0.9506453190680778,1.0,5/20,12.49%,AFG3L2;MICU1;SLC8A3;SPG7;MCUR1
prerank,brain development (GO:0007420),0.2860570193904579,0.7265993040609868,0.937625754527163,0.9692118533999444,1.0,30/136,20.37%,SLC6A4;CX3CR1;EEF1AKMT4-ECE2;BPTF;CXCR4;PLXNB2;TGFBR2;NKX2-1;PAFAH1B2;SCYL2;QARS1;POMK;ADGRG1;SYNJ1;DDIT4;CTNS;SOX6;ZFHX3;MEIS1;POU6F1;JHY;NF1;PTEN;TBC1D23;PHGDH;UTP3;RELN;FBXW11;CNTN4;CDK5R1
prerank,negative regulation by host of viral process (GO:0044793),0.3789173378818932,0.7258940308617762,0.7842565597667639,0.9696617969903011,1.0,1/10,3.54%,CCL8
prerank,negative regulation of dephosphorylation (GO:0035305),0.342541654950428,0.7257537607924502,0.7837837837837838,0.9694571566951349,1.0,7/18,26.14%,YWHAB;ENSA;PTPA;INPP5K;CHP1;PPP1R16B;MFHAS1
prerank,insulin secretion (GO:0030073),0.3296332023275818,0.7255421999498732,0.7808564231738035,0.9693409452071644,1.0,3/19,12.59%,ANXA1;SNX19;RAB11FIP5
prerank,regulation of DNA replication (GO:0006275),0.29922599581046616,0.7254091222596639,0.8652792990142387,0.9691350704900872,1.0,11/49,16.45%,ORC3;DHX9;BRPF3;STN1;PDS5A;PPP2CA;DNA2;KAT7;CDC6;BCAR3;FAF1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.31181915882686007,0.7247465031400148,0.8054892601431981,0.9695438418027525,1.0,6/27,13.39%,ARHGEF18;ARAP1;WASF2;F11R;PFN1;PPFIA1
prerank,peptide metabolic process (GO:0006518),0.2888595499449627,0.7247173794270229,0.8643006263048016,0.9692160901556021,1.0,16/75,18.60%,GSTT4;HPGDS;SPCS2;SEC11C;SPPL3;NLN;SPCS1;NAALADL1;DNPEP;PARL;CTNS;ERAP1;IDE;FURIN;GSTM2;GSR
prerank,negative chemotaxis (GO:0050919),0.3105066728194532,0.7246111710730104,0.8158803222094362,0.9689939827363594,1.0,3/33,5.36%,ITGB3;SEMA4D;LGR6
prerank,regulation of smoothened signaling pathway (GO:0008589),0.2997801287688925,0.7244939384583813,0.8435155412647374,0.968774287713844,1.0,3/50,5.11%,SHH;RAB34;MGRN1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.2461249262570136,-0.7243127642543863,0.8488888888888889,0.9521498980673967,1.0,6/17,18.70%,MPDU1;NUS1;ALG9;SRD5A3;ALG12;ALG1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.3681542415796134,0.7237632284008457,0.7861356932153393,0.9692556845005998,1.0,5/10,25.10%,PRKRA;TARBP2;AGO2;DICER1;DROSHA
prerank,protein homotetramerization (GO:0051289),0.2978915004068236,0.7233994247750174,0.8445154419595314,0.9692994631798053,1.0,11/49,21.94%,ALDH9A1;PKD2;SAMHD1;B2M;ACACA;USP16;APPL2;MCOLN1;KCNJ2;HCN1;GBP5
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.35063233018163037,0.7228956476340551,0.7776315789473685,0.9695128834113628,1.0,3/14,15.92%,MMS19;ACTR2;ERCC6
prerank,regulation of developmental growth (GO:0048638),0.31048145198177646,0.7225828676790468,0.8127906976744186,0.9695258337715327,1.0,4/29,9.78%,STAT5A;APOE;DNM2;STAT5B
prerank,regulation of chromosome organization (GO:0033044),0.3246631862534033,0.7220022507380588,0.8024691358024691,0.9698318371892265,1.0,4/22,14.40%,XRCC5;RB1;SMG1;HNRNPD
prerank,protein mannosylation (GO:0035268),-0.23501443977567604,-0.7219598749258092,0.880184331797235,0.9532748013206811,1.0,10/22,24.70%,DPM1;RXYLT1;POMT2;TMTC1;TMTC3;CRPPA;FKRP;DPM3;TMTC2;DPY19L4
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.2578036979336663,-0.7212299803643871,0.8340807174887892,0.9523108272673713,1.0,4/15,14.41%,REST;HNRNPU;BCL2L11;UBE2L3
prerank,myelination (GO:0042552),0.299677827135177,0.7211713055258182,0.8433079434167573,0.9703942805101944,1.0,10/46,17.96%,SKI;CXCR4;ABCD1;TNFRSF21;ACER3;EIF2B2;MPZ;NF1;DEGS1;ABCD2
prerank,peptidyl-lysine acetylation (GO:0018394),-0.2999625573500281,-0.7211610568024043,0.8090909090909091,0.9505035835558249,1.0,1/10,1.25%,ESCO1
prerank,calcium ion transmembrane transport (GO:0070588),0.2912650522390022,0.7209923497843453,0.8958762886597939,0.9702303629553888,1.0,21/86,19.63%,P2RX7;SLC8A1;PKD2;P2RX4;CACNA1A;ATP2C1;ATP2B1;SLC8B1;ATP2B3;PARL;ATP2A3;GAS6;TRPV3;PMPCB;YME1L1;CACNA1D;TMEM165;MICU2;NALCN;MCOLN1;PMPCA
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.32558593319305534,0.7208179168994678,0.8053613053613053,0.9700703037668157,1.0,5/27,13.20%,CCM2;MAP3K5;KAT7;IKBKG;NFKB1
prerank,negative regulation of ATPase activity (GO:0032780),0.34222611477604226,0.7201615980277478,0.8012987012987013,0.9704754493500483,1.0,2/16,8.56%,TP53;ATP5IF1
prerank,negative regulation of viral transcription (GO:0032897),0.35453249106129847,0.7200464049402427,0.7785515320334262,0.9702463016848838,1.0,5/13,24.01%,TRIM27;MID2;TRIM62;HEXIM1;UBP1
prerank,regulation of cellular senescence (GO:2000772),0.3150775747186124,0.7196593468388378,0.8160651920838184,0.9703452215567165,1.0,10/28,26.59%,NEK6;YPEL3;CDK6;B2M;TERF2;NEK4;NUAK1;SLC30A10;AKT3;FBXO5
prerank,recombinational repair (GO:0000725),0.2911910226439943,0.7195226500965431,0.8800413650465356,0.9701483944757661,1.0,22/77,23.42%,ZFYVE26;NABP1;RMI1;SAMHD1;LIG3;YY1;MCM9;INO80;SLX4;RAD51B;ERCC5;UBE2N;SWI5;RAD51D;SPIDR;SFR1;NSMCE2;ERCC4;RFWD3;SEM1;PARP1;MORF4L1
prerank,regulation of complement activation (GO:0030449),0.2999281023035194,0.7194867629785476,0.8392857142857143,0.9698326629267803,1.0,5/40,14.78%,C1QC;C1QA;C1QB;C3AR1;C4B
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.31643691798833284,0.7184291533675112,0.8279569892473119,0.9706575902550689,1.0,3/29,4.04%,MTOR;MLXIPL;APOE
prerank,mitochondrial translation (GO:0032543),0.2799760334505043,0.7183507277394081,0.8927125506072875,0.9703974681651266,1.0,31/104,25.45%,MRPL46;GFM1;AURKAIP1;CHCHD1;MRPL41;GATB;ERAL1;MRPL51;MTRF1L;LARS2;MRPL19;MRPL15;MRPS25;MRPS9;MRPS21;MRPS14;MRPL39;MRPL3;MRPL30;MTIF3;MRPS26;MRPL10;MRPL54;MRPL21;MRPL52;MRPL18;MRPL12;GATC;MRPL37;MRPS12;MRPS34
prerank,vascular transport (GO:0010232),0.290278530548286,0.7182244278296926,0.891170431211499,0.9701871155873624,1.0,12/81,15.22%,SLCO2B1;ABCC3;ATP8A1;SLC7A8;SLC2A3;SLC16A2;ABCC1;SLC16A1;ATP2A3;ATP1B2;LRP1;SLC1A4
prerank,regulation of multicellular organism growth (GO:0040014),0.3458848799854502,0.7172208314139574,0.7918918918918919,0.9709148705931617,1.0,3/15,14.30%,STAT5A;STAT5B;MBD5
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.32056907258665646,0.7170271574940464,0.8185140073081608,0.9707722800921297,1.0,9/26,20.24%,DUSP3;STAT5B;SOX9;SYAP1;PTPN12;IQGAP1;PDPK1;ZFP36L1;INPP5K
prerank,positive regulation of histone deacetylation (GO:0031065),0.35079805025404653,0.7169056222727743,0.7922636103151862,0.9705448913236407,1.0,5/12,24.06%,PRKD2;AKAP8L;ZBTB7B;CTBP1;VEGFA
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.33590736599860804,0.7167897058228462,0.8084832904884319,0.9703228791907811,1.0,7/19,23.57%,TENT4B;STN1;SRC;TINF2;TERF2;TEN1;DCP2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.3644652146754723,0.7163393880581832,0.792341678939617,0.9704839258001172,1.0,2/10,13.23%,WDFY1;NINJ1
prerank,photoreceptor cell development (GO:0042461),-0.26119446752224257,-0.7156219543530623,0.8307692307692308,0.9553834157791615,1.0,5/14,20.76%,RORB;ARL3;TOPORS;RP1;MFSD2A
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.300243929114551,0.7148011592258044,0.8521358159912377,0.9717763920129856,1.0,10/46,19.51%,TSPO;AIP;CHCHD4;TIMM22;TIMM50;TOMM40;HK2;PITRM1;FIS1;TOMM20
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.37025718053842804,0.7147485294495671,0.7874125874125875,0.9714790637097771,1.0,1/10,6.34%,CTNNB1
prerank,protein homooligomerization (GO:0051260),0.28117419310750313,0.7144151290062063,0.9220647773279352,0.9714908349711303,1.0,17/114,16.59%,CARD11;ALDH9A1;PKD2;PYCARD;SAMHD1;AQP11;ATL1;RNF135;B2M;TMEM120A;NINJ1;ADCY8;PDCD6IP;ACACA;ALS2;USP16;APPL2
prerank,camera-type eye morphogenesis (GO:0048593),0.3652246820945192,0.7136309329812468,0.8101449275362319,0.9719871204075213,1.0,4/10,24.06%,SKI;NF1;KDM2B;VEGFA
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.36095253095501323,0.7133141288126521,0.7963483146067416,0.9719953560348099,1.0,2/11,9.66%,TIMM22;AGK
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.2744130613819376,-0.7132435108929356,0.8552188552188552,0.95630251741022,1.0,3/12,16.20%,B3GNT2;B3GALT5;B3GALT1
prerank,positive regulation of cell junction assembly (GO:1901890),0.29140566895542536,0.7130981485939625,0.8640256959314775,0.9718858844955526,1.0,3/56,2.32%,CLSTN1;THY1;PTPRJ
prerank,ESCRT III complex disassembly (GO:1904903),0.3692330898944416,0.7130055472429828,0.8140200286123033,0.9712805679369072,1.0,1/10,3.68%,VTA1
prerank,ESCRT complex disassembly (GO:1904896),0.3692330898944416,0.7130055472429828,0.8140200286123033,0.9712805679369072,1.0,1/10,3.68%,VTA1
prerank,response to cadmium ion (GO:0046686),0.3165365872984329,0.7127135963107228,0.816953316953317,0.9712371223088802,1.0,11/26,22.40%,HAAO;HSF1;MT3;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,regulation of cytoskeleton organization (GO:0051493),0.2800421349466979,0.7125536915526847,0.9159919028340081,0.971045033520421,1.0,23/108,20.80%,IQGAP2;CORO1A;FZD10;PRKCD;P2RX7;MTOR;CLN3;F11R;DIAPH1;BICD2;TWF2;CAPN2;LRP1;ARHGAP18;IQGAP1;RHOA;TAOK1;CORO2B;RHOD;ROCK2;ARHGEF19;GSK3B;CRK
prerank,fatty acid beta-oxidation (GO:0006635),0.2944095743092671,0.7124934728729397,0.8586839266450917,0.9707544973466524,1.0,11/51,18.76%,EHHADH;ACAD10;ACADL;ABCD1;ECHS1;ECI1;CPT2;PPARD;ABCD2;ETFDH;ECHDC1
prerank,positive regulation of double-strand break repair (GO:2000781),0.3027610944359599,0.7122283392256701,0.8286674132138858,0.9707001743740946,1.0,10/39,20.46%,MAD2L2;MMS19;MGMT;ACTR2;SLF2;ERCC6;SHLD1;SHLD2;SPIDR;PARP3
prerank,mitochondrion distribution (GO:0048311),0.36195153194195145,0.7118362243192724,0.8170391061452514,0.9707521832822628,1.0,4/12,14.11%,MEF2A;MSTO1;ATCAY;LRRK2
prerank,positive regulation of insulin secretion (GO:0032024),-0.20164990757629672,-0.7117318978704236,0.9478260869565217,0.95628254729865,1.0,18/36,41.09%,MYRIP;TCF7L2;GPLD1;BAD;RBP4;IRS2;GPER1;ACSL4;CAPN10;CFTR;AACS;GLUD1;ANO1;C2CD2L;PSMD9;DOC2B;NLGN2;LRRC8A
prerank,signal transduction by p53 class mediator (GO:0072331),0.30829192908898734,0.7112184885350684,0.8159437280187574,0.9710518342193281,1.0,4/30,9.58%,PYCARD;TP53;HINT1;ATRX
prerank,nucleus organization (GO:0006997),0.2920468614326365,0.7109867283200998,0.8574561403508771,0.9709645247025417,1.0,10/47,19.15%,ATXN7;SYNE1;IRAG2;SEH1L;TPR;NUP205;TOR1A;PDCD6IP;BIN1;TMEM170A
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.2457516406790356,-0.7109698286928159,0.8771186440677966,0.9553065947574874,1.0,8/15,30.59%,ACVR1;FKBP1A;ACVR1B;MAGI2;SMAD7;ACVR2B;FSTL3;LEMD3
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.32129769908097605,0.7106170125904725,0.8191881918819188,0.9710100925391036,1.0,3/22,12.38%,PPP2CB;DUSP10;PPP2CA
prerank,response to X-ray (GO:0010165),0.3464699472796863,0.709850067673908,0.7959731543624161,0.9714716779950349,1.0,3/14,14.16%,XRCC5;ANXA1;IKBIP
prerank,mitochondrial translational elongation (GO:0070125),0.2784374387750487,0.7098253187423141,0.8861538461538462,0.9711462316301496,1.0,26/88,25.45%,MRPL46;GFM1;AURKAIP1;CHCHD1;MRPL41;ERAL1;MRPL51;MRPL19;MRPL15;MRPS25;MRPS9;MRPS21;MRPS14;MRPL39;MRPL3;MRPL30;MRPS26;MRPL10;MRPL54;MRPL21;MRPL52;MRPL18;MRPL12;MRPL37;MRPS12;MRPS34
prerank,histone H4 acetylation (GO:0043967),0.2924534340546739,0.7096611378041033,0.8608695652173913,0.9709681033062996,1.0,16/47,24.45%,BRD8;MSL2;EP400;MCRS1;NAA40;KAT7;HCFC1;JADE2;MEAF6;PER1;MSL1;PHF20;MORF4L2;MORF4L1;CHD5;KANSL1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.3316551241859901,0.7085924616420997,0.8133669609079445,0.9717350864361152,1.0,5/19,20.19%,SS18L1;LRP8;CUX1;CUX2;RELN
prerank,telomere maintenance (GO:0000723),0.29488293822498685,0.7082664557484369,0.8710725893824486,0.9717518590739226,1.0,17/50,24.89%,PTGES3;XRCC5;STN1;DNA2;POLD3;TEP1;TINF2;RAD51D;PARP3;TERF2;NSMCE2;ERCC4;TERF2IP;TEN1;PARP1;ATR;RPA1
prerank,positive regulation of growth (GO:0045927),0.28905185793886634,0.7080592890546362,0.8824763903462749,0.9716194804629674,1.0,14/64,23.03%,RFTN1;TGFBR1;BRAT1;CSNK2A1;SDCBP;INO80;WFS1;CXCL16;CDC42;RPTOR;PABIR1;EXOSC2;H3-3A;ZPR1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.35675234802860933,0.7076436422114404,0.8121387283236994,0.9717041829590806,1.0,2/11,10.88%,BCAR1;NRP1
prerank,cellular zinc ion homeostasis (GO:0006882),0.3146841606374166,0.7064927261378781,0.8333333333333334,0.9725623877690718,1.0,12/26,23.30%,ATP13A2;SLC39A6;MT3;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;SLC30A10
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.27235579857284264,0.7055171572177709,0.989,0.9732178955120543,1.0,85/417,20.79%,ASCL1;CIITA;TGFB1;IKZF1;BASP1;CBFA2T3;MLXIPL;YAF2;TNF;CIR1;CEBPA;DDIT3;SPI1;TSC22D4;HDAC5;BHLHE41;XRCC5;PCGF6;CTNNB1;CREB3L1;MTA3;RCOR1;TP53;NKX2-1;GCFC2;CBFA2T2;NKRF;MDFIC;TFAP2B;CIART;RBM15B;RB1;QARS1;ATF7IP;ARID4A;RING1;MIDEAS;HDAC4;PHC1;ZMYND15;LIMS1;DAP;SOX9;HDAC6;GZF1;MBD1;HDAC9;NRG1;KAT7;FOXN3;IRF1;FOXK1;GAS6;BRD7;LBH;CAPN3;TLE5;EID1;SBNO2;RBPJ;SUV39H1;PBXIP1;RSF1;ZNF568;ZGPAT;PPARD;RPS6KA5;SFMBT1;LOXL3;CIPC;PER1;CTBP2;ENO1;CALCA;POU2F1;HEXIM1;FBXW11;INPP5K;ZMYND11;HHEX;CDK5R1;WWP1;SCMH1;YEATS2;PHC2
prerank,eye photoreceptor cell differentiation (GO:0001754),0.35029802671824783,0.7051963354619563,0.7899159663865546,0.9731968732722889,1.0,6/12,24.06%,MYO7A;AGTPBP1;NKD1;STAT3;PROM1;VEGFA
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.27147909584344526,0.7051049894805137,0.9528585757271816,0.9729448214295906,1.0,36/186,18.48%,DRAXIN;TMEM131L;NFATC1;MAD2L2;MDK;TLE3;DKK2;APOE;TPBGL;DDIT3;PSMB10;SCYL2;AMER1;PSMA2;SOX9;NLK;PTPRO;PTPRU;CSNK1A1;PSME3;STK3;PSMB5;SOX2;LRP1;PSMD8;TLE5;PSMD7;GSK3A;PSMB9;STK4;INVS;ZNRF3;PSMD2;IGFBP4;DACT1;GREM1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.2808081765589667,0.7047189258321607,0.9106598984771573,0.9729850602417704,1.0,22/95,21.79%,PRELP;HEXA;CHSY3;B4GALT1;FMOD;AGRN;ST3GAL1;NDST1;BCAN;XYLT1;CHSY1;B4GALT7;CHST15;PXYLP1;CEMIP;NDST2;ANGPT1;CHPF;CSPG4;SLC10A7;B4GALT2;B4GALT6
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.3511359159218231,0.7042562041922038,0.8141112618724559,0.9730808724747707,1.0,2/12,8.17%,DOCK4;MEF2C
prerank,secondary palate development (GO:0062009),0.34027494912115774,0.7040103999767394,0.8121546961325967,0.9729933044615763,1.0,2/14,6.74%,CHD7;TGFBR2
prerank,organelle disassembly (GO:1903008),-0.20565053445211393,-0.7039985219332603,0.9013157894736842,0.9612463096462537,1.0,11/33,25.58%,KIF5B;GFM2;ULK2;EIF2D;GOLGA2;KIF9;DDRGK1;PLK5;KLC1;UFL1;MRRF
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.3619995158840394,0.7029217978783878,0.801980198019802,0.9737638889423802,1.0,2/10,10.73%,NOS1AP;CACNB2
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.32693582382346736,0.702263280522154,0.815,0.9740910517325592,1.0,2/20,7.22%,TGFBR1;SNAI1
prerank,histone deubiquitination (GO:0016578),0.33103891406923325,0.7021725123923692,0.8156209987195903,0.9738355447729294,1.0,4/18,16.18%,ATXN7;USP7;USP21;USP16
prerank,establishment of spindle localization (GO:0051293),0.34845184411860297,0.7017783083306486,0.7994579945799458,0.9738875070639021,1.0,2/14,11.87%,ESPL1;DYNC1H1
prerank,aerobic electron transport chain (GO:0019646),0.28569875524108634,0.7013354618977234,0.8840125391849529,0.9739809522364993,1.0,16/68,20.59%,NDUFB8;NDUFA11;COX6C;NDUFA2;NDUFB4;NDUFV1;COX7C;NDUFS6;NDUFAB1;UQCRB;NDUFB11;COX6B1;SDHD;NDUFB9;COX4I1;SDHA
prerank,Golgi ribbon formation (GO:0090161),-0.2690893919490548,-0.7009552957155726,0.8854961832061069,0.962767338916908,1.0,3/13,11.56%,VAMP4;GCC2;GOLGA2
prerank,response to steroid hormone (GO:0048545),0.3062164121326127,0.70034825751026,0.8261376896149358,0.9746605464277709,1.0,1/31,0.89%,TGFB1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.33833590848683476,0.7003212939134694,0.8204787234042553,0.9743365405723254,1.0,3/14,14.23%,AIF1;MEF2C;LRP1
prerank,neuron migration (GO:0001764),0.28723551140164943,0.699924780123461,0.875,0.9743878818479631,1.0,10/48,13.85%,FGF13;LRP12;DISC1;MEF2C;PEX13;MAP1B;NRP1;DDIT4;NAV1;USP9X
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.28514453773104775,0.6998754776845197,0.8857442348008385,0.9740862202641847,1.0,16/69,20.59%,NDUFB8;NDUFA11;COX6C;NDUFA2;NDUFB4;NDUFV1;COX7C;NDUFS6;NDUFAB1;UQCRB;NDUFB11;COX6B1;SDHD;NDUFB9;COX4I1;SDHA
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.34063882282848157,0.699714922808664,0.8251001335113485,0.9739025101876598,1.0,1/15,2.04%,PLCG2
prerank,positive regulation of cell aging (GO:0090343),0.3638467206779789,0.6989892250859923,0.8051575931232091,0.9743070317483129,1.0,2/11,13.10%,YPEL3;B2M
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.32758266951933895,0.6980766878124985,0.8126684636118598,0.9748802271660727,1.0,7/16,25.24%,CIRBP;TRA2B;PRDX6;THRAP3;RBMXL1;TRA2A;NCBP1
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.19898130648624351,-0.6979627404105603,0.9459459459459459,0.9642652817552887,1.0,5/30,10.65%,ACSL1;ABCD4;HACD1;ELOVL5;ACSL6
prerank,iron ion transmembrane transport (GO:0034755),0.3568433581105115,0.6975086506111743,0.7963483146067416,0.975108245507222,1.0,1/10,4.80%,SLC25A37
prerank,negative regulation of mitochondrion organization (GO:0010823),0.3048652715682195,0.6972045210803774,0.8472222222222222,0.9750691025760577,1.0,10/33,24.07%,FZD9;BCL2L1;FLCN;IAPP;HUWE1;VAT1;GHITM;PRKN;IGF1;PRELID1
prerank,membrane repolarization (GO:0086009),0.3387219655300252,0.6968513444978012,0.8234501347708895,0.9750867365053495,1.0,3/15,13.68%,KCNIP2;ATP1B3;ATP1B2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.3011744475245276,0.6967742572718864,0.8342857142857143,0.9748199828197783,1.0,7/31,18.58%,RPS2;UBE2S;FZR1;ARRDC4;PTEN;UBE2N;DCUN1D5
prerank,nuclear pore organization (GO:0006999),0.3325576822046398,0.6958341568591936,0.8192934782608695,0.9754406308972257,1.0,6/14,21.04%,SEH1L;TPR;NUP205;RTN4;TMEM170A;NUP54
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.3356101024201237,0.6955366023182131,0.8324468085106383,0.9750339394400163,1.0,5/15,22.48%,CPEB3;AGO2;ZFP36L1;CNOT7;CNOT1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.3356101024201237,0.6955366023182131,0.8324468085106383,0.9750339394400163,1.0,5/15,22.48%,CPEB3;AGO2;ZFP36L1;CNOT7;CNOT1
prerank,endodermal cell fate commitment (GO:0001711),0.356724190363101,0.6948964570476505,0.8085714285714286,0.9753501424071609,1.0,2/10,14.18%,LEO1;SOX2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.3405877407262115,0.6943502559649233,0.7965116279069767,0.975205439462769,1.0,5/12,27.94%,RCAN1;GSK3B;CHP1;ATP2B4;PRNP
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.3405877407262115,0.6943502559649233,0.7965116279069767,0.975205439462769,1.0,5/12,27.94%,RCAN1;GSK3B;CHP1;ATP2B4;PRNP
prerank,Notch signaling involved in heart development (GO:0061314),0.3478168557240141,0.6942861112414208,0.8373408769448374,0.9749144836289242,1.0,2/11,16.04%,SNAI1;RBPJ
prerank,meiosis I (GO:0007127),0.3129461642571837,0.6941500230411922,0.8220858895705522,0.9747021989071437,1.0,2/23,12.73%,PTTG1;BRDT
prerank,7-methylguanosine RNA capping (GO:0009452),0.29590350057761433,0.6922837496687685,0.845360824742268,0.9758943805040735,1.0,5/31,19.03%,GTF2H1;CDK7;POLR2L;GTF2H5;POLR2E
prerank,7-methylguanosine mRNA capping (GO:0006370),0.29590350057761433,0.6922837496687685,0.845360824742268,0.9758943805040735,1.0,5/31,19.03%,GTF2H1;CDK7;POLR2L;GTF2H5;POLR2E
prerank,histone H4-K8 acetylation (GO:0043982),0.3363206306397802,0.6922283707115486,0.8301404853128991,0.9752481454295239,1.0,7/15,24.45%,MCRS1;KAT7;HCFC1;JADE2;MEAF6;PHF20;KANSL1
prerank,histone H4-K5 acetylation (GO:0043981),0.3363206306397802,0.6922283707115486,0.8301404853128991,0.9752481454295239,1.0,7/15,24.45%,MCRS1;KAT7;HCFC1;JADE2;MEAF6;PHF20;KANSL1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.3008610316410958,0.6917707741781328,0.8435689455388181,0.9753355733057534,1.0,4/29,10.21%,APOE;CLN3;MCTP1;SYNGR1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.307978050132867,0.6914061411699713,0.8434466019417476,0.9753763253245873,1.0,5/26,20.15%,GCH1;ACER3;SPR;ASAH1;ABCA2
prerank,alpha-amino acid metabolic process (GO:1901605),0.28545124620458606,0.6910600213695812,0.8676148796498906,0.975396662134148,1.0,7/45,13.99%,ATP7A;ASPG;KMO;PYCR2;MMUT;DDAH1;OAT
prerank,histone H3-K36 demethylation (GO:0070544),0.3525499743698763,0.6896989144559567,0.8138847858197932,0.9764144639340708,1.0,4/10,21.83%,KDM7A;RIOX2;KDM4C;KDM2B
prerank,cilium organization (GO:0044782),0.26917309338933454,0.6891862954306212,0.9658976930792377,0.9765642876550255,1.0,34/209,15.54%,MKS1;RAB8B;ASAP1;EXOC6;PKD2;IFT52;TTC29;RP2;CNGB1;BBS9;PLK4;ATP6V0D1;DISC1;SNAP29;ACTR2;RAB11A;ACTR3;HDAC6;WDR11;EXOC8;EXOC7;EXOC1;DYNC2I1;PCM1;IFT80;EXOC2;EXOC5;TXNDC15;RPGR;FNBP1L;EXOC3;CEP162;WDR90;AHI1
prerank,synaptic vesicle transport (GO:0048489),0.3454046557520677,0.6882166428936825,0.8389830508474576,0.977207117671745,1.0,3/11,13.76%,DNM2;SYNJ1;TOR1A
prerank,nucleocytoplasmic transport (GO:0006913),0.29068197517220906,0.687659022279121,0.8698553948832035,0.9773925425898811,1.0,6/40,11.84%,XPO1;ANP32A;SNRPD2;MALT1;RBM15B;NUP205
prerank,male gonad development (GO:0008584),0.29900482257666455,0.687425637701008,0.8568129330254042,0.9772649533688669,1.0,4/34,15.44%,GATA1;INHBA;SOX9;NCOA4
prerank,telomere maintenance via recombination (GO:0000722),0.3544204125700777,0.6868240202705096,0.8309859154929577,0.9775305079562883,1.0,5/11,22.09%,TEP1;ERCC1;RAD51D;NSMCE2;ERCC4
prerank,mitotic spindle assembly (GO:0090307),0.28942021990818917,0.6867901358253391,0.8733624454148472,0.9772148554370278,1.0,7/42,13.96%,BCCIP;CEP192;CHEK2;KIF23;RAB11A;STAG2;KIF2A
prerank,motor neuron axon guidance (GO:0008045),-0.25107909585097377,-0.6867736061158668,0.8813559322033898,0.9742162149333049,1.0,2/15,6.20%,SEMA3A;SLIT2
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.3057909431424022,0.6866007444533925,0.8456057007125891,0.9770671363648296,1.0,4/26,14.11%,NFE2L2;GPR37;FYN;LRRK2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.25837188126837557,-0.6864854885486306,0.8671328671328671,0.9726338595450711,1.0,3/13,16.20%,B3GNT2;B3GALT5;B3GALT1
prerank,axoneme assembly (GO:0035082),-0.2041040404610706,-0.6862295885250135,0.9305555555555556,0.9709655308859363,1.0,12/30,30.73%,SPAG1;TTC12;CCDC39;CFAP74;RP1;SPEF1;SPAG16;GAS8;CFAP46;TTLL3;DNAAF3;LRGUK
prerank,N-terminal protein amino acid modification (GO:0031365),0.33021588776946864,0.685890599070501,0.8256756756756757,0.9774402540332824,1.0,6/14,28.30%,NAA40;METAP2;NAA50;NAA15;NAA10;METAP1D
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.26924332302832493,-0.685314252437733,0.8671586715867159,0.9699829039246737,1.0,7/12,26.82%,MTHFD1;PRPS2;AMPD2;ADSL;PPAT;PRPS1;PRPS1L1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.33371093654686745,0.685119291052424,0.8461538461538461,0.9778537355665999,1.0,5/15,24.07%,BCL2L1;GHITM;PRKN;IGF1;PRELID1
prerank,neuron maturation (GO:0042551),0.3185870840065574,0.6846070585636111,0.8302872062663186,0.9780022098737641,1.0,5/18,21.79%,MTCH1;C1QA;EPHA8;CX3CL1;B4GALT6
prerank,icosanoid biosynthetic process (GO:0046456),-0.28226757823271886,-0.6840717427552836,0.8483870967741935,0.9693387914303215,1.0,1/10,2.20%,LTA4H
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.32864118052393376,0.6836348952014336,0.8291390728476821,0.9786040594484939,1.0,1/16,2.41%,MAD2L2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.32567307930276646,0.6827196697489855,0.8254593175853019,0.9791775810502567,1.0,6/16,26.42%,PHIP;IGFBP4;CDH3;IGFBP2;IGF1;IGFBP3
prerank,positive regulation of mRNA processing (GO:0050685),0.3121536097082066,0.6820982075046705,0.8524173027989822,0.9794359122975903,1.0,6/21,19.34%,CIRBP;LEO1;TRA2B;PRDX6;THRAP3;RBMXL1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.28999290128563976,0.6818530829718463,0.8474770642201835,0.979344986994515,1.0,11/32,25.06%,HDAC5;ANXA1;THBS1;HDAC9;RHOA;MAP2K5;FGF2;MMRN2;VEGFA;AKT3;KDR
prerank,cobalamin metabolic process (GO:0009235),0.32334350661480743,0.6810622436684959,0.8695090439276486,0.9797949269397392,1.0,6/17,24.13%,ABCC1;MMUT;CUBN;MTR;MMAA;MMAB
prerank,androgen receptor signaling pathway (GO:0030521),-0.27492858397181785,-0.6797648375149652,0.8711656441717791,0.9718106778879488,1.0,5/11,25.34%,AR;KDM3A;RNF14;PMEPA1;PLPP1
prerank,negative regulation of lipid catabolic process (GO:0050995),0.32586294381165354,0.6797622416343628,0.8582574772431729,0.9806816687199631,1.0,2/17,12.90%,TNF;SORL1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2761157603903601,0.6797428385761586,0.8914646996838778,0.9803560012181884,1.0,7/63,10.53%,RGCC;CNOT8;TP53;CRADD;PLK2;CHEK2;RPL26
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.28166944072559463,-0.6794478493993362,0.8789808917197452,0.9702633964748693,1.0,8/10,31.13%,IVD;ACAD11;ETFA;ETFB;ACADS;ACADVL;GCDH;ACADM
prerank,lipid droplet formation (GO:0140042),0.3530606938025144,0.6789227251338945,0.8284883720930233,0.9808072774214289,1.0,1/10,5.85%,CDS2
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.2673742229954342,0.6786362119034541,0.9344933469805528,0.9807348251320805,1.0,26/96,21.04%,NUP62;DHX38;NXF1;THOC2;SEH1L;CASC3;RBM15B;SMG1;TPR;DDX39B;NUP205;POLDIP3;THOC3;UPF3B;ALKBH5;SMG7;UPF2;FYTTD1;SLU7;SRSF2;SRSF6;SEC13;SLBP;HHEX;SRSF3;NUP54
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.2922992600222669,0.6785000037603232,0.8767441860465116,0.9805229453625203,1.0,4/32,12.62%,PYCARD;TP53;HINT1;DDIT4
prerank,metal ion homeostasis (GO:0055065),0.28462422312452496,0.6783167234082161,0.8867713004484304,0.9803668422926763,1.0,4/40,8.52%,SLC8A1;SLC7A8;SNCA;TFAP2B
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.25440315338608527,-0.6778310647455045,0.8655172413793103,0.9699349760100984,1.0,3/12,14.78%,GMDS;UGP2;GFPT1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.2810293194921832,0.6763058151378426,0.8872017353579176,0.9819177158803521,1.0,9/54,17.02%,KCNN4;KCNIP2;KCNMA1;NOS1AP;NEDD4L;CD63;GNG2;CACNA1D;BIN1
prerank,divalent inorganic cation homeostasis (GO:0072507),0.296662224952537,0.6762760373612307,0.830166270783848,0.9816027692433116,1.0,3/25,8.52%,SLC8A1;SNCA;TFAP2B
prerank,early endosome to Golgi transport (GO:0034498),0.3490890201130833,0.6761498688081905,0.8455882352941176,0.9813753664004815,1.0,3/11,14.43%,RBSN;STX5;SNX2
prerank,translational elongation (GO:0006414),0.26327354416024124,0.6758475682121732,0.9279187817258884,0.9813281166616009,1.0,30/101,25.87%,MRPL46;GFM1;AURKAIP1;CHCHD1;MRPL41;GTPBP1;ERAL1;MRPL51;MRPL19;MRPL15;MRPS25;MRPS9;MRPS21;MRPS14;MRPL39;MRPL3;MRPL30;MRPS26;MRPL10;MRPL54;MRPL21;EEF1G;RACK1;MRPL52;MRPL18;MRPL12;MRPL37;MRPS12;MRPS34;EEF1A1
prerank,negative regulation of histone modification (GO:0031057),0.33333370084000774,0.6756389859589406,0.8478561549100968,0.9811723654935125,1.0,6/14,29.34%,SNCA;NOC2L;CTBP1;SPHK2;JARID2;PRMT6
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.26921169576162834,0.6754811253174864,0.9159751037344398,0.9809878876524462,1.0,15/74,19.14%,NFE2L2;BACH1;PSMB10;EPO;PSMA2;PSME3;PSMB5;PSMD8;PSMD7;PSMB9;RBPJ;HIF1A;VHL;PSMD2;ELOB
prerank,tRNA metabolic process (GO:0006399),-0.2305392149614391,-0.6753941664136676,0.8813559322033898,0.9703581146545239,1.0,6/17,24.10%,SSB;DTD2;KARS1;RPP21;YARS2;POP5
prerank,peptidyl-proline modification (GO:0018208),0.30010238351730556,0.6753894278687174,0.8533653846153846,0.9807357981667709,1.0,6/25,18.10%,PPIE;CWC27;P3H2;PPIG;PPIH;NKTR
prerank,neuromuscular junction development (GO:0007528),0.3027062177162127,0.6746203648025676,0.8544152744630071,0.9810919035810177,1.0,5/24,14.11%,AGRN;CACNB4;CACNB2;CACNB1;LRRK2
prerank,ncRNA 3'-end processing (GO:0043628),0.322401422755769,0.6744732820799186,0.8324468085106383,0.9809040478162498,1.0,5/14,21.01%,ELAC2;INTS8;INTS6;INTS6L;TOE1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.2921749356917493,0.6738421552603961,0.8606271777003485,0.9811435810187107,1.0,5/32,14.11%,MCTP1;VPS18;MEF2C;DTNBP1;LRRK2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2594665632560621,0.673149632375193,0.998,0.981460307348496,1.0,96/497,20.62%,ASCL1;CIITA;TGFB1;IKZF1;DBI;BASP1;CBFA2T3;MLXIPL;YAF2;TNF;CIR1;CNOT8;CEBPA;DDIT3;SPI1;TSC22D4;HDAC5;BHLHE41;XRCC5;PCGF6;CTNNB1;CREB3L1;MTA3;RCOR1;TP53;NKX2-1;GCFC2;CBFA2T2;NKRF;MDFIC;TFAP2B;CIART;RBM15B;RB1;LARP1;QARS1;EPRS1;ATF7IP;ARID4A;RING1;MIDEAS;HDAC4;CPEB3;PHC1;ZMYND15;LIMS1;DAP;SOX9;HDAC6;PDS5A;GZF1;MBD1;HDAC9;NRG1;KAT7;FOXN3;IRF1;PCIF1;FOXK1;GAS6;CDC6;BRD7;LBH;CAPN3;IGF2BP3;TLE5;EID1;SBNO2;GSK3A;RBPJ;PUS7;SUV39H1;PBXIP1;RSF1;ZNF568;ZGPAT;PPARD;RPS6KA5;SFMBT1;LOXL3;CIPC;PER1;CTBP2;ENO1;CALCA;POU2F1;HEXIM1;FBXW11;INPP5K;ZMYND11;HHEX;GSK3B;CDK5R1;WWP1;SCMH1;YEATS2
prerank,tRNA 5'-leader removal (GO:0001682),0.33335029757566503,0.6726130753989181,0.8379888268156425,0.981627897894901,1.0,3/13,14.99%,RPP38;RPP14;PRORP
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.25422336165993425,-0.6719886880112313,0.8983050847457628,0.9716143264748179,1.0,9/13,42.84%,CACNA1G;SYT4;CACNA1H;CACNA1I;KCNB1;SYT1;DOC2B;HYAL3;SCAMP5
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.33338654355365027,0.6706355170672883,0.8453188602442334,0.9831613690975575,1.0,2/13,10.21%,CLN3;SYNGR1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.34547825903306745,0.669874867471506,0.8457142857142858,0.9835331269401366,1.0,1/10,3.90%,SNCA
prerank,negative regulation of hemostasis (GO:1900047),0.3297210247687566,0.6695969379308769,0.8430813124108416,0.9834601505677999,1.0,1/12,4.04%,APOE
prerank,central nervous system development (GO:0007417),0.2596167407217735,0.6692945177395028,0.981,0.9834091359387257,1.0,49/250,20.39%,SHH;CX3CR1;S100B;EEF1AKMT4-ECE2;PKD2;BPTF;CXCR4;PLXNB2;CHD7;TGFBR2;NKX2-1;C1QA;PAFAH1B2;BCAN;SCYL2;ATP6AP2;ITGAM;QARS1;EIF2B2;SOX9;POMK;SNTG2;ADGRG1;SYNJ1;DDIT4;CTNS;SH3GL3;SOX6;ZFHX3;MEIS1;SOX4;POU6F1;JHY;AHI1;NF1;PTEN;TBC1D23;MARCKS;NPAS2;PHGDH;LOXL3;GBA2;ZIC4;ANKLE2;UTP3;RELN;CNTN4;CDK5R1;WWP1
prerank,regulation of ATP metabolic process (GO:1903578),0.27068743458444694,0.66857478845394,0.9036016949152542,0.9837355330575193,1.0,12/54,19.43%,NUP62;ATP7A;ABCD1;SEH1L;ATP5IF1;TPR;NUP205;HIF1A;GCK;PGAM1;SEC13;FIS1
prerank,blood vessel diameter maintenance (GO:0097746),0.286648133907208,0.6684608051245822,0.8521046643913538,0.9834956563396738,1.0,2/34,4.69%,EDNRB;ADCY6
prerank,detection of calcium ion (GO:0005513),0.32720657036298784,0.6684405463547674,0.8360881542699724,0.9831694739208765,1.0,1/13,4.29%,KCNIP2
prerank,smooth muscle contraction (GO:0006939),0.32407524363225937,0.6682951844793363,0.8492063492063492,0.9829697775928944,1.0,3/14,19.50%,SLC8A1;SMTN;ROCK2
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.33152015397210055,0.6680410669504329,0.8512960436562074,0.9828709767062067,1.0,1/12,3.02%,DHRS3
prerank,skeletal system development (GO:0001501),0.2602478474757586,0.6678695557736889,0.964824120603015,0.9826951813135273,1.0,20/148,14.67%,SH3PXD2B;PRELP;TGFBR1;ATP7A;CD44;TRPS1;CHD7;SULF2;BCAN;XYLT1;CMKLR1;PRDX1;CREB3L2;PAPSS1;SOX9;ANKRD11;SOX6;RAB33B;RFLNA;SOX4
prerank,pigment granule transport (GO:0051904),0.3099768344058493,0.6674429612582784,0.8693982074263764,0.9824177454207289,1.0,2/18,9.82%,MYO5A;RAB11A
prerank,melanosome transport (GO:0032402),0.3099768344058493,0.6674429612582784,0.8693982074263764,0.9824177454207289,1.0,2/18,9.82%,MYO5A;RAB11A
prerank,calcium ion import across plasma membrane (GO:0098703),0.3272061587931163,0.6673978831933566,0.8407557354925776,0.9821151815835976,1.0,2/14,14.09%,SLC8A1;TRPV3
prerank,regulation of mRNA polyadenylation (GO:1900363),0.31724540777085397,0.6672173096717828,0.859375,0.9819384642277269,1.0,9/17,25.24%,HSF1;CPEB3;RNF40;VIRMA;ZC3H3;NELFE;CTR9;NUDT21;NCBP1
prerank,hexose biosynthetic process (GO:0019319),0.2795256288196315,0.6670103194311761,0.8880266075388027,0.9817833388959273,1.0,8/42,16.89%,ALDOB;SORD;ENO3;PPARGC1A;GPI;CHST15;PGAM1;GAPDHS
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.29090560343057686,0.6666568101751175,0.8689265536723164,0.9817645997434081,1.0,3/33,8.17%,TNFAIP3;AIF1;MEF2C
prerank,Golgi to endosome transport (GO:0006895),0.31564799346558314,0.6664899856449987,0.8540051679586563,0.9815710269284605,1.0,6/16,22.88%,RAB14;EPS15;MON2;SORT1;VPS13C;VPS13A
prerank,mRNA transport (GO:0051028),0.26196736044139424,0.6663353613505781,0.9419551934826884,0.9813665087093575,1.0,27/101,21.04%,NUP62;DHX38;NXF1;THOC2;SEH1L;CASC3;RBM15B;SMG1;TPR;DDX39B;NUP205;POLDIP3;THOC3;UPF3B;ALKBH5;SMG7;UPF2;FYTTD1;SLU7;SRSF2;SRSF6;SEC13;SLBP;ZFP36L1;HHEX;SRSF3;NUP54
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.3305979917009715,0.6663047669657287,0.8340486409155937,0.9810506523247078,1.0,2/12,12.85%,METTL4;KAT7
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.3312411708496327,0.6660193981776481,0.8517006802721089,0.9809779025375992,1.0,2/14,12.38%,PPP2CB;PPP2CA
prerank,cellular response to estradiol stimulus (GO:0071392),-0.22684243383682762,-0.6660120442236046,0.9377777777777778,0.975089578770753,1.0,2/18,7.32%,EGFR;CCDC62
prerank,DNA conformation change (GO:0071103),0.3151281385330996,0.6659456434870852,0.85,0.9807095338787738,1.0,7/17,27.16%,HMGB1;TOP2A;TOP1;HHEX;NAA10;TOP3A;HMGB2
prerank,membrane assembly (GO:0071709),0.2857115900902769,0.6659064343972116,0.8716452742123687,0.9803974490005753,1.0,8/34,18.35%,RFTN1;CEL;GAK;PTEN;STX2;UBXN2A;PICALM;FLOT1
prerank,response to UV-A (GO:0070141),0.32487559331860255,0.6656514755559121,0.8578878748370273,0.9802943168702853,1.0,1/14,4.99%,TIMP1
prerank,histone H2B ubiquitination (GO:0033523),0.3398137631793058,0.6654926535766251,0.84593837535014,0.9800995876624259,1.0,4/10,23.67%,LEO1;RNF40;UBE2E1;CTR9
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.31855687042420944,0.6652112077194988,0.8604026845637583,0.980016955159457,1.0,4/15,19.15%,ATL1;RTN4;ATL2;TMEM170A
prerank,autophagy of nucleus (GO:0044804),0.3216579999540768,0.6650017888121003,0.8575233022636485,0.9798666565416745,1.0,3/16,16.08%,ATG7;ATG2B;ATG3
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.2636281694723973,0.6641764946335945,0.9471544715447154,0.9802951198536634,1.0,18/104,18.48%,TGFB1;TGFBR1;UBE2D3;SKI;TGFBR2;NKX2-1;FAM89B;SMAD3;SNX25;SORL1;BAMBI;VASN;STUB1;SMURF1;LDLRAD4;PDPK1;RBPMS2;GREM1
prerank,regulation of phospholipid metabolic process (GO:1903725),0.3434197472288533,0.6639459328020271,0.8502202643171806,0.9801704748759317,1.0,3/10,22.27%,MTMR3;ABCA3;MTMR9
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.34241834753661615,0.6635884455288558,0.8482269503546099,0.9801598584410262,1.0,3/10,21.21%,XYLT1;PXYLP1;B3GAT2
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.3412449312143241,0.6634896351394595,0.8389057750759878,0.9799250042249279,1.0,2/10,14.31%,CCT8;CCT5
prerank,base-excision repair (GO:0006284),0.2733245236152246,0.6630786579764271,0.880901287553648,0.9799425902914544,1.0,8/48,16.23%,NEIL2;LIG3;DNA2;HUWE1;POLD3;ERCC5;ERCC6;OGG1
prerank,calcium ion import into cytosol (GO:1902656),0.31840787982939134,0.6621959974836604,0.8372703412073491,0.9804183025418631,1.0,2/15,14.09%,SLC8A1;TRPV3
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.31411517893951657,0.6620675681798001,0.8609355246523388,0.9801939148217081,1.0,4/17,19.86%,COX6C;COX7C;COX6B1;COX4I1
prerank,negative regulation of wound healing (GO:0061045),0.2889495364335638,0.661490286073014,0.876905041031653,0.9803844937524585,1.0,8/28,22.76%,TNF;APOE;CASK;PTEN;CRK;FGF2;VTN;CLASP1
prerank,synaptonemal complex organization (GO:0070193),0.3167141661139731,0.6612089329257309,0.8494623655913979,0.9799639145095012,1.0,1/15,8.41%,TRIP13
prerank,synaptonemal complex assembly (GO:0007130),0.3167141661139731,0.6612089329257309,0.8494623655913979,0.9799639145095012,1.0,1/15,8.41%,TRIP13
prerank,covalent chromatin modification (GO:0016569),0.32138349198407795,0.6610377472573291,0.853021978021978,0.9797868660979638,1.0,7/14,28.34%,CHD1;SETD5;MT3;MBD2;SIRT7;HDAC1;HELLS
prerank,glucose transmembrane transport (GO:1904659),0.31538849965366955,0.6604949383109382,0.8723958333333334,0.9799230133519924,1.0,3/18,20.04%,SLC2A3;PPARD;SORT1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.2593830030602884,-0.6602110474989477,0.8922155688622755,0.9781341598155503,1.0,2/10,8.71%,ATP1A2;FKBP1A
prerank,inositol phosphate-mediated signaling (GO:0048016),0.3130424261289025,0.6601934409062027,0.8560311284046692,0.9798355201967202,1.0,1/19,2.21%,NFATC1
prerank,peptidyl-arginine modification (GO:0018195),0.3147347362020153,0.6599195883246698,0.8404669260700389,0.9797275143246129,1.0,1/15,3.98%,ART4
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.27022856153888164,0.6590234644864436,0.9128094725511302,0.9802053649461122,1.0,5/52,9.06%,NT5C3B;EXOSC1;CNOT8;RC3H2;RC3H1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.23283705557298112,-0.6587407300530517,0.9227053140096618,0.9774810005299831,1.0,5/17,17.36%,EMC7;EMC10;EMC4;EMC1;GET4
prerank,regulation of keratinocyte proliferation (GO:0010837),0.2969223953602779,0.658260390520862,0.8560975609756097,0.9805474785859934,1.0,8/22,25.94%,MDK;CASK;STXBP4;SRSF6;ZFP36L1;CDH3;EPB41L4B;MED1
prerank,nucleotide biosynthetic process (GO:0009165),0.30957733776104746,0.6579561267358681,0.8571428571428571,0.9804726468715756,1.0,5/18,16.25%,GART;PNP;NMNAT3;PRPSAP1;RRM2B
prerank,central nervous system neuron development (GO:0021954),0.31073875350607577,0.6579434700334462,0.8597883597883598,0.9801477864658349,1.0,7/15,26.87%,ATP7A;PTEN;HSP90AA1;GBA2;B4GALT6;HSP90AB1;B4GALT5
prerank,protein polyglutamylation (GO:0018095),0.33458874980752046,0.6578220011249314,0.8565459610027855,0.9799162787199187,1.0,4/11,25.04%,TPGS1;TTLL1;TTLL7;TTLL4
prerank,maturation of 5.8S rRNA (GO:0000460),0.31464891569176406,0.6578210604412644,0.870722433460076,0.9795780299742785,1.0,4/17,17.86%,LAS1L;C1D;PES1;WDR12
prerank,membrane repolarization during action potential (GO:0086011),0.3264946939909977,0.6577767829802981,0.8687150837988827,0.9792782311947377,1.0,1/13,4.29%,KCNIP2
prerank,water-soluble vitamin metabolic process (GO:0006767),0.26536922467867485,0.6577184893858965,0.9164926931106472,0.9789945574135438,1.0,12/68,17.65%,SLC52A1;MTHFS;SLC2A3;ABCC1;MCCC2;CYB5A;MMUT;CUBN;PDZD11;MTR;FPGS;PCCA
prerank,tetrapyrrole metabolic process (GO:0033013),0.30980964689354795,0.6572045658478416,0.8792884371029225,0.9791187920673919,1.0,6/18,24.13%,ABCC1;MMUT;CUBN;MTR;MMAA;MMAB
prerank,mismatch repair (GO:0006298),0.2936402792028409,0.6565867127200045,0.8662790697674418,0.9793171735074397,1.0,7/27,19.00%,EXO1;SETD2;MCM9;PMS1;POLD3;RNASEH2A;ERCC1
prerank,mitochondrial translational termination (GO:0070126),0.2574487738773146,0.6560555851293617,0.9310699588477366,0.9794670069055722,1.0,26/88,25.45%,MRPL46;AURKAIP1;CHCHD1;MRPL41;ERAL1;MRPL51;MTRF1L;MRPL19;MRPL15;MRPS25;MRPS9;MRPS21;MRPS14;MRPL39;MRPL3;MRPL30;MRPS26;MRPL10;MRPL54;MRPL21;MRPL52;MRPL18;MRPL12;MRPL37;MRPS12;MRPS34
prerank,histone mRNA metabolic process (GO:0008334),-0.1948253604353245,-0.6554690320941874,0.9605263157894737,0.9783083340453756,1.0,8/27,19.11%,SSB;SNRPD3;ERI1;UPF1;ATM;TUT1;SNRPG;SNRPF
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.3210413967410104,0.6547011525508384,0.8766404199475065,0.9803214596011145,1.0,6/15,23.78%,ENTPD1;ENTPD2;AK8;ENTPD3;AK5;AK1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.31568252670611663,0.6542915523224562,0.8443271767810027,0.9803536067921853,1.0,1/16,2.24%,DAGLB
prerank,mitotic DNA replication (GO:1902969),0.33670563014957394,0.6539992409188756,0.8460410557184751,0.9802759485240534,1.0,2/10,10.07%,MCM2;MCM6
prerank,autophagy of peroxisome (GO:0030242),0.3344065676215693,0.653605494694987,0.8583333333333333,0.9802879751202227,1.0,4/12,25.37%,MAP1LC3B;PIK3R4;RB1CC1;NBR1
prerank,RNA export from nucleus (GO:0006405),0.2567953362273749,0.6533073727604064,0.9461382113821138,0.9802209756721012,1.0,26/100,21.04%,NUP62;DHX38;NXF1;THOC2;SEH1L;CASC3;RBM15B;SMG1;TPR;DDX39B;NUP205;POLDIP3;THOC3;UPF3B;ALKBH5;SMG7;UPF2;FYTTD1;SLU7;SRSF2;SRSF6;SEC13;SLBP;HHEX;SRSF3;NUP54
prerank,postreplication repair (GO:0006301),0.2756808442967287,0.6526700917208396,0.901657458563536,0.9804385999520832,1.0,4/45,6.92%,TRIM25;UBE2V2;UBE2V1;POLH
prerank,negative regulation of binding (GO:0051100),0.2609916167202392,0.6526512081927499,0.9204892966360856,0.9801237766780291,1.0,20/81,24.36%,BAG2;PRKCD;ACTB;TFIP11;DISC1;CTSZ;PSME3IP1;SORL1;LRRK2;TLE5;RSF1;DACT1;GSK3B;TFAP4;PIN1;MITD1;RACK1;IFIT1;DDX11;ILRUN
prerank,DNA integrity checkpoint signaling (GO:0031570),0.2773247027591608,0.6522558217851028,0.8882554161915621,0.9801337247095068,1.0,10/36,22.11%,BRIP1;CHEK2;DOT1L;CDC5L;DNA2;CDC6;ERCC6;CEP63;CDC45;RAD1
prerank,glycoprotein biosynthetic process (GO:0009101),0.2625237558153675,0.652160551247917,0.9279835390946503,0.9798801659645261,1.0,15/79,20.41%,GCNT1;ATP7A;ST8SIA4;NPC1;XYLT1;B3GALNT1;FUT9;ST8SIA1;B4GALT7;TMEM106A;LARGE1;DDOST;GOLPH3;MGAT1;COG7
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.2561763464505159,-0.6518790578869512,0.8762214983713354,0.9794409119460866,1.0,4/11,21.99%,ENPP3;SLC19A2;SLC19A3;SLC25A19
prerank,regulation of phosphatase activity (GO:0010921),0.2919569270098625,0.6514753375554054,0.8757612667478685,0.9801525437993786,1.0,8/24,26.84%,PPP6R1;PTPA;CHP1;MTMR9;HTT;CDK5RAP3;TIPRL;TSC1
prerank,sphingosine biosynthetic process (GO:0046512),0.32970109854332613,0.6514529002375716,0.8395953757225434,0.9795051721629374,1.0,4/11,24.82%,ACER3;ASAH1;ABCA2;SPHK2
prerank,sphingoid biosynthetic process (GO:0046520),0.32970109854332613,0.6514529002375716,0.8395953757225434,0.9795051721629374,1.0,4/11,24.82%,ACER3;ASAH1;ABCA2;SPHK2
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.2710713823246926,0.6505792126762033,0.8888888888888888,0.97991248504367,1.0,7/39,16.04%,BMP2K;MAML3;TSPAN14;POGLUT1;NOD2;SRC;RBPJ
prerank,protein heterooligomerization (GO:0051291),0.31285836382241056,0.6501060555960521,0.8621997471554994,0.9799935220516206,1.0,3/17,13.13%,PKD2;FARSB;TMEM120A
prerank,regulation of protein neddylation (GO:2000434),0.3374350342469389,0.6500948743986915,0.8552437223042836,0.9796667085706804,1.0,4/10,18.58%,HIF1A;RPL11;COPS9;DCUN1D5
prerank,regulation of cell morphogenesis (GO:0022604),0.2848096797050062,0.6497323969062389,0.8838028169014085,0.9796423462823829,1.0,6/30,15.59%,CD44;MACF1;CAPZB;MOV10;PHIP;PDZD8
prerank,cellular response to alkaloid (GO:0071312),0.303138874953805,0.6494795184260544,0.8728476821192053,0.9795329846065979,1.0,5/17,22.33%,SLC8A1;CASP7;GSTM2;SPIDR;TGM2
prerank,female gonad development (GO:0008585),0.2989483254805696,0.6494745690263927,0.8884711779448622,0.9792020997039952,1.0,3/19,10.48%,CEBPB;EIF2B2;INHBA
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.327984951003949,0.6490587359095132,0.8711484593837535,0.9792291772326596,1.0,3/11,20.15%,ITM2B;AGO2;ABCA2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2739274647960178,0.6489719265588798,0.9162072767364939,0.9789688121466124,1.0,4/40,12.46%,FAM111A;ATRX;BOD1L1;MCM9
prerank,negative regulation of growth (GO:0045926),0.25308954735901856,0.6485080485621383,0.9443882709807887,0.9790450665141955,1.0,12/121,12.38%,TGFB1;PTPRJ;NME6;CDA;TP53;FLCN;RB1;SMAD3;SIPA1;INHBA;RBBP7;PPP2CA
prerank,cranial nerve development (GO:0021545),0.3271529368803921,0.6480043901472484,0.8575380359612724,0.9791623011368841,1.0,1/11,5.96%,CHD7
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.3208232325387078,0.6479866059608882,0.8571428571428571,0.9788464832672342,1.0,4/12,14.80%,WNK1;ATP1B3;ATP1B2;WNK4
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.270930109143196,0.6476854801047284,0.897914379802415,0.9787593845892678,1.0,10/43,21.26%,TAOK3;NABP1;BABAM2;FZR1;FOXN3;CDC6;BABAM1;TAOK1;PABIR1;BRSK1
prerank,sulfur compound transport (GO:0072348),0.29426710289279895,0.6470383789829368,0.8741092636579573,0.9789971153193069,1.0,4/27,13.11%,LRRC8D;SLC36A1;MGST1;SLC25A30
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.2988770085607977,0.6462850278141969,0.8746803069053708,0.9793029774208687,1.0,2/19,6.02%,RENBP;NAGK
prerank,diol metabolic process (GO:0034311),0.2979258132714711,0.645558006733729,0.8866242038216561,0.9795690685303748,1.0,3/19,16.75%,GCH1;SPR;HSP90AA1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.29641295565710774,0.6450084922335596,0.8828502415458938,0.9797198324483863,1.0,5/21,23.30%,OSBPL10;OSBPL8;PLAAT3;PLA2G5;PLA2G4E
prerank,protein sumoylation (GO:0016925),0.26493103955277564,0.6448845055723431,0.9018143009605123,0.9794978856632021,1.0,7/49,15.11%,BCL11A;NUP62;SEH1L;TPR;NUP205;UBA2;PIAS1
prerank,response to peptide hormone (GO:0043434),0.2699862216965779,0.6448747133648512,0.8994535519125683,0.9791722155830571,1.0,11/43,20.22%,STAT5A;ANXA1;STAT4;STAT5B;EIF2B2;CREB1;SRC;ZBTB7B;ROCK2;SORT1;ZFP36L1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.3258426966292135,0.6448234323341566,0.8629737609329446,0.9788841779553662,1.0,11/11,67.44%,RTP4;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;RTP3;LPO;PKD1L3;PKD2L1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.29644410110045466,0.6442965105680739,0.8941176470588236,0.9789916307642507,1.0,1/17,3.22%,MAML3
prerank,apoptotic mitochondrial changes (GO:0008637),0.28095414805517305,0.6439234555626332,0.8877434135166093,0.9789858082086331,1.0,8/32,19.58%,FZD9;BCL2L1;BAK1;TIMM50;HK2;ATG3;FIS1;DNM1L
prerank,neuron projection regeneration (GO:0031102),0.33168912320637295,0.6435777361942064,0.8801169590643275,0.9789562392650896,1.0,1/10,3.70%,RTN4RL1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.32263433102213834,0.6435693816272854,0.8775790921595599,0.978629563033825,1.0,4/12,13.94%,RBM15B;METTL3;CDYL;LRIF1
prerank,pore complex assembly (GO:0046931),0.3012364900840147,0.6435349525158087,0.8838383838383839,0.9783264945519721,1.0,6/19,19.15%,P2RX7;TPR;NUP205;PDZD11;RTN4;TMEM170A
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.3042454314069302,0.643508965733085,0.8875968992248062,0.9780180499105743,1.0,1/16,2.86%,DHX9
prerank,folic acid-containing compound metabolic process (GO:0006760),0.2994261061185768,0.6432417583124111,0.8732919254658386,0.9779103720279118,1.0,3/19,17.33%,MTHFS;GGH;FPGS
prerank,renal system development (GO:0072001),0.26556013576800624,0.6427125740278241,0.9371002132196162,0.9780447482938054,1.0,6/52,11.39%,PCSK9;TGFBR1;MYOCD;TFAP2B;SULF2;PYGO2
prerank,protein localization to nucleus (GO:0034504),0.2528385616751289,0.6426860496573792,0.9448416751787538,0.9777346230219763,1.0,14/102,16.59%,MMP12;SYK;NUP62;MORC3;CSE1L;TPR;TAF8;RRS1;TOR1AIP2;TOR1A;INTS13;TAF3;RPL11;APPL2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.27027301971241113,0.6424337726807028,0.9102132435465768,0.9776233185962295,1.0,12/39,21.53%,ACTN4;CASK;NF2;THBS1;PTPRO;RASA1;CORO1C;RHOA;SPRY4;CORO2B;MAP4K4;CX3CL1
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.25151904075382214,-0.6422638143806476,0.9081272084805654,0.9851927921036393,1.0,3/11,23.05%,SIK1;C1QTNF3;CRY1
prerank,positive regulation of developmental process (GO:0051094),0.2533991700809421,0.640833026993637,0.9728915662650602,0.9786225337149779,1.0,27/164,19.58%,SHH;BASP1;RREB1;MAD2L2;DDHD1;MDK;TNF;APOE;CEBPB;CPEB3;SOX9;NR2C2;SORL1;LRP8;SOX6;SRC;RTN4;CORO1C;VHL;VLDLR;AGO2;SHLD1;TAPT1;SHLD2;FIS1;GDNF;DNM1L
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.22163257320388974,-0.6407826418517549,0.9510204081632653,0.9844000552393082,1.0,4/17,26.60%,AKAP13;RAPGEF2;DRD2;ADRB2
prerank,receptor recycling (GO:0001881),0.32622363672316623,0.640633617428781,0.8579626972740315,0.9784639959463349,1.0,2/10,12.90%,ARFGEF2;SORL1
prerank,DNA damage checkpoint signaling (GO:0000077),0.281416522881328,0.6399479641888186,0.8918918918918919,0.9786975075917931,1.0,4/28,8.25%,BRIP1;CHEK2;DOT1L;CDC5L
prerank,cellular response to dsRNA (GO:0071359),0.3084124495013745,0.6398349011136202,0.8828947368421053,0.9784673712773937,1.0,5/15,24.47%,DHX9;FLOT1;RIOK3;IFIT1;COLEC12
prerank,global genome nucleotide-excision repair (GO:0070911),0.2859312363249268,0.6396718553979873,0.8963486454652533,0.9782808721029673,1.0,8/26,24.44%,GTF2H1;RNF111;GTF2H5;ERCC1;RAD23B;ERCC4;PARP1;XPC
prerank,positive regulation of mitochondrial fission (GO:0090141),0.29937377686461514,0.6393481251123878,0.8764186633039092,0.9782332433033563,1.0,7/18,27.34%,DDHD1;FIS1;DNM1L;PRKN;KDR;MFF;MCU
prerank,establishment of mitotic spindle localization (GO:0040001),-0.18859476175366857,-0.6392678290004487,0.9577464788732394,0.9836865488219037,1.0,5/28,10.99%,PAFAH1B1;GPSM2;NDEL1;NDE1;CDK5RAP2
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.25723043438801835,0.6389986614184314,0.9376299376299376,0.9781752185052711,1.0,8/72,10.53%,RGCC;CNOT8;TP53;CRADD;PLK2;CHEK2;ATRX;RPL26
prerank,peptidyl-lysine modification (GO:0018205),0.25224398694072264,0.638715950151982,0.9440488301119023,0.9780737964700777,1.0,22/99,21.77%,BCL11A;NUP62;ATP7A;SEH1L;LOX;HDAC4;TPR;HDAC6;NUP205;HDAC9;NDUFAB1;ETFBKMT;UBA2;PIAS1;LOXL3;VPS33B;SENP6;SENP7;NUP54;NSMCE2;SIRT5;EEF1AKMT1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.3285144683853627,0.6385000664582436,0.86002886002886,0.977919989595862,1.0,3/10,16.38%,PIH1D1;NUFIP1;ZNHIT6
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.3125626605193568,0.6384941977368043,0.8548601864181092,0.9775947419244942,1.0,3/13,16.04%,TGFBR2;GSK3A;RBPJ
prerank,folic acid metabolic process (GO:0046655),0.2995441832238268,0.6381894542134109,0.8764044943820225,0.9775220851442308,1.0,1/18,2.80%,MTHFS
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.24644447130355818,-0.6370236524065349,0.9072847682119205,0.9834968532524498,1.0,2/12,6.86%,DSE;VCAN
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.31413207873361315,0.6369521872257363,0.8791666666666667,0.9782334002053439,1.0,1/13,3.21%,SLC8A1
prerank,chromatin assembly (GO:0031497),0.2682450591695138,0.6366624890288172,0.8963210702341137,0.9781498223215724,1.0,11/38,22.96%,TP53;ATRX;NAP1L1;SOX9;NOC2L;SPTY2D1;RSF1;RBBP4;LIN54;SMARCA5;H3-3A
prerank,calcium ion import (GO:0070509),0.28098786500492867,0.636401092408015,0.9064665127020786,0.9780316223227347,1.0,6/28,17.49%,SLC8A1;CACNA1A;CACNB2;CACNA1B;CACNA1D;MICU2
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.32978358261941665,0.6363156084792176,0.8630338733431517,0.9774385132919593,1.0,2/10,18.56%,WNK1;MAP2K5
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.32978358261941665,0.6363156084792176,0.8630338733431517,0.9774385132919593,1.0,2/10,18.56%,WNK1;MAP2K5
prerank,positive regulation of axon extension (GO:0045773),0.2887809855209758,0.6360286649140823,0.8834355828220859,0.9773314132535426,1.0,4/22,13.47%,MACF1;NRP1;TWF2;MEGF8
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.318254987397186,0.6356630823931229,0.875,0.9769775651301358,1.0,1/11,4.08%,PKD2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.318254987397186,0.6356630823931229,0.875,0.9769775651301358,1.0,1/11,4.08%,PKD2
prerank,snRNA 3'-end processing (GO:0034472),0.294415445202516,0.6347118994914379,0.88510101010101,0.9774106205084699,1.0,7/19,22.25%,INTS8;INTS6;INTS6L;INTS1;EXOSC3;TOE1;EXOSC2
prerank,coenzyme A metabolic process (GO:0015936),0.309232091166104,0.6343404554503619,0.8695652173913043,0.9773818631549701,1.0,1/14,3.27%,SLC25A16
prerank,negative regulation of coagulation (GO:0050819),0.30629882638146994,0.6338066806897261,0.8898071625344353,0.9774797064594554,1.0,1/14,4.04%,APOE
prerank,aggrephagy (GO:0035973),0.2824230765907668,0.6333086233783156,0.8991793669402111,0.9775543195652671,1.0,9/27,24.34%,UBE2V1;HDAC6;DYNC1H1;WDR81;UBE2N;WDFY3;PRKN;IFT88;DYNC1LI1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.2777239506902782,0.6330237615322247,0.9010477299185099,0.9774602212208297,1.0,6/30,17.57%,SCN4B;PKP2;NEDD4L;KCNA5;CACNA1D;SCN5A
prerank,regulation of autophagosome assembly (GO:2000785),0.27109996146857096,0.6327028422604083,0.8883826879271071,0.9773779333644657,1.0,11/33,23.86%,PIP4K2A;RAB3GAP2;MTMR3;RAB1B;LRRK2;TBC1D14;TBC1D12;SEC22B;NPRL3;ADPRH;IFT88
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.2877327503954033,0.632552318464887,0.8837209302325582,0.9771744712242242,1.0,4/20,20.32%,BCL2L1;BAK1;GSK3A;GSK3B
prerank,xenobiotic transport (GO:0042908),0.2968470524261101,0.6323327070762497,0.8681177976952625,0.9770308775211365,1.0,3/17,15.52%,ABCC3;ABCC1;ABCA3
prerank,translational termination (GO:0006415),0.2474619783661991,0.6321777990681693,0.9496919917864476,0.9768280145685501,1.0,27/95,25.45%,MRPL46;AURKAIP1;CHCHD1;MRPL41;GSPT1;ERAL1;MRPL51;MTRF1L;MRPL19;MRPL15;MRPS25;MRPS9;MRPS21;MRPS14;MRPL39;MRPL3;MRPL30;MRPS26;MRPL10;MRPL54;MRPL21;MRPL52;MRPL18;MRPL12;MRPL37;MRPS12;MRPS34
prerank,cell-cell junction organization (GO:0045216),0.2514906614684599,0.6314664750606561,0.9579055441478439,0.9771069570932243,1.0,10/79,12.13%,TGFB1;CSF1R;PKP2;FLCN;SMAD3;CDH8;LIMS1;CDH9;CDH12;TLN1
prerank,purine nucleotide metabolic process (GO:0006163),0.28553946337491565,0.6309529095541531,0.8836930455635491,0.977191522493275,1.0,4/24,14.61%,XDH;GART;PNP;PRPSAP1
prerank,tRNA 5'-end processing (GO:0099116),0.30313085550481855,0.6309434458492105,0.8710526315789474,0.9768695085768299,1.0,3/15,14.99%,RPP38;RPP14;PRORP
prerank,histone acetylation (GO:0016573),0.253294930060895,0.6302291782176973,0.9456066945606695,0.9771188572008631,1.0,17/69,24.03%,BRD8;SPI1;EP400;TADA1;BRPF3;NAA40;KAT7;JADE2;NAA50;MEAF6;PER1;BRD1;YEATS2;PHF20;MORF4L2;MORF4L1;CHD5
prerank,peptidyl-lysine dimethylation (GO:0018027),0.29289343184477334,0.6300908865741377,0.8872180451127819,0.9768939087321972,1.0,4/18,18.61%,ASH1L;SETD2;SUV39H1;SETD1B
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.20101127687910275,-0.6297848856903768,0.965,0.9868531510563855,1.0,10/20,32.03%,FAR1;ACLY;PPT1;CBR4;ACSL4;ACSL3;HSD17B4;FITM2;GCDH;SLC25A1
prerank,negative regulation of histone methylation (GO:0031061),0.3292846157028495,0.6297469399166525,0.8639551192145862,0.9768496059015225,1.0,5/10,28.03%,MTF2;PHF1;DNMT3B;BCOR;JARID2
prerank,kinetochore organization (GO:0051383),0.31056563500533624,0.6293610870144392,0.8734525447042641,0.9768239271659217,1.0,13/13,68.97%,MIS12;CENPT;CDT1;POGZ;CENPC;CENPW;NUF2;DLGAP5;CENPA;CENPF;NDC80;CENPH;CENPE
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.28380679966584377,0.6288848308015015,0.8990384615384616,0.9768536856548459,1.0,6/25,23.32%,EAF1;LEO1;ELL;HEXIM1;ZMYND11;NELFE
prerank,post-translational protein modification (GO:0043687),0.2421722570451132,0.6288522643849067,0.996,0.9765492955050573,1.0,57/332,19.62%,PCSK9;WDTC1;COPS6;SPP1;APOE;DNAJC3;FBXL22;TIMP1;RNF7;FBXL18;PTP4A2;KLHL21;PSMB10;P4HB;CHML;RAB11A;FAM20C;RAB1B;VGF;LGALS1;RBBP5;FBXO40;CHGB;PSMA2;KLHL11;RBBP7;FBXO32;F5;PSME3;STT3B;SUMF2;FBXL3;COPS4;GAS6;PSMB5;WFS1;PSMD8;CCDC8;DCAF17;PSMD7;GAN;PSMB9;WSB2;HIF1A;APLP2;DCAF5;FEM1B;VHL;PSMD2;KEAP1;IGFBP4;FBXO44;MXRA8;SPSB2;ELOB;FN3K;STT3A
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.3191735135594633,0.6285475572511459,0.8613037447988904,0.9764556330209442,1.0,1/11,6.34%,CTNNB1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.2517594777102228,0.6281404625540669,0.9239465570400822,0.9764411250710429,1.0,19/80,21.50%,LAPTM5;RPS2;MALT1;PDCD6;DERL1;AMER1;ARRDC4;STUB1;LRRK2;HUWE1;WFS1;GSK3A;UBE2N;ANGPT1;BIRC2;DCUN1D5;BIRC3;CUL3;PIN1
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.18394106918148434,-0.6280994831570005,0.9841269841269841,0.9861423556496139,1.0,20/33,35.07%,RFC1;MRE11;PINX1;CTC1;SHQ1;TNKS1BP1;WRAP53;CDK2;TERT;DCLRE1B;GAR1;PPP6R3;TERF1;NOP10;RTEL1;ACD;ZBTB48;RAD51;PPP6C;NHP2
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.297297982304046,0.6279596531943569,0.8772845953002611,0.9762640277372908,1.0,7/16,23.92%,NF2;SH2B3;ADIPOR1;PPP2CA;VHL;SOCS3;INPP5F
prerank,DNA packaging (GO:0006323),0.2935129005149737,0.6277910686060436,0.8861788617886179,0.9760671177507834,1.0,3/16,19.48%,TP53;NOC2L;RBBP4
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.3066798200385735,0.6276322170094125,0.8854166666666666,0.9758586597828959,1.0,2/15,7.13%,MEF2A;SLC9A1
prerank,vitamin transport (GO:0051180),0.2766231164945051,0.6275461592301874,0.9069767441860465,0.9755947082462468,1.0,1/29,1.98%,SLC52A1
prerank,protein tetramerization (GO:0051262),0.25459359602308074,0.6274466305884355,0.9393939393939394,0.9753549646592109,1.0,5/67,6.13%,ALDH9A1;SNCA;PKD2;FARSB;SAMHD1
prerank,regulation of neurotransmitter transport (GO:0051588),0.2943753379799708,0.6264354312644594,0.8878627968337731,0.9758432782346163,1.0,2/16,8.17%,MCTP1;MEF2C
prerank,cellular response to misfolded protein (GO:0071218),0.28712122039796406,0.6262830641744197,0.9153175591531756,0.9756403205359646,1.0,9/20,27.22%,ATXN3;DERL1;STUB1;TOR1A;CUL3;DNAJB14;KLHL15;UGGT2;VCP
prerank,amino sugar metabolic process (GO:0006040),0.3196891907868157,0.6258291721412601,0.8783977110157367,0.9756751670687339,1.0,3/10,19.57%,ST3GAL1;SLC35A3;FN3K
prerank,regulation of Notch signaling pathway (GO:0008593),0.24873890282941788,0.6256424877467593,0.9376299376299376,0.9754854294378064,1.0,10/76,16.04%,LFNG;BMP2K;MAML3;SREBF2;TSPAN14;POGLUT1;METTL3;NOD2;SRC;RBPJ
prerank,epithelial cell development (GO:0002064),-0.20989472615388555,-0.6255417584025178,0.9419642857142857,0.9859771001884711,1.0,14/20,51.10%,WNT5B;ACTA2;PDZD7;EXPH5;RILPL2;TMEM79;WNT7A;PKHD1;POF1B;GRHL2;WNT7B;RAB25;ROS1;RILPL1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.26863819593518096,0.6253512572524949,0.9196919691969196,0.9753743030811758,1.0,12/40,25.20%,PYCARD;BCL2L1;TP53;BMF;TNFSF10;GHITM;DNM1L;PRKN;BID;IGF1;PRELID1;MFF
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.2851682215586147,0.624783260861241,0.8879310344827587,0.9754931434744323,1.0,8/20,25.59%,PPIE;CWC27;PPIG;PPIH;NKTR;PIN1;PPIA;PPIL3
prerank,regulation of gene silencing by RNA (GO:0060966),0.254851282388566,0.6245877270009172,0.9145945945945946,0.9749865884840121,1.0,7/50,11.84%,NUP62;TNRC6A;SEH1L;PUM2;TPR;POLR2L;NUP205
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.254851282388566,0.6245877270009172,0.9145945945945946,0.9749865884840121,1.0,7/50,11.84%,NUP62;TNRC6A;SEH1L;PUM2;TPR;POLR2L;NUP205
prerank,maturation of SSU-rRNA (GO:0030490),0.26624069224520025,0.6234480706557672,0.9142857142857143,0.975556548837253,1.0,13/34,26.70%,NOB1;RPS16;HEATR1;RPS14;TSR1;NGDN;RIOK3;UTP3;SRFBP1;UTP6;RPS8;NOP14;LSM6
prerank,positive regulation of DNA repair (GO:0045739),0.25926075482011746,0.6228532837439595,0.9303590859630033,0.9757032262102299,1.0,11/46,20.25%,DHX9;HMGB1;MGMT;BABAM2;SLF2;ERCC6;BABAM1;UBE2N;NPAS2;TIGAR;SPIDR
prerank,body fluid secretion (GO:0007589),0.29315119635961334,0.6215829156658632,0.8826666666666667,0.9763611549542157,1.0,4/15,26.43%,PRLR;ZBTB7B;VEGFA;ERBB4
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.2304681623475605,-0.6209563846952183,0.9065743944636678,0.9871129491735159,1.0,6/12,37.39%,HNRNPU;LARP7;NELFB;NELFA;EAPP;RNF8
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.31153522157804514,0.6208613448486323,0.8774647887323944,0.9765871344961167,1.0,2/12,17.63%,SEH1L;MIS12
prerank,acidic amino acid transport (GO:0015800),0.29048507824939807,0.6208461376232198,0.8950695322376738,0.9762729011847896,1.0,3/17,17.69%,LRRC8D;SLC25A18;GIPC1
prerank,sensory perception of taste (GO:0050909),0.3258222445392921,0.6203829504431334,0.8616541353383459,0.9762875904110079,1.0,10/10,67.44%,CD36;ASIC2;TAS1R3;GNAT3;TAS1R2;TAS1R1;ASIC3;ASIC1;PKD1L3;PKD2L1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.28017415668493434,0.619276073176881,0.9051094890510949,0.9768269420562897,1.0,9/24,26.58%,TPGS1;AGBL5;AGTPBP1;TTLL1;NAA80;TTLL7;PARP1;TTLL4;NAA10
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.2655540234276377,0.619237936481668,0.9105504587155964,0.9765313824014819,1.0,8/31,20.32%,YWHAB;TP53;BAK1;CASP8;GSK3A;YWHAH;NMT1;GSK3B
prerank,modified amino acid transport (GO:0072337),0.2994778494950828,0.6189297661623313,0.8839050131926122,0.9764619972782393,1.0,3/15,15.22%,CTNS;MGST1;SLC1A4
prerank,regulation of endocytic recycling (GO:2001135),0.3088372304472521,0.6181899259879934,0.8990182328190743,0.9767147909398481,1.0,5/11,23.92%,ARHGAP1;SORL1;EIPR1;PLA2G4E;INPP5F
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.3021257014253893,0.6179876176005578,0.8891855807743658,0.9765410056360088,1.0,4/14,20.61%,ADPRM;ENTPD1;ENTPD2;ENTPD3
prerank,muscle tissue morphogenesis (GO:0060415),0.29300450830444863,0.6178256160889557,0.8987179487179487,0.9763485802138562,1.0,1/16,4.35%,TTN
prerank,positive regulation of cartilage development (GO:0061036),0.2885354239920456,0.6171518099160764,0.8806366047745358,0.9765285472378128,1.0,3/17,13.72%,MDK;SOX9;SOX6
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.30169555191804054,0.6163211133112498,0.9095816464237517,0.9768321005803612,1.0,6/14,25.49%,SEC24D;SAR1A;SEC13;SEC31A;SEC24C;SEC24A
prerank,regulation of TORC1 signaling (GO:1903432),0.2670807300059187,0.6161276088278151,0.91324200913242,0.9766496498963486,1.0,9/33,22.01%,GPR137B;SEH1L;FLCN;PIP4P1;PIH1D1;RNF152;TELO2;RRAGA;RRAGB
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.3082278705995272,0.6153420462394033,0.8664772727272727,0.9769202672489801,1.0,1/11,6.20%,LIG3
prerank,regulation of lipid metabolic process (GO:0019216),0.24388958692161913,0.6150067525081871,0.9579487179487179,0.9768550227379608,1.0,15/88,18.47%,PSAP;NPC2;SREBF2;ZFP69;TBL1XR1;TBL1X;ADIPOR1;SMARCD3;GPS2;FASN;SREBF1;ACACA;PPARD;NFYA;RXRA
prerank,cellular amino acid catabolic process (GO:0009063),0.2432400976354913,0.6144410324841706,0.957688338493292,0.9769409303905732,1.0,10/87,13.67%,CRYM;HAAO;OGDH;KYNU;KMO;QDPR;ECHS1;MCCC2;ALDH7A1;DDAH1
prerank,negative regulation of endopeptidase activity (GO:0010951),0.2537001610737469,0.6137079867187282,0.9393939393939394,0.9771693340535764,1.0,2/47,4.99%,PCID2;TIMP1
prerank,maintenance of protein location in nucleus (GO:0051457),0.28326031173658345,0.6135266745706166,0.9,0.9769863940608898,1.0,4/20,15.90%,MORC3;SYNE1;TAF8;TAF3
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.30534682166119165,0.613518559711457,0.8893499308437067,0.9766658770025237,1.0,2/12,8.00%,ATIC;GART
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.2688066875859147,0.6129580134105184,0.9156908665105387,0.9767751853601329,1.0,9/30,23.57%,TENT4B;TP53;STN1;SRC;TINF2;TERF2;ERCC4;TEN1;DCP2
prerank,organophosphate ester transport (GO:0015748),0.2740915039472839,0.6129353162613097,0.8902439024390244,0.9764675224874306,1.0,7/24,24.07%,NPC2;PRELID3B;OSBPL8;ABCA3;EPG5;PITPNA;PRELID1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.2917241450732769,0.6129307974363055,0.9110012360939431,0.9761468169692089,1.0,4/19,16.14%,NDST1;XYLT1;EXTL3;NDST2
prerank,organelle fusion (GO:0048284),0.2798705865543412,0.6127835409422334,0.9058679706601467,0.9759298854338312,1.0,7/22,25.20%,VPS18;VPS11;MIGA1;FIS1;MFN1;EEA1;MFF
prerank,establishment of endothelial barrier (GO:0061028),0.2658171555409838,0.6125713276977299,0.895933014354067,0.9757633337430218,1.0,7/29,17.47%,RAP1B;RAP2B;F11R;RAB1B;RAPGEF1;RAP1A;PECAM1
prerank,negative regulation of lipid metabolic process (GO:0045833),0.28444875356671695,0.6122240564314695,0.9021739130434783,0.9756895269067373,1.0,1/22,3.79%,TNF
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.278542754568298,0.6119229329302642,0.9201995012468828,0.975586936250105,1.0,4/22,15.15%,MTOR;HEATR1;SMARCB1;PIH1D1
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.25969116459372077,0.6118125370191626,0.9362912400455062,0.9753477578477294,1.0,4/36,8.50%,RAB34;RAB7A;MACF1;RAB31
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.251602134606123,-0.6116198524113815,0.9368770764119602,0.9909226485357933,1.0,7/10,38.86%,SACS;DNAJB2;DNAJA4;DNAJB1;HSPA1A;HSPA1B;HSPA2
prerank,positive regulation of histone modification (GO:0031058),0.2643765604151668,0.6115397598868023,0.9177142857142857,0.9752165345634498,1.0,12/33,27.30%,PPARGC1A;RPS6KA4;BRD7;AKAP8L;ZBTB7B;UBE2N;RPS6KA5;CTBP1;ARRB1;GLYR1;SART3;MAPK3
prerank,anterograde trans-synaptic signaling (GO:0098916),0.23791656153169474,0.611493219694852,0.994,0.9749271450601208,1.0,27/224,15.95%,PCDHB6;PRKAR2B;SNCA;KCNIP2;CEL;AKAP5;NRGN;ATXN3;APBA1;CACNA1A;PTCHD1;CACNB4;GABRA5;SYT10;DTNA;RAPSN;CACNB2;PRKACB;GLRA2;SDCBP;CACNB1;CAMKK2;GABRA4;CACNA1B;MPZ;GRIA1;RPS6KA2
prerank,skin development (GO:0043588),0.2445895016490334,0.6109408665015881,0.9422875131164743,0.975025826620637,1.0,4/65,6.22%,ALOX12;ATP7A;ITGA6;ANXA1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.31700926024310494,0.6105746460739745,0.8687845303867403,0.9749815336713273,1.0,4/10,19.51%,SVIP;UBE2G2;ERLEC1;OS9
prerank,tricarboxylic acid metabolic process (GO:0072350),0.30622609776996446,0.6099257518804244,0.8993197278911564,0.9751241416684074,1.0,2/12,11.40%,IREB2;ACO1
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.299003045069579,0.6097350324283113,0.9003931847968545,0.9749437991381542,1.0,4/15,18.05%,LDLRAP1;ADM;PPARD;PPM1K
prerank,axonal transport (GO:0098930),0.26066244112318054,0.6097115784908392,0.9148936170212766,0.974637723648124,1.0,9/36,20.23%,AP3D1;AP3S1;DTNBP1;DYNC1H1;DST;HIF1A;KIF1B;KIF3A;FBXW11
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.3138201103098788,0.6093281786017369,0.8832853025936599,0.9745956465217889,1.0,4/10,21.60%,EMC6;EMC2;MMGT1;EMC3
prerank,toxin transport (GO:1901998),0.3176115947958392,0.6092860615084792,0.8912071535022354,0.9743037496013635,1.0,3/10,24.12%,ANTXR2;RAB29;ANTXR1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.2858599442598768,0.6090459042681724,0.8943298969072165,0.9741556855906882,1.0,5/18,22.91%,FZD9;BAK1;GSK3A;GSK3B;BID
prerank,cellular response to BMP stimulus (GO:0071773),0.2428660083614948,0.6081828421056711,0.9328436516264428,0.9744787040491518,1.0,8/66,16.01%,TGFB1;HFE;SMAD3;SOX9;VSTM2A;MEGF8;USP9X;SMURF1
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.26264032421628525,0.6080444102165232,0.9137529137529138,0.9742533342521138,1.0,5/30,13.71%,RAB34;MACF1;RAB31;SEC16A;GGA2
prerank,axon development (GO:0061564),0.24418635438255148,0.6068892053971887,0.9596273291925466,0.974761135952816,1.0,16/78,21.26%,NEFH;S100B;SLITRK1;RTN4RL1;ACTB;MAP1B;ATL1;CAMSAP2;SVBP;MTR;RTN4;SPTBN4;KLF7;CNTN4;CDK5R1;BRSK1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.23992379482217963,0.6060062226352787,0.945417095777549,0.9750664215096615,1.0,19/80,20.41%,KLC2;TMED3;KDELR2;KIF23;UVRAG;RAB1B;COPA;BNIP1;SCYL1;BICD2;KIF2A;LMAN2;USE1;ERGIC1;GOLPH3;KIF3A;SEC22B;ARCN1;COG7
prerank,protein autoubiquitination (GO:0051865),0.2430246946969044,0.605826575677951,0.9525816649104321,0.9748613260611525,1.0,8/61,13.43%,RNF19B;UBE2D3;TRAF2;RNF4;NFX1;RNF10;ITCH;STUB1
prerank,ncRNA metabolic process (GO:0034660),0.25864611405128807,0.605803781560901,0.9369266055045872,0.9745592205520304,1.0,9/37,25.10%,TENT4B;BCDIN3D;PRKRA;TUT7;TARBP2;AGO2;DICER1;ZCCHC8;DROSHA
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.24368263039779897,0.6057609056402238,0.9533195020746889,0.9742724878568224,1.0,14/79,18.48%,PTPN1;UBE2D3;SKI;CREB3L1;CASK;SULF2;PDCD6;THBS1;SORL1;BAMBI;SMURF1;RBPMS2;SPRY4;GREM1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.30718232683801505,0.6053096033144497,0.8985074626865671,0.9742701086051017,1.0,2/11,14.31%,CCT8;CCT5
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.2934531085582992,0.6051377516159289,0.8902116402116402,0.9740749803086082,1.0,3/16,15.43%,MCM2;MCM6;TWNK
prerank,protein mono-ADP-ribosylation (GO:0140289),0.3133503947274006,0.6042402022386355,0.8816901408450705,0.9743899951345774,1.0,5/11,20.46%,PARP8;PARP16;TIPARP;PARP10;PARP3
prerank,regulation of supramolecular fiber organization (GO:1902903),0.2791753160480984,0.604201687137608,0.9163591635916359,0.9741023480806749,1.0,6/22,21.71%,APOE;MAP1B;CAMSAP2;GBA2;AEBP1;PIK3CA
prerank,histone H3 acetylation (GO:0043966),0.25767771326117034,0.6040634124143677,0.9217199558985667,0.9738818823125489,1.0,9/40,20.62%,SPI1;TADA1;BRPF3;KAT7;JADE2;MEAF6;PER1;BRD1;YEATS2
prerank,icosanoid secretion (GO:0032309),0.300026286505892,0.6038718262114012,0.9041095890410958,0.9736868014308524,1.0,3/12,21.87%,ANXA1;PLA2G5;ABCC4
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.2642848752584228,0.6034745338897166,0.9224441833137486,0.9736466033822138,1.0,5/27,15.22%,SLC7A8;SLC25A38;SLC36A4;SLC25A18;SLC1A4
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.2821238947017332,0.60347337797503,0.9118387909319899,0.9733276284033205,1.0,6/19,21.74%,CDA;PNP;POLD3;DCK;APRT;GMPR2
prerank,regulation of glucose transmembrane transport (GO:0010827),0.28497261613229036,0.6031573082671747,0.8986232790988736,0.9732388252637068,1.0,3/18,20.24%,PRKCB;BRAF;INPP5K
prerank,arachidonate transport (GO:1903963),0.30909420194521076,0.6027447655092024,0.9132290184921764,0.9728947467102307,1.0,1/10,6.22%,ANXA1
prerank,arachidonic acid secretion (GO:0050482),0.30909420194521076,0.6027447655092024,0.9132290184921764,0.9728947467102307,1.0,1/10,6.22%,ANXA1
prerank,inositol phosphate catabolic process (GO:0071545),0.302882172561405,0.6023652250808078,0.8906030855539971,0.9728306914841228,1.0,5/12,23.91%,SYNJ1;PTEN;INPP5K;NUDT3;OCRL
prerank,positive regulation of RNA splicing (GO:0033120),0.257728267551804,0.6019066314568934,0.9249106078665077,0.9728660637002063,1.0,5/29,15.67%,ERN1;CIRBP;TRA2B;PRDX6;THRAP3
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.3069517826433615,0.6008421245252377,0.9037356321839081,0.9729763325376919,1.0,3/10,19.40%,MGMT;ALKBH5;FTO
prerank,DNA dealkylation (GO:0035510),0.3069517826433615,0.6008421245252377,0.9037356321839081,0.9729763325376919,1.0,3/10,19.40%,MGMT;ALKBH5;FTO
prerank,regulation of nuclear division (GO:0051783),0.2765210712094276,0.5990136526817309,0.9121706398996235,0.9739290283984272,1.0,5/20,26.66%,KIF20B;CCDC8;PIN1;FBXO5;DAPK3
prerank,establishment of melanosome localization (GO:0032401),0.275658318112039,0.5989052389450292,0.922882427307206,0.9736917132818734,1.0,2/19,9.82%,MYO5A;RAB11A
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.2603757161167917,0.5985576341561537,0.9236111111111112,0.9736057342306337,1.0,6/32,18.19%,TAOK3;BABAM2;FZR1;FOXN3;BABAM1;TAOK1
prerank,signal release from synapse (GO:0099643),0.24747952191045358,0.5979785803053881,0.9481236203090507,0.9736873627608366,1.0,9/43,21.31%,SNCA;PIP5K1C;STXBP3;SYT10;PDZD11;DNAJC5;UNC13A;BRSK1;RIMS1
prerank,histone ubiquitination (GO:0016574),0.27507148140641974,0.5973345014836583,0.9007263922518159,0.9737937273920394,1.0,7/21,23.67%,LEO1;PHC1;RNF40;HUWE1;UBE2N;UBE2E1;CTR9
prerank,dermatan sulfate metabolic process (GO:0030205),-0.22531154828715605,-0.5962434394501769,0.9553264604810997,0.997792090168682,1.0,2/13,6.86%,DSE;VCAN
prerank,negative regulation of DNA recombination (GO:0045910),0.24783630451700037,0.5961997751766098,0.9328193832599119,0.9742359107005819,1.0,9/43,20.54%,MAD2L2;ATRX;POLR2L;SHLD1;POLR2E;SHLD2;TINF2;PARP3;TERF2
prerank,melanosome localization (GO:0032400),0.26817141329598465,0.595613978386715,0.9198520345252774,0.9743286355831994,1.0,4/21,18.23%,MYO5A;RAB11A;RAB27B;VPS33B
prerank,translesion synthesis (GO:0019985),0.2502789610281791,0.5949599483592344,0.9415011037527594,0.9744601209935186,1.0,3/42,6.92%,TRIM25;MAD2L2;POLH
prerank,negative regulation of reproductive process (GO:2000242),0.28496414125005165,0.5944693895310914,0.9168797953964194,0.9744687386657904,1.0,2/17,10.01%,TIMP1;ARHGDIB
prerank,microtubule polymerization (GO:0046785),0.26578490873742805,0.5944108377417753,0.9241540256709452,0.9741934058523515,1.0,4/28,12.65%,FGF13;TUBGCP4;TUBGCP6;RANBP9
prerank,transport along microtubule (GO:0010970),0.28813675950050355,0.5935103024482862,0.9032258064516129,0.9744725836514881,1.0,4/13,17.62%,APBA1;ARHGAP21;BORCS5;CDC42
prerank,hippo signaling (GO:0035329),0.2577626933877332,0.5934063373974522,0.9239904988123515,0.9742271755385746,1.0,8/26,20.81%,TEAD1;YWHAB;STK3;MOB1B;DCHS1;STK4;MOB1A;AMOT
prerank,regulation of double-strand break repair (GO:2000779),0.2507336799719294,0.5931985939932275,0.9318681318681319,0.9740527607360372,1.0,12/39,24.78%,MGMT;ACTR2;SETD2;RNF169;SLF2;PPP4C;PPP4R2;SHLD2;SPIDR;TERF2IP;DDX11;SIRT7
prerank,sulfur amino acid catabolic process (GO:0000098),0.30214500981977577,0.592780159684488,0.909221902017291,0.9739997053196556,1.0,2/10,17.04%,TXN2;CBS
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.2719572469215491,0.5924087177512145,0.9166666666666666,0.9739306572326969,1.0,7/20,23.94%,CEBPA;MYOCD;PTEN;HEXIM1;HHEX;TFAP4;IPO7
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.3007171026668791,0.5920054135298154,0.9,0.9738770085926797,1.0,2/11,12.40%,P4HB;FYN
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.2857478918557874,0.5912388772572158,0.9274809160305344,0.9740569734650385,1.0,2/16,7.13%,MEF2A;SLC9A1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.29552402782150045,0.5908537056261056,0.8978201634877384,0.9739886413317722,1.0,2/12,9.33%,ABCD1;PPARGC1A
prerank,peptidyl-lysine methylation (GO:0018022),0.26905868065049765,0.5908357028957589,0.9224343675417661,0.9736839259950623,1.0,5/26,16.55%,SETD6;SETD2;ETFBKMT;SMYD3;SUV39H1
prerank,negative regulation of translation (GO:0017148),0.2339591164742538,0.5898935288847382,0.9702258726899384,0.9739647854543104,1.0,23/87,23.51%,CNOT8;YTHDF3;EIF4EBP2;LARP1;EPRS1;CPEB3;TPR;METTL3;PCIF1;IGF2BP3;CPEB4;PUS7;CPEB2;MEX3D;AGO2;FTO;ROCK2;LSM14A;CNOT7;CNOT1;EIF3E;ILF3;RACK1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.2856359535965327,0.5898730907019066,0.8962765957446809,0.973658943133607,1.0,3/13,17.50%,ALG2;DPAGT1;ALG11
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.30474804473423645,0.5897812788685017,0.8829479768786127,0.9734049366029315,1.0,3/10,19.23%,GABRA5;GABRA4;GABRG1
prerank,chemical synaptic transmission (GO:0007268),0.22800192761562404,0.5889040134069139,0.999,0.9736812834146299,1.0,36/284,16.47%,PCDHB6;PRKAR2B;SNCA;APOE;KCNIP2;CEL;AKAP5;NRGN;ATXN3;RIMBP2;APBA1;STXBP3;CACNA1A;PTCHD1;CACNB4;GABRA5;SYT10;CDH8;DTNA;RAPSN;CACNB2;PRKACB;GLRA2;SDCBP;CACNB1;STAC3;CAMKK2;GABRA4;CACNA1B;PDZD11;SLC1A4;MPZ;GRIA1;RPS6KA2;DNAJC5;PTEN
prerank,tyrosine metabolic process (GO:0006570),-0.23288271597375146,-0.5886593731875173,0.9415807560137457,0.9998092171254236,1.0,5/11,42.61%,FAH;GSTZ1;TYR;IL4I1;HGD
prerank,regulation of primary metabolic process (GO:0080090),0.22939739065834897,0.5885723612232275,0.9817629179331308,0.9735845751107072,1.0,25/126,19.84%,PSAP;SREBF2;APOE;ZFP69;PSMB10;TBL1XR1;TBL1X;PSMA2;ADIPOR1;PSME3;SMARCD3;GPS2;PSMB5;FASN;PSMD8;SREBF1;PSMD7;PSMB9;ACACA;PPARD;PSMD2;NFYA;RXRA;ROCK2;C1QTNF2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.2357726337728708,0.5883388906965011,0.96760710553814,0.9734423338002788,1.0,6/72,13.53%,CBL;GRB2;RAB14;FLRT1;POLR2L;FIBP
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.21790155991710702,-0.5882533826057684,0.964,0.9981337441994929,1.0,2/15,6.86%,DSE;VCAN
prerank,mitochondrial gene expression (GO:0140053),0.2473490906284918,0.5881946387171372,0.9361936193619362,0.9732196694772266,1.0,15/42,27.60%,FOXO3;GATB;MRPL51;LARS2;TWNK;MRPS21;MRPS14;TFAM;MRPL12;GATC;MRPS12;MRPS34;MRPS15;MRPL16;MRPS24
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.2671793747365088,0.5879218193832866,0.9265060240963855,0.9730826280112154,1.0,8/25,27.31%,NDST1;B3GALNT1;FUT9;NDST2;NDST4;EXT2;B3GALT2;B3GNT9
prerank,regulation of protein localization to Cajal body (GO:1904869),0.2957112471421631,0.5875836996496644,0.8973607038123167,0.9726715370971116,1.0,2/11,14.31%,CCT8;CCT5
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.2957112471421631,0.5875836996496644,0.8973607038123167,0.9726715370971116,1.0,2/11,14.31%,CCT8;CCT5
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.2926208049361051,0.5870672190573114,0.9084302325581395,0.9726853280864425,1.0,2/12,14.31%,CCT8;CCT5
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.2769912997829417,0.5860934817506085,0.9159001314060446,0.972985439709783,1.0,8/16,29.14%,NAA40;NAA50;NAA15;NAA25;NAA80;NAA10;CREBBP;EP300
prerank,negative regulation of cation channel activity (GO:2001258),0.25883058041609885,0.5858951015054359,0.929678188319428,0.9727992191580098,1.0,4/26,17.80%,PKD2;EPO;GNB5;GSTM2
prerank,positive regulation of histone methylation (GO:0031062),0.26310248480313125,0.5856365465179776,0.9254807692307693,0.9726446548864031,1.0,3/24,12.39%,PRDM12;CTNNB1;MTF2
prerank,myelination in peripheral nervous system (GO:0022011),0.2856833559455212,0.5854499311849131,0.899581589958159,0.9724503692244933,1.0,6/13,26.50%,SKI;PRX;NF1;DICER1;CNTNAP1;LGI4
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.2144613793829786,-0.5844616565055105,0.9637681159420289,0.9980848120404269,1.0,6/13,37.39%,HNRNPU;LARP7;NELFB;NELFA;EAPP;RNF8
prerank,protein prenylation (GO:0018342),0.2986059203898014,0.5835268932813209,0.9172610556348074,0.9733101429685516,1.0,1/10,8.78%,CHML
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.18689710000902815,-0.5834962655271362,0.9698492462311558,0.9966785196502492,1.0,6/21,22.31%,ATAD5;BRD4;CDK4;NPM1;CDC7;RAD51C
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.25051044108975307,0.5828239820068762,0.934931506849315,0.9734447458302037,1.0,4/31,13.47%,TGFBR1;TGFBR2;DYNC2I1;MEGF8
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.2780713299120626,0.5822636799254188,0.9217731421121251,0.9734668749697275,1.0,4/16,24.20%,THBS1;FGF2;VEGFA;PPP1R16B
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.2681769646518232,0.5812365956082506,0.9180929095354523,0.9734971753102305,1.0,7/21,24.89%,GTF2H1;ERCC5;GTF2H5;ERCC1;ERCC4;PARP1;RPA1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.2681769646518232,0.5812365956082506,0.9180929095354523,0.9734971753102305,1.0,7/21,24.89%,GTF2H1;ERCC5;GTF2H5;ERCC1;ERCC4;PARP1;RPA1
prerank,DNA biosynthetic process (GO:0071897),-0.21479811317200878,-0.5808295025819268,0.9690265486725663,0.9961202552673728,1.0,11/16,35.85%,WRNIP1;WRN;POLA1;TERT;TYMS;POLD2;RFC3;POLE;POLD4;CDKN2D;POLD1
prerank,amide transport (GO:0042886),0.25835869125671546,0.5807166307724508,0.936094674556213,0.9734901202290847,1.0,3/26,10.42%,SLC14A2;AQP11;TAP1
prerank,regulation of cation transmembrane transport (GO:1904062),0.255959748562015,0.5803612731270391,0.9375,0.973388045359322,1.0,5/29,17.57%,KCNIP2;WNK1;CD63;CACNA1D;SCN5A
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.2807229694139577,0.5779990040722052,0.9293478260869565,0.9745236017626738,1.0,2/13,10.17%,MDFIC;TPR
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.2648990484807143,0.5776672021496738,0.9263803680981595,0.9743957811525291,1.0,1/20,2.80%,MTHFS
prerank,innate immune response in mucosa (GO:0002227),0.29717629032377946,0.5776487561985123,0.9110787172011662,0.9740957095373092,1.0,1/10,12.50%,DEFA6
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.24585273387007942,0.5774892109233423,0.9517396184062851,0.9738874266215746,1.0,1/37,0.89%,TGFB1
prerank,DNA catabolic process (GO:0006308),0.29029416070489455,0.5770548442139641,0.9265785609397944,0.9738329890349504,1.0,4/11,25.67%,REXO4;DNASE1L1;XRN2;DFFB
prerank,cognition (GO:0050890),0.24543017978658388,0.5761453698191057,0.9493813273340832,0.9740505505927798,1.0,12/42,21.49%,TNF;CHD7;PTCHD1;LINS1;CYFIP1;CTNS;SLC1A4;NF1;CUX2;TUSC3;SETD5;MAGT1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.2840592017322496,0.5751506033892693,0.9294964028776979,0.9743446125462898,1.0,4/12,27.55%,ADCY8;PPP3CB;PLA2G6;STX4
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.24377128489312905,0.575119442149233,0.9420935412026726,0.9740480132734983,1.0,10/37,23.51%,DDIT3;BCL2L1;TP53;BECN1;BMF;FIS1;DNM1L;RPS7;BID;RACK1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.22851240608979903,0.5731824496183946,0.9776195320447609,0.9748895804392401,1.0,13/87,15.29%,NDUFB8;NDUFA11;NDUFA2;NDUFB4;FASTKD3;UQCC1;CHCHD4;NDUFV1;NDUFS6;IMMP2L;NDUFAB1;COX20;NDUFB11
prerank,rRNA modification (GO:0000154),0.2609085935623115,0.572548577265283,0.9420468557336621,0.9749566882440045,1.0,3/21,18.51%,FBL;ZCCHC4;NSUN4
prerank,leukotriene biosynthetic process (GO:0019370),-0.2054190918832623,-0.5722367271954266,0.9709090909090909,0.9979488022445485,1.0,1/14,2.20%,LTA4H
prerank,aminoglycan biosynthetic process (GO:0006023),0.24035860486364483,0.5720928791900173,0.9626068376068376,0.9749125689976936,1.0,8/49,16.14%,HEXA;AGRN;NDST1;XYLT1;B3GALNT1;B4GALT7;PXYLP1;NDST2
prerank,ribosome assembly (GO:0042255),0.23575519772862433,0.5703488135256287,0.9569429494079655,0.9756353006154843,1.0,15/47,25.96%,ERAL1;RPL6;MDN1;RPS14;RRS1;RPL11;RPS27;RRP7A;RPS15;EFL1;RPS5;EIF2A;RPL10;C1QBP;RPL5
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.26743211164042685,0.5692418007298053,0.9248704663212435,0.9759566396974837,1.0,2/17,16.91%,NOS1AP;KCNRG
prerank,male meiosis I (GO:0007141),-0.19385860307906894,-0.5687626614481759,0.9795081967213115,0.9975840454226856,1.0,7/16,41.34%,ZSCAN21;MYBL1;FOXJ2;HSF2BP;SYCP3;TDRD9;DDX4
prerank,regulation of membrane repolarization (GO:0060306),-0.21427468598772265,-0.5674068695507657,0.9461538461538461,0.9963018096344933,1.0,1/13,1.07%,CAV1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.26687920640766893,0.5668895734906718,0.9562419562419563,0.9770065261603889,1.0,2/18,9.03%,BCL2L1;BAK1
prerank,intraciliary retrograde transport (GO:0035721),-0.2199411867733301,-0.5651042878182497,0.9584775086505191,0.9953782441539942,1.0,6/12,30.51%,WDR35;DYNC2I2;IFT43;IFT122;WDR19;DYNC2H1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.2891215461181501,0.5647915187654814,0.9229651162790697,0.9778972487688729,1.0,1/10,6.80%,TP53
prerank,regulation of mitotic spindle organization (GO:0060236),0.24134767709508304,0.5647478716469979,0.9508009153318078,0.9776104812748269,1.0,5/35,15.83%,NUP62;TPR;CLTC;DYNC1H1;PDCD6IP
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.2564124240406739,0.5638227770073053,0.9423769507803121,0.9778099243169454,1.0,1/23,2.02%,COPS6
prerank,RNA modification (GO:0009451),0.23132063359995153,0.5633560940616308,0.9692470837751855,0.9777679500829037,1.0,10/54,18.51%,RBM15B;ADAR;CDKAL1;TRMT1;CTU1;METTL3;ADARB1;BCDIN3D;PUS7;NSUN4
prerank,neurotransmitter secretion (GO:0007269),0.2322723926198625,0.5626006478946558,0.9702643171806168,0.9778698083609472,1.0,9/44,21.31%,SNCA;PIP5K1C;STXBP3;SYT10;PDZD11;DNAJC5;UNC13A;BRSK1;RIMS1
prerank,gastrulation (GO:0007369),0.27039516473558733,0.5619886118957222,0.9409448818897638,0.9778778451120075,1.0,3/15,16.68%,LRP5;MEGF8;TASOR
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.22664740558668678,0.5611415575998477,0.9683544303797469,0.978045704213357,1.0,12/59,25.09%,LPL;LIPC;NDUFAB1;OSBP;ACACA;OSBPL7;ACOT8;CYP27A1;GATM;OSBPL3;HSD17B8;XBP1
prerank,mesenchymal cell development (GO:0014031),-0.18676536047189105,-0.5609819950528354,0.9906976744186047,0.9950892361237024,1.0,8/18,33.06%,FOXC1;PEF1;CDH2;HEY2;SOX8;KBTBD8;TCOF1;SOX11
prerank,serine family amino acid biosynthetic process (GO:0009070),0.28398442483765146,0.5586571585562411,0.9217638691322901,0.9790932110454186,1.0,6/12,25.00%,CBS;PHGDH;PSAT1;SERINC3;SEPHS2;PSPH
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.24195874110021964,0.5585117428775169,0.9565217391304348,0.978864875304431,1.0,13/31,26.78%,LRP8;LZTS3;LRRK2;TANC2;PTEN;EPHA4;CUX2;RELN;CDK5R1;CFL1;EFNA1;DBNL;NGEF
prerank,inorganic anion transmembrane transport (GO:0098661),0.2269884357063488,0.5558787051944073,0.9738493723849372,0.979961058066445,1.0,7/63,13.84%,SLC37A2;GABRA5;XPR1;GLRA2;SLC20A2;SLC25A30;GABRA4
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.23298332336155492,0.5557545521880698,0.9810901001112347,0.9797099280371364,1.0,8/41,16.72%,NUP62;SEH1L;TPR;NUP205;LACC1;HIF1A;GCK;PGAM1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.24413485591294487,0.5543555886348356,0.9468713105076741,0.98012055636234,1.0,4/27,14.59%,FBXL22;TP53;FBXL3;PPP1CC
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.2530210211456068,0.5523471579732969,0.9525547445255474,0.9808621065906563,1.0,1/22,2.34%,GTF2H1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.2498180392400728,0.5518336230308222,0.951048951048951,0.9808084610140314,1.0,8/25,26.74%,PYCARD;TP53;BMF;TNFSF10;DNM1L;BID;MFF;FAM162A
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.25064866195115215,0.5512462903895142,0.9507211538461539,0.9808014287406305,1.0,7/22,23.94%,CEBPA;MYOCD;PTEN;HEXIM1;HHEX;TFAP4;IPO7
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.2324545118111517,0.5505195687907426,0.9690265486725663,0.9808662145209401,1.0,8/36,19.68%,HFE;AQP11;USP7;SDCBP;PSME3IP1;RPL11;GIPC1;TLK2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.24551607321431926,0.5502434167537854,0.9576968272620446,0.9806923125557448,1.0,8/29,24.89%,GTF2H1;CDK7;ERCC5;GTF2H5;RAD23B;PARP1;XPC;RPA1
prerank,regulation of smooth muscle cell migration (GO:0014910),0.2494063376828468,0.5495345732274952,0.949748743718593,0.9807443112599162,1.0,8/20,26.95%,NRP1;SORL1;LRP1;VTN;IGF1;CCN4;IGFBP3;NDRG4
prerank,Golgi inheritance (GO:0048313),-0.2146539153469612,-0.5469559870562187,0.9804560260586319,0.998358665830545,1.0,6/11,37.13%,STK25;GOLGA2;PLK5;YWHAZ;GBF1;PLK3
prerank,positive regulation of phospholipase activity (GO:0010518),0.24606834865922012,0.5464075296318368,0.9405339805825242,0.9819907105465389,1.0,7/22,24.63%,GNA13;NTF3;PDPK1;PLA2G5;PLAA;FGF2;ABL2
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.2606376646373607,0.5455404013117712,0.9335071707953064,0.9821156201151697,1.0,6/16,27.68%,VTA1;VPS28;LEPROTL1;TMEM50A;STAM;CHMP7
prerank,retinal metabolic process (GO:0042574),-0.21379936917578796,-0.5455076383175147,0.967948717948718,0.9970091360442328,1.0,1/12,6.25%,RDH10
prerank,metallo-sulfur cluster assembly (GO:0031163),0.25075213754021314,0.5449379320499592,0.9320754716981132,0.9820927961572732,1.0,4/22,13.72%,MMS19;CIAO2A;CIAO1;HSCB
prerank,multivesicular body assembly (GO:0036258),0.23628880571228336,0.5434237210395437,0.9681456200227532,0.982517388342422,1.0,5/30,17.10%,VTA1;RAB11A;VPS37C;PDCD6IP;VPS28
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.18794373233586473,-0.5426397293550203,0.983402489626556,0.9961453006756094,1.0,9/18,35.07%,CCT3;CCT6A;SHQ1;RUVBL1;PARN;NOP10;RUVBL2;NAF1;NHP2
prerank,NIK/NF-kappaB signaling (GO:0038061),0.2156367897236611,0.5399728715352465,0.9842105263157894,0.9838669818070066,1.0,16/72,20.92%,TRAF2;MAP3K14;PSMB10;MALT1;PSMA2;PSME3;PSMB5;PSMD8;PSMD7;PSMB9;REL;PSMD2;BIRC2;BIRC3;FBXW11;DICER1
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.2410177319753709,0.5384140111595076,0.9708029197080292,0.9842707846214462,1.0,7/23,23.89%,TIMM22;AGK;BMF;HSP90AA1;TIMM29;HSPA4;TIMM8B
prerank,respiratory electron transport chain (GO:0022904),0.2632349209311611,0.5378926287334003,0.9475806451612904,0.9842031604523673,1.0,5/14,20.59%,PPARGC1A;SLC25A18;SDHB;ETFDH;SDHA
prerank,protein import into peroxisome matrix (GO:0016558),0.2713726216176483,0.5376246409456307,0.931787175989086,0.9840130033970611,1.0,2/12,11.62%,PEX13;PEX7
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.2547751406521449,0.5367052917700024,0.9561290322580646,0.9841262057403513,1.0,6/16,23.36%,TNKS2;SLX4;TINF2;TERF2;ERCC4;PARP1
prerank,histone H3 deacetylation (GO:0070932),0.253854153946153,0.5361432140713421,0.9530638852672751,0.9840564057388526,1.0,4/15,18.93%,HDAC4;HDAC9;SMARCAD1;PER1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.23039905465429283,0.536057474472119,0.9711316397228638,0.9837828787644118,1.0,5/35,13.35%,SEMA4D;PLXNB2;NRP1;SEMA4A;ARHGDIA
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.2510468102286899,0.5360009511588438,0.9704370179948586,0.9834964680106466,1.0,6/18,25.06%,ANXA1;HDAC9;FGF2;VEGFA;AKT3;KDR
prerank,protein hydroxylation (GO:0018126),0.2573445048575769,0.5357360044293497,0.9459815546772069,0.983305533587507,1.0,2/15,9.87%,ASPH;P3H2
prerank,DNA recombination (GO:0006310),0.229402691025563,0.5336959077094081,0.9624145785876993,0.9838879210789874,1.0,7/37,21.53%,EXO1;HMGB1;RAD54L;RAD51B;ERCC1;RAD51D;RPAIN
prerank,aerobic respiration (GO:0009060),0.2462559402354023,0.5329578031052001,0.9509803921568627,0.9839050615535282,1.0,4/20,17.53%,MTFR2;UQCRB;ME3;SDHB
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.2696971264475459,0.5304178928449412,0.9620253164556962,0.9847425006761513,1.0,4/12,23.96%,ABCD1;FADS1;ACOT8;FADS2
prerank,P-body assembly (GO:0033962),0.261778972649928,0.5293791507187665,0.952513966480447,0.9848698497841974,1.0,2/12,11.87%,RC3H1;DYNC1H1
prerank,negative regulation of mRNA processing (GO:0050686),-0.1912475670245495,-0.5283660466551321,0.9717741935483871,0.9985340536808455,1.0,15/15,80.90%,U2AF2;RBMX;SRSF12;RNPS1;SAP18;SRSF9;SRSF7;BARD1;SFSWAP;SRSF4;PCBP4;C1QBP;PTBP1;SRSF10;SRSF6
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.26593397409300024,0.5230211381247424,0.9363241678726484,0.9869724753913808,1.0,4/11,23.91%,SYNJ1;PTEN;INPP5K;OCRL
prerank,inositol phosphate dephosphorylation (GO:0046855),0.26593397409300024,0.5230211381247424,0.9363241678726484,0.9869724753913808,1.0,4/11,23.91%,SYNJ1;PTEN;INPP5K;OCRL
prerank,iron-sulfur cluster assembly (GO:0016226),0.23652901369719653,0.52091015926298,0.9640198511166254,0.9875112324985579,1.0,4/24,13.72%,MMS19;CIAO2A;CIAO1;HSCB
prerank,response to interleukin-4 (GO:0070670),0.26896211398549147,0.5200618436813096,0.945906432748538,0.9875473711280434,1.0,2/10,25.09%,SHPK;XBP1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.19123556002009043,-0.5172497877329401,0.9724409448818898,0.9995740808554845,1.0,14/14,80.90%,U2AF2;RBMX;SRSF12;RNPS1;SAP18;SRSF9;SRSF7;SFSWAP;SRSF4;PCBP4;C1QBP;PTBP1;SRSF10;SRSF6
prerank,anion transmembrane transport (GO:0098656),0.21009885299531894,0.5166963164862628,0.9845201238390093,0.9885301212660426,1.0,9/67,15.28%,LRRC8D;SLC7A8;SLC25A38;SLC36A4;ABCC1;SLC25A18;SLC25A30;SLC35A3;LRRC8C
prerank,multivesicular body organization (GO:0036257),0.22269723499548277,0.5139883788114025,0.9795454545454545,0.9892350810486357,1.0,5/31,17.10%,VTA1;RAB11A;VPS37C;PDCD6IP;VPS28
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.18970443106742618,-0.5130830783740836,0.9803921568627451,0.9987230028627937,1.0,4/13,25.88%,HACD1;ELOVL5;ELOVL1;HACD2
prerank,tRNA processing (GO:0008033),0.21005311275000374,0.5120851077547948,0.9861554845580405,0.9896114572008066,1.0,8/61,14.11%,TSEN15;ELAC2;CDKAL1;TRMT1;TRMT10A;CTU1;RTRAF;DDX1
prerank,positive regulation of rRNA processing (GO:2000234),-0.20713066875479577,-0.5100664735594034,0.975609756097561,0.9975974739416732,1.0,2/10,14.29%,RIOK2;UTP15
prerank,positive regulation of embryonic development (GO:0040019),-0.16940982557456535,-0.5075748893118773,0.9903381642512077,0.9963794328666502,1.0,8/19,37.19%,WNT4;ZBED3;RBM19;NIBAN2;PLCB1;OSR1;TLE6;LHX1
prerank,ribosomal large subunit assembly (GO:0000027),0.2252312992993959,0.5060154369237664,0.964975845410628,0.9914814562829964,1.0,4/24,16.32%,RPL6;MDN1;RRS1;RPL11
prerank,inner mitochondrial membrane organization (GO:0007007),0.2074552354174018,0.5053716249104879,0.9881465517241379,0.9914087020692425,1.0,12/47,23.89%,ATP5MC2;ATP5F1E;TIMM22;AGK;ATP5F1A;ATP5PD;ATP5MG;GHITM;ATP5MF;TIMM29;LETM1;TIMM8B
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.25794610115203387,0.5050533922081865,0.9546099290780142,0.9912057092144789,1.0,2/10,17.49%,IMPACT;VHL
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.257030946820198,0.5045859368350591,0.9643916913946587,0.9910557869450348,1.0,2/11,13.76%,DERL1;TOR1A
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.19942420674672093,0.5026914284318198,0.9948400412796697,0.9913803373079226,1.0,20/84,23.84%,APOE;CNOT8;LARP1;EPRS1;CPEB3;ORMDL2;SORL1;PCIF1;RTN1;IGF2BP3;RTN4;PUS7;BIN1;LSM14A;PIN1;CNOT7;CNOT1;ILF3;RACK1;IGF1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.2020578104786973,0.5025230049265075,0.9905759162303664,0.9911161987222286,1.0,19/72,25.63%,GTF2H1;PNRC2;DNA2;DDX1;POLD3;ERCC5;REXO4;OGG1;GTF2H5;ERCC1;DICER1;DCP1B;ERCC4;RNASE6;PARP1;DNASE1L1;XRN2;RPA1;DXO
prerank,regulation of endopeptidase activity (GO:0052548),0.2013961922032198,0.4967940209029762,0.9894625922023182,0.9926829891621999,1.0,12/59,24.12%,VSIR;TIMP1;PSME3;PSMB9;FURIN;PICALM;BIRC2;BIRC3;ATP13A2;VTN;PRELID1;SERPINA2
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.21410167787343673,0.49418308640322,0.9788732394366197,0.9931857766449649,1.0,29/29,78.63%,TRIP13;SIRT7;BAG6;RAD21;RNF212;KASH5;SYCE1;SYCE3;SYCP1;TERB2;HORMAD1;ANKRD31;RNF212B;RAD21L1;IHO1;STAG3;TEX12;MEIOB;MAJIN;SYCE2;REC8;TEX11;ZCWPW1;SYCP2;FANCD2;MEI4;TERB1;P3H4;PRDM9
prerank,exit from mitosis (GO:0010458),0.24529373326684284,0.49285936616622716,0.9718706047819972,0.9932861353425079,1.0,1/12,6.50%,UBE2S
prerank,positive regulation of transporter activity (GO:0032411),-0.18475736078849897,-0.4912729151875465,0.9928571428571429,0.9976402368911452,1.0,13/13,81.55%,NR1H3;KCTD7;STK39;SYNGR3;SGK2;TRPC6;PDZK1;PON1;ADIPOQ;KMT2A;WNK3;SGK1;RXRA
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.22022720301061635,0.4910319459570334,0.980440097799511,0.9931826775901588,1.0,4/23,15.76%,YWHAB;TP53;CASP8;YWHAH
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.22022720301061635,0.4910319459570334,0.980440097799511,0.9931826775901588,1.0,4/23,15.76%,YWHAB;TP53;CASP8;YWHAH
prerank,serine family amino acid catabolic process (GO:0009071),0.25137216916211796,0.4909824798062716,0.9779411764705882,0.9928847768198383,1.0,2/10,17.04%,THNSL2;CBS
prerank,RNA biosynthetic process (GO:0032774),-0.14783944807567598,-0.48893608831928836,0.9925925925925926,0.9961883140470413,1.0,7/31,22.09%,TBP;TAF13;POLA1;POLA2;PRIM1;TERT;TAF7
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.18239836096523113,-0.4870472970296961,0.989010989010989,0.9946849050371306,1.0,2/13,12.27%,SPRED2;ATM
prerank,homocysteine metabolic process (GO:0050667),0.24482524244595288,0.4853629994700029,0.9765739385065886,0.9941934722024557,1.0,2/11,17.04%,MMUT;CBS
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.2246493712927276,0.4847864373252444,0.975,0.9940599155206274,1.0,1/18,4.60%,SEL1L
prerank,regulation of histone deacetylation (GO:0031063),0.23084520949708381,0.4790017168515408,0.9702970297029703,0.9953101234171254,1.0,6/13,29.56%,AKAP8L;ZBTB7B;CTBP1;SPHK2;PRMT6;SAP30BP
prerank,nucleic acid-templated transcription (GO:0097659),0.19762225912075168,0.47408522944459336,0.9867403314917127,0.9962680088948962,1.0,11/42,26.57%,MEF2A;MMS19;POLR2L;CREBL2;FUBP3;POLR2E;POLR3A;PAX8;PWP1;XAB2;PTMA
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.2127740998256653,0.47385255801153686,0.9823529411764705,0.9960178002904173,1.0,1/28,2.55%,LFNG
prerank,positive regulation of mitochondrial translation (GO:0070131),0.23262053429920904,0.4734995947020599,0.9797843665768194,0.9957907083035574,1.0,2/14,14.06%,FASTKD3;RCC1L
prerank,nucleoside phosphate catabolic process (GO:1901292),0.23342647924230922,0.473354605766794,0.9823848238482384,0.9955091288097759,1.0,4/13,25.54%,ENTPD1;ENTPD2;ENTPD3;ITPA
prerank,negative regulation of transferase activity (GO:0051348),0.2099212187139335,0.4708756387558293,0.9873708381171068,0.99579745339743,1.0,7/28,22.09%,TP53;PRDX3;SRC;GSK3A;INPP5K;GSK3B;ERCC4
prerank,protein alkylation (GO:0008213),0.21562607935967626,0.470616333959868,0.9771908763505402,0.9955460935301732,1.0,3/22,13.49%,GSPT1;PRMT3;ETFBKMT
prerank,bile acid metabolic process (GO:0008206),0.20594814627330824,0.4697139755986959,0.9871944121071012,0.9954331162927579,1.0,7/27,23.62%,NPC1;OSBP;GBA2;OSBPL7;ACOT8;CYP27A1;OSBPL3
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.15555566864113735,-0.46819678812745075,1.0,0.9954657685168741,1.0,5/20,26.60%,AKAP13;RAPGEF2;DRD2;PDE4D;ADRB2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.21997594090172118,0.4600929807698872,0.9866666666666667,0.997204373510324,1.0,4/16,21.38%,ADIPOR1;FOXK1;PRKN;SCARB2
prerank,regulation of response to stress (GO:0080134),0.2371250394055526,0.4594288211400185,0.9883381924198251,0.9970189717309752,1.0,2/10,18.68%,ADCY8;CORO2B
prerank,regulation of spindle assembly (GO:0090169),0.2029962914279952,0.4592008905771614,0.9890377588306942,0.9967562511115452,1.0,5/25,19.56%,RNF4;TPR;DYNC1H1;PDCD6IP;SENP6
prerank,lipid droplet organization (GO:0034389),0.20707655128410052,0.459076830163609,0.9876543209876543,0.9964643441687827,1.0,1/22,5.85%,CDS2
prerank,response to light stimulus (GO:0009416),0.18701319182830933,0.4589886446936039,0.9936507936507937,0.9961752005513521,1.0,6/55,15.92%,USF1;CIRBP;UVSSA;UBE4B;ERCC5;ERCC6
prerank,engulfment of apoptotic cell (GO:0043652),0.22220007246616894,0.45602451741145694,0.9728682170542635,0.9964368022392637,1.0,4/15,22.43%,THBS1;MEGF10;XKR4;RHOG
prerank,peptidyl-methionine modification (GO:0018206),0.22827934031577424,0.44921655140809674,0.9928774928774928,0.9973739818218766,1.0,3/12,20.88%,METAP2;NAA15;NAA25
prerank,proteoglycan biosynthetic process (GO:0030166),0.19460756964584247,0.4472767312635105,0.9875,0.9974034225229144,1.0,12/31,29.27%,XYLT1;EXTL3;B4GALT7;PXYLP1;B3GAT2;IGF1;EXT2;CHST11;BMPR1B;CHST9;HS3ST3B1;CHST12
prerank,regulation of mitochondrial translation (GO:0070129),0.2049280632023094,0.4463420275688349,0.9900249376558603,0.9972518583048554,1.0,4/21,21.72%,FASTKD3;RCC1L;MTG2;RPUSD4
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.22142971631033675,0.4460609051678259,0.9855263157894737,0.9969825597983588,1.0,5/14,23.78%,PNP;NMNAT3;AK8;AK5;AK1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.2278336721243779,0.4434897213123473,0.9790104947526237,0.9970780724162835,1.0,1/10,8.24%,DGKD
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.2106999740413229,0.44165173818626674,0.9848066298342542,0.9970718563226365,1.0,2/15,14.31%,CCT8;CCT5
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.19106157975778731,0.4413927730145037,0.9976580796252927,0.9968006165400471,1.0,10/29,26.46%,PTGES3;HSP90AA1;TINF2;TERF2;TELO2;TERF2IP;PPIA;RPA1;HSP90AB1;ANKRD28
prerank,regulation of phosphate metabolic process (GO:0019220),0.2088968220797609,0.437768474270829,0.9893048128342246,0.9970613650485827,1.0,3/16,18.74%,SMG7;PGAM1;TIGAR
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.20517986292302004,0.43608149506246235,0.9869109947643979,0.9969982663040248,1.0,2/18,14.19%,LIG3;POLD3
prerank,regulation of DNA recombination (GO:0000018),0.18696297201864107,0.4288821191735895,0.9988713318284425,0.9976839124738585,1.0,8/32,22.68%,SETD2;SMARCAD1;KPNA1;PPP4C;PPP4R2;SHLD2;SPIDR;TERF2IP
prerank,epithelial cell morphogenesis (GO:0003382),0.20152044582752066,0.42868175637243044,0.9860759493670886,0.9973999717033448,1.0,3/17,21.68%,SIPA1L3;COL22A1;COL15A1
prerank,mitotic cytokinetic process (GO:1902410),0.19524653725050875,0.4249036365438543,0.9948979591836735,0.9975805648072698,1.0,5/20,24.65%,CNTROB;PDCD6IP;RHOA;MITD1;CHMP1A
prerank,telomere maintenance via telomerase (GO:0007004),0.17880824449243318,0.41264127081839447,0.9976470588235294,0.9986332850259547,1.0,9/28,26.46%,PTGES3;HSP90AA1;TINF2;TERF2;TELO2;TERF2IP;RPA1;HSP90AB1;ANKRD28
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.2164825508410746,0.4125886739072393,0.9929478138222849,0.9983236392876531,1.0,10/10,78.37%,TUT7;DIS3L2;CHFR;NEDD8;UBB;TUT4;RPS27A;UBA52;ISG15;UBC
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.17598880829003619,0.41187586488226036,0.998898678414097,0.9980854116681214,1.0,4/39,16.55%,RASL10B;HFE;SOX4;GCK
prerank,cellular response to interleukin-4 (GO:0071353),0.2058283072880703,0.4009373298842719,0.9942363112391931,0.9987630148826895,1.0,1/10,13.37%,SHPK
prerank,negative regulation of RNA splicing (GO:0033119),0.18323362047120526,0.4002203123404397,0.9987293519695044,0.9985138974913876,1.0,8/19,27.76%,PTBP2;SRSF6;SRSF10;PTBP1;RPS13;C1QBP;PCBP4;SRSF4
prerank,sphingosine metabolic process (GO:0006670),0.18711751150567246,0.39974113424558544,0.9947368421052631,0.9982405758332494,1.0,4/17,24.82%,ACER3;ASAH1;ABCA2;SPHK2
prerank,mitotic recombination (GO:0006312),0.1878048178828109,0.3877508536314085,0.9960835509138382,0.9988143167959448,1.0,4/15,21.28%,TEP1;ERCC1;RAD51D;NSMCE2
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.19287084949511765,0.3837255892630213,0.9959839357429718,0.998756973180324,1.0,5/12,27.66%,SOX9;GDNF;VEGFA;PAX8;SIX4
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.17784475527928162,0.3743623433433387,1.0,0.9989718590734419,1.0,2/18,14.67%,RAB11A;RAD51B
prerank,monosaccharide transmembrane transport (GO:0015749),0.17882707522290572,0.3729359972969939,0.9973474801061007,0.9987307487305298,1.0,16/16,82.14%,SLC2A12;SLC45A3;SLC2A7;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC2A6;SLC2A10;SLC23A1;SLC23A2;SLC2A2;SLC2A9;SLC2A8;SLC5A3;SLC50A1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.1762490584986193,0.339467348670877,0.9956268221574344,0.9995084373716888,1.0,10/10,82.39%,CDC42;ECT2;SIRT2;NEK2;CCNB1;RCC2;SPAG5;KNSTRN;RACGAP1;APC
